0000081362-21-000008.txt : 20210506 0000081362-21-000008.hdr.sgml : 20210506 20210506163035 ACCESSION NUMBER: 0000081362-21-000008 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 98 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210506 DATE AS OF CHANGE: 20210506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUAKER CHEMICAL CORP CENTRAL INDEX KEY: 0000081362 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRODUCTS OF PETROLEUM & COAL [2990] IRS NUMBER: 230993790 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12019 FILM NUMBER: 21898321 BUSINESS ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR STREET CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 6108324000 MAIL ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR ST CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 10-Q 1 kwr-2021033110q.htm QUAKER CHEMICAL CORPORATION KWR 2021 Q1 10-Q IXBRL
False 2021 --12-31 Q1 0000081362 PA 1 1 1 ☒ ☐ ☐ ☐ ☒ 0000081362 2021-01-01 2021-03-31 0000081362 us-gaap:RestrictedStockMember 2021-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0000081362 2020-01-01 2020-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-01-01 2020-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-01-01 2020-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-01-01 2020-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember 2020-01-01 2020-03-31 0000081362 2021-03-31 0000081362 2020-12-31 0000081362 us-gaap:EMEAMember 2021-03-31 0000081362 srt:AsiaPacificMember 2021-03-31 0000081362 us-gaap:EmployeeStockOptionMember 2021-03-31 0000081362 us-gaap:EMEAMember 2020-12-31 0000081362 srt:AsiaPacificMember 2020-12-31 0000081362 us-gaap:CommonStockMember 2020-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000081362 us-gaap:RetainedEarningsMember 2020-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-03-31 0000081362 2020-03-31 0000081362 us-gaap:CommonStockMember 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-03-31 0000081362 us-gaap:CommonStockMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 2019-12-31 0000081362 us-gaap:CustomerListsMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:AssetsTotalMember 2021-01-01 2021-03-31 0000081362 us-gaap:InterestRateSwapMember 2021-03-31 0000081362 us-gaap:InterestExpenseMember 2020-01-01 2020-03-31 0000081362 us-gaap:InterestExpenseMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember 2021-01-01 2021-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember 2020-01-01 2020-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000081362 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0000081362 kwr:DefinedbenefitplansettlementMember 2020-07-01 2020-09-30 0000081362 2021-04-30 0000081362 srt:AmericasMember 2020-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2021-03-31 0000081362 srt:AmericasMember 2021-03-31 0000081362 kwr:TrademarksFomrulationsAndProductTechnologyMember 2020-12-31 0000081362 us-gaap:InterestExpenseMember us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0000081362 kwr:DebtinstrumentidrbMember 2020-12-31 0000081362 kwr:DebtinstrumentidrbMember 2021-03-31 0000081362 us-gaap:CustomerListsMember 2021-03-31 0000081362 kwr:TrademarksFomrulationsAndProductTechnologyMember 2021-03-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2021-03-31 0000081362 kwr:ArgentinaSubsidiaryMember 2020-01-01 2020-03-31 0000081362 kwr:ArgentinaSubsidiaryMember 2021-01-01 2021-03-31 0000081362 kwr:TinplatingsolutionsMember 2021-01-01 2021-03-31 0000081362 kwr:TinplatingsolutionsMember 2021-03-31 0000081362 us-gaap:CustomerListsMember kwr:TinplatingsolutionsMember 2021-03-31 0000081362 kwr:TinplatingsolutionsMember kwr:ProducttechnologyMember 2021-03-31 0000081362 kwr:TinplatingsolutionsMember kwr:LicensedtrademarkMember 2021-03-31 0000081362 us-gaap:CustomerListsMember kwr:TinplatingsolutionsMember 2021-01-01 2021-03-31 0000081362 kwr:TinplatingsolutionsMember kwr:ProducttechnologyMember 2021-01-01 2021-03-31 0000081362 kwr:TinplatingsolutionsMember kwr:LicensedtrademarkMember 2021-01-01 2021-03-31 0000081362 kwr:GrindaixgmbhMember 2021-03-31 0000081362 kwr:GrindaixgmbhMember 2021-01-01 2021-03-31 0000081362 kwr:CoralchemicalcompanyMember 2020-10-01 2020-12-31 0000081362 kwr:TelnordicMember 2020-04-01 2020-06-30 0000081362 kwr:TelnordicMember 2020-06-30 0000081362 kwr:NormanhaymemberMember 2019-10-01 2019-12-31 0000081362 kwr:NormanhaymemberMember 2020-01-01 2020-03-31 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralchemicalcompanyMember 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralchemicalcompanyMember 2020-12-22 0000081362 kwr:CoralchemicalcompanyMember 2020-12-22 0000081362 kwr:TelnordicMember 2020-01-01 2020-03-31 0000081362 us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000081362 kwr:CustomerconcentrationrisktopfivemembermemberMember 2020-01-01 2020-12-31 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 kwr:MetalworkingandOtherMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember kwr:MetalworkingandOtherMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember kwr:MetalworkingandOtherMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember kwr:MetalworkingandOtherMember 2021-01-01 2021-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-03-31 0000081362 us-gaap:TransferredOverTimeMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-03-31 0000081362 kwr:MetalsMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember kwr:MetalsMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember kwr:MetalsMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember kwr:MetalsMember 2020-01-01 2020-03-31 0000081362 kwr:MetalworkingandOtherMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember kwr:MetalworkingandOtherMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember kwr:MetalworkingandOtherMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember kwr:MetalworkingandOtherMember 2020-01-01 2020-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 us-gaap:LandMember 2021-03-31 0000081362 kwr:FacilitiesvehiclesandmachineryandequipmentMember 2021-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-03-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-01-01 2020-03-31 0000081362 kwr:PerformanceincentivestockunitsMember 2020-01-01 2020-03-31 0000081362 kwr:RestrictedStockGaipPlanMember 2020-01-01 2020-03-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:PerformanceincentivestockunitsMember 2021-01-01 2021-03-31 0000081362 kwr:RestrictedStockGaipPlanMember 2021-01-01 2021-03-31 0000081362 kwr:CombinationandotheracquisitionrelatedMember 2021-01-01 2021-03-31 0000081362 kwr:CombinationandotheracquisitionrelatedMember 2020-01-01 2020-03-31 0000081362 kwr:DefinedContributionPlanMember 2021-01-01 2021-03-31 0000081362 kwr:PerformanceincentivestockunitsMember 2021-03-31 0000081362 kwr:OtherEnvironmentalMattersMember 2020-12-31 0000081362 kwr:OtherEnvironmentalMattersMember 2021-03-31 0000081362 kwr:ForeignconsumptiontaxmemberMember 2021-03-31 0000081362 srt:MaximumMember kwr:ForeignconsumptiontaxmemberMember 2021-03-31 0000081362 srt:MinimumMember kwr:ForeignconsumptiontaxmemberMember 2021-03-31 0000081362 kwr:ForeignconsumptiontaxmemberMember 2021-01-01 2021-03-31 0000081362 us-gaap:InterestRateSwapMember 2021-01-01 2021-03-31 0000081362 us-gaap:InterestRateSwapMember 2020-01-01 2020-03-31 0000081362 2020-01-01 2020-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2020-12-31 0000081362 us-gaap:InterestRateSwapMember 2020-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2021-03-31 0000081362 us-gaap:FairValueInputsLevel1Member 2021-03-31 0000081362 us-gaap:FairValueInputsLevel2Member 2021-03-31 0000081362 us-gaap:FairValueInputsLevel3Member 2021-03-31 0000081362 us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000081362 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000081362 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000081362 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2020-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2021-03-31 0000081362 us-gaap:DomesticLineOfCreditMember 2021-03-31 0000081362 us-gaap:ForeignLineOfCreditMember 2021-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-03-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-03-31 0000081362 us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2021-01-01 2021-03-31 0000081362 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2021-01-01 2021-03-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2021-01-01 2021-03-31 0000081362 us-gaap:DebtMember 2021-01-01 2021-03-31 0000081362 us-gaap:DebtMember 2021-03-31 0000081362 us-gaap:SalesRevenueNetMember 2021-01-01 2021-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:IT 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:BR 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:NL 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:CN 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:MX 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:ES 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:DE 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:GB 2021-01-01 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:CA 2021-01-01 2021-03-31 0000081362 us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-03-31 0000081362 us-gaap:CommonStockMember us-gaap:ChangeInAccountingPrincipleIndirectEffectMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember us-gaap:ChangeInAccountingPrincipleIndirectEffectMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember us-gaap:ChangeInAccountingPrincipleIndirectEffectMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember us-gaap:ChangeInAccountingPrincipleIndirectEffectMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember us-gaap:ChangeInAccountingPrincipleIndirectEffectMember 2020-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-12-31 0000081362 us-gaap:ChangeInAccountingPrincipleIndirectEffectMember 2020-12-31 0000081362 country:IT 2021-03-31 0000081362 country:DE 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:IN 2021-01-01 2021-03-31 0000081362 srt:MinimumMember kwr:AcpMember 2021-03-31 0000081362 srt:MaximumMember kwr:AcpMember 2021-03-31 0000081362 kwr:SbDeckingMember 2021-03-31 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2021-03-31 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2021-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2021-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2020-12-31 0000081362 kwr:HoughtonCombinationMember 2021-03-31 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-01-01 2020-03-31 0000081362 us-gaap:ForeignCountryMember country:IT 2021-03-31 0000081362 us-gaap:ForeignCountryMember country:ES 2021-03-31 0000081362 kwr:LegacyQuakerMember 2019-01-01 2019-03-31 iso4217:DKK iso4217:EUR iso4217:GBP iso4217:USD iso4217:ZAR xbrli:pure xbrli:shares iso4217:USD xbrli:shares dummy:People
 
 
 
 
 
 
 
 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
 
 
 
 
 
 
FORM
10-Q
 
 
 
 
 
 
☒
QUARTERLY
 
REPORT PURSUANT TO SECTION
 
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
 
OF 1934
For the quarterly period ended
March 31, 2021
 
OR
 
☐
TRANSITION REPORT PURSUANT TO
 
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
 
ACT OF 1934
For the transition period from
 
to
 
Commission file number
001-12019
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
(Exact name of Registrant as specified in its charter)
 
 
 
 
 
 
Pennsylvania
 
23-0993790
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
901 E. Hector Street
,
Conshohocken
,
Pennsylvania
 
19428 – 2380
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code:
610
-
832-4000
 
Not Applicable
Former name, former address and former fiscal year,
 
if changed since last report.
 
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $1 par value
KWR
New York Stock Exchange
 
Indicate by check mark whether the Registrant (1) has filed all reports
 
required to be filed by Section 13 or 15(d) of the Securities Exchange
 
Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
 
to file such reports), and (2) has been subject to such filing requirements
 
for the past 90
days.
 
Yes
 
☒
 
No
 
☐
 
 
Indicate by check mark whether the Registrant has submitted electronically
 
every Interactive Data File required to be submitted pursuant to Rule 405
 
of Regulation S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter
 
period that the registrant was required to submit such files).
 
Yes
 
☒
 
No
 
☐
 
 
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
 
“smaller reporting company,”
 
and “emerging growth company” in Rule 12b-2
 
of
the Exchange Act.
 
Large accelerated filer
 
☒
Accelerated filer
 
☐
Non-accelerated filer
 
☐
Smaller reporting company
☐
Emerging growth company
 
☐
 
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period
 
for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange
 
Act.
 
☐
 
 
Indicate by check mark whether the Registrant is a shell company (as defined
 
in Rule 12b-2 of the Exchange Act).
 
Yes
 
☐
 
No
 
☒
 
Indicate the number of shares outstanding of each of the issuer’s classes of common
 
stock, as of the latest practicable date.
Number of Shares of Common Stock
Outstanding on April 30, 2021
 
17,873,331
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
PART
 
I
FINANCIAL INFORMATION
 
Item 1.
 
Financial Statements (Unaudited).
 
Quaker Chemical Corporation
Condensed Consolidated Statements of Operations
(Dollars in thousands, except per share data)
 
Unaudited
Three Months Ended March 31,
2021
2020
Net sales
$
429,783
$
378,561
Cost of goods sold (excluding amortization expense -
 
See Note 14)
 
273,589
 
244,710
 
Gross profit
 
156,194
 
133,851
Selling, general and administrative expenses
 
104,310
 
98,701
Indefinite-lived intangible asset impairment
—
38,000
Restructuring and related charges
1,175
1,716
Combination, integration and other acquisition-related
 
expenses
5,815
7,878
 
Operating income (loss)
 
44,894
 
(12,444)
Other income (expense), net
 
4,687
 
(21,175)
Interest expense, net
 
(5,470)
 
(8,461)
 
Income (loss) before taxes and equity in net income of associated companies
 
44,111
 
(42,080)
Taxes on income
 
(loss) before equity in net income of associated companies
 
10,689
 
(13,070)
 
Income (loss) before equity in net income of associated companies
 
33,422
 
(29,010)
Equity in net income of associated companies
 
5,210
 
666
 
Net income (loss)
 
38,632
(28,344)
Less: Net income attributable to noncontrolling interest
17
37
 
Net income (loss) attributable to Quaker Chemical Corporation
$
38,615
$
(28,381)
Earnings per common share data:
 
 
Net income (loss) attributable to Quaker Chemical Corporation
 
common
shareholders – basic
$
2.16
$
(1.60)
Net income (loss) attributable to Quaker Chemical Corporation
 
common
 
shareholders – diluted
$
2.15
$
(1.60)
Dividends declared
$
0.395
$
0.385
 
The accompanying notes are an integral
 
part of these condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3
Quaker Chemical Corporation
Condensed Consolidated Statements of Comprehensive
 
Income
(Dollars in thousands)
 
 
 
Unaudited
Three Months Ended March 31,
 
2021
2020
Net income (loss)
$
38,632
$
(28,344)
Other comprehensive (loss) income, net of tax
Currency translation adjustments
(25,461)
(54,751)
Defined benefit retirement plans
1,292
16,957
Current period change in fair value of derivatives
562
(3,981)
Unrealized loss on available-for-sale securities
(3,025)
(1,711)
Other comprehensive loss
(26,632)
(43,486)
 
Comprehensive income (loss)
12,000
(71,830)
Less: Comprehensive (income) loss attributable to noncontrolling
 
interest
(15)
95
Comprehensive income (loss) attributable to Quaker Chemical Corporation
$
11,985
$
(71,735)
 
The accompanying notes are an integral
 
part of these condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4
Quaker Chemical Corporation
Condensed Consolidated Balance Sheets
(Dollars in thousands, except par value and share amounts)
 
 
 
Unaudited
March 31,
 
December 31,
2021
2020
ASSETS
 
 
 
 
Current assets
 
 
 
 
Cash and cash equivalents
$
163,455
$
181,833
Accounts receivable, net
 
411,523
 
372,974
Inventories
Raw materials and supplies
97,631
86,148
Work-in-process
 
and finished goods
110,147
101,616
Prepaid expenses and other current assets
 
48,285
 
50,156
Total current
 
assets
 
831,041
 
792,727
Property, plant and
 
equipment, at cost
416,514
423,253
Less accumulated depreciation
(220,724)
(219,370)
Property, plant and
 
equipment, net
 
195,790
 
203,883
Right of use lease assets
38,027
38,507
Goodwill
 
627,574
 
631,212
Other intangible assets, net
 
1,075,343
 
1,081,358
Investments in associated companies
 
96,213
 
95,785
Deferred tax assets
 
17,057
 
16,566
Other non-current assets
 
31,906
 
31,796
Total assets
$
2,912,951
$
2,891,834
 
 
 
LIABILITIES AND EQUITY
 
 
Current liabilities
 
 
Short-term borrowings and current portion of long-term debt
$
43,330
$
38,967
Accounts and other payables
 
214,015
 
198,872
Accrued compensation
 
29,091
 
43,300
Accrued restructuring
5,970
8,248
Other current liabilities
 
104,029
 
93,573
Total current
 
liabilities
 
396,435
 
382,960
Long-term debt
 
859,433
 
849,068
Long-term lease liabilities
27,050
27,070
Deferred tax liabilities
 
186,031
 
192,763
Other non-current liabilities
 
114,549
 
119,059
Total liabilities
 
1,583,498
 
1,570,920
Commitments and contingencies (Note 19)
Equity
 
 
Common stock, $
1
 
par value; authorized
30,000,000
 
shares; issued and
 
 
outstanding 2021 –
17,875,076
 
shares; 2020 –
17,850,616
 
shares
17,875
17,851
Capital in excess of par value
 
908,748
 
905,171
Retained earnings
 
455,493
 
423,940
Accumulated other comprehensive loss
 
(53,228)
 
(26,598)
Total Quaker
 
shareholders’ equity
 
1,328,888
 
1,320,364
Noncontrolling interest
 
565
550
Total equity
1,329,453
1,320,914
Total liabilities and
 
equity
$
2,912,951
$
2,891,834
 
The accompanying notes are an integral
 
part of these condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5
Quaker Chemical Corporation
Condensed Consolidated Statements of Cash Flows
(Dollars in thousands)
 
Unaudited
Three Months Ended March 31,
 
2021
2020
Cash flows from operating activities
 
 
 
 
 
Net income (loss)
 
$
38,632
$
(28,344)
Adjustments to reconcile net income (loss) to net cash (used
 
in) provided by operating
activities:
 
 
Amortization of debt issuance costs
1,187
1,187
Depreciation and amortization
 
22,145
 
21,197
Equity in undistributed earnings of associated companies,
 
net of dividends
 
(5,105)
 
4,285
Acquisition-related fair value adjustments related to inventory
801
—
Deferred compensation, deferred taxes and other,
 
net
(9,888)
(22,988)
Share-based compensation
 
3,779
 
4,682
Gain on disposal of property,
 
plant, equipment and other assets
 
(5,410)
 
(2)
Insurance settlement realized
 
—
 
(229)
Indefinite-lived intangible asset impairment
—
38,000
Combination and other acquisition-related expenses, net
 
of payments
(2,884)
(519)
Restructuring and related charges
1,175
1,716
Pension and other postretirement benefits
 
(1,034)
 
22,453
(Decrease) increase in cash from changes in current assets and
 
current
 
 
liabilities, net of acquisitions:
Accounts receivable
 
(46,270)
 
2,322
Inventories
 
(24,994)
 
(10,162)
Prepaid expenses and other current assets
 
(8,315)
 
(3,263)
Change in restructuring liabilities
(3,034)
(4,841)
Accounts payable and accrued liabilities
 
26,597
 
(5,275)
 
Net cash (used in) provided by operating activities
 
(12,618)
 
20,219
Cash flows from investing activities
 
 
Investments in property,
 
plant and equipment
 
(3,934)
 
(4,892)
Payments related to acquisitions, net of cash acquired
 
(26,655)
 
(3,160)
Proceeds from disposition of assets
14,744
—
Insurance settlement interest earned
 
—
 
31
 
Net cash used in investing activities
 
(15,845)
 
(8,021)
Cash flows from financing activities
 
 
Payments of long-term debt
 
(9,551)
 
(9,371)
Borrowings on revolving credit facilities, net
30,000
205,500
Repayments on other debt, net
(188)
(185)
Dividends paid
 
(7,052)
 
(6,828)
Stock options exercised, other
 
(178)
 
(696)
Purchase of noncontrolling interest in affiliates
—
(1,047)
Distributions to noncontrolling affiliate shareholders
—
(751)
 
Net cash provided by financing activities
 
13,031
 
186,622
 
Effect of foreign exchange rate changes on
 
cash
 
(3,008)
 
(6,424)
Net (decrease) increase in cash, cash equivalents and restricted
 
cash
 
(18,440)
 
192,396
Cash, cash equivalents and restricted cash at the beginning
 
of the period
 
181,895
 
143,555
Cash, cash equivalents and restricted cash at the end of
 
the period
$
163,455
$
335,951
 
The accompanying notes are an integral
 
part of these condensed consolidated financial statements.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
6
Note 1 – Basis of Presentation and Description of Business
 
Basis of Presentation
As used in these Notes to Condensed Consolidated
 
Financial Statements, the terms “Quaker”, “Quaker Houghton”,
 
the
“Company”, “we”, and “our” refer to Quaker Chemical
 
Corporation (doing business as Quaker Houghton), its subsidiaries, and
associated companies, unless the context otherwise requires.
 
As used in these Notes to Condensed Consolidated
 
Financial Statements,
the term Legacy Quaker refers to the Company prior
 
to the closing of its combination with Houghton International,
 
Inc. (“Houghton”)
(herein referred to as the “Combination”).
 
The condensed consolidated financial statements included herein
 
are unaudited and have
been prepared in accordance with generally accepted
 
accounting principles in the United States (“U.S. GAAP”) for
 
interim financial
reporting and the United States Securities and Exchange Commission
 
(“SEC”) regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared
 
in accordance with U.S. GAAP have been condensed or
 
omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all
 
adjustments which are
necessary for a fair statement of the financial position,
 
results of operations and cash flows for the interim periods.
 
The results for the
three months ended March 31, 2021 are not necessarily
 
indicative of the results to be expected for the full year.
 
These financial
statements should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year
 
ended December 31,
2020 (the “2020 Form 10-K”).
 
Description of Business
The Company was organized in 1918, incorporated
 
as a Pennsylvania business corporation in 1930, and in August
 
2019
completed the Combination with Houghton to form
 
Quaker Houghton.
 
Quaker Houghton is a global leader in industrial process
fluids.
 
With a presence around the world,
 
including operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced
 
and specialized steel, aluminum, automotive, aerospace,
 
offshore, can, mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range
 
of formulated chemical specialty products and offers
chemical management services (which the Company refers
 
to as “Fluidcare”) for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”);
 
Asia/Pacific; and Global Specialty
Businesses.
Hyper-inflationary economies
 
Based on various indices or index compilations being
 
used to monitor inflation in Argentina as well as economic
 
instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S.
 
GAAP.
 
As a result, the Company began
applying hyper-inflationary accounting with respect
 
to the Company's wholly owned Argentine
 
subsidiary beginning July 1, 2018.
 
In
addition, Houghton has an Argentina
 
subsidiary to which hyper-inflationary accounting also is applied.
 
As of, and for the three
months ended March 31, 2021, the Company's Argentine
 
subsidiaries represented less than
1
% of the Company’s consolidated
 
total
assets and net sales, respectively.
 
During the three months ended March 31, 2021 and 2020,
 
the Company recorded $
0.2
 
million and
$
0.1
 
million, respectively, of
 
remeasurement losses associated with the applicable currency conversions
 
related to Argentina.
 
These
losses were recorded within foreign exchange (losses) gains,
 
net, which is a component of other income (expense),
 
net, in the
Company’s Condensed
 
Consolidated Statements of Operations.
COVID-19
Management continues to monitor the impact that the COVID-19
 
pandemic is having on the Company,
 
the overall specialty
chemical industry,
 
and the economies and markets in which the Company operates.
 
The full extent of the COVID-19 pandemic
related business and travel restrictions and changes to
 
business and consumer behavior intended to reduce its spread are
 
uncertain as of
the date of this Quarterly Report on Form 10-Q for the
 
period ended March 31, 2021 (the “Report”) as COVID-19
 
and the responses
of governmental authorities continue to evolve globally.
Further, management continues to
 
evaluate how COVID-19-related circumstances, such as remote
 
work arrangements, affect
financial reporting processes, internal control over financial
 
reporting, and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue
 
to present challenges, at this time, Management does not believe that
COVID-19 has had a material impact on financial reporting
 
processes, internal control over financial reporting,
 
and disclosure
controls and procedures.
The Company cannot reasonably estimate the magnitude
 
of the effects these conditions will have on the Company’s
 
operations in
the future as they are subject to significant uncertainties
 
relating to the ultimate geographic spread of the virus,
 
the incidence and
severity of the symptoms, the duration or resurgence
 
of the outbreak, the global availability and acceptance of vaccines
 
as well as their
efficacy,
 
the length of the travel restrictions and business
 
closures imposed by governments of impacted countries,
 
and the economic
response by governments of impacted countries.
To the extent
 
that the Company’s customers and
 
suppliers continue to be significantly and adversely impacted by
 
COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from
 
the Company, which in
 
turn could significantly
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
7
interrupt the Company’s
 
business operations.
 
Such impacts could grow and become more significant to the
 
Company’s operations
and the Company’s liquidity
 
or financial position.
 
Therefore, given the speed and frequency of continuously
 
evolving developments
with respect to this pandemic, the Company cannot reasonably
 
estimate the magnitude or the full extent to which COVID-19
 
may
impact the Company’s results
 
of operations, liquidity or financial position.
Note 2 – Business Acquisitions
2021 Acquisitions
In February 2021, the Company acquired a tin-plating
 
solutions business for the steel end market for approximately $
25
 
million.
 
The Company allocated $
19.6
 
million of the purchase price to intangible assets, comprised
 
of $
18.3
 
million of customer relationships,
to be amortized over
19
 
years; $
0.9
 
million of existing product technology to be amortized over
14
 
years; and $
0.4
 
million of a
licensed trademark to be amortized over
3
 
years.
 
In addition, the Company recorded $
5.0
 
million of goodwill related to expected
value not allocated to other acquired assets, all of which
 
is expected to be tax deductible.
 
As of March 31, 2021, the allocation of the
purchase price has not been finalized and the
one-year
 
measurement period has not ended.
 
Further adjustments may be necessary as a
result of the Company’s
 
on-going assessment of additional information related to the fair value
 
of assets acquired and liabilities
assumed.
Additionally, in
 
February 2021, the Company acquired a
38
% ownership interest in Grindaix-GmbH (“Grindaix”),
 
a privately
held, German-based, high-tech provider of coolant control
 
and delivery systems for approximately
1.4
 
million EUR or approximately
$
1.7
 
million.
 
Grindaix's solutions apply to a wide range of machining processes,
 
including grinding applications in the metalworking
sector.
 
The Company recorded the investment in Grindaix as an equity
 
method investment within the Condensed Consolidated
Financial Statements.
The results of operations of the acquired businesses subsequent
 
to the respective acquisition dates are included in
 
the Condensed
Consolidated Statements of Operations as of March
 
31, 2021.
 
Transaction expenses associated with these
 
acquisitions are included in
Combination, integration and other acquisition-related
 
expenses in the Company’s Condensed
 
Consolidated Statements of Operations.
 
Certain pro forma and other information is not presented,
 
as the operations of the acquired businesses are not considered material to
the overall operations of the Company for the periods presented.
 
Previous Acquisitions
In December 2020,
 
the Company completed its acquisition of Coral Chemical Company
 
(“Coral”), a privately held, U.S.-based
provider of metal finishing fluid solutions.
 
The acquisition provides technical expertise and product solutions
 
for pre-treatment,
metalworking and wastewater treatment applications
 
to the beverage cans and general industrial end markets.
 
The original purchase
price was approximately $
54.1
 
million, subject to routine and customary post-closing adjustments related
 
to working capital and net
indebtedness levels.
 
The Company anticipates finalizing its post-closing adjustments
 
for the Coral acquisition in the second quarter of
2021 and currently estimates it will receive approximately
 
$
0.4
 
million to settle such adjustments.
The following table presents the preliminary estimated fair
 
values of Coral net assets acquired:
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
—
$
958
Accounts receivable
8,473
—
8,473
Inventories
4,527
—
4,527
Prepaid expenses and other assets
181
—
181
Property, plant and
 
equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
53
2,867
Total assets purchased
57,720
205
57,925
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued
 
liabilities
3,482
—
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
(351)
53,704
Less: estimated purchase price settlement
—
(351)
(351)
Less: cash acquired
958
—
958
Net cash paid for Coral
$
53,097
$
—
$
53,097
(1) As previously disclosed in the Company’s
 
2020 Form 10-K.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
8
Measurement period adjustments recorded during the first
 
quarter of 2021 include certain adjustments related to refining
 
original
estimates for assets and liabilities for certain acquired
 
finance leases, as well the adjustment to reflect the expected
 
settlement of post-
closing working capital and net indebtedness true ups to
 
the original purchase price.
 
As of March 31, 2021,
 
the allocation of the
purchase price for Coral has not been finalized and the
one-year
 
measurement period has not ended.
 
Further adjustments may be
necessary as a result of the Company’s
 
on-going assessment of additional information related to the
 
fair value of assets acquired and
liabilities assumed.
 
In May 2020, the Company acquired Tel
 
Nordic ApS (“TEL”), a company that specializes in lubricants and engineering
 
primarily
in high pressure aluminum die casting for its Europe,
 
Middle East and Africa (“EMEA”) reportable segment.
 
Consideration
 
paid was
in the form of a convertible promissory note in the amount
 
of
20.0
 
million DKK, or approximately $
2.9
 
million, which was
subsequently converted into shares of the Company’s
 
common stock.
 
An adjustment to the purchase price of approximately
0.4
million DKK, or less than $
0.1
 
million, was made as a result of finalizing a post-closing
 
settlement in the second quarter of 2020.
 
The
Company allocated approximately $
2.4
 
million of the purchase price to intangible assets to be amortized
 
over
17
 
years.
 
In addition,
the Company recorded approximately $
0.5
 
million of goodwill, related to expected value not allocated to
 
other acquired assets, none
of which will be tax deductible.
 
As of March 31, 2021, the allocation of the purchase price
 
of TEL has not been finalized and the
one-
 
measurement period has not ended.
 
Further adjustments may be necessary as a result of the Company’s
 
on-going assessment of
additional information related to the fair value of assets acquired
 
and liabilities assumed.
In March 2020, the Company acquired the remaining
49
% ownership interest in one of its South African affiliates,
 
Quaker
Chemical South Africa Limited (“QSA”) for
16.7
 
million ZAR, or approximately $
1.0
 
million, from its joint venture partner PQ
Holdings South Africa.
 
QSA is a part of the Company’s
 
Europe, Middle East and Africa (“EMEA”) reportable segment.
 
As this
acquisition was a change in an existing controlling ownership,
 
the Company recorded $
0.7
 
million of excess purchase price over the
carrying value of the non-controlling interest in Capital
 
in excess of par value.
 
In October 2019, the Company completed its acquisition
 
of the operating divisions of Norman Hay plc (“Norman
 
Hay”), a private
U.K. company that provides specialty chemicals, operating
 
equipment, and services to industrial end markets.
 
The acquisition adds
new technologies in automotive, original equipment
 
manufacturer, and aerospace, as well as engineering
 
expertise which is expected
to strengthen the Company’s
 
existing equipment solutions platform.
 
The original purchase price was
80.0
 
million GBP,
 
on a cash-free
and debt-free basis, subject to routine and customary
 
post-closing adjustments related to working capital and
 
net indebtedness levels.
 
The Company finalized its post-closing adjustments for the
 
Norman Hay acquisition and paid approximately
2.5
 
million GBP during
the first quarter of 2020 to settle such adjustments.
 
Note 3 – Recently Issued Accounting Standards
Recently Issued Accounting Standards
 
Adopted
The Financial Accounting Standards Board (“FASB”)
 
issued Account Standards Update (“ASU”)
 
ASU 2019-12
, Income Taxes
(Topic
 
740): Simplifying the Accounting for Income Taxes
 
in December 2019 to simplify the accounting for income taxes.
 
The
guidance within this accounting standard update
 
removes certain exceptions, including the exception to the
 
incremental approach for
certain intra-period tax allocations, to the requirement
 
to recognize or not recognize certain deferred tax liabilities for
 
equity method
investments and foreign subsidiaries, and to the general
 
methodology for calculating income taxes in an interim period
 
when a year-to-
date loss exceeds the anticipated loss for the year.
 
Further, the guidance simplifies the accounting
 
related to franchise taxes, the step
up in tax basis for goodwill, current and deferred tax
 
expense, and codification improvements for income taxes related
 
to employee
stock ownership plans.
 
The guidance is effective for annual and interim
 
periods beginning after December 15, 2020.
 
The Company
adopted this standard on a prospective basis, effective
 
January 1, 2021.
 
There was no cumulative effect of adoption recorded
 
within
retained earnings on January 1, 2021.
The FASB issued
 
ASU 2020-04,
Reference Rate Reform (To
 
pic 848): Facilitation of the Effects of Reference
 
Rate Reform on
Financial Reporting
 
in March 2020.
 
The FASB subsequently
 
issued ASU 2021-01,
Reference Rate Reform (Topic
 
848): Scope
 
in
January 2021 which clarified the guidance but did
 
not materially change the guidance or its applicability to
 
the Company.
 
The
amendments provide temporary optional expedients and
 
exceptions for applying U.S. GAAP to contract modifications,
 
hedging
relationships and other transactions to ease the potential
 
accounting and financial reporting burden associated with transitioning
 
away
from reference rates that are expected to be discontinued,
 
including the London Interbank Offered Rate (“LIBOR”).
 
ASU 2020-04 is
effective for the Company as of March 12,
 
2020 and generally can be applied through December 31, 2022.
 
As of March 31, 2021, the
expedients provided in ASU 2020-04 do not presently
 
impact the Company; however, the Company
 
will continue to monitor for
potential impacts on its consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
9
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments,
 
reflect the structure of the Company’s
internal organization, the method by which
 
the Company’s resources are allocated
 
and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net
 
sales and operations in
each respective region, excluding net sales and operations
 
managed globally by the Global Specialty Businesses segment, which
includes the Company’s
 
container, metal finishing, mining,
 
offshore, specialty coatings, specialty grease and
 
Norman Hay businesses.
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related cost of goods sold (“COGS”) and selling, general
 
and administrative expenses (“SG&A”).
 
Operating expenses not directly
attributable to the net sales of each respective segment
 
,
 
such as certain corporate and administrative costs, Combination,
 
integration
and other acquisition-related expenses, and Restructuring
 
and related charges,
 
are not included in segment operating earnings.
 
Other
items not specifically identified with the Company’s
 
reportable segments include interest expense, net and other
 
income (expense),
net.
The following table presents information about the performance
 
of the Company’s reportable operating
 
segments for the three
months ended March 31, 2021 and 2020:
Three Months Ended
March 31,
 
2021
2020
Net sales
 
 
 
 
 
 
Americas
$
134,871
$
129,896
EMEA
 
119,814
 
104,839
Asia/Pacific
 
96,706
 
73,552
Global Specialty Businesses
 
78,392
 
70,274
Total
 
net sales
$
429,783
$
378,561
Segment operating earnings
Americas
$
32,234
$
29,188
EMEA
25,244
18,359
Asia/Pacific
27,478
19,541
Global Specialty Businesses
 
24,169
 
20,560
Total
 
segment operating earnings
 
109,125
 
87,648
Combination, integration and other acquisition-related
 
expenses
(5,815)
(7,878)
Restructuring and related charges
(1,175)
(1,716)
Fair value step up of acquired inventory sold
(801)
—
Indefinite-lived intangible asset impairment
—
(38,000)
Non-operating and administrative expenses
 
(40,992)
 
(38,451)
Depreciation of corporate assets and amortization
 
(15,448)
 
(14,047)
Operating income (loss)
44,894
(12,444)
Other income (expense), net
4,687
(21,175)
Interest expense, net
 
(5,470)
 
(8,461)
Income (loss) before taxes and equity in net income of
 
associated companies
$
44,111
$
(42,080)
Inter-segment revenues for the three months ended
 
March 31, 2021 and 2020 were $
3.3
 
million and $
2.9
 
million for Americas,
$
8.8
 
million and $
5.5
 
million for EMEA, $
0.1
 
million and $
0.1
 
million for Asia/Pacific and $
2.0
 
million and $
1.3
 
million for Global
Specialty Businesses, respectively.
 
However, all inter-segment transactions
 
have been eliminated from each reportable operating
segment’s net sales and
 
earnings for all periods presented in the above tables.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
10
Note 5 – Net Sales and Revenue Recognition
Business Description
The Company develops, produces, and markets a broad
 
range of formulated chemical specialty products and offers
 
chemical
management services (“Fluidcare”) for various heavy
 
industrial and manufacturing applications throughout its four
 
segments.
 
A
significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services
 
made directly to manufacturers
through its own employees and its Fluidcare programs,
 
with the balance being handled through distributors and
 
agents.
As part of the Company’s
 
Fluidcare business, certain third-party product sales to customers are
 
managed by the Company.
 
Where
the Company acts as a principal, revenues are recognized
 
on a gross reporting basis at the selling price negotiated with
 
its customers.
Where the Company acts as an agent, revenue is recognized on
 
a net reporting basis at the amount of the administrative fee earned
 
by
the Company for ordering the goods.
 
The Company transferred third-party products under arrangements recognized
 
on a net reporting
basis of $
17.8
 
million and $
12.5
 
million for the three months ended March 31, 2021 and 2020,
 
respectively.
 
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020,
 
the Company’s five largest
 
customers (each composed
of multiple subsidiaries or divisions with semiautonomous
 
purchasing authority) accounted for approximately
10
% of consolidated net
sales, with its largest customer accounting
 
for approximately
3
% of consolidated net sales.
Revenue Recognition Model
The Company applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify
 
the contract with a
customer; (ii) identify the performance obligations in
 
the contract; (iii) determine the transaction price; (iv) allocate the
 
transaction
price to the performance obligations in the contract; and
 
(v) recognize revenue when, or as, the Company satisfies a performance
obligation.
 
Refer to the Company’s 2020
 
Form 10-K for additional information on the Company’s
 
revenue recognition policies,
including its practical expedients and accounting policy
 
elections.
 
Allowance for Doubtful Accounts
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company adopted, as required,
 
an accounting
standard update related to the accounting and disclosure
 
of credit losses effective January 1, 2020.
 
The Company recognizes an
allowance for credit losses, which represents the portion
 
of its trade accounts receivable that the Company does not expect
 
to collect
over the contractual life, considering past events
 
and reasonable and supportable forecasts of future economic
 
conditions.
 
The
Company’s allowance
 
for credit losses on its trade accounts receivables
 
is based on specific collectability facts and circumstances for
each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection
 
risk the Company
estimates for certain past due aging categories, and
 
also, the general risk to all outstanding accounts receivable based on historical
amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet
 
credit exposure related to its customers.
Contract Assets and Liabilities
The Company recognizes a contract asset or receivable
 
on its Condensed Consolidated Balance Sheet when the Company
performs a service or transfers a good in advance
 
of receiving consideration.
 
A receivable is the Company’s
 
right to consideration that
is unconditional and only the passage of time is required
 
before payment of that consideration is due.
 
A contract asset is the
Company’s right to consideration
 
in exchange for goods or services that the Company has transferred
 
to a customer.
 
The Company
had no material contract assets recorded on its Condensed
 
Consolidated Balance Sheets as of March 31, 2021 or December
 
31, 2020.
A contract liability is recognized when the Company
 
receives consideration, or if it has the unconditional right
 
to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration,
 
or a specified amount of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue
 
recorded for customer payments received by the Company
 
prior to the
Company satisfying the associated performance obligation.
 
Deferred revenues are presented within other current liabilities
 
in the
Company’s Condensed
 
Consolidated Balance Sheets.
 
The Company had approximately $
6.3
 
million and $
4.0
 
million of deferred
revenue as of March 31, 2021 and December 31, 2020,
 
respectively.
 
For three months ended March 31, 2021, the Company
 
satisfied
all of the associated performance obligations and recognized
 
into revenue the advance payments received and recorded
 
as of
December 31, 2020.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
11
Disaggregated Revenue
The following tables disaggregate the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the three months ended March 31,
 
2021 and 2020.
Three Months Ended March 31,
 
2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
46,793
$
34,274
$
49,743
 
$
130,810
Metalworking and other
88,078
85,540
46,963
220,581
134,871
119,814
96,706
351,391
Global Specialty Businesses
45,256
20,272
12,864
78,392
$
180,127
$
140,086
$
109,570
$
429,783
Timing of Revenue Recognized
Product sales at a point in time
$
171,594
$
131,162
$
106,399
 
$
409,155
Services transferred over time
8,533
8,924
3,171
20,628
$
180,127
$
140,086
$
109,570
$
429,783
 
Three Months Ended March 31,
 
2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
46,673
$
29,888
$
41,589
 
$
118,150
Metalworking and other
83,223
74,951
31,963
190,137
129,896
104,839
73,552
308,287
Global Specialty Businesses
44,231
16,605
9,438
70,274
$
174,127
$
121,444
$
82,990
$
378,561
Timing of Revenue Recognized
Product sales at a point in time
$
168,802
$
118,423
$
81,156
 
$
368,381
Services transferred over time
5,325
3,021
1,834
10,180
$
174,127
$
121,444
$
82,990
$
378,561
Note 6 - Leases
The Company determines if an arrangement is a lease
 
at its inception.
 
This determination generally depends on whether the
arrangement conveys the right to control the use of an
 
identified fixed asset explicitly or implicitly for a period of
 
time in exchange for
consideration.
 
Control of an underlying asset is conveyed if the Company
 
obtains the rights to direct the use of, and obtains
substantially all of the economic benefits from the use
 
of, the underlying asset.
 
Lease expense for variable leases and short-term
leases is recognized when the obligation is incurred.
 
The Company has operating leases for certain facilities, vehicles
 
and machinery and equipment with remaining lease terms up
 
to
10
 
years.
 
In addition, the Company has certain land use leases with remaining
 
lease terms up to
94
 
years.
 
The lease term for all of the
Company’s leases includes
 
the non-cancellable period of the lease plus any additional periods
 
covered by an option to extend the lease
that the Company is reasonably certain it will exercise.
 
Operating leases are included in right of use lease assets, other current
liabilities and long-term lease liabilities on the Condensed
 
Consolidated Balance Sheet.
 
Right of use lease assets and liabilities are
recognized at each lease’s
 
commencement date based on the present value of its lease payments
 
over its respective lease term.
 
The
Company uses the stated borrowing rate for a lease when
 
readily determinable.
 
When a stated borrowing rate is not available in a
lease agreement, the Company uses its incremental borrowing
 
rate based on information available at the lease’s
 
commencement date
to determine the present value of its lease payments.
 
In determining the incremental borrowing rate used to present
 
value each of its
leases, the Company considers certain information
 
including fully secured borrowing rates readily available to the Company
 
and its
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
12
subsidiaries.
 
The Company has immaterial finance leases, which are
 
included in property, plant
 
and equipment, current portion of
long-term debt and long-term debt on the Condensed Consolidated
 
Balance Sheet.
Operating lease expense is recognized on a straight-line
 
basis over the lease term.
 
Operating lease expense for the three months
ended March 31, 2021 and 2020 was $
3.6
 
million and $
3.4
 
million, respectively.
 
Short-term lease expense was $
0.3
 
million and $
0.5
million for the three months ended March 31, 2021
 
and 2020, respectively.
 
The Company has
no
 
material variable lease costs or
sublease income for the three months ended March 31, 2021 and
 
2020.
 
Cash paid for operating leases was $
3.6
 
million and $
3.4
million during the three months ended March 31, 2021
 
and 2020,
 
respectively.
 
The Company recorded new right of use lease assets
and associated lease liabilities of approximately $
3.1
 
million during the three months ended March 31, 2021.
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
March 31,
December 31,
2021
2020
Right of use lease assets
$
38,027
$
38,507
Other current liabilities
10,419
10,901
Long-term lease liabilities
27,050
27,070
Total operating
 
lease liabilities
$
37,469
$
37,971
Weighted average
 
remaining lease term (years)
5.9
6.0
Weighted average
 
discount rate
4.26%
4.20%
Maturities of operating lease liabilities as of March 31,
 
2021 were as follows:
March 31,
2021
For the remainder of 2021
$
9,269
For the year ended December 31, 2022
9,042
For the year ended December 31, 2023
6,932
For the year ended December 31, 2024
5,194
For the year ended December 31, 2025
4,211
For the year ended December 31, 2026 and beyond
8,116
Total lease payments
42,764
Less: imputed interest
(5,295)
Present value of lease liabilities
$
37,469
Note 7 – Restructuring and Related Activities
The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost
synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain
manufacturing and non-manufacturing facilities.
 
The exact timing and total costs associated with the QH Program
 
will depend on a
number of factors and is subject to change; however,
 
the Company currently expects reduction in headcount and
 
site closures to
continue to occur throughout 2021
 
under the QH Program and estimates that anticipated costs synergies
 
realized from the QH
Program will approximate one-times the restructuring costs
 
incurred.
 
Employee separation benefits will vary depending on local
regulations within certain foreign countries and will
 
include severance and other benefits.
 
All costs incurred to date relate to severance costs to reduce
 
headcount as well as costs to close certain facilities and are
 
recorded
in Restructuring and related charges in the
 
Company’s Condensed Statements
 
of Operations.
 
As described in Note 4 of Notes to
Condensed Consolidated Financial Statements, restructuring
 
and related charges are not included in
 
the Company’s calculation of
reportable segments’ measure of operating earnings
 
and therefore these costs are not reviewed by or recorded to
 
reportable segments.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
13
Activity in the Company’s
 
accrual for restructuring under the QH Program for the three months
 
ended March 31, 2021 is as
follows:
QH Program
Accrued restructuring as of December 31, 2020
$
8,248
Restructuring and related charges
1,175
Cash payments
(3,034)
Currency translation adjustments
(419)
Accrued restructuring as of March 31, 2021
$
5,970
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation
 
expense in its Condensed Consolidated Statements of
Operations for the three months ended March 31, 2021
 
and 2020:
Three Months Ended
March 31,
 
2021
2020
Stock options
$
308
$
432
Non-vested stock awards and restricted stock units
1,396
1,264
Non-elective and elective 401(k) matching contribution in
 
stock
1,553
—
Director stock ownership plan
203
40
Performance stock units
319
—
Annual incentive plan
—
2,946
Total share-based
 
compensation expense
$
3,779
$
4,682
Share-based compensation expense is recorded in SG&A,
 
except for $
0.3
 
million and $
0.5
 
million during the three months ended
March 31, 2021 and 2020, respectively,
 
recorded within Combination, integration and other acquisition
 
-related expenses.
 
The change
in total share-based compensation expense for the three
 
months ended March 31, 2021 includes performance stock units
 
and non-
elective 401(k) matching contributions in stock but excludes annual
 
incentive plan costs as a component of share-based compensation
beginning in 2020, each described further below.
Stock Options
During the first quarter of 2021, the Company granted
 
stock options under its long-term incentive plan (“LTIP
 
”) that are subject
only to time vesting over a three-year period.
 
For the purposes of determining the fair value of stock option awards,
 
the Company
used a Black-Scholes option pricing model and the assumptions
 
set forth in the table below:
Number of options granted
23,733
Dividend yield
0.85
%
Expected volatility
37.33
%
Risk-free interest rate
0.60
%
Expected term (years)
4.0
The fair value of these options is amortized on a straight
 
-line basis over the vesting period.
 
As of March 31, 2021, unrecognized
compensation expense related to all stock options
 
granted was $
2.8
 
million, to be recognized over a weighted average remaining
period of
2.5
 
years.
Restricted Stock Awards
 
and Restricted Stock Units
During the first quarter of 2021, the Company granted
12,610
 
nonvested restricted shares and
2,791
 
nonvested restricted stock
units under its LTIP,
 
subject to time-based vesting, generally over a three-year
 
period.
 
The fair value of these grants is based on the
trading price of the Company’s
 
common stock on the date of grant.
 
The Company adjusts the grant date fair value of these awards for
expected forfeitures based on historical experience.
 
As of March 31, 2021, unrecognized compensation expense
 
related to the
nonvested restricted shares was $
6.3
 
million, to be recognized over a weighted average remaining period
 
of
2.1
 
years, and
unrecognized compensation expense related to nonvested
 
restricted stock units was $
1.3
 
million, to be recognized over a weighted
average remaining period of
2.3
 
years.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
14
Performance Stock Units
During the first quarter of 2021,
 
the Company granted performance-dependent stock awards (“PSUs”) as
 
a component of its
LTIP,
 
which will be settled in a certain number of shares subject to market
 
-based and time-based vesting conditions.
 
The number of
fully vested shares that may ultimately be issued as settlement
 
for each award may range from
0
% up to
200
% of the target award,
subject to the achievement of the Company’s
 
total shareholder return (“TSR”) relative to the performance
 
of the Company’s peer
group, the S&P Midcap 400 Materials group.
 
The service period required for the PSUs is three years and the
 
TSR measurement
period for the PSUs is from January 1 of the year of grant
 
through December 31 of the year prior to issuance.
 
Compensation expense for PSUs
 
is measured based on their grant date fair value and
 
is recognized on a straight-line basis over
the three-year vesting period.
 
The grant-date fair value of the PSUs granted during
 
the first quarter of 2021 was estimated using a
Monte Carlo simulation on the grant date and using the
 
following assumptions: (i) a risk-free rate of
0.29
%; (ii) an expected term of
3.0
 
years; and (iii) a three-year daily historical volatility for
 
each of the companies in the peer group, including Quaker
 
Houghton.
 
As of March 31, 2021, the Company estimates that it will issue
 
approximately
28,000
 
fully vested shares as of the applicable
settlement dates of all outstanding PSU awards, based
 
on the conditions of the PSUs and performance to date for each
 
award. As of
March 31, 2021, there was approximately $
4.8
 
million of total unrecognized compensation cost related to
 
PSUs, which the Company
expects to recognize over a weighted-average period
 
of
2.5
 
years.
Annual Incentive Plan
The Company maintains an Annual Incentive Plan
 
(“AIP”), which may be settled in cash or a certain number of
 
shares subject to
performance-based and time-based vesting conditions.
 
As of March 31, 2020, it was the Company’s
 
intention to settle the 2020 AIP
in shares, and therefore, expense associated with the AIP in 2020
 
was recorded as a component of share-based compensation expense.
In the fourth quarter of 2020, the Company determined
 
that it would settle the 2020 AIP in cash.
 
Therefore, the share-based
compensation associated with the AIP during the year
 
ended December 31, 2020 was reclassified from a component
 
of share-based
compensation expense to incentive compensation.
 
This determination and conclusion had no impact on the
 
classification of AIP
expense within the Company’s
 
Condensed Consolidated Statement of Operations for
 
the periods as both are a component of SG&A.
 
As of March 31, 2021, it is the Company’s
 
intention to settle the 2021 AIP in cash.
 
Defined Contribution Plan
The Company has a 401(k) plan with an employer
 
match covering a majority of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum
 
matching contribution of
3
% of compensation.
 
Additionally, the
 
plan provides for non-elective nondiscretionary contributions
 
on behalf of participants who have completed one year
of service equal to
3
% of the eligible participants’ compensation.
 
Beginning in April 2020 and continuing until April 2021, the
Company matched both non-elective and elective 401(k)
 
contributions in fully vested shares
 
of the Company’s common
 
stock rather
than cash.
 
Total Company contributions
 
were $
1.5
 
million for the three months ended March 31, 2021.
 
There were no similar
matching contributions in stock for the three months
 
ended March 31, 2020.
 
Note 9 – Pension and Other Postretirement
 
Benefits
The components of net periodic benefit cost for the
 
three months ended March 31, 2021 and 2020 are as follows:
Three Months Ended March 31,
 
Other
Pension Benefits
Postretirement Benefits
2021
2020
2021
2020
Service cost
$
316
$
1,174
$
1
$
2
Interest cost
1,090
1,769
11
26
Expected return on plan assets
(2,082)
(1,959)
—
—
Settlement loss
—
22,667
—
—
Actuarial loss amortization
855
1,047
—
15
Prior service (credit) cost amortization
2
(40)
—
—
Total net periodic
 
benefit cost
$
181
$
24,658
$
12
$
43
As disclosed in the Company’s
 
2020 Form 10-K, in the fourth quarter of 2018, the
 
Company began the process of terminating its
legacy Quaker non-contributory U.S. pension plan
 
(“Legacy Quaker U.S. Pension Plan”).
 
During the third quarter of 2019, the
Company received a favorable termination determination
 
letter from the Internal Revenue
 
Service (“I.R.S.”) and completed the
Legacy Quaker U.S. Pension Plan termination during the
 
first quarter of 2020.
 
In order to terminate the Legacy Quaker U.S. Pension
Plan in accordance with I.R.S. and Pension Benefit Guaranty Corporation
 
requirements, the Company was required to fully fund the
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
15
Legacy Quaker U.S. Pension Plan on a termination basis
 
and the amount necessary to do so was approximately $
1.8
 
million, subject to
final true up adjustments,
 
which were completed in the third quarter of 2020.
 
In addition, the Company recorded a non-cash pension
settlement charge at plan termination of
 
approximately $
22.7
 
million.
 
This settlement charge included the immediate recognition
 
into
expense of the related unrecognized losses within accumulated
 
other comprehensive (loss) income (“AOCI”) on the balance
 
sheet as
of the plan termination date.
 
Employer Contributions
The Company previously disclosed in its 2020 Form 10-K
 
that it expected to make minimum cash contributions of $
10.0
 
million
to its U.S. and foreign pension plans and approximately
 
$
0.3
 
million to its other postretirement benefit plans in 2021.
 
As of March 31,
2021, $
1.0
 
million and $
0.1
 
million of contributions have been made to the Company’s
 
U.S. and foreign pension plans and its other
postretirement benefit plans, respectively.
 
 
Note 10 – Other Income (Expense), Net
 
The components of other income (expense), net for
 
the three months ended March 31, 2021 and 2020 are as follows:
Three Months Ended
 
March 31,
2021
2020
Income from third party license fees
$
339
$
304
Foreign exchange (losses) gains, net
(1,478)
821
Gain on disposals of property,
 
plant, equipment and other assets, net
5,410
2
Non-income tax refunds and other related credits
97
1,299
Pension and postretirement benefit costs, non-service components
124
(23,525)
Other non-operating income (expense), net
195
(76)
Total other
 
income (expense), net
$
4,687
$
(21,175)
The Gain on disposals of property,
 
plant, equipment and other assets, net, during the three months
 
ended March 31, 2021,
includes the gain on the sale of certain held-for-sale
 
real property assets related to the Combination.
 
Pension and postretirement
benefit costs, non-service components during the three
 
months ended March 31, 2020 includes $
22.7
 
million related to the Legacy
Quaker U.S. Pension Plan non-cash settlement charge
 
described in Note 9 of Notes to Condensed Consolidated Financial Statements.
Note 11 – Income Taxes
 
and Uncertain Income Tax
 
Positions
The Company’s effective
 
tax rate for the three months ended March 31, 2021 was an expense of
24.2
% compared to a benefit of
31.1
% for the three months ended March 31, 2020.
 
The Company’s effective
 
tax rate for the three months ended March 31, 2021 was
largely impacted by the sale of certain held-for-sale
 
real property assets related to the Combination.
 
Comparatively, the prior
 
year first
quarter effective tax rate was impacted by the
 
tax effect of certain one-time pre-tax losses as well as certain tax
 
charges and benefits in
the prior year period including those related to changes
 
in foreign tax credit valuation
 
allowances, tax law changes in a foreign
jurisdiction, and the tax impacts of the Company’s
 
termination of its Legacy Quaker U.S. Pension Plan and the
 
Houghton indefinite-
lived trademarks and tradename intangible asset impairment.
As of December 31, 2020, the Company had a deferred tax liability of $5.9 million, which primarily represents the Company’s
estimate of non-U.S. taxes it will incur to repatriate certain foreign earnings to the U.S. The balance as of March 31, 2021 was $6.5
million.
 
As of March 31, 2021, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
23.5
 
million, an increase of
$
1.3
 
million from the cumulative liability accrued as of December 31, 2020.
 
The Company continues to recognize interest and penalties
 
associated with uncertain tax positions as a component of
 
taxes on
income (loss) before equity in net income of associated
 
companies in its Condensed Consolidated Statements of Operations.
 
The
Company recognized an expense of less than $
0.1
 
million for interest and a benefit of less than $
0.1
 
million for penalties in its
Condensed Consolidated Statement of Operations for the
 
three months ended March 31, 2021, and recognized an expense of
 
less than
$
0.1
 
million for interest and a benefit of less than $
0.1
 
million for penalties in its Condensed Consolidated Statement of
 
Operations for
the three months ended March 31, 2020.
 
As of March 31, 2021, the Company had accrued $
3.0
 
million for cumulative interest and
$
3.6
 
million for cumulative penalties in its Condensed Consolidated Balance
 
Sheets, compared to $
3.0
 
million for cumulative interest
and $
3.9
 
million for cumulative penalties accrued at December 31, 2020.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
16
During the three months ended March 31, 2021 and
 
2020, the Company recognized decreases of $
0.3
 
million and $
0.8
 
million,
respectively, in
 
its cumulative liability for gross unrecognized tax benefits due
 
to the expiration of the applicable statutes of limitations
for certain tax years.
The Company estimates that during the year ending December
 
31, 2021 it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
1.5
 
million due to the expiration of the statute of limitations with regard
 
to certain tax
positions.
 
This estimated reduction in the cumulative liability for unrecogniz
 
ed tax benefits does not consider any increase in liability
for unrecognized tax benefits with regard to existing tax
 
positions or any increase in cumulative liability for unrecognized
 
tax benefits
with regard to new tax positions for the year ending December
 
31, 2021.
The
 
Company and its subsidiaries are subject to U.S. Federal income
 
tax, as well as the income tax of various state and foreign
tax jurisdictions.
 
Tax years that remain
 
subject to examination by major tax jurisdictions include Italy
 
from
2006
, Brazil from
2011
,
the Netherlands and China from
2015
, Mexico, Spain, Germany and the United Kingdom from
2016
, Canada and the U.S. from
2017
,
India from fiscal year beginning April 1, 2018 and ending
 
March 31,
2019
, and various U.S. state tax jurisdictions from
2011
.
 
As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia
S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under
the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except
2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP
proceedings which the Company has accepted.
 
As of March 31, 2021, the Company has received $
1.6
 
million in refunds from the
Netherlands and Spain and expects to pay $
2.4
 
million due to Italy in the second quarter of 2021.
 
As of March 31, 2021, the
Company believes it has adequate reserves for the remaining
 
uncertain tax positions related to 2007.
Houghton Italia, S.r.l
 
is also involved in a corporate income tax audit with the Italian tax
 
authorities covering tax years 2014
through 2018.
 
As of March 31, 2021, the Company has a $
5.5
 
million reserve for uncertain tax positions relating to matters related
 
to
this audit.
 
Since the reserve relates to the tax periods prior to August
 
1, 2019, the tax liability was established through purchase
accounting related to the Combination.
 
The Company has also submitted an indemnification claim against
 
funds held in escrow
 
by
Houghton’s former owners
 
and as a result, a corresponding $
5.5
 
million indemnification receivable has also been established through
purchase accounting.
Houghton Deutschland GmbH is also under audit by
 
the German tax authorities for the tax years 2015-2017.
 
Based on
preliminary audit findings, primarily related to
 
transfer pricing, the Company has recorded reserves for $
0.9
 
million as of March 31,
2021.
 
Of this amount, $
0.8
 
million relates to tax periods prior to the Combination and
 
therefore the Company has submitted an
indemnification claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding
$
0.8
 
million indemnification receivable has also been established to
 
offset the $
0.8
 
million tax liability.
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations
 
for the three months ended March 31, 2021 and 2020:
Three Months Ended
March 31,
 
2021
2020
Basic earnings (loss) per common share
 
Net income (loss) attributable to Quaker Chemical Corporation
$
38,615
$
(28,381)
Less: (income) loss allocated to participating securities
 
(154)
 
101
Net income (loss) available to common shareholders
$
 
38,461
$
(28,280)
Basic weighted average common shares outstanding
17,785,370
17,672,525
Basic earnings (loss) per common share
$
2.16
$
(1.60)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
38,615
$
(28,381)
Less: (income) loss allocated to participating securities
(154)
101
Net income (loss) available to common shareholders
$
38,461
$
(28,280)
Basic weighted average common shares outstanding
17,785,370
17,672,525
Effect of dilutive securities
70,607
—
Diluted weighted average common shares outstanding
17,855,977
17,672,525
Diluted earnings (loss) per common share
$
2.15
$
(1.60)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
17
Certain stock options and restricted stock units are not included in the diluted earnings (loss) per share calculation when the effect
would have been anti-dilutive. The calculated amount of anti-diluted shares not included was 2,083 for the three months ended March
31, 2021. All of the Company’s potentially dilutive shares for the three months ended March 31, 2020 are anti-dilutive and not
included in the dilutive loss per share calculations because of the Company’s net loss during the period.
 
Note 13 – Restricted Cash
Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary
of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an
original total value of $35.0 million. The proceeds of both settlements were restricted and could only be used to pay claims and costs
of defense associated with the subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements were deposited
into interest bearing accounts that earned less than $0.1 million offset by $0.2 million of net payments during the three months ended
March 31, 2020.
 
Due to the restricted nature of the proceeds, a corresponding
 
deferred credit was established in other non-current
liabilities for an equal and offsetting amount
 
that continued until the restrictions lapsed.
 
As disclosed in the Company’s
 
2020 Form
10-K, during December 2020, the restrictions ended
 
on these previously received insurance settlements and the
 
Company transferred
the cash into an operating account.
 
The following table provides a reconciliation of cash,
 
cash equivalents and restricted cash as of March 31, 2021 and
 
2020, as well
as December 31, 2020 and 2019:
March 31,
 
December 31,
2021
2020
2020
2019
Cash and cash equivalents
$
163,455
$
316,437
$
181,833
$
123,524
Restricted cash included in other current assets
—
34
62
353
Restricted cash included in other assets
—
19,480
—
19,678
Cash, cash equivalents and restricted cash
$
163,455
$
335,951
$
181,895
$
143,555
Note 14 – Goodwill and Other Intangible Assets
 
Changes in the carrying amount of goodwill for the
 
three months ended March 31, 2020 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
 
$
631,212
Goodwill additions
1,093
2,626
1,308
25
5,052
Currency translation adjustments
 
(731)
(3,925)
(956)
(3,078)
 
(8,690)
Balance as of March 31,
 
2021
$
213,604
$
138,863
$
158,442
$
116,665
 
$
627,574
Gross carrying amounts and accumulated amortization
 
for definite-lived intangible assets as of March 31, 2021 and
 
December 31,
2020 were as follows:
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
846,052
 
$
839,551
 
$
110,997
 
$
99,806
Trademarks, formulations and product
 
technology
 
167,144
 
 
166,448
 
 
32,533
 
 
30,483
Other
 
6,320
 
 
6,372
 
 
5,743
 
 
5,824
Total definite
 
-lived intangible assets
$
1,019,516
 
$
1,012,371
 
$
149,273
 
$
136,113
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
18
The Company amortizes definite-lived intangible assets on
 
a straight-line basis over their useful lives.
 
The Company recorded
$
14.8
 
million and $
14.0
 
million of amortization expense for the three months ended
 
March 31, 2021 and 2020, respectively.
 
Estimated annual aggregate amortization expense for
 
the current year and subsequent five years is as follows:
For the year ended December 31, 2021
$
59,372
For the year ended December 31, 2022
59,096
For the year ended December 31, 2023
58,927
For the year ended December 31, 2024
58,427
For the year ended December 31, 2025
57,710
For the year ended December 31, 2026
57,484
The Company has four indefinite-lived intangible
 
assets totaling $
205.1
 
million as of both March 31, 2021 and December 31,
2020, including $
204.0
 
million of indefinite-lived intangible assets for trademarks and
 
tradename associated with the Combination.
Goodwill and intangible assets that have indefinite lives are
 
not amortized and are required to be assessed at least annually
 
for
impairment.
 
The Company completes its annual goodwill and indefinite-lived
 
intangible asset impairment test during the fourth
quarter of each year.
 
The Company continuously evaluates if triggering events indicate
 
a possible impairment in one or more of its
reporting units or indefinite-lived or long-lived assets.
The Company previously disclosed in its 2020 Form 10-K
 
that as of March 31, 2020, the Company concluded that the
 
impact of
COVID-19 did not represent a triggering event with
 
regards to the Company’s
 
reporting units or indefinite-lived and long-lived assets,
except for the Company’s
 
Houghton and Fluidcare trademarks and tradename indefinite
 
-lived intangible assets.
 
The determination of
estimated fair value of the Houghton and Fluidcare
 
trademarks and tradename indefinite-lived assets was based on a relief
 
from
royalty valuation method,
 
which requires management’s judgment
 
and often involves the use of significant estimates and assumptions,
including assumptions with respect to the weighted average
 
cost of capital (“WACC”)
 
and royalty rates, as well as revenue growth
rates and terminal growth rates.
 
In the first quarter of 2020, as a result of the impact of
 
COVID-19 driving a decrease in projected
legacy Houghton net sales during that year and the impact
 
of the sales decline on projected future legacy Houghton
 
net sales as well as
an increase in the WACC
 
assumption utilized in the quantitative impairment
 
assessment, the Company concluded that the estimated
fair values of the Houghton and Fluidcare trademarks
 
and tradename intangible assets were less than their carrying values.
 
As a
result, an impairment charge of $
38.0
 
million was recorded in the first quarter of 2020 to write down
 
the carrying values of these
intangible assets to their estimated fair values.
As of March 31, 2021, the Company continued to evaluate
 
the on-going impact of COVID-19 on the Company’s
 
operations, and
the volatility and uncertainty in the economic outlook as a result of
 
COVID-19, to determine if this indicated it was more likely
 
than
not that the carrying value of any of the Company’s
 
reporting units or indefinite-lived or long-lived intangible assets were
 
not
recoverable.
 
The Company concluded that the impact of COVID-19 did not represent
 
a triggering event as of March 31, 2021.
 
While
the Company concluded that the impact of COVID-19
 
did not represent a triggering event as of March 31, 2021,
 
the Company will
continue to evaluate the impact of COVID-19 on the Company’s
 
current and projected results.
 
If the current economic conditions
worsen or projections of the timeline for recovery are
 
significantly extended, then the Company may conclude in the
 
future that the
impact from COVID-19 requires the need to perform
 
further interim quantitative impairment tests, which could
 
result in additional
impairment charges in the future.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
19
Note 15 – Debt
Debt as of March 31, 2021 and December 31, 2020 includes
 
the following:
As of March 31, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.61%
$
190,000
1.65%
$
160,000
U.S. Term Loan
1.61%
562,500
1.65%
570,000
EURO Term Loan
1.50%
148,210
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,377
Various
2,072
Total debt
$
913,087
$
899,134
Less: debt issuance costs
(10,324)
(11,099)
Less: short-term and current portion of long-term debts
(43,330)
(38,967)
Total long
 
-term debt
$
859,433
$
849,068
Credit facilities
The Company’s primary
 
credit facility (as amended, the “Credit Facility”) is comprised
 
of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the
 
“EURO Term Loan”
 
and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a five-year term maturing in
August 2024.
 
Subject to the consent of the administrative agent and certain
 
other conditions, the Company may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be
 
increased by up to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional
 
commitments and the Company has satisfied certain other
 
conditions.
 
Borrowings under the Credit Facility bear interest at a base
 
rate or LIBOR plus an applicable margin based upon
 
the Company’s
consolidated net leverage ratio.
 
There are LIBOR replacement provisions that contemplate a further
 
amendment if and when LIBOR
ceases to be reported.
 
The variable interest rate incurred on the outstanding borrowings under
 
the Credit Facility as of and during the
three months ended March 31, 2021 was approximately
1.6
%.
 
In addition to paying interest on outstanding principal under
 
the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s
 
consolidated net
leverage ratio to the lenders under the Revolver in
 
respect of the unutilized commitments thereunder.
 
The Company has unused
capacity under the Revolver of approximately $
204
 
million, net of bank letters of credit of approximately $
6
 
million, as of March 31,
2021.
 
The Credit Facility is subject to certain financial and
 
other covenants.
 
The Company’s initial consolidated net debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit
Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 4.00 to 1. The Company’s
consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit
Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually
exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to
consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.
 
As of March 31, 2021 and
December 31, 2020, the Company was in compliance with all of the Credit Facility covenants
.
 
The Term Loans
 
have quarterly
principal amortization during their five-year terms,
 
with
5.0
% amortization of the principal balance due in years
 
1 and 2,
7.5
% in year
3, and
10.0
% in years 4 and 5, with the remaining principal amount due at
 
maturity.
 
During the three months ended March 31, 2021,
the Company made quarterly amortization payments
 
related to the Term Loans
 
totaling $
9.6
 
million.
 
The Credit Facility is guaranteed
by certain of the Company’s
 
domestic subsidiaries and is secured by first priority liens on substantially
 
all of the assets of the
Company and the domestic subsidiary guarantors,
 
subject to certain customary exclusions.
 
The obligations of the Dutch borrower are
guaranteed only by certain foreign subsidiaries on an unsecured
 
basis.
The Credit Facility required the Company to fix its variable
 
interest rates on at least 20% of its total Term
 
Loans.
 
In order to
satisfy this requirement as well as to manage the
 
Company’s exposure to variable
 
interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three-year interest rate swaps at a base
 
rate of
1.64
% plus an applicable margin as provided in the Credit
 
Facility, based on the Company’s
 
consolidated net leverage ratio.
 
At the
time the Company entered into the swaps, and as
 
of March 31, 2021, the aggregate interest rate on the swaps,
 
including the fixed base
rate plus an applicable margin, was
3.1
%.
 
See Note 18 of Notes to Condensed Consolidated Financial Statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
20
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection
 
with executing the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s
 
Condensed Consolidated Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were
attributed to the Revolver and recorded within other assets on
 
the Company’s Condensed Consolidated
 
Balance Sheet.
 
These
capitalized costs are being amortized into interest expense
 
over the five-year term of the Credit Facility.
 
As of March 31, 2021 and
December 31, 2020, the Company had $
10.3
 
million and $
11.1
 
million, respectively,
 
of debt issuance costs recorded as a reduction of
long-term debt.
 
As of March 31, 2021 and December 31, 2020, the Company
 
had $
5.5
 
million and $
5.9
 
million, respectively,
 
of debt
issuance costs recorded within other assets.
 
Industrial development bonds
As of March 31, 2021 and December 31, 2020,
 
the Company had fixed rate, industrial development authority
 
bonds totaling
$
10.0
 
million in principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted
 
above.
Bank lines of credit and other
 
debt obligations
 
The Company has certain unsecured bank lines of credit
 
and discounting facilities in certain foreign subsidiaries, which are
 
not
collateralized.
 
The Company’s other debt
 
obligations primarily consist of certain domestic and foreign
 
low interest rate or interest-
free municipality-related loans, local credit facilities of
 
certain foreign subsidiaries and capital lease obligations.
 
Total unused
capacity under these arrangements as of March 31,
 
2021 was approximately $
40
 
million.
 
In addition to the bank letters of credit described in
 
the “Credit facilities” subsection above, the Company’s
 
only other off-balance
sheet arrangements include certain financial and other
 
guarantees.
 
The Company’s total bank
 
letters of credit and guarantees
outstanding as of March 31, 2021 were approximately
 
$
9
 
million.
The Company incurred the following debt related expenses
 
included within Interest expense, net, in the Condensed
 
Consolidated
Statements of Operations:
Three Months Ended
March 31,
 
2021
2020
Interest expense
$
4,650
$
7,712
Amortization of debt issuance costs
1,187
1,187
Total
$
5,837
$
8,899
Based on the variable interest rates associated with the Credit
 
Facility, as of March
 
31, 2021 and December 31, 2020, the amounts
at which the Company’s
 
total debt were recorded are not materially different
 
from their fair market value.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
21
Note 16 – Equity
The following tables present the changes in equity,
 
net of tax, for the three months ended March 31, 2021 and 2020:
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
38,615
—
17
38,632
Amounts reported in other comprehensive
 
loss
—
—
—
(26,630)
(2)
(26,632)
Dividends ($
0.395
 
per share)
—
—
(7,062)
—
—
(7,062)
Share issuance and equity-based
compensation plans
24
3,577
—
—
—
3,601
Balance at March 31, 2021
$
17,875
$
908,748
$
455,493
$
(53,228)
$
565
$
1,329,453
Balance at December 31, 2019
$
17,735
$
888,218
$
412,979
$
(78,170)
$
1,604
$
1,242,366
Cumulative effect of an accounting change
—
—
(402)
—
—
(402)
Balance at January 1, 2020
17,735
888,218
412,577
(78,170)
1,604
1,241,964
Net (loss) income
—
—
(28,381)
—
37
(28,344)
Amounts reported in other comprehensive
 
 
loss
—
—
—
(43,354)
(132)
(43,486)
Dividends ($
0.385
 
per share)
—
—
(6,834)
—
—
(6,834)
Acquisition of noncontrolling interest
—
(707)
—
—
(340)
(1,047)
Distributions to noncontrolling affiliate
 
shareholders
—
—
—
—
(751)
(751)
Share issuance and equity-based
compensation plans
17
1,022
—
—
—
1,039
Balance at March 31, 2020
$
17,752
$
888,533
$
377,362
$
(121,524)
$
418
$
1,162,541
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
22
The following tables show the reclassifications from and
 
resulting balances of AOCI for the three months ended
 
March 31, 2021
and 2020:
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Retirement
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
reclassifications
(25,459)
781
(745)
730
(24,693)
Amounts reclassified from AOCI
—
862
(3,085)
—
(2,223)
Current period other comprehensive (loss) income
(25,459)
1,643
(3,830)
730
(26,916)
Related tax amounts
—
(351)
805
(168)
286
Net current period other comprehensive (loss) income
(25,459)
1,292
(3,025)
562
(26,630)
Balance at March 31, 2021
$
(28,334)
$
(22,175)
$
317
$
(3,036)
$
(53,228)
Balance at December 31, 2019
$
(44,568)
$
(34,533)
$
1,251
$
(320)
$
(78,170)
Other comprehensive (loss) income before
 
reclassifications
(54,619)
828
(2,135)
(5,170)
(61,096)
Amounts reclassified from AOCI
—
24,366
(32)
—
24,334
Current period other comprehensive (loss) income
(54,619)
25,194
(2,167)
(5,170)
(36,762)
Related tax amounts
—
(8,237)
456
1,189
(6,592)
Net current period other comprehensive (loss) income
(54,619)
16,957
(1,711)
(3,981)
(43,354)
Balance at March 31, 2020
$
(99,187)
$
(17,576)
$
(460)
$
(4,301)
$
(121,524)
All reclassifications related to unrealized gain (loss) in
 
available-for-sale securities relate to the Company’s
 
equity interest in a
captive insurance company and are recorded in equity
 
in net income of associated companies.
 
The amounts reported in other
comprehensive income for non-controlling interest are
 
related to currency translation adjustments.
Note 17 – Fair Value
 
Measurements
 
The Company has valued its company-owned life insurance
 
policies at fair value.
 
These assets are subject to fair value
measurement as follows:
 
Fair Value
 
Measurements at March 31, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,015
$
—
$
2,015
$
—
Total
$
2,015
$
—
$
2,015
$
—
 
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
—
$
1,961
$
—
Total
$
1,961
$
—
$
1,961
$
—
The fair values of Company-owned life insurance assets are based
 
on quotes for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of March
 
31, 2021 or December 31, 2020, respectively,
 
so related
disclosures have not been included.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
23
Note 18 – Hedging Activities
In order to satisfy certain requirements of the Credit
 
Facility as well as to manage the Company’s
 
exposure to variable interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of three-
year interest rate swaps.
 
See Note 15 of Notes to Condensed Consolidated Financial Statements.
 
These interest rate swaps are
designated as cash flow hedges and, as such, the contracts
 
are marked-to-market at each reporting date and any unrealized gains
 
or
losses are included in AOCI to the extent effective
 
and reclassified to interest expense in the period during which the
 
transaction
effects earnings or it becomes probable that
 
the forecasted transaction will not occur.
 
The balance sheet classification and fair values of the
 
Company’s derivative instruments,
 
which are Level 2 measurements, are as
follows:
Fair Value
Condensed Consolidated
March 31,
 
December 31,
Balance Sheet Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
3,943
$
4,672
$
3,943
$
4,672
The following table presents the net unrealized loss deferred to
 
AOCI:
March 31,
 
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
3,036
$
3,598
$
3,036
$
3,598
The following table presents the net gain reclassified from
 
AOCI to earnings:
Three Months Ended
March 31,
 
2021
2020
Amount and location of (expense) income reclassified
 
 
from AOCI into (expense) income (Effective Portion)
Interest expense, net
$
(643)
$
19
Interest rate swaps are entered into with a limited number
 
of counterparties, each of which allows for net settlement
 
of all
contracts through a single payment in a single currency
 
in the event of a default on or termination of any one
 
contract.
 
As such, in
accordance with the Company’s
 
accounting policy,
 
these derivative instruments are recorded on a net basis by
 
counterparty within the
Condensed Consolidated Balance Sheets.
Note 19 – Commitments and Contingencies
The Company previously disclosed in its 2020 Form 10-K
 
that AC Products, Inc. (“ACP”), a wholly owned subsidiary,
 
has been
operating a groundwater treatment system to hydraulically
 
contain groundwater contamination emanating from ACP’s
 
site, the
principal contaminant of which is perchloroethylene.
 
As of March 31, 2021, ACP believes it is close to meeting the conditions
 
for
closure of the groundwater treatment system, but continues
 
to operate this system while in discussions with the relevant
 
authorities.
 
As of March 31, 2021, the Company believes that the range
 
of potential-known liabilities associated with the balance
 
of the ACP
water remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length
of operation of the treatment system as determined
 
by groundwater modeling.
 
Costs of operation include the operation and
maintenance of the extraction well, groundwater monitoring
 
and program management.
 
The Company previously disclosed in its 2020 Form 10-K
 
that an inactive subsidiary of the Company that was acquired
 
in 1978
sold certain products containing asbestos, primarily
 
on an installed basis, and is among the defendants in numerous
 
lawsuits alleging
injury due to exposure to asbestos.
 
During the three months ended March 31, 2021, there
 
have been no significant changes to the facts
or circumstances of this previously disclosed matter,
 
aside from on-going claims and routine payments associated with
 
this litigation.
 
Based on a continued analysis of the existing and anticipated
 
future claims against this subsidiary,
 
it is currently projected that the
subsidiary’s total liability
 
over the next 50 years for these claims is approximately
 
$
0.4
 
million (excluding costs of defense).
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
 
- Continued
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
 
24
 
The Company previously disclosed in its 2020 Form 10-K
 
that it is party to certain environmental matters related to certain
domestic and foreign properties currently or previously
 
owned by Houghton.
 
These environmental matters primarily require the
Company to perform long-term monitoring as well as operating
 
and maintenance at each of the applicable sites.
 
During the three
months ended March 31, 2021, there have been no
 
significant changes to the facts or circumstances of these previously
 
disclosed
matters, aside from on-going monitoring and maintenance
 
activities and routine payments associated with each of the
 
sites.
 
The
Company continually evaluates its obligations related to such
 
matters, and based on historical costs incurred and projected
 
costs to be
incurred over the next 28 years, has estimated the present
 
value range of costs for all of the Houghton
 
environmental matters, on a
discounted basis, to be between approximately $
5
 
million and $
6
 
million as of March 31, 2021, for which $
5.7
 
million was accrued
within other accrued liabilities and other non-current
 
liabilities on the Company’s Condensed
 
Consolidated Balance Sheet as of March
31, 2021.
 
Comparatively, as of December
 
31, 2020, the Company had $
6.0
 
million accrued for with respect to these matters.
The Company believes, although there can be no assurance
 
regarding the outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other
 
environmental problems of which it is aware.
 
Approximately $
0.1
million were accrued as of both March 31, 2021 and
 
December 31, 2020, to provide for such anticipated future
 
environmental
assessments and remediation costs.
 
The Company previously disclosed in its 2020 Form 10-K
 
that one of the Company’s subsidiaries
 
received a notice of inspection
from a taxing authority in a country where certain
 
of its subsidiaries operate which related to a non-income (indirect)
 
tax that may be
applicable to certain products the subsidiary sells.
 
To date, the Company
 
has not received any assessment from the authority related
 
to
potential liabilities that may be due from the Company’s
 
subsidiary.
 
Consequently, there is substantial uncertai
 
nty with respect to the
Company’s ultimate liability
 
with respect to this indirect tax, as the application of
 
this tax in its given market is ambiguous and
interpreted differently among other peer companies
 
and taxing authorities.
 
The Company, with assistance
 
from independent experts,
has performed an evaluation of the applicability of this
 
indirect tax to the Company’s
 
subsidiaries in this country.
 
Information
available to the Company at this time is only sufficient
 
to establish a range of probable liability,
 
and no amount within the range is
considered a better estimate than another.
 
During the three months ended March 31, 2021 and through the
 
date of this Report,
 
there
have been no significant changes to the facts or circumstances of
 
this previously disclosed matter, aside
 
from on-going discussions
between the Company and the taxing authority related
 
to this notice of inspection.
 
As of March 31, 2021, the Company has recorded a
liability of $
1.7
 
million in other accrued liabilities, which reflects the low end
 
of the range of probable indirect tax owed, including
interest and taking into account applicable statutes of limitations.
 
Because these amounts in part relate to a Houghton entity acquired
in the Combination and for periods prior to the Combination,
 
the Company has submitted an indemnification claim
 
with Houghton’s
former owners related to this potential indirect tax liability.
 
The Company recorded a receivable in other assets for approximately
$
1.1
 
million, which reflects the amount of the initial recorded liability
 
for which the Company anticipates being indemnified.
 
As
noted, the Company believes there is substantial uncertainty
 
with respect to its ultimate liability given the ambiguous
 
application of
this indirect tax.
 
At this time, the Company’s best estimate
 
of a potential range for possible assessments, including
 
additional amounts
that may be assessed under these indirect tax laws, would
 
be approximately $
0.6
 
million to $
38
 
million, which is net of approximately
$
10
 
million of estimated income tax deductions and approximately $
22
 
million of applicable rights to indemnification from
Houghton’s former owners.
The Company is party to other litigation which management
 
currently believes will not have a material adverse
 
effect on the
Company’s results of
 
operations, cash flows or financial condition.
 
In addition, the Company has an immaterial amount of contractual
purchase obligations.
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
25
 
Item 2.
 
Management’s Discussion and
 
Analysis of Financial Condition and Results of Operations
.
As used in this Report, the terms “Quaker Houghton”,
 
the “Company”, “we” and “our” refer to Quaker Chemical
 
Corporation
(doing business as Quaker Houghton),
 
its subsidiaries, and associated companies, unless the context otherwise
 
requires.
 
As used in
this Report, the term Legacy Quaker refers to the Company
 
prior to the closing of its combination with Houghton International,
 
Inc.
(“Houghton”) (herein referred to as the “Combination”)
 
on August 1, 2019.
 
Throughout the Report, all figures presented, unless
otherwise stated, reflect the results of operations of the
 
combined company for the three months ended March 31, 2021 and
 
2020.
 
Executive Summary
Quaker Houghton is a global leader in industrial process
 
fluids.
 
With a presence around the world,
 
including operations in over
25 countries, our customers include thousands of the world’s
 
most advanced and specialized steel, aluminum, automotive, aerospace,
offshore, can, mining, and metalworking
 
companies.
 
Our high-performing, innovative and sustainable solutions are
 
backed by best-
in-class technology,
 
deep process knowledge, and customized services.
 
Quaker Houghton is headquartered in Conshohocken,
Pennsylvania, located near Philadelphia in the United States.
The Company had a very strong start to 2021, delivering
 
solid first quarter results which reflect the continued COVID-19
recovery in the Company’s
 
end-markets and customer demand as well as the on-going execution
 
of integration activities and synergy
realization.
 
Specifically, net sales of $429.8
 
million in the first quarter of 2021 increased 14% compared to
 
$378.6 million in the first
quarter of 2020, primarily due to higher volumes, which
 
included additional net sales from acquisitions of 3%, and the
 
positive impact
from foreign currency translation of 3%.
 
The increase in sales volumes compared to the first quarter
 
of 2020 was primarily due to
improved end market conditions and continued market
 
share gains.
 
Additional net sales from acquisitions primarily were attributable
to Coral Chemical (“Coral”), which the Company acquired
 
in December 2020.
 
The positive net impact from foreign currency
translation was primarily due to the strengthening of the
 
euro and Chinese renminbi against the U.S. dollar quarter-over-quarter,
partially offset by the ongoing weakening
 
of the Brazilian real.
 
The Company had net income in the first quarter
 
of 2021 of $38.6
million, or $2.15 per diluted share, compared to a first
 
quarter of 2020 net loss of $28.4 million, or $1.60 per diluted
 
share.
 
The
Company’s prior year
 
first quarter net loss was primarily driven by the first quarter
 
of 2020 non-cash impairment charge of $38.0
million for certain indefinite-lived intangible assets and
 
a non-cash $22.7 million settlement charge
 
related to the termination of a U.S.
defined benefit pension plan.
 
Excluding these non-recurring items as well as costs associated
 
with the Combination and other non-
core items in each period, the Company’s
 
first quarter of 2021 non-GAAP earnings per diluted share
 
were $2.11 compared to $1.38 in
the prior year first quarter.
 
The Company’s current
 
quarter adjusted EBITDA of $77.1 million increased
 
28% compared to $60.5
million in the first quarter of 2020 primarily due to
 
the significant increase in net sales quarter over quarter and
 
incremental realized
cost synergies from the Combination as compared
 
to the first quarter of 2020.
 
The Company estimates that it realized cost synergies
associated with the Combination of approximately
 
$18 million during the first quarter of 2021 compared to
 
approximately $10 million
during the first quarter of 2020.
 
See the Non-GAAP Measures section of this Item below,
 
as well as other items discussed in the
Company’s Consolidated
 
Operations Review in the Operations section of this Item,
 
below.
The Company’s first quarter
 
of 2021 operating performance in each of its four reportable
 
segments: (i) Americas; (ii) Europe,
Middle East and Africa (“EMEA”); (iii) Asia/Pacific; and (iv)
 
Global Specialty Businesses, reflect similar drivers to that of
 
its
consolidated performance.
 
All four segments had higher net sales compared to the first quarter
 
of 2020.
 
The Company’s higher sales
volumes were driven by EMEA and Asia/Pacific, while additional
 
net sales from Coral benefited the Americas and the
 
Global
Specialty Businesses.
 
The growth in Asia/Pacific’s vol
 
umes compared to the prior year were partially due to
 
the initial impacts of
COVID-19 in China during the first quarter of 2020,
 
whereas all of the remaining segments weren’t impacted
 
as severely until the
second quarter of 2020.
 
The benefit of higher selling price and product mix positively
 
impacted most of the segments, and foreign
currency translation benefited all segments except the
 
Americas which was driven by the ongoing weakening of the Brazilian real
quarter over quarter.
 
As reported, all of the Company’s
 
segment operating earnings were higher compared to
 
the first quarter of 2020
which reflects higher current quarter net sales coupled
 
with a higher gross margin in all segments as compared
 
to the prior year first
quarter.
 
While the Company has experienced higher raw material costs
 
beginning in the fourth quarter of 2020 and
 
continuing into
2021, the higher gross margin as compared
 
to the prior year first quarter was primarily driven by the Company’s
 
continued execution
of Combination-related logistics, procurement and manufacturing
 
cost savings initiatives as well as the benefit of higher volumes
 
in
the current quarter and the related impact from fixed manufacturing
 
costs.
 
Direct Selling, general and administrative expenses
(“SG&A”) of each segment were relatively consistent with the
 
first quarter of 2020 with only Asia/Pacific up as a result of
 
the
segments strong current quarter performance compared
 
to the prior year which was negatively impacted by the
 
initial COVID-19
conditions in China.
 
In addition, the Company and all of its segments continued to
 
maintain strong cost control and benefit from
COVID-19 cost savings actions, including lower travel
 
expenses, as well as the benefits of realized cost savings associated
 
with the
Combination.
 
Additional details of each segment’s
 
operating performance are further discussed in the Company’s
 
Reportable
Segments Review, in
 
the Operations section of this Item, below.
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
26
The Company had a net operating cash outflow of $12.6
 
million in the first quarter of 2021 as compared to a net operating
 
cash
inflow of $20.2 million in the first quarter of 2020.
 
The decrease in net operating cash flow quarter-over-quarter was
 
primarily driven
by a significant change in working capital, as the
 
Company’s significant increase in
 
net sales and volumes resulted in a large increase
in accounts receivable in the first quarter of 2021.
 
The key drivers of the Company’s
 
operating cash flow and working capital are
further discussed in the Company’s
 
Liquidity and Capital Resources section of this Item,
 
below.
Overall, the Company’s
 
first quarter results were strong with sequential and prior
 
year improvement in all segments primarily due
to the continued recovery in our end-markets and customer
 
demand increases from lower levels experienced during
 
2020 as a result of
COVID-19.
 
The results in the first quarter of 2021 reflected a strong
 
quarterly growth trend across the globe beginning after the
second quarter of 2020, during which the impacts of
 
COVID-19 were most severe.
 
Also, the strong demand in the first quarter of
2021 coupled with continued market share gains and
 
the on-going execution of integration activities and synergy
 
realization helped
offset negative impacts due to the on-going
 
global uncertainty brought on by COVID-19 and other macroeconomic
 
headwinds,
including rising raw material prices and overall supply
 
chain pressures.
 
The global economic slowdown and other impacts due
 
to COVID-19 experienced by almost all companies in 2020
 
posed an
unprecedented challenge, but the Company’s
 
first quarter of 2021 results continue to demonstrate that it can
 
successfully navigate
through market downturns by responding quickly to
 
changing market conditions and delivering on the benefits it anticipated
 
from the
Combination with Houghton.
 
As the Company looks forward, it expects to experience
 
continued short-term headwinds from higher
raw material costs and supply chain pressures, with the
 
magnitude of these raw material cost increases being considerably higher
 
than
the Company previously expected due to stress on global
 
supply chains, weather related shutdowns and unexpected supplier
shutdowns.
 
However, the Company does expect
 
to achieve additional selling price increases to offset
 
these rising raw material costs,
but there will be a lag effect on our gross margin
 
as these price increases catchup to our rising raw material costs.
 
Despite these near
term headwinds, the Company continues to expect 2021
 
to result in a step change in its profitability from 2020 as the Company
completes its integration cost synergies, continues
 
to take further share in the marketplace, benefits from the projected
 
gradual
rebound in demand, and sees the positive impact of its recent
 
acquisitions.
 
On-going impact of COVID-19
The global outbreak of COVID-19 has negatively impacted
 
all locations where the Company does business.
 
Although the
Company has now operated in this COVID-19 environment
 
for a year, the full extent of the outbreak
 
and related business impacts
remain uncertain and volatile, and therefore the full
 
extent to which COVID-19 may impact the Company’s
 
future results of
operations or financial condition is uncertain.
 
This outbreak has significantly disrupted the operations of the
 
Company and those of its
suppliers and customers.
 
The Company has experienced volume declines and lower
 
net sales as compared to pre-COVID-19 levels as
a result of the outbreak, as further described in this section.
 
Management continues to monitor the impact that the COVID-19
pandemic is having on the Company,
 
the overall specialty chemical industry and the economies and
 
markets in which the Company
operates.
 
Given the speed and frequency of the continuously evolving developments
 
with respect to this pandemic, the Company
cannot, as of the date of this Report, reasonably estimate
 
the magnitude or the full extent of the impact to its future results
 
of
operations or to the ability of it or its customers to resume
 
more normal operations, even as certain restrictions are lifted.
 
The
prolonged pandemic and a resurgence
 
of the outbreak, and continued restrictions on day-to-day
 
life and business operations may result
in volume declines and lower net sales in future periods
 
as compared to pre-COVID-19 levels.
 
To the extent that
 
the Company’s
customers and suppliers continue to be significantly and
 
adversely impacted by COVID-19, this could reduce the
 
availability, or result
in delays, of materials or supplies to or from the Company
 
,
 
which in turn could significantly interrupt the Company’s
 
business
operations.
 
Given this ongoing uncertainty,
 
the Company cautions that its future results of operations could
 
be significantly adversely
impacted by COVID-19.
 
Further, management continues to
 
evaluate how COVID-19-related circumstances, such
 
as remote work
arrangements, illness or staffing shortages
 
and travel restrictions have affected financial reporting
 
processes and systems, internal
control over financial reporting, and disclosure controls and
 
procedures.
 
While the circumstances have presented and are expected
 
to
continue to present challenges, and have necessitated
 
additional time and resources to be deployed to sufficiently
 
address the
challenges brought on by the pandemic, at this time, management
 
does not believe that COVID-19 has had a material impact on
financial reporting processes, internal controls over financial
 
reporting, or disclosure controls and procedures.
 
The Company’s top
 
priority is, and especially during this pandemic remains, to protect the health
 
and safety of its employees and
customers, while working to ensure business continuity
 
to meet customers’ needs.
 
The Company continues to take steps to protect the
health and wellbeing of its people in affected
 
areas through various actions, including enabling work at home
 
where needed and
possible, and employing social distancing standards,
 
implementing travel restrictions where applicable, enhancing onsite hygiene
practices, and instituting visitation restrictions at the Company’s
 
facilities.
 
The Company has not and does not expect that it will incur
material expenses implementing these health and safety
 
policies.
 
All of the Company’s 31
 
production facilities worldwide are open
and operating and are deemed as essential businesses
 
in the jurisdictions where they are operating.
 
The Company believes that to date
it has been able to meet the needs of all its customers across
 
the globe despite the current economic challenges.
 
The Company’s first
quarter of 2021 continued the trend of gradual sequential
 
quarterly improvement which began in the second half
 
of 2020.
 
However,
demand still remains uncertain as many customers maintained
 
reduced production levels into the first quarter of 2021.
 
The Company
continues to expect that the impact from COVID-19
 
will gradually improve subject to the effective containment
 
of the virus and its
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
27
variants and successful distribution and acceptance
 
of the vaccines that have been developed.
 
However, the incidence of reported
cases of COVID-19 in several geographies where we have
 
significant operations remains high and it remains highly uncertain
 
as to
how long the global pandemic and related economic challenges
 
will last and when our customers’ businesses will recover
 
to pre-
COVID-19 levels.
 
The Company took various
 
actions to temporarily conserve cash and reduce costs during
 
and these temporary
initiatives were designed and implemented so that
 
the Company could successfully manage through the challenging COVID-19
situation while continuing to protect the health
 
of its employees, meet customers’ needs, maintain the Company’s
 
long-term
competitive advantages and above-market growth, and enable it to
 
continue to effectively integrate Houghton.
 
While the actions taken
to date to protect our workforce, to continue to serve
 
our customers with excellence and to conserve cash and
 
reduce costs, have been
effective thus far, further
 
actions to respond to the pandemic and its effects may
 
be necessary as conditions continue to evolve.
Liquidity and Capital Resources
At March 31, 2021, the Company had cash, cash equivalents
 
and restricted cash of $163.5 million.
 
Total cash, cash
 
equivalents
and restricted cash was $181.9 million at December
 
31, 2020.
 
The approximately $18.4 million decrease in cash, cash equivalents
 
and
restricted cash was the net result of $15.8 million of cash
 
used in investing activities, $12.6 million of cash used in
 
operating activities
and a $3.0 million negative impact due to the effect
 
of foreign currency translation partially offset by $13.0
 
million of cash provided
by financing activities.
Net cash flows used in operating activities were $12.6
 
million in the first three months of 2021 compared to net cash flows
provided by operating activities of $20.2 million in the
 
first three months of 2020.
 
The decrease in net operating cash flows of $32.8
million was primarily driven by a significant change in working
 
capital, as the significant increase in current quarter net
 
sales resulted
in a large increase in accounts receivable
 
in the first three months of 2021.
 
In addition, the Company had higher cash dividends
received from its associated companies in the first three
 
months of 2020, primarily due to $5.0 million received from
 
the Company’s
joint venture in Korea with no similar dividend received
 
in the first three months of 2021 related to the timing of dividends received.
Net cash flows used in investing activities were $15.8
 
million in the first three months of 2021 compared to $8.0 million
 
in the
first three months of 2020.
 
This increase in cash outflows was driven by increases in
 
higher cash payments related to acquisitions
during the three months ending March 31, 2021, including
 
$25.0 million for certain assets related to tin-plating solutions
 
primarily for
steel end markets.
 
These higher cash outflows were partially offset by
 
cash proceeds of approximately $14.7 million from the
disposition of assets, which includes the sale of certain
 
held-for-sale real property assets related to the Combination.
Net cash flows provided by financing activities were $13.0
 
million in the first three months of 2021 compared to
 
$186.6 million
in the first three months of 2020.
 
The decrease of $173.6 million in net cash flows was primarily related
 
to the prior year borrowings
of most of the available liquidity under the Company’s
 
revolving credit facility related to the economic uncertainty
 
brought on by
COVID-19.
 
In addition, the Company paid $7.1 million of cash dividends
 
during the first three months of 2021, a $0.2 million or 3%
increase in cash dividends compared to the prior year.
 
Finally, during the first three
 
months of 2020, the Company used $1.0 million
to purchase the remaining noncontrolling interest in a South
 
Africa affiliate.
 
Prior to this buyout, this South Africa affiliate made
 
a
distribution to the prior noncontrolling affiliate
 
shareholder of approximately $0.8 million in the three
 
months of 2020.
 
There were no
similar noncontrolling interest activities in the first three
 
months of 2021.
The Company’s primary
 
credit facility (the “Credit Facility”) is comprised of a $400.0
 
million multicurrency revolver (the
“Revolver”), a $600.0 million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $150.0 million (as of
August 1, 2019) Euro equivalent term loan (the “Euro
 
Term Loan” and together
 
with the U.S. Term Loan”,
 
the “Term Loans”) with
Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a five-year term maturing in August 2024.
 
Subject
to the consent of the administrative agent and certain other
 
conditions, the Company may designate additional borrowers.
 
The
maximum amount available under the Credit Facility
 
can be increased by up to $300.0 million at the Company’s
 
request if there are
lenders who agree to accept additional commitments and
 
the Company has satisfied certain other conditions.
 
Borrowings under the
Credit Facility bear interest at a base rate or LIBOR plus an
 
applicable margin based on the Company’s
 
consolidated net leverage
ratio.
 
There are LIBOR replacement provisions that contemplate a further
 
amendment if and when LIBOR ceases to be reported.
 
The
weighted average interest rate incurred on the outstanding
 
borrowings under the Credit Facility during both the first quarter of
 
2021
and as of March 31, 2021 was approximately 1.6%.
 
In addition to paying interest on outstanding principal under the
 
Credit Facility,
the Company is required to pay a commitment fee ranging
 
from 0.2% to 0.3% depending on the Company’s
 
consolidated net leverage
ratio to the lenders under the Revolver in respect
 
of the unutilized commitments thereunder.
 
The Credit Facility is subject to certain financial and
 
other covenants.
 
The Company’s initial consolidated
 
net debt to
consolidated adjusted EBITDA ratio could not exceed
 
4.25 to 1, with step downs in the permitted ratio over the
 
term of the Credit
Facility.
 
As of March 31, 2021, the consolidated net debt to consolidated
 
adjusted EBITDA ratio may not exceed 4.00 to 1.
 
The
Company’s consolidated
 
adjusted EBITDA to interest expense ratio may not be less than
 
3.0 to 1 over the term of the agreement.
 
The
Credit Facility also prohibits the payment of cash dividends
 
if the Company is in default or if the amount of the dividends
 
paid
annually exceeds the greater of $50.0 million and
 
20% of consolidated adjusted EBITDA unless the ratio of
 
consolidated net debt to
consolidated adjusted EBITDA is less than 2.0 to 1,
 
in which case there is no such limitation on amount.
 
As of March 31, 2021 and
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
28
December 31, 2020, the Company was in compliance with
 
all of the Credit Facility covenants.
 
The Term Loans
 
have quarterly
principal amortization during their five-year terms,
 
with 5.0% amortization of the principal balance due in years 1 and
 
2, 7.5% in year
3, and 10.0% in years 4 and 5, with the remaining principal
 
amount due at maturity.
 
The Credit Facility is guaranteed by certain of the
Company’s domestic subsidiaries
 
and is secured by first priority liens on substantially all of
 
the assets of the Company and the
domestic subsidiary guarantors, subject to certain customary exclusions.
 
The obligations of the Dutch borrower are guaranteed only
by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable
 
interest rates on at least 20% of its total Term
 
Loans.
 
In order to
satisfy this requirement as well as to manage the
 
Company’s exposure to variable
 
interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $170.0
 
million notional amounts of three-year interest rate swaps at a base
 
rate of
1.64% plus an applicable margin as provided
 
in the Credit Facility, based on
 
the Company’s consolidated net
 
leverage ratio.
 
At the
time the Company entered into the swaps, and as
 
of March 31, 2021, the aggregate interest rate on the swaps,
 
including the fixed base
rate plus an applicable margin, was 3.1%.
 
The Company capitalized $23.7 million of certain third-party
 
debt issuance costs in connection with executing the
 
Credit Facility.
 
Approximately $15.5 million of the capitalized costs were attributed
 
to the Term Loans and
 
recorded as a direct reduction of long-
term debt on the Company’s
 
Consolidated Balance Sheet.
 
Approximately $8.3 million of the capitalized costs were
 
attributed to the
Revolver and recorded within other assets on the Company’s
 
Condensed Consolidated Balance Sheet.
 
These capitalized costs are
being amortized into interest expense over the five-year
 
term of the Credit Facility.
 
As of March 31, 2021, the Company had Credit Facility borrowings
 
outstanding of $900.7 million.
 
As of December 31, 2020, the
Company had Credit Facility borrowings outstanding
 
of $887.1 million.
 
The Company has unused capacity under the Revolver of
approximately $204 million, net of bank letters of
 
credit of approximately $6 million, as of March 31, 2021.
 
The Company’s other
debt obligations are primarily industrial development
 
bonds, bank lines of credit and municipality-related loans, which
 
totaled $12.4
million and $12.1 million as of March 31, 2021 and
 
December 31, 2020, respectively.
 
Total unused capacity
 
under these
arrangements as of March 31, 2021 was approximately
 
$40 million.
 
The Company’s total net debt
 
as of March 31, 2021 was $749.6
million.
The Company estimates that it realized cost synergies
 
in the first quarter of 2021 of approximately $18 million compared to
approximately $10 million in the first quarter of 2020.
 
The Company continues to expect to realize Combination cost synergies
 
of
approximately $75 million in 2021 and $80 million in
 
2022.
 
The Company continues to expect to incur additional costs
 
and make
associated cash payments to integrate Quaker and Houghton
 
and continue realizing the Combination’s
 
total anticipated cost synergies.
 
The Company expects total cash payments, including
 
those pursuant to the QH Program, described below,
 
but excluding incremental
capital expenditures related to the Combination,
 
will be approximately 1.3 times its total anticipated 2022 cost
 
synergies of $80
million.
 
A significant portion of these costs were already incurred
 
in 2019, 2020 and the first quarter of 2021, but the Company
expects to continue to incur such costs throughout
 
the remainder of 2021.
 
The Company incurred $0.8 million of total Combination,
integration and other acquisition-related expenses in the
 
first quarter of 2021, which includes $0.4 million of accelerated
 
depreciation
and is net of a $5.4 million gain on the sale of certain
 
held-for-sale real property assets, described in
 
the Non-GAAP Measures section
of this Item below.
 
Comparatively, in the first
 
quarter of 2020, the Company incurred $8.3 million of
 
total Combination, integration
and other acquisition-related expenses, including $0.5
 
million of accelerated depreciation.
 
The Company had aggregate net cash
outflows of approximately $8.7 million related to the
 
Combination, integration and other acquisition-related expenses during
 
the first
three months of 2021 as compared to $8.3 million during
 
the first three months of 2020.
 
Quaker Houghton’s management
 
approved, and the Company initiated, a global restructuring
 
plan (the “QH Program”) in the
third quarter of 2019 as part of its planned cost synergies
 
associated with the Combination.
 
The QH Program includes restructuring
and associated severance costs to reduce total headcount
 
by approximately 400 people globally and plans for the closure
 
of certain
manufacturing and non-manufacturing facilities.
 
In connection with the plans for closure of certain manufacturing
 
and non-
manufacturing facilities, the Company made a decision
 
to make available for sale certain facilities during the second
 
quarter of 2020.
 
During the first quarter of 2021, certain of these facilities were
 
sold and the Company recognized a gain on disposal of $5.4 million
included within other income (expense), net on the Condensed
 
Consolidated Statement of Operations.
 
The exact timing and total
costs associated with the QH Program will depend
 
on a number of factors and is subject to change; however,
 
reductions in headcount
and site closures have continued into 2021.
 
The Company currently expects additional headcount reductions and
 
site closures to occur
into 2022 and estimates that the anticipated cost synergies
 
realized under the QH Program will approximate one-times restructuring
costs incurred.
 
The Company made cash payments related to the settlement of
 
restructuring liabilities under the QH Program during
the first three months of 2021 of approximately $1.2 million
 
compared to $4.9 million in the first three months of
 
2020.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
29
As of March 31, 2021, the Company’s
 
gross liability for uncertain tax positions, including interest and
 
penalties, was $30.0
million.
 
The Company cannot determine a reliable estimate of the
 
timing of cash flows by period related to its uncertain tax position
liability.
 
However, should the entire liability
 
be paid, the amount of the payment may be reduced by up
 
to $7.5 million as a result of
offsetting benefits in other tax jurisdictions.
 
During the fourth quarter of 2020, one of the Company’s
 
subsidiaries received a notice of
inspection from a taxing authority in a country where certain
 
of its subsidiaries operate, which relate to a non-income
 
(indirect) tax
that may be applicable to certain products the subsidiary
 
sells.
 
To date, the Company
 
has not received any assessment from the
authority related to potential liabilities that may be due
 
from the Company’s subsidiary.
 
Consequently there is substantial uncertainty
with respect to the Company’s
 
ultimate liability with respect to this indirect tax.
 
See Note 19 of Notes to Condensed Consolidated
Financial Statements in Item 1 of this Report.
The Company believes that its existing cash, anticipated
 
cash flows from operations and available additional liquidity
 
will be
sufficient to support its operating requirements
 
and fund its business objectives for at least the next twelve
 
months, including but not
limited to, payments of dividends to shareholders, costs related
 
to the Combination and integration, pension plan contributions,
 
capital
expenditures, other business opportunities (including
 
potential acquisitions) and other potential contingencies.
 
The Company’s
liquidity is affected by many factors, some
 
based on normal operations of our business and others related
 
to the impact of the
pandemic on our business and on global economic
 
conditions as well as industry uncertainties, which we cannot
 
predict.
 
We also
cannot predict economic conditions and industry downturns
 
or the timing, strength or duration of recoveries.
 
We may seek,
 
as we
believe appropriate, additional debt or equity financing
 
which would provide capital for corporate purposes, working
 
capital funding,
additional liquidity needs or to fund future growth opportunities, including
 
possible acquisitions and investments.
 
The timing and
amount of potential capital requirements cannot be
 
determined at this time and will depend on a number of factors,
 
including the
actual and projected demand for our products, specialty
 
chemical industry conditions, competitive factors, and the
 
condition of
financial markets, among others.
 
Non-GAAP Measures
The information in this Form 10-Q filing includes non-GAAP (unaudited)
 
financial information that includes EBITDA, adjusted
EBITDA, adjusted EBITDA margin, non-GAAP operating
 
income, non-GAAP operating margin, non-GAAP
 
net income and non-
GAAP earnings per diluted share.
 
The Company believes these non-GAAP financial measures provide
 
meaningful supplemental
information as they enhance a reader’s understanding
 
of the financial performance of the Company,
 
are indicative of future operating
performance of the Company,
 
and facilitate a comparison among fiscal periods, as the
 
non-GAAP financial measures exclude items
that are not considered indicative of future operating performance
 
or not considered core to the Company’s
 
operations.
 
Non-GAAP
results are presented for supplemental informational
 
purposes only and should not be considered a substitute for the
 
financial
information presented in accordance with GAAP.
 
The Company presents EBITDA which is calculated as net income
 
(loss) attributable to the Company before depreciation and
amortization, interest expense, net, and taxes on income
 
(loss) before equity in net income of associated companies.
 
The Company
also presents adjusted EBITDA which is calculated as EBITDA
 
plus or minus certain items that are not considered indicative of
 
future
operating performance or not considered core to the Company’s
 
operations.
 
In addition, the Company presents non-GAAP operating
income which is calculated as operating income (loss) plus
 
or minus certain items that are not considered indicative of future operating
performance or not considered core to the Company’s
 
operations.
 
Adjusted EBITDA margin and non-GAAP operating
 
margin are
calculated as the percentage of adjusted EBITDA and
 
non-GAAP operating income to consolidated net sales, respectively.
 
The
Company believes these non-GAAP measures provide
 
transparent and useful information and are widely used by analysts, investors,
and competitors in our industry as well as by management
 
in assessing the operating performance of the Company on
 
a consistent
basis.
Additionally, the
 
Company presents non-GAAP net income and non-GAAP earnings
 
per diluted share as additional performance
measures.
 
Non-GAAP net income is calculated as adjusted EBITDA, defined
 
above, less depreciation and amortization, interest
expense, net, and taxes on income before equity in
 
net income of associated companies, in each case adjusted,
 
as applicable, for any
depreciation, amortization, interest or tax impacts resulting
 
from the non-core items identified in the reconciliation
 
of net income
attributable to the Company to adjusted EBITDA.
 
Non-GAAP earnings per diluted share is calculated as non
 
-GAAP net income per
diluted share as accounted for under the “two-class share
 
method.”
 
The Company believes that non-GAAP net income and non-
GAAP earnings per diluted share provide transparent
 
and useful information and are widely used by analysts, investors,
 
and
competitors in our industry as well as by management in
 
assessing the operating performance of the Company on a consistent
 
basis.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
30
The following tables reconcile the Company’s
 
non-GAAP financial measures (unaudited) to their most
 
directly comparable
GAAP (unaudited) financial measures (dollars in thousands unless
 
otherwise noted
 
except per share amounts):
Non-GAAP Operating Income and Margin Reconciliations
Three Months Ended
March 31,
 
2021
2020
Operating income (loss)
 
$
44,894
$
(12,444)
Houghton combination, integration and other acquisition
 
-related expenses (a)
6,230
8,276
Restructuring and related charges (b)
1,175
1,716
Fair value step up of acquired inventory sold (c)
801
—
CEO transition costs (d)
504
—
Inactive subsidiary's non-operating litigation costs (e)
51
—
Customer bankruptcy costs (f)
—
463
Indefinite-lived intangible asset impairment (g)
—
38,000
Non-GAAP operating income
$
53,655
$
36,011
Non-GAAP operating margin (%) (m)
12.5%
9.5%
 
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and
Non-GAAP Net Income Reconciliations
Three Months Ended
March 31,
 
2021
2020
Net income (loss) attributable to Quaker Chemical Corporation
$
38,615
$
(28,381)
Depreciation and amortization (a) (l)
22,448
21,584
Interest expense, net
5,470
8,461
Taxes on income
 
(loss) before equity in net income of associated companies
10,689
(13,070)
EBITDA
$
77,222
$
(11,406)
Equity (income) loss in a captive insurance company
 
(h)
(3,080)
327
Houghton combination, integration and other acquisition
 
-related expenses (a)
427
7,803
Restructuring and related charges (b)
1,175
1,716
Fair value step up of acquired inventory sold (c)
801
—
CEO transition costs (d)
504
—
Inactive subsidiary's non-operating litigation costs (e)
51
—
Customer bankruptcy costs (f)
—
463
Indefinite-lived intangible asset impairment (g)
—
38,000
Pension and postretirement benefit costs, non-service components
 
(i)
(124)
23,525
Currency conversion impacts of hyper-inflationary economies (j)
172
51
Adjusted EBITDA
$
77,148
$
60,479
Adjusted EBITDA margin (%) (m)
18.0%
16.0%
Adjusted EBITDA
$
77,148
$
60,479
Less: Depreciation and amortization - adjusted (a)
22,033
21,111
Less: Interest expense, net
5,470
8,461
Less: Taxes on income
 
before equity in net income of associated companies - adjusted
 
(a)(n)
11,739
6,463
Non-GAAP net income
$
37,906
$
24,444
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
31
Non-GAAP Earnings per Diluted Share Reconciliations
Three Months Ended
March 31,
 
2021
2020
GAAP earnings (loss) per diluted share attributable to Quaker
 
Chemical Corporation
 
 
common shareholders
$
2.15
$
(1.60)
Equity (income) loss in a captive insurance company
 
per diluted share (h)
(0.17)
0.02
Houghton combination, integration and other acquisition
 
-related expenses per diluted share (a)
0.04
0.36
Restructuring and related charges per diluted
 
share (b)
0.05
0.07
Fair value step up of acquired inventory sold per diluted
 
share (c)
0.03
—
CEO transition costs per diluted share (d)
0.02
—
Inactive subsidiary's non-operating litigation costs per
 
diluted share (e)
0.00
 
—
Customer bankruptcy costs per diluted share (f)
—
0.02
Indefinite-lived intangible asset impairment per diluted
 
share (g)
—
1.65
Pension and postretirement benefit costs, non-service components
 
per diluted share (i)
(0.00)
0.88
Currency conversion impacts of hyper-inflationary economies per
 
diluted share (j)
0.01
0.00
 
Impact of certain discrete tax items per diluted share (k)
(0.02)
(0.02)
Non-GAAP earnings per diluted share (o)
$
2.11
$
1.38
(a)
 
Houghton combination, integration and other acquisition-related
 
expenses include certain legal, financial, and other advisory
 
and
consultant costs incurred in connection with post-closing
 
integration activities including
 
internal control readiness and
remediation.
 
These costs are not indicative of the future operating performance
 
of the Company.
 
Approximately $0.1 million for
the three months ended March 31, 2021 of these pre
 
-tax costs were considered non-deductible for
 
the purpose of determining the
Company’s effective
 
tax rate, and, therefore, taxes on income before equity
 
in net income of associated companies - adjusted
reflects the impact of these items.
 
During the three months ended March 31, 2021 and 2020,
 
the Company recorded $0.4 million
and $0.5 million, respectively,
 
of accelerated depreciation related to certain of the Company’s
 
facilities, which is included in the
caption “Houghton combination, integration and other
 
acquisition-related expenses” in the reconciliation of operating
 
income
(loss) to non-GAAP operating income and included
 
in the caption “Depreciation and amortization” in the reconciliation
 
of net
income (loss) attributable to the Company to EBITDA, but
 
excluded from the caption “Depreciation and amortization – adjusted”
in the reconciliation of adjusted EBITDA to non-GAAP net
 
income attributable to the Company.
 
During the three months ended
March 31, 2021, the Company recorded a $5.4 million gain
 
on the sale of certain held-for-sale real property
 
assets related to the
Combination which is included in the caption “Houghton,
 
combination, integration and other acquisition-related expenses” in
 
the
reconciliation of GAAP earnings (loss) per diluted
 
share attributable to Quaker Chemical Corporation common
 
shareholders to
Non-GAAP earnings per diluted share as well as the reconciliation
 
of net income (loss) attributable to Quaker Chemical
Corporation to Adjusted EBITDA and Non-GAAP net
 
income.
 
 
(b)
 
Restructuring and related charges represents
 
the costs incurred by the Company associated with the QH
 
restructuring program
which was initiated in the third quarter of 2019 as part
 
of the Company’s plan
 
to realize cost synergies associated with the
Combination.
 
These costs are not indicative of the future operating performance
 
of the Company.
 
See Note 7 of Notes to
Condensed Consolidated Financial Statements, which appears
 
in Item 1 of this Report.
 
(c)
 
Fair value step up of inventory sold relates to expenses associated
 
with selling inventory from acquired businesses which
 
was
adjusted to fair value as part of purchase accounting.
 
These increases in costs of goods sold (“COGS”) are not indicative
 
of the
future operating performance of the Company.
(d)
 
CEO transition costs represent the costs related to the
 
Company’s on-going search
 
for a new CEO in connection with the
previously announced executive transition planned for
 
the end of 2021.
 
These expenses are not indicative of the future operating
performance of the Company.
(e)
 
Inactive subsidiary’s
 
non-operating litigation costs represents the charges
 
incurred by an inactive subsidiary of the Company and
are a result of the termination of restrictions on insurance
 
settlement reserves as previously disclosed in the Company’s
 
2020
Form 10-K.
 
These charges are not indicative of the future operating
 
performance of the Company.
 
See Note 9 of Notes to
Condensed Consolidated Financial Statements, which appears
 
in Item 1 of this Report.
(f)
 
Customer bankruptcy costs represent the costs associated with
 
a specific reserve for trade accounts receivable related to
 
a
customer who filed for bankruptcy protection. These expenses
 
are not indicative of the future operating performance
 
of the
Company.
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
32
(g)
 
Indefinite-lived intangible asset impairment represents the
 
non-cash charge taken to write down the value
 
of certain indefinite-
lived intangible assets associated with the Houghton
 
Combination.
 
The Company has no prior history of goodwill or intangible
asset impairments and this charge is not indicative
 
of the future operating performance of the Company.
 
See Note 14 of Notes to
Condensed Consolidated Financial Statements, which appears
 
in Item 1 of this Report.
(h)
 
Equity (income) loss in a captive insurance company
 
represents the after-tax (income) loss attributable to the
 
Company’s interest
in Primex, Ltd. (“Primex”), a captive insurance company.
 
The Company holds a 32% investment in and has significant
 
influence
over Primex, and therefore accounts for this interest under
 
the equity method of accounting.
 
The income attributable to Primex is
not indicative of the future operating performance of the
 
Company and is not considered core to the Company’s
 
operations.
(i)
 
Pension and postretirement benefit costs, non-service components
 
represent the pre-tax, non-service component of the Company’s
pension and postretirement net periodic benefit cost in
 
each period.
 
These costs are not indicative of the future operating
performance of the Company.
 
The amount in the three months ended March 31, 2020
 
includes the $22.7 million settlement
charge for the Company’s
 
termination of the Legacy Quaker U.S. Pension Plan.
 
See Note 9 of Notes to Condensed Consolidated
Financial Statements, which appears in Item 1 of this Report.
(j)
 
Currency conversion impacts of hyper-inflationary economies represents
 
the foreign currency remeasurement impacts associated
with the Company’s affiliates
 
whose local economies are designated as hyper-inflationary
 
under U.S. GAAP.
 
During both the
three months ended March 31, 2021 and 2020,
 
the Company incurred non-deductible, pre-tax charges
 
related to the Company’s
Argentine affiliates.
 
The charges incurred related to the immediate recognition
 
of foreign currency remeasurement in the
Condensed Consolidated Statements of Operations associated with
 
these entities are not indicative of the future operating
performance of the Company.
 
See Note 1 of Notes to Condensed Consolidated Financial
 
Statements, which appears in Item 1 of
this Report.
(k)
 
The impact of certain discrete tax items includes the impact
 
of changes in certain valuation allowances recorded on
 
certain of the
Company’s foreign
 
tax credits, changes in withholding rates and the associated impact
 
on previously accrued for distributions at
certain of the Company’s
 
Asia/Pacific subsidiaries as well as the offsetting
 
impact and amortization of a deferred tax benefit the
Company recorded in the fourth quarter of 2019 related
 
to an intercompany intangible asset transfer.
(l)
 
Depreciation and amortization for the three months
 
ended March 31, 2021 and 2020 included $0.3 million and
 
$0.4 million,
respectively, of
 
amortization expense recorded within equity in net income of
 
associated companies in the Company’s
 
Condensed
Consolidated Statement of Operations, which is attributable
 
to the amortization of the fair value step up for the Company’s
 
50%
interest in a Houghton joint venture in Korea as a result
 
of required purchase accounting.
(m)
 
The Company calculates adjusted EBITDA margin
 
and non-GAAP operating margin as the percentage
 
of adjusted EBITDA and
non-GAAP operating income to consolidated net sales.
(n)
 
Taxes on income
 
before equity in net income of associated companies – adjusted
 
presents the impact of any current and deferred
income tax expense (benefit), as applicable, of
 
the reconciling items presented in the reconciliation of net income (loss)
attributable to Quaker Chemical Corporation to adjusted
 
EBITDA, and was determined utilizing the applicable rates in the taxing
jurisdictions in which these adjustments occurred, subject
 
to deductibility.
 
Houghton combination, integration and other
acquisition-related expenses described in (a) resulted in
 
incremental taxes of $0.1 million and $2.0 million during the three
months ended March 31, 2021 and 2020, respectively.
 
Restructuring and related charges described in (b) resulted
 
in incremental
taxes of $0.2 million and $0.4
 
million during the three months ended March 31, 2021
 
and 2020,
 
respectively.
 
Fair value step up
of inventory sold described in (c) resulted in incremental
 
taxes of $0.2 million during the three months ending March 31,
 
2021.
 
CEO transition expenses described in (d) resulted
 
in incremental taxes of $0.1 million during the three months ended
 
March 31,
2021.
 
Inactive subsidiary litigation described in (e) resulted in incremental
 
taxes of less than $0.1 million during the three months
ended March 31, 2021.
 
Customer bankruptcy costs described in (f) resulted in incremental
 
taxes of $0.1 million during the three
months ended March 31, 2020.
 
Indefinite-lived intangible asset impairment described in
 
(g) resulted in incremental taxes of $8.7
million during the three months ended March 31, 2020.
 
Pension and postretirement benefit costs, non-service components
described in (i) resulted in a tax benefit of less than
 
$0.1 million and incremental taxes of $7.9 million for the three
 
months ended
March 31, 2021 and 2020, respectively.
 
Tax impact of certain discrete
 
items described in (k) above resulted in a tax benefit of
$0.4 million during each of the three months ended March
 
31, 2021 and 2020.
(o)
 
The Company calculates non-GAAP earnings per diluted share
 
as non-GAAP net income attributable to the Company
 
per
weighted average diluted shares outstanding using the “two-class share
 
method” to calculate such in each given period.
Off-Balance Sheet Arrangements
The Company had no material off-balance
 
sheet items, as defined under Item 303(a)(4) of Regulation S-K as of
 
March 31, 2021.
The Company’s only
 
off-balance sheet items outstanding as of March 31,
 
2021 represented approximately $9 million of total bank
letters of credit and guarantees.
 
The bank letters of credit and guarantees are not significant to
 
the Company’s liquidity
 
or capital
resources.
 
See Note 15 of Notes to Condensed Consolidated Financial Statements
 
in Item 1 of this Report.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
33
Operations
Consolidated Operations Review – Comparison of the First Quarter
 
of 2021 with the First Quarter of 2020
Net sales were $429.8 million in the first quarter of 2021
 
compared to $378.6 million in the first quarter of 2020.
 
The net sales
increase of $51.2 million or 14% quarter-over-quarter
 
reflects a benefit from higher sales volumes of 5%, additional
 
net sales from
recent acquisitions of 3%, the positive impact from foreign
 
currency translation of 3% and increases in selling price and
 
product mix
of approximately 3%.
 
The increase in sales volumes compared to the first quarter
 
of 2020 was primarily due to improved end market
conditions and continued market share gains.
 
Additional net sales from acquisition primarily related to sales attributable
 
to Coral,
which the Company acquired in December 2020.
 
COGS were $273.6 million in the first quarter of 2021 compared
 
to $244.7 million in the first quarter of 2020.
 
The increase in
COGS of $28.9 million or 12% was driven by the associated
 
COGS on the increase in net sales as described above,
 
and, to a lesser
extent, an expense of $0.8 million associated with selling acquired
 
Coral inventory at its fair value described in the Non-GAAP
Measures section of this Item above.
 
Gross profit in the first quarter of 2021 increased $22.3
 
million or 17% from the first quarter of 2020, due primarily
 
to the
increase in net sales.
 
The Company’s reported gross margin
 
in the first quarter of 2021 was 36.3% compared to 35.4%
 
in the first
quarter of 2020.
 
The Company’s current
 
quarter gross margin includes the impact of the inventory
 
fair value step up described above.
Excluding this and other one-time increases to COGS including
 
accelerated depreciation in both periods, described in the Non-GAAP
Measures section of this Item above, the Company estimates that
 
its gross margins in the first quarters of 2021
 
and 2020 would have
been approximately 36.6% and 35.5%, respectively.
 
While the Company has experienced higher raw material costs beginning
 
in the
fourth quarter of 2020 and continuing into 2021,
 
the higher gross margin as compared to the prior year
 
first quarter was primarily
driven by the Company’s
 
continued execution of Combination-related logistics, procurement
 
and manufacturing cost savings
initiatives as well as the benefit of higher volumes in the
 
current quarter and the related impact from fixed manufacturing
 
costs.
 
SG&A in the first quarter of 2021 increased $5.6
 
million or 6% compared to the first quarter of 2020 due
 
primarily to additional
SG&A from acquisitions, increases due to foreign
 
currency translation and $0.5 million of CEO transition costs described
 
in the Non-
GAAP Measures section of this Item, above, partially
 
offset by lower travel expenses and a decrease in the
 
service component of the
Company’s pension and
 
postretirement benefits as a result of the first quarter of 2020
 
termination of its Legacy Quaker U.S. pension
plan.
 
During the first quarter of 2021 the Company incurred
 
$5.8 million of Combination, integration and other acquisition-related
expenses primarily for professional fees related to Houghton integration
 
and other acquisition-related activities.
 
Comparatively, the
Company incurred $7.9 million of expenses in the prior
 
year first quarter, primarily due
 
to various professional fees related to legal,
financial and other advisory and consultant expenses for integration
 
activities.
 
See the Non-GAAP Measures
 
section of this Item,
above.
The Company initiated a restructuring program during
 
the third quarter of 2019 as part of its global plan to realize cost
 
synergies
associated with the Combination that occurred during
 
2019 and 2020 and are expected to continue throughout 2021.
 
The Company
incurred restructuring and related charges for
 
reductions in headcount and site closures under this program of $1.2
 
million and $1.7
million during the first quarters of 2021 and 2020,
 
respectively.
 
See the Non-GAAP Measures section of this Item, above.
During the first quarter of 2020, the Company recorded
 
a $38.0 million non-cash impairment charge to write
 
down the value of
certain indefinite-lived intangible assets associated with the
 
Combination.
 
This non-cash impairment charge was related to certain
acquired Houghton trademarks and tradenames and
 
was primarily the result of the projected negative impacts of COVID-19
 
as of
March 31, 2020 on their estimated fair values.
 
There was no similar impairment charges recorded
 
during the first quarter of 2021.
Operating income in the first quarter of 2021 was
 
$44.9 million compared to an operating loss of $12.4 million
 
in the first quarter
of 2020.
 
Excluding Combination, integration and other acquisition-related
 
expenses, restructuring and related charges,
 
the indefinite-
lived intangible asset impairment charge, and
 
other expenses that are not indicative of the future operating
 
performance of the
Company described in the Non-GAAP Measures section of
 
this Item,
 
above, the Company’s current
 
quarter non-GAAP operating
income increased to $53.7 million compared to
 
$36.0 million in the prior year first quarter primarily due
 
to the increase in net sales
described above and the benefits from cost savings initiatives
 
related to the Combination.
 
The Company had other income, net, of $4.7 million
 
in the first quarter of 2021 compared to other expense, net of
 
$21.2 million
in the first quarter of 2020.
 
The quarter-over-quarter change was primarily due
 
to the first quarter of 2021 gain on the sale of certain
held-for-sale real property assets compared
 
to the first quarter of 2020 pension plan settlement charge
 
associated with the termination
of the Legacy Quaker U.S. Pension Plan.
 
See the Non-GAAP Measures section of this Item, above.
 
Partially offsetting these impacts
quarter-over-quarter were foreign currency transaction
 
losses of $1.5 million in the first quarter of 2021 compared
 
to foreign currency
transaction gains of $0.8 million in the first quarter of
 
2020.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
34
Interest expense, net,
 
decreased $3.0 million
 
compared to the first
 
quarter of 2020, due
 
to a decline in
 
interest rates in the
 
current
period over the
 
first quarter of
 
2020, as the
 
weighted average interest
 
rate incurred
 
on outstanding borrowings
 
under the Company’
 
s
credit facility was less than 2% during the first quarter
 
of 2021 compared to approximately 3% during the first quarter
 
of 2020.
The Company’s effective
 
tax rates for the first quarters of 2021 and 2020 were an expense of
 
24.2% and a benefit of 31.1%,
respectively.
 
The Company’s effective
 
tax rate for the three months ended March 31, 2021 was impacted
 
by the sale of certain held-
for-sale real property assets related to the Combination
 
as well as certain U.S. tax law changes.
 
Comparatively, the
 
prior year first
quarter effective tax rate was impacted by the
 
tax effect of certain one-time pre-tax losses as well as certain tax
 
charges and benefits in
the current period including those related to changes
 
in foreign tax credit valuation allowances, tax law changes in a foreign
jurisdiction, and the tax impacts of the Company’s
 
termination of its Legacy Quaker U.S. Pension Plan and the
 
Houghton indefinite-
lived trademarks and tradename intangible asset impairment.
 
Excluding the impact of these items as well as all other non-core
 
items
in each quarter, described in
 
the Non-GAAP Measures section of this Item, above, the Company
 
estimates that its effective tax rates
for the first quarter of 2021 and 2020 would have been
 
approximately 25% and 22%, respectively.
 
This quarter-over-quarter increase
was largely driven by the impact of higher
 
pre-tax income in the current quarter as compared to the prior year
 
quarter on certain tax
adjustments as well as increased withholding taxes on
 
expected current year repatriated earnings.
 
The Company expects continued
volatility in its effective tax rates due to several
 
factors, including the timing of tax audits and the expiration
 
of applicable statutes of
limitations as they relate to uncertain tax positions,
 
the unpredictability of the timing and amount of certain incentives in various
 
tax
jurisdictions, the treatment of certain acquisition-related
 
costs and the timing and amount of certain share-based compensation
 
-related
tax benefits, among other factors.
Equity in net income of associated companies increased $4.5 million
 
in the first quarter of 2021 compared to the first quarter of
2020, primarily due to current quarter income from
 
the Company’s interest in
 
a captive insurance company compared to losses in the
prior year first quarter.
 
See the Non-GAAP Measures section of this Item, above.
 
In addition, the Company had higher earnings
quarter-over-quarter from the Company’s
 
50% interest in its joint venture in Korea.
 
Net income attributable to noncontrolling interest was less than
 
$0.1 million in both the first quarters of 2021 and 2020.
 
Foreign exchange negatively impacted the Company’s
 
first quarter of 2021 results by approximately 1% as higher
 
foreign
exchange transaction losses quarter-over-quarter
 
were partially offset by an aggregate positive impact from
 
foreign currency
translation on earnings.
Reportable Segments Review - Comparison of the First Quarter
 
of 2021 with the First Quarter of 2020
The Company’s reportable
 
segments reflect the structure of the Company’s
 
internal organization, the method by which the
Company’s resources are
 
allocated and the manner by which the chief operating decision
 
maker of the Company assesses its
performance.
 
The Company has four reportable segments: (i) Americas;
 
(ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty
Businesses.
 
The three geographic segments are composed of the net
 
sales and operations in each respective region, excluding net
sales and operations managed globally by the Global
 
Specialty Businesses segment, which includes the Company’s
 
container, metal
finishing, mining, offshore, specialty coatings,
 
specialty grease and Norman Hay businesses.
 
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of net sales less directly related
 
COGS
and SG&A.
 
Operating expenses not directly attributable to the net sales of
 
each respective segment,
 
such as certain corporate and
administrative costs, Combination, integration and other
 
acquisition-related expenses, and Restructuring and related
 
charges, are not
included in segment operating earnings.
 
Other items not specifically identified with the Company’s
 
reportable segments include
interest expense, net and other income (expense), net.
 
Americas
Americas represented approximately 31% of the Company’s
 
consolidated net sales in the first quarter of 2021.
 
The segment’s net
sales were $134.9 million, an increase of $5.0 million
 
or 4% compared to the first quarter of 2020.
 
The increase in net sales reflects
the inclusion of additional net sales from acquisitions, primarily
 
Coral.
 
Excluding net sales from acquisitions, the segment’s
 
net sales
were relatively flat compared to the prior year first quarter
 
as the increases from selling price and product mix of 2%
 
were offset by
the negative impacts of foreign currency transaction of
 
2%.
 
The foreign exchange impact was primarily due to the
 
weakening of the
Brazilian real against the U.S. dollar,
 
as this exchange rate averaged
 
5.46 in the first quarter of 2021 compared to 4.43 in the first
quarter of 2020.
 
This segment’s operating
 
earnings were $32.2 million, an increase of $3.0 million or 10%
 
compared to the first
quarter of 2020.
 
The increase in segment operating earnings reflects the higher net
 
sales described above coupled with a higher
current quarter gross margin, partially offset
 
by slightly higher SG&A, including SG&A from acquisitions.
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
35
EMEA
EMEA represented approximately 28% of the Company’s
 
consolidated net sales in the first quarter of 2021.
 
The segment’s net
sales were $119.8 million, an
 
increase of $15.0 million or 14% compared to the first quarter of 2020.
 
The increase in net sales was
driven by increases in volumes of 3%, a benefit from
 
selling price and product mix of 2%, additional set sales from acquisitions
 
of less
than 1% and a positive impact from foreign currency translation
 
of 8%.
 
The current quarter volume increase was driven by the
continued gradual economic rebound from the COVID-19
 
slowdown.
 
The foreign exchange impact was primarily due to the
strengthening of the euro against the U.S. dollar as this exchange
 
rate averaged 1.21 in the first quarter of 2021 compared to 1.10 in
the first quarter of 2020.
 
This segment’s operating earnings
 
were $25.2 million, an increase of $6.9 million or 38%
 
compared to the
first quarter of 2020.
 
The increase in segment operating earnings reflects the higher
 
net sales described above coupled with higher
current quarter gross margin and relatively
 
flat SG&A.
Asia/Pacific
Asia/Pacific represented approximately 23% of the
 
Company’s consolidated net
 
sales in the first quarter of 2021.
 
The segment’s
net sales were $96.7 million, an increase of $23.2 million
 
or 31% compared to the first quarter of 2020.
 
The increase in net sales
reflects increases in volumes of 28% and the positive impact
 
of foreign currency translation of 7% partially offset
 
by decreases in
selling price and product mix of 4%.
 
The increases in volume was primarily driven by the continued gradual
 
economic rebound from
the COVID-19 slowdown as the pandemic notably impacted
 
China during the first quarter of 2020.
 
The foreign exchange impact was
primarily due to the strengthening of the Chinese renminbi
 
against the U.S. dollar as this exchange rate averaged
 
6.48 in the first
quarter of 2021 compared to 6.98 in the first quarter of 2020.
 
This segment’s operating
 
earnings were $27.5 million, an increase of
$8.0 million or 41% compared to the first quarter of 2020.
 
The increase in segment operating earnings reflects the higher net
 
sales
described above on a relatively consistent gross margin
 
quarter-over-quarter.
 
These increases were partially offset by higher SG&A
which was driven by the segment’s
 
improved operating performance compared to the first quarter
 
of 2020.
Global Specialty Businesses
Global Specialty Businesses represented approximately
 
18% of the Company’s consolidated
 
net sales in the first quarter of 2021.
 
The segment’s net sales were
 
$78.4 million, an increase of $8.1 million or 12% compared
 
to the first quarter of 2020.
 
The increase in
net sales reflects the inclusion of additional net sales from
 
the Company’s Coral Chemical
 
acquisition.
 
Excluding net sales from
acquisitions, the segment’s
 
net sales would have increased 6% quarter-over-quarter
 
driven by increases in selling price and product
mix, including Norman Hay,
 
of approximately 20% and the positive impact from foreign
 
currency translation of 2%, partially offset
by decreases in volumes of 16%.
 
The foreign exchange impact was primarily due to the
 
strengthening of the euro against the U.S.
dollar described in the EMEA section above, partially
 
offset by the weakening of the Brazilian real against
 
the U.S. dollar described in
the Americas section, above.
 
Both the changes in selling price and product mix and
 
sales volume were primarily driven by higher
shipments of a lower priced product in the Company’s
 
mining business in the prior year,
 
without the impact of this mining business
item, this segment’s volumes
 
would have been relatively consistent quarter-over-quarter.
 
This segment’s operating
 
earnings were
$24.2 million, an increase of $3.6 million or 18% compared
 
to the first quarter of 2020.
 
The increase in segment operating earnings
reflects the higher net sales described above coupled
 
with higher current quarter gross margin and relatively
 
flat SG&A.
Factors That May Affect Our Future Results
(Cautionary Statements Under the Private Securities
 
Litigation Reform Act of 1995)
Certain information included in this Report and other
 
materials filed or to be filed by Quaker Chemical Corporation
 
with the
Securities and Exchange Commission (“SEC”) (as well as information
 
included in oral statements or other written statements made
 
or
to be made by us) contain or may contain forward-looking
 
statements within the meaning of Section 27A of the Securities Act
 
of
1933, as amended, and Section 21E of the Securities Exchange
 
Act of 1934, as amended.
 
These statements can be identified by the
fact that they do not relate strictly to historical or
 
current facts.
 
We have based
 
these forward-looking
 
statements, including statements
regarding the potential effects of the COVID-19
 
pandemic on the Company’s
 
business, results of operations, and financial condition
 
,
our expectation that we will maintain sufficient
 
liquidity and remediate any of our material weaknesses in internal
 
control over
financial reporting on our current expectations about
 
future events, and statements regarding the impact of increased
 
raw material
costs and pricing initiatives.
 
These forward-looking statements include statements with respect
 
to our beliefs, plans, objectives, goals, expectations,
anticipations, intentions, financial condition, results of operations,
 
future performance, and business, including:
 
•
 
the potential benefits of the Combination and other acquisitions;
 
•
 
the impacts on our business as a result of the COVID-19
 
pandemic and any projected global economic rebound
 
or
anticipated positive results due to Company actions taken
 
in response to the pandemic;
•
 
our current and future results and plans; and
 
•
 
statements that include the words “may,”
 
“could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,”
“intend,” “plan” or similar expressions.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
 
36
Such statements include information relating to current and
 
future business activities, operational matters, capital spending,
 
and
financing sources.
 
From time to time, forward-looking statements are also included in
 
the Company’s other periodic
 
reports on Forms
10-K, 10-Q and 8-K, press releases, and other materials released
 
to, or statements made to, the public.
Any or all of the forward-looking statements in this Report,
 
in the Company’s Annual
 
Report to Shareholders for 2020 and in any
other public statements we make may turn out to be wrong.
 
This can occur as a result of inaccurate assumptions
 
or as a consequence
of known or unknown risks and uncertainties.
 
Many factors discussed in this Report will be important in determining
 
our future
performance.
 
Consequently, actual results may
 
differ materially from those that might be anticipated
 
from our forward-looking
statements.
We undertake
 
no obligation to publicly update any forward-looking statements,
 
whether as a result of new information, future
events or otherwise.
 
However, any further disclosures made
 
on related subjects in the Company’s
 
subsequent reports on Forms 10-K,
10-Q, 8-K and other related filings should be consulted.
 
A major risk is that demand for the Company’s
 
products and services is
largely derived from the demand for our customers’
 
products, which subjects the Company to uncertainties related
 
to downturns in a
customer’s business and unanticipated customer
 
production shutdowns,
 
including as is currently being experienced
 
by many
automotive industry companies.
 
Other major risks and uncertainties include, but
 
are not limited to, the primary and secondary impacts
of the COVID-19 pandemic, including actions taken
 
in response to the pandemic by various governments, which could
 
exacerbate
some or all of the other risks and uncertainties faced by the
 
Company, including
 
the potential for significant increases in raw material
costs, supply chain disruptions, customer financial instability,
 
worldwide economic and political disruptions,
 
foreign currency
fluctuations, significant changes in applicable tax
 
rates and regulations, future terrorist attacks and other acts of
 
violence.
 
Furthermore, the Company is subject to the same business
 
cycles as those experienced by our customers in the
 
steel, automobile,
aircraft, industrial equipment, and durable goods industries.
 
The ultimate impact of COVID-19 on our business will depend
 
on,
among other things, the extent and duration of the pandemic, the
 
severity of the disease and the number of people infected with
 
the
virus, the continued uncertainty regarding global
 
availability, administration
 
,
 
acceptance and long-term efficacy of vaccines, or other
treatments for
 
COVID-19 or its variants,
 
the longer-term effects on the economy by the pandemic,
 
including the resulting market
volatility, and
 
by the measures taken by governmental authorities and other
 
third parties restricting day-to-day life and business
operations and the length of time that such measures
 
remain in place,
 
as well as laws and other governmental programs implemented
to address the pandemic or assist impacted businesses, such
 
as fiscal stimulus and other legislation designed to deliver
 
monetary aid
and other relief.
 
Other factors could also adversely affect us, including
 
those related to the Combination and other acquisitions and the
integration of acquired businesses.
 
Our forward-looking statements are subject to risks,
 
uncertainties and assumptions about the
Company and its operations that are subject to change based
 
on various important factors, some of which are beyond
 
our control.
 
These risks, uncertainties, and possible inaccurate assumptions
 
relevant to our business could cause our actual results
 
to differ
materially from expected and historical results.
 
Therefore, we caution you not to place undue reliance
 
on our forward-looking statements.
 
For more information regarding these
risks and uncertainties as well as certain additional
 
risks that we face, refer to the Risk Factors section, which appears
 
in Item 1A in
our 2020 Form 10-K and in our quarterly and other reports
 
filed from time to time with the SEC.
 
This discussion is provided as
permitted by the Private Securities Litigation Reform Act
 
of 1995.
Quaker Houghton on the Internet
 
Financial results, news and other information about
 
Quaker Houghton can be accessed from the Company’s
 
website at
https://www.quakerhoughton.com
 
.
 
This site includes important information on the Company’s
 
locations, products and services,
financial reports, news releases and career opportunities.
 
The Company’s periodic
 
and current reports on Forms 10-K, 10-Q, 8-K, and
other filings, including exhibits and supplemental
 
schedules filed therewith, and amendments to those reports, filed with
 
the SEC are
available on the Company’s
 
website, free of charge, as soon as reasonably
 
practicable after they are electronically filed with or
furnished to the SEC.
 
Information contained on, or that may be accessed through,
 
the Company’s website is not
 
incorporated by
reference in this Report and, accordingly,
 
you should not consider that information part of this Report.
 
37
Item 3.
 
Quantitative and Qualitative Disclosures About Market
 
Risk.
 
We have evaluated
 
the information required under this Item that was disclosed in Part II,
 
Item 7A, of our Annual Report on Form
10-K for the year ended December 31, 2020, and we
 
believe there has been no material change to that information.
 
 
38
Item 4.
 
Controls and Procedures.
 
Evaluation of disclosure controls
 
and procedures.
 
As required by Rule 13a-15(b) under the Securities Exchange
 
Act of 1934, as
amended (the “Exchange Act”), our management,
 
including our principal executive officer and principal financial
 
officer, has
evaluated the effectiveness of our disclosure
 
controls and procedures (as defined in Rule 13a-15(e) under the
 
Exchange Act ) as of the
end of the period covered by this Report.
 
Based on that evaluation, our principal executive officer
 
and our principal financial officer
have concluded that, as of the end of the period covered by
 
this Report, our disclosure controls and procedures (as defined
 
in Rule
13a-15(e) under the Exchange Act) were not effective
 
as of March 31, 2021 because of the material weaknesses in
 
our internal control
over financial reporting, as described below.
As previously disclosed in “Item 9A. Controls and Procedures.”
 
in the Company’s 2020
 
Form 10-K, through the process of
evaluating risks and corresponding changes to the
 
design of existing or the implementation of new controls
 
in light of the significant
non-recurring transactions that occurred during 2019,
 
including the Combination, the Company identified certain deficiencies in
 
its
application of the principles associated with the Committee
 
of Sponsoring Organization of the Treadway
 
Commission in Internal
Control – Integrated Framework (2013) that management
 
has concluded in the aggregate constitute a material weakness.
 
A material
weakness is a deficiency,
 
or combination of deficiencies, in internal control over financial reporting,
 
such that there is a reasonable
possibility that a material misstatement of annual or interim
 
financial statements
 
will not be prevented or detected on a timely basis.
 
We did not
 
design and maintain effective controls in response to the
 
risks of material misstatement.
 
Specifically, changes to existing
controls or the implementation of new controls were not
 
sufficient to respond to changes to the risks of material
 
misstatement in
financial reporting as a result of becoming a larger,
 
more complex global organization due to the Combination.
 
This material
weakness also contributed to an additional material weakness as we did
 
not design and maintain effective controls
 
over the review of
pricing, quantity and customer data to verify that revenue
 
recognized was complete and accurate.
 
These material weaknesses did not
result in material misstatements to the interim or annual
 
consolidated financial statements.
 
However, these material weaknesses could
result in misstatements to our account balances and disclosures
 
that could result in a material misstatement to the interim
 
or annual
consolidated financial statements that would not be
 
prevented or detected.
Notwithstanding these material weaknesses, the Company
 
has concluded that the unaudited condensed consolidated financial
statements included in this Report present fairly,
 
in all material respects, the financial position of the Company as of
 
March 31, 2021
and December 31, 2020, and that the results of its operations
 
and its cash flows and changes in equity for both the
 
three month periods
ended March 31, 2021 and March 31, 2020, are in conformity
 
with accounting principles generally accepted in the United States of
America.
 
Progress on Remediation
 
of Material Weaknesses
The Company and its Board of Directors, including the
 
Audit Committee of the Board of Directors, are committed to maintaining
a strong internal control environment.
 
Since identifying the material weaknesses, the Company
 
has dedicated a significant amount of
time and resources to remediate all of the previously identified
 
material weaknesses as quickly and effectively
 
as possible. In 2020, the
Company dedicated multiple internal resources and
 
supplemented those internal resources with various third-party specialists to
 
assist
with the formalization of a robust and detailed remediation
 
plan.
 
In undertaking remediation activities, the Company has hired
additional personnel dedicated to financial and information
 
technology compliance to further supplement its internal
 
resources.
 
In
addition, the Company has established a global network
 
of personnel to assist local management in understanding control performance
and documentation requirements.
 
In order to sustain this network, the Company conducts periodic
 
trainings and hosts discussions to
address questions on a current basis.
 
However, the impact of COVID-19,
 
including travel restrictions and remote work arrangements
required the Company to adapt and make changes to its internal
 
controls integration plans as well as its remediation
 
plans, and has
presented and is expected to continue to present challenges
 
with regards to the timing of the Company’s
 
remediation and integration
plan activities.
 
Despite the challenges brought on by COVID-19 and
 
driven by the Company’s
 
priority of creating a long-term sustainable control
structure to ensure stability for a company that has more
 
than doubled in size since August 2019, the Company continues
 
to make
substantial strides towards remediating the underlying
 
causes of the previously disclosed material weaknesses in our
 
risk assessment
process and within our revenue process, as further discussed
 
below.
Risk Assessment –
 
We previously determined
 
that our risk assessment process was not designed adequately
 
to respond to changes
to the risks of material misstatement to financial rep
 
orting.
 
In order to remediate this material weakness, we have designed
 
and
implemented an improved risk assessment process, including
 
identifying and assessing those risks attendant to the
 
significant changes
within the Company as a result of becoming a larger,
 
more complex global organization due to the
 
Combination.
 
During 2020, a full
review was performed of our processes and controls across
 
significant locations in order to identify and address potential
 
design gaps.
 
In addition to individual transactional-level control
 
enhancements, this review resulted in (i) an enhanced financial
 
statement risk
assessment, (ii) the standardization of existing legal entity
 
and newly implemented segment quarterly analytics and
 
quarterly closing
packages completed by key financial reporting personnel, (iii) a
 
global account reconciliation review program and (iv)
 
enhancements
to our quarterly identification and reassessment of new and
 
existing business and information technology risks that could
 
affect our
financial reporting.
 
Monitoring is also performed through our enhanced quarterly
 
controls certification process, whereby changes in
business or information technology processes or control
 
owners are identified and addressed timely.
 
Although we have implemented
 
39
and tested the additional controls as noted in our remediation
 
plan and found them to be effective, this material
 
weakness will not be
considered remediated due to the Revenue – Price and
 
Quantity material weakness, discussed below.
 
Once the Revenue – Price and
Quantity material weakness is remediated, we expect
 
the Risk Assessment material weakness will also be remediated.
 
Revenue – Price and Quantity –
We previously
 
determined that we did not design and maintain effective
 
controls over the review
of pricing, quantity and customer data to verify that revenue
 
recognized was complete and accurate.
 
In order to remediate this
material weakness, the Company made significant progress
 
in its redesign of certain aspects of its revenue process and related
controls.
 
The Company has identified and agreed upon design enhancements
 
and requirements for each revenue sub-process.
 
The
design includes enhancements to entity-level and transactional
 
-level manual controls as well as IT general and application
 
controls
and the Company is in the process of implementing
 
these design changes both centrally and locally.
 
However, because the additional
controls have not been fully implemented and tested, this
 
material weakness is not yet remediated.
 
This existing material weakness
will not be considered remediated until the applicable
 
remedial controls have been fully implemented and operate
 
for a sufficient
period of time and management has concluded, through
 
testing, that the controls are operating effectively.
 
Given the significant resources the Company has dedicated
 
to remediation of its material weaknesses, the Company is committed
to remediation and expects that in 2021 it will successfully implement
 
the enhanced design of its revenue processes and have a
sufficient operational effectiveness period
 
to evidence remediation over its price and quantity material weakness
 
and, concurrently,
evidence remediation over its risk assessment material weakness
 
in 2021 as well.
 
 
Changes in internal control over financial
 
reporting.
 
As required by Rule 13a-15(d) under the Exchange Act,
 
our
management, including our principal executive officer
 
and principal financial officer, has evaluated
 
our internal control over
financial reporting to determine whether any changes
 
to our internal control over financial reporting occurred during
 
the
quarter ended March 31, 2021 that have materially affec
 
ted, or are reasonably likely to materially affect, our
 
internal control
over financial reporting.
 
Based on that evaluation, there were no changes that have materially
 
affected, or are reasonably
likely to materially affect, our internal control
 
over financial reporting during the quarter ended March
 
31, 2021.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40
PART
 
II.
 
OTHER INFORMATION
Items 3, 4 and 5 of Part II are inapplicable and have been
 
omitted.
Item 1.
 
Legal Proceedings.
 
Incorporated by reference is the information in Note
 
19 of the Notes to the Condensed Consolidated Financial
 
Statements in Part
I, Item 1, of this Report.
Item 1A.
 
Risk Factors.
 
In addition to the other information set forth in this Report,
 
you should carefully consider the risk factors previously disclosed
 
in
Part I, Item 1A of our 2020 Form 10-K, which includes the
 
on-going risk and uncertainty related to the outbreak of
 
COVID-19 and its
impact on business and economic conditions.
 
The risks associated with COVID-19 and the other risks described
 
in our 2020 Form
 
10-K are not the only risks we face. Additional risks and
 
uncertainties not currently known to us or that we currently deem to
 
be
immaterial may also materially and adversely affect
 
our business, financial condition or operating results.
Item 2.
 
Unregistered Sales of Equity Securities and Use of
 
Proceeds.
The following table sets forth information concerning
 
shares of the Company’s
 
common stock acquired by the Company during
the period covered by this Report:
(c)
(d)
Total
 
Number of
Approximate Dollar
(a)
(b)
Shares Purchased
 
Value of
 
Shares that
Total
 
Number
Average
as part of
May Yet
 
be
of Shares
Price Paid
Publicly Announced
Purchased Under the
Period
Purchased (1)
Per Share (2)
Plans or Programs
Plans or Programs (3)
January 1 - January 31
—
$
—
—
$
86,865,026
 
February 1 - February 28
4,595
 
$
284.56
 
—
$
86,865,026
 
March 1 - March 31
45
 
$
240.55
 
—
$
86,865,026
 
Total
4,640
 
$
284.14
 
—
$
86,865,026
 
 
(1)
 
All of these shares were acquired from employees upon
 
their surrender of Quaker Chemical Corporation shares in payment
 
of
the exercise price of employee stock options exercised or
 
for the payment of taxes upon exercise of employee stock
 
options
or the vesting of restricted stock.
(2)
 
The price paid for shares acquired from employees pursuant
 
to employee benefit and share-based compensation
 
plans is, in
each case, based on the closing price of the Company’s
 
common stock on the date of exercise or vesting as specified by the
plan pursuant to which the applicable option or restricted
 
stock was granted.
(3)
 
On May 6, 2015, the Board of Directors of the Company
 
approved, and the Company announced, a share repurchase
program, pursuant to which the Company is authorized
 
to repurchase up to $100,000,000 of Quaker Chemical Corporation
common stock (the “2015 Share Repurchase Program”),
 
and it has no expiration date.
 
There were no shares acquired by the
Company pursuant to the 2015 Share Repurchase Program
 
during the quarter ended March 31, 2021.
Limitation on the Payment of Dividends
The New Credit Facility has certain limitations on the
 
payment of dividends and other so-called restricted
 
payments. See Note 15
of Notes to Condensed Consolidated Financial Statements,
 
in Part I, Item 1, of this Report.
 
 
 
 
41
Item 6.
 
Exhibits.
 
(a) Exhibits
3.1
–
3.2
–
10.1
–
10.2
–
10.3
–
10.4
–
31.1
–
31.2
–
32.1
–
32.2
–
101.INS
–
Inline XBRL Instance Document*
101.SCH
–
Inline XBRL Taxonomy
 
Extension Schema Document*
101.CAL
–
Inline XBRL Taxonomy
 
Calculation Linkbase Document*
101.DEF
–
Inline XBRL Taxonomy
 
Definition Linkbase Document*
101.LAB
–
Inline XBRL Taxonomy
 
Label Linkbase Document*
101.PRE
–
Inline XBRL Taxonomy
 
Presentation Linkbase Document*
104
–
Cover Page Interactive Data File (formatted as Inline XBRL and
 
contained in Exhibit 101.INS)*
* Filed herewith.
** Furnished herewith.
† Management contract or compensatory plan.
 
 
*********
 
Pursuant to the requirements of the Securities Exchange
 
Act of 1934, the registrant has duly caused this report to be signed on
 
its
behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
(Registrant)
 
 
 
 
/s/ Shane W.
 
Hostetter________________________________
Date: May 6, 2021
 
 
 
Shane W.
 
Hostetter,
 
Senior Vice President, Chief Financial
Officer (officer duly authorized on behalf of, and principal
financial officer of, the Registrant)
 
 EX-10.1 2 exhibit101.htm EMPLOYMENT AGREEMENT - S. HOSTETTER exhibit101
 
 
 
 
 
1
EXHIBIT 10.1
 
MEMORANDUM OF EMPLOYMENT
 
April 19, 2021
Shane W.
 
Hostetter
[ Redacted ]
 
 
The parties
 
to this
 
Memorandum of
 
Employment (“Agreement”)
 
are
Shane W.
 
Hostetter
and
Quaker Chemical
Corporation
, a Pennsylvania corporation, doing business as Quaker Houghton
 
(“Quaker Houghton” or the “Company”).
 
You
 
are appointed Quaker Houghton’s
 
Senior Vice President
 
and Chief Financial Officer
 
effective as of the
 
date listed above
and Quaker Houghton wishes to enter into this Agreement
 
containing certain covenants in connection with this appointment.
 
 
NOW THEREFORE
 
in consideration
 
of the
 
mutual promises
 
and covenants
 
herein contained
 
and intending
 
to be
 
legally
bound hereby the parties hereto agree as follows:
 
1.
 
Duties
Quaker Houghton
 
agrees to
 
employ you
 
and you
 
agree to
 
serve as
 
Quaker Houghton’s
 
Senior
 
Vice President
 
and Chief
Financial Officer,
 
located at our Conshohocken, PA
 
facility.
 
You
 
shall perform all duties
 
consistent with such position as well
 
as any
other duties that are assigned
 
to you from time to time
 
by Quaker Houghton’s
 
Chief Executive Officer.
 
You
 
agree that during the term
of your employment
 
with Quaker Houghton
 
to devote your knowledge,
 
skill, and working time
 
solely and exclusively
 
to the business
and interests of
 
Quaker Houghton and
 
its subsidiaries. Any
 
and all prior
 
employment or other
 
agreements, with the
 
exception of the
April
 
19, 2021 Change of Control agreement, are hereby terminated
 
and have no further legal effect.
 
2. Compensation
 
 
Your
 
base salary will be
 
determined from time to
 
time by the Compensation
 
and Human Resources Committee
 
of the Board
of Directors, in
 
consultation with the
 
Chief Executive Officer.
 
In addition, you
 
will be entitled to
 
participate, to the
 
extent eligible, in
any of Quaker Houghton’s
 
annual and long term
 
incentive plans, retirement savings plan
 
(401k plan), and will be
 
entitled to paid time
off, paid
 
holidays, and
 
medical, dental, and
 
other benefits as
 
are made
 
generally available
 
by Quaker
 
Houghton to
 
its full-time U.S.
employees.
 
3. Term
 
of Employment
.
Your
 
employment with
 
Quaker Houghton
 
may be
 
terminated on
 
thirty (30)
 
days' written
 
notice by
 
either party,
 
with or
without cause or reason whatsoever.
 
Within thirty (30) days after termination
 
of your employment, you will be given an accounting
 
of
all monies
 
due you.
 
Notwithstanding the
 
foregoing, Quaker
 
Houghton has
 
the right
 
to terminate
 
your employment
 
upon less
 
than
thirty (30) days’ notice for Cause (as defined below).
 
4. Covenant
 
Not to Disclose
 
a. You
 
acknowledge that the
 
identity of Quaker
 
Houghton's (and any
 
of Quaker Houghton's
 
affiliates’) customers,
 
the
requirements of such customers,
 
pricing and payment
 
terms quoted and charged
 
to such customers, the
 
identity of Quaker Houghton's
suppliers and
 
terms of
 
supply (and
 
the suppliers
 
and related
 
terms of
 
supply of
 
any of
 
Quaker Houghton's
 
customers for
 
which
management services are being
 
provided), information concerning
 
the method and conduct of
 
Quaker Houghton's (and any
 
affiliate’s)
business such
 
as formulae,
 
formulation information,
 
application technology,
 
manufacturing information,
 
marketing information,
strategic and
 
marketing plans,
 
financial information,
 
financial statements
 
(audited and
 
unaudited), budgets,
 
corporate practices
 
and
procedures, research and
 
development efforts, and
 
laboratory test methods
 
and all of Quaker
 
Houghton's (and its
 
affiliates’) manuals,
documents, notes,
 
letters, records,
 
and computer
 
programs are
 
Quaker Houghton's
 
confidential information
 
("Confidential
Information") and
 
are Quaker Houghton’s
 
(and/or any
 
of its affiliates’,
 
as the case
 
may be)
 
sole and exclusive
 
property.
 
You
 
agree
that at no
 
time during or
 
following your employment
 
with Quaker Houghton
 
will you appropriate
 
for your own
 
use, divulge or
 
pass
on, directly
 
or through
 
any other
 
individual or
 
entity or
 
to any
 
third party,
 
any Quaker
 
Houghton Confidential
 
Information. Upon
termination of your employment
 
with Quaker Houghton
 
and prior to final payment
 
of all monies due
 
to you under Section
 
2 or at any
other time
 
upon Quaker
 
Houghton's request,
 
you agree
 
to surrender
 
immediately to
 
Quaker Houghton
 
any and
 
all materials in
 
your
possession or control which include or contain any
 
Quaker Houghton Confidential Information.
b. You
 
acknowledge that,
 
by this Section
 
4(b), you
 
have been
 
notified in
 
accordance with
 
the Defend
 
Trade Secrets
Act that, notwithstanding the foregoing:
(i)
 
You
 
will not be
 
held criminally or
 
civilly liable under
 
any federal or
 
state trade secret
 
law or this
Agreement for the disclosure
 
of Confidential Information that:
 
(A) you make (1)
 
in confidence to a
 
federal, state, or local government
official, either
 
directly or
 
indirectly, or
 
to your
 
attorney; and
 
(2) solely
 
for the
 
purpose of
 
reporting or
 
investigating a
 
suspected
violation of law; or (B) you make in a complaint or other
 
document that is filed under seal in a lawsuit or other proceeding.
 
 
 
 
2
(ii)
 
If you file a lawsuit
 
for retaliation by Quaker
 
Houghton for reporting a
 
suspected violation of law,
you may disclose
 
Confidential Information
 
to your attorney
 
and use the
 
Confidential Information in
 
the court proceeding
 
if you: (A)
file any document containing Confidential
 
Information under seal and (B) do not disclose
 
Confidential Information, except pursuant
 
to
court order.
 
c. Additionally,
 
Quaker Houghton confirms
 
that nothing in
 
this Agreement is
 
intended to or
 
shall prevent, impede
 
or
interfere with
 
your right,
 
without prior
 
notice to
 
Quaker Houghton,
 
to provide
 
information to
 
the government,
 
participate in
 
any
government investigations, file a
 
court or administrative complaint,
 
testify in proceedings regarding
 
Quaker Houghton’s past
 
or future
conduct, or engage in any future activities protected
 
under any statute administered by any government agency.
 
5. Covenant
 
Not to Compete
In consideration of your new position with Quaker
 
Houghton and the training and Confidential Information
 
you are to receive
from Quaker
 
Houghton, you
 
agree that
 
during your
 
employment with
 
Quaker Houghton
 
and for
 
a period
 
of one (1)
 
year thereafter,
regardless of the reason for your termination, you will not:
a. directly
 
or indirectly,
 
together or separately
 
or with any
 
third party,
 
whether as an
 
employee, individual proprietor,
partner, stockholder,
 
officer, director,
 
or investor, or in a joint venture
 
or any other capacity whatsoever,
 
actively engage in business or
assist anyone or
 
any firm in
 
business as a manufacturer,
 
seller, or distributor
 
of specialty chemical
 
products which are
 
the same, like,
similar to, or which compete with Quaker Houghton’s
 
(or any of its affiliates’) products or services; and
 
b. directly
 
or indirectly
 
recruit, solicit
 
or encourage
 
any Quaker
 
Houghton (or
 
any of
 
its affiliates’)
 
employee or
otherwise induce such employee to leave Quaker
 
Houghton’s (or any
 
of its affiliates’) employ,
 
or to become an employee or otherwise
be associated with you or any firm, corporation, business, or
 
other entity with which you are or may become associated;
 
and
. solicit
 
or induce
 
any of
 
Quaker Houghton's suppliers
 
of products
 
and/or services
 
(or a
 
supplier of
 
products and/or
services of a customer
 
who is being provided
 
or solicited for the provision
 
of chemical management services
 
by Quaker Houghton) to
terminate or alter its contractual relationship with Quaker
 
Houghton (and/or any such customer).
The parties
 
consider these
 
restrictions reasonable,
 
including the
 
period of
 
time during
 
which the
 
restrictions are
 
effective.
 
However, if
 
any restriction
 
or the
 
period of
 
time specified
 
should be
 
found to
 
be unreasonable
 
in any
 
court proceeding,
 
then such
restriction shall be modified
 
or the period of time
 
shall be shortened as is
 
found to be reasonab
 
le so that the
 
foregoing covenant not to
compete may
 
be enforced.
 
You
 
agree that
 
in the event
 
of a breach
 
or threatened
 
breach by
 
you of
 
the provisions
 
of the restrictive
covenants contained in
 
Section 4 or in
 
this Section 5,
 
Quaker Houghton will
 
suffer irreparable harm,
 
and monetary damages
 
may not
be an
 
adequate remedy.
 
Therefore, if
 
any breach
 
occurs, or
 
is threatened,
 
in addition
 
to all
 
other remedies
 
available to
 
Quaker
Houghton, at
 
law or
 
in equity,
 
Quaker Houghton
 
shall be
 
entitled as
 
a matter
 
of right
 
to specific
 
performance of
 
the covenants
contained herein by
 
way of temporary or
 
permanent injunctive relief.
 
In the event of
 
any breach of the
 
restrictive covenant contained
in this Section
 
5, the term
 
of the restrictive
 
covenant shall be
 
extended by a
 
period of time
 
equal to that
 
period beginning on
 
the date
such violation commenced and ending when the activities
 
constituting such violation cease.
 
6. Contractual
 
Restrictions
 
You
 
represent and warrant to Quaker Houghton
 
that: (a) there are no restrictions, agreements, or
 
understandings to which you
are a
 
party that
 
would prevent
 
or make
 
unlawful your
 
employment with
 
Quaker Houghton
 
and (b)
 
your employment
 
by Quaker
Houghton shall
 
not constitute
 
a breach of
 
any contract,
 
agreement, or
 
understanding, oral
 
or written, to
 
which you
 
are a party
 
or by
which you are
 
bound.
 
You
 
further represent that
 
you will not
 
use any trade
 
secret, proprietary or
 
otherwise confidential information
belonging to a prior employer or other third party in connection
 
with your employment with Quaker Houghton.
 
7. Inventions
 
All improvements,
 
modifications, formulations,
 
processes, discoveries
 
or inventions
 
("Inventions"), whether
 
or not
patentable, which
 
were originated,
 
conceived or
 
developed by
 
you solely
 
or jointly
 
with others (a)
 
during your
 
working hours
 
or at
Quaker Houghton’s
 
expense or
 
at Quaker
 
Houghton's premises
 
or at
 
a customer’s
 
premises or
 
(b) during
 
your employment
 
with
Quaker Houghton and
 
additionally for a
 
period of one
 
year thereafter,
 
and which relate
 
to (i) Quaker
 
Houghton’s business
 
or (ii) any
research, products,
 
processes, devices, or
 
machines under actual
 
or anticipated development
 
or investigation by
 
Quaker Houghton at
the earlier
 
of (i)
 
that time
 
or (ii)
 
as the
 
date of
 
termination of
 
employment, shall
 
be Quaker
 
Houghton’s sole
 
property.
 
You
 
shall
promptly disclose to Quaker
 
Houghton all Inventions that you
 
conceive or become aware of
 
at any time during your
 
employment with
Quaker Houghton and
 
shall keep complete,
 
accurate, and authentic
 
notes, data and
 
records of all
 
Inventions and of
 
all work done
 
by
you solely or jointly with
 
others, in the manner directed
 
by Quaker Houghton. You
 
hereby transfer and assign to
 
Quaker Houghton all
of your right,
 
title, and interest
 
in and to
 
any and all
 
Inventions which may
 
be conceived or
 
developed by
 
you solely or
 
jointly with
others during your
 
employment with Quaker
 
Houghton.
 
You
 
shall assist Quaker Houghton
 
in applying, obtaining,
 
and enforcing any
United States Letters
 
Patent and Foreign
 
Letters Patent on
 
any such Inventions
 
and to take
 
such other actions
 
as may be necessary
 
or
desirable to
 
protect Quaker
 
Houghton's interests
 
therein.
 
Upon request,
 
you shall
 
execute any
 
and all
 
applications, assignments,
 
or
other documents
 
that Quaker
 
Houghton deems
 
necessary and
 
desirable for
 
such purposes.
 
You
 
have attached
 
hereto a
 
list of
unpatented inventions
 
that you have
 
made or conceived
 
prior to your
 
employment with Quaker
 
Houghton, and it
 
is agreed that
 
those
inventions shall be excluded from the terms of this Agreement.
 
 
 
 
3
 
8.
 
Termination
 
 
Quaker Houghton, in its sole
 
discretion, may terminate your
 
employment at any time and
 
for any reason, including
 
Cause (as
defined herein).
 
If you incur a
 
Separation from Service
 
by decision and
 
action of Quaker Houghton
 
for any reason
 
other than Cause,
death, or Disability (as defined below), Quaker Houghton
 
agrees to:
 
a. Provide
 
you with
 
reasonable outplacement
 
assistance, either
 
by providing
 
the services
 
in-kind, or
 
by reimbursing
reasonable expenses
 
actually incurred
 
by you in
 
connection with your
 
Separation from
 
Service.
 
The outplacement
 
services must be
provided during the
 
one-year period following
 
your Separation from Service.
 
If any expenses are
 
to be reimbursed, you
 
must request
the reimbursement within
 
eighteen months of
 
your Separation from
 
Service and reimbursement
 
will be made
 
within 30 days
 
of your
request.
 
b. Pay
 
you one
 
year's severance
 
in twenty
 
-four semi-monthly
 
installments commencing
 
on the
 
Payment Date
 
and
continuing on
 
Quaker Houghton's
 
normal semi-monthly
 
payroll dates
 
each month
 
thereafter, each
 
of which
 
is equal
 
to your
 
semi-
monthly base salary
 
at the time
 
of your Separation
 
from Service, provided
 
you sign a
 
Release within 45
 
days of the
 
later of the
 
date
you receive
 
the Release
 
or your
 
Separation from
 
Service. Continuation
 
of medical
 
and dental
 
coverage’s will
 
be consistent
 
with
current Quaker Houghton severance program in place
 
at the time of termination.
“Separation from Service”
 
means your separation
 
from service with Quaker
 
Houghton and its affiliates
 
within the meaning
of Treas. Reg. §1.409A-1(h) or any
 
successor thereto.
 
“Cause”
 
means your
 
employment with
 
Quaker Houghton
 
has been
 
terminated by
 
reason of
 
(i) your
 
willful and
 
material
breach of
 
this Agreement
 
(after hav
 
ing received
 
notice thereof
 
and a
 
reasonable opportunity
 
to cure
 
or correct)
 
or the
 
Company’s
policies, (ii) dishonesty,
 
fraud, willful malfeasance, gross
 
negligence, or other gross misconduct,
 
in each case relating to the
performance of your duties hereun
 
der which is materially injurious
 
to Quaker Houghton, or (iii)
 
conviction of or plea of guilty
 
or nolo
contendere to a felony.
“Payment Date”
 
means (x)
 
the 60th
 
day after
 
your Separation
 
from Service
 
or (y)
 
if you
 
are a
 
specified employee
 
(as
defined in Treas.
 
Reg. §1.409A-1(i)) as
 
of the date
 
of your Separation
 
from Service, and
 
the severance described
 
in subsection (b)
 
is
deferred compensation subject
 
to section 409A of
 
the Code, the first business
 
day of the seventh
 
month following the month
 
in which
your Separation
 
from Service
 
occurs.
 
If the
 
Payment Date
 
is described
 
in clause
 
(y), the
 
amount paid
 
on the
 
Payment Date
 
shall
include all monthly
 
installments that would
 
have been paid
 
earlier had clause
 
(y) not been
 
applicable, plus interest
 
at the Wall
 
Street
Journal Prime Rate
 
published in the
 
Wall Street
 
Journal on the
 
date of your
 
Separation from Service
 
(or the previous
 
business day if
such day
 
is not
 
a business
 
day), for
 
the period
 
from the
 
date payment
 
would have
 
been made
 
had clause
 
(y) not
 
been applicable
through the date payment is made.
 
“Release”
 
means a release
 
(in a form
 
satisfactory to Quaker
 
Houghton) of any
 
and all claims against
 
Quaker Houghton and
all related parties
 
with respect to
 
all matters arising
 
out of your
 
employment with Quaker
 
Houghton, or the
 
termination thereof (other
than for claims for any entitlements under the
 
terms of this Agreement or any plans or programs of
 
Quaker Houghton under which you
have accrued a benefit) that Quaker Houghton
 
provides to you no later than ten days after your
 
Separation from Service.
 
If a release is
not provided to you within this time period, the severance
 
shall be paid even if you do not sign a release.
“Disability”
 
means total and permanent
 
disability as defined
 
in the long-term disability
 
plan maintained by
 
Quaker
Houghton for employees
 
generally or,
 
if Quaker Houghton
 
does not maintain
 
such a plan, the
 
long-term disability plan
 
most recently
maintained by Quaker Houghton for employees generally.
9. Indemnification.
 
The Company
 
shall defend you
 
and hold you
 
harmless to
 
the fullest
 
extent permitted
 
by applicable
 
law in connection
 
with
any claim, action,
 
suit, investigation or
 
proceeding arising out
 
of or relating
 
to performance by
 
you of services
 
for, or
 
action of you,
director, officer
 
or employee
 
of the
 
Company or
 
any parent,
 
subsidiary or
 
affiliate of
 
the Company,
 
or of
 
any other
 
person or
enterprise at
 
the Company’s
 
request. Expenses
 
incurred by
 
you in
 
defending such
 
claim, action,
 
suit or
 
investigation or
 
criminal
proceeding shall
 
be paid
 
by the
 
Company in
 
advance of
 
the final
 
disposition thereof
 
upon the
 
receipt by
 
the Company
 
of an
undertaking by
 
or on
 
behalf of
 
you to
 
repay said
 
amount unless
 
it shall
 
ultimately be
 
determined that
 
you are
 
entitled to
 
be
indemnified hereunder;
 
provided, however,
 
that this
 
shall not
 
apply to
 
a nonderivative
 
action commenced
 
by the
 
Company against
you.
 
10. Governing
 
Law.
 
The provisions of this Agreement shall be construed in
 
accordance with the laws of the Commonwealth of
Pennsylvania without reference to principles of conflicts of
 
laws.
 
 
 
 
 
 
 
4
11. Miscellaneous
 
This Agreement and
 
any Change in
 
Control Agreement to
 
which you are
 
a party,
 
constitute the entire
 
integrated agreement
concerning the subjects
 
covered herein.
 
In case any
 
provision of this
 
Agreement shall be
 
invalid, illegal, or
 
otherwise unenforceable,
the validity, legality,
 
and enforceability of the remaining provisions shall not
 
thereby be affected or impaired.
 
You
 
may not assign any
of your rights
 
or obligations under
 
this Agreement without
 
Quaker Houghton’s
 
prior written consent.
 
Quaker Houghton may
 
assign
this Agreement
 
in its discretion,
 
including to
 
any affiliate
 
or upon
 
a sale
 
of assets
 
or equity,
 
merger or
 
other corporate
 
transaction;
provided that Quaker
 
Houghton obtains the
 
assignee’s written
 
commitment to honor
 
the terms and
 
conditions contained herein.
 
This
Agreement shall be governed
 
by, and
 
construed in accordance with, the
 
laws of the Commonwealth
 
of Pennsylvania without regard
 
to
any conflict
 
of laws.
 
This Agreement
 
shall be
 
binding upon
 
you, your
 
heirs, executors,
 
and administrators
 
and shall
 
inure to
 
the
benefit of
 
Quaker Houghton
 
as well
 
as its
 
successors and
 
assigns.
 
In the
 
event of
 
any overlap
 
in the
 
restrictions contained
 
herein,
including Sections 4 and/or 5
 
above, with similar restrictions contained
 
in any other agreement, such restrictions
 
shall be read together
so as to provide the broadest restriction possible.
 
 
IN WITNESS WHEREOF,
 
the parties hereto have executed this Agreement the
 
day and year first above written.
 
WITNESS:
QUAKER CHEMICAL CORPORATION
 
DBA
QUAKER HOUGHTON
/s/ Robert T. Traub
/s/ Michael F. Barry
 
 
Michael F. Barry
WITNESS:
/s/ Victoria K. Gehris
/s/ Shane W.
 
Hostetter
 
 
Shane W.
 
Hostetter
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5
 
 
 
 
 
 
 
 
 
Shane W. Hostetter
ADDENDUM 1
 
Base Salary:
Your
 
salary will be
 
payable on a
 
bi-weekly basis at
 
an annualized rate
 
of $390,000.
 
You
 
will be eligible for your next salary increase in 2022.
Annual and Long-
Term Bonuses:
For your position, you are
 
eligible to participate in
 
the Annual Incentive Plan
(“AIP”) with target
 
and double target
 
award percentages
 
for 2021 under
 
the AIP of
60% and
 
120%, respectively,
 
of your
 
base salary,
 
dependent upon
 
Quaker
Houghton’s financial
 
results and other objectives to be determined.
You
 
were eligible to
 
participate in the 2021
 
-2023 Long Term
 
Incentive Plan (LTIP)
at a
 
target level
 
award of
 
$103,000.
 
In consideration
 
of accepting
 
your new
 
role,
you award will be increased by $200,000 for a total target
 
level award opportunity of
$303,000.
 
Your
 
award for the 2021
 
-2023 performance period
 
includes an even
 
mix
of time-based restricted stock, stock options, and target
 
performance stock units.
 
All incentive compensation
 
awards are made
 
at the Company’s
 
discretion, are
subject to change, and require the approval of the Compensation
 
Committee.
Benefits:
Quaker Houghton offers
 
a Flexible Benefits Program
 
that is subject to
 
change.
 
This
gives you the
 
opportunity to choose
 
from a variety of
 
options creating a
 
customized
benefits package.
 
The following benefits
 
are currently part
 
of the program.
 
In each
of these
 
areas, you
 
are offered
 
a range of
 
options so you
 
may choose
 
the ones that
make the most sense for your personal situation.
●
 
Medical
●
 
Dental
●
 
Life & AD&D Insurance
●
 
Long-term Disability
●
 
Health Care and Dependent Care Flexible Spending
 
Accounts (FSAs)
●
 
Retirement Savings Plan (401k)
PTO/Holidays:
You
 
will be
 
eligible for
 
the amount
 
of PTO
 
days per
 
calendar year
 
based on
 
your
tenure with
 
Quaker Houghton
 
per the
 
Company’s PTO
 
Plan.
 
In addition,
 
you will
continue to be
 
eligible to be
 
paid for regional
 
holidays.
 
Unused PTO days
 
will not
roll over from
 
year to year
 
(other than a
 
maximum of 5
 
days in 2021
 
as previously
announced by the Company).
 
 
 EX-10.3 3 exhibit103.htm EMPLOYMENT AGREEMENT - D. WILL exhibit103
 
 
1
EXHIBIT 10.3
 
 
 
 
 
 
March 22, 2021
 
David Will
Quaker Houghton
 
Dear David:
 
Congratulations!
 
I am pleased to
 
offer you this
 
promotion with Quaker
 
Houghton as VP,
 
Global Controller.
 
Your
 
tentative start date
for this
 
position is
 
April 19,
 
2021.
 
We believe
 
you can
 
make significant
 
contributions in
 
this role
 
and will
 
find this
 
opportunity
exciting and rewarding.
 
Please review the details of the offer below.
 
 
Salary
Your
 
new annualized salary
 
is $260,000 and
 
is inclusive of
 
your 2020 merit
 
increase and is
 
effective on April
 
19
,
2021.
 
You
 
will be
eligible for your next merit increase in April 2022, reflective of
 
performance year 2021.
 
Annual Incentive Plan
 
You
 
will be eligible to participate in our 2021 Annual Incentive Plan
 
(AIP), with an annual bonus target of 30% of
 
your base salary.
 
Long Term
 
Incentive Plan
You
 
will be eligible to
 
participate in our 2021
 
Long Term
 
Incentive Plan (LTIP)
 
at a level valued at
 
$70,000 which is inclusive
 
of the
$47,000 grant you
 
received on March
 
15
th
.
 
The $23,000 value
 
in the difference
 
will be reflected
 
in an additional
 
grant on your
 
start
date of April 19, 2021.
 
As a reminder, the grant will consist of Restricted
 
Stock (60%) and Performance Stock Units (40%).
 
 
The terms and conditions of your employment
 
as they existed remain in effect, except
 
as specifically set forth above and in restrictions
from what you signed previously.
 
Quaker Houghton reserves the right to modify
 
your job title, duties and compensation, as well as all
company rules, practices and other terms of employment.
 
We are
 
excited about this
 
opportunity for
 
you David and
 
look forward to
 
you accepting this
 
role with Quaker
 
Houghton.
 
After your
review of this offer,
 
please sign below to confirm your acceptance and return
 
to me with a copy to Rob Traub and Kym
 
Johnson.
 
Sincerely,
 
/s/ Shane Hostetter
Shane Hostetter
VP,
 
Finance and Chief Accounting Officer
 
Employee Offer Acceptance
I accept the terms and conditions outlined above:
 
 
/s/ David Will
 
4/7/2021
 
David Will
 
Date
 
 
 
 EX-10.4 4 exhibit104.htm CEO TRANSITION AGREEMENT exhibit104
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
EXHIBIT 10.4
TRANSITION AGREEMENT
 
This Transition Agreement (this “
Agreement
”), dated as of April 22, 2021 is made between Michael F.
 
Barry (“
Executive
”)
and Quaker Chemical Corporation (“
Quaker
” or the “
Company
”).
 
 
WHEREAS, Executive and Quaker are parties to the
 
Employment Agreement dated July 1, 2008 regarding Executive’s
employment as the Company’s
 
Chief
 
Executive Officer and President (the “
Employment Agreement
”);
 
 
WHEREAS, Executive and Quaker contemplate that
 
effective December 31, 2021, Executive will retire as the
 
Chief
Executive Officer and President and will continue
 
to serve on the Board of Directors of the Company (the “
Board
”) as a non-
executive director;
 
WHEREAS, as used in this Agreement, any reference
 
to Executive shall include Executive and, in their capacities as such,
Executive’s heirs, administrators,
 
representatives, executors, legatees, successors, agents and
 
assigns; and
 
WHEREAS, all capitalized terms used but not defined
 
in this Agreement shall have the meanings ascribed to such terms
 
in the
Employment Agreement;
 
 
In consideration of the mutual promises, agreements and
 
representations contained herein, the parties agree as follows:
 
1.
 
Transition
. Executive shall continue to serve as President and
 
Chief Executive Officer of the Company,
 
at his current level of
compensation (including the full amount of his Annual
 
Incentive
 
Plan (
“AIP”
) bonus earned with respect to calendar year 2021)
and benefits (with such increases as may be approved
 
by the Board) through December 31, 2021. Effective
 
January 1, 2022,
Executive shall resign as an employee of the Company,
 
and from such positions and from all positions as an officer
 
or director of
any Company subsidiary (but, for the sake of clarity,
 
he shall not be expected to resign as a director of the Company).
 
However,
with the approval
 
of the Board, Executive may resign from such positions
 
prior to January 1, 2022, and in that event may also, if
he desires, resign as an employee prior to January 1, 2022.
 
In either event, Executive shall make himself reasonably
 
available to
the Board to provide strategic advice and counsel through
 
December 31, 2021 and shall continue to receive, through December
31, 2021 the same level of compensation and benefits to
 
which he was entitled as of the date of his resignation as President
 
and
Chief Executive Officer (including the
 
full amount of his AIP bonus earned with respect to calendar
 
year 2021).
 
If the Board
requests, and Executive provides his written consent,
 
Executive’s employment may
 
be extended beyond December 31, 2021 at his
current level of compensation and benefits, or upon such
 
other terms and conditions that the Board and Executive
 
may mutually
agree. The date of Executive’s
 
resignation as President and Chief Executive Officer
 
of the Company is referred to in the
Agreement as the “
Resignation Date.
” Following his resignation as President and Chief Executive
 
Officer, Executive shall,
subject to further action by the Board, continue to
 
serve as Chair of the Board, in the capacity as non-executive
 
Chair.
 
 
2.
 
Compensation.
 
If the Resignation Date occurs before January 1, 2022, the
 
Company shall compensate Executive through
December 31, 2021 as provided in Section 1 above.
 
From and after January 1, 2022 and continuing for as long
 
as Executive
serves as a director, the Company
 
shall compensate Executive for his services as a director on the same
 
basis as it compensates
the non-management members of the Board and shall
 
pay him additional compensation of $100,000 per annum (or
 
such greater
amount as may be approved by the Board)
 
for his services as non-executive Chair.
 
Such compensation shall be paid on the same
basis as the compensation payable to the Lead Director
 
(if there is one, otherwise on the same basis as for those directors serving
as chairs of Board committees), pro-rated in the event of
 
a partial year; provided that Executive’s
 
compensation for serving as
non-executive Chair shall, if paid in cash, shall be paid in
 
monthly installments. The Company shall reimburse Executive for
 
all
reasonable business expenses incurred
 
by him in the performance of duties as a director and non-executive
 
Chair in accordance
with the Company’s business
 
expense reimbursement policies. While serving as non
 
-executive Chair, the Company shall provide
Executive with support services as Executive may reasonably
 
request, including computer and telephone access, IT support and
support from an administrative assistant.
 
3.
 
Non-Executive Chair of the Board.
 
As the non-executive Chair, it is contemplated
 
that Executive shall, when present, preside at
all meetings of the Board and at all meetings of shareholders of
 
the Company, and together
 
with the President and Chief
Executive Officer and (if there is one) the
 
Lead Director, set the agenda for meetings
 
of the Board. In addition, Executive shall,
upon request, provide his advice and counsel with respect
 
to the transition of management,
 
new business opportunities, strategic
planning, customer and investor relations and such
 
other matters as the Company’s
 
Chief Executive Officer or the Board may
reasonably request.
 
4.
 
No Termination
 
of Service
. Executive and the Company hereby acknowledge that the Compensation
 
and Human Resources
Committee of the Board (or such other committee described
 
in the LTIP)
 
has provided that Executive will not be considered to
have had a “
Termination
 
of Service
” as defined in the LTIP
 
for so long as Executive is a director or employee of
 
the Company.
 
 
 
 
 
 
 
 
 
 
 
 
 
2
Any further amendment to the interpretation of Termination
 
of Service will be considered an amendment to an outstanding
 
award
pursuant to section 2.6 of the LTIP
 
and may only be made with the Executive’s
 
consent.
 
5.
 
Company’s Obligations
.
 
a.
 
The Company will pay Executive for any amounts of Executive’s
 
accrued salary payable under the Employment Agreement
and reimbursement for any reasonable business expenses
 
and other amounts to which Executive is entitled thereunder.
 
Such
payment will be made in accordance with the Company’s
 
regular payroll practices.
 
b.
 
Executive shall receive
 
any incentive cash bonus amount accrued or earned by Executive
 
in accordance with the terms of an
award granted under the AIP or LTIP
 
prior January 1, 2022 in accordance with the terms of the AIP
 
or LTIP,
 
as applicable.
Any such amount shall be paid to Executive as provided
 
under the AIP or LTIP,
 
as applicable.
 
 
c.
 
Following the Resignation Date, Executive shall not be
 
eligible to participate in the Company’s
 
benefit plans except as
provided below with respect to Executive’s
 
participation in the Company’s
 
existing medical plan, as such plan may be
changed by the Company from time to time for its senior employees
 
generally (“
Medical Coverage
”) and the Company’s
existing short-term disability plan and long-term disability
 
plan as such plans may be changed by the Company
 
from time to
time for its senior employees generally (“
Disability Coverage
”):
 
i.
 
Subject to approval from the applicable insurance provider,
 
if any, the Company
 
shall, until April 30, 2023, permit
Executive to elect Medical Coverage (including medical,
 
vision and dental coverage) for himself and his family
 
as
follows:
 
1.
 
Executive shall pay the premium cost of the Medical Coverage
 
he elects at the rate provided to active employees of
the Company, and
 
on an after-tax basis. In addition, the Company will pay
 
the portion of the premium cost paid by
the Company for active employees for such Medical Coverage
 
and the portion of the premium cost paid by the
Company will be includable in Executive’s
 
taxable income.
 
 
2.
 
Upon the termination of the Medical Coverage, Executive
 
and if applicable, his family may be eligible to elect
COBRA continuation coverage in accordance with the
 
terms of the Medical Coverage and applicable law.
 
 
3.
 
If at any time during such period Executive is not eligible
 
to participate in the Medical Coverage, the Company will
pay to Executive additional compensation in an amount
 
necessary to purchase coverage similar to the Medical
Coverage.
 
ii.
 
For as long as Executive is entitled to elect Medical Coverage
 
from the Company,
 
Executive will continue to be eligible
for Disability Coverage under the same terms and conditions as
 
active employees, subject to approval from the applicable
insurance provider, if any.
 
d.
 
Executive’s outstanding
 
equity awards as of December 31, 2021 shall be administered
 
according to the terms of the
applicable award agreements (the “
Award Agreements
”) and the terms of the LTIP.
 
e.
 
In the event of the death of Executive, any payments due
 
to Executive under this Agreement or the Award
 
Agreements and
not paid prior to Executive’s
 
death shall be made to the personal representative of Executive’s
 
estate.
 
f.
 
The Company shall withhold from any payments under this
 
Agreement any federal, state and local taxes that the Company
 
is
required to withhold pursuant to any law or governmental
 
rule or regulation. Executive shall be responsible for all Executive
taxes applicable to amounts payable under this Agreement.
 
g.
 
Executive shall not be entitled to any severance amounts
 
under any severance plans of the Company or the
 
Employment
Agreement.
 
6.
 
Restrictive Covenants
. Executive shall comply with the Restrictive Covenants set forth
 
in Section 6 of the Employment
Agreement (the “
Restrictive Covenants
”) for the applicable periods set forth therein; provided
 
that, notwithstanding anything to
the contrary in the Employment Agreement, Executive
 
shall comply with the Restrictive Covenants set forth in Section
 
6.2 of the
Employment Agreement regarding non-competition
 
and non-solicitation for so long as he is a member of the Board,
 
and for a
period of 18 months following the end of Executive’s
 
Board service.
 
7.
 
Return of Property
.
 
Executive agrees to return all Company property to the Company
 
on or before the Resignation Date (other
than as relates to his services as a director,
 
including his computer, cellphone and
 
email access) and not retain any property of the
 
 
 
 
 
 
 
 
 
 
3
Company (other than his cellphone, computer and any
 
other items that the Company expressly permits Executive
 
to keep). To the
extent that Executive retains any such items, or if he made
 
use of his own personal
 
computing devices (e.g., cellphone, laptop,
thumb drive, etc.), Executive will, upon request, deliver such
 
items to the Company for review and will permit the
 
Company to
delete all Company property and information therefrom,
 
and/or permit the Company to remotely delete all Company property
 
and
information from such items. For the avoidance of doubt,
 
notwithstanding anything to the contrary,
 
Executive shall be permitted
to retain his contacts (in electronic and paper form).
 
The Company shall pack and ship at its expense the personal items of
Executive that are in his office at the Company following
 
the Resignation Date.
 
8.
 
Cooperation
. Executive agrees that, upon the Company’s
 
reasonable notice to Executive and taking into consideration
Executive’s other commitments and
 
obligations, Executive shall fully cooperate with the Company
 
in investigating, defending,
prosecuting, litigating, filing, initiating or asserting any actual or
 
potential claims or investigations that may be made
 
by or against
the Company to the extent that such claims or investigations relate
 
to any matter in which Executive was involved (or alleged to
have been involved) while employed with the Company,
 
or during his service as a director, of
 
which Executive has knowledge by
virtue of Executive’s employment
 
with the Company or Executive’s
 
capacity as a director of the Company.
 
The Company will
advance to Executive the reasonable out-of-pocket expenses incurred
 
in rendering such cooperation.
 
9.
 
Permitted Conduct
. Nothing in this Agreement or the Employment Agreement
 
shall prohibit or restrict Executive from initiating
communications directly with, or responding to any inquiry
 
from, or providing testimony before, the Equal Employment
Opportunity Commission, the Department of Justice, the
 
Securities and Exchange Commission, or any other federal,
 
state or local
regulatory authority.
 
To the extent permitted
 
by law, upon receipt of any
 
subpoena, court order, or other legal process
 
compelling
the disclosure of any confidential information and trade secrets of
 
the Company, Executive agrees
 
to give prompt written notice to
the Company so as to permit the Company to protect its interests
 
in confidentiality to the fullest extent possible. Please take
 
notice
that federal law provides criminal and civil immunity
 
to federal and state claims for trade secret misappropriation
 
to individuals
who disclose a trade secret to their attorney,
 
a court, or a government official in certain, confidential
 
circumstances that are set
forth at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related
 
to the reporting or investigation of a suspected violation of the law,
 
or in
connection with a lawsuit for retaliation for reporting
 
a suspected violation of the law.
 
10.
 
Indemnification.
The Company shall defend and hold Executive harmle
 
ss to the fullest extent permitted by applicable law in
connection with any claim, action, suit, investigation
 
or proceeding arising out of or relating to performance by Executive
 
of
services for, or action of Executive
 
hereunder or as a director, officer,
 
employee or executive of the Company or of any parent,
subsidiary or affiliate of the Company,
 
or of any other person or enterprise at the Company’s
 
request. Expenses incurred by
Executive in defending such a claim, action, suit or investigation
 
or criminal proceeding shall be paid by the Company in
 
advance
of the final disposition thereof upon the receipt by the Company
 
of an undertaking by or on behalf of Executive to repay said
amount unless it shall ultimately be determined that Executive
 
is entitled to be indemnified hereunder; provided, however,
 
that
this shall not apply to a nonderivative action commenced
 
by the Company against Executive. This indemnification
 
obligation is in
addition to the obligations of the Company pursuant to
 
its articles of incorporation and bylaws.
 
11.
 
Controlling Law
.
 
This Agreement and all matters arising out of, or relating
 
to it, shall be governed by,
 
and construed in
accordance with, the laws of the Commonwealth of Pennsylvania.
 
12.
 
 
Jurisdiction
.
 
Any action arising out of, or relating to, any breach
 
of the Restrictive Covenants shall be brought and prosecuted
only in the United States District Court for the Eastern
 
District of Pennsylvania, or if such court does not have jurisdiction
 
or will
not accept jurisdiction, in any court
 
of general jurisdiction in Philadelphia, Pennsylvania, and the
 
jurisdiction of such court in any
such proceeding shall be exclusive. Executive also irrevocably
 
and unconditionally consents to the service of any process,
pleadings, notices or other papers.
 
13.
 
Amendment
.
 
The parties agree that this Agreement may not be altered,
 
amended or modified, in any respect, except by a writing
duly executed by both Parties.
 
14.
 
Entire Agreement
.
 
The parties understand that no promise, inducement or
 
other agreement not expressly contained herein has
been made conferring any benefit upon them, and that
 
this Agreement contains the entire agreement between the parties with
respect to the subject matter hereof, and that the terms of
 
this Agreement are contractual and not recitals only.
 
Prior to the
Resignation Date, the Employment Agreemen
 
t
 
shall apply to any termination of Executive’s
 
employment with the Company,
provided, however, that in the
 
event of a Separation from Service prior to the Resignation
 
Date, by action of the Company for any
reason other than Cause or the death or Disability of the
 
Executive, Executive shall receive the same compensation and benefits
that he would receive in the event of a resignation
 
prior to January 1, 2022, as set forth in Section 1 of this Agreement,
 
in lieu of
any payment under Section 4.4 of the Employment
 
Agreement. Following the Resignation Date, the provisions of
 
this Agreement
shall govern Executive’s service
 
as a director other than those provisions of the Employment
 
Agreement that by their terms apply
following termination of Executive’s
 
employment
 
as Chief Executive Officer and President of the Company
 
(including without
limitation Section 6 and 7.7), which shall continue
 
to apply to Executive.
 
 
 
 
 
 
 
 
 
4
 
15.
 
Section 409A
.
 
 
a.
 
This Agreement is intended to comply with Code section
 
409A, or an exemption, and the provisions of this Subsection
 
shall
apply notwithstanding any provisions of this Agreement
 
to the contrary. For purposes of
 
section 409A of the Code, the right
to a series of payments under this Agreement shall be treated
 
as a right to a series of separate payments and each payment
shall be treated as a separate payment. With
 
respect to any payments that are subject to section 409A of
 
the Code, in no event
shall Executive, directly or indirectly,
 
designate the calendar year of a payment and if a payment could
 
be made in more than
one taxable year, based on timing
 
of the execution of this Agreement, payment shall be made in the
 
later taxable year. Any
reimbursements and in-kind benefits provided under
 
this Agreement shall be made or provided in accordance with
 
the
requirements of section 409A of the Code.
 
b.
 
Notwithstanding any provision of this Agreement to
 
the contrary, any payment
 
or benefit under this Agreement that
constitutes deferred compensation subject to section 409A
 
of the Code and for which the payment event is a Separation
 
from
Service shall not be made or provided before the date that
 
is six months after the date of Executive’s
 
Separation from Service.
Any payment or benefit that is delayed pursuant to this Subsection
 
shall be made or provided on the first business day of the
seventh month following the month in which Executive’s
 
Separation from Service occurs. With respect
 
to any cash payment
delayed pursuant to this Subsection, the first payment
 
shall include interest, at the Wall
 
Street Journal Prime Rate published
in the Wall Street
 
Journal on the date of Executive’s
 
Separation from Service (or the previous business day
 
if such date is not
a business day), for the period from the date the payment would
 
have been made but for this Subsection through the date
payment is made. The provisions of this Subsection shall
 
apply only to the extent required to avoid Executive’s
 
incurrence of
any additional tax or interest under section 409A of the
 
Code.
 
For purposes of this Subsection, a “
Separation from Service
”
shall mean Executive’s separation
 
from service with the Company and its affiliates within
 
the meaning of Treas. Reg.
§1.409A-1(h) or any successor thereto.
 
16.
 
Agreement Severability
.
 
If any provision of this Agreement is construed to be invalid,
 
unlawful or unenforceable, then the
remaining provisions hereof shall not be affected
 
thereby and shall be enforceable without regard thereto.
 
 
IN WITNESS WHEREOF,
 
and intending to be legally bound, the parties agree
 
to the terms of this Agreement.
 
 
Quaker Chemical
 
Corporation
Date: 4/22/2021
 
 
By:
 
/s/ Robert T. Traub
 
Name:
 
Robert T. Traub
 
Title:
 
Sr. VP,
 
General Counsel and Corporate Secretary
Date: 4/22/2021
 
By:
 
/s/ Michael F. Barry
 
 
Michael F. Barry
 
 
 EX-31.1 5 exhibit311.htm SECTION 302 CEO CERTIFICATION exhibit311
 
 
1
EXHIBIT 31.1
 
 
CERTIFICATION
 
OF CHIEF EXECUTIVE OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
I, Michael F.
 
Barry, certify that:
 
1.
I have reviewed this quarterly report on Form 10
 
-Q of Quaker Chemical Corporation;
 
2.
Based on my knowledge, this report does not contain
 
any untrue statement of a material fact or omit to state a material
 
fact
necessary to make the statements made, in light of
 
the circumstances under which such statements were made,
 
not misleading with
respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and
 
other financial information included in this report, fairly
 
present in all
material respects the financial condition, results of operations
 
and cash flows of the registrant as of, and for,
 
the periods presented
in this report;
 
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and
 
maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and
 
15d-15(e)) and internal control over financial reporting (as defined
 
in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant
 
and have:
 
 
(a)
Designed such disclosure controls and procedures, or
 
caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information
 
relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those
 
entities, particularly during the period in which this report
 
is
being prepared;
 
 
(b)
Designed such internal control over financial reporting,
 
or caused such internal control over financial reporting to
 
be
designed under our supervision, to provide reasonable
 
assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes
 
in accordance with generally accepted accounting
principles;
 
 
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report
 
our
conclusions about the effectiveness of the disclosure
 
controls and procedures, as of the end of the period covered
 
by
this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
the registrant’s most recent
 
fiscal quarter (the registrant’s
 
fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely
 
to materially affect, the registrant’s
 
internal control over financial
reporting; and
 
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent
 
evaluation of internal control over financial
reporting, to the registrant’s
 
auditors and the audit committee of the registrant’s
 
board of directors (or persons performing the
equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the
 
design or operation of internal control over financial
reporting which are reasonably likely to adversely affect
 
the registrant’s ability to record,
 
process, summarize and
report financial information; and
 
 
(b)
Any fraud, whether or not material, that involves management
 
or other employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
Date: May 6, 2021
 
/s/ Michael F. Barry
Michael F. Barry
Chief Executive Officer
 
 EX-31.2 6 exhibit312.htm SECTION 302 CFO CERTIFICATION exhibit312
 
 
1
EXHIBIT 31.2
 
 
CERTIFICATION
 
OF CHIEF FINANCIAL OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
I, Shane Hostetter, certify that:
 
1.
I have reviewed this quarterly report on Form 10
 
-Q of Quaker Chemical Corporation;
 
2.
Based on my knowledge, this report does not contain
 
any untrue statement of a material fact or omit to state a material
 
fact
necessary to make the statements made, in light of
 
the circumstances under which such statements were made,
 
not misleading with
respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and
 
other financial information included in this report, fairly
 
present in all
material respects the financial condition, results of operations
 
and cash flows of the registrant as of, and for,
 
the periods presented
in this report;
 
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and
 
maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and
 
15d-15(e)) and internal control over financial reporting (as defined
 
in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant
 
and have:
 
 
(a)
Designed such disclosure controls and procedures, or
 
caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information
 
relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those
 
entities, particularly during the period in which this report
 
is
being prepared;
 
 
(b)
Designed such internal control over financial reporting,
 
or caused such internal control over financial reporting to
 
be
designed under our supervision, to provide reasonable
 
assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes
 
in accordance with generally accepted accounting
principles;
 
 
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report
 
our
conclusions about the effectiveness of the disclosure
 
controls and procedures, as of the end of the period covered
 
by
this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
the registrant’s most recent
 
fiscal quarter (the registrant’s
 
fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely
 
to materially affect, the registrant’s
 
internal control over financial
reporting; and
 
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent
 
evaluation of internal control over financial
reporting, to the registrant’s
 
auditors and the audit committee of the registrant’s
 
board of directors (or persons performing the
equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the
 
design or operation of internal control over financial
reporting which are reasonably likely to adversely affect
 
the registrant’s ability to record,
 
process, summarize and
report financial information; and
 
 
(b)
Any fraud, whether or not material, that involves management
 
or other employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
Date: May 6, 2021
 
/s/ Shane W.
 
Hostetter
Shane W.
 
Hostetter
Chief Financial Officer
 
 EX-32.1 7 exhibit321.htm SECTION 906 CEO CERTIFICATION exhibit321
 
 
1
EXHIBIT 32.1
 
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that the Form 10-Q Quarterly
 
Report of Quaker Chemical Corporation (the “Company”)
 
for the
quarterly period ended March 31, 2021 filed with
 
the Securities and Exchange Commission (the “Report”) fully
 
complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition
 
and results of operations of the Company.
 
 
Dated: May 6, 2021
 
 
/s/ Michael F. Barry
 
 
Michael F. Barry
 
 
Chief Executive Officer of Quaker Chemical
 
Corporation
 
 EX-32.2 8 exhibit322.htm SECTION 906 CFO CERTIFICATION exhibit322
 
 
1
EXHIBIT 32.2
 
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that the Form 10-Q Quarterly
 
Report of Quaker Chemical Corporation (the “Company”)
 
for the
quarterly period ended March 31, 2021 filed with
 
the Securities and Exchange Commission (the “Report”) fully
 
complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition
 
and results of operations of the Company.
 
 
Dated: May 6, 2021
 
 
/s/ Shane W.
 
Hostetter
 
 
Shane W.
 
Hostetter
 
 
Chief Financial Officer of Quaker Chemical Corporation
 
 EX-101.SCH 9 kwr-20210331.xsd XBRL EXTENSION SCHEMA DOCUMENT 000200 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 000300 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 000400 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 000500 - Statement - Condensed Consolidated Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 011110 - Disclosure - Income Taxes and Uncertain Tax Positions link:presentationLink link:calculationLink link:definitionLink 011810 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 011910 - Disclosure - Hedging Activities link:presentationLink link:calculationLink link:definitionLink 010810 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 011210 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 010410 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 011410 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 010910 - Disclosure - Pension and Postretirement Benefits link:presentationLink link:calculationLink link:definitionLink 012010 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 011610 - Disclosure - Equity and Noncontrolling Interest link:presentationLink link:calculationLink link:definitionLink 010310 - Disclosure - Recently Issued Accounting Standards link:presentationLink link:calculationLink link:definitionLink 010110 - Disclosure - Condensed Financial Information link:presentationLink link:calculationLink link:definitionLink 000250 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 020110 - Disclosure - Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 040110 - Disclosure - Condensed Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 031110 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 040910 - Disclosure - Pension and Postretirement Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 031510 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 041110 - Disclosure - Income Taxes and Uncertain Tax Positions (Details) link:presentationLink link:calculationLink link:definitionLink 031710 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 041210 - Disclosure - Earnings Per Share - Basic (Details) link:presentationLink link:calculationLink link:definitionLink 041220 - Disclosure - Earnings Per Share - Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 041230 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 041710 - Disclosure - Fair Value Measurements - Assets (Details) link:presentationLink link:calculationLink link:definitionLink 040220 - Disclosure - Business Combinations - Purchase accounting (Details) link:presentationLink link:calculationLink link:definitionLink 040211 - Disclosure - Business Combination- Other (Details) link:presentationLink link:calculationLink link:definitionLink 031610 - Disclosure - Equity and Noncontrolling Interest (Tables) link:presentationLink link:calculationLink link:definitionLink 030410 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 040409 - Disclosure - Business Segments (Details) link:presentationLink link:calculationLink link:definitionLink 041610 - Disclosure - Equity and Noncontrolling Interest (Details) link:presentationLink link:calculationLink link:definitionLink 031910 - Disclosure - Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 041820 - Disclosure - Hedging Activities - Table (Details) link:presentationLink link:calculationLink link:definitionLink 041810 - Disclosure - Hedging Activities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 041620 - Disclosure - Equity and Noncontrolling Interest - Parentheticals (Details) link:presentationLink link:calculationLink link:definitionLink 030810 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 040810 - Disclosure - Share-Based Compensation - Expense Table (Details) link:presentationLink link:calculationLink link:definitionLink 031310 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 041410 - Disclosure - Goodwill Assets (Details) link:presentationLink link:calculationLink link:definitionLink 041910 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 040820 - Disclosure - Share-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 041720 - Disclosure - Fair Value Measurements - Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 041730 - Disclosure - Fair Value Measurements - Level 3 Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 041420 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 041430 - Disclosure - Intangible Assets - Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 040830 - Disclosure - Share-Based Compensation - Excess Tax Benefit (Details) link:presentationLink link:calculationLink link:definitionLink 010210 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 041630 - Disclosure - Equity and Noncontrolling Interest - Reclassifications (Details) link:presentationLink link:calculationLink link:definitionLink 041510 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 011510 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 011010 - Disclosure - Other Income (Expense) link:presentationLink link:calculationLink link:definitionLink 031010 - Disclosure - Other Income (Expense) (Tables) link:presentationLink link:calculationLink link:definitionLink 041010 - Disclosure - Other Income (expense) - (Details) link:presentationLink link:calculationLink link:definitionLink 040120 - Disclosure - Condensed Financial Information - Foreign currency (Details) link:presentationLink link:calculationLink link:definitionLink 041440 - Disclosure - Intangible Assets - Future Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 041450 - Disclosure - Intangible Assets - Finite Lived (Details) link:presentationLink link:calculationLink link:definitionLink 010710 - Disclosure - Restructuring and Related Activities link:presentationLink link:calculationLink link:definitionLink 030710 - Disclosure - Restructuring Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 040710 - Disclosure - Restructuring Activities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 040720 - Disclosure - Restructuring Activities (Details) link:presentationLink link:calculationLink link:definitionLink 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 040840 - Disclosure - Share-Based Compensation - Options Grant (Details) link:presentationLink link:calculationLink link:definitionLink 040310 - Disclosure - Recently Issued Accounting Standards - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 010510 - Disclosure - Net Sales and Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 030510 - Disclosure - Net Sales and Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 040510 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 040520 - Disclosure - Net Sales and Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 011310 - Disclosure - Restricted Cash link:presentationLink link:calculationLink link:definitionLink 031210 - Disclosure - Restricted Cash (Tables) link:presentationLink link:calculationLink link:definitionLink 041310 - Disclosure - Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 040625 - Disclosure - Leases Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 040626 - Disclosure - Leases Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 040627 - Disclosure - Leases Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 040628 - Disclosure - Leases Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 010610 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 030610 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 012110 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 030310 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 041509 - Disclosure - Debt - Table Interest rates (Details) link:presentationLink link:calculationLink link:definitionLink 041508 - Disclosure - Debt - Table (Details) link:presentationLink link:calculationLink link:definitionLink 041511 - Disclosure - Debt - Maturity Schedules (Details) link:presentationLink link:calculationLink link:definitionLink 041512 - Disclosure - Debt - Interest Expense Table (Details) link:presentationLink link:calculationLink link:definitionLink 030910 - Disclosure - Pension and Postretirement Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 041411 - Disclosure - Goodwill Narrative (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 kwr-20210331_cal.xml XBRL CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 kwr-20210331_def.xml XBRL DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 kwr-20210331_lab.xml XBRL LABEL LINKBASE DOCUMENT EX-101.PRE 13 kwr-20210331_pre.xml XBRL PRESENTATION LINKBASE DOCUMENT XML 14 kwr-2021033110q_htm.xml IDEA: XBRL DOCUMENT 0000081362 2021-01-01 2021-03-31 0000081362 us-gaap:RestrictedStockMember 2021-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0000081362 2020-01-01 2020-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-01-01 2020-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-01-01 2020-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-01-01 2020-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember 2020-01-01 2020-03-31 0000081362 2021-03-31 0000081362 2020-12-31 0000081362 us-gaap:EMEAMember 2021-03-31 0000081362 srt:AsiaPacificMember 2021-03-31 0000081362 us-gaap:EmployeeStockOptionMember 2021-03-31 0000081362 us-gaap:EMEAMember 2020-12-31 0000081362 srt:AsiaPacificMember 2020-12-31 0000081362 us-gaap:CommonStockMember 2020-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000081362 us-gaap:RetainedEarningsMember 2020-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-03-31 0000081362 2020-03-31 0000081362 us-gaap:CommonStockMember 2021-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-03-31 0000081362 us-gaap:CommonStockMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 2019-12-31 0000081362 us-gaap:CustomerListsMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2020-01-01 2020-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2020-01-01 2020-03-31 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:AssetsTotalMember 2021-01-01 2021-03-31 0000081362 us-gaap:InterestRateSwapMember 2021-03-31 0000081362 us-gaap:InterestExpenseMember 2020-01-01 2020-03-31 0000081362 us-gaap:InterestExpenseMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember 2021-01-01 2021-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember 2020-01-01 2020-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2020-01-01 2020-03-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0000081362 kwr:DefinedbenefitplansettlementMember 2020-07-01 2020-09-30 0000081362 2021-04-30 0000081362 srt:AmericasMember 2020-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2021-03-31 0000081362 srt:AmericasMember 2021-03-31 0000081362 kwr:TrademarksFomrulationsAndProductTechnologyMember 2020-12-31 0000081362 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2020-01-01 2020-12-31 0000081362 kwr:DebtinstrumentidrbMember 2020-12-31 0000081362 kwr:DebtinstrumentidrbMember 2021-03-31 0000081362 us-gaap:CustomerListsMember 2021-03-31 0000081362 kwr:TrademarksFomrulationsAndProductTechnologyMember 2021-03-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2021-03-31 0000081362 kwr:ArgentinaSubsidiaryMember 2020-01-01 2020-03-31 0000081362 kwr:ArgentinaSubsidiaryMember 2021-01-01 2021-03-31 0000081362 kwr:TinplatingsolutionsMember 2021-01-01 2021-03-31 0000081362 kwr:TinplatingsolutionsMember 2021-03-31 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerListsMember 2021-03-31 0000081362 kwr:TinplatingsolutionsMember kwr:ProducttechnologyMember 2021-03-31 0000081362 kwr:TinplatingsolutionsMember kwr:LicensedtrademarkMember 2021-03-31 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerListsMember 2021-01-01 2021-03-31 0000081362 kwr:TinplatingsolutionsMember kwr:ProducttechnologyMember 2021-01-01 2021-03-31 0000081362 kwr:TinplatingsolutionsMember kwr:LicensedtrademarkMember 2021-01-01 2021-03-31 0000081362 kwr:GrindaixgmbhMember 2021-03-31 0000081362 kwr:GrindaixgmbhMember 2021-01-01 2021-03-31 0000081362 kwr:CoralchemicalcompanyMember 2020-10-01 2020-12-31 0000081362 kwr:TelnordicMember 2020-04-01 2020-06-30 0000081362 kwr:TelnordicMember 2020-06-30 0000081362 kwr:NormanhaymemberMember 2019-10-01 2019-12-31 0000081362 kwr:NormanhaymemberMember 2020-01-01 2020-03-31 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralchemicalcompanyMember 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralchemicalcompanyMember 2020-12-22 0000081362 kwr:CoralchemicalcompanyMember 2020-12-22 0000081362 kwr:TelnordicMember 2020-01-01 2020-03-31 0000081362 us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000081362 kwr:CustomerconcentrationrisktopfivemembermemberMember 2020-01-01 2020-12-31 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-03-31 0000081362 kwr:MetalsMember 2021-01-01 2021-03-31 0000081362 kwr:MetalsMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 kwr:MetalsMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 kwr:MetalsMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 kwr:MetalworkingandOtherMember 2021-01-01 2021-03-31 0000081362 kwr:MetalworkingandOtherMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 kwr:MetalworkingandOtherMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 kwr:MetalworkingandOtherMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember srt:AmericasMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2021-01-01 2021-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2021-01-01 2021-03-31 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-03-31 0000081362 us-gaap:TransferredOverTimeMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-03-31 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-03-31 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-03-31 0000081362 kwr:MetalsMember 2020-01-01 2020-03-31 0000081362 kwr:MetalsMember srt:AmericasMember 2020-01-01 2020-03-31 0000081362 kwr:MetalsMember us-gaap:EMEAMember 2020-01-01 2020-03-31 0000081362 kwr:MetalsMember srt:AsiaPacificMember 2020-01-01 2020-03-31 0000081362 kwr:MetalworkingandOtherMember 2020-01-01 2020-03-31 0000081362 kwr:MetalworkingandOtherMember srt:AmericasMember 2020-01-01 2020-03-31 0000081362 kwr:MetalworkingandOtherMember us-gaap:EMEAMember 2020-01-01 2020-03-31 0000081362 kwr:MetalworkingandOtherMember srt:AsiaPacificMember 2020-01-01 2020-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember srt:AmericasMember 2020-01-01 2020-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2020-01-01 2020-03-31 0000081362 kwr:GlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember srt:AmericasMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithGlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember srt:AmericasMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2020-01-01 2020-03-31 0000081362 kwr:TotalSalesWithoutGlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2020-01-01 2020-03-31 0000081362 us-gaap:LandMember 2021-03-31 0000081362 kwr:FacilitiesvehiclesandmachineryandequipmentMember 2021-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-03-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-01-01 2020-03-31 0000081362 kwr:PerformanceincentivestockunitsMember 2020-01-01 2020-03-31 0000081362 kwr:RestrictedStockGaipPlanMember 2020-01-01 2020-03-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-01-01 2021-03-31 0000081362 kwr:PerformanceincentivestockunitsMember 2021-01-01 2021-03-31 0000081362 kwr:RestrictedStockGaipPlanMember 2021-01-01 2021-03-31 0000081362 kwr:CombinationandotheracquisitionrelatedMember 2021-01-01 2021-03-31 0000081362 kwr:CombinationandotheracquisitionrelatedMember 2020-01-01 2020-03-31 0000081362 kwr:DefinedContributionPlanMember 2021-01-01 2021-03-31 0000081362 kwr:PerformanceincentivestockunitsMember 2021-03-31 0000081362 kwr:OtherEnvironmentalMattersMember 2020-12-31 0000081362 kwr:OtherEnvironmentalMattersMember 2021-03-31 0000081362 kwr:ForeignconsumptiontaxmemberMember 2021-03-31 0000081362 srt:MaximumMember kwr:ForeignconsumptiontaxmemberMember 2021-03-31 0000081362 srt:MinimumMember kwr:ForeignconsumptiontaxmemberMember 2021-03-31 0000081362 kwr:ForeignconsumptiontaxmemberMember 2021-01-01 2021-03-31 0000081362 us-gaap:InterestRateSwapMember 2021-01-01 2021-03-31 0000081362 us-gaap:InterestRateSwapMember 2020-01-01 2020-03-31 0000081362 2020-01-01 2020-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2020-12-31 0000081362 us-gaap:InterestRateSwapMember 2020-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2021-03-31 0000081362 us-gaap:FairValueInputsLevel1Member 2021-03-31 0000081362 us-gaap:FairValueInputsLevel2Member 2021-03-31 0000081362 us-gaap:FairValueInputsLevel3Member 2021-03-31 0000081362 us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000081362 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000081362 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000081362 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000081362 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2020-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2021-03-31 0000081362 us-gaap:DomesticLineOfCreditMember 2021-03-31 0000081362 us-gaap:ForeignLineOfCreditMember 2021-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-03-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-03-31 0000081362 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember 2021-01-01 2021-03-31 0000081362 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2021-01-01 2021-03-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2021-01-01 2021-03-31 0000081362 us-gaap:DebtMember 2021-01-01 2021-03-31 0000081362 us-gaap:DebtMember 2021-03-31 0000081362 us-gaap:SalesRevenueNetMember 2021-01-01 2021-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-01-01 2021-03-31 0000081362 country:IT us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 country:BR us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 country:NL us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 country:CN us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 country:MX us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 country:ES us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 country:DE us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 country:GB us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 country:CA us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-03-31 0000081362 us-gaap:ChangeInAccountingPrincipleIndirectEffectMember us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:ChangeInAccountingPrincipleIndirectEffectMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:ChangeInAccountingPrincipleIndirectEffectMember us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:ChangeInAccountingPrincipleIndirectEffectMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:ChangeInAccountingPrincipleIndirectEffectMember us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonStockMember 2020-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2020-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-12-31 0000081362 us-gaap:ChangeInAccountingPrincipleIndirectEffectMember 2020-12-31 0000081362 country:IT 2021-03-31 0000081362 country:DE 2021-03-31 0000081362 country:IN us-gaap:ForeignCountryMember 2021-01-01 2021-03-31 0000081362 srt:MinimumMember kwr:AcpMember 2021-03-31 0000081362 srt:MaximumMember kwr:AcpMember 2021-03-31 0000081362 kwr:SbDeckingMember 2021-03-31 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2021-03-31 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2021-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2021-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2020-12-31 0000081362 kwr:HoughtonCombinationMember 2021-03-31 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-01-01 2020-03-31 0000081362 country:IT us-gaap:ForeignCountryMember 2021-03-31 0000081362 country:ES us-gaap:ForeignCountryMember 2021-03-31 0000081362 kwr:LegacyQuakerMember 2019-01-01 2019-03-31 iso4217:DKK iso4217:EUR iso4217:GBP iso4217:USD iso4217:ZAR pure shares iso4217:USD shares dummy:People false 2021 --12-31 Q1 0000081362 PA P1Y P1Y P1Y true false false false false 10-Q 2021-03-31 001-12019 QUAKER CHEMICAL CORPORATION 23-0993790 901 E. Hector Street Conshohocken PA 19428 – 2380 610 832-4000 Common Stock, $1 par value KWR NYSE Yes Yes Large Accelerated Filer 17873331 429783000 378561000 273589000 244710000 156194000 133851000 104310000 98701000 0 38000000 1175000 1716000 5815000 7878000 44894000 -12444000 4687000 -21175000 -5470000 -8461000 44111000 -42080000 10689000 -13070000 33422000 -29010000 5210000 666000 38632000 -28344000 17000 37000 38615000 -28381000 2.16 -1.60 2.15 -1.60 0.395 0.385 38632000 -28344000 -25461000 -54751000 -1292000 -16957000 562000 -3981000 -3025000 -1711000 -26632000 -43486000 12000000 -71830000 15000 -95000 11985000 -71735000 163455000 181833000 411523000 372974000 97631000 86148000 110147000 101616000 48285000 50156000 831041000 792727000 416514000 423253000 220724000 219370000 195790000 203883000 38027000 38507000 627574000 631212000 1075343000 1081358000 96213000 95785000 17057000 16566000 31906000 31796000 2912951000 2891834000 43330000 38967000 214015000 198872000 29091000 43300000 5970000 8248000 104029000 93573000 396435000 382960000 859433000 849068000 27050000 27070000 186031000 192763000 114549000 119059000 1583498000 1570920000 1 1 30000000 30000000 17875076 17850616 17875000 17851000 908748000 905171000 455493000 423940000 -53228000 -26598000 1328888000 1320364000 565000 550000 1329453000 1320914000 2912951000 2891834000 38632000 -28344000 1187000 1187000 22145000 21197000 5105000 -4285000 801000 0 -9888000 -22988000 3779000 4682000 5410000 2000 0 229000 0 38000000 -2884000 -519000 1175000 1716000 -1034000 22453000 46270000 -2322000 24994000 10162000 8315000 3263000 -3034000 -4841000 26597000 -5275000 -12618000 20219000 3934000 4892000 26655000 3160000 14744000 0 0 31000 -15845000 -8021000 9551000 9371000 30000000 205500000 -188000 -185000 7052000 6828000 -178000 -696000 0 1047000 0 751000 13031000 186622000 -3008000 -6424000 -18440000 192396000 181895000 143555000 163455000 335951000 <div id="TextBlockContainer4" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:739px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3170" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 1 – Basis of Presentation and Description of Business<div style="display:inline-block;width:4.9px"> </div></div><div id="a3192" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:20.8px;">Basis of Presentation </div><div id="a3198" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:41.4px;">As used in these Notes to Condensed Consolidated<div style="display:inline-block;width:4.74px"> </div>Financial Statements, the terms “Quaker”, “Quaker Houghton”,<div style="display:inline-block;width:4.79px"> </div>the </div><div id="a3230" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:56.6px;">“Company”, “we”, and “our” refer to Quaker Chemical<div style="display:inline-block;width:4.82px"> </div>Corporation (doing business as Quaker Houghton), its subsidiaries, and </div><div id="a3264" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:72px;">associated companies, unless the context otherwise requires.<div style="display:inline-block;width:8.19px"> </div>As used in these Notes to Condensed Consolidated<div style="display:inline-block;width:4.74px"> </div>Financial Statements, </div><div id="a3299" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:87.4px;">the term Legacy Quaker refers to the Company prior<div style="display:inline-block;width:4.72px"> </div>to the closing of its combination with Houghton International,<div style="display:inline-block;width:4.62px"> </div>Inc. (“Houghton”) </div><div id="a3339" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.7px;">(herein referred to as the “Combination”).<div style="display:inline-block;width:7.75px"> </div></div><div id="div_2_XBRL_TS_84e0054e89654e269d0603ff9702e4d1" style="position:absolute;left:0px;top:102.7px;float:left;"><div id="TextBlockContainer3" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:139px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3339_44_87" style="position:absolute;font-weight:normal;font-style:normal;left:234.893px;top:0px;">The condensed consolidated financial statements included herein<div style="display:inline-block;width:4.83px"> </div>are unaudited and have </div><div id="a3373" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">been prepared in accordance with generally accepted<div style="display:inline-block;width:4.74px"> </div>accounting principles in the United States (“U.S. GAAP”) for<div style="display:inline-block;width:4.73px"> </div>interim financial </div><div id="a3409" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">reporting and the United States Securities and Exchange Commission<div style="display:inline-block;width:4.92px"> </div>(“SEC”) regulations.<div style="display:inline-block;width:7.15px"> </div>Certain information and footnote </div><div id="a3440" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">disclosures normally included in financial statements prepared<div style="display:inline-block;width:4.81px"> </div>in accordance with U.S. GAAP have been condensed or<div style="display:inline-block;width:4.6px"> </div>omitted </div><div id="a3474" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">pursuant to such rules and regulations.<div style="display:inline-block;width:7.74px"> </div>In the opinion of management, the financial statements reflect all<div style="display:inline-block;width:4.7px"> </div>adjustments which are </div><div id="a3513" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">necessary for a fair statement of the financial position,<div style="display:inline-block;width:4.62px"> </div>results of operations and cash flows for the interim periods.<div style="display:inline-block;width:8.21px"> </div>The results for the </div><div id="a3559" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92px;">three months ended March 31, 2021 are not necessarily<div style="display:inline-block;width:4.72px"> </div>indicative of the results to be expected for the full year.<div style="display:inline-block;width:8.83px"> </div>These financial </div><div id="a3603" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.4px;">statements should be read in conjunction with the Company’s<div style="display:inline-block;width:5.45px"> </div>Annual Report filed on Form 10-K for the year<div style="display:inline-block;width:4.74px"> </div>ended December 31, </div><div id="a3648" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:122.8px;">2020 (the “2020 Form 10-K”).</div></div></div><div id="a3648_28_3" style="position:absolute;font-weight:normal;font-style:normal;left:167.813px;top:225.5px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a3663" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:246.1px;">Description of Business </div><div id="a3669" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:266.8px;">The Company was organized in 1918, incorporated<div style="display:inline-block;width:4.89px"> </div>as a Pennsylvania business corporation in 1930, and in August<div style="display:inline-block;width:4.75px"> </div>2019 </div><div id="a3705" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:282.1px;">completed the Combination with Houghton to form<div style="display:inline-block;width:4.79px"> </div>Quaker Houghton.<div style="display:inline-block;width:7.08px"> </div>Quaker Houghton is a global leader in industrial process </div><div id="a3742" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:297.3px;">fluids.<div style="display:inline-block;width:6.94px"> </div>With a presence around the world,<div style="display:inline-block;width:4.71px"> </div>including operations in over </div><div id="a3742_72_2" style="position:absolute;left:385.293px;top:297.3px;">25</div><div id="a3742_74_57" style="position:absolute;font-weight:normal;font-style:normal;left:398.6px;top:297.3px;"><div style="display:inline-block;width:3.36px"> </div>countries, the Company’s customers<div style="display:inline-block;width:4.95px"> </div>include thousands of </div><div id="a3781" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:312.7px;">the world’s most advanced<div style="display:inline-block;width:4.76px"> </div>and specialized steel, aluminum, automotive, aerospace,<div style="display:inline-block;width:4.63px"> </div>offshore, can, mining, and metalworking </div><div id="a3811" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:328px;">companies.<div style="display:inline-block;width:7.12px"> </div>Quaker Houghton develops, produces, and markets a broad range<div style="display:inline-block;width:4.68px"> </div>of formulated chemical specialty products and offers </div><div id="a3845" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:343.4px;">chemical management services (which the Company refers<div style="display:inline-block;width:4.72px"> </div>to as “Fluidcare”) for various heavy industrial and manufacturing </div><div id="a3878" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:358.8px;">applications throughout its </div><div id="a3878_28_4" style="position:absolute;left:150.053px;top:358.8px;">four</div><div id="a3878_32_97" style="position:absolute;font-weight:normal;font-style:normal;left:172.293px;top:358.8px;"><div style="display:inline-block;width:3.36px"> </div>segments: Americas; Europe, Middle East and Africa (“EMEA”);<div style="display:inline-block;width:4.81px"> </div>Asia/Pacific; and Global Specialty </div><div id="a3910" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:374.1px;">Businesses. </div><div id="a3912" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:394.8px;">Hyper-inflationary economies</div><div id="a3917" style="position:absolute;font-weight:normal;font-style:normal;left:164.773px;top:394.8px;"> </div><div id="a3918" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:415.4px;">Based on various indices or index compilations being<div style="display:inline-block;width:4.67px"> </div>used to monitor inflation in Argentina as well as economic<div style="display:inline-block;width:4.99px"> </div>instability, </div><div id="a3956" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:430.8px;">effective July 1, 2018, Argentina’s<div style="display:inline-block;width:5.33px"> </div>economy was considered hyper-inflationary under U.S.<div style="display:inline-block;width:4.55px"> </div>GAAP.<div style="display:inline-block;width:8.23px"> </div>As a result, the Company began </div><div id="a3995" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:446.1px;">applying hyper-inflationary accounting with respect<div style="display:inline-block;width:4.71px"> </div>to the Company's wholly owned Argentine<div style="display:inline-block;width:4.52px"> </div>subsidiary beginning July 1, 2018.<div style="display:inline-block;width:7.48px"> </div>In </div><div id="a4035" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:461.3px;">addition, Houghton has an Argentina<div style="display:inline-block;width:4.49px"> </div>subsidiary to which hyper-inflationary accounting also is applied.<div style="display:inline-block;width:8.24px"> </div>As of, and for the three </div><div id="a4076" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:476.7px;">months ended March 31, 2021, the Company's Argentine<div style="display:inline-block;width:4.9px"> </div>subsidiaries represented less than </div><div id="a4076_88_1" style="position:absolute;left:493.64px;top:476.7px;">1</div><div id="a4076_89_38" style="position:absolute;font-weight:normal;font-style:normal;left:500.36px;top:476.7px;">% of the Company’s consolidated<div style="display:inline-block;width:4.79px"> </div>total </div><div id="a4115" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:492.1px;">assets and net sales, respectively.<div style="display:inline-block;width:8.46px"> </div>During the three months ended March 31, 2021 and 2020,<div style="display:inline-block;width:4.75px"> </div>the Company recorded $</div><div id="a4115_114_3" style="position:absolute;left:632.56px;top:492.1px;">0.2</div><div id="a4115_117_13" style="position:absolute;font-weight:normal;font-style:normal;left:649.04px;top:492.1px;"><div style="display:inline-block;width:3.36px"> </div>million and </div><div id="a4161" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:507.4px;">$</div><div id="a4161_1_3" style="position:absolute;left:11.147px;top:507.4px;">0.1</div><div id="a4161_4_129" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:507.4px;"><div style="display:inline-block;width:3.36px"> </div>million, respectively, of<div style="display:inline-block;width:4.58px"> </div>remeasurement losses associated with the applicable currency conversions<div style="display:inline-block;width:5.13px"> </div>related to Argentina.<div style="display:inline-block;width:7.25px"> </div>These </div><div id="a4195" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:522.8px;">losses were recorded within foreign exchange (losses) gains,<div style="display:inline-block;width:4.74px"> </div>net, which is a component of other income (expense),<div style="display:inline-block;width:4.66px"> </div>net, in the </div><div id="a4235" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:538.1px;">Company’s Condensed<div style="display:inline-block;width:4.71px"> </div>Consolidated Statements of Operations. </div><div id="a4248" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:558.8px;">COVID-19 </div><div id="a4252" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:579.4px;">Management continues to monitor the impact that the COVID-19<div style="display:inline-block;width:4.97px"> </div>pandemic is having on the Company,<div style="display:inline-block;width:5px"> </div>the overall specialty </div><div id="a4290" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:594.8px;">chemical industry,<div style="display:inline-block;width:4.71px"> </div>and the economies and markets in which the Company operates.<div style="display:inline-block;width:8.17px"> </div>The full extent of the COVID-19 pandemic </div><div id="a4330" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:610px;">related business and travel restrictions and changes to<div style="display:inline-block;width:4.77px"> </div>business and consumer behavior intended to reduce its spread are<div style="display:inline-block;width:4.74px"> </div>uncertain as of </div><div id="a4372" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:625.3px;">the date of this Quarterly Report on Form 10-Q for the<div style="display:inline-block;width:4.59px"> </div>period ended March 31, 2021 (the “Report”) as COVID-19<div style="display:inline-block;width:4.8px"> </div>and the responses </div><div id="a4422" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:640.7px;">of governmental authorities continue to evolve globally. </div><div id="a4436" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:661.4px;">Further, management continues to<div style="display:inline-block;width:4.71px"> </div>evaluate how COVID-19-related circumstances, such as remote<div style="display:inline-block;width:4.81px"> </div>work arrangements, affect </div><div id="a4468" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:676.7px;">financial reporting processes, internal control over financial<div style="display:inline-block;width:4.82px"> </div>reporting, and disclosure controls and procedures.<div style="display:inline-block;width:7.87px"> </div>While the </div><div id="a4499" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:692.1px;">circumstances have presented and are expected to continue<div style="display:inline-block;width:4.79px"> </div>to present challenges, at this time, Management does not believe that </div><div id="a4538" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:707.5px;">COVID-19 has had a material impact on financial reporting<div style="display:inline-block;width:4.69px"> </div>processes, internal control over financial reporting,<div style="display:inline-block;width:4.71px"> </div>and disclosure </div><div id="a4574" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:722.8px;">controls and procedures.</div></div><div id="TextBlockContainer6" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:113px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4579" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company cannot reasonably estimate the magnitude<div style="display:inline-block;width:4.81px"> </div>of the effects these conditions will have on the Company’s<div style="display:inline-block;width:5.57px"> </div>operations in </div><div id="a4617" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">the future as they are subject to significant uncertainties<div style="display:inline-block;width:4.71px"> </div>relating to the ultimate geographic spread of the virus,<div style="display:inline-block;width:4.7px"> </div>the incidence and </div><div id="a4659" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">severity of the symptoms, the duration or resurgence<div style="display:inline-block;width:4.93px"> </div>of the outbreak, the global availability and acceptance of vaccines<div style="display:inline-block;width:4.66px"> </div>as well as their </div><div id="a4703" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">efficacy,<div style="display:inline-block;width:4.82px"> </div>the length of the travel restrictions and business<div style="display:inline-block;width:4.27px"> </div>closures imposed by governments of impacted countries,<div style="display:inline-block;width:4.74px"> </div>and the economic </div><div id="a4742" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">response by governments of impacted countries. </div><div id="a4754" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:81.9px;">To the extent<div style="display:inline-block;width:4.81px"> </div>that the Company’s customers and<div style="display:inline-block;width:4.78px"> </div>suppliers continue to be significantly and adversely impacted by<div style="display:inline-block;width:4.81px"> </div>COVID-19, this </div><div id="a4795" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:97.3px;">could reduce the availability,<div style="display:inline-block;width:4.84px"> </div>or result in delays, of materials or supplies to or from<div style="display:inline-block;width:4.71px"> </div>the Company, which in<div style="display:inline-block;width:4.81px"> </div>turn could significantly </div></div><div id="TextBlockContainer8" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:722px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4889" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">interrupt the Company’s<div style="display:inline-block;width:4.7px"> </div>business operations.<div style="display:inline-block;width:7.15px"> </div>Such impacts could grow and become more significant to the<div style="display:inline-block;width:4.76px"> </div>Company’s operations </div><div id="a4924" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">and the Company’s liquidity<div style="display:inline-block;width:4.84px"> </div>or financial position.<div style="display:inline-block;width:7.21px"> </div>Therefore, given the speed and frequency of continuously<div style="display:inline-block;width:4.78px"> </div>evolving developments </div><div id="a4958" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">with respect to this pandemic, the Company cannot reasonably<div style="display:inline-block;width:4.81px"> </div>estimate the magnitude or the full extent to which COVID-19<div style="display:inline-block;width:4.78px"> </div>may </div><div id="a5001" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">impact the Company’s results<div style="display:inline-block;width:4.77px"> </div>of operations, liquidity or financial position.</div></div> <div id="TextBlockContainer3" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:139px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3339_44_87" style="position:absolute;font-weight:normal;font-style:normal;left:234.893px;top:0px;">The condensed consolidated financial statements included herein<div style="display:inline-block;width:4.83px"> </div>are unaudited and have </div><div id="a3373" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">been prepared in accordance with generally accepted<div style="display:inline-block;width:4.74px"> </div>accounting principles in the United States (“U.S. GAAP”) for<div style="display:inline-block;width:4.73px"> </div>interim financial </div><div id="a3409" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">reporting and the United States Securities and Exchange Commission<div style="display:inline-block;width:4.92px"> </div>(“SEC”) regulations.<div style="display:inline-block;width:7.15px"> </div>Certain information and footnote </div><div id="a3440" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">disclosures normally included in financial statements prepared<div style="display:inline-block;width:4.81px"> </div>in accordance with U.S. GAAP have been condensed or<div style="display:inline-block;width:4.6px"> </div>omitted </div><div id="a3474" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">pursuant to such rules and regulations.<div style="display:inline-block;width:7.74px"> </div>In the opinion of management, the financial statements reflect all<div style="display:inline-block;width:4.7px"> </div>adjustments which are </div><div id="a3513" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">necessary for a fair statement of the financial position,<div style="display:inline-block;width:4.62px"> </div>results of operations and cash flows for the interim periods.<div style="display:inline-block;width:8.21px"> </div>The results for the </div><div id="a3559" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92px;">three months ended March 31, 2021 are not necessarily<div style="display:inline-block;width:4.72px"> </div>indicative of the results to be expected for the full year.<div style="display:inline-block;width:8.83px"> </div>These financial </div><div id="a3603" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.4px;">statements should be read in conjunction with the Company’s<div style="display:inline-block;width:5.45px"> </div>Annual Report filed on Form 10-K for the year<div style="display:inline-block;width:4.74px"> </div>ended December 31, </div><div id="a3648" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:122.8px;">2020 (the “2020 Form 10-K”).</div></div> 25 4 0.01 0.01 200000 100000 <div id="TextBlockContainer10" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:734px;height:331px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5021" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 2 – Business Acquisitions </div><div id="a5031" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:20.6px;">2021 Acquisitions </div><div id="a5035" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:41.3px;">In February 2021, the Company acquired a tin-plating<div style="display:inline-block;width:4.83px"> </div>solutions business for the steel end market for approximately $</div><div id="a5035_116_2" style="position:absolute;left:655.279px;top:41.3px;">25</div><div id="a5035_118_11" style="position:absolute;font-weight:normal;font-style:normal;left:668.559px;top:41.3px;"><div style="display:inline-block;width:3.2px"> </div>million.<div style="display:inline-block;width:3.59px"> </div></div><div id="a5075" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:56.6px;">The Company allocated $</div><div id="a5075_23_4" style="position:absolute;left:141.893px;top:56.6px;">19.6</div><div id="a5075_27_67" style="position:absolute;font-weight:normal;font-style:normal;left:165.093px;top:56.6px;"><div style="display:inline-block;width:3.36px"> </div>million of the purchase price to intangible assets, comprised<div style="display:inline-block;width:4.74px"> </div>of $</div><div id="a5075_94_4" style="position:absolute;left:513.479px;top:56.6px;">18.3</div><div id="a5075_98_36" style="position:absolute;font-weight:normal;font-style:normal;left:536.84px;top:56.6px;"><div style="display:inline-block;width:3.2px"> </div>million of customer relationships, </div><div id="a5113" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:72px;">to be amortized over </div><div id="a5113_21_2" style="position:absolute;left:117.893px;top:72px;">19</div><div id="a5113_23_9" style="position:absolute;font-weight:normal;font-style:normal;left:131.173px;top:72px;"><div style="display:inline-block;width:3.36px"> </div>years; $</div><div id="a5113_32_3" style="position:absolute;left:176.293px;top:72px;">0.9</div><div id="a5113_35_61" style="position:absolute;font-weight:normal;font-style:normal;left:193.093px;top:72px;"><div style="display:inline-block;width:3.2px"> </div>million of existing product technology to be amortized over </div><div id="a5113_96_2" style="position:absolute;left:518.28px;top:72px;">14</div><div id="a5113_98_13" style="position:absolute;font-weight:normal;font-style:normal;left:531.56px;top:72px;"><div style="display:inline-block;width:3.36px"> </div>years; and $</div><div id="a5113_111_3" style="position:absolute;left:599.279px;top:72px;">0.4</div><div id="a5113_114_14" style="position:absolute;font-weight:normal;font-style:normal;left:616.079px;top:72px;"><div style="display:inline-block;width:3.36px"> </div>million of a </div><div id="a5160" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:87.2px;">licensed trademark to be amortized over </div><div id="a5160_40_1" style="position:absolute;left:222.253px;top:87.2px;">3</div><div id="a5160_41_44" style="position:absolute;font-weight:normal;font-style:normal;left:228.973px;top:87.2px;"><div style="display:inline-block;width:3.36px"> </div>years.<div style="display:inline-block;width:6.74px"> </div>In addition, the Company recorded $</div><div id="a5160_85_3" style="position:absolute;left:466.76px;top:87.2px;">5.0</div><div id="a5160_88_41" style="position:absolute;font-weight:normal;font-style:normal;left:483.4px;top:87.2px;"><div style="display:inline-block;width:3.2px"> </div>million of goodwill related to expected </div><div id="a5200" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.6px;">value not allocated to other acquired assets, all of which<div style="display:inline-block;width:4.83px"> </div>is expected to be tax deductible.<div style="display:inline-block;width:7.1px"> </div>As of March 31, 2021, the allocation of the </div><div id="a5251" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117.9px;">purchase price has not been finalized and the </div><div id="a5251_46_8" style="position:absolute;left:247.533px;top:117.9px;-sec-ix-hidden:ID_553;">one-year</div><div id="a5251_54_78" style="position:absolute;font-weight:normal;font-style:normal;left:294.253px;top:117.9px;"><div style="display:inline-block;width:3.2px"> </div>measurement period has not ended.<div style="display:inline-block;width:7.52px"> </div>Further adjustments may be necessary as a </div><div id="a5295" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:133.3px;">result of the Company’s<div style="display:inline-block;width:4.78px"> </div>on-going assessment of additional information related to the fair value<div style="display:inline-block;width:4.73px"> </div>of assets acquired and liabilities </div><div id="a5336" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:148.7px;">assumed. </div><div id="a5338" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:169.3px;">Additionally, in<div style="display:inline-block;width:4.79px"> </div>February 2021, the Company acquired a </div><div id="a5338_55_2" style="position:absolute;left:334.413px;top:169.3px;">38</div><div id="a5338_57_64" style="position:absolute;font-weight:normal;font-style:normal;left:347.693px;top:169.3px;">% ownership interest in Grindaix-GmbH (“Grindaix”),<div style="display:inline-block;width:4.88px"> </div>a privately </div><div id="a5372" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.7px;">held, German-based, high-tech provider of coolant control<div style="display:inline-block;width:4.87px"> </div>and delivery systems for approximately </div><div id="a5372_97_3" style="position:absolute;left:533.48px;top:184.7px;">1.4</div><div id="a5372_100_30" style="position:absolute;font-weight:normal;font-style:normal;left:550.12px;top:184.7px;"><div style="display:inline-block;width:3.36px"> </div>million EUR or approximately </div><div id="a5410" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:199.9px;">$</div><div id="a5410_1_3" style="position:absolute;left:11.147px;top:199.9px;">1.7</div><div id="a5410_4_130" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:199.9px;"><div style="display:inline-block;width:3.36px"> </div>million.<div style="display:inline-block;width:6.82px"> </div>Grindaix's solutions apply to a wide range of machining processes,<div style="display:inline-block;width:4.77px"> </div>including grinding applications in the metalworking </div><div id="a5447" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:215.2px;">sector.<div style="display:inline-block;width:7.66px"> </div>The Company recorded the investment in Grindaix as an equity<div style="display:inline-block;width:4.83px"> </div>method investment within the Condensed Consolidated </div><div id="a5481" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:230.6px;">Financial Statements. </div><div id="a5485" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:254px;">The results of operations of the acquired businesses subsequent<div style="display:inline-block;width:4.84px"> </div>to the respective acquisition dates are included in<div style="display:inline-block;width:4.7px"> </div>the Condensed </div><div id="a5524" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:269.3px;">Consolidated Statements of Operations as of March<div style="display:inline-block;width:4.71px"> </div>31, 2021.<div style="display:inline-block;width:6.84px"> </div>Transaction expenses associated with these<div style="display:inline-block;width:4.76px"> </div>acquisitions are included in </div><div id="a5560" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:284.7px;">Combination, integration and other acquisition-related<div style="display:inline-block;width:4.74px"> </div>expenses in the Company’s Condensed<div style="display:inline-block;width:4.74px"> </div>Consolidated Statements of Operations.<div style="display:inline-block;width:4.27px"> </div></div><div id="a5590" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:299.9px;">Certain pro forma and other information is not presented,<div style="display:inline-block;width:4.78px"> </div>as the operations of the acquired businesses are not considered material to </div><div id="a5632" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:315.2px;">the overall operations of the Company for the periods presented.</div></div><div id="TextBlockContainer12" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:130px;height:16px;display:inline-block;"><div id="a5653" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Previous Acquisitions</div></div><div id="TextBlockContainer14" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5657" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">In December 2020,<div style="display:inline-block;width:3.96px"> </div>the Company completed its acquisition of Coral Chemical Company<div style="display:inline-block;width:4.73px"> </div>(“Coral”), a privately held, U.S.-based </div><div id="a5697" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">provider of metal finishing fluid solutions.<div style="display:inline-block;width:7.77px"> </div>The acquisition provides technical expertise and product solutions<div style="display:inline-block;width:4.77px"> </div>for pre-treatment, </div><div id="a5732" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">metalworking and wastewater treatment applications<div style="display:inline-block;width:4.77px"> </div>to the beverage cans and general industrial end markets.<div style="display:inline-block;width:7.93px"> </div>The original purchase </div><div id="a5768" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">price was approximately $</div><div id="a5768_25_4" style="position:absolute;left:145.573px;top:45.9px;">54.1</div><div id="a5768_29_103" style="position:absolute;font-weight:normal;font-style:normal;left:168.933px;top:45.9px;"><div style="display:inline-block;width:3.36px"> </div>million, subject to routine and customary post-closing adjustments related<div style="display:inline-block;width:4.92px"> </div>to working capital and net </div><div id="a5808" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">indebtedness levels.<div style="display:inline-block;width:7.25px"> </div>The Company anticipates finalizing its post-closing adjustments<div style="display:inline-block;width:4.87px"> </div>for the Coral acquisition in the second quarter of </div><div id="a5847" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.7px;">2021 and currently estimates it will receive approximately<div style="display:inline-block;width:4.75px"> </div>$</div><div id="a5847_60_3" style="position:absolute;left:325.133px;top:76.7px;">0.4</div><div id="a5847_63_36" style="position:absolute;font-weight:normal;font-style:normal;left:341.933px;top:76.7px;"><div style="display:inline-block;width:3.36px"> </div>million to settle such adjustments.</div></div><div id="TextBlockContainer16" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:519px;height:16px;display:inline-block;"><div id="a5876" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">The following table presents the preliminary estimated fair<div style="display:inline-block;width:4.68px"> </div>values of Coral net assets acquired:</div></div><div id="TextBlockContainer20" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:703px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_18_XBRL_TS_66687ce8d476422e9e0b66f50ce2769f" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer19" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:703px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5910" style="position:absolute;font-weight:bold;font-style:normal;left:508.2px;top:0px;">Measurement </div><div id="a5913" style="position:absolute;font-weight:bold;font-style:normal;left:610.64px;top:0px;">December 22, </div><div id="a5920" style="position:absolute;font-weight:bold;font-style:normal;left:406.6px;top:17.6px;">December 22, </div><div id="a5923" style="position:absolute;font-weight:bold;font-style:normal;left:528.52px;top:17.6px;">Period </div><div id="a5926" style="position:absolute;font-weight:bold;font-style:normal;left:636.24px;top:17.6px;">2020 </div><div id="a5932" style="position:absolute;font-weight:bold;font-style:normal;left:422.76px;top:35.2px;">2020 (1) </div><div id="a5935" style="position:absolute;font-weight:bold;font-style:normal;left:511.08px;top:35.2px;">Adjustments </div><div id="a5938" style="position:absolute;font-weight:bold;font-style:normal;left:613.04px;top:35.2px;">(as adjusted) </div><div id="a5942" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.3px;">Cash and cash equivalents </div><div id="a5944" style="position:absolute;font-weight:normal;font-style:normal;left:400.52px;top:52.3px;">$ </div><div id="a5946" style="position:absolute;left:466.6px;top:52.3px;">958</div><div id="a5949" style="position:absolute;font-weight:normal;font-style:normal;left:502.44px;top:52.3px;">$ </div><div id="a5951" style="position:absolute;left:575.28px;top:52.3px;">—</div><div id="a5954" style="position:absolute;font-weight:normal;font-style:normal;left:604.56px;top:52.3px;">$ </div><div id="a5956" style="position:absolute;left:670.64px;top:52.3px;">958</div><div id="a5960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.6px;">Accounts receivable </div><div id="a5963" style="position:absolute;left:456.52px;top:66.6px;">8,473</div><div id="a5967" style="position:absolute;left:575.28px;top:66.6px;">—</div><div id="a5971" style="position:absolute;left:660.56px;top:66.6px;">8,473</div><div id="a5975" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.6px;">Inventories </div><div id="a5978" style="position:absolute;left:456.52px;top:81.6px;">4,527</div><div id="a5982" style="position:absolute;left:575.28px;top:81.6px;">—</div><div id="a5986" style="position:absolute;left:660.56px;top:81.6px;">4,527</div><div id="a5990" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:96.6px;">Prepaid expenses and other assets </div><div id="a5993" style="position:absolute;left:466.6px;top:96.6px;">181</div><div id="a5997" style="position:absolute;left:575.28px;top:96.6px;">—</div><div id="a6001" style="position:absolute;left:670.64px;top:96.6px;">181</div><div id="a6005" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:111.7px;">Property, plant and<div style="display:inline-block;width:4.72px"> </div>equipment </div><div id="a6008" style="position:absolute;left:449.96px;top:111.7px;">10,467</div><div id="a6012" style="position:absolute;left:568.56px;top:111.7px;">652</div><div id="a6016" style="position:absolute;left:654px;top:111.7px;">11,119</div><div id="a6020" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:126.6px;">Intangible assets </div><div id="a6023" style="position:absolute;left:449.96px;top:126.6px;">30,300</div><div id="a6027" style="position:absolute;left:563.6px;top:126.6px;">(500)</div><div id="a6031" style="position:absolute;left:654px;top:126.6px;">29,800</div><div id="a6035" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:141.6px;">Goodwill </div><div id="a6038" style="position:absolute;left:456.52px;top:141.6px;">2,814</div><div id="a6042" style="position:absolute;left:575.28px;top:141.6px;">53</div><div id="a6046" style="position:absolute;left:660.56px;top:141.6px;">2,867</div><div id="a6051" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:157.3px;">Total assets purchased </div><div id="a6054" style="position:absolute;left:449.96px;top:157.3px;">57,720</div><div id="a6058" style="position:absolute;left:568.56px;top:157.3px;">205</div><div id="a6062" style="position:absolute;left:654px;top:157.3px;">57,925</div><div id="a6066" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:171.7px;">Long-term debt including current portions and finance leases </div><div id="a6071" style="position:absolute;left:466.6px;top:171.7px;">183</div><div id="a6075" style="position:absolute;left:568.56px;top:171.7px;">556</div><div id="a6079" style="position:absolute;left:670.64px;top:171.7px;">739</div><div id="a6083" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:186.6px;">Accounts payable, accrued expenses and other accrued<div style="display:inline-block;width:4.7px"> </div>liabilities </div><div id="a6088" style="position:absolute;left:456.52px;top:186.6px;">3,482</div><div id="a6092" style="position:absolute;left:575.28px;top:186.6px;">—</div><div id="a6096" style="position:absolute;left:660.56px;top:186.6px;">3,482</div><div id="a6101" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:203.4px;">Total liabilities assumed </div><div id="a6104" style="position:absolute;left:456.52px;top:203.4px;">3,665</div><div id="a6108" style="position:absolute;left:568.56px;top:203.4px;">556</div><div id="a6112" style="position:absolute;left:660.56px;top:203.4px;">4,221</div><div id="a6117" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:220.4px;">Total consideration<div style="display:inline-block;width:4.76px"> </div>paid for Coral </div><div id="a6120" style="position:absolute;left:449.96px;top:220.4px;">54,055</div><div id="a6124" style="position:absolute;left:563.6px;top:220.4px;">(351)</div><div id="a6128" style="position:absolute;left:654px;top:220.4px;">53,704</div><div id="a6133" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:237.3px;">Less: estimated purchase price settlement </div><div id="a6136" style="position:absolute;left:473.32px;top:237.3px;">—</div><div id="a6140" style="position:absolute;left:563.6px;top:237.3px;">(351)</div><div id="a6144" style="position:absolute;left:665.68px;top:237.3px;">(351)</div><div id="a6149" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:254.3px;">Less: cash acquired </div><div id="a6152" style="position:absolute;font-weight:normal;font-style:normal;left:466.6px;top:254.3px;">958 </div><div id="a6157" style="position:absolute;font-weight:normal;font-style:normal;left:575.28px;top:254.3px;">— </div><div id="a6161" style="position:absolute;font-weight:normal;font-style:normal;left:670.64px;top:254.3px;">958 </div><div id="a6166" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:271.4px;">Net cash paid for Coral </div><div id="a6168" style="position:absolute;font-weight:normal;font-style:normal;left:400.52px;top:271.4px;">$ </div><div id="a6170" style="position:absolute;left:449.96px;top:271.4px;">53,097</div><div id="a6173" style="position:absolute;font-weight:normal;font-style:normal;left:502.44px;top:271.4px;">$ </div><div id="a6175" style="position:absolute;left:575.28px;top:271.4px;">—</div><div id="a6178" style="position:absolute;font-weight:normal;font-style:normal;left:604.56px;top:271.4px;">$ </div><div id="a6180" style="position:absolute;left:654px;top:271.4px;">53,097</div></div></div></div><div id="TextBlockContainer22" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:354px;height:16px;display:inline-block;"><div id="a6183" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">(1) As previously disclosed in the Company’s<div style="display:inline-block;width:5.2px"> </div>2020 Form 10-K. </div></div><div id="TextBlockContainer24" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:726px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6256" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Measurement period adjustments recorded during the first<div style="display:inline-block;width:4.73px"> </div>quarter of 2021 include certain adjustments related to refining<div style="display:inline-block;width:4.73px"> </div>original </div><div id="a6291" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">estimates for assets and liabilities for certain acquired<div style="display:inline-block;width:4.62px"> </div>finance leases, as well the adjustment to reflect the expected<div style="display:inline-block;width:4.81px"> </div>settlement of post-</div><div id="a6334" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">closing working capital and net indebtedness true ups to<div style="display:inline-block;width:4.79px"> </div>the original purchase price.<div style="display:inline-block;width:7.32px"> </div>As of March 31, 2021,<div style="display:inline-block;width:3.96px"> </div>the allocation of the </div><div id="a6379" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">purchase price for Coral has not been finalized and the </div><div id="a6379_56_8" style="position:absolute;left:299.373px;top:45.9px;-sec-ix-hidden:ID_552;">one-year</div><div id="a6379_64_63" style="position:absolute;font-weight:normal;font-style:normal;left:345.933px;top:45.9px;"><div style="display:inline-block;width:3.36px"> </div>measurement period has not ended.<div style="display:inline-block;width:7.52px"> </div>Further adjustments may be </div><div id="a6421" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">necessary as a result of the Company’s<div style="display:inline-block;width:5.12px"> </div>on-going assessment of additional information related to the<div style="display:inline-block;width:4.8px"> </div>fair value of assets acquired and </div><div id="a6465" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">liabilities assumed.</div></div><div id="TextBlockContainer26" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:354px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6470" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">In May 2020, the Company acquired Tel<div style="display:inline-block;width:5.47px"> </div>Nordic ApS (“TEL”), a company that specializes in lubricants and engineering<div style="display:inline-block;width:4.89px"> </div>primarily </div><div id="a6508" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">in high pressure aluminum die casting for its Europe,<div style="display:inline-block;width:4.8px"> </div>Middle East and Africa (“EMEA”) reportable segment.<div style="display:inline-block;width:7.78px"> </div>Consideration<div style="display:inline-block;width:3.57px"> </div>paid was </div><div id="a6547" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">in the form of a convertible promissory note in the amount<div style="display:inline-block;width:4.8px"> </div>of </div><div id="a6547_62_4" style="position:absolute;left:334.893px;top:30.7px;">20.0</div><div id="a6547_66_32" style="position:absolute;font-weight:normal;font-style:normal;left:358.253px;top:30.7px;"><div style="display:inline-block;width:3.36px"> </div>million DKK, or approximately $</div><div id="a6547_98_3" style="position:absolute;left:540.52px;top:30.7px;">2.9</div><div id="a6547_101_20" style="position:absolute;font-weight:normal;font-style:normal;left:557.16px;top:30.7px;"><div style="display:inline-block;width:3.36px"> </div>million, which was </div><div id="a6589" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">subsequently converted into shares of the Company’s<div style="display:inline-block;width:5.3px"> </div>common stock.<div style="display:inline-block;width:7.17px"> </div>An adjustment to the purchase price of approximately </div><div id="a6589_120_3" style="position:absolute;left:671.44px;top:45.9px;">0.4</div><div id="a6589_123_1" style="position:absolute;font-weight:normal;font-style:normal;left:688.24px;top:45.9px;"> </div><div id="a6625" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">million DKK, or less than $</div><div id="a6625_27_3" style="position:absolute;left:152.773px;top:61.3px;">0.1</div><div id="a6625_30_107" style="position:absolute;font-weight:normal;font-style:normal;left:169.253px;top:61.3px;"><div style="display:inline-block;width:3.36px"> </div>million, was made as a result of finalizing a post-closing<div style="display:inline-block;width:4.82px"> </div>settlement in the second quarter of 2020.<div style="display:inline-block;width:7.57px"> </div>The </div><div id="a6675" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">Company allocated approximately $</div><div id="a6675_33_3" style="position:absolute;left:198.213px;top:76.6px;">2.4</div><div id="a6675_36_73" style="position:absolute;font-weight:normal;font-style:normal;left:214.853px;top:76.6px;"><div style="display:inline-block;width:3.4px"> </div>million of the purchase price to intangible assets to be amortized<div style="display:inline-block;width:4.74px"> </div>over </div><div id="a6675_109_2" style="position:absolute;left:593.04px;top:76.6px;">17</div><div id="a6675_111_22" style="position:absolute;font-weight:normal;font-style:normal;left:606.48px;top:76.6px;"><div style="display:inline-block;width:3.2px"> </div>years.<div style="display:inline-block;width:6.9px"> </div>In addition, </div><div id="a6716" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92px;">the Company recorded approximately $</div><div id="a6716_36_3" style="position:absolute;left:216.293px;top:92px;">0.5</div><div id="a6716_39_93" style="position:absolute;font-weight:normal;font-style:normal;left:232.973px;top:92px;"><div style="display:inline-block;width:3.36px"> </div>million of goodwill, related to expected value not allocated to<div style="display:inline-block;width:4.71px"> </div>other acquired assets, none </div><div id="a6754" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.4px;">of which will be tax deductible.<div style="display:inline-block;width:7.54px"> </div>As of March 31, 2021, the allocation of the purchase price<div style="display:inline-block;width:4.7px"> </div>of TEL has not been finalized and the </div><div id="a6754_131_4" style="position:absolute;left:699.119px;top:107.4px;-sec-ix-hidden:ID_551;">one-</div><div id="a6807_4_125" style="position:absolute;font-weight:normal;font-style:normal;left:27.467px;top:122.8px;"><div style="display:inline-block;width:3.36px"> </div>measurement period has not ended.<div style="display:inline-block;width:7.56px"> </div>Further adjustments may be necessary as a result of the Company’s<div style="display:inline-block;width:5.63px"> </div>on-going assessment of </div><div id="a6849" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.1px;">additional information related to the fair value of assets acquired<div style="display:inline-block;width:4.92px"> </div>and liabilities assumed. </div><div id="a6875" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:161.3px;">In March 2020, the Company acquired the remaining </div><div id="a6875_50_2" style="position:absolute;left:315.693px;top:161.3px;">49</div><div id="a6875_52_68" style="position:absolute;font-weight:normal;font-style:normal;left:328.973px;top:161.3px;">% ownership interest in one of its South African affiliates,<div style="display:inline-block;width:4.76px"> </div>Quaker </div><div id="a6914" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:176.7px;">Chemical South Africa Limited (“QSA”) for </div><div id="a6914_42_4" style="position:absolute;left:245.933px;top:176.7px;">16.7</div><div id="a6914_46_32" style="position:absolute;font-weight:normal;font-style:normal;left:269.293px;top:176.7px;"><div style="display:inline-block;width:3.36px"> </div>million ZAR, or approximately $</div><div id="a6914_78_3" style="position:absolute;left:449.32px;top:176.7px;">1.0</div><div id="a6914_81_44" style="position:absolute;font-weight:normal;font-style:normal;left:466.12px;top:176.7px;"><div style="display:inline-block;width:3.2px"> </div>million, from its joint venture partner PQ </div><div id="a6953" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:192px;">Holdings South Africa.<div style="display:inline-block;width:7.34px"> </div>QSA is a part of the Company’s<div style="display:inline-block;width:4.77px"> </div>Europe, Middle East and Africa (“EMEA”) reportable segment.<div style="display:inline-block;width:8.07px"> </div>As this </div><div id="a6993" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:207.4px;">acquisition was a change in an existing controlling ownership,<div style="display:inline-block;width:4.93px"> </div>the Company recorded $</div><div id="a6993_85_3" style="position:absolute;left:471.72px;top:207.4px;">0.7</div><div id="a6993_88_43" style="position:absolute;font-weight:normal;font-style:normal;left:488.2px;top:207.4px;"><div style="display:inline-block;width:3.36px"> </div>million of excess purchase price over the </div><div id="a7034" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:222.8px;">carrying value of the non-controlling interest in Capital<div style="display:inline-block;width:4.71px"> </div>in excess of par value.<div style="display:inline-block;width:7.1px"> </div></div><div id="a7063" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:246px;">In October 2019, the Company completed its acquisition<div style="display:inline-block;width:4.71px"> </div>of the operating divisions of Norman Hay plc (“Norman<div style="display:inline-block;width:4.7px"> </div>Hay”), a private </div><div id="a7103" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:261.3px;">U.K. company that provides specialty chemicals, operating<div style="display:inline-block;width:4.64px"> </div>equipment, and services to industrial end markets.<div style="display:inline-block;width:8.04px"> </div>The acquisition adds </div><div id="a7138" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:276.7px;">new technologies in automotive, original equipment<div style="display:inline-block;width:4.74px"> </div>manufacturer, and aerospace, as well as engineering<div style="display:inline-block;width:4.99px"> </div>expertise which is expected </div><div id="a7172" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:292px;">to strengthen the Company’s<div style="display:inline-block;width:4.82px"> </div>existing equipment solutions platform.<div style="display:inline-block;width:7.6px"> </div>The original purchase price was </div><div id="a7172_100_4" style="position:absolute;left:547.72px;top:292px;">80.0</div><div id="a7172_104_29" style="position:absolute;font-weight:normal;font-style:normal;left:571.12px;top:292px;"><div style="display:inline-block;width:3.36px"> </div>million GBP,<div style="display:inline-block;width:5.03px"> </div>on a cash-free </div><div id="a7212" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:307.4px;">and debt-free basis, subject to routine and customary<div style="display:inline-block;width:4.76px"> </div>post-closing adjustments related to working capital and<div style="display:inline-block;width:4.58px"> </div>net indebtedness levels.<div style="display:inline-block;width:3.68px"> </div></div><div id="a7252" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:322.6px;">The Company finalized its post-closing adjustments for the<div style="display:inline-block;width:4.66px"> </div>Norman Hay acquisition and paid approximately </div><div id="a7252_105_3" style="position:absolute;left:587.599px;top:322.6px;">2.5</div><div id="a7252_108_20" style="position:absolute;font-weight:normal;font-style:normal;left:604.239px;top:322.6px;"><div style="display:inline-block;width:3.36px"> </div>million GBP during </div><div id="a7290" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:338px;">the first quarter of 2020 to settle such adjustments.</div></div> 25000000 19600000 18300000 P19Y 900000 P14Y 400000 P3Y 5000000.0 0.38 1400000 1700000 54100000 400000 <div id="TextBlockContainer19" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:703px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5910" style="position:absolute;font-weight:bold;font-style:normal;left:508.2px;top:0px;">Measurement </div><div id="a5913" style="position:absolute;font-weight:bold;font-style:normal;left:610.64px;top:0px;">December 22, </div><div id="a5920" style="position:absolute;font-weight:bold;font-style:normal;left:406.6px;top:17.6px;">December 22, </div><div id="a5923" style="position:absolute;font-weight:bold;font-style:normal;left:528.52px;top:17.6px;">Period </div><div id="a5926" style="position:absolute;font-weight:bold;font-style:normal;left:636.24px;top:17.6px;">2020 </div><div id="a5932" style="position:absolute;font-weight:bold;font-style:normal;left:422.76px;top:35.2px;">2020 (1) </div><div id="a5935" style="position:absolute;font-weight:bold;font-style:normal;left:511.08px;top:35.2px;">Adjustments </div><div id="a5938" style="position:absolute;font-weight:bold;font-style:normal;left:613.04px;top:35.2px;">(as adjusted) </div><div id="a5942" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.3px;">Cash and cash equivalents </div><div id="a5944" style="position:absolute;font-weight:normal;font-style:normal;left:400.52px;top:52.3px;">$ </div><div id="a5946" style="position:absolute;left:466.6px;top:52.3px;">958</div><div id="a5949" style="position:absolute;font-weight:normal;font-style:normal;left:502.44px;top:52.3px;">$ </div><div id="a5951" style="position:absolute;left:575.28px;top:52.3px;">—</div><div id="a5954" style="position:absolute;font-weight:normal;font-style:normal;left:604.56px;top:52.3px;">$ </div><div id="a5956" style="position:absolute;left:670.64px;top:52.3px;">958</div><div id="a5960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.6px;">Accounts receivable </div><div id="a5963" style="position:absolute;left:456.52px;top:66.6px;">8,473</div><div id="a5967" style="position:absolute;left:575.28px;top:66.6px;">—</div><div id="a5971" style="position:absolute;left:660.56px;top:66.6px;">8,473</div><div id="a5975" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.6px;">Inventories </div><div id="a5978" style="position:absolute;left:456.52px;top:81.6px;">4,527</div><div id="a5982" style="position:absolute;left:575.28px;top:81.6px;">—</div><div id="a5986" style="position:absolute;left:660.56px;top:81.6px;">4,527</div><div id="a5990" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:96.6px;">Prepaid expenses and other assets </div><div id="a5993" style="position:absolute;left:466.6px;top:96.6px;">181</div><div id="a5997" style="position:absolute;left:575.28px;top:96.6px;">—</div><div id="a6001" style="position:absolute;left:670.64px;top:96.6px;">181</div><div id="a6005" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:111.7px;">Property, plant and<div style="display:inline-block;width:4.72px"> </div>equipment </div><div id="a6008" style="position:absolute;left:449.96px;top:111.7px;">10,467</div><div id="a6012" style="position:absolute;left:568.56px;top:111.7px;">652</div><div id="a6016" style="position:absolute;left:654px;top:111.7px;">11,119</div><div id="a6020" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:126.6px;">Intangible assets </div><div id="a6023" style="position:absolute;left:449.96px;top:126.6px;">30,300</div><div id="a6027" style="position:absolute;left:563.6px;top:126.6px;">(500)</div><div id="a6031" style="position:absolute;left:654px;top:126.6px;">29,800</div><div id="a6035" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:141.6px;">Goodwill </div><div id="a6038" style="position:absolute;left:456.52px;top:141.6px;">2,814</div><div id="a6042" style="position:absolute;left:575.28px;top:141.6px;">53</div><div id="a6046" style="position:absolute;left:660.56px;top:141.6px;">2,867</div><div id="a6051" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:157.3px;">Total assets purchased </div><div id="a6054" style="position:absolute;left:449.96px;top:157.3px;">57,720</div><div id="a6058" style="position:absolute;left:568.56px;top:157.3px;">205</div><div id="a6062" style="position:absolute;left:654px;top:157.3px;">57,925</div><div id="a6066" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:171.7px;">Long-term debt including current portions and finance leases </div><div id="a6071" style="position:absolute;left:466.6px;top:171.7px;">183</div><div id="a6075" style="position:absolute;left:568.56px;top:171.7px;">556</div><div id="a6079" style="position:absolute;left:670.64px;top:171.7px;">739</div><div id="a6083" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:186.6px;">Accounts payable, accrued expenses and other accrued<div style="display:inline-block;width:4.7px"> </div>liabilities </div><div id="a6088" style="position:absolute;left:456.52px;top:186.6px;">3,482</div><div id="a6092" style="position:absolute;left:575.28px;top:186.6px;">—</div><div id="a6096" style="position:absolute;left:660.56px;top:186.6px;">3,482</div><div id="a6101" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:203.4px;">Total liabilities assumed </div><div id="a6104" style="position:absolute;left:456.52px;top:203.4px;">3,665</div><div id="a6108" style="position:absolute;left:568.56px;top:203.4px;">556</div><div id="a6112" style="position:absolute;left:660.56px;top:203.4px;">4,221</div><div id="a6117" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:220.4px;">Total consideration<div style="display:inline-block;width:4.76px"> </div>paid for Coral </div><div id="a6120" style="position:absolute;left:449.96px;top:220.4px;">54,055</div><div id="a6124" style="position:absolute;left:563.6px;top:220.4px;">(351)</div><div id="a6128" style="position:absolute;left:654px;top:220.4px;">53,704</div><div id="a6133" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:237.3px;">Less: estimated purchase price settlement </div><div id="a6136" style="position:absolute;left:473.32px;top:237.3px;">—</div><div id="a6140" style="position:absolute;left:563.6px;top:237.3px;">(351)</div><div id="a6144" style="position:absolute;left:665.68px;top:237.3px;">(351)</div><div id="a6149" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:254.3px;">Less: cash acquired </div><div id="a6152" style="position:absolute;font-weight:normal;font-style:normal;left:466.6px;top:254.3px;">958 </div><div id="a6157" style="position:absolute;font-weight:normal;font-style:normal;left:575.28px;top:254.3px;">— </div><div id="a6161" style="position:absolute;font-weight:normal;font-style:normal;left:670.64px;top:254.3px;">958 </div><div id="a6166" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:271.4px;">Net cash paid for Coral </div><div id="a6168" style="position:absolute;font-weight:normal;font-style:normal;left:400.52px;top:271.4px;">$ </div><div id="a6170" style="position:absolute;left:449.96px;top:271.4px;">53,097</div><div id="a6173" style="position:absolute;font-weight:normal;font-style:normal;left:502.44px;top:271.4px;">$ </div><div id="a6175" style="position:absolute;left:575.28px;top:271.4px;">—</div><div id="a6178" style="position:absolute;font-weight:normal;font-style:normal;left:604.56px;top:271.4px;">$ </div><div id="a6180" style="position:absolute;left:654px;top:271.4px;">53,097</div></div> 958000 0 958000 8473000 0 8473000 4527000 0 4527000 181000 0 181000 10467000 652000 11119000 30300000 -500000 29800000 2814000 53000 2867000 57720000 205000 57925000 183000 556000 739000 3482000 0 3482000 3665000 556000 4221000 54055000 -351000 53704000 0 -351000 -351000 53097000 0 53097000 20000000.0 2900000 400000 100000 2400000 P17Y 500000 0.49 16700000 1000000.0 700000 80000000.0 2500000 <div id="TextBlockContainer28" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:730px;height:346px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7309" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 3 – Recently Issued Accounting Standards </div><div id="a7323" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:24.3px;">Recently Issued Accounting Standards<div style="display:inline-block;width:4.89px"> </div>Adopted </div><div id="a7333" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:46.2px;">The Financial Accounting Standards Board (“FASB”)<div style="display:inline-block;width:5.59px"> </div>issued Account Standards Update (“ASU”)</div><div id="a7354" style="position:absolute;font-size:14.72px;font-weight:normal;font-style:normal;left:550.6px;top:44.9px;"> </div><div id="a7355" style="position:absolute;font-weight:normal;font-style:normal;left:554.28px;top:46.2px;">ASU 2019-12</div><div id="a7360" style="position:absolute;font-weight:normal;font-style:italic;left:629.04px;top:46.2px;">, Income Taxes </div><div id="a7366" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:61.6px;">(Topic<div style="display:inline-block;width:4.82px"> </div>740): Simplifying the Accounting for Income Taxes</div><div id="a7381" style="position:absolute;font-weight:normal;font-style:normal;left:315.373px;top:61.6px;"><div style="display:inline-block;width:3.36px"> </div>in December 2019 to simplify the accounting for income taxes.<div style="display:inline-block;width:8.15px"> </div>The </div><div id="a7404" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:77px;">guidance within this accounting standard update<div style="display:inline-block;width:4.56px"> </div>removes certain exceptions, including the exception to the<div style="display:inline-block;width:4.8px"> </div>incremental approach for </div><div id="a7438" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92.3px;">certain intra-period tax allocations, to the requirement<div style="display:inline-block;width:4.75px"> </div>to recognize or not recognize certain deferred tax liabilities for<div style="display:inline-block;width:4.88px"> </div>equity method </div><div id="a7479" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.7px;">investments and foreign subsidiaries, and to the general<div style="display:inline-block;width:4.71px"> </div>methodology for calculating income taxes in an interim period<div style="display:inline-block;width:4.64px"> </div>when a year-to-</div><div id="a7521" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:123px;">date loss exceeds the anticipated loss for the year.<div style="display:inline-block;width:8.73px"> </div>Further, the guidance simplifies the accounting<div style="display:inline-block;width:4.76px"> </div>related to franchise taxes, the step </div><div id="a7564" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.2px;">up in tax basis for goodwill, current and deferred tax<div style="display:inline-block;width:4.7px"> </div>expense, and codification improvements for income taxes related<div style="display:inline-block;width:4.74px"> </div>to employee </div><div id="a7604" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153.6px;">stock ownership plans.<div style="display:inline-block;width:7.32px"> </div>The guidance is effective for annual and interim<div style="display:inline-block;width:4.59px"> </div>periods beginning after December 15, 2020.<div style="display:inline-block;width:7.82px"> </div>The Company </div><div id="a7643" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169px;">adopted this standard on a prospective basis, effective<div style="display:inline-block;width:4.86px"> </div>January 1, 2021.<div style="display:inline-block;width:7.1px"> </div>There was no cumulative effect of adoption recorded<div style="display:inline-block;width:4.73px"> </div>within </div><div id="a7685" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.3px;">retained earnings on January 1, 2021. </div><div id="a7699" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:207.7px;">The FASB issued<div style="display:inline-block;width:4.75px"> </div>ASU 2020-04, </div><div id="a7711" style="position:absolute;font-weight:normal;font-style:italic;left:207.173px;top:207.7px;">Reference Rate Reform (To<div style="display:inline-block;width:2.27px"> </div>pic 848): Facilitation of the Effects of Reference<div style="display:inline-block;width:4.81px"> </div>Rate Reform on </div><div id="a7740" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:222.9px;">Financial Reporting</div><div id="a7743" style="position:absolute;font-weight:normal;font-style:normal;left:113.093px;top:222.9px;"><div style="display:inline-block;width:3.36px"> </div>in March 2020.<div style="display:inline-block;width:6.97px"> </div>The FASB subsequently<div style="display:inline-block;width:4.78px"> </div>issued ASU 2021-01, </div><div id="a7765" style="position:absolute;font-weight:normal;font-style:italic;left:456.52px;top:222.9px;">Reference Rate Reform (Topic<div style="display:inline-block;width:5.57px"> </div>848): Scope</div><div id="a7776" style="position:absolute;font-weight:normal;font-style:normal;left:685.68px;top:222.9px;"><div style="display:inline-block;width:3.36px"> </div>in </div><div id="a7779" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:238.3px;">January 2021 which clarified the guidance but did<div style="display:inline-block;width:4.58px"> </div>not materially change the guidance or its applicability to<div style="display:inline-block;width:4.78px"> </div>the Company.<div style="display:inline-block;width:7.64px"> </div>The </div><div id="a7820" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:253.6px;">amendments provide temporary optional expedients and<div style="display:inline-block;width:4.76px"> </div>exceptions for applying U.S. GAAP to contract modifications,<div style="display:inline-block;width:4.54px"> </div>hedging </div><div id="a7850" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:269px;">relationships and other transactions to ease the potential<div style="display:inline-block;width:4.8px"> </div>accounting and financial reporting burden associated with transitioning<div style="display:inline-block;width:5.11px"> </div>away </div><div id="a7884" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:284.4px;">from reference rates that are expected to be discontinued,<div style="display:inline-block;width:4.84px"> </div>including the London Interbank Offered Rate (“LIBOR”).<div style="display:inline-block;width:8.23px"> </div>ASU 2020-04 is </div><div id="a7925" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:299.7px;">effective for the Company as of March 12,<div style="display:inline-block;width:4.61px"> </div>2020 and generally can be applied through December 31, 2022.<div style="display:inline-block;width:8.09px"> </div>As of March 31, 2021, the </div><div id="a7973" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:314.9px;">expedients provided in ASU 2020-04 do not presently<div style="display:inline-block;width:4.74px"> </div>impact the Company; however, the Company<div style="display:inline-block;width:4.8px"> </div>will continue to monitor for </div><div id="a8014" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:330.3px;">potential impacts on its consolidated financial statements.</div></div> <div id="TextBlockContainer32" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:216px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8078" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 4 – Business Segments </div><div id="div_30_XBRL_TS_78797eca5d804e5a81d000fca15d3224" style="position:absolute;left:0px;top:23.4px;float:left;"><div id="TextBlockContainer31" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8088" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company’s operating<div style="display:inline-block;width:4.81px"> </div>segments, which are consistent with its reportable segments,<div style="display:inline-block;width:4.7px"> </div>reflect the structure of the Company’s </div><div id="a8122" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">internal organization, the method by which<div style="display:inline-block;width:4.78px"> </div>the Company’s resources are allocated<div style="display:inline-block;width:4.86px"> </div>and the manner by which the chief operating </div><div id="a8160" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">decision maker assesses the Company’s<div style="display:inline-block;width:5.1px"> </div>performance.<div style="display:inline-block;width:7.03px"> </div>The Company has </div><div id="a8160_68_4" style="position:absolute;left:398.28px;top:30.6px;">four</div><div id="a8160_72_53" style="position:absolute;font-weight:normal;font-style:normal;left:420.52px;top:30.6px;"><div style="display:inline-block;width:3.2px"> </div>reportable segments: (i) Americas; (ii) EMEA; (iii) </div><div id="a8194" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">Asia/Pacific; and (iv) Global Specialty Businesses.<div style="display:inline-block;width:7.76px"> </div>The three geographic segments are composed of the net<div style="display:inline-block;width:4.81px"> </div>sales and operations in </div><div id="a8233" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">each respective region, excluding net sales and operations<div style="display:inline-block;width:4.85px"> </div>managed globally by the Global Specialty Businesses segment, which </div><div id="a8268" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">includes the Company’s<div style="display:inline-block;width:4.73px"> </div>container, metal finishing, mining,<div style="display:inline-block;width:4.58px"> </div>offshore, specialty coatings, specialty grease and<div style="display:inline-block;width:4.75px"> </div>Norman Hay businesses.</div></div></div><div id="a8268_132_1" style="position:absolute;font-weight:normal;font-style:normal;left:720.4px;top:100px;"> </div><div id="a8302" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:123.4px;">Segment operating earnings for each of the Company’s<div style="display:inline-block;width:5.54px"> </div>reportable segments are comprised of the segment’s<div style="display:inline-block;width:5.13px"> </div>net sales less directly </div><div id="a8340" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.7px;">related cost of goods sold (“COGS”) and selling, general<div style="display:inline-block;width:4.74px"> </div>and administrative expenses (“SG&amp;A”).<div style="display:inline-block;width:7.57px"> </div>Operating expenses not directly </div><div id="a8380" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153.9px;">attributable to the net sales of each respective segment<div style="display:inline-block;width:1.37px"> </div>,<div style="display:inline-block;width:3.4px"> </div>such as certain corporate and administrative costs, Combination,<div style="display:inline-block;width:4.5px"> </div>integration </div><div id="a8418" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169.3px;">and other acquisition-related expenses, and Restructuring<div style="display:inline-block;width:4.74px"> </div>and related charges,<div style="display:inline-block;width:4.05px"> </div>are not included in segment operating earnings.<div style="display:inline-block;width:7.69px"> </div>Other </div><div id="a8457" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.6px;">items not specifically identified with the Company’s<div style="display:inline-block;width:5.34px"> </div>reportable segments include interest expense, net and other<div style="display:inline-block;width:4.71px"> </div>income (expense), </div><div id="a8493" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">net.</div></div><div id="TextBlockContainer34" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:711px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8495" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The following table presents information about the performance<div style="display:inline-block;width:4.82px"> </div>of the Company’s reportable operating<div style="display:inline-block;width:4.94px"> </div>segments for the three </div><div id="a8529" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">months ended March 31, 2021 and 2020:</div></div><div id="TextBlockContainer38" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:673px;height:442px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_36_XBRL_CS_ff764c7c9c2843e0849dafb07fab15c2" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer37" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:673px;height:442px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8546" style="position:absolute;font-weight:bold;font-style:normal;left:505.8px;top:0px;">Three Months Ended </div><div id="a8552" style="position:absolute;font-weight:bold;font-style:normal;left:537.2px;top:17px;">March 31,<div style="display:inline-block;width:3.89px"> </div></div><div id="a8558" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:34.2px;">2021 </div><div id="a8561" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:34.2px;">2020 </div><div id="a8565" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:51.4px;">Net sales </div><div id="a8567" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8569" style="position:absolute;font-weight:normal;font-style:normal;left:486.44px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8571" style="position:absolute;font-weight:normal;font-style:normal;left:561.52px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8573" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8575" style="position:absolute;font-weight:normal;font-style:normal;left:585.52px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8577" style="position:absolute;font-weight:normal;font-style:normal;left:660.56px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8581" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:68px;">Americas </div><div id="a8583" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:68px;">$ </div><div id="a8585" style="position:absolute;left:512.2px;top:68px;">134,871</div><div id="a8588" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:68px;">$ </div><div id="a8590" style="position:absolute;left:611.28px;top:68px;">129,896</div><div id="a8595" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:85px;">EMEA </div><div id="a8597" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:85px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8599" style="position:absolute;left:512.2px;top:85px;">119,814</div><div id="a8602" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:85px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8604" style="position:absolute;left:611.28px;top:85px;">104,839</div><div id="a8609" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:101.9px;">Asia/Pacific </div><div id="a8611" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:101.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8613" style="position:absolute;left:518.92px;top:101.9px;">96,706</div><div id="a8616" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:101.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8618" style="position:absolute;left:618px;top:101.9px;">73,552</div><div id="a8623" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:119px;">Global Specialty Businesses </div><div id="a8625" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:119px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8627" style="position:absolute;left:518.92px;top:119px;">78,392</div><div id="a8630" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:119px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8632" style="position:absolute;left:618px;top:119px;">70,274</div><div id="a8636" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:136.3px;">Total<div style="display:inline-block;width:4.73px"> </div>net sales </div><div id="a8638" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:136.3px;">$ </div><div id="a8640" style="position:absolute;left:512.2px;top:136.3px;">429,783</div><div id="a8643" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:136.3px;">$ </div><div id="a8645" style="position:absolute;left:611.28px;top:136.3px;">378,561</div><div id="a8658" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:169.9px;">Segment operating earnings </div><div id="a8668" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:187.1px;">Americas </div><div id="a8670" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:187.1px;">$ </div><div id="a8672" style="position:absolute;left:518.92px;top:187.1px;">32,234</div><div id="a8675" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:187.1px;">$ </div><div id="a8677" style="position:absolute;left:618px;top:187.1px;">29,188</div><div id="a8682" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:204px;">EMEA </div><div id="a8685" style="position:absolute;left:518.92px;top:204px;">25,244</div><div id="a8689" style="position:absolute;left:618px;top:204px;">18,359</div><div id="a8694" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:221px;">Asia/Pacific </div><div id="a8697" style="position:absolute;left:518.92px;top:221px;">27,478</div><div id="a8701" style="position:absolute;left:618px;top:221px;">19,541</div><div id="a8706" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:237.9px;">Global Specialty Businesses </div><div id="a8708" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:237.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8710" style="position:absolute;left:518.92px;top:237.9px;">24,169</div><div id="a8713" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:237.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8715" style="position:absolute;left:618px;top:237.9px;">20,560</div><div id="a8719" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:255.4px;">Total<div style="display:inline-block;width:4.73px"> </div>segment operating earnings </div><div id="a8721" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:255.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8723" style="position:absolute;left:512.2px;top:255.4px;">109,125</div><div id="a8726" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:255.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8728" style="position:absolute;left:618px;top:255.4px;">87,648</div><div id="a8732" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:272px;">Combination, integration and other acquisition-related<div style="display:inline-block;width:4.74px"> </div>expenses </div><div id="a8737" style="position:absolute;left:520.68px;top:272px;">(5,815)</div><div id="a8741" style="position:absolute;left:619.76px;top:272px;">(7,878)</div><div id="a8745" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:289px;">Restructuring and related charges </div><div id="a8748" style="position:absolute;left:520.68px;top:289px;">(1,175)</div><div id="a8752" style="position:absolute;left:619.76px;top:289px;">(1,716)</div><div id="a8756" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:305.9px;">Fair value step up of acquired inventory sold </div><div id="a8759" style="position:absolute;left:530.6px;top:305.9px;">(801)</div><div id="a8763" style="position:absolute;left:641.36px;top:305.9px;">—</div><div id="a8767" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:323.1px;">Indefinite-lived intangible asset impairment </div><div id="a8772" style="position:absolute;left:542.32px;top:323.1px;">—</div><div id="a8776" style="position:absolute;left:613.04px;top:323.1px;">(38,000)</div><div id="a8780" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:340px;">Non-operating and administrative expenses </div><div id="a8784" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:340px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8786" style="position:absolute;left:513.96px;top:340px;">(40,992)</div><div id="a8789" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:340px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8791" style="position:absolute;left:613.04px;top:340px;">(38,451)</div><div id="a8795" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:357px;">Depreciation of corporate assets and amortization </div><div id="a8797" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:357px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8799" style="position:absolute;left:513.96px;top:357px;">(15,448)</div><div id="a8802" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:357px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8804" style="position:absolute;left:613.04px;top:357px;">(14,047)</div><div id="a8808" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:374.3px;">Operating income (loss) </div><div id="a8811" style="position:absolute;left:518.92px;top:374.3px;">44,894</div><div id="a8815" style="position:absolute;left:613.04px;top:374.3px;">(12,444)</div><div id="a8819" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:391.1px;">Other income (expense), net </div><div id="a8822" style="position:absolute;left:525.48px;top:391.1px;">4,687</div><div id="a8826" style="position:absolute;left:613.04px;top:391.1px;">(21,175)</div><div id="a8830" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:408.1px;">Interest expense, net </div><div id="a8832" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:408.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8834" style="position:absolute;left:520.68px;top:408.1px;">(5,470)</div><div id="a8837" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:408.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8839" style="position:absolute;left:619.76px;top:408.1px;">(8,461)</div><div id="a8843" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:426.1px;">Income (loss) before taxes and equity in net income of<div style="display:inline-block;width:4.83px"> </div>associated companies </div><div id="a8845" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:426.1px;">$ </div><div id="a8847" style="position:absolute;left:518.92px;top:426.1px;">44,111</div><div id="a8850" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:426.1px;">$ </div><div id="a8852" style="position:absolute;left:613.04px;top:426.1px;">(42,080)</div></div></div></div><div id="TextBlockContainer40" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:721px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8855" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Inter-segment revenues for the three months ended<div style="display:inline-block;width:4.81px"> </div>March 31, 2021 and 2020 were $</div><div id="a8855_80_3" style="position:absolute;left:479.56px;top:0px;">3.3</div><div id="a8855_83_14" style="position:absolute;font-weight:normal;font-style:normal;left:496.2px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a8855_97_3" style="position:absolute;left:570.64px;top:0px;">2.9</div><div id="a8855_100_23" style="position:absolute;font-weight:normal;font-style:normal;left:587.28px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million for Americas, </div><div id="a8901" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">$</div><div id="a8901_1_3" style="position:absolute;left:11.147px;top:15.4px;">8.8</div><div id="a8901_4_14" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a8901_18_3" style="position:absolute;left:102.373px;top:15.4px;">5.5</div><div id="a8901_21_20" style="position:absolute;font-weight:normal;font-style:normal;left:119.013px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million for EMEA, $</div><div id="a8901_41_3" style="position:absolute;left:234.253px;top:15.4px;">0.1</div><div id="a8901_44_14" style="position:absolute;font-weight:normal;font-style:normal;left:250.893px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a8901_58_3" style="position:absolute;left:325.293px;top:15.4px;">0.1</div><div id="a8901_61_31" style="position:absolute;font-weight:normal;font-style:normal;left:342.093px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million for Asia/Pacific and $</div><div id="a8901_92_3" style="position:absolute;left:503.879px;top:15.4px;">2.0</div><div id="a8901_95_14" style="position:absolute;font-weight:normal;font-style:normal;left:520.519px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a8901_109_3" style="position:absolute;left:594.959px;top:15.4px;">1.3</div><div id="a8901_112_20" style="position:absolute;font-weight:normal;font-style:normal;left:611.759px;top:15.4px;"><div style="display:inline-block;width:3.2px"> </div>million for Global </div><div id="a8949" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Specialty Businesses, respectively.<div style="display:inline-block;width:7.68px"> </div>However, all inter-segment transactions<div style="display:inline-block;width:4.77px"> </div>have been eliminated from each reportable operating </div><div id="a8980" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">segment’s net sales and<div style="display:inline-block;width:4.7px"> </div>earnings for all periods presented in the above tables.</div></div> <div id="TextBlockContainer31" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8088" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company’s operating<div style="display:inline-block;width:4.81px"> </div>segments, which are consistent with its reportable segments,<div style="display:inline-block;width:4.7px"> </div>reflect the structure of the Company’s </div><div id="a8122" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">internal organization, the method by which<div style="display:inline-block;width:4.78px"> </div>the Company’s resources are allocated<div style="display:inline-block;width:4.86px"> </div>and the manner by which the chief operating </div><div id="a8160" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">decision maker assesses the Company’s<div style="display:inline-block;width:5.1px"> </div>performance.<div style="display:inline-block;width:7.03px"> </div>The Company has </div><div id="a8160_68_4" style="position:absolute;left:398.28px;top:30.6px;">four</div><div id="a8160_72_53" style="position:absolute;font-weight:normal;font-style:normal;left:420.52px;top:30.6px;"><div style="display:inline-block;width:3.2px"> </div>reportable segments: (i) Americas; (ii) EMEA; (iii) </div><div id="a8194" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">Asia/Pacific; and (iv) Global Specialty Businesses.<div style="display:inline-block;width:7.76px"> </div>The three geographic segments are composed of the net<div style="display:inline-block;width:4.81px"> </div>sales and operations in </div><div id="a8233" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">each respective region, excluding net sales and operations<div style="display:inline-block;width:4.85px"> </div>managed globally by the Global Specialty Businesses segment, which </div><div id="a8268" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">includes the Company’s<div style="display:inline-block;width:4.73px"> </div>container, metal finishing, mining,<div style="display:inline-block;width:4.58px"> </div>offshore, specialty coatings, specialty grease and<div style="display:inline-block;width:4.75px"> </div>Norman Hay businesses.</div></div> 4 <div id="TextBlockContainer37" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:673px;height:442px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8546" style="position:absolute;font-weight:bold;font-style:normal;left:505.8px;top:0px;">Three Months Ended </div><div id="a8552" style="position:absolute;font-weight:bold;font-style:normal;left:537.2px;top:17px;">March 31,<div style="display:inline-block;width:3.89px"> </div></div><div id="a8558" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:34.2px;">2021 </div><div id="a8561" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:34.2px;">2020 </div><div id="a8565" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:51.4px;">Net sales </div><div id="a8567" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8569" style="position:absolute;font-weight:normal;font-style:normal;left:486.44px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8571" style="position:absolute;font-weight:normal;font-style:normal;left:561.52px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8573" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8575" style="position:absolute;font-weight:normal;font-style:normal;left:585.52px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8577" style="position:absolute;font-weight:normal;font-style:normal;left:660.56px;top:51.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8581" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:68px;">Americas </div><div id="a8583" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:68px;">$ </div><div id="a8585" style="position:absolute;left:512.2px;top:68px;">134,871</div><div id="a8588" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:68px;">$ </div><div id="a8590" style="position:absolute;left:611.28px;top:68px;">129,896</div><div id="a8595" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:85px;">EMEA </div><div id="a8597" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:85px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8599" style="position:absolute;left:512.2px;top:85px;">119,814</div><div id="a8602" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:85px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8604" style="position:absolute;left:611.28px;top:85px;">104,839</div><div id="a8609" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:101.9px;">Asia/Pacific </div><div id="a8611" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:101.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8613" style="position:absolute;left:518.92px;top:101.9px;">96,706</div><div id="a8616" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:101.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8618" style="position:absolute;left:618px;top:101.9px;">73,552</div><div id="a8623" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:119px;">Global Specialty Businesses </div><div id="a8625" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:119px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8627" style="position:absolute;left:518.92px;top:119px;">78,392</div><div id="a8630" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:119px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8632" style="position:absolute;left:618px;top:119px;">70,274</div><div id="a8636" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:136.3px;">Total<div style="display:inline-block;width:4.73px"> </div>net sales </div><div id="a8638" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:136.3px;">$ </div><div id="a8640" style="position:absolute;left:512.2px;top:136.3px;">429,783</div><div id="a8643" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:136.3px;">$ </div><div id="a8645" style="position:absolute;left:611.28px;top:136.3px;">378,561</div><div id="a8658" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:169.9px;">Segment operating earnings </div><div id="a8668" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:187.1px;">Americas </div><div id="a8670" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:187.1px;">$ </div><div id="a8672" style="position:absolute;left:518.92px;top:187.1px;">32,234</div><div id="a8675" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:187.1px;">$ </div><div id="a8677" style="position:absolute;left:618px;top:187.1px;">29,188</div><div id="a8682" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:204px;">EMEA </div><div id="a8685" style="position:absolute;left:518.92px;top:204px;">25,244</div><div id="a8689" style="position:absolute;left:618px;top:204px;">18,359</div><div id="a8694" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:221px;">Asia/Pacific </div><div id="a8697" style="position:absolute;left:518.92px;top:221px;">27,478</div><div id="a8701" style="position:absolute;left:618px;top:221px;">19,541</div><div id="a8706" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:237.9px;">Global Specialty Businesses </div><div id="a8708" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:237.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8710" style="position:absolute;left:518.92px;top:237.9px;">24,169</div><div id="a8713" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:237.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8715" style="position:absolute;left:618px;top:237.9px;">20,560</div><div id="a8719" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:255.4px;">Total<div style="display:inline-block;width:4.73px"> </div>segment operating earnings </div><div id="a8721" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:255.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8723" style="position:absolute;left:512.2px;top:255.4px;">109,125</div><div id="a8726" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:255.4px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8728" style="position:absolute;left:618px;top:255.4px;">87,648</div><div id="a8732" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:272px;">Combination, integration and other acquisition-related<div style="display:inline-block;width:4.74px"> </div>expenses </div><div id="a8737" style="position:absolute;left:520.68px;top:272px;">(5,815)</div><div id="a8741" style="position:absolute;left:619.76px;top:272px;">(7,878)</div><div id="a8745" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:289px;">Restructuring and related charges </div><div id="a8748" style="position:absolute;left:520.68px;top:289px;">(1,175)</div><div id="a8752" style="position:absolute;left:619.76px;top:289px;">(1,716)</div><div id="a8756" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:305.9px;">Fair value step up of acquired inventory sold </div><div id="a8759" style="position:absolute;left:530.6px;top:305.9px;">(801)</div><div id="a8763" style="position:absolute;left:641.36px;top:305.9px;">—</div><div id="a8767" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:323.1px;">Indefinite-lived intangible asset impairment </div><div id="a8772" style="position:absolute;left:542.32px;top:323.1px;">—</div><div id="a8776" style="position:absolute;left:613.04px;top:323.1px;">(38,000)</div><div id="a8780" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:340px;">Non-operating and administrative expenses </div><div id="a8784" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:340px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8786" style="position:absolute;left:513.96px;top:340px;">(40,992)</div><div id="a8789" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:340px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8791" style="position:absolute;left:613.04px;top:340px;">(38,451)</div><div id="a8795" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:357px;">Depreciation of corporate assets and amortization </div><div id="a8797" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:357px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8799" style="position:absolute;left:513.96px;top:357px;">(15,448)</div><div id="a8802" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:357px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8804" style="position:absolute;left:613.04px;top:357px;">(14,047)</div><div id="a8808" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:374.3px;">Operating income (loss) </div><div id="a8811" style="position:absolute;left:518.92px;top:374.3px;">44,894</div><div id="a8815" style="position:absolute;left:613.04px;top:374.3px;">(12,444)</div><div id="a8819" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:391.1px;">Other income (expense), net </div><div id="a8822" style="position:absolute;left:525.48px;top:391.1px;">4,687</div><div id="a8826" style="position:absolute;left:613.04px;top:391.1px;">(21,175)</div><div id="a8830" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:408.1px;">Interest expense, net </div><div id="a8832" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:408.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8834" style="position:absolute;left:520.68px;top:408.1px;">(5,470)</div><div id="a8837" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:408.1px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a8839" style="position:absolute;left:619.76px;top:408.1px;">(8,461)</div><div id="a8843" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:426.1px;">Income (loss) before taxes and equity in net income of<div style="display:inline-block;width:4.83px"> </div>associated companies </div><div id="a8845" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:426.1px;">$ </div><div id="a8847" style="position:absolute;left:518.92px;top:426.1px;">44,111</div><div id="a8850" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:426.1px;">$ </div><div id="a8852" style="position:absolute;left:613.04px;top:426.1px;">(42,080)</div></div> 134871000 129896000 119814000 104839000 96706000 73552000 78392000 70274000 429783000 378561000 32234000 29188000 25244000 18359000 27478000 19541000 24169000 20560000 109125000 87648000 5815000 7878000 1175000 1716000 801000 0 0 38000000 40992000 38451000 15448000 14047000 44894000 -12444000 4687000 -21175000 -5470000 -8461000 44111000 -42080000 3300000 2900000 8800000 5500000 100000 100000 2000000.0 1300000 <div id="TextBlockContainer52" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:765px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9057" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 5 – Net Sales and Revenue Recognition </div><div id="a9073" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:25.6px;">Business Description </div><div id="a9077" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:49px;">The Company develops, produces, and markets a broad<div style="display:inline-block;width:4.77px"> </div>range of formulated chemical specialty products and offers<div style="display:inline-block;width:4.85px"> </div>chemical </div><div id="a9111" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.3px;">management services (“Fluidcare”) for various heavy<div style="display:inline-block;width:4.74px"> </div>industrial and manufacturing applications throughout its four<div style="display:inline-block;width:4.89px"> </div>segments.<div style="display:inline-block;width:6.78px"> </div>A </div><div id="a9142" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:79.7px;">significant portion of the Company’s<div style="display:inline-block;width:5.02px"> </div>revenues are realized from the sale of process fluids and services<div style="display:inline-block;width:4.8px"> </div>made directly to manufacturers </div><div id="a9183" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:95px;">through its own employees and its Fluidcare programs,<div style="display:inline-block;width:4.76px"> </div>with the balance being handled through distributors and<div style="display:inline-block;width:4.72px"> </div>agents. </div><div id="div_42_XBRL_TS_af29953d559a47c5acdd56efb4e4d52a" style="position:absolute;left:0px;top:118.2px;float:left;"><div id="TextBlockContainer43" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9217" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As part of the Company’s<div style="display:inline-block;width:4.84px"> </div>Fluidcare business, certain third-party product sales to customers are<div style="display:inline-block;width:4.79px"> </div>managed by the Company.<div style="display:inline-block;width:8.3px"> </div>Where </div><div id="a9258" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">the Company acts as a principal, revenues are recognized<div style="display:inline-block;width:4.67px"> </div>on a gross reporting basis at the selling price negotiated with<div style="display:inline-block;width:4.77px"> </div>its customers. </div><div id="a9303" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Where the Company acts as an agent, revenue is recognized on<div style="display:inline-block;width:4.88px"> </div>a net reporting basis at the amount of the administrative fee earned<div style="display:inline-block;width:4.74px"> </div>by </div><div id="a9352" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">the Company for ordering the goods.</div></div></div><div id="a9352_35_96" style="position:absolute;font-weight:normal;font-style:normal;left:201.573px;top:164.3px;"><div style="display:inline-block;width:6.72px"> </div>The Company transferred third-party products under arrangements recognized<div style="display:inline-block;width:5.01px"> </div>on a net reporting </div><div id="a9390" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:179.7px;">basis of $</div><div id="a9390_10_4" style="position:absolute;left:55.659px;top:179.7px;">17.8</div><div id="a9390_14_14" style="position:absolute;font-weight:normal;font-style:normal;left:79.019px;top:179.7px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a9390_28_4" style="position:absolute;left:153.413px;top:179.7px;">12.5</div><div id="a9390_32_76" style="position:absolute;font-weight:normal;font-style:normal;left:176.773px;top:179.7px;"><div style="display:inline-block;width:3.36px"> </div>million for the three months ended March 31, 2021 and 2020,<div style="display:inline-block;width:4.72px"> </div>respectively.<div style="display:inline-block;width:4.31px"> </div></div><div id="a9433" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:202.9px;">As previously disclosed in the Company’s<div style="display:inline-block;width:5.29px"> </div>2020 Form 10-K, during 2020,<div style="display:inline-block;width:4.06px"> </div>the Company’s five largest<div style="display:inline-block;width:4.75px"> </div>customers (each composed </div><div id="a9473" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:218.3px;">of multiple subsidiaries or divisions with semiautonomous<div style="display:inline-block;width:4.84px"> </div>purchasing authority) accounted for approximately </div><div id="a9473_108_2" style="position:absolute;left:594.16px;top:218.3px;">10</div><div id="a9473_110_22" style="position:absolute;font-weight:normal;font-style:normal;left:607.6px;top:218.3px;">% of consolidated net </div><div id="a9507" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:233.6px;">sales, with its largest customer accounting<div style="display:inline-block;width:4.72px"> </div>for approximately </div><div id="a9507_62_1" style="position:absolute;left:332.333px;top:233.6px;">3</div><div id="a9507_63_29" style="position:absolute;font-weight:normal;font-style:normal;left:339.053px;top:233.6px;">% of consolidated net sales. </div><div id="a9534" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:257px;">Revenue Recognition Model </div><div id="div_44_XBRL_TS_6f87d1c3576c491e9be171e2b979ed46" style="position:absolute;left:0px;top:280.4px;float:left;"><div id="TextBlockContainer45" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9540" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company applies the five-step model in the FASB’s<div style="display:inline-block;width:6.16px"> </div>guidance, which requires the Company to: (i) identify<div style="display:inline-block;width:4.86px"> </div>the contract with a </div><div id="a9584" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">customer; (ii) identify the performance obligations in<div style="display:inline-block;width:4.78px"> </div>the contract; (iii) determine the transaction price; (iv) allocate the<div style="display:inline-block;width:4.78px"> </div>transaction </div><div id="a9620" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">price to the performance obligations in the contract; and<div style="display:inline-block;width:4.68px"> </div>(v) recognize revenue when, or as, the Company satisfies a performance </div><div id="a9660" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">obligation.<div style="display:inline-block;width:7.02px"> </div>Refer to the Company’s 2020<div style="display:inline-block;width:4.77px"> </div>Form 10-K for additional information on the Company’s<div style="display:inline-block;width:5.34px"> </div>revenue recognition policies, </div><div id="a9698" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">including its practical expedients and accounting policy<div style="display:inline-block;width:4.79px"> </div>elections.</div></div></div><div id="a9698_67_3" style="position:absolute;font-weight:normal;font-style:normal;left:355.533px;top:341.6px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a9715" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:365px;">Allowance for Doubtful Accounts </div><div id="a9723" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:388.4px;">As previously disclosed in the Company’s<div style="display:inline-block;width:5.29px"> </div>2020 Form 10-K, during 2020, the Company adopted, as required,<div style="display:inline-block;width:4.8px"> </div>an accounting </div><div id="a9762" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:403.6px;">standard update related to the accounting and disclosure<div style="display:inline-block;width:4.72px"> </div>of credit losses effective January 1, 2020.<div style="display:inline-block;width:7.91px"> </div></div><div id="div_46_XBRL_TS_5a12d86a90f843fb8d2b5e36c13acde9" style="position:absolute;left:0px;top:403.6px;float:left;"><div id="TextBlockContainer47" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:725px;height:108px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9762_102_26" style="position:absolute;font-weight:normal;font-style:normal;left:534.92px;top:0px;">The Company recognizes an </div><div id="a9800" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">allowance for credit losses, which represents the portion<div style="display:inline-block;width:4.72px"> </div>of its trade accounts receivable that the Company does not expect<div style="display:inline-block;width:4.76px"> </div>to collect </div><div id="a9842" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">over the contractual life, considering past events<div style="display:inline-block;width:4.49px"> </div>and reasonable and supportable forecasts of future economic<div style="display:inline-block;width:4.72px"> </div>conditions.<div style="display:inline-block;width:6.79px"> </div>The </div><div id="a9877" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">Company’s allowance<div style="display:inline-block;width:4.62px"> </div>for credit losses on its trade accounts receivables<div style="display:inline-block;width:4.33px"> </div>is based on specific collectability facts and circumstances for </div><div id="a9916" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.5px;">each outstanding receivable and customer,<div style="display:inline-block;width:4.9px"> </div>the aging of outstanding receivables, and the associated collection<div style="display:inline-block;width:4.89px"> </div>risk the Company </div><div id="a9950" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.8px;">estimates for certain past due aging categories, and<div style="display:inline-block;width:4.77px"> </div>also, the general risk to all outstanding accounts receivable based on historical </div><div id="a9991" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92.2px;">amounts determined to be uncollectible.</div></div></div><div id="a9991_39_92" style="position:absolute;font-weight:normal;font-style:normal;left:218.093px;top:495.7px;"><div style="display:inline-block;width:6.72px"> </div>The Company does not have any off-balance-sheet<div style="display:inline-block;width:4.74px"> </div>credit exposure related to its customers. </div><div id="a10031" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:518.9px;">Contract Assets and Liabilities </div><div id="div_48_XBRL_TS_f84cbe25d52a4889807f70c82e63f9f0" style="position:absolute;left:0px;top:542.3px;float:left;"><div id="TextBlockContainer49" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10039" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company recognizes a contract asset or receivable<div style="display:inline-block;width:4.63px"> </div>on its Condensed Consolidated Balance Sheet when the Company </div><div id="a10073" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">performs a service or transfers a good in advance<div style="display:inline-block;width:4.61px"> </div>of receiving consideration.<div style="display:inline-block;width:7.34px"> </div>A receivable is the Company’s<div style="display:inline-block;width:4.72px"> </div>right to consideration that </div><div id="a10117" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">is unconditional and only the passage of time is required<div style="display:inline-block;width:4.71px"> </div>before payment of that consideration is due.<div style="display:inline-block;width:7.88px"> </div>A contract asset is the </div><div id="a10161" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">Company’s right to consideration<div style="display:inline-block;width:4.85px"> </div>in exchange for goods or services that the Company has transferred<div style="display:inline-block;width:4.92px"> </div>to a customer.</div></div></div><div id="a10161_114_14" style="position:absolute;font-weight:normal;font-style:normal;left:624.399px;top:588.4px;"><div style="display:inline-block;width:6.72px"> </div>The Company </div><div id="a10202" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:603.7px;">had no material contract assets recorded on its Condensed<div style="display:inline-block;width:4.83px"> </div>Consolidated Balance Sheets as of March 31, 2021 or December<div style="display:inline-block;width:4.78px"> </div>31, 2020. </div><div id="div_50_XBRL_TS_36f6eb8e5fc94143a314768b55d04f8e" style="position:absolute;left:0px;top:626.9px;float:left;"><div id="TextBlockContainer51" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10244" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">A contract liability is recognized when the Company<div style="display:inline-block;width:4.7px"> </div>receives consideration, or if it has the unconditional right<div style="display:inline-block;width:4.72px"> </div>to receive </div><div id="a10283" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">consideration, in advance of performance.<div style="display:inline-block;width:7.82px"> </div>A contract liability is the Company’s<div style="display:inline-block;width:4.98px"> </div>obligation to transfer goods or services to a customer </div><div id="a10323" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">for which the Company has received consideration,<div style="display:inline-block;width:4.73px"> </div>or a specified amount of consideration is due, from the customer.<div style="display:inline-block;width:8.96px"> </div>The Company’s </div><div id="a10364" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">contract liabilities primarily represent deferred revenue<div style="display:inline-block;width:4.7px"> </div>recorded for customer payments received by the Company<div style="display:inline-block;width:4.73px"> </div>prior to the </div><div id="a10398" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.5px;">Company satisfying the associated performance obligation.<div style="display:inline-block;width:8px"> </div>Deferred revenues are presented within other current liabilities<div style="display:inline-block;width:4.71px"> </div>in the </div><div id="a10431" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.7px;">Company’s Condensed<div style="display:inline-block;width:4.71px"> </div>Consolidated Balance Sheets.</div></div></div><div id="a10431_48_33" style="position:absolute;font-weight:normal;font-style:normal;left:289.933px;top:703.6px;"><div style="display:inline-block;width:6.72px"> </div>The Company had approximately $</div><div id="a10431_81_3" style="position:absolute;left:485.64px;top:703.6px;">6.3</div><div id="a10431_84_14" style="position:absolute;font-weight:normal;font-style:normal;left:502.28px;top:703.6px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a10431_98_3" style="position:absolute;left:576.719px;top:703.6px;">4.0</div><div id="a10431_101_21" style="position:absolute;font-weight:normal;font-style:normal;left:593.519px;top:703.6px;"><div style="display:inline-block;width:3.36px"> </div>million of deferred </div><div id="a10467" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:719px;">revenue as of March 31, 2021 and December 31, 2020,<div style="display:inline-block;width:4.8px"> </div>respectively.<div style="display:inline-block;width:7.79px"> </div>For three months ended March 31, 2021, the Company<div style="display:inline-block;width:4.7px"> </div>satisfied </div><div id="a10509" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:734.3px;">all of the associated performance obligations and recognized<div style="display:inline-block;width:4.88px"> </div>into revenue the advance payments received and recorded<div style="display:inline-block;width:4.61px"> </div>as of </div><div id="a10545" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:749.7px;">December 31, 2020.</div></div><div id="TextBlockContainer54" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:701px;height:55px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10601" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Disaggregated Revenue </div><div id="a10605" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The following tables disaggregate the Company’s<div style="display:inline-block;width:5.33px"> </div>net sales by segment, geographic region, customer industry,<div style="display:inline-block;width:5.59px"> </div>and timing of </div><div id="a10639" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">revenue recognized for the three months ended March 31,<div style="display:inline-block;width:4.75px"> </div>2021 and 2020.</div></div><div id="TextBlockContainer57" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:242px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10664" style="position:absolute;font-weight:bold;font-style:normal;left:383.533px;top:0px;">Three Months Ended March 31,<div style="display:inline-block;width:7.96px"> </div>2021 </div><div id="a10675" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:16.8px;">Consolidated </div><div id="a10678" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31px;">Americas </div><div id="a10681" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31px;">EMEA </div><div id="a10684" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31px;">Asia/Pacific </div><div id="a10687" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31px;">Total </div><div id="a10689" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a10702" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.6px;">Metals </div><div id="a10704" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.4px;">$ </div><div id="a10706" style="position:absolute;left:326.413px;top:65.4px;">46,793</div><div id="a10709" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.4px;">$ </div><div id="a10711" style="position:absolute;left:444.52px;top:65.4px;">34,274</div><div id="a10714" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.4px;">$ </div><div id="a10716" style="position:absolute;left:562.44px;top:65.4px;">49,743</div><div id="a10718" style="position:absolute;font-weight:normal;font-style:normal;left:608.56px;top:65.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a10720" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.4px;">$ </div><div id="a10722" style="position:absolute;left:671.76px;top:65.4px;">130,810</div><div id="a10724" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.6px;">Metalworking and other </div><div id="a10727" style="position:absolute;left:326.413px;top:82.4px;">88,078</div><div id="a10731" style="position:absolute;left:444.52px;top:82.4px;">85,540</div><div id="a10735" style="position:absolute;left:562.44px;top:82.4px;">46,963</div><div id="a10739" style="position:absolute;left:671.76px;top:82.4px;">220,581</div><div id="a10743" style="position:absolute;left:319.693px;top:98.9px;">134,871</div><div id="a10747" style="position:absolute;left:437.8px;top:98.9px;">119,814</div><div id="a10751" style="position:absolute;left:562.44px;top:98.9px;">96,706</div><div id="a10755" style="position:absolute;left:671.76px;top:98.9px;">351,391</div><div id="a10757" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a10760" style="position:absolute;left:326.413px;top:116.5px;">45,256</div><div id="a10764" style="position:absolute;left:444.52px;top:116.5px;">20,272</div><div id="a10768" style="position:absolute;left:562.44px;top:116.5px;">12,864</div><div id="a10772" style="position:absolute;left:678.48px;top:116.5px;">78,392</div><div id="a10775" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:135px;">$ </div><div id="a10777" style="position:absolute;left:319.693px;top:135px;">180,127</div><div id="a10780" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:135px;">$ </div><div id="a10782" style="position:absolute;left:437.8px;top:135px;">140,086</div><div id="a10785" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:135px;">$ </div><div id="a10787" style="position:absolute;left:555.72px;top:135px;">109,570</div><div id="a10790" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:135px;">$ </div><div id="a10792" style="position:absolute;left:671.76px;top:135px;">429,783</div><div id="a10806" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:172.4px;">Timing of Revenue Recognized </div><div id="a10819" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:189.3px;">Product sales at a point in time </div><div id="a10821" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:190.1px;">$ </div><div id="a10823" style="position:absolute;left:319.693px;top:190.1px;">171,594</div><div id="a10826" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:190.1px;">$ </div><div id="a10828" style="position:absolute;left:437.8px;top:190.1px;">131,162</div><div id="a10831" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:190.1px;">$ </div><div id="a10833" style="position:absolute;left:555.72px;top:190.1px;">106,399</div><div id="a10835" style="position:absolute;font-weight:normal;font-style:normal;left:608.56px;top:190.1px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a10837" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:190.1px;">$ </div><div id="a10839" style="position:absolute;left:671.76px;top:190.1px;">409,155</div><div id="a10841" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:206.3px;">Services transferred over time </div><div id="a10844" style="position:absolute;left:332.973px;top:207.1px;">8,533</div><div id="a10848" style="position:absolute;left:451.08px;top:207.1px;">8,924</div><div id="a10852" style="position:absolute;left:569.04px;top:207.1px;">3,171</div><div id="a10856" style="position:absolute;left:678.48px;top:207.1px;">20,628</div><div id="a10859" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:225.8px;">$ </div><div id="a10861" style="position:absolute;left:319.693px;top:225.8px;">180,127</div><div id="a10864" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:225.8px;">$ </div><div id="a10866" style="position:absolute;left:437.8px;top:225.8px;">140,086</div><div id="a10869" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:225.8px;">$ </div><div id="a10871" style="position:absolute;left:555.72px;top:225.8px;">109,570</div><div id="a10874" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:225.8px;">$ </div><div id="a10876" style="position:absolute;left:671.76px;top:225.8px;">429,783</div></div><div id="TextBlockContainer61" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:242px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10880" style="position:absolute;font-weight:bold;font-style:normal;left:383.533px;top:0px;">Three Months Ended March 31,<div style="display:inline-block;width:7.96px"> </div>2020 </div><div id="a10891" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:16.8px;">Consolidated </div><div id="a10894" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a10897" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a10900" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a10903" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a10905" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a10918" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.6px;">Metals </div><div id="a10920" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.4px;">$ </div><div id="a10922" style="position:absolute;left:326.413px;top:65.4px;">46,673</div><div id="a10925" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.4px;">$ </div><div id="a10927" style="position:absolute;left:444.52px;top:65.4px;">29,888</div><div id="a10930" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.4px;">$ </div><div id="a10932" style="position:absolute;left:562.44px;top:65.4px;">41,589</div><div id="a10934" style="position:absolute;font-weight:normal;font-style:normal;left:608.56px;top:65.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a10936" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.4px;">$ </div><div id="a10938" style="position:absolute;left:671.76px;top:65.4px;">118,150</div><div id="a10940" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.6px;">Metalworking and other </div><div id="a10943" style="position:absolute;left:326.413px;top:82.6px;">83,223</div><div id="a10947" style="position:absolute;left:444.52px;top:82.6px;">74,951</div><div id="a10951" style="position:absolute;left:562.44px;top:82.6px;">31,963</div><div id="a10955" style="position:absolute;left:671.76px;top:82.6px;">190,137</div><div id="a10959" style="position:absolute;left:319.693px;top:99px;">129,896</div><div id="a10963" style="position:absolute;left:437.8px;top:99px;">104,839</div><div id="a10967" style="position:absolute;left:562.44px;top:99px;">73,552</div><div id="a10971" style="position:absolute;left:671.76px;top:99px;">308,287</div><div id="a10973" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a10976" style="position:absolute;left:326.413px;top:116.5px;">44,231</div><div id="a10980" style="position:absolute;left:444.52px;top:116.5px;">16,605</div><div id="a10984" style="position:absolute;left:569.04px;top:116.5px;">9,438</div><div id="a10989" style="position:absolute;left:678.48px;top:116.5px;">70,274</div><div id="a10992" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:135.2px;">$ </div><div id="a10994" style="position:absolute;left:319.693px;top:133.8px;">174,127</div><div id="a10997" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:135.2px;">$ </div><div id="a10999" style="position:absolute;left:437.8px;top:133.8px;">121,444</div><div id="a11002" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:135.2px;">$ </div><div id="a11004" style="position:absolute;left:562.44px;top:133.8px;">82,990</div><div id="a11007" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:135.2px;">$ </div><div id="a11009" style="position:absolute;left:671.76px;top:133.8px;">378,561</div><div id="a11023" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:172.3px;">Timing of Revenue Recognized </div><div id="a11036" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:189.3px;">Product sales at a point in time </div><div id="a11038" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:190.1px;">$ </div><div id="a11040" style="position:absolute;left:319.693px;top:190.1px;">168,802</div><div id="a11043" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:190.1px;">$ </div><div id="a11045" style="position:absolute;left:437.8px;top:190.1px;">118,423</div><div id="a11048" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:190.1px;">$ </div><div id="a11050" style="position:absolute;left:562.44px;top:190.1px;">81,156</div><div id="a11052" style="position:absolute;font-weight:normal;font-style:normal;left:608.56px;top:190.1px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a11054" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:190.1px;">$ </div><div id="a11056" style="position:absolute;left:671.76px;top:190.1px;">368,381</div><div id="a11058" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:206.3px;">Services transferred over time </div><div id="a11061" style="position:absolute;left:332.973px;top:207.2px;">5,325</div><div id="a11065" style="position:absolute;left:451.08px;top:207.2px;">3,021</div><div id="a11069" style="position:absolute;left:569.04px;top:207.2px;">1,834</div><div id="a11073" style="position:absolute;left:678.48px;top:207.2px;">10,180</div><div id="a11076" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:225.8px;">$ </div><div id="a11078" style="position:absolute;left:319.693px;top:224.5px;">174,127</div><div id="a11081" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:225.8px;">$ </div><div id="a11083" style="position:absolute;left:437.8px;top:224.5px;">121,444</div><div id="a11086" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:225.8px;">$ </div><div id="a11088" style="position:absolute;left:562.44px;top:224.5px;">82,990</div><div id="a11091" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:225.8px;">$ </div><div id="a11093" style="position:absolute;left:671.76px;top:224.5px;">378,561</div></div> <div id="TextBlockContainer43" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9217" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As part of the Company’s<div style="display:inline-block;width:4.84px"> </div>Fluidcare business, certain third-party product sales to customers are<div style="display:inline-block;width:4.79px"> </div>managed by the Company.<div style="display:inline-block;width:8.3px"> </div>Where </div><div id="a9258" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">the Company acts as a principal, revenues are recognized<div style="display:inline-block;width:4.67px"> </div>on a gross reporting basis at the selling price negotiated with<div style="display:inline-block;width:4.77px"> </div>its customers. </div><div id="a9303" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Where the Company acts as an agent, revenue is recognized on<div style="display:inline-block;width:4.88px"> </div>a net reporting basis at the amount of the administrative fee earned<div style="display:inline-block;width:4.74px"> </div>by </div><div id="a9352" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">the Company for ordering the goods.</div></div> 17800000 12500000 0.10 0.03 <div id="TextBlockContainer45" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9540" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company applies the five-step model in the FASB’s<div style="display:inline-block;width:6.16px"> </div>guidance, which requires the Company to: (i) identify<div style="display:inline-block;width:4.86px"> </div>the contract with a </div><div id="a9584" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">customer; (ii) identify the performance obligations in<div style="display:inline-block;width:4.78px"> </div>the contract; (iii) determine the transaction price; (iv) allocate the<div style="display:inline-block;width:4.78px"> </div>transaction </div><div id="a9620" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">price to the performance obligations in the contract; and<div style="display:inline-block;width:4.68px"> </div>(v) recognize revenue when, or as, the Company satisfies a performance </div><div id="a9660" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">obligation.<div style="display:inline-block;width:7.02px"> </div>Refer to the Company’s 2020<div style="display:inline-block;width:4.77px"> </div>Form 10-K for additional information on the Company’s<div style="display:inline-block;width:5.34px"> </div>revenue recognition policies, </div><div id="a9698" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">including its practical expedients and accounting policy<div style="display:inline-block;width:4.79px"> </div>elections.</div></div><div id="TextBlockContainer49" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10039" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company recognizes a contract asset or receivable<div style="display:inline-block;width:4.63px"> </div>on its Condensed Consolidated Balance Sheet when the Company </div><div id="a10073" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">performs a service or transfers a good in advance<div style="display:inline-block;width:4.61px"> </div>of receiving consideration.<div style="display:inline-block;width:7.34px"> </div>A receivable is the Company’s<div style="display:inline-block;width:4.72px"> </div>right to consideration that </div><div id="a10117" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">is unconditional and only the passage of time is required<div style="display:inline-block;width:4.71px"> </div>before payment of that consideration is due.<div style="display:inline-block;width:7.88px"> </div>A contract asset is the </div><div id="a10161" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">Company’s right to consideration<div style="display:inline-block;width:4.85px"> </div>in exchange for goods or services that the Company has transferred<div style="display:inline-block;width:4.92px"> </div>to a customer.</div></div><div id="TextBlockContainer51" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10244" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">A contract liability is recognized when the Company<div style="display:inline-block;width:4.7px"> </div>receives consideration, or if it has the unconditional right<div style="display:inline-block;width:4.72px"> </div>to receive </div><div id="a10283" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">consideration, in advance of performance.<div style="display:inline-block;width:7.82px"> </div>A contract liability is the Company’s<div style="display:inline-block;width:4.98px"> </div>obligation to transfer goods or services to a customer </div><div id="a10323" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">for which the Company has received consideration,<div style="display:inline-block;width:4.73px"> </div>or a specified amount of consideration is due, from the customer.<div style="display:inline-block;width:8.96px"> </div>The Company’s </div><div id="a10364" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">contract liabilities primarily represent deferred revenue<div style="display:inline-block;width:4.7px"> </div>recorded for customer payments received by the Company<div style="display:inline-block;width:4.73px"> </div>prior to the </div><div id="a10398" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.5px;">Company satisfying the associated performance obligation.<div style="display:inline-block;width:8px"> </div>Deferred revenues are presented within other current liabilities<div style="display:inline-block;width:4.71px"> </div>in the </div><div id="a10431" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.7px;">Company’s Condensed<div style="display:inline-block;width:4.71px"> </div>Consolidated Balance Sheets.</div></div> <div id="TextBlockContainer47" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:725px;height:108px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9762_102_26" style="position:absolute;font-weight:normal;font-style:normal;left:534.92px;top:0px;">The Company recognizes an </div><div id="a9800" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">allowance for credit losses, which represents the portion<div style="display:inline-block;width:4.72px"> </div>of its trade accounts receivable that the Company does not expect<div style="display:inline-block;width:4.76px"> </div>to collect </div><div id="a9842" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">over the contractual life, considering past events<div style="display:inline-block;width:4.49px"> </div>and reasonable and supportable forecasts of future economic<div style="display:inline-block;width:4.72px"> </div>conditions.<div style="display:inline-block;width:6.79px"> </div>The </div><div id="a9877" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">Company’s allowance<div style="display:inline-block;width:4.62px"> </div>for credit losses on its trade accounts receivables<div style="display:inline-block;width:4.33px"> </div>is based on specific collectability facts and circumstances for </div><div id="a9916" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.5px;">each outstanding receivable and customer,<div style="display:inline-block;width:4.9px"> </div>the aging of outstanding receivables, and the associated collection<div style="display:inline-block;width:4.89px"> </div>risk the Company </div><div id="a9950" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.8px;">estimates for certain past due aging categories, and<div style="display:inline-block;width:4.77px"> </div>also, the general risk to all outstanding accounts receivable based on historical </div><div id="a9991" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92.2px;">amounts determined to be uncollectible.</div></div> 6300000 4000000.0 <div id="TextBlockContainer58" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:242px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_56_XBRL_TS_034b2fa7e8e8496cbdcf19045cee1506" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer57" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:242px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10664" style="position:absolute;font-weight:bold;font-style:normal;left:383.533px;top:0px;">Three Months Ended March 31,<div style="display:inline-block;width:7.96px"> </div>2021 </div><div id="a10675" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:16.8px;">Consolidated </div><div id="a10678" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31px;">Americas </div><div id="a10681" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31px;">EMEA </div><div id="a10684" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31px;">Asia/Pacific </div><div id="a10687" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31px;">Total </div><div id="a10689" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a10702" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.6px;">Metals </div><div id="a10704" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.4px;">$ </div><div id="a10706" style="position:absolute;left:326.413px;top:65.4px;">46,793</div><div id="a10709" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.4px;">$ </div><div id="a10711" style="position:absolute;left:444.52px;top:65.4px;">34,274</div><div id="a10714" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.4px;">$ </div><div id="a10716" style="position:absolute;left:562.44px;top:65.4px;">49,743</div><div id="a10718" style="position:absolute;font-weight:normal;font-style:normal;left:608.56px;top:65.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a10720" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.4px;">$ </div><div id="a10722" style="position:absolute;left:671.76px;top:65.4px;">130,810</div><div id="a10724" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.6px;">Metalworking and other </div><div id="a10727" style="position:absolute;left:326.413px;top:82.4px;">88,078</div><div id="a10731" style="position:absolute;left:444.52px;top:82.4px;">85,540</div><div id="a10735" style="position:absolute;left:562.44px;top:82.4px;">46,963</div><div id="a10739" style="position:absolute;left:671.76px;top:82.4px;">220,581</div><div id="a10743" style="position:absolute;left:319.693px;top:98.9px;">134,871</div><div id="a10747" style="position:absolute;left:437.8px;top:98.9px;">119,814</div><div id="a10751" style="position:absolute;left:562.44px;top:98.9px;">96,706</div><div id="a10755" style="position:absolute;left:671.76px;top:98.9px;">351,391</div><div id="a10757" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a10760" style="position:absolute;left:326.413px;top:116.5px;">45,256</div><div id="a10764" style="position:absolute;left:444.52px;top:116.5px;">20,272</div><div id="a10768" style="position:absolute;left:562.44px;top:116.5px;">12,864</div><div id="a10772" style="position:absolute;left:678.48px;top:116.5px;">78,392</div><div id="a10775" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:135px;">$ </div><div id="a10777" style="position:absolute;left:319.693px;top:135px;">180,127</div><div id="a10780" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:135px;">$ </div><div id="a10782" style="position:absolute;left:437.8px;top:135px;">140,086</div><div id="a10785" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:135px;">$ </div><div id="a10787" style="position:absolute;left:555.72px;top:135px;">109,570</div><div id="a10790" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:135px;">$ </div><div id="a10792" style="position:absolute;left:671.76px;top:135px;">429,783</div><div id="a10806" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:172.4px;">Timing of Revenue Recognized </div><div id="a10819" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:189.3px;">Product sales at a point in time </div><div id="a10821" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:190.1px;">$ </div><div id="a10823" style="position:absolute;left:319.693px;top:190.1px;">171,594</div><div id="a10826" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:190.1px;">$ </div><div id="a10828" style="position:absolute;left:437.8px;top:190.1px;">131,162</div><div id="a10831" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:190.1px;">$ </div><div id="a10833" style="position:absolute;left:555.72px;top:190.1px;">106,399</div><div id="a10835" style="position:absolute;font-weight:normal;font-style:normal;left:608.56px;top:190.1px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a10837" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:190.1px;">$ </div><div id="a10839" style="position:absolute;left:671.76px;top:190.1px;">409,155</div><div id="a10841" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:206.3px;">Services transferred over time </div><div id="a10844" style="position:absolute;left:332.973px;top:207.1px;">8,533</div><div id="a10848" style="position:absolute;left:451.08px;top:207.1px;">8,924</div><div id="a10852" style="position:absolute;left:569.04px;top:207.1px;">3,171</div><div id="a10856" style="position:absolute;left:678.48px;top:207.1px;">20,628</div><div id="a10859" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:225.8px;">$ </div><div id="a10861" style="position:absolute;left:319.693px;top:225.8px;">180,127</div><div id="a10864" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:225.8px;">$ </div><div id="a10866" style="position:absolute;left:437.8px;top:225.8px;">140,086</div><div id="a10869" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:225.8px;">$ </div><div id="a10871" style="position:absolute;left:555.72px;top:225.8px;">109,570</div><div id="a10874" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:225.8px;">$ </div><div id="a10876" style="position:absolute;left:671.76px;top:225.8px;">429,783</div></div></div></div><div id="TextBlockContainer62" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:242px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_60_XBRL_TS_0eebd7d9b80f4fd096ec458ff6ac5b0c" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer61" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:242px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10880" style="position:absolute;font-weight:bold;font-style:normal;left:383.533px;top:0px;">Three Months Ended March 31,<div style="display:inline-block;width:7.96px"> </div>2020 </div><div id="a10891" style="position:absolute;font-weight:bold;font-style:normal;left:630.48px;top:16.8px;">Consolidated </div><div id="a10894" style="position:absolute;font-weight:bold;font-style:normal;left:288.813px;top:31.2px;">Americas </div><div id="a10897" style="position:absolute;font-weight:bold;font-style:normal;left:413.8px;top:31.2px;">EMEA </div><div id="a10900" style="position:absolute;font-weight:bold;font-style:normal;left:518.12px;top:31.2px;">Asia/Pacific </div><div id="a10903" style="position:absolute;font-weight:bold;font-style:normal;left:652.72px;top:31.2px;">Total </div><div id="a10905" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:47.7px;">Customer Industries </div><div id="a10918" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.6px;">Metals </div><div id="a10920" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:65.4px;">$ </div><div id="a10922" style="position:absolute;left:326.413px;top:65.4px;">46,673</div><div id="a10925" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:65.4px;">$ </div><div id="a10927" style="position:absolute;left:444.52px;top:65.4px;">29,888</div><div id="a10930" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:65.4px;">$ </div><div id="a10932" style="position:absolute;left:562.44px;top:65.4px;">41,589</div><div id="a10934" style="position:absolute;font-weight:normal;font-style:normal;left:608.56px;top:65.4px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a10936" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:65.4px;">$ </div><div id="a10938" style="position:absolute;left:671.76px;top:65.4px;">118,150</div><div id="a10940" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.6px;">Metalworking and other </div><div id="a10943" style="position:absolute;left:326.413px;top:82.6px;">83,223</div><div id="a10947" style="position:absolute;left:444.52px;top:82.6px;">74,951</div><div id="a10951" style="position:absolute;left:562.44px;top:82.6px;">31,963</div><div id="a10955" style="position:absolute;left:671.76px;top:82.6px;">190,137</div><div id="a10959" style="position:absolute;left:319.693px;top:99px;">129,896</div><div id="a10963" style="position:absolute;left:437.8px;top:99px;">104,839</div><div id="a10967" style="position:absolute;left:562.44px;top:99px;">73,552</div><div id="a10971" style="position:absolute;left:671.76px;top:99px;">308,287</div><div id="a10973" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:116.5px;">Global Specialty Businesses </div><div id="a10976" style="position:absolute;left:326.413px;top:116.5px;">44,231</div><div id="a10980" style="position:absolute;left:444.52px;top:116.5px;">16,605</div><div id="a10984" style="position:absolute;left:569.04px;top:116.5px;">9,438</div><div id="a10989" style="position:absolute;left:678.48px;top:116.5px;">70,274</div><div id="a10992" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:135.2px;">$ </div><div id="a10994" style="position:absolute;left:319.693px;top:133.8px;">174,127</div><div id="a10997" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:135.2px;">$ </div><div id="a10999" style="position:absolute;left:437.8px;top:133.8px;">121,444</div><div id="a11002" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:135.2px;">$ </div><div id="a11004" style="position:absolute;left:562.44px;top:133.8px;">82,990</div><div id="a11007" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:135.2px;">$ </div><div id="a11009" style="position:absolute;left:671.76px;top:133.8px;">378,561</div><div id="a11023" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:172.3px;">Timing of Revenue Recognized </div><div id="a11036" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:189.3px;">Product sales at a point in time </div><div id="a11038" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:190.1px;">$ </div><div id="a11040" style="position:absolute;left:319.693px;top:190.1px;">168,802</div><div id="a11043" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:190.1px;">$ </div><div id="a11045" style="position:absolute;left:437.8px;top:190.1px;">118,423</div><div id="a11048" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:190.1px;">$ </div><div id="a11050" style="position:absolute;left:562.44px;top:190.1px;">81,156</div><div id="a11052" style="position:absolute;font-weight:normal;font-style:normal;left:608.56px;top:190.1px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a11054" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:190.1px;">$ </div><div id="a11056" style="position:absolute;left:671.76px;top:190.1px;">368,381</div><div id="a11058" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:206.3px;">Services transferred over time </div><div id="a11061" style="position:absolute;left:332.973px;top:207.2px;">5,325</div><div id="a11065" style="position:absolute;left:451.08px;top:207.2px;">3,021</div><div id="a11069" style="position:absolute;left:569.04px;top:207.2px;">1,834</div><div id="a11073" style="position:absolute;left:678.48px;top:207.2px;">10,180</div><div id="a11076" style="position:absolute;font-weight:normal;font-style:normal;left:264.493px;top:225.8px;">$ </div><div id="a11078" style="position:absolute;left:319.693px;top:224.5px;">174,127</div><div id="a11081" style="position:absolute;font-weight:normal;font-style:normal;left:382.413px;top:225.8px;">$ </div><div id="a11083" style="position:absolute;left:437.8px;top:224.5px;">121,444</div><div id="a11086" style="position:absolute;font-weight:normal;font-style:normal;left:500.52px;top:225.8px;">$ </div><div id="a11088" style="position:absolute;left:562.44px;top:224.5px;">82,990</div><div id="a11091" style="position:absolute;font-weight:normal;font-style:normal;left:616.56px;top:225.8px;">$ </div><div id="a11093" style="position:absolute;left:671.76px;top:224.5px;">378,561</div></div></div></div> 46793000 34274000 49743000 130810000 88078000 85540000 46963000 220581000 134871000 134871000 119814000 119814000 96706000 96706000 351391000 45256000 20272000 12864000 78392000 180127000 140086000 109570000 429783000 429783000 171594000 131162000 106399000 409155000 8533000 8924000 3171000 20628000 180127000 140086000 109570000 429783000 46673000 29888000 41589000 118150000 83223000 74951000 31963000 190137000 129896000 129896000 104839000 104839000 73552000 73552000 308287000 44231000 16605000 9438000 70274000 174127000 121444000 82990000 378561000 378561000 168802000 118423000 81156000 368381000 5325000 3021000 1834000 10180000 174127000 121444000 82990000 378561000 <div id="TextBlockContainer66" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:264px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11095" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 6 - Leases </div><div id="div_64_XBRL_TS_2f0d9bb75921417ea5f6825946ac2bc0" style="position:absolute;left:0px;top:25.6px;float:left;"><div id="TextBlockContainer65" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:78px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11103" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company determines if an arrangement is a lease<div style="display:inline-block;width:4.74px"> </div>at its inception.<div style="display:inline-block;width:7.16px"> </div>This determination generally depends on whether the </div><div id="a11141" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">arrangement conveys the right to control the use of an<div style="display:inline-block;width:4.74px"> </div>identified fixed asset explicitly or implicitly for a period of<div style="display:inline-block;width:4.73px"> </div>time in exchange for </div><div id="a11190" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">consideration.<div style="display:inline-block;width:7.09px"> </div>Control of an underlying asset is conveyed if the Company<div style="display:inline-block;width:4.54px"> </div>obtains the rights to direct the use of, and obtains </div><div id="a11233" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">substantially all of the economic benefits from the use<div style="display:inline-block;width:4.73px"> </div>of, the underlying asset.<div style="display:inline-block;width:7.19px"> </div>Lease expense for variable leases and short-term </div><div id="a11275" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.5px;">leases is recognized when the obligation is incurred.</div></div></div><div id="a11275_53_2" style="position:absolute;font-weight:normal;font-style:normal;left:283.213px;top:87.1px;"><div style="display:inline-block;width:3.2px"> </div></div><div id="a11293" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:110.3px;">The Company has operating leases for certain facilities, vehicles<div style="display:inline-block;width:4.7px"> </div>and machinery and equipment with remaining lease terms up<div style="display:inline-block;width:4.76px"> </div>to </div><div id="a11332" style="position:absolute;left:4.427px;top:125.6px;">10</div><div id="a11332_2_95" style="position:absolute;font-weight:normal;font-style:normal;left:17.867px;top:125.6px;"><div style="display:inline-block;width:3.36px"> </div>years.<div style="display:inline-block;width:6.77px"> </div>In addition, the Company has certain land use leases with remaining<div style="display:inline-block;width:4.9px"> </div>lease terms up to </div><div id="a11332_97_2" style="position:absolute;left:520.04px;top:125.6px;">94</div><div id="a11332_99_39" style="position:absolute;font-weight:normal;font-style:normal;left:533.48px;top:125.6px;"><div style="display:inline-block;width:3.36px"> </div>years.<div style="display:inline-block;width:6.78px"> </div>The lease term for all of the </div><div id="a11385" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:141px;">Company’s leases includes<div style="display:inline-block;width:4.76px"> </div>the non-cancellable period of the lease plus any additional periods<div style="display:inline-block;width:4.8px"> </div>covered by an option to extend the lease </div><div id="a11430" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:156.4px;">that the Company is reasonably certain it will exercise.<div style="display:inline-block;width:8.05px"> </div>Operating leases are included in right of use lease assets, other current </div><div id="a11473" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:171.7px;">liabilities and long-term lease liabilities on the Condensed<div style="display:inline-block;width:4.82px"> </div>Consolidated Balance Sheet.<div style="display:inline-block;width:7.4px"> </div>Right of use lease assets and liabilities are </div><div id="a11513" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:186.9px;">recognized at each lease’s<div style="display:inline-block;width:4.75px"> </div>commencement date based on the present value of its lease payments<div style="display:inline-block;width:4.79px"> </div>over its respective lease term.<div style="display:inline-block;width:7.55px"> </div>The </div><div id="a11555" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:202.3px;">Company uses the stated borrowing rate for a lease when<div style="display:inline-block;width:4.73px"> </div>readily determinable.<div style="display:inline-block;width:7.2px"> </div>When a stated borrowing rate is not available in a </div><div id="a11599" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:217.6px;">lease agreement, the Company uses its incremental borrowing<div style="display:inline-block;width:4.78px"> </div>rate based on information available at the lease’s<div style="display:inline-block;width:5.1px"> </div>commencement date </div><div id="a11635" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:233px;">to determine the present value of its lease payments.<div style="display:inline-block;width:7.99px"> </div>In determining the incremental borrowing rate used to present<div style="display:inline-block;width:4.73px"> </div>value each of its </div><div id="a11679" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:248.4px;">leases, the Company considers certain information<div style="display:inline-block;width:4.71px"> </div>including fully secured borrowing rates readily available to the Company<div style="display:inline-block;width:4.92px"> </div>and its </div></div><div id="TextBlockContainer68" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:727px;height:155px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11765" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">subsidiaries.<div style="display:inline-block;width:6.97px"> </div>The Company has immaterial finance leases, which are<div style="display:inline-block;width:4.75px"> </div>included in property, plant<div style="display:inline-block;width:4.81px"> </div>and equipment, current portion of </div><div id="a11804" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">long-term debt and long-term debt on the Condensed Consolidated<div style="display:inline-block;width:4.95px"> </div>Balance Sheet. </div><div id="a11830" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:38.7px;">Operating lease expense is recognized on a straight-line<div style="display:inline-block;width:4.76px"> </div>basis over the lease term.<div style="display:inline-block;width:7.13px"> </div>Operating lease expense for the three months </div><div id="a11872" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">ended March 31, 2021 and 2020 was $</div><div id="a11872_35_3" style="position:absolute;left:211.173px;top:53.9px;">3.6</div><div id="a11872_38_14" style="position:absolute;font-weight:normal;font-style:normal;left:227.853px;top:53.9px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a11872_52_3" style="position:absolute;left:302.253px;top:53.9px;">3.4</div><div id="a11872_55_55" style="position:absolute;font-weight:normal;font-style:normal;left:319.053px;top:53.9px;"><div style="display:inline-block;width:3.2px"> </div>million, respectively.<div style="display:inline-block;width:8.24px"> </div>Short-term lease expense was $</div><div id="a11872_110_3" style="position:absolute;left:610.159px;top:53.9px;">0.3</div><div id="a11872_113_14" style="position:absolute;font-weight:normal;font-style:normal;left:626.799px;top:53.9px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a11872_127_3" style="position:absolute;left:701.199px;top:53.9px;">0.5</div><div id="a11872_130_1" style="position:absolute;font-weight:normal;font-style:normal;left:717.839px;top:53.9px;"> </div><div id="a11928" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">million for the three months ended March 31, 2021<div style="display:inline-block;width:4.73px"> </div>and 2020, respectively.<div style="display:inline-block;width:7.96px"> </div>The Company has </div><div id="a11928_91_2" style="position:absolute;left:511.56px;top:69.3px;">no</div><div id="a11928_93_34" style="position:absolute;font-weight:normal;font-style:normal;left:525px;top:69.3px;"><div style="display:inline-block;width:3.36px"> </div>material variable lease costs or </div><div id="a11975" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">sublease income for the three months ended March 31, 2021 and<div style="display:inline-block;width:4.89px"> </div>2020.<div style="display:inline-block;width:6.76px"> </div>Cash paid for operating leases was $</div><div id="a11975_105_3" style="position:absolute;left:583.919px;top:84.6px;">3.6</div><div id="a11975_108_14" style="position:absolute;font-weight:normal;font-style:normal;left:600.719px;top:84.6px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a11975_122_3" style="position:absolute;left:675.279px;top:84.6px;">3.4</div><div id="a11975_125_1" style="position:absolute;font-weight:normal;font-style:normal;left:691.919px;top:84.6px;"> </div><div id="a12028" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">million during the three months ended March 31, 2021<div style="display:inline-block;width:4.75px"> </div>and 2020,<div style="display:inline-block;width:3.47px"> </div>respectively.<div style="display:inline-block;width:7.11px"> </div>The Company recorded new right of use lease assets </div><div id="a12074" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">and associated lease liabilities of approximately $</div><div id="a12074_51_3" style="position:absolute;left:269.773px;top:115.4px;">3.1</div><div id="a12074_54_55" style="position:absolute;font-weight:normal;font-style:normal;left:286.413px;top:115.4px;"><div style="display:inline-block;width:3.36px"> </div>million during the three months ended March 31, 2021. </div><div id="a12111" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:138.7px;">Supplemental balance sheet information related to the Company’s<div style="display:inline-block;width:5.61px"> </div>leases is as follows:</div></div><div id="TextBlockContainer71" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:167px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12138" style="position:absolute;font-weight:bold;font-style:normal;left:487.72px;top:0px;">March 31, </div><div id="a12141" style="position:absolute;font-weight:bold;font-style:normal;left:577.2px;top:0px;">December 31, </div><div id="a12146" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:17px;">2021 </div><div id="a12149" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17px;">2020 </div><div id="a12153" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33px;">Right of use lease assets </div><div id="a12155" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:33px;">$ </div><div id="a12157" style="position:absolute;left:518.92px;top:33px;">38,027</div><div id="a12160" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:33px;">$ </div><div id="a12162" style="position:absolute;left:618px;top:33px;">38,507</div><div id="a12174" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66px;">Other current liabilities </div><div id="a12177" style="position:absolute;left:518.92px;top:66px;">10,419</div><div id="a12181" style="position:absolute;left:618px;top:66px;">10,901</div><div id="a12185" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:83.1px;">Long-term lease liabilities </div><div id="a12190" style="position:absolute;left:518.92px;top:83.1px;">27,050</div><div id="a12194" style="position:absolute;left:618px;top:83.1px;">27,070</div><div id="a12198" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">Total operating<div style="display:inline-block;width:4.71px"> </div>lease liabilities </div><div id="a12200" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:100px;">$ </div><div id="a12202" style="position:absolute;left:518.92px;top:100px;">37,469</div><div id="a12205" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:100px;">$ </div><div id="a12207" style="position:absolute;left:618px;top:100px;">37,971</div><div id="a12220" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:134px;">Weighted average<div style="display:inline-block;width:4.84px"> </div>remaining lease term (years) </div><div id="a12223" style="position:absolute;left:538.96px;top:134px;">5.9</div><div id="a12227" style="position:absolute;left:638px;top:134px;">6.0</div><div id="a12231" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:151.1px;">Weighted average<div style="display:inline-block;width:4.84px"> </div>discount rate </div><div id="a12234" style="position:absolute;left:525.16px;top:151.1px;display:flex;">4.26%</div><div id="a12238" style="position:absolute;left:624.24px;top:151.1px;display:flex;">4.20%</div></div><div id="TextBlockContainer74" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:427px;height:16px;display:inline-block;"><div id="a12241" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Maturities of operating lease liabilities as of March 31,<div style="display:inline-block;width:4.68px"> </div>2021 were as follows:</div></div><div id="TextBlockContainer77" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:184px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12270" style="position:absolute;font-weight:bold;font-style:normal;left:586.8px;top:0px;">March 31, </div><div id="a12275" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17px;">2021 </div><div id="a12279" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33px;">For the remainder of 2021 </div><div id="a12282" style="position:absolute;font-weight:normal;font-style:normal;left:575.12px;top:33px;">$ </div><div id="a12284" style="position:absolute;left:624.56px;top:33px;">9,269</div><div id="a12288" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:49px;">For the year ended December 31, 2022 </div><div id="a12291" style="position:absolute;left:624.56px;top:49px;">9,042</div><div id="a12295" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:65.9px;">For the year ended December 31, 2023 </div><div id="a12298" style="position:absolute;left:624.56px;top:65.9px;">6,932</div><div id="a12302" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:82.9px;">For the year ended December 31, 2024 </div><div id="a12305" style="position:absolute;left:624.56px;top:82.9px;">5,194</div><div id="a12309" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">For the year ended December 31, 2025 </div><div id="a12312" style="position:absolute;left:624.56px;top:100px;">4,211</div><div id="a12316" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117px;">For the year ended December 31, 2026 and beyond </div><div id="a12320" style="position:absolute;left:624.56px;top:117px;">8,116</div><div id="a12324" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:133.9px;">Total lease payments </div><div id="a12327" style="position:absolute;left:618px;top:133.9px;">42,764</div><div id="a12331" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:150.9px;">Less: imputed interest </div><div id="a12334" style="position:absolute;left:619.76px;top:150.9px;">(5,295)</div><div id="a12338" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:168px;">Present value of lease liabilities </div><div id="a12340" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:168px;">$ </div><div id="a12342" style="position:absolute;left:618px;top:168px;">37,469</div></div> <div id="TextBlockContainer65" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:78px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11103" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company determines if an arrangement is a lease<div style="display:inline-block;width:4.74px"> </div>at its inception.<div style="display:inline-block;width:7.16px"> </div>This determination generally depends on whether the </div><div id="a11141" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">arrangement conveys the right to control the use of an<div style="display:inline-block;width:4.74px"> </div>identified fixed asset explicitly or implicitly for a period of<div style="display:inline-block;width:4.73px"> </div>time in exchange for </div><div id="a11190" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">consideration.<div style="display:inline-block;width:7.09px"> </div>Control of an underlying asset is conveyed if the Company<div style="display:inline-block;width:4.54px"> </div>obtains the rights to direct the use of, and obtains </div><div id="a11233" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">substantially all of the economic benefits from the use<div style="display:inline-block;width:4.73px"> </div>of, the underlying asset.<div style="display:inline-block;width:7.19px"> </div>Lease expense for variable leases and short-term </div><div id="a11275" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.5px;">leases is recognized when the obligation is incurred.</div></div> P10Y P94Y 3600000 3400000 300000 500000 0 0 0 0 3600000 3400000 3100000 <div id="TextBlockContainer72" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:167px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_70_XBRL_TS_7303e64ea2504327b542fb33fe5d0dcb" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer71" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:167px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12138" style="position:absolute;font-weight:bold;font-style:normal;left:487.72px;top:0px;">March 31, </div><div id="a12141" style="position:absolute;font-weight:bold;font-style:normal;left:577.2px;top:0px;">December 31, </div><div id="a12146" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:17px;">2021 </div><div id="a12149" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17px;">2020 </div><div id="a12153" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33px;">Right of use lease assets </div><div id="a12155" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:33px;">$ </div><div id="a12157" style="position:absolute;left:518.92px;top:33px;">38,027</div><div id="a12160" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:33px;">$ </div><div id="a12162" style="position:absolute;left:618px;top:33px;">38,507</div><div id="a12174" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66px;">Other current liabilities </div><div id="a12177" style="position:absolute;left:518.92px;top:66px;">10,419</div><div id="a12181" style="position:absolute;left:618px;top:66px;">10,901</div><div id="a12185" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:83.1px;">Long-term lease liabilities </div><div id="a12190" style="position:absolute;left:518.92px;top:83.1px;">27,050</div><div id="a12194" style="position:absolute;left:618px;top:83.1px;">27,070</div><div id="a12198" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">Total operating<div style="display:inline-block;width:4.71px"> </div>lease liabilities </div><div id="a12200" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:100px;">$ </div><div id="a12202" style="position:absolute;left:518.92px;top:100px;">37,469</div><div id="a12205" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:100px;">$ </div><div id="a12207" style="position:absolute;left:618px;top:100px;">37,971</div><div id="a12220" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:134px;">Weighted average<div style="display:inline-block;width:4.84px"> </div>remaining lease term (years) </div><div id="a12223" style="position:absolute;left:538.96px;top:134px;">5.9</div><div id="a12227" style="position:absolute;left:638px;top:134px;">6.0</div><div id="a12231" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:151.1px;">Weighted average<div style="display:inline-block;width:4.84px"> </div>discount rate </div><div id="a12234" style="position:absolute;left:525.16px;top:151.1px;display:flex;">4.26%</div><div id="a12238" style="position:absolute;left:624.24px;top:151.1px;display:flex;">4.20%</div></div></div></div> 38027000 38507000 10419000 10901000 27050000 27070000 37469000 37971000 P5Y10M24D P6Y 4.26 4.20 <div id="TextBlockContainer78" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:184px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_76_XBRL_TS_1aec7f5fca5343b7bf8367857717f3d6" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer77" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:184px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12270" style="position:absolute;font-weight:bold;font-style:normal;left:586.8px;top:0px;">March 31, </div><div id="a12275" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17px;">2021 </div><div id="a12279" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33px;">For the remainder of 2021 </div><div id="a12282" style="position:absolute;font-weight:normal;font-style:normal;left:575.12px;top:33px;">$ </div><div id="a12284" style="position:absolute;left:624.56px;top:33px;">9,269</div><div id="a12288" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:49px;">For the year ended December 31, 2022 </div><div id="a12291" style="position:absolute;left:624.56px;top:49px;">9,042</div><div id="a12295" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:65.9px;">For the year ended December 31, 2023 </div><div id="a12298" style="position:absolute;left:624.56px;top:65.9px;">6,932</div><div id="a12302" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:82.9px;">For the year ended December 31, 2024 </div><div id="a12305" style="position:absolute;left:624.56px;top:82.9px;">5,194</div><div id="a12309" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">For the year ended December 31, 2025 </div><div id="a12312" style="position:absolute;left:624.56px;top:100px;">4,211</div><div id="a12316" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117px;">For the year ended December 31, 2026 and beyond </div><div id="a12320" style="position:absolute;left:624.56px;top:117px;">8,116</div><div id="a12324" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:133.9px;">Total lease payments </div><div id="a12327" style="position:absolute;left:618px;top:133.9px;">42,764</div><div id="a12331" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:150.9px;">Less: imputed interest </div><div id="a12334" style="position:absolute;left:619.76px;top:150.9px;">(5,295)</div><div id="a12338" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:168px;">Present value of lease liabilities </div><div id="a12340" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:168px;">$ </div><div id="a12342" style="position:absolute;left:618px;top:168px;">37,469</div></div></div></div> 9269000 9042000 6932000 5194000 4211000 8116000 42764000 5295000 37469000 <div id="TextBlockContainer80" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:726px;height:216px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12345" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 7 – Restructuring and Related Activities </div><div id="a12359" style="position:absolute;left:28.427px;top:23.4px;">The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost </div><div id="a12399" style="position:absolute;left:4.427px;top:38.7px;">synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated </div><div id="a12435" style="position:absolute;left:4.427px;top:54.1px;">severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain </div><div id="a12476" style="position:absolute;left:4.427px;top:69.4px;">manufacturing and non-manufacturing facilities.</div><div id="a12476_47_83" style="position:absolute;font-weight:normal;font-style:normal;left:263.053px;top:69.4px;"><div style="display:inline-block;width:6.72px"> </div>The exact timing and total costs associated with the QH Program<div style="display:inline-block;width:4.95px"> </div>will depend on a </div><div id="a12516" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">number of factors and is subject to change; however,<div style="display:inline-block;width:5.25px"> </div>the Company currently expects reduction in headcount and<div style="display:inline-block;width:4.74px"> </div>site closures to </div><div id="a12557" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">continue to occur throughout 2021<div style="display:inline-block;width:4.2px"> </div>under the QH Program and estimates that anticipated costs synergies<div style="display:inline-block;width:5.01px"> </div>realized from the QH </div><div id="a12597" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">Program will approximate one-times the restructuring costs<div style="display:inline-block;width:4.69px"> </div>incurred.<div style="display:inline-block;width:7px"> </div>Employee separation benefits will vary depending on local </div><div id="a12631" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.8px;">regulations within certain foreign countries and will<div style="display:inline-block;width:4.69px"> </div>include severance and other benefits.<div style="display:inline-block;width:7.34px"> </div></div><div id="a12656" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:154.1px;">All costs incurred to date relate to severance costs to reduce<div style="display:inline-block;width:4.78px"> </div>headcount as well as costs to close certain facilities and are<div style="display:inline-block;width:4.78px"> </div>recorded </div><div id="a12702" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169.3px;">in Restructuring and related charges in the<div style="display:inline-block;width:4.8px"> </div>Company’s Condensed Statements<div style="display:inline-block;width:4.72px"> </div>of Operations.<div style="display:inline-block;width:7.07px"> </div>As described in Note 4 of Notes to </div><div id="a12743" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.7px;">Condensed Consolidated Financial Statements, restructuring<div style="display:inline-block;width:4.74px"> </div>and related charges are not included in<div style="display:inline-block;width:4.7px"> </div>the Company’s calculation of </div><div id="a12776" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">reportable segments’ measure of operating earnings<div style="display:inline-block;width:4.71px"> </div>and therefore these costs are not reviewed by or recorded to<div style="display:inline-block;width:4.72px"> </div>reportable segments.</div></div><div id="TextBlockContainer82" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:697px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12864" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Activity in the Company’s<div style="display:inline-block;width:4.77px"> </div>accrual for restructuring under the QH Program for the three months<div style="display:inline-block;width:4.79px"> </div>ended March 31, 2021 is as </div><div id="a12906" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">follows:</div></div><div id="TextBlockContainer86" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:104px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_84_XBRL_TS_084b9e3fa45045daa11eed560188d9d9" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer85" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:104px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12911" style="position:absolute;font-weight:bold;font-style:normal;left:578.48px;top:0px;">QH Program </div><div id="a12915" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17.3px;">Accrued restructuring as of December 31, 2020 </div><div id="a12917" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:17.3px;">$ </div><div id="a12919" style="position:absolute;left:625.52px;top:17.3px;">8,248</div><div id="a12924" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:34.9px;">Restructuring and related charges </div><div id="a12927" style="position:absolute;left:625.52px;top:34.9px;">1,175</div><div id="a12932" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:52.5px;">Cash payments </div><div id="a12935" style="position:absolute;left:619.76px;top:52.5px;">(3,034)</div><div id="a12940" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:70.1px;">Currency translation adjustments </div><div id="a12943" style="position:absolute;left:629.68px;top:70.1px;">(419)</div><div id="a12947" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:88.5px;">Accrued restructuring as of March 31, 2021 </div><div id="a12949" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:88.5px;">$ </div><div id="a12951" style="position:absolute;left:625.52px;top:88.5px;">5,970</div></div></div></div> The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain manufacturing and non-manufacturing facilities. 400 <div id="TextBlockContainer85" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:104px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12911" style="position:absolute;font-weight:bold;font-style:normal;left:578.48px;top:0px;">QH Program </div><div id="a12915" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17.3px;">Accrued restructuring as of December 31, 2020 </div><div id="a12917" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:17.3px;">$ </div><div id="a12919" style="position:absolute;left:625.52px;top:17.3px;">8,248</div><div id="a12924" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:34.9px;">Restructuring and related charges </div><div id="a12927" style="position:absolute;left:625.52px;top:34.9px;">1,175</div><div id="a12932" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:52.5px;">Cash payments </div><div id="a12935" style="position:absolute;left:619.76px;top:52.5px;">(3,034)</div><div id="a12940" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:70.1px;">Currency translation adjustments </div><div id="a12943" style="position:absolute;left:629.68px;top:70.1px;">(419)</div><div id="a12947" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:88.5px;">Accrued restructuring as of March 31, 2021 </div><div id="a12949" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:88.5px;">$ </div><div id="a12951" style="position:absolute;left:625.52px;top:88.5px;">5,970</div></div> 8248000 1175000 3034000 419000 5970000 <div id="TextBlockContainer88" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:682px;height:55px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a12954" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 8 – Share-Based Compensation </div><div id="a12967" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company recognized the following share-based compensation<div style="display:inline-block;width:4.83px"> </div>expense in its Condensed Consolidated Statements of </div><div id="a12998" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">Operations for the three months ended March 31, 2021<div style="display:inline-block;width:4.83px"> </div>and 2020:</div></div><div id="TextBlockContainer92" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_90_XBRL_CS_9124b2f837344956950080968fa61aa7" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer91" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13022" style="position:absolute;font-weight:bold;font-style:normal;left:505.8px;top:0px;">Three Months Ended </div><div id="a13027" style="position:absolute;font-weight:bold;font-style:normal;left:537.2px;top:17px;">March 31,<div style="display:inline-block;width:3.89px"> </div></div><div id="a13032" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:34.1px;">2021 </div><div id="a13035" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:34.1px;">2020 </div><div id="a13039" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51px;">Stock options </div><div id="a13042" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:51px;">$ </div><div id="a13044" style="position:absolute;left:535.56px;top:51px;">308</div><div id="a13047" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:51px;">$ </div><div id="a13049" style="position:absolute;left:634.64px;top:51px;">432</div><div id="a13053" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Non-vested stock awards and restricted stock units </div><div id="a13058" style="position:absolute;left:525.48px;top:68px;">1,396</div><div id="a13062" style="position:absolute;left:624.56px;top:68px;">1,264</div><div id="a13066" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85px;">Non-elective and elective 401(k) matching contribution in<div style="display:inline-block;width:4.77px"> </div>stock </div><div id="a13071" style="position:absolute;left:525.48px;top:85px;">1,553</div><div id="a13075" style="position:absolute;left:641.36px;top:85px;">—</div><div id="a13079" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.1px;">Director stock ownership plan </div><div id="a13082" style="position:absolute;left:535.56px;top:102.1px;">203</div><div id="a13086" style="position:absolute;left:641.36px;top:102.1px;">40</div><div id="a13090" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:119px;">Performance stock units </div><div id="a13093" style="position:absolute;left:535.56px;top:119px;">319</div><div id="a13097" style="position:absolute;left:641.36px;top:119px;">—</div><div id="a13101" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:136px;">Annual incentive plan </div><div id="a13104" style="position:absolute;left:542.32px;top:136px;">—</div><div id="a13108" style="position:absolute;left:624.56px;top:136px;">2,946</div><div id="a13112" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:154.1px;">Total share-based<div style="display:inline-block;width:4.85px"> </div>compensation expense </div><div id="a13116" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:154.1px;">$ </div><div id="a13118" style="position:absolute;left:525.48px;top:154.1px;">3,779</div><div id="a13121" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:154.1px;">$ </div><div id="a13123" style="position:absolute;left:624.56px;top:154.1px;">4,682</div></div></div></div><div id="TextBlockContainer94" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:155px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13126" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Share-based compensation expense is recorded in SG&amp;A,<div style="display:inline-block;width:4.71px"> </div>except for $</div><div id="a13126_66_3" style="position:absolute;left:404.04px;top:0px;">0.3</div><div id="a13126_69_14" style="position:absolute;font-weight:normal;font-style:normal;left:420.68px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a13126_83_3" style="position:absolute;left:495.079px;top:0px;">0.5</div><div id="a13126_86_39" style="position:absolute;font-weight:normal;font-style:normal;left:511.72px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million during the three months ended </div><div id="a13167" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">March 31, 2021 and 2020, respectively,<div style="display:inline-block;width:5.34px"> </div>recorded within Combination, integration and other acquisition<div style="display:inline-block;width:1.42px"> </div>-related expenses.<div style="display:inline-block;width:6.99px"> </div>The change </div><div id="a13201" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">in total share-based compensation expense for the three<div style="display:inline-block;width:4.8px"> </div>months ended March 31, 2021 includes performance stock units<div style="display:inline-block;width:4.62px"> </div>and non-</div><div id="a13242" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">elective 401(k) matching contributions in stock but excludes annual<div style="display:inline-block;width:4.93px"> </div>incentive plan costs as a component of share-based compensation </div><div id="a13280" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.5px;">beginning in 2020, each described further below. </div><div id="a13294" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:84.7px;">Stock Options </div><div id="a13298" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:108px;">During the first quarter of 2021, the Company granted<div style="display:inline-block;width:4.84px"> </div>stock options under its long-term incentive plan (“LTIP<div style="display:inline-block;width:2.43px"> </div>”) that are subject </div><div id="a13342" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:123.4px;">only to time vesting over a three-year period.<div style="display:inline-block;width:7.89px"> </div>For the purposes of determining the fair value of stock option awards,<div style="display:inline-block;width:4.9px"> </div>the Company </div><div id="a13388" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.7px;">used a Black-Scholes option pricing model and the assumptions<div style="display:inline-block;width:4.91px"> </div>set forth in the table below:</div></div><div id="TextBlockContainer97" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:436px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13422" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Number of options granted </div><div id="a13424" style="position:absolute;left:373.933px;top:0px;">23,733</div><div id="a13429" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17px;">Dividend yield </div><div id="a13431" style="position:absolute;left:388.333px;top:17px;">0.85</div><div id="a13433" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:17px;">% </div><div id="a13437" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33.9px;">Expected volatility </div><div id="a13439" style="position:absolute;left:381.613px;top:33.9px;">37.33</div><div id="a13441" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:33.9px;">% </div><div id="a13445" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:50.9px;">Risk-free interest rate </div><div id="a13449" style="position:absolute;left:388.333px;top:50.9px;">0.60</div><div id="a13451" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:50.9px;">% </div><div id="a13455" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Expected term (years) </div><div id="a13458" style="position:absolute;left:395.053px;top:68px;">4.0</div></div><div id="TextBlockContainer100" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:730px;height:185px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13462" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The fair value of these options is amortized on a straight<div style="display:inline-block;width:1.42px"> </div>-line basis over the vesting period.<div style="display:inline-block;width:7.34px"> </div>As of March 31, 2021, unrecognized </div><div id="a13508" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">compensation expense related to all stock options<div style="display:inline-block;width:4.59px"> </div>granted was $</div><div id="a13508_63_3" style="position:absolute;left:346.413px;top:15.4px;">2.8</div><div id="a13508_66_61" style="position:absolute;font-weight:normal;font-style:normal;left:363.213px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million, to be recognized over a weighted average remaining </div><div id="a13546" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.8px;">period of </div><div id="a13546_10_3" style="position:absolute;left:56.459px;top:30.8px;">2.5</div><div id="a13546_13_8" style="position:absolute;font-weight:normal;font-style:normal;left:73.098px;top:30.8px;"><div style="display:inline-block;width:3.36px"> </div>years. </div><div id="a13554" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:54px;">Restricted Stock Awards<div style="display:inline-block;width:5.03px"> </div>and Restricted Stock Units </div><div id="a13568" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:77.3px;">During the first quarter of 2021, the Company granted </div><div id="a13568_54_6" style="position:absolute;left:321.133px;top:77.3px;">12,610</div><div id="a13568_60_33" style="position:absolute;font-weight:normal;font-style:normal;left:357.773px;top:77.3px;"><div style="display:inline-block;width:3.36px"> </div>nonvested restricted shares and </div><div id="a13568_93_5" style="position:absolute;left:530.76px;top:77.3px;">2,791</div><div id="a13568_98_28" style="position:absolute;font-weight:normal;font-style:normal;left:560.84px;top:77.3px;"><div style="display:inline-block;width:3.2px"> </div>nonvested restricted stock </div><div id="a13604" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92.7px;">units under its LTIP,<div style="display:inline-block;width:6.71px"> </div>subject to time-based vesting, generally over a three-year<div style="display:inline-block;width:4.55px"> </div>period.<div style="display:inline-block;width:6.91px"> </div>The fair value of these grants is based on the </div><div id="a13655" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:108px;">trading price of the Company’s<div style="display:inline-block;width:4.72px"> </div>common stock on the date of grant.<div style="display:inline-block;width:7.52px"> </div>The Company adjusts the grant date fair value of these awards for </div><div id="a13703" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:123.4px;">expected forfeitures based on historical experience.<div style="display:inline-block;width:8.02px"> </div>As of March 31, 2021, unrecognized compensation expense<div style="display:inline-block;width:4.85px"> </div>related to the </div><div id="a13737" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.6px;">nonvested restricted shares was $</div><div id="a13737_33_3" style="position:absolute;left:182.213px;top:138.6px;">6.3</div><div id="a13737_36_71" style="position:absolute;font-weight:normal;font-style:normal;left:199.013px;top:138.6px;"><div style="display:inline-block;width:3.36px"> </div>million, to be recognized over a weighted average remaining period<div style="display:inline-block;width:4.65px"> </div>of </div><div id="a13737_107_3" style="position:absolute;left:581.52px;top:138.6px;">2.1</div><div id="a13737_110_12" style="position:absolute;font-weight:normal;font-style:normal;left:598.16px;top:138.6px;"><div style="display:inline-block;width:3.36px"> </div>years, and </div><div id="a13775" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:154px;">unrecognized compensation expense related to nonvested<div style="display:inline-block;width:4.71px"> </div>restricted stock units was $</div><div id="a13775_83_3" style="position:absolute;left:458.44px;top:154px;">1.3</div><div id="a13775_86_43" style="position:absolute;font-weight:normal;font-style:normal;left:475.24px;top:154px;"><div style="display:inline-block;width:3.2px"> </div>million, to be recognized over a weighted </div><div id="a13812" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169.3px;">average remaining period of </div><div id="a13812_28_3" style="position:absolute;left:158.533px;top:169.3px;">2.3</div><div id="a13812_31_7" style="position:absolute;font-weight:normal;font-style:normal;left:175.173px;top:169.3px;"><div style="display:inline-block;width:3.36px"> </div>years.</div></div><div id="TextBlockContainer102" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:255px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13874" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Performance Stock Units </div><div id="a13880" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">During the first quarter of 2021,<div style="display:inline-block;width:4.2px"> </div>the Company granted performance-dependent stock awards (“PSUs”) as<div style="display:inline-block;width:4.71px"> </div>a component of its </div><div id="a13920" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">LTIP,<div style="display:inline-block;width:6.22px"> </div>which will be settled in a certain number of shares subject to market<div style="display:inline-block;width:1.64px"> </div>-based and time-based vesting conditions.<div style="display:inline-block;width:7.73px"> </div>The number of </div><div id="a13966" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">fully vested shares that may ultimately be issued as settlement<div style="display:inline-block;width:4.87px"> </div>for each award may range from </div><div id="a13966_94_1" style="position:absolute;left:510.599px;top:53.9px;">0</div><div id="a13966_95_8" style="position:absolute;font-weight:normal;font-style:normal;left:517.319px;top:53.9px;">% up to </div><div id="a13966_103_3" style="position:absolute;left:562.119px;top:53.9px;">200</div><div id="a13966_106_23" style="position:absolute;font-weight:normal;font-style:normal;left:582.119px;top:53.9px;">% of the target award, </div><div id="a14015" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">subject to the achievement of the Company’s<div style="display:inline-block;width:5.25px"> </div>total shareholder return (“TSR”) relative to the performance<div style="display:inline-block;width:4.8px"> </div>of the Company’s peer </div><div id="a14053" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">group, the S&amp;P Midcap 400 Materials group.<div style="display:inline-block;width:7.74px"> </div>The service period required for the PSUs is three years and the<div style="display:inline-block;width:4.83px"> </div>TSR measurement </div><div id="a14095" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">period for the PSUs is from January 1 of the year of grant<div style="display:inline-block;width:4.85px"> </div>through December 31 of the year prior to issuance.<div style="display:inline-block;width:7.53px"> </div></div><div id="a14142" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:123.4px;">Compensation expense for PSUs<div style="display:inline-block;width:3.96px"> </div>is measured based on their grant date fair value and<div style="display:inline-block;width:4.75px"> </div>is recognized on a straight-line basis over </div><div id="a14187" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.7px;">the three-year vesting period.<div style="display:inline-block;width:7.3px"> </div>The grant-date fair value of the PSUs granted during<div style="display:inline-block;width:4.7px"> </div>the first quarter of 2021 was estimated using a </div><div id="a14236" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153.9px;">Monte Carlo simulation on the grant date and using the<div style="display:inline-block;width:4.78px"> </div>following assumptions: (i) a risk-free rate of </div><div id="a14236_102_4" style="position:absolute;left:541.799px;top:153.9px;">0.29</div><div id="a14236_106_28" style="position:absolute;font-weight:normal;font-style:normal;left:565.319px;top:153.9px;">%; (ii) an expected term of </div><div id="a14286" style="position:absolute;left:4.427px;top:169.3px;">3.0</div><div id="a14286_3_133" style="position:absolute;font-weight:normal;font-style:normal;left:21.227px;top:169.3px;"><div style="display:inline-block;width:3.36px"> </div>years; and (iii) a three-year daily historical volatility for<div style="display:inline-block;width:4.55px"> </div>each of the companies in the peer group, including Quaker<div style="display:inline-block;width:4.84px"> </div>Houghton.<div style="display:inline-block;width:6.92px"> </div></div><div id="a14336" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:192.6px;">As of March 31, 2021, the Company estimates that it will issue<div style="display:inline-block;width:4.79px"> </div>approximately </div><div id="a14336_77_6" style="position:absolute;left:449px;top:192.6px;">28,000</div><div id="a14336_83_42" style="position:absolute;font-weight:normal;font-style:normal;left:485.64px;top:192.6px;"><div style="display:inline-block;width:3.36px"> </div>fully vested shares as of the applicable </div><div id="a14382" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:208px;">settlement dates of all outstanding PSU awards, based<div style="display:inline-block;width:4.81px"> </div>on the conditions of the PSUs and performance to date for each<div style="display:inline-block;width:4.81px"> </div>award. As of </div><div id="a14433" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:223.4px;">March 31, 2021, there was approximately $</div><div id="a14433_41_3" style="position:absolute;left:237.133px;top:223.4px;">4.8</div><div id="a14433_44_84" style="position:absolute;font-weight:normal;font-style:normal;left:253.773px;top:223.4px;"><div style="display:inline-block;width:3.36px"> </div>million of total unrecognized compensation cost related to<div style="display:inline-block;width:4.74px"> </div>PSUs, which the Company </div><div id="a14473" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:238.8px;">expects to recognize over a weighted-average period<div style="display:inline-block;width:4.59px"> </div>of </div><div id="a14473_55_3" style="position:absolute;left:303.053px;top:238.8px;">2.5</div><div id="a14473_58_7" style="position:absolute;font-weight:normal;font-style:normal;left:319.693px;top:238.8px;"><div style="display:inline-block;width:3.2px"> </div>years.</div></div><div id="TextBlockContainer104" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:147px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14496" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Annual Incentive Plan </div><div id="a14502" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.2px;">The Company maintains an Annual Incentive Plan<div style="display:inline-block;width:4.7px"> </div>(“AIP”), which may be settled in cash or a certain number of<div style="display:inline-block;width:4.72px"> </div>shares subject to </div><div id="a14550" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.6px;">performance-based and time-based vesting conditions.<div style="display:inline-block;width:8.02px"> </div>As of March 31, 2020, it was the Company’s<div style="display:inline-block;width:4.95px"> </div>intention to settle the 2020 AIP </div><div id="a14595" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">in shares, and therefore, expense associated with the AIP in 2020<div style="display:inline-block;width:5.03px"> </div>was recorded as a component of share-based compensation expense. </div><div id="a14639" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">In the fourth quarter of 2020, the Company determined<div style="display:inline-block;width:4.74px"> </div>that it would settle the 2020 AIP in cash.<div style="display:inline-block;width:7.52px"> </div>Therefore, the share-based </div><div id="a14684" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.5px;">compensation associated with the AIP during the year<div style="display:inline-block;width:4.72px"> </div>ended December 31, 2020 was reclassified from a component<div style="display:inline-block;width:4.72px"> </div>of share-based </div><div id="a14725" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:99.8px;">compensation expense to incentive compensation.<div style="display:inline-block;width:7.93px"> </div>This determination and conclusion had no impact on the<div style="display:inline-block;width:4.7px"> </div>classification of AIP </div><div id="a14760" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.2px;">expense within the Company’s<div style="display:inline-block;width:4.79px"> </div>Condensed Consolidated Statement of Operations for<div style="display:inline-block;width:4.77px"> </div>the periods as both are a component of SG&amp;A.<div style="display:inline-block;width:4.38px"> </div></div><div id="a14799" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.6px;">As of March 31, 2021, it is the Company’s<div style="display:inline-block;width:5.27px"> </div>intention to settle the 2021 AIP in cash.</div></div><div id="TextBlockContainer106" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:730px;height:131px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14835" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Defined Contribution Plan </div><div id="a14841" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company has a 401(k) plan with an employer<div style="display:inline-block;width:4.58px"> </div>match covering a majority of its U.S. employees.<div style="display:inline-block;width:7.97px"> </div>The Company matches </div><div id="a14841_117_2" style="position:absolute;left:694.479px;top:23.4px;">50</div><div id="a14841_119_2" style="position:absolute;font-weight:normal;font-style:normal;left:707.919px;top:23.4px;">% </div><div id="a14885" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.6px;">of the first </div><div id="a14885_13_1" style="position:absolute;left:63.499px;top:38.6px;">6</div><div id="a14885_14_91" style="position:absolute;font-weight:normal;font-style:normal;left:70.219px;top:38.6px;">% of compensation that is contributed to the plan, with a maximum<div style="display:inline-block;width:4.71px"> </div>matching contribution of </div><div id="a14885_105_1" style="position:absolute;left:568.52px;top:38.6px;">3</div><div id="a14885_106_20" style="position:absolute;font-weight:normal;font-style:normal;left:575.239px;top:38.6px;">% of compensation.<div style="display:inline-block;width:3.64px"> </div></div><div id="a14927" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">Additionally, the<div style="display:inline-block;width:4.65px"> </div>plan provides for non-elective nondiscretionary contributions<div style="display:inline-block;width:4.83px"> </div>on behalf of participants who have completed one year </div><div id="a14963" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">of service equal to </div><div id="a14963_20_1" style="position:absolute;left:106.053px;top:69.3px;">3</div><div id="a14963_21_108" style="position:absolute;font-weight:normal;font-style:normal;left:112.773px;top:69.3px;">% of the eligible participants’ compensation.<div style="display:inline-block;width:7.57px"> </div>Beginning in April 2020 and continuing until April 2021, the </div><div id="a15004" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.7px;">Company matched both non-elective and elective 401(k)<div style="display:inline-block;width:4.82px"> </div>contributions in fully vested shares<div style="display:inline-block;width:3.9px"> </div>of the Company’s common<div style="display:inline-block;width:4.78px"> </div>stock rather </div><div id="a15044" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">than cash.<div style="display:inline-block;width:7.09px"> </div>Total Company contributions<div style="display:inline-block;width:4.89px"> </div>were $</div><div id="a15044_46_3" style="position:absolute;left:260.813px;top:100px;">1.5</div><div id="a15044_49_75" style="position:absolute;font-weight:normal;font-style:normal;left:277.453px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>million for the three months ended March 31, 2021.<div style="display:inline-block;width:7.77px"> </div>There were no similar </div><div id="a15086" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">matching contributions in stock for the three months<div style="display:inline-block;width:4.81px"> </div>ended March 31, 2020.</div></div> <div id="TextBlockContainer91" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13022" style="position:absolute;font-weight:bold;font-style:normal;left:505.8px;top:0px;">Three Months Ended </div><div id="a13027" style="position:absolute;font-weight:bold;font-style:normal;left:537.2px;top:17px;">March 31,<div style="display:inline-block;width:3.89px"> </div></div><div id="a13032" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:34.1px;">2021 </div><div id="a13035" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:34.1px;">2020 </div><div id="a13039" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51px;">Stock options </div><div id="a13042" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:51px;">$ </div><div id="a13044" style="position:absolute;left:535.56px;top:51px;">308</div><div id="a13047" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:51px;">$ </div><div id="a13049" style="position:absolute;left:634.64px;top:51px;">432</div><div id="a13053" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Non-vested stock awards and restricted stock units </div><div id="a13058" style="position:absolute;left:525.48px;top:68px;">1,396</div><div id="a13062" style="position:absolute;left:624.56px;top:68px;">1,264</div><div id="a13066" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85px;">Non-elective and elective 401(k) matching contribution in<div style="display:inline-block;width:4.77px"> </div>stock </div><div id="a13071" style="position:absolute;left:525.48px;top:85px;">1,553</div><div id="a13075" style="position:absolute;left:641.36px;top:85px;">—</div><div id="a13079" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:102.1px;">Director stock ownership plan </div><div id="a13082" style="position:absolute;left:535.56px;top:102.1px;">203</div><div id="a13086" style="position:absolute;left:641.36px;top:102.1px;">40</div><div id="a13090" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:119px;">Performance stock units </div><div id="a13093" style="position:absolute;left:535.56px;top:119px;">319</div><div id="a13097" style="position:absolute;left:641.36px;top:119px;">—</div><div id="a13101" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:136px;">Annual incentive plan </div><div id="a13104" style="position:absolute;left:542.32px;top:136px;">—</div><div id="a13108" style="position:absolute;left:624.56px;top:136px;">2,946</div><div id="a13112" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:154.1px;">Total share-based<div style="display:inline-block;width:4.85px"> </div>compensation expense </div><div id="a13116" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:154.1px;">$ </div><div id="a13118" style="position:absolute;left:525.48px;top:154.1px;">3,779</div><div id="a13121" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:154.1px;">$ </div><div id="a13123" style="position:absolute;left:624.56px;top:154.1px;">4,682</div></div> 308000 432000 1396000 1264000 1553000 0 203000 40000 319000 0 0 2946000 3779000 4682000 300000 500000 <div id="TextBlockContainer98" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:436px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_96_XBRL_TS_4ec098ca5b0c4cf8add5f4d7263393bb" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer97" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:436px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13422" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Number of options granted </div><div id="a13424" style="position:absolute;left:373.933px;top:0px;">23,733</div><div id="a13429" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17px;">Dividend yield </div><div id="a13431" style="position:absolute;left:388.333px;top:17px;">0.85</div><div id="a13433" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:17px;">% </div><div id="a13437" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:33.9px;">Expected volatility </div><div id="a13439" style="position:absolute;left:381.613px;top:33.9px;">37.33</div><div id="a13441" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:33.9px;">% </div><div id="a13445" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:50.9px;">Risk-free interest rate </div><div id="a13449" style="position:absolute;left:388.333px;top:50.9px;">0.60</div><div id="a13451" style="position:absolute;font-weight:normal;font-style:normal;left:416.493px;top:50.9px;">% </div><div id="a13455" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;">Expected term (years) </div><div id="a13458" style="position:absolute;left:395.053px;top:68px;">4.0</div></div></div></div> 23733 0.0085 0.3733 0.0060 P4Y 2800000 P2Y6M 12610 2791 6300000 P2Y1M6D 1300000 P2Y3M18D 0 2 0.0029 P3Y 28000 4800000 P2Y6M 0.50 0.06 0.03 0.03 1500000 <div id="TextBlockContainer108" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:640px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15111" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 9 – Pension and Other Postretirement<div style="display:inline-block;width:5.03px"> </div>Benefits </div><div id="a15127" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.2px;">The components of net periodic benefit cost for the<div style="display:inline-block;width:4.72px"> </div>three months ended March 31, 2021 and 2020 are as follows:</div></div><div id="TextBlockContainer111" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:179px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15170" style="position:absolute;font-weight:bold;font-style:normal;left:375.72px;top:0px;">Three Months Ended March 31,<div style="display:inline-block;width:4.64px"> </div></div><div id="a15181" style="position:absolute;font-weight:bold;font-style:normal;left:549.52px;top:15.7px;">Other </div><div id="a15186" style="position:absolute;font-weight:bold;font-style:normal;left:321.613px;top:30.1px;">Pension Benefits </div><div id="a15189" style="position:absolute;font-weight:bold;font-style:normal;left:499.24px;top:30.1px;">Postretirement Benefits </div><div id="a15195" style="position:absolute;font-weight:bold;font-style:normal;left:311.693px;top:45.6px;">2021 </div><div id="a15199" style="position:absolute;font-weight:bold;font-style:normal;left:410.76px;top:45.6px;">2020 </div><div id="a15203" style="position:absolute;font-weight:bold;font-style:normal;left:509.64px;top:45.6px;">2021 </div><div id="a15207" style="position:absolute;font-weight:bold;font-style:normal;left:608.72px;top:45.6px;">2020 </div><div id="a15211" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:60.6px;">Service cost </div><div id="a15213" style="position:absolute;font-weight:normal;font-style:normal;left:276.493px;top:60.6px;">$ </div><div id="a15215" style="position:absolute;left:337.613px;top:60.6px;">316</div><div id="a15218" style="position:absolute;font-weight:normal;font-style:normal;left:375.56px;top:60.6px;">$ </div><div id="a15220" style="position:absolute;left:426.6px;top:60.6px;">1,174</div><div id="a15223" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:60.6px;">$ </div><div id="a15225" style="position:absolute;left:548.88px;top:60.6px;">1</div><div id="a15228" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:60.6px;">$ </div><div id="a15230" style="position:absolute;left:647.92px;top:60.6px;">2</div><div id="a15234" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.7px;">Interest cost </div><div id="a15237" style="position:absolute;left:327.533px;top:76.7px;">1,090</div><div id="a15241" style="position:absolute;left:426.6px;top:76.7px;">1,769</div><div id="a15246" style="position:absolute;left:542.32px;top:76.7px;">11</div><div id="a15250" style="position:absolute;left:641.36px;top:76.7px;">26</div><div id="a15254" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:93.6px;">Expected return on plan assets </div><div id="a15257" style="position:absolute;left:322.733px;top:93.6px;">(2,082)</div><div id="a15261" style="position:absolute;left:421.8px;top:93.6px;">(1,959)</div><div id="a15265" style="position:absolute;left:542.32px;top:93.6px;">—</div><div id="a15269" style="position:absolute;left:641.36px;top:93.6px;">—</div><div id="a15273" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:110.8px;">Settlement loss </div><div id="a15276" style="position:absolute;left:344.333px;top:110.8px;">—</div><div id="a15280" style="position:absolute;left:420.04px;top:110.8px;">22,667</div><div id="a15284" style="position:absolute;left:542.32px;top:110.8px;">—</div><div id="a15288" style="position:absolute;left:641.36px;top:110.8px;">—</div><div id="a15292" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:127.7px;">Actuarial loss amortization </div><div id="a15295" style="position:absolute;left:337.613px;top:127.7px;">855</div><div id="a15299" style="position:absolute;left:426.6px;top:127.7px;">1,047</div><div id="a15303" style="position:absolute;left:542.32px;top:127.7px;">—</div><div id="a15307" style="position:absolute;left:641.36px;top:127.7px;">15</div><div id="a15311" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:144.7px;">Prior service (credit) cost amortization </div><div id="a15314" style="position:absolute;left:350.893px;top:144.7px;">2</div><div id="a15318" style="position:absolute;left:438.44px;top:144.7px;">(40)</div><div id="a15322" style="position:absolute;left:542.32px;top:144.7px;">—</div><div id="a15326" style="position:absolute;left:641.36px;top:144.7px;">—</div><div id="a15330" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:162.8px;">Total net periodic<div style="display:inline-block;width:4.77px"> </div>benefit cost </div><div id="a15332" style="position:absolute;font-weight:normal;font-style:normal;left:276.493px;top:162.8px;">$ </div><div id="a15334" style="position:absolute;left:337.613px;top:162.8px;">181</div><div id="a15337" style="position:absolute;font-weight:normal;font-style:normal;left:375.56px;top:162.8px;">$ </div><div id="a15339" style="position:absolute;left:420.04px;top:162.8px;">24,658</div><div id="a15342" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:162.8px;">$ </div><div id="a15344" style="position:absolute;left:542.32px;top:162.8px;">12</div><div id="a15347" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:162.8px;">$ </div><div id="a15349" style="position:absolute;left:641.36px;top:162.8px;">43</div></div><div id="TextBlockContainer114" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:726px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15352" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">As disclosed in the Company’s<div style="display:inline-block;width:4.79px"> </div>2020 Form 10-K, in the fourth quarter of 2018, the<div style="display:inline-block;width:4.7px"> </div>Company began the process of terminating its </div><div id="a15399" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">legacy Quaker non-contributory U.S. pension plan<div style="display:inline-block;width:4.59px"> </div>(“Legacy Quaker U.S. Pension Plan”).<div style="display:inline-block;width:7.51px"> </div>During the third quarter of 2019, the </div><div id="a15441" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Company received a favorable termination determination<div style="display:inline-block;width:4.81px"> </div>letter from the Internal Revenue<div style="display:inline-block;width:3.76px"> </div>Service (“I.R.S.”) and completed the </div><div id="a15474" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.1px;">Legacy Quaker U.S. Pension Plan termination during the<div style="display:inline-block;width:4.79px"> </div>first quarter of 2020.<div style="display:inline-block;width:7.09px"> </div>In order to terminate the Legacy Quaker U.S. Pension </div><div id="a15516" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.4px;">Plan in accordance with I.R.S. and Pension Benefit Guaranty Corporation<div style="display:inline-block;width:5.06px"> </div>requirements, the Company was required to fully fund the </div></div><div id="TextBlockContainer116" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15606" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">Legacy Quaker U.S. Pension Plan on a termination basis<div style="display:inline-block;width:4.71px"> </div>and the amount necessary to do so was approximately $</div><div id="a15606_108_3" style="position:absolute;left:607.44px;top:0px;">1.8</div><div id="a15606_111_21" style="position:absolute;font-weight:normal;font-style:normal;left:624.24px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million, subject to </div><div id="a15651" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">final true up adjustments,<div style="display:inline-block;width:4.08px"> </div>which were completed in the third quarter of 2020.<div style="display:inline-block;width:7.84px"> </div>In addition, the Company recorded a non-cash pension </div><div id="a15698" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">settlement charge at plan termination of<div style="display:inline-block;width:4.69px"> </div>approximately $</div><div id="a15698_56_4" style="position:absolute;left:307.053px;top:30.7px;">22.7</div><div id="a15698_60_74" style="position:absolute;font-weight:normal;font-style:normal;left:330.413px;top:30.7px;"><div style="display:inline-block;width:3.36px"> </div>million.<div style="display:inline-block;width:6.95px"> </div>This settlement charge included the immediate recognition<div style="display:inline-block;width:4.97px"> </div>into </div><div id="a15734" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">expense of the related unrecognized losses within accumulated<div style="display:inline-block;width:4.91px"> </div>other comprehensive (loss) income (“AOCI”) on the balance<div style="display:inline-block;width:4.77px"> </div>sheet as </div><div id="a15770" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">of the plan termination date.</div></div><div id="TextBlockContainer118" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15782" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Employer Contributions </div><div id="a15786" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that it expected to make minimum cash contributions of $</div><div id="a15786_111_4" style="position:absolute;left:650.639px;top:23.4px;">10.0</div><div id="a15786_115_9" style="position:absolute;font-weight:normal;font-style:normal;left:673.999px;top:23.4px;"><div style="display:inline-block;width:3.36px"> </div>million </div><div id="a15829" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">to its U.S. and foreign pension plans and approximately<div style="display:inline-block;width:4.75px"> </div>$</div><div id="a15829_57_3" style="position:absolute;left:311.533px;top:38.7px;">0.3</div><div id="a15829_60_77" style="position:absolute;font-weight:normal;font-style:normal;left:328.173px;top:38.7px;"><div style="display:inline-block;width:3.36px"> </div>million to its other postretirement benefit plans in 2021.<div style="display:inline-block;width:7.96px"> </div>As of March 31, </div><div id="a15878" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:54.1px;">2021, $</div><div id="a15878_7_3" style="position:absolute;left:44.619px;top:54.1px;">1.0</div><div id="a15878_10_14" style="position:absolute;font-weight:normal;font-style:normal;left:61.259px;top:54.1px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a15878_24_3" style="position:absolute;left:135.653px;top:54.1px;">0.1</div><div id="a15878_27_103" style="position:absolute;font-weight:normal;font-style:normal;left:152.293px;top:54.1px;"><div style="display:inline-block;width:3.36px"> </div>million of contributions have been made to the Company’s<div style="display:inline-block;width:5.48px"> </div>U.S. and foreign pension plans and its other </div><div id="a15925" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.4px;">postretirement benefit plans, respectively.</div></div> <div id="TextBlockContainer112" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:179px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_110_XBRL_TS_07aa3ef302cd42afa99e1b5474319892" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer111" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:179px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15170" style="position:absolute;font-weight:bold;font-style:normal;left:375.72px;top:0px;">Three Months Ended March 31,<div style="display:inline-block;width:4.64px"> </div></div><div id="a15181" style="position:absolute;font-weight:bold;font-style:normal;left:549.52px;top:15.7px;">Other </div><div id="a15186" style="position:absolute;font-weight:bold;font-style:normal;left:321.613px;top:30.1px;">Pension Benefits </div><div id="a15189" style="position:absolute;font-weight:bold;font-style:normal;left:499.24px;top:30.1px;">Postretirement Benefits </div><div id="a15195" style="position:absolute;font-weight:bold;font-style:normal;left:311.693px;top:45.6px;">2021 </div><div id="a15199" style="position:absolute;font-weight:bold;font-style:normal;left:410.76px;top:45.6px;">2020 </div><div id="a15203" style="position:absolute;font-weight:bold;font-style:normal;left:509.64px;top:45.6px;">2021 </div><div id="a15207" style="position:absolute;font-weight:bold;font-style:normal;left:608.72px;top:45.6px;">2020 </div><div id="a15211" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:60.6px;">Service cost </div><div id="a15213" style="position:absolute;font-weight:normal;font-style:normal;left:276.493px;top:60.6px;">$ </div><div id="a15215" style="position:absolute;left:337.613px;top:60.6px;">316</div><div id="a15218" style="position:absolute;font-weight:normal;font-style:normal;left:375.56px;top:60.6px;">$ </div><div id="a15220" style="position:absolute;left:426.6px;top:60.6px;">1,174</div><div id="a15223" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:60.6px;">$ </div><div id="a15225" style="position:absolute;left:548.88px;top:60.6px;">1</div><div id="a15228" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:60.6px;">$ </div><div id="a15230" style="position:absolute;left:647.92px;top:60.6px;">2</div><div id="a15234" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.7px;">Interest cost </div><div id="a15237" style="position:absolute;left:327.533px;top:76.7px;">1,090</div><div id="a15241" style="position:absolute;left:426.6px;top:76.7px;">1,769</div><div id="a15246" style="position:absolute;left:542.32px;top:76.7px;">11</div><div id="a15250" style="position:absolute;left:641.36px;top:76.7px;">26</div><div id="a15254" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:93.6px;">Expected return on plan assets </div><div id="a15257" style="position:absolute;left:322.733px;top:93.6px;">(2,082)</div><div id="a15261" style="position:absolute;left:421.8px;top:93.6px;">(1,959)</div><div id="a15265" style="position:absolute;left:542.32px;top:93.6px;">—</div><div id="a15269" style="position:absolute;left:641.36px;top:93.6px;">—</div><div id="a15273" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:110.8px;">Settlement loss </div><div id="a15276" style="position:absolute;left:344.333px;top:110.8px;">—</div><div id="a15280" style="position:absolute;left:420.04px;top:110.8px;">22,667</div><div id="a15284" style="position:absolute;left:542.32px;top:110.8px;">—</div><div id="a15288" style="position:absolute;left:641.36px;top:110.8px;">—</div><div id="a15292" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:127.7px;">Actuarial loss amortization </div><div id="a15295" style="position:absolute;left:337.613px;top:127.7px;">855</div><div id="a15299" style="position:absolute;left:426.6px;top:127.7px;">1,047</div><div id="a15303" style="position:absolute;left:542.32px;top:127.7px;">—</div><div id="a15307" style="position:absolute;left:641.36px;top:127.7px;">15</div><div id="a15311" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:144.7px;">Prior service (credit) cost amortization </div><div id="a15314" style="position:absolute;left:350.893px;top:144.7px;">2</div><div id="a15318" style="position:absolute;left:438.44px;top:144.7px;">(40)</div><div id="a15322" style="position:absolute;left:542.32px;top:144.7px;">—</div><div id="a15326" style="position:absolute;left:641.36px;top:144.7px;">—</div><div id="a15330" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:162.8px;">Total net periodic<div style="display:inline-block;width:4.77px"> </div>benefit cost </div><div id="a15332" style="position:absolute;font-weight:normal;font-style:normal;left:276.493px;top:162.8px;">$ </div><div id="a15334" style="position:absolute;left:337.613px;top:162.8px;">181</div><div id="a15337" style="position:absolute;font-weight:normal;font-style:normal;left:375.56px;top:162.8px;">$ </div><div id="a15339" style="position:absolute;left:420.04px;top:162.8px;">24,658</div><div id="a15342" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:162.8px;">$ </div><div id="a15344" style="position:absolute;left:542.32px;top:162.8px;">12</div><div id="a15347" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:162.8px;">$ </div><div id="a15349" style="position:absolute;left:641.36px;top:162.8px;">43</div></div></div></div> 316000 1174000 1000 2000 1090000 1769000 11000 26000 2082000 1959000 0 0 0 -22667000 0 0 -855000 -1047000 0 -15000 2000 -40000 0 0 181000 24658000 12000 43000 1800000 22700000 10000000.0 300000 1000000.0 100000 <div id="TextBlockContainer120" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:660px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15934" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 10 – Other Income (Expense), Net</div><div id="a15947" style="position:absolute;font-weight:normal;font-style:normal;left:227.053px;top:0px;"> </div><div id="a15948" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The components of other income (expense), net for<div style="display:inline-block;width:4.72px"> </div>the three months ended March 31, 2021 and 2020 are as follows:</div></div><div id="TextBlockContainer124" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:167px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_122_XBRL_TS_41e8327c4f0c4e2687870dd1e56a1a50" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer123" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:167px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15991" style="position:absolute;font-weight:bold;font-style:normal;left:505.8px;top:0px;">Three Months Ended<div style="display:inline-block;width:4.07px"> </div></div><div id="a15997" style="position:absolute;font-weight:bold;font-style:normal;left:537.2px;top:17.1px;">March 31, </div><div id="a16002" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:34.1px;">2021 </div><div id="a16005" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:34.1px;">2020 </div><div id="a16009" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:50.1px;">Income from third party license fees </div><div id="a16011" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:50.1px;">$ </div><div id="a16013" style="position:absolute;left:535.56px;top:50.1px;">339</div><div id="a16016" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:50.1px;">$ </div><div id="a16018" style="position:absolute;left:634.64px;top:50.1px;">304</div><div id="a16022" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.1px;">Foreign exchange (losses) gains, net </div><div id="a16025" style="position:absolute;left:520.68px;top:66.1px;">(1,478)</div><div id="a16029" style="position:absolute;left:634.64px;top:66.1px;">821</div><div id="a16033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:83px;">Gain on disposals of property,<div style="display:inline-block;width:4.9px"> </div>plant, equipment and other assets, net </div><div id="a16036" style="position:absolute;left:525.48px;top:83px;">5,410</div><div id="a16040" style="position:absolute;left:647.92px;top:83px;">2</div><div id="a16044" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">Non-income tax refunds and other related credits </div><div id="a16049" style="position:absolute;left:542.32px;top:100px;">97</div><div id="a16053" style="position:absolute;left:624.56px;top:100px;">1,299</div><div id="a16057" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117.1px;">Pension and postretirement benefit costs, non-service components </div><div id="a16062" style="position:absolute;left:535.56px;top:117.1px;">124</div><div id="a16066" style="position:absolute;left:613.04px;top:117.1px;">(23,525)</div><div id="a16070" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:134.1px;">Other non-operating income (expense), net </div><div id="a16075" style="position:absolute;left:535.56px;top:134.1px;">195</div><div id="a16079" style="position:absolute;left:636.4px;top:134.1px;">(76)</div><div id="a16083" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:151px;">Total other<div style="display:inline-block;width:4.7px"> </div>income (expense), net </div><div id="a16085" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:151px;">$ </div><div id="a16087" style="position:absolute;left:525.48px;top:151px;">4,687</div><div id="a16090" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:151px;">$ </div><div id="a16092" style="position:absolute;left:613.04px;top:151px;">(21,175)</div></div></div></div><div id="TextBlockContainer126" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:725px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a16095" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Gain on disposals of property,<div style="display:inline-block;width:5.16px"> </div>plant, equipment and other assets, net, during the three months<div style="display:inline-block;width:4.81px"> </div>ended March 31, 2021, </div><div id="a16136" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">includes the gain on the sale of certain held-for-sale<div style="display:inline-block;width:4.77px"> </div>real property assets related to the Combination.<div style="display:inline-block;width:7.77px"> </div>Pension and postretirement </div><div id="a16179" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">benefit costs, non-service components during the three<div style="display:inline-block;width:4.72px"> </div>months ended March 31, 2020 includes $</div><div id="a16179_93_4" style="position:absolute;left:519.88px;top:30.6px;">22.7</div><div id="a16179_97_31" style="position:absolute;font-weight:normal;font-style:normal;left:543.24px;top:30.6px;"><div style="display:inline-block;width:3.36px"> </div>million related to the Legacy </div><div id="a16219" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">Quaker U.S. Pension Plan non-cash settlement charge<div style="display:inline-block;width:5px"> </div>described in Note 9 of Notes to Condensed Consolidated Financial Statements.</div></div> <div id="TextBlockContainer123" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:667px;height:167px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15991" style="position:absolute;font-weight:bold;font-style:normal;left:505.8px;top:0px;">Three Months Ended<div style="display:inline-block;width:4.07px"> </div></div><div id="a15997" style="position:absolute;font-weight:bold;font-style:normal;left:537.2px;top:17.1px;">March 31, </div><div id="a16002" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:34.1px;">2021 </div><div id="a16005" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:34.1px;">2020 </div><div id="a16009" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:50.1px;">Income from third party license fees </div><div id="a16011" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:50.1px;">$ </div><div id="a16013" style="position:absolute;left:535.56px;top:50.1px;">339</div><div id="a16016" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:50.1px;">$ </div><div id="a16018" style="position:absolute;left:634.64px;top:50.1px;">304</div><div id="a16022" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.1px;">Foreign exchange (losses) gains, net </div><div id="a16025" style="position:absolute;left:520.68px;top:66.1px;">(1,478)</div><div id="a16029" style="position:absolute;left:634.64px;top:66.1px;">821</div><div id="a16033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:83px;">Gain on disposals of property,<div style="display:inline-block;width:4.9px"> </div>plant, equipment and other assets, net </div><div id="a16036" style="position:absolute;left:525.48px;top:83px;">5,410</div><div id="a16040" style="position:absolute;left:647.92px;top:83px;">2</div><div id="a16044" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">Non-income tax refunds and other related credits </div><div id="a16049" style="position:absolute;left:542.32px;top:100px;">97</div><div id="a16053" style="position:absolute;left:624.56px;top:100px;">1,299</div><div id="a16057" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117.1px;">Pension and postretirement benefit costs, non-service components </div><div id="a16062" style="position:absolute;left:535.56px;top:117.1px;">124</div><div id="a16066" style="position:absolute;left:613.04px;top:117.1px;">(23,525)</div><div id="a16070" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:134.1px;">Other non-operating income (expense), net </div><div id="a16075" style="position:absolute;left:535.56px;top:134.1px;">195</div><div id="a16079" style="position:absolute;left:636.4px;top:134.1px;">(76)</div><div id="a16083" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:151px;">Total other<div style="display:inline-block;width:4.7px"> </div>income (expense), net </div><div id="a16085" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:151px;">$ </div><div id="a16087" style="position:absolute;left:525.48px;top:151px;">4,687</div><div id="a16090" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:151px;">$ </div><div id="a16092" style="position:absolute;left:613.04px;top:151px;">(21,175)</div></div> 339000 304000 -1478000 821000 5410000 2000 97000 1299000 -124000 23525000 195000 -76000 4687000 -21175000 22700000 <div id="TextBlockContainer128" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:378px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a16257" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 11 – Income Taxes<div style="display:inline-block;width:6.03px"> </div>and Uncertain Income Tax<div style="display:inline-block;width:5.07px"> </div>Positions </div><div id="a16277" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company’s effective<div style="display:inline-block;width:5.08px"> </div>tax rate for the three months ended March 31, 2021 was an expense of </div><div id="a16277_93_4" style="position:absolute;left:545.48px;top:23.4px;">24.2</div><div id="a16277_97_27" style="position:absolute;font-weight:normal;font-style:normal;left:568.839px;top:23.4px;">% compared to a benefit of </div><div id="a16323" style="position:absolute;left:4.427px;top:38.7px;">31.1</div><div id="a16323_4_125" style="position:absolute;font-weight:normal;font-style:normal;left:27.946px;top:38.7px;">% for the three months ended March 31, 2020.<div style="display:inline-block;width:7.76px"> </div>The Company’s effective<div style="display:inline-block;width:4.76px"> </div>tax rate for the three months ended March 31, 2021 was </div><div id="a16369" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">largely impacted by the sale of certain held-for-sale<div style="display:inline-block;width:5.01px"> </div>real property assets related to the Combination.<div style="display:inline-block;width:7.77px"> </div>Comparatively, the prior<div style="display:inline-block;width:4.7px"> </div>year first </div><div id="a16416" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">quarter effective tax rate was impacted by the<div style="display:inline-block;width:4.79px"> </div>tax effect of certain one-time pre-tax losses as well as certain tax<div style="display:inline-block;width:4.77px"> </div>charges and benefits in </div><div id="a16468" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">the prior year period including those related to changes<div style="display:inline-block;width:4.71px"> </div>in foreign tax credit valuation<div style="display:inline-block;width:3.96px"> </div>allowances, tax law changes in a foreign </div><div id="a16511" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">jurisdiction, and the tax impacts of the Company’s<div style="display:inline-block;width:5.26px"> </div>termination of its Legacy Quaker U.S. Pension Plan and the<div style="display:inline-block;width:4.76px"> </div>Houghton indefinite-</div><div id="a16551" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">lived trademarks and tradename intangible asset impairment. </div><div id="a16565" style="position:absolute;left:28.427px;top:138.7px;">As of December 31, 2020, the Company had a deferred tax liability of $5.9 million, which primarily represents the Company’s </div><div id="a16605" style="position:absolute;left:4.427px;top:153.9px;">estimate of non-U.S. taxes it will incur to repatriate certain foreign earnings to the U.S. The balance as of March 31, 2021 was $6.5 </div><div id="a16656" style="position:absolute;left:4.427px;top:169.3px;">million.</div><div id="a16656_8_2" style="position:absolute;font-weight:normal;font-style:normal;left:46.379px;top:169.3px;"><div style="display:inline-block;width:3.2px"> </div></div><div id="a16659" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:192.7px;">As of March 31, 2021, the Company’s<div style="display:inline-block;width:5.1px"> </div>cumulative liability for gross unrecognized tax benefits was $</div><div id="a16659_98_4" style="position:absolute;left:565.799px;top:192.7px;">23.5</div><div id="a16659_102_25" style="position:absolute;font-weight:normal;font-style:normal;left:589.359px;top:192.7px;"><div style="display:inline-block;width:3.36px"> </div>million, an increase of </div><div id="a16700" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:208px;">$</div><div id="a16700_1_3" style="position:absolute;left:11.147px;top:208px;">1.3</div><div id="a16700_4_73" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:208px;"><div style="display:inline-block;width:3.36px"> </div>million from the cumulative liability accrued as of December 31, 2020.<div style="display:inline-block;width:4.61px"> </div></div><div id="a16725" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:231.4px;">The Company continues to recognize interest and penalties<div style="display:inline-block;width:4.8px"> </div>associated with uncertain tax positions as a component of<div style="display:inline-block;width:4.78px"> </div>taxes on </div><div id="a16764" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:246.6px;">income (loss) before equity in net income of associated<div style="display:inline-block;width:4.77px"> </div>companies in its Condensed Consolidated Statements of Operations.<div style="display:inline-block;width:8.18px"> </div>The </div><div id="a16800" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:262px;">Company recognized an expense of less than $</div><div id="a16800_44_3" style="position:absolute;left:254.573px;top:262px;">0.1</div><div id="a16800_47_50" style="position:absolute;font-weight:normal;font-style:normal;left:271.213px;top:262px;"><div style="display:inline-block;width:3.36px"> </div>million for interest and a benefit of less than $</div><div id="a16800_97_3" style="position:absolute;left:520.679px;top:262px;">0.1</div><div id="a16800_100_30" style="position:absolute;font-weight:normal;font-style:normal;left:537.479px;top:262px;"><div style="display:inline-block;width:3.36px"> </div>million for penalties in its </div><div id="a16846" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:277.3px;">Condensed Consolidated Statement of Operations for the<div style="display:inline-block;width:4.74px"> </div>three months ended March 31, 2021, and recognized an expense of<div style="display:inline-block;width:4.74px"> </div>less than </div><div id="a16886" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:292.7px;">$</div><div id="a16886_1_3" style="position:absolute;left:11.147px;top:292.7px;">0.1</div><div id="a16886_4_50" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:292.7px;"><div style="display:inline-block;width:3.36px"> </div>million for interest and a benefit of less than $</div><div id="a16886_54_3" style="position:absolute;left:277.453px;top:292.7px;">0.1</div><div id="a16886_57_81" style="position:absolute;font-weight:normal;font-style:normal;left:294.093px;top:292.7px;"><div style="display:inline-block;width:3.36px"> </div>million for penalties in its Condensed Consolidated Statement of<div style="display:inline-block;width:4.63px"> </div>Operations for </div><div id="a16930" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:308px;">the three months ended March 31, 2020.<div style="display:inline-block;width:7.83px"> </div>As of March 31, 2021, the Company had accrued $</div><div id="a16930_87_3" style="position:absolute;left:499.879px;top:308px;">3.0</div><div id="a16930_90_37" style="position:absolute;font-weight:normal;font-style:normal;left:516.52px;top:308px;"><div style="display:inline-block;width:3.36px"> </div>million for cumulative interest and </div><div id="a16974" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:323.4px;">$</div><div id="a16974_1_3" style="position:absolute;left:11.147px;top:323.4px;">3.6</div><div id="a16974_4_93" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:323.4px;"><div style="display:inline-block;width:3.36px"> </div>million for cumulative penalties in its Condensed Consolidated Balance<div style="display:inline-block;width:4.82px"> </div>Sheets, compared to $</div><div id="a16974_97_3" style="position:absolute;left:535.24px;top:323.4px;">3.0</div><div id="a16974_100_33" style="position:absolute;font-weight:normal;font-style:normal;left:552.04px;top:323.4px;"><div style="display:inline-block;width:3.2px"> </div>million for cumulative interest </div><div id="a17011" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:338.8px;">and $</div><div id="a17011_5_3" style="position:absolute;left:33.867px;top:338.8px;">3.9</div><div id="a17011_8_64" style="position:absolute;font-weight:normal;font-style:normal;left:50.539px;top:338.8px;"><div style="display:inline-block;width:3.36px"> </div>million for cumulative penalties accrued at December 31, 2020. </div><div id="a17033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:362px;"><div style="display:inline-block;width:192.03px"> </div></div></div><div id="TextBlockContainer130" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:487px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17085" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">During the three months ended March 31, 2021 and<div style="display:inline-block;width:4.67px"> </div>2020, the Company recognized decreases of $</div><div id="a17085_92_3" style="position:absolute;left:553.32px;top:0px;">0.3</div><div id="a17085_95_14" style="position:absolute;font-weight:normal;font-style:normal;left:570.16px;top:0px;"><div style="display:inline-block;width:3.2px"> </div>million and $</div><div id="a17085_109_3" style="position:absolute;left:644.559px;top:0px;">0.8</div><div id="a17085_112_10" style="position:absolute;font-weight:normal;font-style:normal;left:661.2px;top:0px;"><div style="display:inline-block;width:3.2px"> </div>million, </div><div id="a17125" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">respectively, in<div style="display:inline-block;width:4.73px"> </div>its cumulative liability for gross unrecognized tax benefits due<div style="display:inline-block;width:4.79px"> </div>to the expiration of the applicable statutes of limitations </div><div id="a17166" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">for certain tax years. </div><div id="a17174" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:51.4px;">The Company estimates that during the year ending December<div style="display:inline-block;width:4.88px"> </div>31, 2021 it will reduce its cumulative liability for gross </div><div id="a17212" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:66.7px;">unrecognized tax benefits by approximately $</div><div id="a17212_44_3" style="position:absolute;left:248.653px;top:66.7px;">1.5</div><div id="a17212_47_88" style="position:absolute;font-weight:normal;font-style:normal;left:265.293px;top:66.7px;"><div style="display:inline-block;width:3.36px"> </div>million due to the expiration of the statute of limitations with regard<div style="display:inline-block;width:4.82px"> </div>to certain tax </div><div id="a17254" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.9px;">positions.<div style="display:inline-block;width:6.99px"> </div>This estimated reduction in the cumulative liability for unrecogniz<div style="display:inline-block;width:1.59px"> </div>ed tax benefits does not consider any increase in liability </div><div id="a17293" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:97.3px;">for unrecognized tax benefits with regard to existing tax<div style="display:inline-block;width:4.66px"> </div>positions or any increase in cumulative liability for unrecognized<div style="display:inline-block;width:4.71px"> </div>tax benefits </div><div id="a17333" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:112.6px;">with regard to new tax positions for the year ending December<div style="display:inline-block;width:4.88px"> </div>31, 2021. </div><div id="a17360" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:133.3px;">The<div style="display:inline-block;width:3.55px"> </div>Company and its subsidiaries are subject to U.S. Federal income<div style="display:inline-block;width:4.79px"> </div>tax, as well as the income tax of various state and foreign </div><div id="a17407" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:148.6px;">tax jurisdictions.<div style="display:inline-block;width:7.18px"> </div>Tax years that remain<div style="display:inline-block;width:4.76px"> </div>subject to examination by major tax jurisdictions include Italy<div style="display:inline-block;width:4.56px"> </div>from </div><div id="a17407_111_4" style="position:absolute;left:582.96px;top:148.6px;">2006</div><div id="a17407_115_14" style="position:absolute;font-weight:normal;font-style:normal;left:609.68px;top:148.6px;">, Brazil from </div><div id="a17407_129_4" style="position:absolute;left:681.36px;top:148.6px;">2011</div><div id="a17407_133_2" style="position:absolute;font-weight:normal;font-style:normal;left:708.08px;top:148.6px;">, </div><div id="a17448" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:164px;">the Netherlands and China from </div><div id="a17448_31_4" style="position:absolute;left:178.853px;top:164px;">2015</div><div id="a17448_35_53" style="position:absolute;font-weight:normal;font-style:normal;left:205.573px;top:164px;">, Mexico, Spain, Germany and the United Kingdom from </div><div id="a17448_88_4" style="position:absolute;left:514.6px;top:164px;">2016</div><div id="a17448_92_27" style="position:absolute;font-weight:normal;font-style:normal;left:541.32px;top:164px;">, Canada and the U.S. from </div><div id="a17448_119_4" style="position:absolute;left:689.84px;top:164px;">2017</div><div id="a17448_123_2" style="position:absolute;font-weight:normal;font-style:normal;left:716.4px;top:164px;">, </div><div id="a17490" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:179.4px;">India from fiscal year beginning April 1, 2018 and ending<div style="display:inline-block;width:4.65px"> </div>March 31, </div><div id="a17490_68_4" style="position:absolute;left:374.893px;top:179.4px;">2019</div><div id="a17490_72_48" style="position:absolute;font-weight:normal;font-style:normal;left:401.613px;top:179.4px;">, and various U.S. state tax jurisdictions from </div><div id="a17490_120_4" style="position:absolute;left:646.32px;top:179.4px;">2011</div><div id="a17490_124_4" style="position:absolute;font-weight:normal;font-style:normal;left:673.039px;top:179.4px;">.<div style="display:inline-block;width:6.6px"> </div></div><div id="a17534" style="position:absolute;left:28.427px;top:200px;">As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia </div><div id="a17570" style="position:absolute;left:4.427px;top:215.4px;">S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under </div><div id="a17613" style="position:absolute;left:4.427px;top:230.8px;">the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except </div><div id="a17649" style="position:absolute;left:4.427px;top:246px;">2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP </div><div id="a17689" style="position:absolute;left:4.427px;top:261.3px;">proceedings which the Company has accepted.</div><div id="a17689_43_50" style="position:absolute;font-weight:normal;font-style:normal;left:254.093px;top:261.3px;"><div style="display:inline-block;width:6.72px"> </div>As of March 31, 2021, the Company has received $</div><div id="a17689_93_3" style="position:absolute;left:535.879px;top:261.3px;">1.6</div><div id="a17689_96_29" style="position:absolute;font-weight:normal;font-style:normal;left:552.519px;top:261.3px;"><div style="display:inline-block;width:3.36px"> </div>million in refunds from the </div><div id="a17731" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:276.7px;">Netherlands and Spain and expects to pay $</div><div id="a17731_42_3" style="position:absolute;left:237.453px;top:276.7px;">2.4</div><div id="a17731_45_80" style="position:absolute;font-weight:normal;font-style:normal;left:254.253px;top:276.7px;"><div style="display:inline-block;width:3.2px"> </div>million due to Italy in the second quarter of 2021.<div style="display:inline-block;width:7.96px"> </div>As of March 31, 2021, the </div><div id="a17779" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:292px;">Company believes it has adequate reserves for the remaining<div style="display:inline-block;width:4.71px"> </div>uncertain tax positions related to 2007. </div><div id="a17809" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:312.7px;">Houghton Italia, S.r.l<div style="display:inline-block;width:4.74px"> </div>is also involved in a corporate income tax audit with the Italian tax<div style="display:inline-block;width:4.82px"> </div>authorities covering tax years 2014 </div><div id="a17851" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:328px;">through 2018.<div style="display:inline-block;width:7.12px"> </div>As of March 31, 2021, the Company has a $</div><div id="a17851_56_3" style="position:absolute;left:321.933px;top:328px;">5.5</div><div id="a17851_59_76" style="position:absolute;font-weight:normal;font-style:normal;left:338.733px;top:328px;"><div style="display:inline-block;width:3.36px"> </div>million reserve for uncertain tax positions relating to matters related<div style="display:inline-block;width:4.7px"> </div>to </div><div id="a17897" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:343.4px;">this audit.<div style="display:inline-block;width:7.01px"> </div>Since the reserve relates to the tax periods prior to August<div style="display:inline-block;width:4.7px"> </div>1, 2019, the tax liability was established through purchase </div><div id="a17942" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:358.6px;">accounting related to the Combination.<div style="display:inline-block;width:7.74px"> </div>The Company has also submitted an indemnification claim against<div style="display:inline-block;width:4.73px"> </div>funds held in escrow<div style="display:inline-block;width:3.65px"> </div>by </div><div id="a17981" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:374px;">Houghton’s former owners<div style="display:inline-block;width:4.76px"> </div>and as a result, a corresponding $</div><div id="a17981_59_3" style="position:absolute;left:330.413px;top:374px;">5.5</div><div id="a17981_62_70" style="position:absolute;font-weight:normal;font-style:normal;left:347.213px;top:374px;"><div style="display:inline-block;width:3.36px"> </div>million indemnification receivable has also been established through </div><div id="a18017" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:389.3px;">purchase accounting. </div><div id="a18021" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:410px;">Houghton Deutschland GmbH is also under audit by<div style="display:inline-block;width:4.7px"> </div>the German tax authorities for the tax years 2015-2017.<div style="display:inline-block;width:7.82px"> </div>Based on </div><div id="a18062" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:425.3px;">preliminary audit findings, primarily related to<div style="display:inline-block;width:4.72px"> </div>transfer pricing, the Company has recorded reserves for $</div><div id="a18062_106_3" style="position:absolute;left:563.879px;top:425.3px;">0.9</div><div id="a18062_109_25" style="position:absolute;font-weight:normal;font-style:normal;left:580.56px;top:425.3px;"><div style="display:inline-block;width:3.36px"> </div>million as of March 31, </div><div id="a18102" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:440.7px;">2021.<div style="display:inline-block;width:6.95px"> </div>Of this amount, $</div><div id="a18102_24_3" style="position:absolute;left:134.533px;top:440.7px;">0.8</div><div id="a18102_27_100" style="position:absolute;font-weight:normal;font-style:normal;left:151.333px;top:440.7px;"><div style="display:inline-block;width:3.2px"> </div>million relates to tax periods prior to the Combination and<div style="display:inline-block;width:4.71px"> </div>therefore the Company has submitted an </div><div id="a18145" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:456.1px;">indemnification claim with Houghton’s<div style="display:inline-block;width:5.18px"> </div>former owners for any tax liabilities arising pre-Combination.<div style="display:inline-block;width:7.96px"> </div>As a result, a corresponding </div><div id="a18181" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:471.4px;">$</div><div id="a18181_1_3" style="position:absolute;left:11.147px;top:471.4px;">0.8</div><div id="a18181_4_77" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:471.4px;"><div style="display:inline-block;width:3.36px"> </div>million indemnification receivable has also been established to<div style="display:inline-block;width:4.72px"> </div>offset the $</div><div id="a18181_81_3" style="position:absolute;left:429.8px;top:471.4px;">0.8</div><div id="a18181_84_23" style="position:absolute;font-weight:normal;font-style:normal;left:446.44px;top:471.4px;"><div style="display:inline-block;width:3.36px"> </div>million tax liability.</div></div> 0.242 0.311 As of December 31, 2020, the Company had a deferred tax liability of $5.9 million, which primarily represents the Company’s estimate of non-U.S. taxes it will incur to repatriate certain foreign earnings to the U.S. The balance as of March 31, 2021 was $6.5 million. 5900000 6500000 23500000 1300000 100000 100000 100000 100000 3000000.0 3600000 3000000.0 3900000 300000 800000 1500000 2006 2011 2015 2015 2016 2016 2016 2016 2017 2019 2011 As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except 2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP proceedings which the Company has accepted. 1600000 2400000 5500000 5500000 5500000 900000 800000 800000 800000 <div id="TextBlockContainer132" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:668px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18211" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 12 – Earnings Per Share </div><div id="a18223" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The following table summarizes earnings per share calculations<div style="display:inline-block;width:4.95px"> </div>for the three months ended March 31, 2021 and 2020:</div></div><div id="TextBlockContainer136" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:666px;height:304px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_134_XBRL_CS_5dcb52a1e43d41cf94260a6d9a167108" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer135" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:666px;height:304px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18262" style="position:absolute;font-weight:bold;font-style:normal;left:504.68px;top:0px;">Three Months Ended </div><div id="a18268" style="position:absolute;font-weight:bold;font-style:normal;left:536.2px;top:17px;">March 31,<div style="display:inline-block;width:3.93px"> </div></div><div id="a18274" style="position:absolute;font-weight:bold;font-style:normal;left:502.6px;top:33.8px;">2021 </div><div id="a18277" style="position:absolute;font-weight:bold;font-style:normal;left:600.72px;top:33.8px;">2020 </div><div id="a18281" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:49.8px;">Basic earnings (loss) per common share </div><div id="a18284" style="position:absolute;font-weight:normal;font-style:normal;left:484.52px;top:49.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a18292" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:66.7px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a18294" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:66.7px;">$ </div><div id="a18296" style="position:absolute;left:517px;top:66.7px;">38,615</div><div id="a18299" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:66.7px;">$ </div><div id="a18301" style="position:absolute;left:611.12px;top:66.7px;">(28,381)</div><div id="a18306" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:83.8px;">Less: (income) loss allocated to participating securities </div><div id="a18308" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:83.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a18310" style="position:absolute;left:528.68px;top:83.8px;">(154)</div><div id="a18313" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:83.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a18315" style="position:absolute;left:632.72px;top:83.8px;">101</div><div id="a18320" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:100.8px;">Net income (loss) available to common shareholders </div><div id="a18322" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:100.8px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a18324" style="position:absolute;left:517px;top:100.8px;">38,461</div><div id="a18327" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:100.8px;">$ </div><div id="a18329" style="position:absolute;left:611.12px;top:100.8px;">(28,280)</div><div id="a18334" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:117.8px;">Basic weighted average common shares outstanding </div><div id="a18337" style="position:absolute;left:494.6px;top:117.8px;">17,785,370</div><div id="a18341" style="position:absolute;left:593.68px;top:117.8px;">17,672,525</div><div id="a18345" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:134.8px;">Basic earnings (loss) per common share </div><div id="a18348" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:134.8px;">$ </div><div id="a18350" style="position:absolute;left:530.28px;top:134.8px;">2.16</div><div id="a18353" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:134.8px;">$ </div><div id="a18355" style="position:absolute;left:624.56px;top:134.8px;">(1.60)</div><div id="a18368" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168.8px;">Diluted earnings (loss) per common share </div><div id="a18378" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:185.8px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a18380" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:185.8px;">$ </div><div id="a18382" style="position:absolute;left:517px;top:185.8px;">38,615</div><div id="a18385" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:185.8px;">$ </div><div id="a18387" style="position:absolute;left:611.12px;top:185.8px;">(28,381)</div><div id="a18392" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:202.8px;">Less: (income) loss allocated to participating securities </div><div id="a18396" style="position:absolute;left:528.68px;top:202.8px;">(154)</div><div id="a18400" style="position:absolute;left:632.72px;top:202.8px;">101</div><div id="a18405" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:219.9px;">Net income (loss) available to common shareholders </div><div id="a18407" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:219.9px;">$ </div><div id="a18409" style="position:absolute;left:517px;top:219.9px;">38,461</div><div id="a18412" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:219.9px;">$ </div><div id="a18414" style="position:absolute;left:611.12px;top:219.9px;">(28,280)</div><div id="a18419" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:236px;">Basic weighted average common shares outstanding </div><div id="a18422" style="position:absolute;left:494.6px;top:236px;">17,785,370</div><div id="a18426" style="position:absolute;left:593.68px;top:236px;">17,672,525</div><div id="a18431" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:253px;">Effect of dilutive securities </div><div id="a18434" style="position:absolute;left:517.96px;top:253px;">70,607</div><div id="a18438" style="position:absolute;left:640.4px;top:253px;">—</div><div id="a18443" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:270.3px;">Diluted weighted average common shares outstanding </div><div id="a18446" style="position:absolute;left:494.6px;top:270.3px;">17,855,977</div><div id="a18450" style="position:absolute;left:593.68px;top:270.3px;">17,672,525</div><div id="a18454" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:287.9px;">Diluted earnings (loss) per common share </div><div id="a18457" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:286.9px;">$ </div><div id="a18459" style="position:absolute;left:530.28px;top:287.9px;">2.15</div><div id="a18462" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:286.9px;">$ </div><div id="a18464" style="position:absolute;left:624.56px;top:287.9px;">(1.60)</div></div></div></div><div id="TextBlockContainer138" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18518" style="position:absolute;left:28.427px;top:0px;">Certain stock options and restricted stock units are not included in the diluted earnings (loss) per share calculation when the effect </div><div id="a18560" style="position:absolute;left:4.427px;top:15.4px;">would have been anti-dilutive. The calculated amount of anti-diluted shares not included was 2,083 for the three months ended March </div><div id="a18605" style="position:absolute;left:4.427px;top:30.7px;">31, 2021. All of the Company’s potentially dilutive shares for the three months ended March 31, 2020 are anti-dilutive and not </div><div id="a18649" style="position:absolute;left:4.427px;top:46.1px;">included in the dilutive loss per share calculations because of the Company’s net loss during the period.</div></div> <div id="TextBlockContainer135" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:666px;height:304px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18262" style="position:absolute;font-weight:bold;font-style:normal;left:504.68px;top:0px;">Three Months Ended </div><div id="a18268" style="position:absolute;font-weight:bold;font-style:normal;left:536.2px;top:17px;">March 31,<div style="display:inline-block;width:3.93px"> </div></div><div id="a18274" style="position:absolute;font-weight:bold;font-style:normal;left:502.6px;top:33.8px;">2021 </div><div id="a18277" style="position:absolute;font-weight:bold;font-style:normal;left:600.72px;top:33.8px;">2020 </div><div id="a18281" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:49.8px;">Basic earnings (loss) per common share </div><div id="a18284" style="position:absolute;font-weight:normal;font-style:normal;left:484.52px;top:49.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a18292" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:66.7px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a18294" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:66.7px;">$ </div><div id="a18296" style="position:absolute;left:517px;top:66.7px;">38,615</div><div id="a18299" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:66.7px;">$ </div><div id="a18301" style="position:absolute;left:611.12px;top:66.7px;">(28,381)</div><div id="a18306" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:83.8px;">Less: (income) loss allocated to participating securities </div><div id="a18308" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:83.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a18310" style="position:absolute;left:528.68px;top:83.8px;">(154)</div><div id="a18313" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:83.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a18315" style="position:absolute;left:632.72px;top:83.8px;">101</div><div id="a18320" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:100.8px;">Net income (loss) available to common shareholders </div><div id="a18322" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:100.8px;">$<div style="display:inline-block;width:3.44px"> </div></div><div id="a18324" style="position:absolute;left:517px;top:100.8px;">38,461</div><div id="a18327" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:100.8px;">$ </div><div id="a18329" style="position:absolute;left:611.12px;top:100.8px;">(28,280)</div><div id="a18334" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:117.8px;">Basic weighted average common shares outstanding </div><div id="a18337" style="position:absolute;left:494.6px;top:117.8px;">17,785,370</div><div id="a18341" style="position:absolute;left:593.68px;top:117.8px;">17,672,525</div><div id="a18345" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:134.8px;">Basic earnings (loss) per common share </div><div id="a18348" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:134.8px;">$ </div><div id="a18350" style="position:absolute;left:530.28px;top:134.8px;">2.16</div><div id="a18353" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:134.8px;">$ </div><div id="a18355" style="position:absolute;left:624.56px;top:134.8px;">(1.60)</div><div id="a18368" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:168.8px;">Diluted earnings (loss) per common share </div><div id="a18378" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:185.8px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a18380" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:185.8px;">$ </div><div id="a18382" style="position:absolute;left:517px;top:185.8px;">38,615</div><div id="a18385" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:185.8px;">$ </div><div id="a18387" style="position:absolute;left:611.12px;top:185.8px;">(28,381)</div><div id="a18392" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:202.8px;">Less: (income) loss allocated to participating securities </div><div id="a18396" style="position:absolute;left:528.68px;top:202.8px;">(154)</div><div id="a18400" style="position:absolute;left:632.72px;top:202.8px;">101</div><div id="a18405" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:219.9px;">Net income (loss) available to common shareholders </div><div id="a18407" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:219.9px;">$ </div><div id="a18409" style="position:absolute;left:517px;top:219.9px;">38,461</div><div id="a18412" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:219.9px;">$ </div><div id="a18414" style="position:absolute;left:611.12px;top:219.9px;">(28,280)</div><div id="a18419" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:236px;">Basic weighted average common shares outstanding </div><div id="a18422" style="position:absolute;left:494.6px;top:236px;">17,785,370</div><div id="a18426" style="position:absolute;left:593.68px;top:236px;">17,672,525</div><div id="a18431" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:253px;">Effect of dilutive securities </div><div id="a18434" style="position:absolute;left:517.96px;top:253px;">70,607</div><div id="a18438" style="position:absolute;left:640.4px;top:253px;">—</div><div id="a18443" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:270.3px;">Diluted weighted average common shares outstanding </div><div id="a18446" style="position:absolute;left:494.6px;top:270.3px;">17,855,977</div><div id="a18450" style="position:absolute;left:593.68px;top:270.3px;">17,672,525</div><div id="a18454" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:287.9px;">Diluted earnings (loss) per common share </div><div id="a18457" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:286.9px;">$ </div><div id="a18459" style="position:absolute;left:530.28px;top:287.9px;">2.15</div><div id="a18462" style="position:absolute;font-weight:normal;font-style:normal;left:571.6px;top:286.9px;">$ </div><div id="a18464" style="position:absolute;left:624.56px;top:287.9px;">(1.60)</div></div> 38615000 -28381000 154000 -101000 38461000 -28280000 17785370 17672525 2.16 -1.60 38615000 -28381000 154000 -101000 38461000 -28280000 17785370 17672525 70607 0 17855977 17672525 2.15 -1.60 Certain stock options and restricted stock units are not included in the diluted earnings (loss) per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included was 2,083 for the three months ended March 31, 2021. All of the Company’s potentially dilutive shares for the three months ended March 31, 2020 are anti-dilutive and not included in the dilutive loss per share calculations because of the Company’s net loss during the period. 2083 <div id="TextBlockContainer140" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:730px;height:201px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18685" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 13 – Restricted Cash </div><div id="a18695" style="position:absolute;left:28.427px;top:23.4px;">Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary </div><div id="a18737" style="position:absolute;left:4.427px;top:38.7px;">of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an </div><div id="a18775" style="position:absolute;left:4.427px;top:54.1px;">original total value of $35.0 million. The proceeds of both settlements were restricted and could only be used to pay claims and costs </div><div id="a18822" style="position:absolute;left:4.427px;top:69.4px;">of defense associated with the subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements were deposited </div><div id="a18859" style="position:absolute;left:4.427px;top:84.6px;">into interest bearing accounts that earned less than $0.1 million offset by $0.2 million of net payments during the three months ended </div><div id="a18905" style="position:absolute;left:4.427px;top:100px;">March 31, 2020.</div><div id="a18905_15_117" style="position:absolute;font-weight:normal;font-style:normal;left:92.773px;top:100px;"><div style="display:inline-block;width:6.72px"> </div>Due to the restricted nature of the proceeds, a corresponding<div style="display:inline-block;width:4.54px"> </div>deferred credit was established in other non-current </div><div id="a18950" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">liabilities for an equal and offsetting amount<div style="display:inline-block;width:4.76px"> </div>that continued until the restrictions lapsed.<div style="display:inline-block;width:7.6px"> </div>As disclosed in the Company’s<div style="display:inline-block;width:4.8px"> </div>2020 Form </div><div id="a18993" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.7px;">10-K, during December 2020, the restrictions ended<div style="display:inline-block;width:4.6px"> </div>on these previously received insurance settlements and the<div style="display:inline-block;width:4.72px"> </div>Company transferred </div><div id="a19029" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:146.1px;">the cash into an operating account.<div style="display:inline-block;width:7.49px"> </div></div><div id="a19042" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:169.5px;">The following table provides a reconciliation of cash,<div style="display:inline-block;width:4.76px"> </div>cash equivalents and restricted cash as of March 31, 2021 and<div style="display:inline-block;width:4.62px"> </div>2020, as well </div><div id="a19086" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.8px;">as December 31, 2020 and 2019:</div></div><div id="TextBlockContainer144" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_142_XBRL_TS_77cb4d2ae540449a9ed4915e3b71475c" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer143" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19102" style="position:absolute;font-weight:bold;font-style:normal;left:355.213px;top:0px;">March 31,<div style="display:inline-block;width:3.92px"> </div></div><div id="a19105" style="position:absolute;font-weight:bold;font-style:normal;left:531.56px;top:0px;">December 31, </div><div id="a19111" style="position:absolute;font-weight:bold;font-style:normal;left:324.653px;top:17.6px;">2021 </div><div id="a19114" style="position:absolute;font-weight:bold;font-style:normal;left:417.64px;top:17.6px;">2020 </div><div id="a19117" style="position:absolute;font-weight:bold;font-style:normal;left:510.6px;top:17.6px;">2020 </div><div id="a19120" style="position:absolute;font-weight:bold;font-style:normal;left:603.76px;top:17.6px;">2019 </div><div id="a19124" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:35.2px;">Cash and cash equivalents </div><div id="a19126" style="position:absolute;font-weight:normal;font-style:normal;left:296.493px;top:35.2px;">$ </div><div id="a19128" style="position:absolute;left:332.173px;top:35.2px;">163,455</div><div id="a19131" style="position:absolute;font-weight:normal;font-style:normal;left:389.48px;top:35.2px;">$ </div><div id="a19133" style="position:absolute;left:425.32px;top:35.2px;">316,437</div><div id="a19136" style="position:absolute;font-weight:normal;font-style:normal;left:482.44px;top:35.2px;">$ </div><div id="a19138" style="position:absolute;left:518.28px;top:35.2px;">181,833</div><div id="a19141" style="position:absolute;font-weight:normal;font-style:normal;left:575.6px;top:35.2px;">$ </div><div id="a19143" style="position:absolute;left:611.28px;top:35.2px;">123,524</div><div id="a19147" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.8px;">Restricted cash included in other current assets </div><div id="a19150" style="position:absolute;left:362.28px;top:52.8px;">—</div><div id="a19154" style="position:absolute;left:455.4px;top:52.8px;">34</div><div id="a19158" style="position:absolute;left:548.4px;top:52.8px;">62</div><div id="a19162" style="position:absolute;left:634.64px;top:52.8px;">353</div><div id="a19166" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:70.4px;">Restricted cash included in other assets </div><div id="a19169" style="position:absolute;left:362.28px;top:70.4px;">—</div><div id="a19173" style="position:absolute;left:432.04px;top:70.4px;">19,480</div><div id="a19177" style="position:absolute;left:548.4px;top:70.4px;">—</div><div id="a19181" style="position:absolute;left:618px;top:70.4px;">19,678</div><div id="a19185" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:88.8px;">Cash, cash equivalents and restricted cash </div><div id="a19187" style="position:absolute;font-weight:normal;font-style:normal;left:296.493px;top:88.8px;">$ </div><div id="a19189" style="position:absolute;left:332.173px;top:88.8px;">163,455</div><div id="a19192" style="position:absolute;font-weight:normal;font-style:normal;left:389.48px;top:88.8px;">$ </div><div id="a19194" style="position:absolute;left:425.32px;top:88.8px;">335,951</div><div id="a19197" style="position:absolute;font-weight:normal;font-style:normal;left:482.44px;top:88.8px;">$ </div><div id="a19199" style="position:absolute;left:518.28px;top:88.8px;">181,895</div><div id="a19202" style="position:absolute;font-weight:normal;font-style:normal;left:575.6px;top:88.8px;">$ </div><div id="a19204" style="position:absolute;left:611.28px;top:88.8px;">143,555</div></div></div></div> Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0 million. The proceeds of both settlements were restricted and could only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements were deposited into interest bearing accounts that earned less than $0.1 million offset by $0.2 million of net payments during the three months ended March 31, 2020. 100000 200000 <div id="TextBlockContainer143" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19102" style="position:absolute;font-weight:bold;font-style:normal;left:355.213px;top:0px;">March 31,<div style="display:inline-block;width:3.92px"> </div></div><div id="a19105" style="position:absolute;font-weight:bold;font-style:normal;left:531.56px;top:0px;">December 31, </div><div id="a19111" style="position:absolute;font-weight:bold;font-style:normal;left:324.653px;top:17.6px;">2021 </div><div id="a19114" style="position:absolute;font-weight:bold;font-style:normal;left:417.64px;top:17.6px;">2020 </div><div id="a19117" style="position:absolute;font-weight:bold;font-style:normal;left:510.6px;top:17.6px;">2020 </div><div id="a19120" style="position:absolute;font-weight:bold;font-style:normal;left:603.76px;top:17.6px;">2019 </div><div id="a19124" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:35.2px;">Cash and cash equivalents </div><div id="a19126" style="position:absolute;font-weight:normal;font-style:normal;left:296.493px;top:35.2px;">$ </div><div id="a19128" style="position:absolute;left:332.173px;top:35.2px;">163,455</div><div id="a19131" style="position:absolute;font-weight:normal;font-style:normal;left:389.48px;top:35.2px;">$ </div><div id="a19133" style="position:absolute;left:425.32px;top:35.2px;">316,437</div><div id="a19136" style="position:absolute;font-weight:normal;font-style:normal;left:482.44px;top:35.2px;">$ </div><div id="a19138" style="position:absolute;left:518.28px;top:35.2px;">181,833</div><div id="a19141" style="position:absolute;font-weight:normal;font-style:normal;left:575.6px;top:35.2px;">$ </div><div id="a19143" style="position:absolute;left:611.28px;top:35.2px;">123,524</div><div id="a19147" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.8px;">Restricted cash included in other current assets </div><div id="a19150" style="position:absolute;left:362.28px;top:52.8px;">—</div><div id="a19154" style="position:absolute;left:455.4px;top:52.8px;">34</div><div id="a19158" style="position:absolute;left:548.4px;top:52.8px;">62</div><div id="a19162" style="position:absolute;left:634.64px;top:52.8px;">353</div><div id="a19166" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:70.4px;">Restricted cash included in other assets </div><div id="a19169" style="position:absolute;left:362.28px;top:70.4px;">—</div><div id="a19173" style="position:absolute;left:432.04px;top:70.4px;">19,480</div><div id="a19177" style="position:absolute;left:548.4px;top:70.4px;">—</div><div id="a19181" style="position:absolute;left:618px;top:70.4px;">19,678</div><div id="a19185" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:88.8px;">Cash, cash equivalents and restricted cash </div><div id="a19187" style="position:absolute;font-weight:normal;font-style:normal;left:296.493px;top:88.8px;">$ </div><div id="a19189" style="position:absolute;left:332.173px;top:88.8px;">163,455</div><div id="a19192" style="position:absolute;font-weight:normal;font-style:normal;left:389.48px;top:88.8px;">$ </div><div id="a19194" style="position:absolute;left:425.32px;top:88.8px;">335,951</div><div id="a19197" style="position:absolute;font-weight:normal;font-style:normal;left:482.44px;top:88.8px;">$ </div><div id="a19199" style="position:absolute;left:518.28px;top:88.8px;">181,895</div><div id="a19202" style="position:absolute;font-weight:normal;font-style:normal;left:575.6px;top:88.8px;">$ </div><div id="a19204" style="position:absolute;left:611.28px;top:88.8px;">143,555</div></div> 163455000 316437000 181833000 123524000 0 34000 62000 353000 0 19480000 0 19678000 163455000 335951000 181895000 143555000 <div id="TextBlockContainer146" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:598px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19207" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 14 – Goodwill and Other Intangible Assets<div style="display:inline-block;width:4.54px"> </div></div><div id="a19224" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">Changes in the carrying amount of goodwill for the<div style="display:inline-block;width:4.75px"> </div>three months ended March 31, 2020 were as follows:</div></div><div id="TextBlockContainer149" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19271" style="position:absolute;font-weight:bold;font-style:normal;left:568.68px;top:0px;">Global </div><div id="a19286" style="position:absolute;font-weight:bold;font-style:normal;left:562.12px;top:16.2px;">Specialty </div><div id="a19293" style="position:absolute;font-weight:bold;font-style:normal;left:278.093px;top:31.2px;">Americas </div><div id="a19296" style="position:absolute;font-weight:bold;font-style:normal;left:380.013px;top:31.2px;">EMEA </div><div id="a19299" style="position:absolute;font-weight:bold;font-style:normal;left:461.32px;top:31.2px;">Asia/Pacific </div><div id="a19302" style="position:absolute;font-weight:bold;font-style:normal;left:557.96px;top:31.2px;">Businesses </div><div id="a19305" style="position:absolute;font-weight:bold;font-style:normal;left:666px;top:31.2px;">Total </div><div id="a19307" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:47.8px;">Balance as of December 31, 2020 </div><div id="a19310" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:47.8px;">$ </div><div id="a19312" style="position:absolute;left:300.173px;top:47.8px;">213,242</div><div id="a19315" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:47.8px;">$ </div><div id="a19317" style="position:absolute;left:395.24px;top:47.8px;">140,162</div><div id="a19320" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:47.8px;">$ </div><div id="a19322" style="position:absolute;left:490.28px;top:47.8px;">158,090</div><div id="a19325" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:47.8px;">$ </div><div id="a19327" style="position:absolute;left:583.28px;top:47.8px;">119,718</div><div id="a19329" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:47.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19331" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:47.8px;">$ </div><div id="a19333" style="position:absolute;left:676.24px;top:47.8px;">631,212</div><div id="a19336" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:64.8px;">Goodwill additions </div><div id="a19339" style="position:absolute;left:312.493px;top:64.8px;">1,093</div><div id="a19343" style="position:absolute;left:407.56px;top:64.8px;">2,626</div><div id="a19347" style="position:absolute;left:502.6px;top:64.8px;">1,308</div><div id="a19351" style="position:absolute;left:612.4px;top:64.8px;">25</div><div id="a19355" style="position:absolute;left:688.56px;top:64.8px;">5,052</div><div id="a19358" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:81.9px;">Currency translation adjustments </div><div id="a19360" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:81.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19362" style="position:absolute;left:317.613px;top:81.9px;">(731)</div><div id="a19366" style="position:absolute;left:402.76px;top:81.9px;">(3,925)</div><div id="a19370" style="position:absolute;left:507.72px;top:81.9px;">(956)</div><div id="a19374" style="position:absolute;left:590.8px;top:81.9px;">(3,078)</div><div id="a19376" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:81.9px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19379" style="position:absolute;left:683.76px;top:81.9px;">(8,690)</div><div id="a19381" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:99.8px;">Balance as of March 31,<div style="display:inline-block;width:7.4px"> </div>2021 </div><div id="a19384" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:99.8px;">$ </div><div id="a19386" style="position:absolute;left:300.173px;top:99.8px;">213,604</div><div id="a19389" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:99.8px;">$ </div><div id="a19391" style="position:absolute;left:395.24px;top:99.8px;">138,863</div><div id="a19394" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:99.8px;">$ </div><div id="a19396" style="position:absolute;left:490.28px;top:99.8px;">158,442</div><div id="a19399" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:99.8px;">$ </div><div id="a19401" style="position:absolute;left:583.28px;top:99.8px;">116,665</div><div id="a19403" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:99.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19405" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:99.8px;">$ </div><div id="a19407" style="position:absolute;left:676.24px;top:99.8px;">627,574</div></div><div id="TextBlockContainer152" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19409" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Gross carrying amounts and accumulated amortization<div style="display:inline-block;width:4.73px"> </div>for definite-lived intangible assets as of March 31, 2021 and<div style="display:inline-block;width:4.76px"> </div>December 31, </div><div id="a19447" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">2020 were as follows:</div></div><div id="TextBlockContainer156" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_154_XBRL_TS_58cc4e7752f74e77946993da6a91dd27" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer155" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19457" style="position:absolute;font-weight:bold;font-style:normal;left:402.76px;top:0px;">Gross Carrying </div><div id="a19460" style="position:absolute;font-weight:bold;font-style:normal;left:596.72px;top:0px;">Accumulated </div><div id="a19464" style="position:absolute;font-weight:bold;font-style:normal;left:424.04px;top:14.9px;">Amount </div><div id="a19467" style="position:absolute;font-weight:bold;font-style:normal;left:596.4px;top:14.9px;">Amortization </div><div id="a19471" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:31px;">2021 </div><div id="a19474" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:31px;">2020 </div><div id="a19477" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:31px;">2021 </div><div id="a19480" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:31px;">2020 </div><div id="a19482" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:48.2px;">Customer lists and rights to sell </div><div id="a19484" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:48.2px;">$ </div><div id="a19486" style="position:absolute;left:395.24px;top:48.2px;">846,052</div><div id="a19488" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:48.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19490" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:48.2px;">$ </div><div id="a19492" style="position:absolute;left:490.28px;top:48.2px;">839,551</div><div id="a19494" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:48.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19496" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:48.2px;">$ </div><div id="a19498" style="position:absolute;left:583.28px;top:48.2px;">110,997</div><div id="a19500" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:48.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19502" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:48.2px;">$ </div><div id="a19504" style="position:absolute;left:682.96px;top:48.2px;">99,806</div><div id="a19506" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.8px;">Trademarks, formulations and product<div style="display:inline-block;width:4.8px"> </div>technology </div><div id="a19508" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:64.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19510" style="position:absolute;left:395.24px;top:64.8px;">167,144</div><div id="a19512" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:64.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19514" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:64.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19516" style="position:absolute;left:490.28px;top:64.8px;">166,448</div><div id="a19518" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:64.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19520" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:64.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19522" style="position:absolute;left:590px;top:64.8px;">32,533</div><div id="a19524" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:64.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19526" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:64.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19528" style="position:absolute;left:682.96px;top:64.8px;">30,483</div><div id="a19530" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.8px;">Other </div><div id="a19532" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:81.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19534" style="position:absolute;left:408.52px;top:81.8px;">6,320</div><div id="a19536" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:81.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19538" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:81.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19540" style="position:absolute;left:503.56px;top:81.8px;">6,372</div><div id="a19542" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:81.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19544" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:81.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19546" style="position:absolute;left:596.56px;top:81.8px;">5,743</div><div id="a19548" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:81.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19550" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:81.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19552" style="position:absolute;left:689.52px;top:81.8px;">5,824</div><div id="a19554" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:99.7px;">Total definite<div style="display:inline-block;width:1.37px"> </div>-lived intangible assets </div><div id="a19558" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:99.7px;">$ </div><div id="a19560" style="position:absolute;left:385.293px;top:99.7px;">1,019,516</div><div id="a19562" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:99.7px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19564" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:99.7px;">$ </div><div id="a19566" style="position:absolute;left:480.36px;top:99.7px;">1,012,371</div><div id="a19568" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:99.7px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19570" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:99.7px;">$ </div><div id="a19572" style="position:absolute;left:583.28px;top:99.7px;">149,273</div><div id="a19574" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:99.7px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19576" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:99.7px;">$ </div><div id="a19578" style="position:absolute;left:676.24px;top:99.7px;">136,113</div></div></div></div><div id="TextBlockContainer158" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:714px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19630" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company amortizes definite-lived intangible assets on<div style="display:inline-block;width:4.77px"> </div>a straight-line basis over their useful lives.<div style="display:inline-block;width:7.53px"> </div>The Company recorded </div><div id="a19670" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">$</div><div id="a19670_1_4" style="position:absolute;left:11.147px;top:15.4px;">14.8</div><div id="a19670_5_14" style="position:absolute;font-weight:normal;font-style:normal;left:34.507px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a19670_19_4" style="position:absolute;left:108.933px;top:15.4px;">14.0</div><div id="a19670_23_100" style="position:absolute;font-weight:normal;font-style:normal;left:132.293px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million of amortization expense for the three months ended<div style="display:inline-block;width:4.81px"> </div>March 31, 2021 and 2020, respectively.<div style="display:inline-block;width:5.15px"> </div></div><div id="a19711" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Estimated annual aggregate amortization expense for<div style="display:inline-block;width:4.7px"> </div>the current year and subsequent five years is as follows:</div></div><div id="TextBlockContainer162" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:366px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_160_XBRL_TS_6f6041769ca24538b4f7f8cd03e9bb31" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer161" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:366px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19744" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0.8px;">For the year ended December 31, 2021 </div><div id="a19746" style="position:absolute;font-weight:normal;font-style:normal;left:275.533px;top:0.8px;">$ </div><div id="a19748" style="position:absolute;left:320.973px;top:0px;">59,372</div><div id="a19752" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17.8px;">For the year ended December 31, 2022 </div><div id="a19755" style="position:absolute;left:320.973px;top:17px;">59,096</div><div id="a19759" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:34.7px;">For the year ended December 31, 2023 </div><div id="a19762" style="position:absolute;left:320.973px;top:33.9px;">58,927</div><div id="a19766" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.8px;">For the year ended December 31, 2024 </div><div id="a19769" style="position:absolute;left:320.973px;top:50.9px;">58,427</div><div id="a19773" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68.8px;">For the year ended December 31, 2025 </div><div id="a19776" style="position:absolute;left:320.973px;top:68px;">57,710</div><div id="a19780" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85.8px;">For the year ended December 31, 2026 </div><div id="a19783" style="position:absolute;left:320.973px;top:85px;">57,484</div></div></div></div><div id="TextBlockContainer166" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:439px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19786" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company has four indefinite-lived intangible<div style="display:inline-block;width:4.7px"> </div>assets totaling $</div><div id="a19786_66_5" style="position:absolute;left:381.933px;top:0px;">205.1</div><div id="a19786_71_52" style="position:absolute;font-weight:normal;font-style:normal;left:411.88px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million as of both March 31, 2021 and December 31, </div><div id="a19826" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">2020, including $</div><div id="a19826_17_5" style="position:absolute;left:98.213px;top:15.4px;">204.0</div><div id="a19826_22_109" style="position:absolute;font-weight:normal;font-style:normal;left:128.293px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million of indefinite-lived intangible assets for trademarks and<div style="display:inline-block;width:4.75px"> </div>tradename associated with the Combination. </div><div id="div_164_XBRL_TS_be95bbe869c74141af4f0d83d34e8547" style="position:absolute;left:0px;top:38.8px;float:left;"><div id="TextBlockContainer165" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:714px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19860" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Goodwill and intangible assets that have indefinite lives are<div style="display:inline-block;width:4.67px"> </div>not amortized and are required to be assessed at least annually<div style="display:inline-block;width:4.87px"> </div>for </div><div id="a19902" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">impairment.<div style="display:inline-block;width:7.17px"> </div>The Company completes its annual goodwill and indefinite-lived<div style="display:inline-block;width:4.73px"> </div>intangible asset impairment test during the fourth </div><div id="a19936" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">quarter of each year.<div style="display:inline-block;width:7.96px"> </div>The Company continuously evaluates if triggering events indicate<div style="display:inline-block;width:4.81px"> </div>a possible impairment in one or more of its </div><div id="a19978" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">reporting units or indefinite-lived or long-lived assets.</div></div></div><div id="a19978_57_1" style="position:absolute;font-weight:normal;font-style:normal;left:292.973px;top:84.7px;"> </div><div id="a19996" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:108px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that as of March 31, 2020, the Company concluded that the<div style="display:inline-block;width:4.79px"> </div>impact of </div><div id="a20044" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:123.4px;">COVID-19 did not represent a triggering event with<div style="display:inline-block;width:4.64px"> </div>regards to the Company’s<div style="display:inline-block;width:4.73px"> </div>reporting units or indefinite-lived and long-lived assets, </div><div id="a20088" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.8px;">except for the Company’s<div style="display:inline-block;width:4.81px"> </div>Houghton and Fluidcare trademarks and tradename indefinite<div style="display:inline-block;width:1.34px"> </div>-lived intangible assets.<div style="display:inline-block;width:7.01px"> </div>The determination of </div><div id="a20124" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:154px;">estimated fair value of the Houghton and Fluidcare<div style="display:inline-block;width:4.7px"> </div>trademarks and tradename indefinite-lived assets was based on a relief<div style="display:inline-block;width:4.83px"> </div>from </div><div id="a20164" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169.3px;">royalty valuation method,<div style="display:inline-block;width:4.16px"> </div>which requires management’s judgment<div style="display:inline-block;width:4.95px"> </div>and often involves the use of significant estimates and assumptions, </div><div id="a20199" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.7px;">including assumptions with respect to the weighted average<div style="display:inline-block;width:4.71px"> </div>cost of capital (“WACC”)<div style="display:inline-block;width:5.3px"> </div>and royalty rates, as well as revenue growth </div><div id="a20239" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">rates and terminal growth rates.<div style="display:inline-block;width:7.44px"> </div>In the first quarter of 2020, as a result of the impact of<div style="display:inline-block;width:4.7px"> </div>COVID-19 driving a decrease in projected </div><div id="a20289" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:215.4px;">legacy Houghton net sales during that year and the impact<div style="display:inline-block;width:4.68px"> </div>of the sales decline on projected future legacy Houghton<div style="display:inline-block;width:4.7px"> </div>net sales as well as </div><div id="a20337" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:230.6px;">an increase in the WACC<div style="display:inline-block;width:5.31px"> </div>assumption utilized in the quantitative impairment<div style="display:inline-block;width:4.84px"> </div>assessment, the Company concluded that the estimated </div><div id="a20373" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:246px;">fair values of the Houghton and Fluidcare trademarks<div style="display:inline-block;width:4.71px"> </div>and tradename intangible assets were less than their carrying values.<div style="display:inline-block;width:8.09px"> </div>As a </div><div id="a20414" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:261.3px;">result, an impairment charge of $</div><div id="a20414_33_4" style="position:absolute;left:181.573px;top:261.3px;">38.0</div><div id="a20414_37_94" style="position:absolute;font-weight:normal;font-style:normal;left:204.933px;top:261.3px;"><div style="display:inline-block;width:3.36px"> </div>million was recorded in the first quarter of 2020 to write down<div style="display:inline-block;width:4.74px"> </div>the carrying values of these </div><div id="a20461" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:276.7px;">intangible assets to their estimated fair values. </div><div id="a20475" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:300.1px;">As of March 31, 2021, the Company continued to evaluate<div style="display:inline-block;width:4.75px"> </div>the on-going impact of COVID-19 on the Company’s<div style="display:inline-block;width:5.29px"> </div>operations, and </div><div id="a20519" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:315.4px;">the volatility and uncertainty in the economic outlook as a result of<div style="display:inline-block;width:4.82px"> </div>COVID-19, to determine if this indicated it was more likely<div style="display:inline-block;width:4.72px"> </div>than </div><div id="a20567" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:330.6px;">not that the carrying value of any of the Company’s<div style="display:inline-block;width:5.42px"> </div>reporting units or indefinite-lived or long-lived intangible assets were<div style="display:inline-block;width:4.94px"> </div>not </div><div id="a20611" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:346px;">recoverable.<div style="display:inline-block;width:7.11px"> </div>The Company concluded that the impact of COVID-19 did not represent<div style="display:inline-block;width:4.87px"> </div>a triggering event as of March 31, 2021.<div style="display:inline-block;width:7.64px"> </div>While </div><div id="a20656" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:361.3px;">the Company concluded that the impact of COVID-19<div style="display:inline-block;width:4.74px"> </div>did not represent a triggering event as of March 31, 2021,<div style="display:inline-block;width:4.7px"> </div>the Company will </div><div id="a20702" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:376.7px;">continue to evaluate the impact of COVID-19 on the Company’s<div style="display:inline-block;width:5.67px"> </div>current and projected results.<div style="display:inline-block;width:7.17px"> </div>If the current economic conditions </div><div id="a20743" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:392.1px;">worsen or projections of the timeline for recovery are<div style="display:inline-block;width:4.78px"> </div>significantly extended, then the Company may conclude in the<div style="display:inline-block;width:4.75px"> </div>future that the </div><div id="a20785" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:407.4px;">impact from COVID-19 requires the need to perform<div style="display:inline-block;width:4.68px"> </div>further interim quantitative impairment tests, which could<div style="display:inline-block;width:4.7px"> </div>result in additional </div><div id="a20824" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:422.8px;">impairment charges in the future.</div></div> <div id="TextBlockContainer150" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_148_XBRL_TS_6ac2bc78a1bd475284994bf380a8c4d7" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer149" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19271" style="position:absolute;font-weight:bold;font-style:normal;left:568.68px;top:0px;">Global </div><div id="a19286" style="position:absolute;font-weight:bold;font-style:normal;left:562.12px;top:16.2px;">Specialty </div><div id="a19293" style="position:absolute;font-weight:bold;font-style:normal;left:278.093px;top:31.2px;">Americas </div><div id="a19296" style="position:absolute;font-weight:bold;font-style:normal;left:380.013px;top:31.2px;">EMEA </div><div id="a19299" style="position:absolute;font-weight:bold;font-style:normal;left:461.32px;top:31.2px;">Asia/Pacific </div><div id="a19302" style="position:absolute;font-weight:bold;font-style:normal;left:557.96px;top:31.2px;">Businesses </div><div id="a19305" style="position:absolute;font-weight:bold;font-style:normal;left:666px;top:31.2px;">Total </div><div id="a19307" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:47.8px;">Balance as of December 31, 2020 </div><div id="a19310" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:47.8px;">$ </div><div id="a19312" style="position:absolute;left:300.173px;top:47.8px;">213,242</div><div id="a19315" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:47.8px;">$ </div><div id="a19317" style="position:absolute;left:395.24px;top:47.8px;">140,162</div><div id="a19320" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:47.8px;">$ </div><div id="a19322" style="position:absolute;left:490.28px;top:47.8px;">158,090</div><div id="a19325" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:47.8px;">$ </div><div id="a19327" style="position:absolute;left:583.28px;top:47.8px;">119,718</div><div id="a19329" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:47.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19331" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:47.8px;">$ </div><div id="a19333" style="position:absolute;left:676.24px;top:47.8px;">631,212</div><div id="a19336" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:64.8px;">Goodwill additions </div><div id="a19339" style="position:absolute;left:312.493px;top:64.8px;">1,093</div><div id="a19343" style="position:absolute;left:407.56px;top:64.8px;">2,626</div><div id="a19347" style="position:absolute;left:502.6px;top:64.8px;">1,308</div><div id="a19351" style="position:absolute;left:612.4px;top:64.8px;">25</div><div id="a19355" style="position:absolute;left:688.56px;top:64.8px;">5,052</div><div id="a19358" style="position:absolute;font-weight:normal;font-style:normal;left:19.467px;top:81.9px;">Currency translation adjustments </div><div id="a19360" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:81.9px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19362" style="position:absolute;left:317.613px;top:81.9px;">(731)</div><div id="a19366" style="position:absolute;left:402.76px;top:81.9px;">(3,925)</div><div id="a19370" style="position:absolute;left:507.72px;top:81.9px;">(956)</div><div id="a19374" style="position:absolute;left:590.8px;top:81.9px;">(3,078)</div><div id="a19376" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:81.9px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19379" style="position:absolute;left:683.76px;top:81.9px;">(8,690)</div><div id="a19381" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:99.8px;">Balance as of March 31,<div style="display:inline-block;width:7.4px"> </div>2021 </div><div id="a19384" style="position:absolute;font-weight:normal;font-style:normal;left:263.533px;top:99.8px;">$ </div><div id="a19386" style="position:absolute;left:300.173px;top:99.8px;">213,604</div><div id="a19389" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:99.8px;">$ </div><div id="a19391" style="position:absolute;left:395.24px;top:99.8px;">138,863</div><div id="a19394" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:99.8px;">$ </div><div id="a19396" style="position:absolute;left:490.28px;top:99.8px;">158,442</div><div id="a19399" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:99.8px;">$ </div><div id="a19401" style="position:absolute;left:583.28px;top:99.8px;">116,665</div><div id="a19403" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:99.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19405" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:99.8px;">$ </div><div id="a19407" style="position:absolute;left:676.24px;top:99.8px;">627,574</div></div></div></div> 213242000 140162000 158090000 119718000 631212000 1093000 2626000 1308000 25000 5052000 -731000 -3925000 -956000 -3078000 -8690000 213604000 138863000 158442000 116665000 627574000 <div id="TextBlockContainer155" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19457" style="position:absolute;font-weight:bold;font-style:normal;left:402.76px;top:0px;">Gross Carrying </div><div id="a19460" style="position:absolute;font-weight:bold;font-style:normal;left:596.72px;top:0px;">Accumulated </div><div id="a19464" style="position:absolute;font-weight:bold;font-style:normal;left:424.04px;top:14.9px;">Amount </div><div id="a19467" style="position:absolute;font-weight:bold;font-style:normal;left:596.4px;top:14.9px;">Amortization </div><div id="a19471" style="position:absolute;font-weight:bold;font-style:normal;left:386.573px;top:31px;">2021 </div><div id="a19474" style="position:absolute;font-weight:bold;font-style:normal;left:481.64px;top:31px;">2020 </div><div id="a19477" style="position:absolute;font-weight:bold;font-style:normal;left:574.64px;top:31px;">2021 </div><div id="a19480" style="position:absolute;font-weight:bold;font-style:normal;left:667.76px;top:31px;">2020 </div><div id="a19482" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:48.2px;">Customer lists and rights to sell </div><div id="a19484" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:48.2px;">$ </div><div id="a19486" style="position:absolute;left:395.24px;top:48.2px;">846,052</div><div id="a19488" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:48.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19490" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:48.2px;">$ </div><div id="a19492" style="position:absolute;left:490.28px;top:48.2px;">839,551</div><div id="a19494" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:48.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19496" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:48.2px;">$ </div><div id="a19498" style="position:absolute;left:583.28px;top:48.2px;">110,997</div><div id="a19500" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:48.2px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19502" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:48.2px;">$ </div><div id="a19504" style="position:absolute;left:682.96px;top:48.2px;">99,806</div><div id="a19506" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.8px;">Trademarks, formulations and product<div style="display:inline-block;width:4.8px"> </div>technology </div><div id="a19508" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:64.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19510" style="position:absolute;left:395.24px;top:64.8px;">167,144</div><div id="a19512" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:64.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19514" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:64.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19516" style="position:absolute;left:490.28px;top:64.8px;">166,448</div><div id="a19518" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:64.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19520" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:64.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19522" style="position:absolute;left:590px;top:64.8px;">32,533</div><div id="a19524" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:64.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19526" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:64.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19528" style="position:absolute;left:682.96px;top:64.8px;">30,483</div><div id="a19530" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:81.8px;">Other </div><div id="a19532" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:81.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19534" style="position:absolute;left:408.52px;top:81.8px;">6,320</div><div id="a19536" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:81.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19538" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:81.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19540" style="position:absolute;left:503.56px;top:81.8px;">6,372</div><div id="a19542" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:81.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19544" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:81.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19546" style="position:absolute;left:596.56px;top:81.8px;">5,743</div><div id="a19548" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:81.8px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19550" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:81.8px;"><div style="display:inline-block;width:3.36px"> </div></div><div id="a19552" style="position:absolute;left:689.52px;top:81.8px;">5,824</div><div id="a19554" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:99.7px;">Total definite<div style="display:inline-block;width:1.37px"> </div>-lived intangible assets </div><div id="a19558" style="position:absolute;font-weight:normal;font-style:normal;left:358.413px;top:99.7px;">$ </div><div id="a19560" style="position:absolute;left:385.293px;top:99.7px;">1,019,516</div><div id="a19562" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:99.7px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19564" style="position:absolute;font-weight:normal;font-style:normal;left:453.48px;top:99.7px;">$ </div><div id="a19566" style="position:absolute;left:480.36px;top:99.7px;">1,012,371</div><div id="a19568" style="position:absolute;font-weight:normal;font-style:normal;left:538.44px;top:99.7px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19570" style="position:absolute;font-weight:normal;font-style:normal;left:546.44px;top:99.7px;">$ </div><div id="a19572" style="position:absolute;left:583.28px;top:99.7px;">149,273</div><div id="a19574" style="position:absolute;font-weight:normal;font-style:normal;left:631.6px;top:99.7px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a19576" style="position:absolute;font-weight:normal;font-style:normal;left:639.6px;top:99.7px;">$ </div><div id="a19578" style="position:absolute;left:676.24px;top:99.7px;">136,113</div></div> 846052000 839551000 110997000 99806000 167144000 166448000 32533000 30483000 6320000 6372000 5743000 5824000 1019516000 1012371000 149273000 136113000 14800000 14000000.0 <div id="TextBlockContainer161" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:366px;height:102px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19744" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0.8px;">For the year ended December 31, 2021 </div><div id="a19746" style="position:absolute;font-weight:normal;font-style:normal;left:275.533px;top:0.8px;">$ </div><div id="a19748" style="position:absolute;left:320.973px;top:0px;">59,372</div><div id="a19752" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:17.8px;">For the year ended December 31, 2022 </div><div id="a19755" style="position:absolute;left:320.973px;top:17px;">59,096</div><div id="a19759" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:34.7px;">For the year ended December 31, 2023 </div><div id="a19762" style="position:absolute;left:320.973px;top:33.9px;">58,927</div><div id="a19766" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.8px;">For the year ended December 31, 2024 </div><div id="a19769" style="position:absolute;left:320.973px;top:50.9px;">58,427</div><div id="a19773" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68.8px;">For the year ended December 31, 2025 </div><div id="a19776" style="position:absolute;left:320.973px;top:68px;">57,710</div><div id="a19780" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:85.8px;">For the year ended December 31, 2026 </div><div id="a19783" style="position:absolute;left:320.973px;top:85px;">57,484</div></div> 59372000 59096000 58927000 58427000 57710000 57484000 205100000 205100000 204000000.0 204000000.0 <div id="TextBlockContainer165" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:714px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19860" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Goodwill and intangible assets that have indefinite lives are<div style="display:inline-block;width:4.67px"> </div>not amortized and are required to be assessed at least annually<div style="display:inline-block;width:4.87px"> </div>for </div><div id="a19902" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.2px;">impairment.<div style="display:inline-block;width:7.17px"> </div>The Company completes its annual goodwill and indefinite-lived<div style="display:inline-block;width:4.73px"> </div>intangible asset impairment test during the fourth </div><div id="a19936" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">quarter of each year.<div style="display:inline-block;width:7.96px"> </div>The Company continuously evaluates if triggering events indicate<div style="display:inline-block;width:4.81px"> </div>a possible impairment in one or more of its </div><div id="a19978" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">reporting units or indefinite-lived or long-lived assets.</div></div> 38000000.0 <div id="TextBlockContainer168" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:437px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20886" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 15 – Debt </div><div id="a20894" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">Debt as of March 31, 2021 and December 31, 2020 includes<div style="display:inline-block;width:4.76px"> </div>the following:</div></div><div id="TextBlockContainer171" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:674px;height:223px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20925" style="position:absolute;font-weight:bold;font-style:normal;left:334.093px;top:0px;">As of March 31, 2021 </div><div id="a20928" style="position:absolute;font-weight:bold;font-style:normal;left:511.56px;top:0px;">As of December 31, 2020 </div><div id="a20934" style="position:absolute;font-weight:bold;font-style:normal;left:313.933px;top:17.1px;">Interest </div><div id="a20937" style="position:absolute;font-weight:bold;font-style:normal;left:396.68px;top:17.1px;">Outstanding<div style="display:inline-block;width:3.55px"> </div></div><div id="a20940" style="position:absolute;font-weight:bold;font-style:normal;left:505.96px;top:17.1px;">Interest </div><div id="a20942" style="position:absolute;font-weight:bold;font-style:normal;left:578.64px;top:17.1px;">Outstanding<div style="display:inline-block;width:3.55px"> </div></div><div id="a20948" style="position:absolute;font-weight:bold;font-style:normal;left:322.893px;top:31.5px;">Rate </div><div id="a20951" style="position:absolute;font-weight:bold;font-style:normal;left:409.64px;top:31.5px;">Balance </div><div id="a20954" style="position:absolute;font-weight:bold;font-style:normal;left:514.92px;top:31.5px;">Rate </div><div id="a20956" style="position:absolute;font-weight:bold;font-style:normal;left:591.6px;top:31.5px;">Balance </div><div id="a20960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:48px;">Credit Facilities: </div><div id="a20975" style="position:absolute;font-weight:normal;font-style:normal;left:14.379px;top:65.8px;">Revolver </div><div id="a20978" style="position:absolute;left:324.013px;top:65.8px;display:flex;">1.61%</div><div id="a20981" style="position:absolute;font-weight:normal;font-style:normal;left:381.48px;top:65.8px;">$ </div><div id="a20983" style="position:absolute;left:435.72px;top:65.8px;">190,000</div><div id="a20986" style="position:absolute;left:505.96px;top:65.8px;display:flex;">1.65%</div><div id="a20989" style="position:absolute;font-weight:normal;font-style:normal;left:563.44px;top:65.8px;">$ </div><div id="a20991" style="position:absolute;left:618.8px;top:65.8px;">160,000</div><div id="a20996" style="position:absolute;font-weight:normal;font-style:normal;left:14.379px;top:83.4px;">U.S. Term Loan </div><div id="a20999" style="position:absolute;left:324.013px;top:83.4px;display:flex;">1.61%</div><div id="a21003" style="position:absolute;left:435.72px;top:83.4px;">562,500</div><div id="a21006" style="position:absolute;left:505.96px;top:83.4px;display:flex;">1.65%</div><div id="a21010" style="position:absolute;left:617.68px;top:83.4px;">570,000</div><div id="a21015" style="position:absolute;font-weight:normal;font-style:normal;left:14.379px;top:101px;">EURO Term Loan </div><div id="a21018" style="position:absolute;left:324.013px;top:101px;display:flex;">1.50%</div><div id="a21022" style="position:absolute;left:435.72px;top:101px;">148,210</div><div id="a21025" style="position:absolute;left:505.96px;top:101px;display:flex;">1.50%</div><div id="a21029" style="position:absolute;left:617.68px;top:101px;">157,062</div><div id="a21033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117.4px;">Industrial development bonds </div><div id="a21036" style="position:absolute;left:324.013px;top:118.6px;display:flex;">5.26%</div><div id="a21040" style="position:absolute;left:442.44px;top:118.6px;">10,000</div><div id="a21043" style="position:absolute;left:505.96px;top:118.6px;display:flex;">5.26%</div><div id="a21047" style="position:absolute;left:624.4px;top:118.6px;">10,000</div><div id="a21051" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:135px;">Bank lines of credit and other debt obligations </div><div id="a21054" style="position:absolute;font-weight:normal;font-style:normal;left:320.173px;top:136.2px;">Various </div><div id="a21058" style="position:absolute;left:449px;top:136.2px;">2,377</div><div id="a21061" style="position:absolute;font-weight:normal;font-style:normal;left:502.12px;top:136.2px;">Various </div><div id="a21065" style="position:absolute;left:630.96px;top:136.2px;">2,072</div><div id="a21069" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153px;">Total debt </div><div id="a21074" style="position:absolute;font-weight:normal;font-style:normal;left:381.48px;top:153.8px;">$ </div><div id="a21076" style="position:absolute;left:435.72px;top:153.8px;">913,087</div><div id="a21081" style="position:absolute;font-weight:normal;font-style:normal;left:563.44px;top:153.8px;">$ </div><div id="a21083" style="position:absolute;left:617.68px;top:153.8px;">899,134</div><div id="a21087" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:170.3px;">Less: debt issuance costs </div><div id="a21093" style="position:absolute;left:437.48px;top:171.4px;">(10,324)</div><div id="a21099" style="position:absolute;left:619.44px;top:171.4px;">(11,099)</div><div id="a21103" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:187.9px;">Less: short-term and current portion of long-term debts </div><div id="a21113" style="position:absolute;left:437.48px;top:189px;">(43,330)</div><div id="a21119" style="position:absolute;left:619.44px;top:189px;">(38,967)</div><div id="a21123" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:206.3px;">Total long<div style="display:inline-block;width:1.36px"> </div>-term debt </div><div id="a21130" style="position:absolute;font-weight:normal;font-style:normal;left:381.48px;top:207.4px;">$ </div><div id="a21132" style="position:absolute;left:436.84px;top:207.4px;">859,433</div><div id="a21137" style="position:absolute;font-weight:normal;font-style:normal;left:563.44px;top:207.4px;">$ </div><div id="a21139" style="position:absolute;left:618.8px;top:207.4px;">849,068</div></div><div id="TextBlockContainer174" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:577px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a21142" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Credit facilities </div><div id="a21146" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company’s primary<div style="display:inline-block;width:4.76px"> </div>credit facility (as amended, the “Credit Facility”) is comprised<div style="display:inline-block;width:4.71px"> </div>of a $</div><div id="a21146_93_5" style="position:absolute;left:529.639px;top:23.4px;">400.0</div><div id="a21146_98_23" style="position:absolute;font-weight:normal;font-style:normal;left:559.719px;top:23.4px;"><div style="display:inline-block;width:3.36px"> </div>million multicurrency </div><div id="a21180" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.6px;">revolver (the “Revolver”), a $</div><div id="a21180_30_5" style="position:absolute;left:163.973px;top:38.6px;">600.0</div><div id="a21180_35_85" style="position:absolute;font-weight:normal;font-style:normal;left:194.053px;top:38.6px;"><div style="display:inline-block;width:3.36px"> </div>million term loan (the “U.S. Term<div style="display:inline-block;width:5px"> </div>Loan”), each with the Company as borrower,<div style="display:inline-block;width:5.06px"> </div>and a $</div><div id="a21180_120_5" style="position:absolute;left:665.199px;top:38.6px;">150.0</div><div id="a21180_125_1" style="position:absolute;font-weight:normal;font-style:normal;left:695.279px;top:38.6px;"> </div><div id="a21222" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">million (as of August 1, 2019) Euro equivalent term loan (the<div style="display:inline-block;width:4.71px"> </div>“EURO Term Loan”<div style="display:inline-block;width:4.89px"> </div>and together with the “U.S. Term<div style="display:inline-block;width:5.02px"> </div>Loan”, the </div><div id="a21266" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">“Term Loans”)<div style="display:inline-block;width:4.86px"> </div>with Quaker Chemical B.V.,<div style="display:inline-block;width:5.48px"> </div>a Dutch subsidiary of the Company as borrower,<div style="display:inline-block;width:4.96px"> </div>each with a five-year term maturing in </div><div id="a21310" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">August 2024.<div style="display:inline-block;width:7.18px"> </div>Subject to the consent of the administrative agent and certain<div style="display:inline-block;width:4.71px"> </div>other conditions, the Company may designate additional </div><div id="a21349" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">borrowers.<div style="display:inline-block;width:7.03px"> </div>The maximum amount available under the Credit Facility can be<div style="display:inline-block;width:4.73px"> </div>increased by up to $</div><div id="a21349_94_5" style="position:absolute;left:524.04px;top:100px;">300.0</div><div id="a21349_99_26" style="position:absolute;font-weight:normal;font-style:normal;left:554.12px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>million at the Company’s </div><div id="a21389" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">request if there are lenders who agree to accept additional<div style="display:inline-block;width:4.87px"> </div>commitments and the Company has satisfied certain other<div style="display:inline-block;width:4.76px"> </div>conditions.<div style="display:inline-block;width:3.43px"> </div></div><div id="a21428" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.6px;">Borrowings under the Credit Facility bear interest at a base<div style="display:inline-block;width:4.8px"> </div>rate or LIBOR plus an applicable margin based upon<div style="display:inline-block;width:4.89px"> </div>the Company’s </div><div id="a21470" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:145.9px;">consolidated net leverage ratio.<div style="display:inline-block;width:7.38px"> </div>There are LIBOR replacement provisions that contemplate a further<div style="display:inline-block;width:4.88px"> </div>amendment if and when LIBOR </div><div id="a21506" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:161.3px;">ceases to be reported.<div style="display:inline-block;width:7.33px"> </div>The variable interest rate incurred on the outstanding borrowings under<div style="display:inline-block;width:4.86px"> </div>the Credit Facility as of and during the </div><div id="a21550" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:176.7px;">three months ended March 31, 2021 was approximately </div><div id="a21550_52_3" style="position:absolute;left:304.973px;top:176.7px;">1.6</div><div id="a21550_55_77" style="position:absolute;font-weight:normal;font-style:normal;left:321.453px;top:176.7px;">%.<div style="display:inline-block;width:6.74px"> </div>In addition to paying interest on outstanding principal under<div style="display:inline-block;width:4.83px"> </div>the Credit </div><div id="a21590" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:192px;">Facility, the Company<div style="display:inline-block;width:4.89px"> </div>is required to pay a commitment fee ranging from </div><div id="a21590_71_3" style="position:absolute;left:396.04px;top:192px;">0.2</div><div id="a21590_74_5" style="position:absolute;font-weight:normal;font-style:normal;left:412.84px;top:192px;">% to </div><div id="a21590_79_3" style="position:absolute;left:440.84px;top:192px;">0.3</div><div id="a21590_82_46" style="position:absolute;font-weight:normal;font-style:normal;left:457.64px;top:192px;">% depending on the Company’s<div style="display:inline-block;width:4.78px"> </div>consolidated net </div><div id="a21632" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:207.2px;">leverage ratio to the lenders under the Revolver in<div style="display:inline-block;width:4.55px"> </div>respect of the unutilized commitments thereunder.<div style="display:inline-block;width:7.92px"> </div>The Company has unused </div><div id="a21671" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:222.6px;">capacity under the Revolver of approximately $</div><div id="a21671_46_3" style="position:absolute;left:259.373px;top:222.6px;">204</div><div id="a21671_49_58" style="position:absolute;font-weight:normal;font-style:normal;left:279.373px;top:222.6px;"><div style="display:inline-block;width:3.36px"> </div>million, net of bank letters of credit of approximately $</div><div id="a21671_107_1" style="position:absolute;left:576.88px;top:222.6px;">6</div><div id="a21671_108_26" style="position:absolute;font-weight:normal;font-style:normal;left:583.44px;top:222.6px;"><div style="display:inline-block;width:3.36px"> </div>million, as of March 31, </div><div id="a21716" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:237.9px;">2021.<div style="display:inline-block;width:6.79px"> </div></div><div id="a21719" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:261.3px;">The Credit Facility is subject to certain financial and<div style="display:inline-block;width:4.54px"> </div>other covenants.<div style="display:inline-block;width:7.24px"> </div></div><div id="a21719_74_47" style="position:absolute;left:406.759px;top:261.3px;">The Company’s initial consolidated net debt to </div><div id="a21755" style="position:absolute;left:4.427px;top:276.7px;">consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit </div><div id="a21801" style="position:absolute;left:4.427px;top:292px;">Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 4.00 to 1. The Company’s </div><div id="a21844" style="position:absolute;left:4.427px;top:307.2px;">consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit </div><div id="a21889" style="position:absolute;left:4.427px;top:322.6px;">Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually </div><div id="a21935" style="position:absolute;left:4.427px;top:337.9px;">exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to </div><div id="a21976" style="position:absolute;left:4.427px;top:353.3px;">consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.</div><div id="a21976_104_2" style="position:absolute;font-weight:normal;font-style:normal;left:561.96px;top:353.3px;"><div style="display:inline-block;width:6.72px"> </div></div><div id="a21976_106_25" style="position:absolute;left:568.68px;top:353.3px;">As of March 31, 2021 and </div><div id="a22026" style="position:absolute;left:4.427px;top:368.7px;">December 31, 2020, the Company was in compliance with all of the Credit Facility covenants</div><div id="a22026_90_33" style="position:absolute;font-weight:normal;font-style:normal;left:504.999px;top:368.7px;">.<div style="display:inline-block;width:6.76px"> </div>The Term Loans<div style="display:inline-block;width:4.79px"> </div>have quarterly </div><div id="a22067" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:384.1px;">principal amortization during their five-year terms,<div style="display:inline-block;width:4.76px"> </div>with </div><div id="a22067_58_3" style="position:absolute;left:306.733px;top:384.1px;">5.0</div><div id="a22067_61_62" style="position:absolute;font-weight:normal;font-style:normal;left:323.373px;top:384.1px;">% amortization of the principal balance due in years<div style="display:inline-block;width:4.54px"> </div>1 and 2, </div><div id="a22067_123_3" style="position:absolute;left:651.119px;top:384.1px;">7.5</div><div id="a22067_126_10" style="position:absolute;font-weight:normal;font-style:normal;left:667.919px;top:384.1px;">% in year </div><div id="a22113" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:399.3px;">3, and </div><div id="a22113_7_4" style="position:absolute;left:40.459px;top:399.3px;">10.0</div><div id="a22113_11_120" style="position:absolute;font-weight:normal;font-style:normal;left:63.818px;top:399.3px;">% in years 4 and 5, with the remaining principal amount due at<div style="display:inline-block;width:4.77px"> </div>maturity.<div style="display:inline-block;width:7.75px"> </div>During the three months ended March 31, 2021, </div><div id="a22161" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:414.6px;">the Company made quarterly amortization payments<div style="display:inline-block;width:4.74px"> </div>related to the Term Loans<div style="display:inline-block;width:4.9px"> </div>totaling $</div><div id="a22161_85_3" style="position:absolute;left:480.2px;top:414.6px;">9.6</div><div id="a22161_88_45" style="position:absolute;font-weight:normal;font-style:normal;left:496.84px;top:414.6px;"><div style="display:inline-block;width:3.36px"> </div>million.<div style="display:inline-block;width:6.95px"> </div>The Credit Facility is guaranteed </div><div id="a22202" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:430px;">by certain of the Company’s<div style="display:inline-block;width:4.76px"> </div>domestic subsidiaries and is secured by first priority liens on substantially<div style="display:inline-block;width:4.91px"> </div>all of the assets of the </div><div id="a22246" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:445.3px;">Company and the domestic subsidiary guarantors,<div style="display:inline-block;width:4.76px"> </div>subject to certain customary exclusions.<div style="display:inline-block;width:7.33px"> </div>The obligations of the Dutch borrower are </div><div id="a22283" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:460.7px;">guaranteed only by certain foreign subsidiaries on an unsecured<div style="display:inline-block;width:4.9px"> </div>basis. </div><div id="a22303" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:484.1px;">The Credit Facility required the Company to fix its variable<div style="display:inline-block;width:4.87px"> </div>interest rates on at least 20% of its total Term<div style="display:inline-block;width:5.2px"> </div>Loans.<div style="display:inline-block;width:6.95px"> </div>In order to </div><div id="a22351" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:499.3px;">satisfy this requirement as well as to manage the<div style="display:inline-block;width:4.74px"> </div>Company’s exposure to variable<div style="display:inline-block;width:4.69px"> </div>interest rate risk associated with the Credit Facility, </div><div id="a22393" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:514.6px;">in November 2019, the Company entered into $</div><div id="a22393_44_5" style="position:absolute;left:259.373px;top:514.6px;">170.0</div><div id="a22393_49_78" style="position:absolute;font-weight:normal;font-style:normal;left:289.453px;top:514.6px;"><div style="display:inline-block;width:3.36px"> </div>million notional amounts of three-year interest rate swaps at a base<div style="display:inline-block;width:4.73px"> </div>rate of </div><div id="a22438" style="position:absolute;left:4.427px;top:530px;">1.64</div><div id="a22438_4_128" style="position:absolute;font-weight:normal;font-style:normal;left:27.946px;top:530px;">% plus an applicable margin as provided in the Credit<div style="display:inline-block;width:4.74px"> </div>Facility, based on the Company’s<div style="display:inline-block;width:5.4px"> </div>consolidated net leverage ratio.<div style="display:inline-block;width:7.55px"> </div>At the </div><div id="a22480" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:545.3px;">time the Company entered into the swaps, and as<div style="display:inline-block;width:4.7px"> </div>of March 31, 2021, the aggregate interest rate on the swaps,<div style="display:inline-block;width:4.8px"> </div>including the fixed base </div><div id="a22529" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:560.7px;">rate plus an applicable margin, was </div><div id="a22529_36_3" style="position:absolute;left:195.813px;top:560.7px;">3.1</div><div id="a22529_39_73" style="position:absolute;font-weight:normal;font-style:normal;left:212.613px;top:560.7px;">%.<div style="display:inline-block;width:6.78px"> </div>See Note 18 of Notes to Condensed Consolidated Financial Statements. </div></div><div id="TextBlockContainer176" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:734px;height:123px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a22613" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The Company capitalized $</div><div id="a22613_25_4" style="position:absolute;left:175.493px;top:0px;">23.7</div><div id="a22613_29_103" style="position:absolute;font-weight:normal;font-style:normal;left:198.853px;top:0px;"><div style="display:inline-block;width:3.36px"> </div>million of certain third-party debt issuance costs in connection<div style="display:inline-block;width:4.8px"> </div>with executing the Credit Facility.<div style="display:inline-block;width:4.84px"> </div></div><div id="a22652" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">Approximately $</div><div id="a22652_15_4" style="position:absolute;left:95.339px;top:15.4px;">15.5</div><div id="a22652_19_111" style="position:absolute;font-weight:normal;font-style:normal;left:118.693px;top:15.4px;"><div style="display:inline-block;width:3.36px"> </div>million of the capitalized costs were attributed to the Term<div style="display:inline-block;width:5.55px"> </div>Loans and recorded as a direct reduction of long-</div><div id="a22694" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">term debt on the Company’s<div style="display:inline-block;width:4.74px"> </div>Condensed Consolidated Balance Sheet.<div style="display:inline-block;width:7.79px"> </div>Approximately $</div><div id="a22694_81_3" style="position:absolute;left:472.84px;top:30.7px;">8.3</div><div id="a22694_84_39" style="position:absolute;font-weight:normal;font-style:normal;left:489.48px;top:30.7px;"><div style="display:inline-block;width:3.36px"> </div>million of the capitalized costs were </div><div id="a22729" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">attributed to the Revolver and recorded within other assets on<div style="display:inline-block;width:4.8px"> </div>the Company’s Condensed Consolidated<div style="display:inline-block;width:4.89px"> </div>Balance Sheet.<div style="display:inline-block;width:7.05px"> </div>These </div><div id="a22763" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:61.3px;">capitalized costs are being amortized into interest expense<div style="display:inline-block;width:4.87px"> </div>over the five-year term of the Credit Facility.<div style="display:inline-block;width:8.56px"> </div>As of March 31, 2021 and </div><div id="a22811" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:76.6px;">December 31, 2020, the Company had $</div><div id="a22811_36_4" style="position:absolute;left:220.133px;top:76.6px;">10.3</div><div id="a22811_40_14" style="position:absolute;font-weight:normal;font-style:normal;left:243.533px;top:76.6px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a22811_54_4" style="position:absolute;left:317.933px;top:76.6px;">11.1</div><div id="a22811_58_74" style="position:absolute;font-weight:normal;font-style:normal;left:341.133px;top:76.6px;"><div style="display:inline-block;width:3.36px"> </div>million, respectively,<div style="display:inline-block;width:4.72px"> </div>of debt issuance costs recorded as a reduction of </div><div id="a22853" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:92px;">long-term debt.<div style="display:inline-block;width:7.11px"> </div>As of March 31, 2021 and December 31, 2020, the Company<div style="display:inline-block;width:4.91px"> </div>had $</div><div id="a22853_78_3" style="position:absolute;left:452.519px;top:92px;">5.5</div><div id="a22853_81_14" style="position:absolute;font-weight:normal;font-style:normal;left:469.159px;top:92px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a22853_95_3" style="position:absolute;left:543.559px;top:92px;">5.9</div><div id="a22853_98_32" style="position:absolute;font-weight:normal;font-style:normal;left:560.359px;top:92px;"><div style="display:inline-block;width:3.2px"> </div>million, respectively,<div style="display:inline-block;width:4.74px"> </div>of debt </div><div id="a22900" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:107.4px;">issuance costs recorded within other assets.</div></div><div id="TextBlockContainer178" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:240px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a22914" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:0px;">Industrial development bonds </div><div id="a22921" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.2px;">As of March 31, 2021 and December 31, 2020,<div style="display:inline-block;width:4.53px"> </div>the Company had fixed rate, industrial development authority<div style="display:inline-block;width:4.58px"> </div>bonds totaling </div><div id="a22960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.6px;">$</div><div id="a22960_1_4" style="position:absolute;left:11.147px;top:38.6px;">10.0</div><div id="a22960_5_36" style="position:absolute;font-weight:normal;font-style:normal;left:34.507px;top:38.6px;"><div style="display:inline-block;width:3.36px"> </div>million in principal amount due in </div><div id="a22960_41_4" style="position:absolute;left:223.853px;top:38.6px;">2028</div><div id="a22960_45_74" style="position:absolute;font-weight:normal;font-style:normal;left:250.573px;top:38.6px;">.<div style="display:inline-block;width:6.6px"> </div>These bonds have similar covenants to the Credit Facility noted<div style="display:inline-block;width:4.75px"> </div>above. </div><div id="a23000" style="position:absolute;font-weight:normal;font-style:italic;left:4.427px;top:61.9px;">Bank lines of credit and other<div style="display:inline-block;width:4.53px"> </div>debt obligations</div><div id="a23015" style="position:absolute;font-size:16px;font-weight:normal;font-style:normal;left:252.973px;top:59.4px;"> </div><div id="a23016" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:85.3px;">The Company has certain unsecured bank lines of credit<div style="display:inline-block;width:4.89px"> </div>and discounting facilities in certain foreign subsidiaries, which are<div style="display:inline-block;width:4.75px"> </div>not </div><div id="a23056" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100.7px;">collateralized.<div style="display:inline-block;width:7.12px"> </div>The Company’s other debt<div style="display:inline-block;width:4.7px"> </div>obligations primarily consist of certain domestic and foreign<div style="display:inline-block;width:4.88px"> </div>low interest rate or interest-</div><div id="a23094" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:116px;">free municipality-related loans, local credit facilities of<div style="display:inline-block;width:4.79px"> </div>certain foreign subsidiaries and capital lease obligations.<div style="display:inline-block;width:7.84px"> </div>Total unused </div><div id="a23129" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:131.4px;">capacity under these arrangements as of March 31,<div style="display:inline-block;width:4.71px"> </div>2021 was approximately $</div><div id="a23129_74_2" style="position:absolute;left:420.04px;top:131.4px;">40</div><div id="a23129_76_9" style="position:absolute;font-weight:normal;font-style:normal;left:433.48px;top:131.4px;"><div style="display:inline-block;width:3.36px"> </div>million.</div><div id="a23157" style="position:absolute;font-size:16px;font-weight:normal;font-style:normal;left:478.44px;top:128.9px;"> </div><div id="a23158" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:154.6px;">In addition to the bank letters of credit described in<div style="display:inline-block;width:4.76px"> </div>the “Credit facilities” subsection above, the Company’s<div style="display:inline-block;width:5.24px"> </div>only other off-balance </div><div id="a23200" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:170px;">sheet arrangements include certain financial and other<div style="display:inline-block;width:4.72px"> </div>guarantees.<div style="display:inline-block;width:6.78px"> </div>The Company’s total bank<div style="display:inline-block;width:4.78px"> </div>letters of credit and guarantees </div><div id="a23235" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:185.3px;">outstanding as of March 31, 2021 were approximately<div style="display:inline-block;width:4.57px"> </div>$</div><div id="a23235_53_1" style="position:absolute;left:303.373px;top:185.3px;">9</div><div id="a23235_54_10" style="position:absolute;font-weight:normal;font-style:normal;left:310.093px;top:185.3px;"><div style="display:inline-block;width:3.36px"> </div>million. </div><div id="a23257" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:208.7px;">The Company incurred the following debt related expenses<div style="display:inline-block;width:4.7px"> </div>included within Interest expense, net, in the Condensed<div style="display:inline-block;width:4.86px"> </div>Consolidated </div><div id="a23291" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:224px;">Statements of Operations:</div></div><div id="TextBlockContainer181" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:658px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a23300" style="position:absolute;font-weight:bold;font-style:normal;left:502.76px;top:0px;">Three Months Ended </div><div id="a23305" style="position:absolute;font-weight:bold;font-style:normal;left:534.12px;top:17.6px;">March 31,<div style="display:inline-block;width:3.93px"> </div></div><div id="a23310" style="position:absolute;font-weight:bold;font-style:normal;left:502.6px;top:35.2px;">2021 </div><div id="a23313" style="position:absolute;font-weight:bold;font-style:normal;left:597.68px;top:35.2px;">2020 </div><div id="a23317" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.8px;">Interest expense </div><div id="a23320" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:52.8px;">$ </div><div id="a23322" style="position:absolute;left:523.56px;top:52.8px;">4,650</div><div id="a23325" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:52.8px;">$ </div><div id="a23327" style="position:absolute;left:618.64px;top:52.8px;">7,712</div><div id="a23331" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:70.4px;">Amortization of debt issuance costs </div><div id="a23334" style="position:absolute;left:523.56px;top:70.4px;">1,187</div><div id="a23338" style="position:absolute;left:618.64px;top:70.4px;">1,187</div><div id="a23342" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:88.8px;">Total </div><div id="a23344" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:88.8px;">$ </div><div id="a23346" style="position:absolute;left:523.56px;top:88.8px;">5,837</div><div id="a23349" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:88.8px;">$ </div><div id="a23351" style="position:absolute;left:618.64px;top:88.8px;">8,899</div></div><div id="TextBlockContainer184" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:732px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a23354" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Based on the variable interest rates associated with the Credit<div style="display:inline-block;width:4.75px"> </div>Facility, as of March<div style="display:inline-block;width:4.81px"> </div>31, 2021 and December 31, 2020, the amounts </div><div id="a23398" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">at which the Company’s<div style="display:inline-block;width:4.75px"> </div>total debt were recorded are not materially different<div style="display:inline-block;width:4.66px"> </div>from their fair market value.</div></div> <div id="TextBlockContainer172" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:674px;height:223px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_170_XBRL_TS_3c2c76cd76d34f9e99f3e8fb29acffb0" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer171" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:674px;height:223px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20925" style="position:absolute;font-weight:bold;font-style:normal;left:334.093px;top:0px;">As of March 31, 2021 </div><div id="a20928" style="position:absolute;font-weight:bold;font-style:normal;left:511.56px;top:0px;">As of December 31, 2020 </div><div id="a20934" style="position:absolute;font-weight:bold;font-style:normal;left:313.933px;top:17.1px;">Interest </div><div id="a20937" style="position:absolute;font-weight:bold;font-style:normal;left:396.68px;top:17.1px;">Outstanding<div style="display:inline-block;width:3.55px"> </div></div><div id="a20940" style="position:absolute;font-weight:bold;font-style:normal;left:505.96px;top:17.1px;">Interest </div><div id="a20942" style="position:absolute;font-weight:bold;font-style:normal;left:578.64px;top:17.1px;">Outstanding<div style="display:inline-block;width:3.55px"> </div></div><div id="a20948" style="position:absolute;font-weight:bold;font-style:normal;left:322.893px;top:31.5px;">Rate </div><div id="a20951" style="position:absolute;font-weight:bold;font-style:normal;left:409.64px;top:31.5px;">Balance </div><div id="a20954" style="position:absolute;font-weight:bold;font-style:normal;left:514.92px;top:31.5px;">Rate </div><div id="a20956" style="position:absolute;font-weight:bold;font-style:normal;left:591.6px;top:31.5px;">Balance </div><div id="a20960" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:48px;">Credit Facilities: </div><div id="a20975" style="position:absolute;font-weight:normal;font-style:normal;left:14.379px;top:65.8px;">Revolver </div><div id="a20978" style="position:absolute;left:324.013px;top:65.8px;display:flex;">1.61%</div><div id="a20981" style="position:absolute;font-weight:normal;font-style:normal;left:381.48px;top:65.8px;">$ </div><div id="a20983" style="position:absolute;left:435.72px;top:65.8px;">190,000</div><div id="a20986" style="position:absolute;left:505.96px;top:65.8px;display:flex;">1.65%</div><div id="a20989" style="position:absolute;font-weight:normal;font-style:normal;left:563.44px;top:65.8px;">$ </div><div id="a20991" style="position:absolute;left:618.8px;top:65.8px;">160,000</div><div id="a20996" style="position:absolute;font-weight:normal;font-style:normal;left:14.379px;top:83.4px;">U.S. Term Loan </div><div id="a20999" style="position:absolute;left:324.013px;top:83.4px;display:flex;">1.61%</div><div id="a21003" style="position:absolute;left:435.72px;top:83.4px;">562,500</div><div id="a21006" style="position:absolute;left:505.96px;top:83.4px;display:flex;">1.65%</div><div id="a21010" style="position:absolute;left:617.68px;top:83.4px;">570,000</div><div id="a21015" style="position:absolute;font-weight:normal;font-style:normal;left:14.379px;top:101px;">EURO Term Loan </div><div id="a21018" style="position:absolute;left:324.013px;top:101px;display:flex;">1.50%</div><div id="a21022" style="position:absolute;left:435.72px;top:101px;">148,210</div><div id="a21025" style="position:absolute;left:505.96px;top:101px;display:flex;">1.50%</div><div id="a21029" style="position:absolute;left:617.68px;top:101px;">157,062</div><div id="a21033" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:117.4px;">Industrial development bonds </div><div id="a21036" style="position:absolute;left:324.013px;top:118.6px;display:flex;">5.26%</div><div id="a21040" style="position:absolute;left:442.44px;top:118.6px;">10,000</div><div id="a21043" style="position:absolute;left:505.96px;top:118.6px;display:flex;">5.26%</div><div id="a21047" style="position:absolute;left:624.4px;top:118.6px;">10,000</div><div id="a21051" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:135px;">Bank lines of credit and other debt obligations </div><div id="a21054" style="position:absolute;font-weight:normal;font-style:normal;left:320.173px;top:136.2px;">Various </div><div id="a21058" style="position:absolute;left:449px;top:136.2px;">2,377</div><div id="a21061" style="position:absolute;font-weight:normal;font-style:normal;left:502.12px;top:136.2px;">Various </div><div id="a21065" style="position:absolute;left:630.96px;top:136.2px;">2,072</div><div id="a21069" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:153px;">Total debt </div><div id="a21074" style="position:absolute;font-weight:normal;font-style:normal;left:381.48px;top:153.8px;">$ </div><div id="a21076" style="position:absolute;left:435.72px;top:153.8px;">913,087</div><div id="a21081" style="position:absolute;font-weight:normal;font-style:normal;left:563.44px;top:153.8px;">$ </div><div id="a21083" style="position:absolute;left:617.68px;top:153.8px;">899,134</div><div id="a21087" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:170.3px;">Less: debt issuance costs </div><div id="a21093" style="position:absolute;left:437.48px;top:171.4px;">(10,324)</div><div id="a21099" style="position:absolute;left:619.44px;top:171.4px;">(11,099)</div><div id="a21103" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:187.9px;">Less: short-term and current portion of long-term debts </div><div id="a21113" style="position:absolute;left:437.48px;top:189px;">(43,330)</div><div id="a21119" style="position:absolute;left:619.44px;top:189px;">(38,967)</div><div id="a21123" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:206.3px;">Total long<div style="display:inline-block;width:1.36px"> </div>-term debt </div><div id="a21130" style="position:absolute;font-weight:normal;font-style:normal;left:381.48px;top:207.4px;">$ </div><div id="a21132" style="position:absolute;left:436.84px;top:207.4px;">859,433</div><div id="a21137" style="position:absolute;font-weight:normal;font-style:normal;left:563.44px;top:207.4px;">$ </div><div id="a21139" style="position:absolute;left:618.8px;top:207.4px;">849,068</div></div></div></div> 0.0161 190000000 0.0165 160000000 0.0161 562500000 0.0165 570000000 0.0150 148210000 0.0150 157062000 0.0526 10000000 0.0526 10000000 2377000 2072000 913087000 899134000 10324000 11099000 43330000 38967000 859433000 849068000 400000000.0 600000000.0 150000000.0 300000000.0 0.016 0.002 0.003 204000000 6000000 The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 4.00 to 1. The Company’s consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount. As of March 31, 2021 and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants 0.050 0.075 0.100 9600000 170000000.0 0.0164 0.031 23700000 15500000 8300000 10300000 11100000 5500000 5900000 10000000.0 10000000.0 2028 40000000 9000000 <div id="TextBlockContainer182" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:658px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_180_XBRL_TS_428080fd6e224fb3a15fbbdfb81b4cd3" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer181" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:658px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a23300" style="position:absolute;font-weight:bold;font-style:normal;left:502.76px;top:0px;">Three Months Ended </div><div id="a23305" style="position:absolute;font-weight:bold;font-style:normal;left:534.12px;top:17.6px;">March 31,<div style="display:inline-block;width:3.93px"> </div></div><div id="a23310" style="position:absolute;font-weight:bold;font-style:normal;left:502.6px;top:35.2px;">2021 </div><div id="a23313" style="position:absolute;font-weight:bold;font-style:normal;left:597.68px;top:35.2px;">2020 </div><div id="a23317" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:52.8px;">Interest expense </div><div id="a23320" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:52.8px;">$ </div><div id="a23322" style="position:absolute;left:523.56px;top:52.8px;">4,650</div><div id="a23325" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:52.8px;">$ </div><div id="a23327" style="position:absolute;left:618.64px;top:52.8px;">7,712</div><div id="a23331" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:70.4px;">Amortization of debt issuance costs </div><div id="a23334" style="position:absolute;left:523.56px;top:70.4px;">1,187</div><div id="a23338" style="position:absolute;left:618.64px;top:70.4px;">1,187</div><div id="a23342" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:88.8px;">Total </div><div id="a23344" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:88.8px;">$ </div><div id="a23346" style="position:absolute;left:523.56px;top:88.8px;">5,837</div><div id="a23349" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:88.8px;">$ </div><div id="a23351" style="position:absolute;left:618.64px;top:88.8px;">8,899</div></div></div></div> 4650000 7712000 1187000 1187000 5837000 8899000 <div id="TextBlockContainer186" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:109px;height:16px;display:inline-block;"><div id="a23482" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 16 – Equity</div></div><div id="TextBlockContainer188" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:633px;height:16px;display:inline-block;"><div id="a23490" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">The following tables present the changes in equity,<div style="display:inline-block;width:5.44px"> </div>net of tax, for the three months ended March 31, 2021 and 2020:</div></div><div id="TextBlockContainer191" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:437px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a23546" style="position:absolute;font-weight:bold;font-style:normal;left:468.84px;top:0px;">Accumulated </div><div id="a23560" style="position:absolute;font-weight:bold;font-style:normal;left:325.773px;top:14.9px;">Capital in </div><div id="a23566" style="position:absolute;font-weight:bold;font-style:normal;left:489.48px;top:14.9px;">Other </div><div id="a23577" style="position:absolute;font-weight:bold;font-style:normal;left:262.253px;top:29.9px;">Common </div><div id="a23580" style="position:absolute;font-weight:bold;font-style:normal;left:328.013px;top:29.9px;">Excess of </div><div id="a23583" style="position:absolute;font-weight:bold;font-style:normal;left:399.08px;top:29.9px;">Retained </div><div id="a23585" style="position:absolute;font-weight:bold;font-style:normal;left:459.72px;top:29.9px;">Comprehensive </div><div id="a23588" style="position:absolute;font-weight:bold;font-style:normal;left:557.16px;top:29.9px;">Noncontrolling </div><div id="a23595" style="position:absolute;font-weight:bold;font-style:normal;left:272.653px;top:45px;">Stock </div><div id="a23598" style="position:absolute;font-weight:bold;font-style:normal;left:325.293px;top:45px;">Par Value </div><div id="a23601" style="position:absolute;font-weight:bold;font-style:normal;left:398.6px;top:45px;">Earnings </div><div id="a23604" style="position:absolute;font-weight:bold;font-style:normal;left:493.64px;top:45px;">Loss </div><div id="a23607" style="position:absolute;font-weight:bold;font-style:normal;left:575.44px;top:45px;">Interest </div><div id="a23610" style="position:absolute;font-weight:bold;font-style:normal;left:669.36px;top:45px;">Total </div><div id="a23612" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:61.6px;">Balance at December 31, 2020 </div><div id="a23614" style="position:absolute;font-weight:normal;font-style:normal;left:260.493px;top:61.1px;">$ </div><div id="a23616" style="position:absolute;left:276.013px;top:61.6px;">17,851</div><div id="a23619" style="position:absolute;font-weight:normal;font-style:normal;left:323.533px;top:61.1px;">$ </div><div id="a23621" style="position:absolute;left:337.293px;top:61.6px;">905,171</div><div id="a23624" style="position:absolute;font-weight:normal;font-style:normal;left:391.533px;top:61.1px;">$ </div><div id="a23626" style="position:absolute;left:410.28px;top:61.6px;">423,940</div><div id="a23629" style="position:absolute;font-weight:normal;font-style:normal;left:464.52px;top:61.1px;">$ </div><div id="a23631" style="position:absolute;left:503.08px;top:61.6px;">(26,598)</div><div id="a23634" style="position:absolute;font-weight:normal;font-style:normal;left:555.56px;top:61.1px;">$ </div><div id="a23636" style="position:absolute;left:615.76px;top:61.6px;">550</div><div id="a23639" style="position:absolute;font-weight:normal;font-style:normal;left:646.48px;top:61.1px;">$ </div><div id="a23641" style="position:absolute;left:665.36px;top:61.6px;">1,320,914</div><div id="a23644" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:78.6px;">Net income </div><div id="a23647" style="position:absolute;left:299.373px;top:78.6px;">—</div><div id="a23651" style="position:absolute;left:367.373px;top:78.6px;">—</div><div id="a23655" style="position:absolute;left:417px;top:78.6px;">38,615</div><div id="a23659" style="position:absolute;left:531.4px;top:78.6px;">—</div><div id="a23663" style="position:absolute;left:622.48px;top:78.6px;">17</div><div id="a23667" style="position:absolute;left:682px;top:78.6px;">38,632</div><div id="a23670" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:95.7px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a23691" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:112.6px;">loss </div><div id="a23694" style="position:absolute;left:299.373px;top:112.6px;">—</div><div id="a23698" style="position:absolute;left:367.373px;top:112.6px;">—</div><div id="a23702" style="position:absolute;left:440.36px;top:112.6px;">—</div><div id="a23706" style="position:absolute;left:503.08px;top:112.6px;">(26,630)</div><div id="a23710" style="position:absolute;left:624.24px;top:112.6px;">(2)</div><div id="a23714" style="position:absolute;left:677.04px;top:112.6px;">(26,632)</div><div id="a23717" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:129.6px;">Dividends ($</div><div id="a23717_12_5" style="position:absolute;left:83.786px;top:129.6px;">0.395</div><div id="a23717_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:129.6px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a23720" style="position:absolute;left:299.373px;top:129.6px;">—</div><div id="a23724" style="position:absolute;left:367.373px;top:129.6px;">—</div><div id="a23728" style="position:absolute;left:418.76px;top:129.6px;">(7,062)</div><div id="a23732" style="position:absolute;left:531.4px;top:129.6px;">—</div><div id="a23736" style="position:absolute;left:622.48px;top:129.6px;">—</div><div id="a23740" style="position:absolute;left:683.76px;top:129.6px;">(7,062)</div><div id="a23743" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:146.6px;">Share issuance and equity-based </div><div id="a23766" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:163.7px;">compensation plans </div><div id="a23769" style="position:absolute;left:299.373px;top:163.7px;">24</div><div id="a23773" style="position:absolute;left:350.573px;top:163.7px;">3,577</div><div id="a23777" style="position:absolute;left:440.36px;top:163.7px;">—</div><div id="a23781" style="position:absolute;left:531.4px;top:163.7px;">—</div><div id="a23785" style="position:absolute;left:622.48px;top:163.7px;">—</div><div id="a23789" style="position:absolute;left:688.56px;top:163.7px;">3,601</div><div id="a23791" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:181.6px;">Balance at March 31, 2021 </div><div id="a23793" style="position:absolute;font-weight:normal;font-style:normal;left:260.493px;top:180.7px;">$ </div><div id="a23795" style="position:absolute;left:276.013px;top:181.6px;">17,875</div><div id="a23798" style="position:absolute;font-weight:normal;font-style:normal;left:323.533px;top:180.7px;">$ </div><div id="a23800" style="position:absolute;left:337.293px;top:181.6px;">908,748</div><div id="a23803" style="position:absolute;font-weight:normal;font-style:normal;left:391.533px;top:180.7px;">$ </div><div id="a23805" style="position:absolute;left:410.28px;top:181.6px;">455,493</div><div id="a23808" style="position:absolute;font-weight:normal;font-style:normal;left:464.52px;top:180.7px;">$ </div><div id="a23810" style="position:absolute;left:503.08px;top:181.6px;">(53,228)</div><div id="a23813" style="position:absolute;font-weight:normal;font-style:normal;left:555.56px;top:180.7px;">$ </div><div id="a23815" style="position:absolute;left:615.76px;top:181.6px;">565</div><div id="a23818" style="position:absolute;font-weight:normal;font-style:normal;left:646.48px;top:180.7px;">$ </div><div id="a23820" style="position:absolute;left:665.36px;top:181.6px;">1,329,453</div><div id="a23842" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:216.7px;">Balance at December 31, 2019 </div><div id="a23844" style="position:absolute;font-weight:normal;font-style:normal;left:260.493px;top:215.9px;">$ </div><div id="a23846" style="position:absolute;left:276.013px;top:216.7px;">17,735</div><div id="a23849" style="position:absolute;font-weight:normal;font-style:normal;left:323.533px;top:215.9px;">$ </div><div id="a23851" style="position:absolute;left:337.293px;top:216.7px;">888,218</div><div id="a23854" style="position:absolute;font-weight:normal;font-style:normal;left:391.533px;top:215.9px;">$ </div><div id="a23856" style="position:absolute;left:410.28px;top:216.7px;">412,979</div><div id="a23859" style="position:absolute;font-weight:normal;font-style:normal;left:464.52px;top:215.9px;">$ </div><div id="a23861" style="position:absolute;left:503.08px;top:216.7px;">(78,170)</div><div id="a23864" style="position:absolute;font-weight:normal;font-style:normal;left:555.56px;top:215.9px;">$ </div><div id="a23866" style="position:absolute;left:605.68px;top:216.7px;">1,604</div><div id="a23869" style="position:absolute;font-weight:normal;font-style:normal;left:646.48px;top:215.9px;">$ </div><div id="a23871" style="position:absolute;left:665.36px;top:216.7px;">1,242,366</div><div id="a23874" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:233.6px;">Cumulative effect of an accounting change </div><div id="a23877" style="position:absolute;left:299.373px;top:233.6px;">—</div><div id="a23881" style="position:absolute;left:367.373px;top:233.6px;">—</div><div id="a23885" style="position:absolute;left:428.68px;top:233.6px;">(402)</div><div id="a23889" style="position:absolute;left:531.4px;top:233.6px;">—</div><div id="a23893" style="position:absolute;left:622.48px;top:233.6px;">—</div><div id="a23897" style="position:absolute;left:693.68px;top:233.6px;">(402)</div><div id="a23899" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:250.6px;">Balance at January 1, 2020 </div><div id="a23902" style="position:absolute;left:276.013px;top:250.6px;">17,735</div><div id="a23906" style="position:absolute;left:337.293px;top:250.6px;">888,218</div><div id="a23910" style="position:absolute;left:410.28px;top:250.6px;">412,577</div><div id="a23914" style="position:absolute;left:503.08px;top:250.6px;">(78,170)</div><div id="a23918" style="position:absolute;left:605.68px;top:250.6px;">1,604</div><div id="a23922" style="position:absolute;left:665.36px;top:250.6px;">1,241,964</div><div id="a23925" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:267.7px;">Net (loss) income </div><div id="a23928" style="position:absolute;left:299.373px;top:267.7px;">—</div><div id="a23932" style="position:absolute;left:367.373px;top:267.7px;">—</div><div id="a23936" style="position:absolute;left:412.04px;top:267.7px;">(28,381)</div><div id="a23940" style="position:absolute;left:531.4px;top:267.7px;">—</div><div id="a23944" style="position:absolute;left:622.48px;top:267.7px;">37</div><div id="a23948" style="position:absolute;left:677.04px;top:267.7px;">(28,344)</div><div id="a23951" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:284.7px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a23972" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:301.6px;"><div style="display:inline-block;width:3.36px"> </div>loss </div><div id="a23976" style="position:absolute;left:299.373px;top:301.6px;">—</div><div id="a23980" style="position:absolute;left:367.373px;top:301.6px;">—</div><div id="a23984" style="position:absolute;left:440.36px;top:301.6px;">—</div><div id="a23988" style="position:absolute;left:503.08px;top:301.6px;">(43,354)</div><div id="a23992" style="position:absolute;left:610.8px;top:301.6px;">(132)</div><div id="a23996" style="position:absolute;left:677.04px;top:301.6px;">(43,486)</div><div id="a23999" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:318.6px;">Dividends ($</div><div id="a23999_12_5" style="position:absolute;left:83.786px;top:318.6px;">0.385</div><div id="a23999_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:318.6px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a24002" style="position:absolute;left:299.373px;top:318.6px;">—</div><div id="a24006" style="position:absolute;left:367.373px;top:318.6px;">—</div><div id="a24010" style="position:absolute;left:418.76px;top:318.6px;">(6,834)</div><div id="a24014" style="position:absolute;left:531.4px;top:318.6px;">—</div><div id="a24018" style="position:absolute;left:622.48px;top:318.6px;">—</div><div id="a24022" style="position:absolute;left:683.76px;top:318.6px;">(6,834)</div><div id="a24025" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:335.7px;">Acquisition of noncontrolling interest </div><div id="a24028" style="position:absolute;left:299.373px;top:335.7px;">—</div><div id="a24032" style="position:absolute;left:355.693px;top:335.7px;">(707)</div><div id="a24036" style="position:absolute;left:440.36px;top:335.7px;">—</div><div id="a24040" style="position:absolute;left:531.4px;top:335.7px;">—</div><div id="a24044" style="position:absolute;left:610.8px;top:335.7px;">(340)</div><div id="a24048" style="position:absolute;left:683.76px;top:335.7px;">(1,047)</div><div id="a24051" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:352.7px;">Distributions to noncontrolling affiliate<div style="display:inline-block;width:4.46px"> </div></div><div id="a24072" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:369.6px;">shareholders </div><div id="a24075" style="position:absolute;left:299.373px;top:369.6px;">—</div><div id="a24079" style="position:absolute;left:367.373px;top:369.6px;">—</div><div id="a24083" style="position:absolute;left:440.36px;top:369.6px;">—</div><div id="a24087" style="position:absolute;left:531.4px;top:369.6px;">—</div><div id="a24091" style="position:absolute;left:610.8px;top:369.6px;">(751)</div><div id="a24095" style="position:absolute;left:693.68px;top:369.6px;">(751)</div><div id="a24098" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:386.6px;">Share issuance and equity-based </div><div id="a24121" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:403.7px;">compensation plans </div><div id="a24124" style="position:absolute;left:299.373px;top:403.7px;">17</div><div id="a24128" style="position:absolute;left:350.573px;top:403.7px;">1,022</div><div id="a24132" style="position:absolute;left:440.36px;top:403.7px;">—</div><div id="a24136" style="position:absolute;left:531.4px;top:403.7px;">—</div><div id="a24140" style="position:absolute;left:622.48px;top:403.7px;">—</div><div id="a24144" style="position:absolute;left:688.56px;top:403.7px;">1,039</div><div id="a24146" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:421.7px;">Balance at March 31, 2020 </div><div id="a24148" style="position:absolute;font-weight:normal;font-style:normal;left:260.493px;top:420.7px;">$ </div><div id="a24150" style="position:absolute;left:276.013px;top:421.7px;">17,752</div><div id="a24153" style="position:absolute;font-weight:normal;font-style:normal;left:323.533px;top:421.7px;">$ </div><div id="a24155" style="position:absolute;left:337.293px;top:421.7px;">888,533</div><div id="a24158" style="position:absolute;font-weight:normal;font-style:normal;left:391.533px;top:420.7px;">$ </div><div id="a24160" style="position:absolute;left:410.28px;top:421.7px;">377,362</div><div id="a24163" style="position:absolute;font-weight:normal;font-style:normal;left:464.52px;top:420.7px;">$ </div><div id="a24165" style="position:absolute;left:496.52px;top:421.7px;">(121,524)</div><div id="a24168" style="position:absolute;font-weight:normal;font-style:normal;left:555.56px;top:420.7px;">$ </div><div id="a24170" style="position:absolute;left:615.76px;top:421.7px;">418</div><div id="a24173" style="position:absolute;font-weight:normal;font-style:normal;left:646.48px;top:420.7px;">$ </div><div id="a24175" style="position:absolute;left:665.36px;top:421.7px;">1,162,541</div></div><div id="TextBlockContainer194" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:724px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24228" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The following tables show the reclassifications from and<div style="display:inline-block;width:4.68px"> </div>resulting balances of AOCI for the three months ended<div style="display:inline-block;width:4.73px"> </div>March 31, 2021 </div><div id="a24268" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">and 2020:</div></div><div id="TextBlockContainer197" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:358px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24278" style="position:absolute;font-weight:bold;font-style:normal;left:404.36px;top:0px;">Defined </div><div id="a24281" style="position:absolute;font-weight:bold;font-style:normal;left:485.96px;top:0px;">Unrealized </div><div id="a24291" style="position:absolute;font-weight:bold;font-style:normal;left:316.013px;top:17px;">Currency </div><div id="a24294" style="position:absolute;font-weight:bold;font-style:normal;left:406.12px;top:17px;">Benefit </div><div id="a24297" style="position:absolute;font-weight:bold;font-style:normal;left:476.84px;top:17px;">Gain (Loss) in<div style="display:inline-block;width:3.72px"> </div></div><div id="a24307" style="position:absolute;font-weight:bold;font-style:normal;left:310.093px;top:34.1px;">Translation </div><div id="a24311" style="position:absolute;font-weight:bold;font-style:normal;left:394.28px;top:34.1px;">Retirement </div><div id="a24314" style="position:absolute;font-weight:bold;font-style:normal;left:477.16px;top:34.1px;">Available-for<div style="display:inline-block;width:1.37px"> </div>- </div><div id="a24320" style="position:absolute;font-weight:bold;font-style:normal;left:580.4px;top:34.1px;">Derivative </div><div id="a24328" style="position:absolute;font-weight:bold;font-style:normal;left:307.213px;top:51px;">Adjustments </div><div id="a24331" style="position:absolute;font-weight:bold;font-style:normal;left:410.92px;top:51px;">Plans </div><div id="a24334" style="position:absolute;font-weight:bold;font-style:normal;left:475.88px;top:51px;">Sale Securities </div><div id="a24337" style="position:absolute;font-weight:bold;font-style:normal;left:575.28px;top:51px;">Instruments </div><div id="a24340" style="position:absolute;font-weight:bold;font-style:normal;left:674.8px;top:51px;">Total </div><div id="a24342" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:68px;">Balance at December 31, 2020 </div><div id="a24344" style="position:absolute;font-weight:normal;font-style:normal;left:305.453px;top:68px;">$ </div><div id="a24346" style="position:absolute;left:342.733px;top:68px;">(2,875)</div><div id="a24349" style="position:absolute;font-weight:normal;font-style:normal;left:388.493px;top:68px;">$ </div><div id="a24351" style="position:absolute;left:419.08px;top:68px;">(23,467)</div><div id="a24354" style="position:absolute;font-weight:normal;font-style:normal;left:471.56px;top:68px;">$ </div><div id="a24356" style="position:absolute;left:528.68px;top:68px;">3,342</div><div id="a24359" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:68px;">$ </div><div id="a24361" style="position:absolute;left:611.76px;top:68px;">(3,598)</div><div id="a24364" style="position:absolute;font-weight:normal;font-style:normal;left:657.52px;top:68px;">$ </div><div id="a24366" style="position:absolute;left:677.04px;top:68px;">(26,598)</div><div id="a24369" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:85px;">Other comprehensive (loss) income before </div><div id="a24388" style="position:absolute;font-weight:normal;font-style:normal;left:20.427px;top:104.2px;">reclassifications </div><div id="a24391" style="position:absolute;left:336.013px;top:104.2px;">(25,459)</div><div id="a24395" style="position:absolute;left:440.68px;top:104.2px;">781</div><div id="a24399" style="position:absolute;left:533.8px;top:104.2px;">(745)</div><div id="a24403" style="position:absolute;left:626.64px;top:104.2px;">730</div><div id="a24407" style="position:absolute;left:677.04px;top:104.2px;">(24,693)</div><div id="a24410" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:121.3px;">Amounts reclassified from AOCI </div><div id="a24413" style="position:absolute;left:364.333px;top:121.3px;">—</div><div id="a24417" style="position:absolute;left:440.68px;top:121.3px;">862</div><div id="a24421" style="position:absolute;left:523.88px;top:121.3px;">(3,085)</div><div id="a24425" style="position:absolute;left:633.36px;top:121.3px;">—</div><div id="a24429" style="position:absolute;left:683.76px;top:121.3px;">(2,223)</div><div id="a24432" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:138.2px;">Current period other comprehensive (loss) income </div><div id="a24435" style="position:absolute;left:336.013px;top:138.2px;">(25,459)</div><div id="a24439" style="position:absolute;left:430.6px;top:138.2px;">1,643</div><div id="a24443" style="position:absolute;left:523.88px;top:138.2px;">(3,830)</div><div id="a24447" style="position:absolute;left:626.64px;top:138.2px;">730</div><div id="a24451" style="position:absolute;left:677.04px;top:138.2px;">(26,916)</div><div id="a24454" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:155.2px;">Related tax amounts </div><div id="a24457" style="position:absolute;left:368.333px;top:155.2px;">—</div><div id="a24461" style="position:absolute;left:435.72px;top:155.2px;">(351)</div><div id="a24465" style="position:absolute;left:538.76px;top:155.2px;">805</div><div id="a24469" style="position:absolute;left:621.68px;top:155.2px;">(168)</div><div id="a24473" style="position:absolute;left:698.64px;top:155.2px;">286</div><div id="a24476" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:172.2px;">Net current period other comprehensive (loss) income </div><div id="a24479" style="position:absolute;left:336.013px;top:172.2px;">(25,459)</div><div id="a24483" style="position:absolute;left:430.6px;top:172.2px;">1,292</div><div id="a24487" style="position:absolute;left:523.88px;top:172.2px;">(3,025)</div><div id="a24491" style="position:absolute;left:626.64px;top:172.2px;">562</div><div id="a24495" style="position:absolute;left:677.04px;top:172.2px;">(26,630)</div><div id="a24497" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:189.3px;">Balance at March 31, 2021 </div><div id="a24501" style="position:absolute;font-weight:normal;font-style:normal;left:305.453px;top:189.3px;">$ </div><div id="a24503" style="position:absolute;left:336.013px;top:189.3px;">(28,334)</div><div id="a24506" style="position:absolute;font-weight:normal;font-style:normal;left:388.493px;top:189.3px;">$ </div><div id="a24508" style="position:absolute;left:419.08px;top:189.3px;">(22,175)</div><div id="a24511" style="position:absolute;font-weight:normal;font-style:normal;left:471.56px;top:189.3px;">$ </div><div id="a24513" style="position:absolute;left:538.76px;top:189.3px;">317</div><div id="a24516" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:189.3px;">$ </div><div id="a24518" style="position:absolute;left:611.76px;top:189.3px;">(3,036)</div><div id="a24521" style="position:absolute;font-weight:normal;font-style:normal;left:657.52px;top:189.3px;">$ </div><div id="a24523" style="position:absolute;left:677.04px;top:189.3px;">(53,228)</div><div id="a24542" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:223.2px;">Balance at December 31, 2019 </div><div id="a24545" style="position:absolute;font-weight:normal;font-style:normal;left:305.453px;top:223.2px;">$ </div><div id="a24547" style="position:absolute;left:336.013px;top:223.2px;">(44,568)</div><div id="a24550" style="position:absolute;font-weight:normal;font-style:normal;left:388.493px;top:223.2px;">$ </div><div id="a24552" style="position:absolute;left:419.08px;top:223.2px;">(34,533)</div><div id="a24555" style="position:absolute;font-weight:normal;font-style:normal;left:471.56px;top:223.2px;">$ </div><div id="a24557" style="position:absolute;left:528.68px;top:223.2px;">1,251</div><div id="a24560" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:223.2px;">$ </div><div id="a24562" style="position:absolute;left:621.68px;top:223.2px;">(320)</div><div id="a24565" style="position:absolute;font-weight:normal;font-style:normal;left:657.52px;top:223.2px;">$ </div><div id="a24567" style="position:absolute;left:677.04px;top:223.2px;">(78,170)</div><div id="a24570" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:240.2px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4.37px"> </div></div><div id="a24588" style="position:absolute;font-weight:normal;font-style:normal;left:20.427px;top:257.3px;">reclassifications </div><div id="a24591" style="position:absolute;left:336.013px;top:257.3px;">(54,619)</div><div id="a24595" style="position:absolute;left:440.68px;top:257.3px;">828</div><div id="a24599" style="position:absolute;left:523.88px;top:257.3px;">(2,135)</div><div id="a24603" style="position:absolute;left:611.76px;top:257.3px;">(5,170)</div><div id="a24607" style="position:absolute;left:677.04px;top:257.3px;">(61,096)</div><div id="a24610" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:274.3px;">Amounts reclassified from AOCI </div><div id="a24613" style="position:absolute;left:364.333px;top:274.3px;">—</div><div id="a24617" style="position:absolute;left:424.04px;top:274.3px;">24,366</div><div id="a24621" style="position:absolute;left:540.52px;top:274.3px;">(32)</div><div id="a24625" style="position:absolute;left:633.36px;top:274.3px;">—</div><div id="a24629" style="position:absolute;left:682px;top:274.3px;">24,334</div><div id="a24632" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:291.2px;">Current period other comprehensive (loss) income </div><div id="a24635" style="position:absolute;left:336.013px;top:291.2px;">(54,619)</div><div id="a24639" style="position:absolute;left:424.04px;top:291.2px;">25,194</div><div id="a24643" style="position:absolute;left:523.88px;top:291.2px;">(2,167)</div><div id="a24647" style="position:absolute;left:611.76px;top:291.2px;">(5,170)</div><div id="a24651" style="position:absolute;left:677.04px;top:291.2px;">(36,762)</div><div id="a24654" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:308.2px;">Related tax amounts </div><div id="a24657" style="position:absolute;left:364.333px;top:308.2px;">—</div><div id="a24661" style="position:absolute;left:425.8px;top:308.2px;">(8,237)</div><div id="a24665" style="position:absolute;left:538.76px;top:308.2px;">456</div><div id="a24669" style="position:absolute;left:616.56px;top:308.2px;">1,189</div><div id="a24673" style="position:absolute;left:683.76px;top:308.2px;">(6,592)</div><div id="a24676" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:325.3px;">Net current period other comprehensive (loss) income </div><div id="a24679" style="position:absolute;left:336.013px;top:325.3px;">(54,619)</div><div id="a24683" style="position:absolute;left:424.04px;top:325.3px;">16,957</div><div id="a24687" style="position:absolute;left:523.88px;top:325.3px;">(1,711)</div><div id="a24691" style="position:absolute;left:611.76px;top:325.3px;">(3,981)</div><div id="a24695" style="position:absolute;left:677.04px;top:325.3px;">(43,354)</div><div id="a24697" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:342.3px;">Balance at March 31, 2020 </div><div id="a24700" style="position:absolute;font-weight:normal;font-style:normal;left:305.453px;top:342.3px;">$ </div><div id="a24702" style="position:absolute;left:336.013px;top:342.3px;">(99,187)</div><div id="a24705" style="position:absolute;font-weight:normal;font-style:normal;left:388.493px;top:342.3px;">$ </div><div id="a24707" style="position:absolute;left:419.08px;top:342.3px;">(17,576)</div><div id="a24710" style="position:absolute;font-weight:normal;font-style:normal;left:471.56px;top:342.3px;">$ </div><div id="a24712" style="position:absolute;left:533.8px;top:342.3px;">(460)</div><div id="a24715" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:342.3px;">$ </div><div id="a24717" style="position:absolute;left:611.76px;top:342.3px;">(4,301)</div><div id="a24720" style="position:absolute;font-weight:normal;font-style:normal;left:657.52px;top:342.3px;">$ </div><div id="a24722" style="position:absolute;left:670.48px;top:342.3px;">(121,524)</div></div><div id="TextBlockContainer200" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:712px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24724" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">All reclassifications related to unrealized gain (loss) in<div style="display:inline-block;width:4.73px"> </div>available-for-sale securities relate to the Company’s<div style="display:inline-block;width:5.42px"> </div>equity interest in a </div><div id="a24765" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">captive insurance company and are recorded in equity<div style="display:inline-block;width:4.77px"> </div>in net income of associated companies.<div style="display:inline-block;width:7.56px"> </div>The amounts reported in other </div><div id="a24804" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">comprehensive income for non-controlling interest are<div style="display:inline-block;width:4.67px"> </div>related to currency translation adjustments.</div></div> <div id="TextBlockContainer192" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:437px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_190_XBRL_TS_0b8e732c4f1a45f5be23bc0024798004" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer191" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:437px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a23546" style="position:absolute;font-weight:bold;font-style:normal;left:468.84px;top:0px;">Accumulated </div><div id="a23560" style="position:absolute;font-weight:bold;font-style:normal;left:325.773px;top:14.9px;">Capital in </div><div id="a23566" style="position:absolute;font-weight:bold;font-style:normal;left:489.48px;top:14.9px;">Other </div><div id="a23577" style="position:absolute;font-weight:bold;font-style:normal;left:262.253px;top:29.9px;">Common </div><div id="a23580" style="position:absolute;font-weight:bold;font-style:normal;left:328.013px;top:29.9px;">Excess of </div><div id="a23583" style="position:absolute;font-weight:bold;font-style:normal;left:399.08px;top:29.9px;">Retained </div><div id="a23585" style="position:absolute;font-weight:bold;font-style:normal;left:459.72px;top:29.9px;">Comprehensive </div><div id="a23588" style="position:absolute;font-weight:bold;font-style:normal;left:557.16px;top:29.9px;">Noncontrolling </div><div id="a23595" style="position:absolute;font-weight:bold;font-style:normal;left:272.653px;top:45px;">Stock </div><div id="a23598" style="position:absolute;font-weight:bold;font-style:normal;left:325.293px;top:45px;">Par Value </div><div id="a23601" style="position:absolute;font-weight:bold;font-style:normal;left:398.6px;top:45px;">Earnings </div><div id="a23604" style="position:absolute;font-weight:bold;font-style:normal;left:493.64px;top:45px;">Loss </div><div id="a23607" style="position:absolute;font-weight:bold;font-style:normal;left:575.44px;top:45px;">Interest </div><div id="a23610" style="position:absolute;font-weight:bold;font-style:normal;left:669.36px;top:45px;">Total </div><div id="a23612" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:61.6px;">Balance at December 31, 2020 </div><div id="a23614" style="position:absolute;font-weight:normal;font-style:normal;left:260.493px;top:61.1px;">$ </div><div id="a23616" style="position:absolute;left:276.013px;top:61.6px;">17,851</div><div id="a23619" style="position:absolute;font-weight:normal;font-style:normal;left:323.533px;top:61.1px;">$ </div><div id="a23621" style="position:absolute;left:337.293px;top:61.6px;">905,171</div><div id="a23624" style="position:absolute;font-weight:normal;font-style:normal;left:391.533px;top:61.1px;">$ </div><div id="a23626" style="position:absolute;left:410.28px;top:61.6px;">423,940</div><div id="a23629" style="position:absolute;font-weight:normal;font-style:normal;left:464.52px;top:61.1px;">$ </div><div id="a23631" style="position:absolute;left:503.08px;top:61.6px;">(26,598)</div><div id="a23634" style="position:absolute;font-weight:normal;font-style:normal;left:555.56px;top:61.1px;">$ </div><div id="a23636" style="position:absolute;left:615.76px;top:61.6px;">550</div><div id="a23639" style="position:absolute;font-weight:normal;font-style:normal;left:646.48px;top:61.1px;">$ </div><div id="a23641" style="position:absolute;left:665.36px;top:61.6px;">1,320,914</div><div id="a23644" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:78.6px;">Net income </div><div id="a23647" style="position:absolute;left:299.373px;top:78.6px;">—</div><div id="a23651" style="position:absolute;left:367.373px;top:78.6px;">—</div><div id="a23655" style="position:absolute;left:417px;top:78.6px;">38,615</div><div id="a23659" style="position:absolute;left:531.4px;top:78.6px;">—</div><div id="a23663" style="position:absolute;left:622.48px;top:78.6px;">17</div><div id="a23667" style="position:absolute;left:682px;top:78.6px;">38,632</div><div id="a23670" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:95.7px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a23691" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:112.6px;">loss </div><div id="a23694" style="position:absolute;left:299.373px;top:112.6px;">—</div><div id="a23698" style="position:absolute;left:367.373px;top:112.6px;">—</div><div id="a23702" style="position:absolute;left:440.36px;top:112.6px;">—</div><div id="a23706" style="position:absolute;left:503.08px;top:112.6px;">(26,630)</div><div id="a23710" style="position:absolute;left:624.24px;top:112.6px;">(2)</div><div id="a23714" style="position:absolute;left:677.04px;top:112.6px;">(26,632)</div><div id="a23717" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:129.6px;">Dividends ($</div><div id="a23717_12_5" style="position:absolute;left:83.786px;top:129.6px;">0.395</div><div id="a23717_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:129.6px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a23720" style="position:absolute;left:299.373px;top:129.6px;">—</div><div id="a23724" style="position:absolute;left:367.373px;top:129.6px;">—</div><div id="a23728" style="position:absolute;left:418.76px;top:129.6px;">(7,062)</div><div id="a23732" style="position:absolute;left:531.4px;top:129.6px;">—</div><div id="a23736" style="position:absolute;left:622.48px;top:129.6px;">—</div><div id="a23740" style="position:absolute;left:683.76px;top:129.6px;">(7,062)</div><div id="a23743" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:146.6px;">Share issuance and equity-based </div><div id="a23766" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:163.7px;">compensation plans </div><div id="a23769" style="position:absolute;left:299.373px;top:163.7px;">24</div><div id="a23773" style="position:absolute;left:350.573px;top:163.7px;">3,577</div><div id="a23777" style="position:absolute;left:440.36px;top:163.7px;">—</div><div id="a23781" style="position:absolute;left:531.4px;top:163.7px;">—</div><div id="a23785" style="position:absolute;left:622.48px;top:163.7px;">—</div><div id="a23789" style="position:absolute;left:688.56px;top:163.7px;">3,601</div><div id="a23791" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:181.6px;">Balance at March 31, 2021 </div><div id="a23793" style="position:absolute;font-weight:normal;font-style:normal;left:260.493px;top:180.7px;">$ </div><div id="a23795" style="position:absolute;left:276.013px;top:181.6px;">17,875</div><div id="a23798" style="position:absolute;font-weight:normal;font-style:normal;left:323.533px;top:180.7px;">$ </div><div id="a23800" style="position:absolute;left:337.293px;top:181.6px;">908,748</div><div id="a23803" style="position:absolute;font-weight:normal;font-style:normal;left:391.533px;top:180.7px;">$ </div><div id="a23805" style="position:absolute;left:410.28px;top:181.6px;">455,493</div><div id="a23808" style="position:absolute;font-weight:normal;font-style:normal;left:464.52px;top:180.7px;">$ </div><div id="a23810" style="position:absolute;left:503.08px;top:181.6px;">(53,228)</div><div id="a23813" style="position:absolute;font-weight:normal;font-style:normal;left:555.56px;top:180.7px;">$ </div><div id="a23815" style="position:absolute;left:615.76px;top:181.6px;">565</div><div id="a23818" style="position:absolute;font-weight:normal;font-style:normal;left:646.48px;top:180.7px;">$ </div><div id="a23820" style="position:absolute;left:665.36px;top:181.6px;">1,329,453</div><div id="a23842" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:216.7px;">Balance at December 31, 2019 </div><div id="a23844" style="position:absolute;font-weight:normal;font-style:normal;left:260.493px;top:215.9px;">$ </div><div id="a23846" style="position:absolute;left:276.013px;top:216.7px;">17,735</div><div id="a23849" style="position:absolute;font-weight:normal;font-style:normal;left:323.533px;top:215.9px;">$ </div><div id="a23851" style="position:absolute;left:337.293px;top:216.7px;">888,218</div><div id="a23854" style="position:absolute;font-weight:normal;font-style:normal;left:391.533px;top:215.9px;">$ </div><div id="a23856" style="position:absolute;left:410.28px;top:216.7px;">412,979</div><div id="a23859" style="position:absolute;font-weight:normal;font-style:normal;left:464.52px;top:215.9px;">$ </div><div id="a23861" style="position:absolute;left:503.08px;top:216.7px;">(78,170)</div><div id="a23864" style="position:absolute;font-weight:normal;font-style:normal;left:555.56px;top:215.9px;">$ </div><div id="a23866" style="position:absolute;left:605.68px;top:216.7px;">1,604</div><div id="a23869" style="position:absolute;font-weight:normal;font-style:normal;left:646.48px;top:215.9px;">$ </div><div id="a23871" style="position:absolute;left:665.36px;top:216.7px;">1,242,366</div><div id="a23874" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:233.6px;">Cumulative effect of an accounting change </div><div id="a23877" style="position:absolute;left:299.373px;top:233.6px;">—</div><div id="a23881" style="position:absolute;left:367.373px;top:233.6px;">—</div><div id="a23885" style="position:absolute;left:428.68px;top:233.6px;">(402)</div><div id="a23889" style="position:absolute;left:531.4px;top:233.6px;">—</div><div id="a23893" style="position:absolute;left:622.48px;top:233.6px;">—</div><div id="a23897" style="position:absolute;left:693.68px;top:233.6px;">(402)</div><div id="a23899" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:250.6px;">Balance at January 1, 2020 </div><div id="a23902" style="position:absolute;left:276.013px;top:250.6px;">17,735</div><div id="a23906" style="position:absolute;left:337.293px;top:250.6px;">888,218</div><div id="a23910" style="position:absolute;left:410.28px;top:250.6px;">412,577</div><div id="a23914" style="position:absolute;left:503.08px;top:250.6px;">(78,170)</div><div id="a23918" style="position:absolute;left:605.68px;top:250.6px;">1,604</div><div id="a23922" style="position:absolute;left:665.36px;top:250.6px;">1,241,964</div><div id="a23925" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:267.7px;">Net (loss) income </div><div id="a23928" style="position:absolute;left:299.373px;top:267.7px;">—</div><div id="a23932" style="position:absolute;left:367.373px;top:267.7px;">—</div><div id="a23936" style="position:absolute;left:412.04px;top:267.7px;">(28,381)</div><div id="a23940" style="position:absolute;left:531.4px;top:267.7px;">—</div><div id="a23944" style="position:absolute;left:622.48px;top:267.7px;">37</div><div id="a23948" style="position:absolute;left:677.04px;top:267.7px;">(28,344)</div><div id="a23951" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:284.7px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4.32px"> </div></div><div id="a23972" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:301.6px;"><div style="display:inline-block;width:3.36px"> </div>loss </div><div id="a23976" style="position:absolute;left:299.373px;top:301.6px;">—</div><div id="a23980" style="position:absolute;left:367.373px;top:301.6px;">—</div><div id="a23984" style="position:absolute;left:440.36px;top:301.6px;">—</div><div id="a23988" style="position:absolute;left:503.08px;top:301.6px;">(43,354)</div><div id="a23992" style="position:absolute;left:610.8px;top:301.6px;">(132)</div><div id="a23996" style="position:absolute;left:677.04px;top:301.6px;">(43,486)</div><div id="a23999" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:318.6px;">Dividends ($</div><div id="a23999_12_5" style="position:absolute;left:83.786px;top:318.6px;">0.385</div><div id="a23999_17_12" style="position:absolute;font-weight:normal;font-style:normal;left:113.706px;top:318.6px;"><div style="display:inline-block;width:3.36px"> </div>per share) </div><div id="a24002" style="position:absolute;left:299.373px;top:318.6px;">—</div><div id="a24006" style="position:absolute;left:367.373px;top:318.6px;">—</div><div id="a24010" style="position:absolute;left:418.76px;top:318.6px;">(6,834)</div><div id="a24014" style="position:absolute;left:531.4px;top:318.6px;">—</div><div id="a24018" style="position:absolute;left:622.48px;top:318.6px;">—</div><div id="a24022" style="position:absolute;left:683.76px;top:318.6px;">(6,834)</div><div id="a24025" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:335.7px;">Acquisition of noncontrolling interest </div><div id="a24028" style="position:absolute;left:299.373px;top:335.7px;">—</div><div id="a24032" style="position:absolute;left:355.693px;top:335.7px;">(707)</div><div id="a24036" style="position:absolute;left:440.36px;top:335.7px;">—</div><div id="a24040" style="position:absolute;left:531.4px;top:335.7px;">—</div><div id="a24044" style="position:absolute;left:610.8px;top:335.7px;">(340)</div><div id="a24048" style="position:absolute;left:683.76px;top:335.7px;">(1,047)</div><div id="a24051" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:352.7px;">Distributions to noncontrolling affiliate<div style="display:inline-block;width:4.46px"> </div></div><div id="a24072" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:369.6px;">shareholders </div><div id="a24075" style="position:absolute;left:299.373px;top:369.6px;">—</div><div id="a24079" style="position:absolute;left:367.373px;top:369.6px;">—</div><div id="a24083" style="position:absolute;left:440.36px;top:369.6px;">—</div><div id="a24087" style="position:absolute;left:531.4px;top:369.6px;">—</div><div id="a24091" style="position:absolute;left:610.8px;top:369.6px;">(751)</div><div id="a24095" style="position:absolute;left:693.68px;top:369.6px;">(751)</div><div id="a24098" style="position:absolute;font-weight:normal;font-style:normal;left:14.347px;top:386.6px;">Share issuance and equity-based </div><div id="a24121" style="position:absolute;font-weight:normal;font-style:normal;left:24.427px;top:403.7px;">compensation plans </div><div id="a24124" style="position:absolute;left:299.373px;top:403.7px;">17</div><div id="a24128" style="position:absolute;left:350.573px;top:403.7px;">1,022</div><div id="a24132" style="position:absolute;left:440.36px;top:403.7px;">—</div><div id="a24136" style="position:absolute;left:531.4px;top:403.7px;">—</div><div id="a24140" style="position:absolute;left:622.48px;top:403.7px;">—</div><div id="a24144" style="position:absolute;left:688.56px;top:403.7px;">1,039</div><div id="a24146" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:421.7px;">Balance at March 31, 2020 </div><div id="a24148" style="position:absolute;font-weight:normal;font-style:normal;left:260.493px;top:420.7px;">$ </div><div id="a24150" style="position:absolute;left:276.013px;top:421.7px;">17,752</div><div id="a24153" style="position:absolute;font-weight:normal;font-style:normal;left:323.533px;top:421.7px;">$ </div><div id="a24155" style="position:absolute;left:337.293px;top:421.7px;">888,533</div><div id="a24158" style="position:absolute;font-weight:normal;font-style:normal;left:391.533px;top:420.7px;">$ </div><div id="a24160" style="position:absolute;left:410.28px;top:421.7px;">377,362</div><div id="a24163" style="position:absolute;font-weight:normal;font-style:normal;left:464.52px;top:420.7px;">$ </div><div id="a24165" style="position:absolute;left:496.52px;top:421.7px;">(121,524)</div><div id="a24168" style="position:absolute;font-weight:normal;font-style:normal;left:555.56px;top:420.7px;">$ </div><div id="a24170" style="position:absolute;left:615.76px;top:421.7px;">418</div><div id="a24173" style="position:absolute;font-weight:normal;font-style:normal;left:646.48px;top:420.7px;">$ </div><div id="a24175" style="position:absolute;left:665.36px;top:421.7px;">1,162,541</div></div></div></div> 17851000 905171000 423940000 -26598000 550000 1320914000 0 0 38615000 0 17000 38632000 0 0 0 -26630000 -2000 -26632000 0.395 0 0 7062000 0 0 7062000 24000 3577000 0 0 0 3601000 17875000 908748000 455493000 -53228000 565000 1329453000 17735000 888218000 412979000 -78170000 1604000 1242366000 0 0 -402000 0 0 -402000 17735000 888218000 412577000 -78170000 1604000 1241964000 0 0 -28381000 0 37000 -28344000 0 0 0 -43354000 -132000 -43486000 0.385 0 0 6834000 0 0 6834000 0 707000 0 0 340000 1047000 0 0 0 0 751000 751000 17000 1022000 0 0 0 1039000 17752000 888533000 377362000 -121524000 418000 1162541000 <div id="TextBlockContainer198" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:358px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_196_XBRL_TS_b56c2f72a37a4d35bb6cdf5979bcd19b" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer197" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:358px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24278" style="position:absolute;font-weight:bold;font-style:normal;left:404.36px;top:0px;">Defined </div><div id="a24281" style="position:absolute;font-weight:bold;font-style:normal;left:485.96px;top:0px;">Unrealized </div><div id="a24291" style="position:absolute;font-weight:bold;font-style:normal;left:316.013px;top:17px;">Currency </div><div id="a24294" style="position:absolute;font-weight:bold;font-style:normal;left:406.12px;top:17px;">Benefit </div><div id="a24297" style="position:absolute;font-weight:bold;font-style:normal;left:476.84px;top:17px;">Gain (Loss) in<div style="display:inline-block;width:3.72px"> </div></div><div id="a24307" style="position:absolute;font-weight:bold;font-style:normal;left:310.093px;top:34.1px;">Translation </div><div id="a24311" style="position:absolute;font-weight:bold;font-style:normal;left:394.28px;top:34.1px;">Retirement </div><div id="a24314" style="position:absolute;font-weight:bold;font-style:normal;left:477.16px;top:34.1px;">Available-for<div style="display:inline-block;width:1.37px"> </div>- </div><div id="a24320" style="position:absolute;font-weight:bold;font-style:normal;left:580.4px;top:34.1px;">Derivative </div><div id="a24328" style="position:absolute;font-weight:bold;font-style:normal;left:307.213px;top:51px;">Adjustments </div><div id="a24331" style="position:absolute;font-weight:bold;font-style:normal;left:410.92px;top:51px;">Plans </div><div id="a24334" style="position:absolute;font-weight:bold;font-style:normal;left:475.88px;top:51px;">Sale Securities </div><div id="a24337" style="position:absolute;font-weight:bold;font-style:normal;left:575.28px;top:51px;">Instruments </div><div id="a24340" style="position:absolute;font-weight:bold;font-style:normal;left:674.8px;top:51px;">Total </div><div id="a24342" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:68px;">Balance at December 31, 2020 </div><div id="a24344" style="position:absolute;font-weight:normal;font-style:normal;left:305.453px;top:68px;">$ </div><div id="a24346" style="position:absolute;left:342.733px;top:68px;">(2,875)</div><div id="a24349" style="position:absolute;font-weight:normal;font-style:normal;left:388.493px;top:68px;">$ </div><div id="a24351" style="position:absolute;left:419.08px;top:68px;">(23,467)</div><div id="a24354" style="position:absolute;font-weight:normal;font-style:normal;left:471.56px;top:68px;">$ </div><div id="a24356" style="position:absolute;left:528.68px;top:68px;">3,342</div><div id="a24359" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:68px;">$ </div><div id="a24361" style="position:absolute;left:611.76px;top:68px;">(3,598)</div><div id="a24364" style="position:absolute;font-weight:normal;font-style:normal;left:657.52px;top:68px;">$ </div><div id="a24366" style="position:absolute;left:677.04px;top:68px;">(26,598)</div><div id="a24369" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:85px;">Other comprehensive (loss) income before </div><div id="a24388" style="position:absolute;font-weight:normal;font-style:normal;left:20.427px;top:104.2px;">reclassifications </div><div id="a24391" style="position:absolute;left:336.013px;top:104.2px;">(25,459)</div><div id="a24395" style="position:absolute;left:440.68px;top:104.2px;">781</div><div id="a24399" style="position:absolute;left:533.8px;top:104.2px;">(745)</div><div id="a24403" style="position:absolute;left:626.64px;top:104.2px;">730</div><div id="a24407" style="position:absolute;left:677.04px;top:104.2px;">(24,693)</div><div id="a24410" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:121.3px;">Amounts reclassified from AOCI </div><div id="a24413" style="position:absolute;left:364.333px;top:121.3px;">—</div><div id="a24417" style="position:absolute;left:440.68px;top:121.3px;">862</div><div id="a24421" style="position:absolute;left:523.88px;top:121.3px;">(3,085)</div><div id="a24425" style="position:absolute;left:633.36px;top:121.3px;">—</div><div id="a24429" style="position:absolute;left:683.76px;top:121.3px;">(2,223)</div><div id="a24432" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:138.2px;">Current period other comprehensive (loss) income </div><div id="a24435" style="position:absolute;left:336.013px;top:138.2px;">(25,459)</div><div id="a24439" style="position:absolute;left:430.6px;top:138.2px;">1,643</div><div id="a24443" style="position:absolute;left:523.88px;top:138.2px;">(3,830)</div><div id="a24447" style="position:absolute;left:626.64px;top:138.2px;">730</div><div id="a24451" style="position:absolute;left:677.04px;top:138.2px;">(26,916)</div><div id="a24454" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:155.2px;">Related tax amounts </div><div id="a24457" style="position:absolute;left:368.333px;top:155.2px;">—</div><div id="a24461" style="position:absolute;left:435.72px;top:155.2px;">(351)</div><div id="a24465" style="position:absolute;left:538.76px;top:155.2px;">805</div><div id="a24469" style="position:absolute;left:621.68px;top:155.2px;">(168)</div><div id="a24473" style="position:absolute;left:698.64px;top:155.2px;">286</div><div id="a24476" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:172.2px;">Net current period other comprehensive (loss) income </div><div id="a24479" style="position:absolute;left:336.013px;top:172.2px;">(25,459)</div><div id="a24483" style="position:absolute;left:430.6px;top:172.2px;">1,292</div><div id="a24487" style="position:absolute;left:523.88px;top:172.2px;">(3,025)</div><div id="a24491" style="position:absolute;left:626.64px;top:172.2px;">562</div><div id="a24495" style="position:absolute;left:677.04px;top:172.2px;">(26,630)</div><div id="a24497" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:189.3px;">Balance at March 31, 2021 </div><div id="a24501" style="position:absolute;font-weight:normal;font-style:normal;left:305.453px;top:189.3px;">$ </div><div id="a24503" style="position:absolute;left:336.013px;top:189.3px;">(28,334)</div><div id="a24506" style="position:absolute;font-weight:normal;font-style:normal;left:388.493px;top:189.3px;">$ </div><div id="a24508" style="position:absolute;left:419.08px;top:189.3px;">(22,175)</div><div id="a24511" style="position:absolute;font-weight:normal;font-style:normal;left:471.56px;top:189.3px;">$ </div><div id="a24513" style="position:absolute;left:538.76px;top:189.3px;">317</div><div id="a24516" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:189.3px;">$ </div><div id="a24518" style="position:absolute;left:611.76px;top:189.3px;">(3,036)</div><div id="a24521" style="position:absolute;font-weight:normal;font-style:normal;left:657.52px;top:189.3px;">$ </div><div id="a24523" style="position:absolute;left:677.04px;top:189.3px;">(53,228)</div><div id="a24542" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:223.2px;">Balance at December 31, 2019 </div><div id="a24545" style="position:absolute;font-weight:normal;font-style:normal;left:305.453px;top:223.2px;">$ </div><div id="a24547" style="position:absolute;left:336.013px;top:223.2px;">(44,568)</div><div id="a24550" style="position:absolute;font-weight:normal;font-style:normal;left:388.493px;top:223.2px;">$ </div><div id="a24552" style="position:absolute;left:419.08px;top:223.2px;">(34,533)</div><div id="a24555" style="position:absolute;font-weight:normal;font-style:normal;left:471.56px;top:223.2px;">$ </div><div id="a24557" style="position:absolute;left:528.68px;top:223.2px;">1,251</div><div id="a24560" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:223.2px;">$ </div><div id="a24562" style="position:absolute;left:621.68px;top:223.2px;">(320)</div><div id="a24565" style="position:absolute;font-weight:normal;font-style:normal;left:657.52px;top:223.2px;">$ </div><div id="a24567" style="position:absolute;left:677.04px;top:223.2px;">(78,170)</div><div id="a24570" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:240.2px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4.37px"> </div></div><div id="a24588" style="position:absolute;font-weight:normal;font-style:normal;left:20.427px;top:257.3px;">reclassifications </div><div id="a24591" style="position:absolute;left:336.013px;top:257.3px;">(54,619)</div><div id="a24595" style="position:absolute;left:440.68px;top:257.3px;">828</div><div id="a24599" style="position:absolute;left:523.88px;top:257.3px;">(2,135)</div><div id="a24603" style="position:absolute;left:611.76px;top:257.3px;">(5,170)</div><div id="a24607" style="position:absolute;left:677.04px;top:257.3px;">(61,096)</div><div id="a24610" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:274.3px;">Amounts reclassified from AOCI </div><div id="a24613" style="position:absolute;left:364.333px;top:274.3px;">—</div><div id="a24617" style="position:absolute;left:424.04px;top:274.3px;">24,366</div><div id="a24621" style="position:absolute;left:540.52px;top:274.3px;">(32)</div><div id="a24625" style="position:absolute;left:633.36px;top:274.3px;">—</div><div id="a24629" style="position:absolute;left:682px;top:274.3px;">24,334</div><div id="a24632" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:291.2px;">Current period other comprehensive (loss) income </div><div id="a24635" style="position:absolute;left:336.013px;top:291.2px;">(54,619)</div><div id="a24639" style="position:absolute;left:424.04px;top:291.2px;">25,194</div><div id="a24643" style="position:absolute;left:523.88px;top:291.2px;">(2,167)</div><div id="a24647" style="position:absolute;left:611.76px;top:291.2px;">(5,170)</div><div id="a24651" style="position:absolute;left:677.04px;top:291.2px;">(36,762)</div><div id="a24654" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:308.2px;">Related tax amounts </div><div id="a24657" style="position:absolute;left:364.333px;top:308.2px;">—</div><div id="a24661" style="position:absolute;left:425.8px;top:308.2px;">(8,237)</div><div id="a24665" style="position:absolute;left:538.76px;top:308.2px;">456</div><div id="a24669" style="position:absolute;left:616.56px;top:308.2px;">1,189</div><div id="a24673" style="position:absolute;left:683.76px;top:308.2px;">(6,592)</div><div id="a24676" style="position:absolute;font-weight:normal;font-style:normal;left:12.427px;top:325.3px;">Net current period other comprehensive (loss) income </div><div id="a24679" style="position:absolute;left:336.013px;top:325.3px;">(54,619)</div><div id="a24683" style="position:absolute;left:424.04px;top:325.3px;">16,957</div><div id="a24687" style="position:absolute;left:523.88px;top:325.3px;">(1,711)</div><div id="a24691" style="position:absolute;left:611.76px;top:325.3px;">(3,981)</div><div id="a24695" style="position:absolute;left:677.04px;top:325.3px;">(43,354)</div><div id="a24697" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:342.3px;">Balance at March 31, 2020 </div><div id="a24700" style="position:absolute;font-weight:normal;font-style:normal;left:305.453px;top:342.3px;">$ </div><div id="a24702" style="position:absolute;left:336.013px;top:342.3px;">(99,187)</div><div id="a24705" style="position:absolute;font-weight:normal;font-style:normal;left:388.493px;top:342.3px;">$ </div><div id="a24707" style="position:absolute;left:419.08px;top:342.3px;">(17,576)</div><div id="a24710" style="position:absolute;font-weight:normal;font-style:normal;left:471.56px;top:342.3px;">$ </div><div id="a24712" style="position:absolute;left:533.8px;top:342.3px;">(460)</div><div id="a24715" style="position:absolute;font-weight:normal;font-style:normal;left:569.52px;top:342.3px;">$ </div><div id="a24717" style="position:absolute;left:611.76px;top:342.3px;">(4,301)</div><div id="a24720" style="position:absolute;font-weight:normal;font-style:normal;left:657.52px;top:342.3px;">$ </div><div id="a24722" style="position:absolute;left:670.48px;top:342.3px;">(121,524)</div></div></div></div> -2875000 -23467000 3342000 -3598000 -26598000 -25459000 781000 -745000 730000 -24693000 0 862000 -3085000 0 -2223000 -25459000 1643000 -3830000 730000 -26916000 0 -351000 805000 -168000 286000 -25459000 1292000 -3025000 562000 -26630000 -28334000 -22175000 317000 -3036000 -53228000 -44568000 -34533000 1251000 -320000 -78170000 -54619000 828000 -2135000 -5170000 -61096000 0 24366000 -32000 0 24334000 -54619000 25194000 -2167000 -5170000 -36762000 0 -8237000 456000 1189000 -6592000 -54619000 16957000 -1711000 -3981000 -43354000 -99187000 -17576000 -460000 -4301000 -121524000 <div id="TextBlockContainer202" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:674px;height:55px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24828" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 17 – Fair Value<div style="display:inline-block;width:5.24px"> </div>Measurements</div><div id="a24839" style="position:absolute;font-weight:normal;font-style:normal;left:209.253px;top:0px;"> </div><div id="a24840" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company has valued its company-owned life insurance<div style="display:inline-block;width:4.69px"> </div>policies at fair value.<div style="display:inline-block;width:7.23px"> </div>These assets are subject to fair value </div><div id="a24880" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">measurement as follows:</div></div><div id="TextBlockContainer206" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_204_XBRL_TS_8409ced421f94676af9b49f5f58e72bf" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer205" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24891" style="position:absolute;font-weight:bold;font-style:normal;left:450.76px;top:0px;">Fair Value<div style="display:inline-block;width:4.84px"> </div>Measurements at March 31, 2021 </div><div id="a24897" style="position:absolute;font-weight:bold;font-style:normal;left:373.773px;top:15px;">Total </div><div id="a24900" style="position:absolute;font-weight:bold;font-style:normal;left:503.72px;top:15px;">Using Fair Value<div style="display:inline-block;width:4.89px"> </div>Hierarchy </div><div id="a24902" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Assets </div><div id="a24904" style="position:absolute;font-weight:bold;font-style:normal;left:358.413px;top:30.7px;">Fair Value </div><div id="a24907" style="position:absolute;font-weight:bold;font-style:normal;left:465.48px;top:30.7px;">Level 1 </div><div id="a24910" style="position:absolute;font-weight:bold;font-style:normal;left:562.44px;top:30.7px;">Level 2 </div><div id="a24913" style="position:absolute;font-weight:bold;font-style:normal;left:659.44px;top:30.7px;">Level 3 </div><div id="a24915" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.6px;">Company-owned life insurance </div><div id="a24919" style="position:absolute;font-weight:normal;font-style:normal;left:346.413px;top:46.6px;">$ </div><div id="a24921" style="position:absolute;left:401.48px;top:46.6px;">2,015</div><div id="a24924" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:46.6px;">$ </div><div id="a24926" style="position:absolute;left:515.4px;top:46.6px;">—</div><div id="a24929" style="position:absolute;font-weight:normal;font-style:normal;left:540.52px;top:46.6px;">$ </div><div id="a24931" style="position:absolute;left:595.6px;top:46.6px;">2,015</div><div id="a24934" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:46.6px;">$ </div><div id="a24936" style="position:absolute;left:709.36px;top:46.6px;">—</div><div id="a24938" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.5px;">Total </div><div id="a24940" style="position:absolute;font-weight:normal;font-style:normal;left:346.413px;top:64.5px;">$ </div><div id="a24942" style="position:absolute;left:401.48px;top:64.5px;">2,015</div><div id="a24945" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:64.5px;">$ </div><div id="a24947" style="position:absolute;left:515.4px;top:64.5px;">—</div><div id="a24950" style="position:absolute;font-weight:normal;font-style:normal;left:540.52px;top:64.5px;">$ </div><div id="a24952" style="position:absolute;left:595.6px;top:64.5px;">2,015</div><div id="a24955" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:64.5px;">$ </div><div id="a24957" style="position:absolute;left:709.36px;top:64.5px;">—</div></div></div></div><div id="TextBlockContainer210" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_208_XBRL_TS_43e169c323bc403f919308537470c7ec" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer209" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24965" style="position:absolute;font-weight:bold;font-style:normal;left:441.16px;top:0px;">Fair Value<div style="display:inline-block;width:4.84px"> </div>Measurements at December 31, 2020 </div><div id="a24970" style="position:absolute;font-weight:bold;font-style:normal;left:373.773px;top:15px;">Total </div><div id="a24973" style="position:absolute;font-weight:bold;font-style:normal;left:503.72px;top:15px;">Using Fair Value<div style="display:inline-block;width:4.89px"> </div>Hierarchy </div><div id="a24975" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.8px;">Assets </div><div id="a24977" style="position:absolute;font-weight:bold;font-style:normal;left:358.413px;top:30.8px;">Fair Value </div><div id="a24980" style="position:absolute;font-weight:bold;font-style:normal;left:465.48px;top:30.8px;">Level 1 </div><div id="a24983" style="position:absolute;font-weight:bold;font-style:normal;left:562.44px;top:30.8px;">Level 2 </div><div id="a24986" style="position:absolute;font-weight:bold;font-style:normal;left:659.44px;top:30.8px;">Level 3 </div><div id="a24988" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.6px;">Company-owned life insurance<div style="display:inline-block;width:4.06px"> </div></div><div id="a24992" style="position:absolute;font-weight:normal;font-style:normal;left:346.413px;top:46.6px;">$ </div><div id="a24994" style="position:absolute;left:398.44px;top:46.6px;">1,961</div><div id="a24997" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:46.6px;">$ </div><div id="a24999" style="position:absolute;left:512.36px;top:46.6px;">—</div><div id="a25002" style="position:absolute;font-weight:normal;font-style:normal;left:540.52px;top:46.6px;">$ </div><div id="a25004" style="position:absolute;left:592.56px;top:46.6px;">1,961</div><div id="a25007" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:46.6px;">$ </div><div id="a25009" style="position:absolute;left:706.32px;top:46.6px;">—</div><div id="a25011" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.5px;">Total </div><div id="a25013" style="position:absolute;font-weight:normal;font-style:normal;left:346.413px;top:64.5px;">$ </div><div id="a25015" style="position:absolute;left:398.44px;top:64.5px;">1,961</div><div id="a25018" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:64.5px;">$ </div><div id="a25020" style="position:absolute;left:512.36px;top:64.5px;">—</div><div id="a25023" style="position:absolute;font-weight:normal;font-style:normal;left:540.52px;top:64.5px;">$ </div><div id="a25025" style="position:absolute;left:592.56px;top:64.5px;">1,961</div><div id="a25028" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:64.5px;">$ </div><div id="a25030" style="position:absolute;left:706.32px;top:64.5px;">—</div></div></div></div><div id="TextBlockContainer212" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:716px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25032" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">The fair values of Company-owned life insurance assets are based<div style="display:inline-block;width:4.81px"> </div>on quotes for like instruments with similar credit ratings and </div><div id="a25075" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">terms.<div style="display:inline-block;width:6.89px"> </div>The Company did not hold any Level 3 investments as of March<div style="display:inline-block;width:4.93px"> </div>31, 2021 or December 31, 2020, respectively,<div style="display:inline-block;width:5.31px"> </div>so related </div><div id="a25119" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">disclosures have not been included.</div></div> <div id="TextBlockContainer205" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:731px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24891" style="position:absolute;font-weight:bold;font-style:normal;left:450.76px;top:0px;">Fair Value<div style="display:inline-block;width:4.84px"> </div>Measurements at March 31, 2021 </div><div id="a24897" style="position:absolute;font-weight:bold;font-style:normal;left:373.773px;top:15px;">Total </div><div id="a24900" style="position:absolute;font-weight:bold;font-style:normal;left:503.72px;top:15px;">Using Fair Value<div style="display:inline-block;width:4.89px"> </div>Hierarchy </div><div id="a24902" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.7px;">Assets </div><div id="a24904" style="position:absolute;font-weight:bold;font-style:normal;left:358.413px;top:30.7px;">Fair Value </div><div id="a24907" style="position:absolute;font-weight:bold;font-style:normal;left:465.48px;top:30.7px;">Level 1 </div><div id="a24910" style="position:absolute;font-weight:bold;font-style:normal;left:562.44px;top:30.7px;">Level 2 </div><div id="a24913" style="position:absolute;font-weight:bold;font-style:normal;left:659.44px;top:30.7px;">Level 3 </div><div id="a24915" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.6px;">Company-owned life insurance </div><div id="a24919" style="position:absolute;font-weight:normal;font-style:normal;left:346.413px;top:46.6px;">$ </div><div id="a24921" style="position:absolute;left:401.48px;top:46.6px;">2,015</div><div id="a24924" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:46.6px;">$ </div><div id="a24926" style="position:absolute;left:515.4px;top:46.6px;">—</div><div id="a24929" style="position:absolute;font-weight:normal;font-style:normal;left:540.52px;top:46.6px;">$ </div><div id="a24931" style="position:absolute;left:595.6px;top:46.6px;">2,015</div><div id="a24934" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:46.6px;">$ </div><div id="a24936" style="position:absolute;left:709.36px;top:46.6px;">—</div><div id="a24938" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.5px;">Total </div><div id="a24940" style="position:absolute;font-weight:normal;font-style:normal;left:346.413px;top:64.5px;">$ </div><div id="a24942" style="position:absolute;left:401.48px;top:64.5px;">2,015</div><div id="a24945" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:64.5px;">$ </div><div id="a24947" style="position:absolute;left:515.4px;top:64.5px;">—</div><div id="a24950" style="position:absolute;font-weight:normal;font-style:normal;left:540.52px;top:64.5px;">$ </div><div id="a24952" style="position:absolute;left:595.6px;top:64.5px;">2,015</div><div id="a24955" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:64.5px;">$ </div><div id="a24957" style="position:absolute;left:709.36px;top:64.5px;">—</div></div><div id="TextBlockContainer209" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a24965" style="position:absolute;font-weight:bold;font-style:normal;left:441.16px;top:0px;">Fair Value<div style="display:inline-block;width:4.84px"> </div>Measurements at December 31, 2020 </div><div id="a24970" style="position:absolute;font-weight:bold;font-style:normal;left:373.773px;top:15px;">Total </div><div id="a24973" style="position:absolute;font-weight:bold;font-style:normal;left:503.72px;top:15px;">Using Fair Value<div style="display:inline-block;width:4.89px"> </div>Hierarchy </div><div id="a24975" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.8px;">Assets </div><div id="a24977" style="position:absolute;font-weight:bold;font-style:normal;left:358.413px;top:30.8px;">Fair Value </div><div id="a24980" style="position:absolute;font-weight:bold;font-style:normal;left:465.48px;top:30.8px;">Level 1 </div><div id="a24983" style="position:absolute;font-weight:bold;font-style:normal;left:562.44px;top:30.8px;">Level 2 </div><div id="a24986" style="position:absolute;font-weight:bold;font-style:normal;left:659.44px;top:30.8px;">Level 3 </div><div id="a24988" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:46.6px;">Company-owned life insurance<div style="display:inline-block;width:4.06px"> </div></div><div id="a24992" style="position:absolute;font-weight:normal;font-style:normal;left:346.413px;top:46.6px;">$ </div><div id="a24994" style="position:absolute;left:398.44px;top:46.6px;">1,961</div><div id="a24997" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:46.6px;">$ </div><div id="a24999" style="position:absolute;left:512.36px;top:46.6px;">—</div><div id="a25002" style="position:absolute;font-weight:normal;font-style:normal;left:540.52px;top:46.6px;">$ </div><div id="a25004" style="position:absolute;left:592.56px;top:46.6px;">1,961</div><div id="a25007" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:46.6px;">$ </div><div id="a25009" style="position:absolute;left:706.32px;top:46.6px;">—</div><div id="a25011" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:64.5px;">Total </div><div id="a25013" style="position:absolute;font-weight:normal;font-style:normal;left:346.413px;top:64.5px;">$ </div><div id="a25015" style="position:absolute;left:398.44px;top:64.5px;">1,961</div><div id="a25018" style="position:absolute;font-weight:normal;font-style:normal;left:443.56px;top:64.5px;">$ </div><div id="a25020" style="position:absolute;left:512.36px;top:64.5px;">—</div><div id="a25023" style="position:absolute;font-weight:normal;font-style:normal;left:540.52px;top:64.5px;">$ </div><div id="a25025" style="position:absolute;left:592.56px;top:64.5px;">1,961</div><div id="a25028" style="position:absolute;font-weight:normal;font-style:normal;left:637.52px;top:64.5px;">$ </div><div id="a25030" style="position:absolute;left:706.32px;top:64.5px;">—</div></div> 2015000 0 2015000 0 2015000 0 2015000 0 1961000 0 1961000 0 1961000 0 1961000 0 <div id="TextBlockContainer214" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:155px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25179" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 18 – Hedging Activities </div><div id="a25189" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">In order to satisfy certain requirements of the Credit<div style="display:inline-block;width:4.78px"> </div>Facility as well as to manage the Company’s<div style="display:inline-block;width:4.96px"> </div>exposure to variable interest </div><div id="a25231" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">rate risk associated with the Credit Facility,<div style="display:inline-block;width:5.22px"> </div>in November 2019, the Company entered into $</div><div id="a25231_91_5" style="position:absolute;left:494.76px;top:38.7px;">170.0</div><div id="a25231_96_35" style="position:absolute;font-weight:normal;font-style:normal;left:524.84px;top:38.7px;"><div style="display:inline-block;width:3.36px"> </div>million notional amounts of three-</div><div id="a25272" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">year interest rate swaps.<div style="display:inline-block;width:7.33px"> </div>See Note 15 of Notes to Condensed Consolidated Financial Statements.<div style="display:inline-block;width:8.23px"> </div>These interest rate swaps are </div><div id="a25310" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">designated as cash flow hedges and, as such, the contracts<div style="display:inline-block;width:4.78px"> </div>are marked-to-market at each reporting date and any unrealized gains<div style="display:inline-block;width:4.85px"> </div>or </div><div id="a25356" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">losses are included in AOCI to the extent effective<div style="display:inline-block;width:4.97px"> </div>and reclassified to interest expense in the period during which the<div style="display:inline-block;width:4.81px"> </div>transaction </div><div id="a25398" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">effects earnings or it becomes probable that<div style="display:inline-block;width:4.74px"> </div>the forecasted transaction will not occur.<div style="display:inline-block;width:4.83px"> </div></div><div id="a25425" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:123.4px;">The balance sheet classification and fair values of the<div style="display:inline-block;width:4.79px"> </div>Company’s derivative instruments,<div style="display:inline-block;width:4.74px"> </div>which are Level 2 measurements, are as </div><div id="a25463" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:138.7px;">follows:</div></div><div id="TextBlockContainer217" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:664px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25471" style="position:absolute;font-weight:bold;font-style:normal;left:535.88px;top:0px;">Fair Value </div><div id="a25477" style="position:absolute;font-weight:bold;font-style:normal;left:311.853px;top:18.1px;">Condensed Consolidated </div><div id="a25480" style="position:absolute;font-weight:bold;font-style:normal;left:487.72px;top:18.1px;">March 31,<div style="display:inline-block;width:3.93px"> </div></div><div id="a25483" style="position:absolute;font-weight:bold;font-style:normal;left:577.2px;top:18.1px;">December 31, </div><div id="a25489" style="position:absolute;font-weight:bold;font-style:normal;left:315.853px;top:35.2px;">Balance Sheet Location </div><div id="a25492" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:35.2px;">2021 </div><div id="a25495" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:35.2px;">2020 </div><div id="a25499" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:53.3px;">Derivatives designated as cash flow hedges: </div><div id="a25512" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:70.4px;">Interest rate swaps </div><div id="a25514" style="position:absolute;font-weight:normal;font-style:normal;left:302.413px;top:70.4px;">Other non-current liabilities </div><div id="a25519" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:70.4px;">$ </div><div id="a25521" style="position:absolute;left:526.44px;top:70.4px;">3,943</div><div id="a25524" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:70.4px;">$ </div><div id="a25526" style="position:absolute;left:625.52px;top:70.4px;">4,672</div><div id="a25535" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:88.8px;">$ </div><div id="a25537" style="position:absolute;left:526.44px;top:88.8px;">3,943</div><div id="a25540" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:88.8px;">$ </div><div id="a25542" style="position:absolute;left:625.52px;top:88.8px;">4,672</div></div><div id="TextBlockContainer220" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:389px;height:16px;display:inline-block;"><div id="a25545" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">The following table presents the net unrealized loss deferred to<div style="display:inline-block;width:4.8px"> </div>AOCI:</div></div><div id="TextBlockContainer224" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:664px;height:87px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_222_XBRL_TS_b34c985f90f84749aeca8c083ec9fd7a" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer223" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:664px;height:87px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25573" style="position:absolute;font-weight:bold;font-style:normal;left:487.72px;top:0px;">March 31,<div style="display:inline-block;width:3.93px"> </div></div><div id="a25576" style="position:absolute;font-weight:bold;font-style:normal;left:577.2px;top:0px;">December 31, </div><div id="a25584" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:17.6px;">2021 </div><div id="a25587" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17.6px;">2020 </div><div id="a25591" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:35.5px;">Derivatives designated as cash flow hedges: </div><div id="a25603" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:52.8px;">Interest rate swaps </div><div id="a25606" style="position:absolute;font-weight:normal;font-style:normal;left:312.493px;top:52.8px;">AOCI </div><div id="a25608" style="position:absolute;font-weight:normal;font-style:normal;left:477.8px;top:52.8px;">$ </div><div id="a25610" style="position:absolute;left:526.44px;top:52.8px;">3,036</div><div id="a25613" style="position:absolute;font-weight:normal;font-style:normal;left:576.88px;top:52.8px;">$ </div><div id="a25615" style="position:absolute;left:625.52px;top:52.8px;">3,598</div><div id="a25623" style="position:absolute;font-weight:normal;font-style:normal;left:477.8px;top:71.2px;">$ </div><div id="a25625" style="position:absolute;left:526.44px;top:71.2px;">3,036</div><div id="a25628" style="position:absolute;font-weight:normal;font-style:normal;left:576.88px;top:71.2px;">$ </div><div id="a25630" style="position:absolute;left:625.52px;top:71.2px;">3,598</div></div></div></div><div id="TextBlockContainer226" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:426px;height:16px;display:inline-block;"><div id="a25633" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:0px;">The following table presents the net gain reclassified from<div style="display:inline-block;width:4.7px"> </div>AOCI to earnings:</div></div><div id="TextBlockContainer229" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25662" style="position:absolute;font-weight:bold;font-style:normal;left:505.8px;top:0px;">Three Months Ended </div><div id="a25669" style="position:absolute;font-weight:bold;font-style:normal;left:537.2px;top:17px;">March 31,<div style="display:inline-block;width:3.89px"> </div></div><div id="a25676" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:34.3px;">2021 </div><div id="a25679" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:34.3px;">2020 </div><div id="a25683" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.4px;">Amount and location of (expense) income reclassified<div style="display:inline-block;width:7.95px"> </div></div><div id="a25694" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;"><div style="display:inline-block;width:3.39px"> </div>from AOCI into (expense) income (Effective Portion) </div><div id="a25698" style="position:absolute;font-weight:normal;font-style:normal;left:312.493px;top:68px;">Interest expense, net </div><div id="a25700" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:68px;">$ </div><div id="a25702" style="position:absolute;left:530.6px;top:68px;">(643)</div><div id="a25705" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:68px;">$ </div><div id="a25707" style="position:absolute;left:641.36px;top:68px;">19</div></div><div id="TextBlockContainer232" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:729px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25710" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;">Interest rate swaps are entered into with a limited number<div style="display:inline-block;width:4.77px"> </div>of counterparties, each of which allows for net settlement<div style="display:inline-block;width:4.71px"> </div>of all </div><div id="a25752" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:15.4px;">contracts through a single payment in a single currency<div style="display:inline-block;width:4.77px"> </div>in the event of a default on or termination of any one<div style="display:inline-block;width:4.72px"> </div>contract.<div style="display:inline-block;width:6.88px"> </div>As such, in </div><div id="a25802" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:30.6px;">accordance with the Company’s<div style="display:inline-block;width:4.75px"> </div>accounting policy,<div style="display:inline-block;width:4.73px"> </div>these derivative instruments are recorded on a net basis by<div style="display:inline-block;width:4.82px"> </div>counterparty within the </div><div id="a25840" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:45.9px;">Condensed Consolidated Balance Sheets.</div></div> 170000000.0 <div id="TextBlockContainer218" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:664px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_216_XBRL_TS_f138596a148a4525a2afc60fbd8414c5" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer217" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:664px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25471" style="position:absolute;font-weight:bold;font-style:normal;left:535.88px;top:0px;">Fair Value </div><div id="a25477" style="position:absolute;font-weight:bold;font-style:normal;left:311.853px;top:18.1px;">Condensed Consolidated </div><div id="a25480" style="position:absolute;font-weight:bold;font-style:normal;left:487.72px;top:18.1px;">March 31,<div style="display:inline-block;width:3.93px"> </div></div><div id="a25483" style="position:absolute;font-weight:bold;font-style:normal;left:577.2px;top:18.1px;">December 31, </div><div id="a25489" style="position:absolute;font-weight:bold;font-style:normal;left:315.853px;top:35.2px;">Balance Sheet Location </div><div id="a25492" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:35.2px;">2021 </div><div id="a25495" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:35.2px;">2020 </div><div id="a25499" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:53.3px;">Derivatives designated as cash flow hedges: </div><div id="a25512" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:70.4px;">Interest rate swaps </div><div id="a25514" style="position:absolute;font-weight:normal;font-style:normal;left:302.413px;top:70.4px;">Other non-current liabilities </div><div id="a25519" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:70.4px;">$ </div><div id="a25521" style="position:absolute;left:526.44px;top:70.4px;">3,943</div><div id="a25524" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:70.4px;">$ </div><div id="a25526" style="position:absolute;left:625.52px;top:70.4px;">4,672</div><div id="a25535" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:88.8px;">$ </div><div id="a25537" style="position:absolute;left:526.44px;top:88.8px;">3,943</div><div id="a25540" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:88.8px;">$ </div><div id="a25542" style="position:absolute;left:625.52px;top:88.8px;">4,672</div></div></div></div><div id="TextBlockContainer223" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:664px;height:87px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25573" style="position:absolute;font-weight:bold;font-style:normal;left:487.72px;top:0px;">March 31,<div style="display:inline-block;width:3.93px"> </div></div><div id="a25576" style="position:absolute;font-weight:bold;font-style:normal;left:577.2px;top:0px;">December 31, </div><div id="a25584" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:17.6px;">2021 </div><div id="a25587" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:17.6px;">2020 </div><div id="a25591" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:35.5px;">Derivatives designated as cash flow hedges: </div><div id="a25603" style="position:absolute;font-weight:normal;font-style:normal;left:16.459px;top:52.8px;">Interest rate swaps </div><div id="a25606" style="position:absolute;font-weight:normal;font-style:normal;left:312.493px;top:52.8px;">AOCI </div><div id="a25608" style="position:absolute;font-weight:normal;font-style:normal;left:477.8px;top:52.8px;">$ </div><div id="a25610" style="position:absolute;left:526.44px;top:52.8px;">3,036</div><div id="a25613" style="position:absolute;font-weight:normal;font-style:normal;left:576.88px;top:52.8px;">$ </div><div id="a25615" style="position:absolute;left:625.52px;top:52.8px;">3,598</div><div id="a25623" style="position:absolute;font-weight:normal;font-style:normal;left:477.8px;top:71.2px;">$ </div><div id="a25625" style="position:absolute;left:526.44px;top:71.2px;">3,036</div><div id="a25628" style="position:absolute;font-weight:normal;font-style:normal;left:576.88px;top:71.2px;">$ </div><div id="a25630" style="position:absolute;left:625.52px;top:71.2px;">3,598</div></div><div id="TextBlockContainer230" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_228_XBRL_TS_9cd7d881d88c45b18c4850de5902e395" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer229" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:663px;height:84px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25662" style="position:absolute;font-weight:bold;font-style:normal;left:505.8px;top:0px;">Three Months Ended </div><div id="a25669" style="position:absolute;font-weight:bold;font-style:normal;left:537.2px;top:17px;">March 31,<div style="display:inline-block;width:3.89px"> </div></div><div id="a25676" style="position:absolute;font-weight:bold;font-style:normal;left:503.56px;top:34.3px;">2021 </div><div id="a25679" style="position:absolute;font-weight:bold;font-style:normal;left:602.64px;top:34.3px;">2020 </div><div id="a25683" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:51.4px;">Amount and location of (expense) income reclassified<div style="display:inline-block;width:7.95px"> </div></div><div id="a25694" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:68px;"><div style="display:inline-block;width:3.39px"> </div>from AOCI into (expense) income (Effective Portion) </div><div id="a25698" style="position:absolute;font-weight:normal;font-style:normal;left:312.493px;top:68px;">Interest expense, net </div><div id="a25700" style="position:absolute;font-weight:normal;font-style:normal;left:474.44px;top:68px;">$ </div><div id="a25702" style="position:absolute;left:530.6px;top:68px;">(643)</div><div id="a25705" style="position:absolute;font-weight:normal;font-style:normal;left:573.52px;top:68px;">$ </div><div id="a25707" style="position:absolute;left:641.36px;top:68px;">19</div></div></div></div> 3943000 4672000 3943000 4672000 3036000 3598000 3036000 3598000 3598000 -643000 19000 <div id="TextBlockContainer234" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:270px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a25848" style="position:absolute;font-weight:bold;font-style:normal;left:4.427px;top:0px;">Note 19 – Commitments and Contingencies </div><div id="a25860" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that AC Products, Inc. (“ACP”), a wholly owned subsidiary,<div style="display:inline-block;width:5.48px"> </div>has been </div><div id="a25903" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">operating a groundwater treatment system to hydraulically<div style="display:inline-block;width:4.76px"> </div>contain groundwater contamination emanating from ACP’s<div style="display:inline-block;width:5.16px"> </div>site, the </div><div id="a25933" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:54.1px;">principal contaminant of which is perchloroethylene.<div style="display:inline-block;width:8.03px"> </div>As of March 31, 2021, ACP believes it is close to meeting the conditions<div style="display:inline-block;width:4.9px"> </div>for </div><div id="a25976" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">closure of the groundwater treatment system, but continues<div style="display:inline-block;width:4.74px"> </div>to operate this system while in discussions with the relevant<div style="display:inline-block;width:4.81px"> </div>authorities.<div style="display:inline-block;width:3.5px"> </div></div><div id="a26015" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">As of March 31, 2021, the Company believes that the range<div style="display:inline-block;width:4.66px"> </div>of potential-known liabilities associated with the balance<div style="display:inline-block;width:4.71px"> </div>of the ACP </div><div id="a26059" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">water remediation program is approximately $</div><div id="a26059_44_3" style="position:absolute;left:252.333px;top:100px;">0.1</div><div id="a26059_47_13" style="position:absolute;font-weight:normal;font-style:normal;left:268.973px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>million to $</div><div id="a26059_60_3" style="position:absolute;left:334.413px;top:100px;">1.0</div><div id="a26059_63_70" style="position:absolute;font-weight:normal;font-style:normal;left:351.213px;top:100px;"><div style="display:inline-block;width:3.36px"> </div>million.<div style="display:inline-block;width:6.82px"> </div>The low and high ends of the range are based on the length </div><div id="a26107" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">of operation of the treatment system as determined<div style="display:inline-block;width:4.74px"> </div>by groundwater modeling.<div style="display:inline-block;width:7.19px"> </div>Costs of operation include the operation and </div><div id="a26143" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.8px;">maintenance of the extraction well, groundwater monitoring<div style="display:inline-block;width:4.67px"> </div>and program management. </div><div id="a26163" style="position:absolute;font-weight:bold;font-style:normal;left:474.76px;top:130.8px;"> </div><div id="a26164" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:154.1px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that an inactive subsidiary of the Company that was acquired<div style="display:inline-block;width:4.71px"> </div>in 1978 </div><div id="a26209" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:169.3px;">sold certain products containing asbestos, primarily<div style="display:inline-block;width:4.65px"> </div>on an installed basis, and is among the defendants in numerous<div style="display:inline-block;width:4.91px"> </div>lawsuits alleging </div><div id="a26248" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:184.7px;">injury due to exposure to asbestos.<div style="display:inline-block;width:7.39px"> </div>During the three months ended March 31, 2021, there<div style="display:inline-block;width:4.7px"> </div>have been no significant changes to the facts </div><div id="a26294" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">or circumstances of this previously disclosed matter,<div style="display:inline-block;width:5.26px"> </div>aside from on-going claims and routine payments associated with<div style="display:inline-block;width:4.72px"> </div>this litigation.<div style="display:inline-block;width:3.66px"> </div></div><div id="a26333" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:215.4px;">Based on a continued analysis of the existing and anticipated<div style="display:inline-block;width:4.8px"> </div>future claims against this subsidiary,<div style="display:inline-block;width:5.08px"> </div>it is currently projected that the </div><div id="a26376" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:230.8px;">subsidiary’s total liability<div style="display:inline-block;width:4.7px"> </div>over the next 50 years for these claims is approximately<div style="display:inline-block;width:4.81px"> </div>$</div><div id="a26376_87_3" style="position:absolute;left:452.36px;top:230.8px;">0.4</div><div id="a26376_90_39" style="position:absolute;font-weight:normal;font-style:normal;left:469.16px;top:230.8px;"><div style="display:inline-block;width:3.2px"> </div>million (excluding costs of defense). </div><div id="a26416" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:254.1px;"> </div></div><div id="TextBlockContainer236" style="position:relative;font-family:Times New Roman;font-size:13.28px;color:#000000;line-height:normal;width:733px;height:631px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a26467" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:0px;"> </div><div id="a26468" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:23.4px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that it is party to certain environmental matters related to certain </div><div id="a26511" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:38.7px;">domestic and foreign properties currently or previously<div style="display:inline-block;width:4.6px"> </div>owned by Houghton.<div style="display:inline-block;width:7.14px"> </div>These environmental matters primarily require the </div><div id="a26543" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:53.9px;">Company to perform long-term monitoring as well as operating<div style="display:inline-block;width:4.96px"> </div>and maintenance at each of the applicable sites.<div style="display:inline-block;width:7.7px"> </div>During the three </div><div id="a26586" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:69.3px;">months ended March 31, 2021, there have been no<div style="display:inline-block;width:4.71px"> </div>significant changes to the facts or circumstances of these previously<div style="display:inline-block;width:4.8px"> </div>disclosed </div><div id="a26628" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:84.6px;">matters, aside from on-going monitoring and maintenance<div style="display:inline-block;width:4.83px"> </div>activities and routine payments associated with each of the<div style="display:inline-block;width:4.73px"> </div>sites.<div style="display:inline-block;width:6.51px"> </div>The </div><div id="a26667" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:100px;">Company continually evaluates its obligations related to such<div style="display:inline-block;width:4.71px"> </div>matters, and based on historical costs incurred and projected<div style="display:inline-block;width:4.73px"> </div>costs to be </div><div id="a26707" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:115.4px;">incurred over the next 28 years, has estimated the present<div style="display:inline-block;width:4.76px"> </div>value range of costs for all of the Houghton<div style="display:inline-block;width:4.43px"> </div>environmental matters, on a </div><div id="a26754" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:130.7px;">discounted basis, to be between approximately $</div><div id="a26754_47_1" style="position:absolute;left:263.373px;top:130.7px;">5</div><div id="a26754_48_14" style="position:absolute;font-weight:normal;font-style:normal;left:270.093px;top:130.7px;"><div style="display:inline-block;width:3.36px"> </div>million and $</div><div id="a26754_62_1" style="position:absolute;left:344.493px;top:130.7px;">6</div><div id="a26754_63_42" style="position:absolute;font-weight:normal;font-style:normal;left:351.213px;top:130.7px;"><div style="display:inline-block;width:3.36px"> </div>million as of March 31, 2021, for which $</div><div id="a26754_105_3" style="position:absolute;left:578.319px;top:130.7px;">5.7</div><div id="a26754_108_21" style="position:absolute;font-weight:normal;font-style:normal;left:594.96px;top:130.7px;"><div style="display:inline-block;width:3.36px"> </div>million was accrued </div><div id="a26798" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:145.9px;">within other accrued liabilities and other non-current<div style="display:inline-block;width:4.77px"> </div>liabilities on the Company’s Condensed<div style="display:inline-block;width:4.79px"> </div>Consolidated Balance Sheet as of March </div><div id="a26837" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:161.3px;">31, 2021.<div style="display:inline-block;width:7.03px"> </div>Comparatively, as of December<div style="display:inline-block;width:4.81px"> </div>31, 2020, the Company had $</div><div id="a26837_68_3" style="position:absolute;left:391.533px;top:161.3px;">6.0</div><div id="a26837_71_52" style="position:absolute;font-weight:normal;font-style:normal;left:408.36px;top:161.3px;"><div style="display:inline-block;width:3.2px"> </div>million accrued for with respect to these matters. </div><div id="a26878" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:184.6px;">The Company believes, although there can be no assurance<div style="display:inline-block;width:4.72px"> </div>regarding the outcome of other unrelated environmental matters, that </div><div id="a26914" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:200px;">it has made adequate accruals for costs associated with other<div style="display:inline-block;width:4.71px"> </div>environmental problems of which it is aware.<div style="display:inline-block;width:7.73px"> </div>Approximately $</div><div id="a26914_123_3" style="position:absolute;left:670.319px;top:200px;">0.1</div><div id="a26914_126_1" style="position:absolute;font-weight:normal;font-style:normal;left:686.959px;top:200px;"> </div><div id="a26953" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:215.4px;">million were accrued as of both March 31, 2021 and<div style="display:inline-block;width:4.73px"> </div>December 31, 2020, to provide for such anticipated future<div style="display:inline-block;width:4.74px"> </div>environmental </div><div id="a26993" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:230.8px;">assessments and remediation costs.<div style="display:inline-block;width:7.49px"> </div></div><div id="a27002" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:254px;">The Company previously disclosed in its 2020 Form 10-K<div style="display:inline-block;width:4.78px"> </div>that one of the Company’s subsidiaries<div style="display:inline-block;width:4.73px"> </div>received a notice of inspection </div><div id="a27044" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:269.3px;">from a taxing authority in a country where certain<div style="display:inline-block;width:4.58px"> </div>of its subsidiaries operate which related to a non-income (indirect)<div style="display:inline-block;width:4.92px"> </div>tax that may be </div><div id="a27093" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:284.7px;">applicable to certain products the subsidiary sells.<div style="display:inline-block;width:7.81px"> </div>To date, the Company<div style="display:inline-block;width:4.86px"> </div>has not received any assessment from the authority related<div style="display:inline-block;width:4.74px"> </div>to </div><div id="a27136" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:300px;">potential liabilities that may be due from the Company’s<div style="display:inline-block;width:5.39px"> </div>subsidiary.<div style="display:inline-block;width:7.91px"> </div>Consequently, there is substantial uncertai<div style="display:inline-block;width:1.61px"> </div>nty with respect to the </div><div id="a27176" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:315.4px;">Company’s ultimate liability<div style="display:inline-block;width:4.7px"> </div>with respect to this indirect tax, as the application of<div style="display:inline-block;width:4.72px"> </div>this tax in its given market is ambiguous and </div><div id="a27220" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:330.6px;">interpreted differently among other peer companies<div style="display:inline-block;width:4.83px"> </div>and taxing authorities.<div style="display:inline-block;width:7.24px"> </div>The Company, with assistance<div style="display:inline-block;width:4.7px"> </div>from independent experts, </div><div id="a27254" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:346px;">has performed an evaluation of the applicability of this<div style="display:inline-block;width:4.74px"> </div>indirect tax to the Company’s<div style="display:inline-block;width:4.83px"> </div>subsidiaries in this country.<div style="display:inline-block;width:8.12px"> </div>Information </div><div id="a27292" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:361.3px;">available to the Company at this time is only sufficient<div style="display:inline-block;width:4.99px"> </div>to establish a range of probable liability,<div style="display:inline-block;width:5.03px"> </div>and no amount within the range is </div><div id="a27341" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:376.7px;">considered a better estimate than another.<div style="display:inline-block;width:8.62px"> </div>During the three months ended March 31, 2021 and through the<div style="display:inline-block;width:4.65px"> </div>date of this Report,<div style="display:inline-block;width:3.81px"> </div>there </div><div id="a27386" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:392px;">have been no significant changes to the facts or circumstances of<div style="display:inline-block;width:4.78px"> </div>this previously disclosed matter, aside<div style="display:inline-block;width:4.8px"> </div>from on-going discussions </div><div id="a27427" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:407.4px;">between the Company and the taxing authority related<div style="display:inline-block;width:4.7px"> </div>to this notice of inspection.<div style="display:inline-block;width:7.33px"> </div>As of March 31, 2021, the Company has recorded a </div><div id="a27473" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:422.6px;">liability of $</div><div id="a27473_14_3" style="position:absolute;left:70.538px;top:422.6px;">1.7</div><div id="a27473_17_120" style="position:absolute;font-weight:normal;font-style:normal;left:87.179px;top:422.6px;"><div style="display:inline-block;width:3.35px"> </div>million in other accrued liabilities, which reflects the low end<div style="display:inline-block;width:4.85px"> </div>of the range of probable indirect tax owed, including </div><div id="a27517" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:438px;">interest and taking into account applicable statutes of limitations.<div style="display:inline-block;width:8.27px"> </div>Because these amounts in part relate to a Houghton entity acquired </div><div id="a27558" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:453.3px;">in the Combination and for periods prior to the Combination,<div style="display:inline-block;width:4.77px"> </div>the Company has submitted an indemnification claim<div style="display:inline-block;width:4.72px"> </div>with Houghton’s </div><div id="a27597" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:468.7px;">former owners related to this potential indirect tax liability.<div style="display:inline-block;width:8.92px"> </div>The Company recorded a receivable in other assets for approximately </div><div id="a27636" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:484.1px;">$</div><div id="a27636_1_3" style="position:absolute;left:11.147px;top:484.1px;">1.1</div><div id="a27636_4_127" style="position:absolute;font-weight:normal;font-style:normal;left:27.947px;top:484.1px;"><div style="display:inline-block;width:3.36px"> </div>million, which reflects the amount of the initial recorded liability<div style="display:inline-block;width:4.8px"> </div>for which the Company anticipates being indemnified.<div style="display:inline-block;width:8.01px"> </div>As </div><div id="a27676" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:499.4px;">noted, the Company believes there is substantial uncertainty<div style="display:inline-block;width:4.69px"> </div>with respect to its ultimate liability given the ambiguous<div style="display:inline-block;width:4.74px"> </div>application of </div><div id="a27714" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:514.6px;">this indirect tax.<div style="display:inline-block;width:7.22px"> </div>At this time, the Company’s best estimate<div style="display:inline-block;width:4.77px"> </div>of a potential range for possible assessments, including<div style="display:inline-block;width:4.83px"> </div>additional amounts </div><div id="a27755" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:530px;">that may be assessed under these indirect tax laws, would<div style="display:inline-block;width:4.79px"> </div>be approximately $</div><div id="a27755_76_3" style="position:absolute;left:417.48px;top:530px;">0.6</div><div id="a27755_79_13" style="position:absolute;font-weight:normal;font-style:normal;left:434.28px;top:530px;"><div style="display:inline-block;width:3.36px"> </div>million to $</div><div id="a27755_92_2" style="position:absolute;left:499.72px;top:530px;">38</div><div id="a27755_94_40" style="position:absolute;font-weight:normal;font-style:normal;left:513px;top:530px;"><div style="display:inline-block;width:3.36px"> </div>million, which is net of approximately </div><div id="a27800" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:545.3px;">$</div><div id="a27800_1_2" style="position:absolute;left:11.147px;top:545.3px;">10</div><div id="a27800_3_63" style="position:absolute;font-weight:normal;font-style:normal;left:24.587px;top:545.3px;"><div style="display:inline-block;width:3.36px"> </div>million of estimated income tax deductions and approximately $</div><div id="a27800_66_2" style="position:absolute;left:371.533px;top:545.3px;">22</div><div id="a27800_68_54" style="position:absolute;font-weight:normal;font-style:normal;left:384.813px;top:545.3px;"><div style="display:inline-block;width:3.36px"> </div>million of applicable rights to indemnification from </div><div id="a27834" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:560.7px;">Houghton’s former owners. </div><div id="a27840" style="position:absolute;font-weight:normal;font-style:normal;left:28.427px;top:584.1px;">The Company is party to other litigation which management<div style="display:inline-block;width:4.81px"> </div>currently believes will not have a material adverse<div style="display:inline-block;width:4.74px"> </div>effect on the </div><div id="a27880" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:599.3px;">Company’s results of<div style="display:inline-block;width:4.59px"> </div>operations, cash flows or financial condition.<div style="display:inline-block;width:7.89px"> </div>In addition, the Company has an immaterial amount of contractual </div><div id="a27918" style="position:absolute;font-weight:normal;font-style:normal;left:4.427px;top:614.6px;">purchase obligations.</div></div> 100000 1000000.0 400000 5000000 6000000 5700000 6000000.0 100000 100000 1700000 1100000 600000 38000000 10000000 22000000 XML 15 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2021
Apr. 30, 2021
Document And Entity Information [Abstract]    
Document type 10-Q  
Document period end date Mar. 31, 2021  
Entity file number 001-12019  
Entity registrant name QUAKER CHEMICAL CORPORATION  
Entity tax identification number 23-0993790  
Entity address, address line 1 901 E. Hector Street  
Entity address, city or town Conshohocken  
Entity address, state or province PA  
Entity address, postal zip code 19428 – 2380  
City area code 610  
Local phone number 832-4000  
Trading symbol KWR  
Entity filer category Large Accelerated Filer  
Entity small business false  
Entity emerging growth company false  
Entity current reporting status Yes  
Amendment flag false  
Document fiscal year focus 2021  
Document period focus Q1  
Entity common stock shares outstanding   17,873,331
Current fiscal year end date --12-31  
Entity central index key 0000081362  
Entity shell company false  
Document transition report false  
Document quarterly report true  
Entity incorporation state country code PA  
Security exchange name NYSE  
Security 12b title Common Stock, $1 par value  
Entity interactive data current Yes  
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Net sales $ 429,783 $ 378,561
Cost of goods sold 273,589 244,710
Gross profit 156,194 133,851
Selling, general and administrative expenses 104,310 98,701
Indefinite-lived intangible asset impairment 0 38,000
Restructuring and related charges 1,175 1,716
Combination, integration and other acquisition-related expenses 5,815 7,878
Operating income (loss) 44,894 (12,444)
Other income (expense), net 4,687 (21,175)
Interest expense, net (5,470) (8,461)
Income (loss) before taxes and equity in net income of associated companies 44,111 (42,080)
Taxes on income (loss) before equity in net income of associated companies 10,689 (13,070)
Income (loss) before equity in net income of associated companies 33,422 (29,010)
Equity in net income of associated companies 5,210 666
Net income (loss) 38,632 (28,344)
Less: Net income attributable to noncontrolling interest 17 37
Net income (loss) attributable to Quaker Chemical Corporation $ 38,615 $ (28,381)
Per share data:    
Basic earnings (loss) per common share $ 2.16 $ (1.60)
Diluted earnings (loss) per common share 2.15 (1.60)
Dividends declared $ 0.395 $ 0.385
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Statement of Comprehensive Income [Abstract]    
Net income (loss) $ 38,632 $ (28,344)
Currency translation adjustments (25,461) (54,751)
Defined benefit retirement plans 1,292 16,957
Current period change in fair value of derivatives 562 (3,981)
Unrealized loss on available-for-sale securities (3,025) (1,711)
Other comprehensive loss (26,632) (43,486)
Comprehensive income (loss) 12,000 (71,830)
Less: Comprehensive (income) loss attributable to noncontrolling interest (15) 95
Comprehensive income (loss) attributable to Quaker Chemical Corporation $ 11,985 $ (71,735)
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 163,455 $ 181,833
Accounts receivable, net 411,523 372,974
Inventories    
Raw materials and supplies 97,631 86,148
Work-in-process and finished goods 110,147 101,616
Prepaid expenses and other current assets 48,285 50,156
Total current assets 831,041 792,727
Property, plant and equipment, at cost 416,514 423,253
Less accumulated depreciation (220,724) (219,370)
Property, plant and equipment, net 195,790 203,883
Right of use lease assets 38,027 38,507
Goodwill 627,574 631,212
Other intangible assets, net 1,075,343 1,081,358
Investments in associated companies 96,213 95,785
Deferred tax assets 17,057 16,566
Other non-current assets 31,906 31,796
Total assets 2,912,951 2,891,834
Current liabilities    
Short-term borrowings and current portion of long-term debt 43,330 38,967
Accounts and other payables 214,015 198,872
Accrued compensation 29,091 43,300
Accrued restructuring 5,970 8,248
Other current liabilities 104,029 93,573
Total current liabilities 396,435 382,960
Long-term debt 859,433 849,068
Long-term lease liabilities 27,050 27,070
Deferred tax liabilities 186,031 192,763
Other non-current liabilities 114,549 119,059
Total liabilities 1,583,498 1,570,920
Equity    
Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding 2021 - 17,875,076 shares; 2020 - 17,850,616 shares 17,875 17,851
Capital in excess of par value 908,748 905,171
Retained earnings 455,493 423,940
Accumulated other comprehensive loss (53,228) (26,598)
Total Quaker shareholders' equity 1,328,888 1,320,364
Noncontrolling interest 565 550
Total equity 1,329,453 1,320,914
Total liabilities and equity $ 2,912,951 $ 2,891,834
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2021
Dec. 31, 2020
Statement Of Financial Position [Abstract]    
Common Stock Par Value $ 1 $ 1
Common Stock, Shares Authorized 30,000,000 30,000,000
Common Stock, Shares, Issued 17,875,076 17,850,616
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Net income (loss) $ 38,632 $ (28,344)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Amortization of debt issuance costs 1,187 1,187
Depreciation and amortization 22,145 21,197
Equity in undistributed earnings of associated companies, net of dividends (5,105) 4,285
Acquisition-related fair value adjustments related to inventory 801 0
Deferred compensation, deferred taxes and other, net (9,888) (22,988)
Share-based compensation 3,779 4,682
Gain on disposal of property, plant and equipment and other assets (5,410) (2)
Insurance settlement realized 0 (229)
Indefinite-lived intangible asset impairment 0 38,000
Combination and other acquisition-related expenses, net of payments (2,884) (519)
Restructuring and related charges 1,175 1,716
Pension and other postretirement benefit expense (1,034) 22,453
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:    
Accounts receivable (46,270) 2,322
Inventories (24,994) (10,162)
Prepaid expenses and other current assets (8,315) (3,263)
Change in restructuring liabilities (3,034) (4,841)
Accounts payable and accrued liabilities 26,597 (5,275)
Net cash (used in) provided by operating activities (12,618) 20,219
Cash flows from investing activities    
Investments in property, plant and equipment (3,934) (4,892)
Payments related to acquisitions, net of cash acquired (26,655) (3,160)
Proceeds from disposition of assets 14,744 0
Insurance settlement interest earned 0 31
Net cash used in investing activities (15,845) (8,021)
Cash flows from financing activities    
Payments of long-term debt (9,551) (9,371)
Borrowings on revolving credit facilities, net 30,000 205,500
Repayments on other debt, net (188) (185)
Dividends paid (7,052) (6,828)
Stock options exercised, other (178) (696)
Purchase of noncontrolling affiliate shareholders 0 (1,047)
Distributions to noncontrolling affiliate shareholders 0 (751)
Net cash (used in) provided by financing activities 13,031 186,622
Effect of foreign exchange rate changes on cash (3,008) (6,424)
Net (decrease) increase in cash, cash equivalents and restricted cash (18,440) 192,396
Cash, cash equivalents and restricted cash at the beginning of the period 181,895 143,555
Cash, cash equivalents and restricted cash at the end of the period $ 163,455 $ 335,951
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Financial Information
 3 Months Ended
Mar. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note 1 – Basis of Presentation and Description of Business
 
Basis of Presentation
As used in these Notes to Condensed Consolidated
 
Financial Statements, the terms “Quaker”, “Quaker Houghton”,
 
the
“Company”, “we”, and “our” refer to Quaker Chemical
 
Corporation (doing business as Quaker Houghton), its subsidiaries, and
associated companies, unless the context otherwise requires.
 
As used in these Notes to Condensed Consolidated
 
Financial Statements,
the term Legacy Quaker refers to the Company prior
 
to the closing of its combination with Houghton International,
 
Inc. (“Houghton”)
(herein referred to as the “Combination”).
 
The condensed consolidated financial statements included herein
 
are unaudited and have
been prepared in accordance with generally accepted
 
accounting principles in the United States (“U.S. GAAP”) for
 
interim financial
reporting and the United States Securities and Exchange Commission
 
(“SEC”) regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared
 
in accordance with U.S. GAAP have been condensed or
 
omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all
 
adjustments which are
necessary for a fair statement of the financial position,
 
results of operations and cash flows for the interim periods.
 
The results for the
three months ended March 31, 2021 are not necessarily
 
indicative of the results to be expected for the full year.
 
These financial
statements should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year
 
ended December 31,
2020 (the “2020 Form 10-K”).
 
Description of Business
The Company was organized in 1918, incorporated
 
as a Pennsylvania business corporation in 1930, and in August
 
2019
completed the Combination with Houghton to form
 
Quaker Houghton.
 
Quaker Houghton is a global leader in industrial process
fluids.
 
With a presence around the world,
 
including operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced
 
and specialized steel, aluminum, automotive, aerospace,
 
offshore, can, mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range
 
of formulated chemical specialty products and offers
chemical management services (which the Company refers
 
to as “Fluidcare”) for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”);
 
Asia/Pacific; and Global Specialty
Businesses.
Hyper-inflationary economies
 
Based on various indices or index compilations being
 
used to monitor inflation in Argentina as well as economic
 
instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S.
 
GAAP.
 
As a result, the Company began
applying hyper-inflationary accounting with respect
 
to the Company's wholly owned Argentine
 
subsidiary beginning July 1, 2018.
 
In
addition, Houghton has an Argentina
 
subsidiary to which hyper-inflationary accounting also is applied.
 
As of, and for the three
months ended March 31, 2021, the Company's Argentine
 
subsidiaries represented less than
1
% of the Company’s consolidated
 
total
assets and net sales, respectively.
 
During the three months ended March 31, 2021 and 2020,
 
the Company recorded $
0.2
 
million and
$
0.1
 
million, respectively, of
 
remeasurement losses associated with the applicable currency conversions
 
related to Argentina.
 
These
losses were recorded within foreign exchange (losses) gains,
 
net, which is a component of other income (expense),
 
net, in the
Company’s Condensed
 
Consolidated Statements of Operations.
COVID-19
Management continues to monitor the impact that the COVID-19
 
pandemic is having on the Company,
 
the overall specialty
chemical industry,
 
and the economies and markets in which the Company operates.
 
The full extent of the COVID-19 pandemic
related business and travel restrictions and changes to
 
business and consumer behavior intended to reduce its spread are
 
uncertain as of
the date of this Quarterly Report on Form 10-Q for the
 
period ended March 31, 2021 (the “Report”) as COVID-19
 
and the responses
of governmental authorities continue to evolve globally.
Further, management continues to
 
evaluate how COVID-19-related circumstances, such as remote
 
work arrangements, affect
financial reporting processes, internal control over financial
 
reporting, and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue
 
to present challenges, at this time, Management does not believe that
COVID-19 has had a material impact on financial reporting
 
processes, internal control over financial reporting,
 
and disclosure
controls and procedures.
The Company cannot reasonably estimate the magnitude
 
of the effects these conditions will have on the Company’s
 
operations in
the future as they are subject to significant uncertainties
 
relating to the ultimate geographic spread of the virus,
 
the incidence and
severity of the symptoms, the duration or resurgence
 
of the outbreak, the global availability and acceptance of vaccines
 
as well as their
efficacy,
 
the length of the travel restrictions and business
 
closures imposed by governments of impacted countries,
 
and the economic
response by governments of impacted countries.
To the extent
 
that the Company’s customers and
 
suppliers continue to be significantly and adversely impacted by
 
COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from
 
the Company, which in
 
turn could significantly
interrupt the Company’s
 
business operations.
 
Such impacts could grow and become more significant to the
 
Company’s operations
and the Company’s liquidity
 
or financial position.
 
Therefore, given the speed and frequency of continuously
 
evolving developments
with respect to this pandemic, the Company cannot reasonably
 
estimate the magnitude or the full extent to which COVID-19
 
may
impact the Company’s results
 
of operations, liquidity or financial position.
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Business Combinations
 3 Months Ended
Mar. 31, 2021
Business Combination Separately Recognized Transaction [Abstract]  
Business Combination Disclosure [Text Block]
Note 2 – Business Acquisitions
2021 Acquisitions
In February 2021, the Company acquired a tin-plating
 
solutions business for the steel end market for approximately $
25
 
million.
 
The Company allocated $
19.6
 
million of the purchase price to intangible assets, comprised
 
of $
18.3
 
million of customer relationships,
to be amortized over
19
 
years; $
0.9
 
million of existing product technology to be amortized over
14
 
years; and $
0.4
 
million of a
licensed trademark to be amortized over
3
 
years.
 
In addition, the Company recorded $
5.0
 
million of goodwill related to expected
value not allocated to other acquired assets, all of which
 
is expected to be tax deductible.
 
As of March 31, 2021, the allocation of the
purchase price has not been finalized and the
one-year
 
measurement period has not ended.
 
Further adjustments may be necessary as a
result of the Company’s
 
on-going assessment of additional information related to the fair value
 
of assets acquired and liabilities
assumed.
Additionally, in
 
February 2021, the Company acquired a
38
% ownership interest in Grindaix-GmbH (“Grindaix”),
 
a privately
held, German-based, high-tech provider of coolant control
 
and delivery systems for approximately
1.4
 
million EUR or approximately
$
1.7
 
million.
 
Grindaix's solutions apply to a wide range of machining processes,
 
including grinding applications in the metalworking
sector.
 
The Company recorded the investment in Grindaix as an equity
 
method investment within the Condensed Consolidated
Financial Statements.
The results of operations of the acquired businesses subsequent
 
to the respective acquisition dates are included in
 
the Condensed
Consolidated Statements of Operations as of March
 
31, 2021.
 
Transaction expenses associated with these
 
acquisitions are included in
Combination, integration and other acquisition-related
 
expenses in the Company’s Condensed
 
Consolidated Statements of Operations.
 
Certain pro forma and other information is not presented,
 
as the operations of the acquired businesses are not considered material to
the overall operations of the Company for the periods presented.
Previous Acquisitions
In December 2020,
 
the Company completed its acquisition of Coral Chemical Company
 
(“Coral”), a privately held, U.S.-based
provider of metal finishing fluid solutions.
 
The acquisition provides technical expertise and product solutions
 
for pre-treatment,
metalworking and wastewater treatment applications
 
to the beverage cans and general industrial end markets.
 
The original purchase
price was approximately $
54.1
 
million, subject to routine and customary post-closing adjustments related
 
to working capital and net
indebtedness levels.
 
The Company anticipates finalizing its post-closing adjustments
 
for the Coral acquisition in the second quarter of
2021 and currently estimates it will receive approximately
 
$
0.4
 
million to settle such adjustments.
The following table presents the preliminary estimated fair
 
values of Coral net assets acquired:
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
—
$
958
Accounts receivable
8,473
—
8,473
Inventories
4,527
—
4,527
Prepaid expenses and other assets
181
—
181
Property, plant and
 
equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
53
2,867
Total assets purchased
57,720
205
57,925
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued
 
liabilities
3,482
—
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
(351)
53,704
Less: estimated purchase price settlement
—
(351)
(351)
Less: cash acquired
958
—
958
Net cash paid for Coral
$
53,097
$
—
$
53,097
(1) As previously disclosed in the Company’s
 
2020 Form 10-K.
Measurement period adjustments recorded during the first
 
quarter of 2021 include certain adjustments related to refining
 
original
estimates for assets and liabilities for certain acquired
 
finance leases, as well the adjustment to reflect the expected
 
settlement of post-
closing working capital and net indebtedness true ups to
 
the original purchase price.
 
As of March 31, 2021,
 
the allocation of the
purchase price for Coral has not been finalized and the
one-year
 
measurement period has not ended.
 
Further adjustments may be
necessary as a result of the Company’s
 
on-going assessment of additional information related to the
 
fair value of assets acquired and
liabilities assumed.
In May 2020, the Company acquired Tel
 
Nordic ApS (“TEL”), a company that specializes in lubricants and engineering
 
primarily
in high pressure aluminum die casting for its Europe,
 
Middle East and Africa (“EMEA”) reportable segment.
 
Consideration
 
paid was
in the form of a convertible promissory note in the amount
 
of
20.0
 
million DKK, or approximately $
2.9
 
million, which was
subsequently converted into shares of the Company’s
 
common stock.
 
An adjustment to the purchase price of approximately
0.4
million DKK, or less than $
0.1
 
million, was made as a result of finalizing a post-closing
 
settlement in the second quarter of 2020.
 
The
Company allocated approximately $
2.4
 
million of the purchase price to intangible assets to be amortized
 
over
17
 
years.
 
In addition,
the Company recorded approximately $
0.5
 
million of goodwill, related to expected value not allocated to
 
other acquired assets, none
of which will be tax deductible.
 
As of March 31, 2021, the allocation of the purchase price
 
of TEL has not been finalized and the
one-
 
measurement period has not ended.
 
Further adjustments may be necessary as a result of the Company’s
 
on-going assessment of
additional information related to the fair value of assets acquired
 
and liabilities assumed.
In March 2020, the Company acquired the remaining
49
% ownership interest in one of its South African affiliates,
 
Quaker
Chemical South Africa Limited (“QSA”) for
16.7
 
million ZAR, or approximately $
1.0
 
million, from its joint venture partner PQ
Holdings South Africa.
 
QSA is a part of the Company’s
 
Europe, Middle East and Africa (“EMEA”) reportable segment.
 
As this
acquisition was a change in an existing controlling ownership,
 
the Company recorded $
0.7
 
million of excess purchase price over the
carrying value of the non-controlling interest in Capital
 
in excess of par value.
 
In October 2019, the Company completed its acquisition
 
of the operating divisions of Norman Hay plc (“Norman
 
Hay”), a private
U.K. company that provides specialty chemicals, operating
 
equipment, and services to industrial end markets.
 
The acquisition adds
new technologies in automotive, original equipment
 
manufacturer, and aerospace, as well as engineering
 
expertise which is expected
to strengthen the Company’s
 
existing equipment solutions platform.
 
The original purchase price was
80.0
 
million GBP,
 
on a cash-free
and debt-free basis, subject to routine and customary
 
post-closing adjustments related to working capital and
 
net indebtedness levels.
 
The Company finalized its post-closing adjustments for the
 
Norman Hay acquisition and paid approximately
2.5
 
million GBP during
the first quarter of 2020 to settle such adjustments.
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Recently Issued Accounting Standards
 3 Months Ended
Mar. 31, 2021
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]  
New Accounting Pronouncements And Changes In Accounting Principles [Text Block]
Note 3 – Recently Issued Accounting Standards
Recently Issued Accounting Standards
 
Adopted
The Financial Accounting Standards Board (“FASB”)
 
issued Account Standards Update (“ASU”)
 
ASU 2019-12
, Income Taxes
(Topic
 
740): Simplifying the Accounting for Income Taxes
 
in December 2019 to simplify the accounting for income taxes.
 
The
guidance within this accounting standard update
 
removes certain exceptions, including the exception to the
 
incremental approach for
certain intra-period tax allocations, to the requirement
 
to recognize or not recognize certain deferred tax liabilities for
 
equity method
investments and foreign subsidiaries, and to the general
 
methodology for calculating income taxes in an interim period
 
when a year-to-
date loss exceeds the anticipated loss for the year.
 
Further, the guidance simplifies the accounting
 
related to franchise taxes, the step
up in tax basis for goodwill, current and deferred tax
 
expense, and codification improvements for income taxes related
 
to employee
stock ownership plans.
 
The guidance is effective for annual and interim
 
periods beginning after December 15, 2020.
 
The Company
adopted this standard on a prospective basis, effective
 
January 1, 2021.
 
There was no cumulative effect of adoption recorded
 
within
retained earnings on January 1, 2021.
The FASB issued
 
ASU 2020-04,
Reference Rate Reform (To
 
pic 848): Facilitation of the Effects of Reference
 
Rate Reform on
Financial Reporting
 
in March 2020.
 
The FASB subsequently
 
issued ASU 2021-01,
Reference Rate Reform (Topic
 
848): Scope
 
in
January 2021 which clarified the guidance but did
 
not materially change the guidance or its applicability to
 
the Company.
 
The
amendments provide temporary optional expedients and
 
exceptions for applying U.S. GAAP to contract modifications,
 
hedging
relationships and other transactions to ease the potential
 
accounting and financial reporting burden associated with transitioning
 
away
from reference rates that are expected to be discontinued,
 
including the London Interbank Offered Rate (“LIBOR”).
 
ASU 2020-04 is
effective for the Company as of March 12,
 
2020 and generally can be applied through December 31, 2022.
 
As of March 31, 2021, the
expedients provided in ASU 2020-04 do not presently
 
impact the Company; however, the Company
 
will continue to monitor for
potential impacts on its consolidated financial statements.
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Business Segments
 3 Months Ended
Mar. 31, 2021
Segment Reporting Measurement Disclosures [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments,
 
reflect the structure of the Company’s
internal organization, the method by which
 
the Company’s resources are allocated
 
and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net
 
sales and operations in
each respective region, excluding net sales and operations
 
managed globally by the Global Specialty Businesses segment, which
includes the Company’s
 
container, metal finishing, mining,
 
offshore, specialty coatings, specialty grease and
 
Norman Hay businesses.
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related cost of goods sold (“COGS”) and selling, general
 
and administrative expenses (“SG&A”).
 
Operating expenses not directly
attributable to the net sales of each respective segment
 
,
 
such as certain corporate and administrative costs, Combination,
 
integration
and other acquisition-related expenses, and Restructuring
 
and related charges,
 
are not included in segment operating earnings.
 
Other
items not specifically identified with the Company’s
 
reportable segments include interest expense, net and other
 
income (expense),
net.
The following table presents information about the performance
 
of the Company’s reportable operating
 
segments for the three
months ended March 31, 2021 and 2020:
Three Months Ended
March 31,
 
2021
2020
Net sales
 
 
 
 
 
 
Americas
$
134,871
$
129,896
EMEA
 
119,814
 
104,839
Asia/Pacific
 
96,706
 
73,552
Global Specialty Businesses
 
78,392
 
70,274
Total
 
net sales
$
429,783
$
378,561
Segment operating earnings
Americas
$
32,234
$
29,188
EMEA
25,244
18,359
Asia/Pacific
27,478
19,541
Global Specialty Businesses
 
24,169
 
20,560
Total
 
segment operating earnings
 
109,125
 
87,648
Combination, integration and other acquisition-related
 
expenses
(5,815)
(7,878)
Restructuring and related charges
(1,175)
(1,716)
Fair value step up of acquired inventory sold
(801)
—
Indefinite-lived intangible asset impairment
—
(38,000)
Non-operating and administrative expenses
 
(40,992)
 
(38,451)
Depreciation of corporate assets and amortization
 
(15,448)
 
(14,047)
Operating income (loss)
44,894
(12,444)
Other income (expense), net
4,687
(21,175)
Interest expense, net
 
(5,470)
 
(8,461)
Income (loss) before taxes and equity in net income of
 
associated companies
$
44,111
$
(42,080)
Inter-segment revenues for the three months ended
 
March 31, 2021 and 2020 were $
3.3
 
million and $
2.9
 
million for Americas,
$
8.8
 
million and $
5.5
 
million for EMEA, $
0.1
 
million and $
0.1
 
million for Asia/Pacific and $
2.0
 
million and $
1.3
 
million for Global
Specialty Businesses, respectively.
 
However, all inter-segment transactions
 
have been eliminated from each reportable operating
segment’s net sales and
 
earnings for all periods presented in the above tables.
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Net Sales and Revenue Recognition
 3 Months Ended
Mar. 31, 2021
Revenue From Contract With Customer [Abstract]  
Revenue From Contract With Customer [Text Block]
Note 5 – Net Sales and Revenue Recognition
Business Description
The Company develops, produces, and markets a broad
 
range of formulated chemical specialty products and offers
 
chemical
management services (“Fluidcare”) for various heavy
 
industrial and manufacturing applications throughout its four
 
segments.
 
A
significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services
 
made directly to manufacturers
through its own employees and its Fluidcare programs,
 
with the balance being handled through distributors and
 
agents.
As part of the Company’s
 
Fluidcare business, certain third-party product sales to customers are
 
managed by the Company.
 
Where
the Company acts as a principal, revenues are recognized
 
on a gross reporting basis at the selling price negotiated with
 
its customers.
Where the Company acts as an agent, revenue is recognized on
 
a net reporting basis at the amount of the administrative fee earned
 
by
the Company for ordering the goods.
 
The Company transferred third-party products under arrangements recognized
 
on a net reporting
basis of $
17.8
 
million and $
12.5
 
million for the three months ended March 31, 2021 and 2020,
 
respectively.
 
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020,
 
the Company’s five largest
 
customers (each composed
of multiple subsidiaries or divisions with semiautonomous
 
purchasing authority) accounted for approximately
10
% of consolidated net
sales, with its largest customer accounting
 
for approximately
3
% of consolidated net sales.
Revenue Recognition Model
The Company applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify
 
the contract with a
customer; (ii) identify the performance obligations in
 
the contract; (iii) determine the transaction price; (iv) allocate the
 
transaction
price to the performance obligations in the contract; and
 
(v) recognize revenue when, or as, the Company satisfies a performance
obligation.
 
Refer to the Company’s 2020
 
Form 10-K for additional information on the Company’s
 
revenue recognition policies,
including its practical expedients and accounting policy
 
elections.
 
Allowance for Doubtful Accounts
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company adopted, as required,
 
an accounting
standard update related to the accounting and disclosure
 
of credit losses effective January 1, 2020.
 
The Company recognizes an
allowance for credit losses, which represents the portion
 
of its trade accounts receivable that the Company does not expect
 
to collect
over the contractual life, considering past events
 
and reasonable and supportable forecasts of future economic
 
conditions.
 
The
Company’s allowance
 
for credit losses on its trade accounts receivables
 
is based on specific collectability facts and circumstances for
each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection
 
risk the Company
estimates for certain past due aging categories, and
 
also, the general risk to all outstanding accounts receivable based on historical
amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet
 
credit exposure related to its customers.
Contract Assets and Liabilities
The Company recognizes a contract asset or receivable
 
on its Condensed Consolidated Balance Sheet when the Company
performs a service or transfers a good in advance
 
of receiving consideration.
 
A receivable is the Company’s
 
right to consideration that
is unconditional and only the passage of time is required
 
before payment of that consideration is due.
 
A contract asset is the
Company’s right to consideration
 
in exchange for goods or services that the Company has transferred
 
to a customer.
 
The Company
had no material contract assets recorded on its Condensed
 
Consolidated Balance Sheets as of March 31, 2021 or December
 
31, 2020.
A contract liability is recognized when the Company
 
receives consideration, or if it has the unconditional right
 
to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration,
 
or a specified amount of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue
 
recorded for customer payments received by the Company
 
prior to the
Company satisfying the associated performance obligation.
 
Deferred revenues are presented within other current liabilities
 
in the
Company’s Condensed
 
Consolidated Balance Sheets.
 
The Company had approximately $
6.3
 
million and $
4.0
 
million of deferred
revenue as of March 31, 2021 and December 31, 2020,
 
respectively.
 
For three months ended March 31, 2021, the Company
 
satisfied
all of the associated performance obligations and recognized
 
into revenue the advance payments received and recorded
 
as of
December 31, 2020.
Disaggregated Revenue
The following tables disaggregate the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the three months ended March 31,
 
2021 and 2020.
Three Months Ended March 31,
 
2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
46,793
$
34,274
$
49,743
 
$
130,810
Metalworking and other
88,078
85,540
46,963
220,581
134,871
119,814
96,706
351,391
Global Specialty Businesses
45,256
20,272
12,864
78,392
$
180,127
$
140,086
$
109,570
$
429,783
Timing of Revenue Recognized
Product sales at a point in time
$
171,594
$
131,162
$
106,399
 
$
409,155
Services transferred over time
8,533
8,924
3,171
20,628
$
180,127
$
140,086
$
109,570
$
429,783
Three Months Ended March 31,
 
2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
46,673
$
29,888
$
41,589
 
$
118,150
Metalworking and other
83,223
74,951
31,963
190,137
129,896
104,839
73,552
308,287
Global Specialty Businesses
44,231
16,605
9,438
70,274
$
174,127
$
121,444
$
82,990
$
378,561
Timing of Revenue Recognized
Product sales at a point in time
$
168,802
$
118,423
$
81,156
 
$
368,381
Services transferred over time
5,325
3,021
1,834
10,180
$
174,127
$
121,444
$
82,990
$
378,561
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Leases
 3 Months Ended
Mar. 31, 2021
Leases [Abstract]  
Leases Of Lessee Disclosure [Text Block]
Note 6 - Leases
The Company determines if an arrangement is a lease
 
at its inception.
 
This determination generally depends on whether the
arrangement conveys the right to control the use of an
 
identified fixed asset explicitly or implicitly for a period of
 
time in exchange for
consideration.
 
Control of an underlying asset is conveyed if the Company
 
obtains the rights to direct the use of, and obtains
substantially all of the economic benefits from the use
 
of, the underlying asset.
 
Lease expense for variable leases and short-term
leases is recognized when the obligation is incurred.
 
The Company has operating leases for certain facilities, vehicles
 
and machinery and equipment with remaining lease terms up
 
to
10
 
years.
 
In addition, the Company has certain land use leases with remaining
 
lease terms up to
94
 
years.
 
The lease term for all of the
Company’s leases includes
 
the non-cancellable period of the lease plus any additional periods
 
covered by an option to extend the lease
that the Company is reasonably certain it will exercise.
 
Operating leases are included in right of use lease assets, other current
liabilities and long-term lease liabilities on the Condensed
 
Consolidated Balance Sheet.
 
Right of use lease assets and liabilities are
recognized at each lease’s
 
commencement date based on the present value of its lease payments
 
over its respective lease term.
 
The
Company uses the stated borrowing rate for a lease when
 
readily determinable.
 
When a stated borrowing rate is not available in a
lease agreement, the Company uses its incremental borrowing
 
rate based on information available at the lease’s
 
commencement date
to determine the present value of its lease payments.
 
In determining the incremental borrowing rate used to present
 
value each of its
leases, the Company considers certain information
 
including fully secured borrowing rates readily available to the Company
 
and its
subsidiaries.
 
The Company has immaterial finance leases, which are
 
included in property, plant
 
and equipment, current portion of
long-term debt and long-term debt on the Condensed Consolidated
 
Balance Sheet.
Operating lease expense is recognized on a straight-line
 
basis over the lease term.
 
Operating lease expense for the three months
ended March 31, 2021 and 2020 was $
3.6
 
million and $
3.4
 
million, respectively.
 
Short-term lease expense was $
0.3
 
million and $
0.5
million for the three months ended March 31, 2021
 
and 2020, respectively.
 
The Company has
no
 
material variable lease costs or
sublease income for the three months ended March 31, 2021 and
 
2020.
 
Cash paid for operating leases was $
3.6
 
million and $
3.4
million during the three months ended March 31, 2021
 
and 2020,
 
respectively.
 
The Company recorded new right of use lease assets
and associated lease liabilities of approximately $
3.1
 
million during the three months ended March 31, 2021.
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
March 31,
December 31,
2021
2020
Right of use lease assets
$
38,027
$
38,507
Other current liabilities
10,419
10,901
Long-term lease liabilities
27,050
27,070
Total operating
 
lease liabilities
$
37,469
$
37,971
Weighted average
 
remaining lease term (years)
5.9
6.0
Weighted average
 
discount rate
4.26%
4.20%
Maturities of operating lease liabilities as of March 31,
 
2021 were as follows:
March 31,
2021
For the remainder of 2021
$
9,269
For the year ended December 31, 2022
9,042
For the year ended December 31, 2023
6,932
For the year ended December 31, 2024
5,194
For the year ended December 31, 2025
4,211
For the year ended December 31, 2026 and beyond
8,116
Total lease payments
42,764
Less: imputed interest
(5,295)
Present value of lease liabilities
$
37,469
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring and Related Activities
 3 Months Ended
Mar. 31, 2021
Restructuring And Related Activities [Abstract]  
Restructuring And Related Activities Disclosure [TextBlock]
Note 7 – Restructuring and Related Activities
The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost
synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain
manufacturing and non-manufacturing facilities.
 
The exact timing and total costs associated with the QH Program
 
will depend on a
number of factors and is subject to change; however,
 
the Company currently expects reduction in headcount and
 
site closures to
continue to occur throughout 2021
 
under the QH Program and estimates that anticipated costs synergies
 
realized from the QH
Program will approximate one-times the restructuring costs
 
incurred.
 
Employee separation benefits will vary depending on local
regulations within certain foreign countries and will
 
include severance and other benefits.
 
All costs incurred to date relate to severance costs to reduce
 
headcount as well as costs to close certain facilities and are
 
recorded
in Restructuring and related charges in the
 
Company’s Condensed Statements
 
of Operations.
 
As described in Note 4 of Notes to
Condensed Consolidated Financial Statements, restructuring
 
and related charges are not included in
 
the Company’s calculation of
reportable segments’ measure of operating earnings
 
and therefore these costs are not reviewed by or recorded to
 
reportable segments.
Activity in the Company’s
 
accrual for restructuring under the QH Program for the three months
 
ended March 31, 2021 is as
follows:
QH Program
Accrued restructuring as of December 31, 2020
$
8,248
Restructuring and related charges
1,175
Cash payments
(3,034)
Currency translation adjustments
(419)
Accrued restructuring as of March 31, 2021
$
5,970
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation
 3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Share based Payments [Abstract]  
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation
 
expense in its Condensed Consolidated Statements of
Operations for the three months ended March 31, 2021
 
and 2020:
Three Months Ended
March 31,
 
2021
2020
Stock options
$
308
$
432
Non-vested stock awards and restricted stock units
1,396
1,264
Non-elective and elective 401(k) matching contribution in
 
stock
1,553
—
Director stock ownership plan
203
40
Performance stock units
319
—
Annual incentive plan
—
2,946
Total share-based
 
compensation expense
$
3,779
$
4,682
Share-based compensation expense is recorded in SG&A,
 
except for $
0.3
 
million and $
0.5
 
million during the three months ended
March 31, 2021 and 2020, respectively,
 
recorded within Combination, integration and other acquisition
 
-related expenses.
 
The change
in total share-based compensation expense for the three
 
months ended March 31, 2021 includes performance stock units
 
and non-
elective 401(k) matching contributions in stock but excludes annual
 
incentive plan costs as a component of share-based compensation
beginning in 2020, each described further below.
Stock Options
During the first quarter of 2021, the Company granted
 
stock options under its long-term incentive plan (“LTIP
 
”) that are subject
only to time vesting over a three-year period.
 
For the purposes of determining the fair value of stock option awards,
 
the Company
used a Black-Scholes option pricing model and the assumptions
 
set forth in the table below:
Number of options granted
23,733
Dividend yield
0.85
%
Expected volatility
37.33
%
Risk-free interest rate
0.60
%
Expected term (years)
4.0
The fair value of these options is amortized on a straight
 
-line basis over the vesting period.
 
As of March 31, 2021, unrecognized
compensation expense related to all stock options
 
granted was $
2.8
 
million, to be recognized over a weighted average remaining
period of
2.5
 
years.
Restricted Stock Awards
 
and Restricted Stock Units
During the first quarter of 2021, the Company granted
12,610
 
nonvested restricted shares and
2,791
 
nonvested restricted stock
units under its LTIP,
 
subject to time-based vesting, generally over a three-year
 
period.
 
The fair value of these grants is based on the
trading price of the Company’s
 
common stock on the date of grant.
 
The Company adjusts the grant date fair value of these awards for
expected forfeitures based on historical experience.
 
As of March 31, 2021, unrecognized compensation expense
 
related to the
nonvested restricted shares was $
6.3
 
million, to be recognized over a weighted average remaining period
 
of
2.1
 
years, and
unrecognized compensation expense related to nonvested
 
restricted stock units was $
1.3
 
million, to be recognized over a weighted
average remaining period of
2.3
 
years.
Performance Stock Units
During the first quarter of 2021,
 
the Company granted performance-dependent stock awards (“PSUs”) as
 
a component of its
LTIP,
 
which will be settled in a certain number of shares subject to market
 
-based and time-based vesting conditions.
 
The number of
fully vested shares that may ultimately be issued as settlement
 
for each award may range from
0
% up to
200
% of the target award,
subject to the achievement of the Company’s
 
total shareholder return (“TSR”) relative to the performance
 
of the Company’s peer
group, the S&P Midcap 400 Materials group.
 
The service period required for the PSUs is three years and the
 
TSR measurement
period for the PSUs is from January 1 of the year of grant
 
through December 31 of the year prior to issuance.
 
Compensation expense for PSUs
 
is measured based on their grant date fair value and
 
is recognized on a straight-line basis over
the three-year vesting period.
 
The grant-date fair value of the PSUs granted during
 
the first quarter of 2021 was estimated using a
Monte Carlo simulation on the grant date and using the
 
following assumptions: (i) a risk-free rate of
0.29
%; (ii) an expected term of
3.0
 
years; and (iii) a three-year daily historical volatility for
 
each of the companies in the peer group, including Quaker
 
Houghton.
 
As of March 31, 2021, the Company estimates that it will issue
 
approximately
28,000
 
fully vested shares as of the applicable
settlement dates of all outstanding PSU awards, based
 
on the conditions of the PSUs and performance to date for each
 
award. As of
March 31, 2021, there was approximately $
4.8
 
million of total unrecognized compensation cost related to
 
PSUs, which the Company
expects to recognize over a weighted-average period
 
of
2.5
 
years.
Annual Incentive Plan
The Company maintains an Annual Incentive Plan
 
(“AIP”), which may be settled in cash or a certain number of
 
shares subject to
performance-based and time-based vesting conditions.
 
As of March 31, 2020, it was the Company’s
 
intention to settle the 2020 AIP
in shares, and therefore, expense associated with the AIP in 2020
 
was recorded as a component of share-based compensation expense.
In the fourth quarter of 2020, the Company determined
 
that it would settle the 2020 AIP in cash.
 
Therefore, the share-based
compensation associated with the AIP during the year
 
ended December 31, 2020 was reclassified from a component
 
of share-based
compensation expense to incentive compensation.
 
This determination and conclusion had no impact on the
 
classification of AIP
expense within the Company’s
 
Condensed Consolidated Statement of Operations for
 
the periods as both are a component of SG&A.
 
As of March 31, 2021, it is the Company’s
 
intention to settle the 2021 AIP in cash.
Defined Contribution Plan
The Company has a 401(k) plan with an employer
 
match covering a majority of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum
 
matching contribution of
3
% of compensation.
 
Additionally, the
 
plan provides for non-elective nondiscretionary contributions
 
on behalf of participants who have completed one year
of service equal to
3
% of the eligible participants’ compensation.
 
Beginning in April 2020 and continuing until April 2021, the
Company matched both non-elective and elective 401(k)
 
contributions in fully vested shares
 
of the Company’s common
 
stock rather
than cash.
 
Total Company contributions
 
were $
1.5
 
million for the three months ended March 31, 2021.
 
There were no similar
matching contributions in stock for the three months
 
ended March 31, 2020.
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Pension and Postretirement Benefits
 3 Months Ended
Mar. 31, 2021
General Discussion Of Pension And Other Postretirement Benefits [Abstract]  
Pension And Other Postretirement Benefits Disclosure [Text Block]
Note 9 – Pension and Other Postretirement
 
Benefits
The components of net periodic benefit cost for the
 
three months ended March 31, 2021 and 2020 are as follows:
Three Months Ended March 31,
 
Other
Pension Benefits
Postretirement Benefits
2021
2020
2021
2020
Service cost
$
316
$
1,174
$
1
$
2
Interest cost
1,090
1,769
11
26
Expected return on plan assets
(2,082)
(1,959)
—
—
Settlement loss
—
22,667
—
—
Actuarial loss amortization
855
1,047
—
15
Prior service (credit) cost amortization
2
(40)
—
—
Total net periodic
 
benefit cost
$
181
$
24,658
$
12
$
43
As disclosed in the Company’s
 
2020 Form 10-K, in the fourth quarter of 2018, the
 
Company began the process of terminating its
legacy Quaker non-contributory U.S. pension plan
 
(“Legacy Quaker U.S. Pension Plan”).
 
During the third quarter of 2019, the
Company received a favorable termination determination
 
letter from the Internal Revenue
 
Service (“I.R.S.”) and completed the
Legacy Quaker U.S. Pension Plan termination during the
 
first quarter of 2020.
 
In order to terminate the Legacy Quaker U.S. Pension
Plan in accordance with I.R.S. and Pension Benefit Guaranty Corporation
 
requirements, the Company was required to fully fund the
Legacy Quaker U.S. Pension Plan on a termination basis
 
and the amount necessary to do so was approximately $
1.8
 
million, subject to
final true up adjustments,
 
which were completed in the third quarter of 2020.
 
In addition, the Company recorded a non-cash pension
settlement charge at plan termination of
 
approximately $
22.7
 
million.
 
This settlement charge included the immediate recognition
 
into
expense of the related unrecognized losses within accumulated
 
other comprehensive (loss) income (“AOCI”) on the balance
 
sheet as
of the plan termination date.
Employer Contributions
The Company previously disclosed in its 2020 Form 10-K
 
that it expected to make minimum cash contributions of $
10.0
 
million
to its U.S. and foreign pension plans and approximately
 
$
0.3
 
million to its other postretirement benefit plans in 2021.
 
As of March 31,
2021, $
1.0
 
million and $
0.1
 
million of contributions have been made to the Company’s
 
U.S. and foreign pension plans and its other
postretirement benefit plans, respectively.
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Other Income (Expense)
 3 Months Ended
Mar. 31, 2021
Other Income And Expenses [Abstract]  
Other Income And Other Expense Disclosure [Text Block]
Note 10 – Other Income (Expense), Net
 
The components of other income (expense), net for
 
the three months ended March 31, 2021 and 2020 are as follows:
Three Months Ended
 
March 31,
2021
2020
Income from third party license fees
$
339
$
304
Foreign exchange (losses) gains, net
(1,478)
821
Gain on disposals of property,
 
plant, equipment and other assets, net
5,410
2
Non-income tax refunds and other related credits
97
1,299
Pension and postretirement benefit costs, non-service components
124
(23,525)
Other non-operating income (expense), net
195
(76)
Total other
 
income (expense), net
$
4,687
$
(21,175)
The Gain on disposals of property,
 
plant, equipment and other assets, net, during the three months
 
ended March 31, 2021,
includes the gain on the sale of certain held-for-sale
 
real property assets related to the Combination.
 
Pension and postretirement
benefit costs, non-service components during the three
 
months ended March 31, 2020 includes $
22.7
 
million related to the Legacy
Quaker U.S. Pension Plan non-cash settlement charge
 
described in Note 9 of Notes to Condensed Consolidated Financial Statements.
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes and Uncertain Tax Positions
 3 Months Ended
Mar. 31, 2021
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
Note 11 – Income Taxes
 
and Uncertain Income Tax
 
Positions
The Company’s effective
 
tax rate for the three months ended March 31, 2021 was an expense of
24.2
% compared to a benefit of
31.1
% for the three months ended March 31, 2020.
 
The Company’s effective
 
tax rate for the three months ended March 31, 2021 was
largely impacted by the sale of certain held-for-sale
 
real property assets related to the Combination.
 
Comparatively, the prior
 
year first
quarter effective tax rate was impacted by the
 
tax effect of certain one-time pre-tax losses as well as certain tax
 
charges and benefits in
the prior year period including those related to changes
 
in foreign tax credit valuation
 
allowances, tax law changes in a foreign
jurisdiction, and the tax impacts of the Company’s
 
termination of its Legacy Quaker U.S. Pension Plan and the
 
Houghton indefinite-
lived trademarks and tradename intangible asset impairment.
As of December 31, 2020, the Company had a deferred tax liability of $5.9 million, which primarily represents the Company’s
estimate of non-U.S. taxes it will incur to repatriate certain foreign earnings to the U.S. The balance as of March 31, 2021 was $6.5
million.
 
As of March 31, 2021, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
23.5
 
million, an increase of
$
1.3
 
million from the cumulative liability accrued as of December 31, 2020.
 
The Company continues to recognize interest and penalties
 
associated with uncertain tax positions as a component of
 
taxes on
income (loss) before equity in net income of associated
 
companies in its Condensed Consolidated Statements of Operations.
 
The
Company recognized an expense of less than $
0.1
 
million for interest and a benefit of less than $
0.1
 
million for penalties in its
Condensed Consolidated Statement of Operations for the
 
three months ended March 31, 2021, and recognized an expense of
 
less than
$
0.1
 
million for interest and a benefit of less than $
0.1
 
million for penalties in its Condensed Consolidated Statement of
 
Operations for
the three months ended March 31, 2020.
 
As of March 31, 2021, the Company had accrued $
3.0
 
million for cumulative interest and
$
3.6
 
million for cumulative penalties in its Condensed Consolidated Balance
 
Sheets, compared to $
3.0
 
million for cumulative interest
and $
3.9
 
million for cumulative penalties accrued at December 31, 2020.
 
During the three months ended March 31, 2021 and
 
2020, the Company recognized decreases of $
0.3
 
million and $
0.8
 
million,
respectively, in
 
its cumulative liability for gross unrecognized tax benefits due
 
to the expiration of the applicable statutes of limitations
for certain tax years.
The Company estimates that during the year ending December
 
31, 2021 it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
1.5
 
million due to the expiration of the statute of limitations with regard
 
to certain tax
positions.
 
This estimated reduction in the cumulative liability for unrecogniz
 
ed tax benefits does not consider any increase in liability
for unrecognized tax benefits with regard to existing tax
 
positions or any increase in cumulative liability for unrecognized
 
tax benefits
with regard to new tax positions for the year ending December
 
31, 2021.
The
 
Company and its subsidiaries are subject to U.S. Federal income
 
tax, as well as the income tax of various state and foreign
tax jurisdictions.
 
Tax years that remain
 
subject to examination by major tax jurisdictions include Italy
 
from
2006
, Brazil from
2011
,
the Netherlands and China from
2015
, Mexico, Spain, Germany and the United Kingdom from
2016
, Canada and the U.S. from
2017
,
India from fiscal year beginning April 1, 2018 and ending
 
March 31,
2019
, and various U.S. state tax jurisdictions from
2011
.
 
As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia
S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under
the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except
2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP
proceedings which the Company has accepted.
 
As of March 31, 2021, the Company has received $
1.6
 
million in refunds from the
Netherlands and Spain and expects to pay $
2.4
 
million due to Italy in the second quarter of 2021.
 
As of March 31, 2021, the
Company believes it has adequate reserves for the remaining
 
uncertain tax positions related to 2007.
Houghton Italia, S.r.l
 
is also involved in a corporate income tax audit with the Italian tax
 
authorities covering tax years 2014
through 2018.
 
As of March 31, 2021, the Company has a $
5.5
 
million reserve for uncertain tax positions relating to matters related
 
to
this audit.
 
Since the reserve relates to the tax periods prior to August
 
1, 2019, the tax liability was established through purchase
accounting related to the Combination.
 
The Company has also submitted an indemnification claim against
 
funds held in escrow
 
by
Houghton’s former owners
 
and as a result, a corresponding $
5.5
 
million indemnification receivable has also been established through
purchase accounting.
Houghton Deutschland GmbH is also under audit by
 
the German tax authorities for the tax years 2015-2017.
 
Based on
preliminary audit findings, primarily related to
 
transfer pricing, the Company has recorded reserves for $
0.9
 
million as of March 31,
2021.
 
Of this amount, $
0.8
 
million relates to tax periods prior to the Combination and
 
therefore the Company has submitted an
indemnification claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding
$
0.8
 
million indemnification receivable has also been established to
 
offset the $
0.8
 
million tax liability.
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share
 3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations
 
for the three months ended March 31, 2021 and 2020:
Three Months Ended
March 31,
 
2021
2020
Basic earnings (loss) per common share
 
Net income (loss) attributable to Quaker Chemical Corporation
$
38,615
$
(28,381)
Less: (income) loss allocated to participating securities
 
(154)
 
101
Net income (loss) available to common shareholders
$
 
38,461
$
(28,280)
Basic weighted average common shares outstanding
17,785,370
17,672,525
Basic earnings (loss) per common share
$
2.16
$
(1.60)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
38,615
$
(28,381)
Less: (income) loss allocated to participating securities
(154)
101
Net income (loss) available to common shareholders
$
38,461
$
(28,280)
Basic weighted average common shares outstanding
17,785,370
17,672,525
Effect of dilutive securities
70,607
—
Diluted weighted average common shares outstanding
17,855,977
17,672,525
Diluted earnings (loss) per common share
$
2.15
$
(1.60)
Certain stock options and restricted stock units are not included in the diluted earnings (loss) per share calculation when the effect
would have been anti-dilutive. The calculated amount of anti-diluted shares not included was 2,083 for the three months ended March
31, 2021. All of the Company’s potentially dilutive shares for the three months ended March 31, 2020 are anti-dilutive and not
included in the dilutive loss per share calculations because of the Company’s net loss during the period.
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Restricted Cash
 3 Months Ended
Mar. 31, 2021
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]  
Cash And Cash Equivalents Disclosure [Text Block]
Note 13 – Restricted Cash
Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary
of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an
original total value of $35.0 million. The proceeds of both settlements were restricted and could only be used to pay claims and costs
of defense associated with the subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements were deposited
into interest bearing accounts that earned less than $0.1 million offset by $0.2 million of net payments during the three months ended
March 31, 2020.
 
Due to the restricted nature of the proceeds, a corresponding
 
deferred credit was established in other non-current
liabilities for an equal and offsetting amount
 
that continued until the restrictions lapsed.
 
As disclosed in the Company’s
 
2020 Form
10-K, during December 2020, the restrictions ended
 
on these previously received insurance settlements and the
 
Company transferred
the cash into an operating account.
 
The following table provides a reconciliation of cash,
 
cash equivalents and restricted cash as of March 31, 2021 and
 
2020, as well
as December 31, 2020 and 2019:
March 31,
 
December 31,
2021
2020
2020
2019
Cash and cash equivalents
$
163,455
$
316,437
$
181,833
$
123,524
Restricted cash included in other current assets
—
34
62
353
Restricted cash included in other assets
—
19,480
—
19,678
Cash, cash equivalents and restricted cash
$
163,455
$
335,951
$
181,895
$
143,555
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Goodwill and Intangible Assets
 3 Months Ended
Mar. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]  
Goodwill And Intangible Assets Disclosure [Text Block]
Note 14 – Goodwill and Other Intangible Assets
 
Changes in the carrying amount of goodwill for the
 
three months ended March 31, 2020 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
 
$
631,212
Goodwill additions
1,093
2,626
1,308
25
5,052
Currency translation adjustments
 
(731)
(3,925)
(956)
(3,078)
 
(8,690)
Balance as of March 31,
 
2021
$
213,604
$
138,863
$
158,442
$
116,665
 
$
627,574
Gross carrying amounts and accumulated amortization
 
for definite-lived intangible assets as of March 31, 2021 and
 
December 31,
2020 were as follows:
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
846,052
 
$
839,551
 
$
110,997
 
$
99,806
Trademarks, formulations and product
 
technology
 
167,144
 
 
166,448
 
 
32,533
 
 
30,483
Other
 
6,320
 
 
6,372
 
 
5,743
 
 
5,824
Total definite
 
-lived intangible assets
$
1,019,516
 
$
1,012,371
 
$
149,273
 
$
136,113
The Company amortizes definite-lived intangible assets on
 
a straight-line basis over their useful lives.
 
The Company recorded
$
14.8
 
million and $
14.0
 
million of amortization expense for the three months ended
 
March 31, 2021 and 2020, respectively.
 
Estimated annual aggregate amortization expense for
 
the current year and subsequent five years is as follows:
For the year ended December 31, 2021
$
59,372
For the year ended December 31, 2022
59,096
For the year ended December 31, 2023
58,927
For the year ended December 31, 2024
58,427
For the year ended December 31, 2025
57,710
For the year ended December 31, 2026
57,484
The Company has four indefinite-lived intangible
 
assets totaling $
205.1
 
million as of both March 31, 2021 and December 31,
2020, including $
204.0
 
million of indefinite-lived intangible assets for trademarks and
 
tradename associated with the Combination.
Goodwill and intangible assets that have indefinite lives are
 
not amortized and are required to be assessed at least annually
 
for
impairment.
 
The Company completes its annual goodwill and indefinite-lived
 
intangible asset impairment test during the fourth
quarter of each year.
 
The Company continuously evaluates if triggering events indicate
 
a possible impairment in one or more of its
reporting units or indefinite-lived or long-lived assets.
The Company previously disclosed in its 2020 Form 10-K
 
that as of March 31, 2020, the Company concluded that the
 
impact of
COVID-19 did not represent a triggering event with
 
regards to the Company’s
 
reporting units or indefinite-lived and long-lived assets,
except for the Company’s
 
Houghton and Fluidcare trademarks and tradename indefinite
 
-lived intangible assets.
 
The determination of
estimated fair value of the Houghton and Fluidcare
 
trademarks and tradename indefinite-lived assets was based on a relief
 
from
royalty valuation method,
 
which requires management’s judgment
 
and often involves the use of significant estimates and assumptions,
including assumptions with respect to the weighted average
 
cost of capital (“WACC”)
 
and royalty rates, as well as revenue growth
rates and terminal growth rates.
 
In the first quarter of 2020, as a result of the impact of
 
COVID-19 driving a decrease in projected
legacy Houghton net sales during that year and the impact
 
of the sales decline on projected future legacy Houghton
 
net sales as well as
an increase in the WACC
 
assumption utilized in the quantitative impairment
 
assessment, the Company concluded that the estimated
fair values of the Houghton and Fluidcare trademarks
 
and tradename intangible assets were less than their carrying values.
 
As a
result, an impairment charge of $
38.0
 
million was recorded in the first quarter of 2020 to write down
 
the carrying values of these
intangible assets to their estimated fair values.
As of March 31, 2021, the Company continued to evaluate
 
the on-going impact of COVID-19 on the Company’s
 
operations, and
the volatility and uncertainty in the economic outlook as a result of
 
COVID-19, to determine if this indicated it was more likely
 
than
not that the carrying value of any of the Company’s
 
reporting units or indefinite-lived or long-lived intangible assets were
 
not
recoverable.
 
The Company concluded that the impact of COVID-19 did not represent
 
a triggering event as of March 31, 2021.
 
While
the Company concluded that the impact of COVID-19
 
did not represent a triggering event as of March 31, 2021,
 
the Company will
continue to evaluate the impact of COVID-19 on the Company’s
 
current and projected results.
 
If the current economic conditions
worsen or projections of the timeline for recovery are
 
significantly extended, then the Company may conclude in the
 
future that the
impact from COVID-19 requires the need to perform
 
further interim quantitative impairment tests, which could
 
result in additional
impairment charges in the future.
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Debt
 3 Months Ended
Mar. 31, 2021
Debt [Abstract]  
Debt Disclosure [Text Block]
Note 15 – Debt
Debt as of March 31, 2021 and December 31, 2020 includes
 
the following:
As of March 31, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.61%
$
190,000
1.65%
$
160,000
U.S. Term Loan
1.61%
562,500
1.65%
570,000
EURO Term Loan
1.50%
148,210
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,377
Various
2,072
Total debt
$
913,087
$
899,134
Less: debt issuance costs
(10,324)
(11,099)
Less: short-term and current portion of long-term debts
(43,330)
(38,967)
Total long
 
-term debt
$
859,433
$
849,068
Credit facilities
The Company’s primary
 
credit facility (as amended, the “Credit Facility”) is comprised
 
of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the
 
“EURO Term Loan”
 
and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a five-year term maturing in
August 2024.
 
Subject to the consent of the administrative agent and certain
 
other conditions, the Company may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be
 
increased by up to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional
 
commitments and the Company has satisfied certain other
 
conditions.
 
Borrowings under the Credit Facility bear interest at a base
 
rate or LIBOR plus an applicable margin based upon
 
the Company’s
consolidated net leverage ratio.
 
There are LIBOR replacement provisions that contemplate a further
 
amendment if and when LIBOR
ceases to be reported.
 
The variable interest rate incurred on the outstanding borrowings under
 
the Credit Facility as of and during the
three months ended March 31, 2021 was approximately
1.6
%.
 
In addition to paying interest on outstanding principal under
 
the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s
 
consolidated net
leverage ratio to the lenders under the Revolver in
 
respect of the unutilized commitments thereunder.
 
The Company has unused
capacity under the Revolver of approximately $
204
 
million, net of bank letters of credit of approximately $
6
 
million, as of March 31,
2021.
 
The Credit Facility is subject to certain financial and
 
other covenants.
 
The Company’s initial consolidated net debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit
Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 4.00 to 1. The Company’s
consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit
Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually
exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to
consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.
 
As of March 31, 2021 and
December 31, 2020, the Company was in compliance with all of the Credit Facility covenants
.
 
The Term Loans
 
have quarterly
principal amortization during their five-year terms,
 
with
5.0
% amortization of the principal balance due in years
 
1 and 2,
7.5
% in year
3, and
10.0
% in years 4 and 5, with the remaining principal amount due at
 
maturity.
 
During the three months ended March 31, 2021,
the Company made quarterly amortization payments
 
related to the Term Loans
 
totaling $
9.6
 
million.
 
The Credit Facility is guaranteed
by certain of the Company’s
 
domestic subsidiaries and is secured by first priority liens on substantially
 
all of the assets of the
Company and the domestic subsidiary guarantors,
 
subject to certain customary exclusions.
 
The obligations of the Dutch borrower are
guaranteed only by certain foreign subsidiaries on an unsecured
 
basis.
The Credit Facility required the Company to fix its variable
 
interest rates on at least 20% of its total Term
 
Loans.
 
In order to
satisfy this requirement as well as to manage the
 
Company’s exposure to variable
 
interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three-year interest rate swaps at a base
 
rate of
1.64
% plus an applicable margin as provided in the Credit
 
Facility, based on the Company’s
 
consolidated net leverage ratio.
 
At the
time the Company entered into the swaps, and as
 
of March 31, 2021, the aggregate interest rate on the swaps,
 
including the fixed base
rate plus an applicable margin, was
3.1
%.
 
See Note 18 of Notes to Condensed Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection
 
with executing the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s
 
Condensed Consolidated Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were
attributed to the Revolver and recorded within other assets on
 
the Company’s Condensed Consolidated
 
Balance Sheet.
 
These
capitalized costs are being amortized into interest expense
 
over the five-year term of the Credit Facility.
 
As of March 31, 2021 and
December 31, 2020, the Company had $
10.3
 
million and $
11.1
 
million, respectively,
 
of debt issuance costs recorded as a reduction of
long-term debt.
 
As of March 31, 2021 and December 31, 2020, the Company
 
had $
5.5
 
million and $
5.9
 
million, respectively,
 
of debt
issuance costs recorded within other assets.
Industrial development bonds
As of March 31, 2021 and December 31, 2020,
 
the Company had fixed rate, industrial development authority
 
bonds totaling
$
10.0
 
million in principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted
 
above.
Bank lines of credit and other
 
debt obligations
 
The Company has certain unsecured bank lines of credit
 
and discounting facilities in certain foreign subsidiaries, which are
 
not
collateralized.
 
The Company’s other debt
 
obligations primarily consist of certain domestic and foreign
 
low interest rate or interest-
free municipality-related loans, local credit facilities of
 
certain foreign subsidiaries and capital lease obligations.
 
Total unused
capacity under these arrangements as of March 31,
 
2021 was approximately $
40
 
million.
 
In addition to the bank letters of credit described in
 
the “Credit facilities” subsection above, the Company’s
 
only other off-balance
sheet arrangements include certain financial and other
 
guarantees.
 
The Company’s total bank
 
letters of credit and guarantees
outstanding as of March 31, 2021 were approximately
 
$
9
 
million.
The Company incurred the following debt related expenses
 
included within Interest expense, net, in the Condensed
 
Consolidated
Statements of Operations:
Three Months Ended
March 31,
 
2021
2020
Interest expense
$
4,650
$
7,712
Amortization of debt issuance costs
1,187
1,187
Total
$
5,837
$
8,899
Based on the variable interest rates associated with the Credit
 
Facility, as of March
 
31, 2021 and December 31, 2020, the amounts
at which the Company’s
 
total debt were recorded are not materially different
 
from their fair market value.
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Equity and Noncontrolling Interest
 3 Months Ended
Mar. 31, 2021
Stockholders Equity [Abstract]  
Stockholders Equity Note Disclosure [Text Block]
Note 16 – Equity
The following tables present the changes in equity,
 
net of tax, for the three months ended March 31, 2021 and 2020:
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
38,615
—
17
38,632
Amounts reported in other comprehensive
 
loss
—
—
—
(26,630)
(2)
(26,632)
Dividends ($
0.395
 
per share)
—
—
(7,062)
—
—
(7,062)
Share issuance and equity-based
compensation plans
24
3,577
—
—
—
3,601
Balance at March 31, 2021
$
17,875
$
908,748
$
455,493
$
(53,228)
$
565
$
1,329,453
Balance at December 31, 2019
$
17,735
$
888,218
$
412,979
$
(78,170)
$
1,604
$
1,242,366
Cumulative effect of an accounting change
—
—
(402)
—
—
(402)
Balance at January 1, 2020
17,735
888,218
412,577
(78,170)
1,604
1,241,964
Net (loss) income
—
—
(28,381)
—
37
(28,344)
Amounts reported in other comprehensive
 
 
loss
—
—
—
(43,354)
(132)
(43,486)
Dividends ($
0.385
 
per share)
—
—
(6,834)
—
—
(6,834)
Acquisition of noncontrolling interest
—
(707)
—
—
(340)
(1,047)
Distributions to noncontrolling affiliate
 
shareholders
—
—
—
—
(751)
(751)
Share issuance and equity-based
compensation plans
17
1,022
—
—
—
1,039
Balance at March 31, 2020
$
17,752
$
888,533
$
377,362
$
(121,524)
$
418
$
1,162,541
The following tables show the reclassifications from and
 
resulting balances of AOCI for the three months ended
 
March 31, 2021
and 2020:
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Retirement
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
reclassifications
(25,459)
781
(745)
730
(24,693)
Amounts reclassified from AOCI
—
862
(3,085)
—
(2,223)
Current period other comprehensive (loss) income
(25,459)
1,643
(3,830)
730
(26,916)
Related tax amounts
—
(351)
805
(168)
286
Net current period other comprehensive (loss) income
(25,459)
1,292
(3,025)
562
(26,630)
Balance at March 31, 2021
$
(28,334)
$
(22,175)
$
317
$
(3,036)
$
(53,228)
Balance at December 31, 2019
$
(44,568)
$
(34,533)
$
1,251
$
(320)
$
(78,170)
Other comprehensive (loss) income before
 
reclassifications
(54,619)
828
(2,135)
(5,170)
(61,096)
Amounts reclassified from AOCI
—
24,366
(32)
—
24,334
Current period other comprehensive (loss) income
(54,619)
25,194
(2,167)
(5,170)
(36,762)
Related tax amounts
—
(8,237)
456
1,189
(6,592)
Net current period other comprehensive (loss) income
(54,619)
16,957
(1,711)
(3,981)
(43,354)
Balance at March 31, 2020
$
(99,187)
$
(17,576)
$
(460)
$
(4,301)
$
(121,524)
All reclassifications related to unrealized gain (loss) in
 
available-for-sale securities relate to the Company’s
 
equity interest in a
captive insurance company and are recorded in equity
 
in net income of associated companies.
 
The amounts reported in other
comprehensive income for non-controlling interest are
 
related to currency translation adjustments.
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
Note 17 – Fair Value
 
Measurements
 
The Company has valued its company-owned life insurance
 
policies at fair value.
 
These assets are subject to fair value
measurement as follows:
Fair Value
 
Measurements at March 31, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,015
$
—
$
2,015
$
—
Total
$
2,015
$
—
$
2,015
$
—
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
—
$
1,961
$
—
Total
$
1,961
$
—
$
1,961
$
—
The fair values of Company-owned life insurance assets are based
 
on quotes for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of March
 
31, 2021 or December 31, 2020, respectively,
 
so related
disclosures have not been included.
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Hedging Activities
 3 Months Ended
Mar. 31, 2021
General Discussion Of Derivative Instruments And Hedging Activities [Abstract]  
Derivative Instruments And Hedging Activities Disclosure [Text Block]
Note 18 – Hedging Activities
In order to satisfy certain requirements of the Credit
 
Facility as well as to manage the Company’s
 
exposure to variable interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of three-
year interest rate swaps.
 
See Note 15 of Notes to Condensed Consolidated Financial Statements.
 
These interest rate swaps are
designated as cash flow hedges and, as such, the contracts
 
are marked-to-market at each reporting date and any unrealized gains
 
or
losses are included in AOCI to the extent effective
 
and reclassified to interest expense in the period during which the
 
transaction
effects earnings or it becomes probable that
 
the forecasted transaction will not occur.
 
The balance sheet classification and fair values of the
 
Company’s derivative instruments,
 
which are Level 2 measurements, are as
follows:
Fair Value
Condensed Consolidated
March 31,
 
December 31,
Balance Sheet Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
3,943
$
4,672
$
3,943
$
4,672
The following table presents the net unrealized loss deferred to
 
AOCI:
March 31,
 
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
3,036
$
3,598
$
3,036
$
3,598
The following table presents the net gain reclassified from
 
AOCI to earnings:
Three Months Ended
March 31,
 
2021
2020
Amount and location of (expense) income reclassified
 
 
from AOCI into (expense) income (Effective Portion)
Interest expense, net
$
(643)
$
19
Interest rate swaps are entered into with a limited number
 
of counterparties, each of which allows for net settlement
 
of all
contracts through a single payment in a single currency
 
in the event of a default on or termination of any one
 
contract.
 
As such, in
accordance with the Company’s
 
accounting policy,
 
these derivative instruments are recorded on a net basis by
 
counterparty within the
Condensed Consolidated Balance Sheets.
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2021
Commitments And Contingencies Disclosure [Abstract]  
Commitments And Contingencies Disclosure [Text Block]
Note 19 – Commitments and Contingencies
The Company previously disclosed in its 2020 Form 10-K
 
that AC Products, Inc. (“ACP”), a wholly owned subsidiary,
 
has been
operating a groundwater treatment system to hydraulically
 
contain groundwater contamination emanating from ACP’s
 
site, the
principal contaminant of which is perchloroethylene.
 
As of March 31, 2021, ACP believes it is close to meeting the conditions
 
for
closure of the groundwater treatment system, but continues
 
to operate this system while in discussions with the relevant
 
authorities.
 
As of March 31, 2021, the Company believes that the range
 
of potential-known liabilities associated with the balance
 
of the ACP
water remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length
of operation of the treatment system as determined
 
by groundwater modeling.
 
Costs of operation include the operation and
maintenance of the extraction well, groundwater monitoring
 
and program management.
 
The Company previously disclosed in its 2020 Form 10-K
 
that an inactive subsidiary of the Company that was acquired
 
in 1978
sold certain products containing asbestos, primarily
 
on an installed basis, and is among the defendants in numerous
 
lawsuits alleging
injury due to exposure to asbestos.
 
During the three months ended March 31, 2021, there
 
have been no significant changes to the facts
or circumstances of this previously disclosed matter,
 
aside from on-going claims and routine payments associated with
 
this litigation.
 
Based on a continued analysis of the existing and anticipated
 
future claims against this subsidiary,
 
it is currently projected that the
subsidiary’s total liability
 
over the next 50 years for these claims is approximately
 
$
0.4
 
million (excluding costs of defense).
 
 
The Company previously disclosed in its 2020 Form 10-K
 
that it is party to certain environmental matters related to certain
domestic and foreign properties currently or previously
 
owned by Houghton.
 
These environmental matters primarily require the
Company to perform long-term monitoring as well as operating
 
and maintenance at each of the applicable sites.
 
During the three
months ended March 31, 2021, there have been no
 
significant changes to the facts or circumstances of these previously
 
disclosed
matters, aside from on-going monitoring and maintenance
 
activities and routine payments associated with each of the
 
sites.
 
The
Company continually evaluates its obligations related to such
 
matters, and based on historical costs incurred and projected
 
costs to be
incurred over the next 28 years, has estimated the present
 
value range of costs for all of the Houghton
 
environmental matters, on a
discounted basis, to be between approximately $
5
 
million and $
6
 
million as of March 31, 2021, for which $
5.7
 
million was accrued
within other accrued liabilities and other non-current
 
liabilities on the Company’s Condensed
 
Consolidated Balance Sheet as of March
31, 2021.
 
Comparatively, as of December
 
31, 2020, the Company had $
6.0
 
million accrued for with respect to these matters.
The Company believes, although there can be no assurance
 
regarding the outcome of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other
 
environmental problems of which it is aware.
 
Approximately $
0.1
million were accrued as of both March 31, 2021 and
 
December 31, 2020, to provide for such anticipated future
 
environmental
assessments and remediation costs.
 
The Company previously disclosed in its 2020 Form 10-K
 
that one of the Company’s subsidiaries
 
received a notice of inspection
from a taxing authority in a country where certain
 
of its subsidiaries operate which related to a non-income (indirect)
 
tax that may be
applicable to certain products the subsidiary sells.
 
To date, the Company
 
has not received any assessment from the authority related
 
to
potential liabilities that may be due from the Company’s
 
subsidiary.
 
Consequently, there is substantial uncertai
 
nty with respect to the
Company’s ultimate liability
 
with respect to this indirect tax, as the application of
 
this tax in its given market is ambiguous and
interpreted differently among other peer companies
 
and taxing authorities.
 
The Company, with assistance
 
from independent experts,
has performed an evaluation of the applicability of this
 
indirect tax to the Company’s
 
subsidiaries in this country.
 
Information
available to the Company at this time is only sufficient
 
to establish a range of probable liability,
 
and no amount within the range is
considered a better estimate than another.
 
During the three months ended March 31, 2021 and through the
 
date of this Report,
 
there
have been no significant changes to the facts or circumstances of
 
this previously disclosed matter, aside
 
from on-going discussions
between the Company and the taxing authority related
 
to this notice of inspection.
 
As of March 31, 2021, the Company has recorded a
liability of $
1.7
 
million in other accrued liabilities, which reflects the low end
 
of the range of probable indirect tax owed, including
interest and taking into account applicable statutes of limitations.
 
Because these amounts in part relate to a Houghton entity acquired
in the Combination and for periods prior to the Combination,
 
the Company has submitted an indemnification claim
 
with Houghton’s
former owners related to this potential indirect tax liability.
 
The Company recorded a receivable in other assets for approximately
$
1.1
 
million, which reflects the amount of the initial recorded liability
 
for which the Company anticipates being indemnified.
 
As
noted, the Company believes there is substantial uncertainty
 
with respect to its ultimate liability given the ambiguous
 
application of
this indirect tax.
 
At this time, the Company’s best estimate
 
of a potential range for possible assessments, including
 
additional amounts
that may be assessed under these indirect tax laws, would
 
be approximately $
0.6
 
million to $
38
 
million, which is net of approximately
$
10
 
million of estimated income tax deductions and approximately $
22
 
million of applicable rights to indemnification from
Houghton’s former owners.
The Company is party to other litigation which management
 
currently believes will not have a material adverse
 
effect on the
Company’s results of
 
operations, cash flows or financial condition.
 
In addition, the Company has an immaterial amount of contractual
purchase obligations.
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Basis Of Accounting Policy [Policy Text Block]
The condensed consolidated financial statements included herein
 
are unaudited and have
been prepared in accordance with generally accepted
 
accounting principles in the United States (“U.S. GAAP”) for
 
interim financial
reporting and the United States Securities and Exchange Commission
 
(“SEC”) regulations.
 
Certain information and footnote
disclosures normally included in financial statements prepared
 
in accordance with U.S. GAAP have been condensed or
 
omitted
pursuant to such rules and regulations.
 
In the opinion of management, the financial statements reflect all
 
adjustments which are
necessary for a fair statement of the financial position,
 
results of operations and cash flows for the interim periods.
 
The results for the
three months ended March 31, 2021 are not necessarily
 
indicative of the results to be expected for the full year.
 
These financial
statements should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year
 
ended December 31,
2020 (the “2020 Form 10-K”).
Segment Reporting, Policy [Policy Text Block]
The Company’s operating
 
segments, which are consistent with its reportable segments,
 
reflect the structure of the Company’s
internal organization, the method by which
 
the Company’s resources are allocated
 
and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net
 
sales and operations in
each respective region, excluding net sales and operations
 
managed globally by the Global Specialty Businesses segment, which
includes the Company’s
 
container, metal finishing, mining,
 
offshore, specialty coatings, specialty grease and
 
Norman Hay businesses.
Revenue Recognition [Policy Text Block]
The Company applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify
 
the contract with a
customer; (ii) identify the performance obligations in
 
the contract; (iii) determine the transaction price; (iv) allocate the
 
transaction
price to the performance obligations in the contract; and
 
(v) recognize revenue when, or as, the Company satisfies a performance
obligation.
 
Refer to the Company’s 2020
 
Form 10-K for additional information on the Company’s
 
revenue recognition policies,
including its practical expedients and accounting policy
 
elections.
The Company recognizes a contract asset or receivable
 
on its Condensed Consolidated Balance Sheet when the Company
performs a service or transfers a good in advance
 
of receiving consideration.
 
A receivable is the Company’s
 
right to consideration that
is unconditional and only the passage of time is required
 
before payment of that consideration is due.
 
A contract asset is the
Company’s right to consideration
 
in exchange for goods or services that the Company has transferred
 
to a customer.
A contract liability is recognized when the Company
 
receives consideration, or if it has the unconditional right
 
to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration,
 
or a specified amount of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue
 
recorded for customer payments received by the Company
 
prior to the
Company satisfying the associated performance obligation.
 
Deferred revenues are presented within other current liabilities
 
in the
Company’s Condensed
 
Consolidated Balance Sheets.
Revenue From Contract With Customer [Policy Text Block]
As part of the Company’s
 
Fluidcare business, certain third-party product sales to customers are
 
managed by the Company.
 
Where
the Company acts as a principal, revenues are recognized
 
on a gross reporting basis at the selling price negotiated with
 
its customers.
Where the Company acts as an agent, revenue is recognized on
 
a net reporting basis at the amount of the administrative fee earned
 
by
the Company for ordering the goods.
Goodwill And Intangible Assets, Goodwill, Policy [Policy Text Block]
Goodwill and intangible assets that have indefinite lives are
 
not amortized and are required to be assessed at least annually
 
for
impairment.
 
The Company completes its annual goodwill and indefinite-lived
 
intangible asset impairment test during the fourth
quarter of each year.
 
The Company continuously evaluates if triggering events indicate
 
a possible impairment in one or more of its
reporting units or indefinite-lived or long-lived assets.
Lessee Leases [Policy Text Block]
The Company determines if an arrangement is a lease
 
at its inception.
 
This determination generally depends on whether the
arrangement conveys the right to control the use of an
 
identified fixed asset explicitly or implicitly for a period of
 
time in exchange for
consideration.
 
Control of an underlying asset is conveyed if the Company
 
obtains the rights to direct the use of, and obtains
substantially all of the economic benefits from the use
 
of, the underlying asset.
 
Lease expense for variable leases and short-term
leases is recognized when the obligation is incurred.
Credit Loss Financial Instrument [Policy Text Block]
The Company recognizes an
allowance for credit losses, which represents the portion
 
of its trade accounts receivable that the Company does not expect
 
to collect
over the contractual life, considering past events
 
and reasonable and supportable forecasts of future economic
 
conditions.
 
The
Company’s allowance
 
for credit losses on its trade accounts receivables
 
is based on specific collectability facts and circumstances for
each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection
 
risk the Company
estimates for certain past due aging categories, and
 
also, the general risk to all outstanding accounts receivable based on historical
amounts determined to be uncollectible.
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Business Combinations (Tables)
 3 Months Ended
Mar. 31, 2021
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
—
$
958
Accounts receivable
8,473
—
8,473
Inventories
4,527
—
4,527
Prepaid expenses and other assets
181
—
181
Property, plant and
 
equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
53
2,867
Total assets purchased
57,720
205
57,925
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued
 
liabilities
3,482
—
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
(351)
53,704
Less: estimated purchase price settlement
—
(351)
(351)
Less: cash acquired
958
—
958
Net cash paid for Coral
$
53,097
$
—
$
53,097
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Business Segments (Tables)
 3 Months Ended
Mar. 31, 2021
Segment Reporting Measurement Disclosures [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Three Months Ended
March 31,
 
2021
2020
Net sales
 
 
 
 
 
 
Americas
$
134,871
$
129,896
EMEA
 
119,814
 
104,839
Asia/Pacific
 
96,706
 
73,552
Global Specialty Businesses
 
78,392
 
70,274
Total
 
net sales
$
429,783
$
378,561
Segment operating earnings
Americas
$
32,234
$
29,188
EMEA
25,244
18,359
Asia/Pacific
27,478
19,541
Global Specialty Businesses
 
24,169
 
20,560
Total
 
segment operating earnings
 
109,125
 
87,648
Combination, integration and other acquisition-related
 
expenses
(5,815)
(7,878)
Restructuring and related charges
(1,175)
(1,716)
Fair value step up of acquired inventory sold
(801)
—
Indefinite-lived intangible asset impairment
—
(38,000)
Non-operating and administrative expenses
 
(40,992)
 
(38,451)
Depreciation of corporate assets and amortization
 
(15,448)
 
(14,047)
Operating income (loss)
44,894
(12,444)
Other income (expense), net
4,687
(21,175)
Interest expense, net
 
(5,470)
 
(8,461)
Income (loss) before taxes and equity in net income of
 
associated companies
$
44,111
$
(42,080)
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Net Sales and Revenue Recognition (Tables)
 3 Months Ended
Mar. 31, 2021
Disaggregation Of Revenue [Abstract]  
Disaggregation Of Revenue [Table Text Block]
Three Months Ended March 31,
 
2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
46,793
$
34,274
$
49,743
 
$
130,810
Metalworking and other
88,078
85,540
46,963
220,581
134,871
119,814
96,706
351,391
Global Specialty Businesses
45,256
20,272
12,864
78,392
$
180,127
$
140,086
$
109,570
$
429,783
Timing of Revenue Recognized
Product sales at a point in time
$
171,594
$
131,162
$
106,399
 
$
409,155
Services transferred over time
8,533
8,924
3,171
20,628
$
180,127
$
140,086
$
109,570
$
429,783
Three Months Ended March 31,
 
2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
46,673
$
29,888
$
41,589
 
$
118,150
Metalworking and other
83,223
74,951
31,963
190,137
129,896
104,839
73,552
308,287
Global Specialty Businesses
44,231
16,605
9,438
70,274
$
174,127
$
121,444
$
82,990
$
378,561
Timing of Revenue Recognized
Product sales at a point in time
$
168,802
$
118,423
$
81,156
 
$
368,381
Services transferred over time
5,325
3,021
1,834
10,180
$
174,127
$
121,444
$
82,990
$
378,561
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Leases (Tables)
 3 Months Ended
Mar. 31, 2021
Leases [Abstract]  
Operating Leases Of Lessee Disclosure [Text Block]
March 31,
December 31,
2021
2020
Right of use lease assets
$
38,027
$
38,507
Other current liabilities
10,419
10,901
Long-term lease liabilities
27,050
27,070
Total operating
 
lease liabilities
$
37,469
$
37,971
Weighted average
 
remaining lease term (years)
5.9
6.0
Weighted average
 
discount rate
4.26%
4.20%
Lessee Operating Lease Liability Maturity [Table Text Block]
March 31,
2021
For the remainder of 2021
$
9,269
For the year ended December 31, 2022
9,042
For the year ended December 31, 2023
6,932
For the year ended December 31, 2024
5,194
For the year ended December 31, 2025
4,211
For the year ended December 31, 2026 and beyond
8,116
Total lease payments
42,764
Less: imputed interest
(5,295)
Present value of lease liabilities
$
37,469
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring Activities (Tables)
 3 Months Ended
Mar. 31, 2021
Restructuring And Related Activities [Abstract]  
Restructuring and Related Costs [Table Text Block]
QH Program
Accrued restructuring as of December 31, 2020
$
8,248
Restructuring and related charges
1,175
Cash payments
(3,034)
Currency translation adjustments
(419)
Accrued restructuring as of March 31, 2021
$
5,970
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Share based Payments [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
Three Months Ended
March 31,
 
2021
2020
Stock options
$
308
$
432
Non-vested stock awards and restricted stock units
1,396
1,264
Non-elective and elective 401(k) matching contribution in
 
stock
1,553
—
Director stock ownership plan
203
40
Performance stock units
319
—
Annual incentive plan
—
2,946
Total share-based
 
compensation expense
$
3,779
$
4,682
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Number of options granted
23,733
Dividend yield
0.85
%
Expected volatility
37.33
%
Risk-free interest rate
0.60
%
Expected term (years)
4.0
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Pension and Postretirement Benefits (Tables)
 3 Months Ended
Mar. 31, 2021
General Discussion Of Pension And Other Postretirement Benefits [Abstract]  
Schedule Of Net Benefit Costs [Table Text Block]
Three Months Ended March 31,
 
Other
Pension Benefits
Postretirement Benefits
2021
2020
2021
2020
Service cost
$
316
$
1,174
$
1
$
2
Interest cost
1,090
1,769
11
26
Expected return on plan assets
(2,082)
(1,959)
—
—
Settlement loss
—
22,667
—
—
Actuarial loss amortization
855
1,047
—
15
Prior service (credit) cost amortization
2
(40)
—
—
Total net periodic
 
benefit cost
$
181
$
24,658
$
12
$
43
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Other Income (Expense) (Tables)
 3 Months Ended
Mar. 31, 2021
Other Income And Expenses [Abstract]  
Schedule Of Other Nonoperating Income (Expense) [Table Text Block]
Three Months Ended
 
March 31,
2021
2020
Income from third party license fees
$
339
$
304
Foreign exchange (losses) gains, net
(1,478)
821
Gain on disposals of property,
 
plant, equipment and other assets, net
5,410
2
Non-income tax refunds and other related credits
97
1,299
Pension and postretirement benefit costs, non-service components
124
(23,525)
Other non-operating income (expense), net
195
(76)
Total other
 
income (expense), net
$
4,687
$
(21,175)
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Three Months Ended
March 31,
 
2021
2020
Basic earnings (loss) per common share
 
Net income (loss) attributable to Quaker Chemical Corporation
$
38,615
$
(28,381)
Less: (income) loss allocated to participating securities
 
(154)
 
101
Net income (loss) available to common shareholders
$
 
38,461
$
(28,280)
Basic weighted average common shares outstanding
17,785,370
17,672,525
Basic earnings (loss) per common share
$
2.16
$
(1.60)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
38,615
$
(28,381)
Less: (income) loss allocated to participating securities
(154)
101
Net income (loss) available to common shareholders
$
38,461
$
(28,280)
Basic weighted average common shares outstanding
17,785,370
17,672,525
Effect of dilutive securities
70,607
—
Diluted weighted average common shares outstanding
17,855,977
17,672,525
Diluted earnings (loss) per common share
$
2.15
$
(1.60)
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.21.1
Restricted Cash (Tables)
 3 Months Ended
Mar. 31, 2021
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]  
Schedule Of Cash And Cash Equivalents [Table Text Block]
March 31,
 
December 31,
2021
2020
2020
2019
Cash and cash equivalents
$
163,455
$
316,437
$
181,833
$
123,524
Restricted cash included in other current assets
—
34
62
353
Restricted cash included in other assets
—
19,480
—
19,678
Cash, cash equivalents and restricted cash
$
163,455
$
335,951
$
181,895
$
143,555
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Goodwill and Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill [Table Text Block]
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
 
$
631,212
Goodwill additions
1,093
2,626
1,308
25
5,052
Currency translation adjustments
 
(731)
(3,925)
(956)
(3,078)
 
(8,690)
Balance as of March 31,
 
2021
$
213,604
$
138,863
$
158,442
$
116,665
 
$
627,574
Schedule Of Finite Lived Intangible Assets [Table Text Block]
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
846,052
 
$
839,551
 
$
110,997
 
$
99,806
Trademarks, formulations and product
 
technology
 
167,144
 
 
166,448
 
 
32,533
 
 
30,483
Other
 
6,320
 
 
6,372
 
 
5,743
 
 
5,824
Total definite
 
-lived intangible assets
$
1,019,516
 
$
1,012,371
 
$
149,273
 
$
136,113
Schedule of Finite Lived Intangible Assets Future Amortization Expense [TableText Block]
For the year ended December 31, 2021
$
59,372
For the year ended December 31, 2022
59,096
For the year ended December 31, 2023
58,927
For the year ended December 31, 2024
58,427
For the year ended December 31, 2025
57,710
For the year ended December 31, 2026
57,484
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Debt (Tables)
 3 Months Ended
Mar. 31, 2021
Debt [Abstract]  
Schedule Of Debt [Table Text Block]
As of March 31, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.61%
$
190,000
1.65%
$
160,000
U.S. Term Loan
1.61%
562,500
1.65%
570,000
EURO Term Loan
1.50%
148,210
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,377
Various
2,072
Total debt
$
913,087
$
899,134
Less: debt issuance costs
(10,324)
(11,099)
Less: short-term and current portion of long-term debts
(43,330)
(38,967)
Total long
 
-term debt
$
859,433
$
849,068
Interest Income And Interest Expense Disclosure [Table Text Block]
Three Months Ended
March 31,
 
2021
2020
Interest expense
$
4,650
$
7,712
Amortization of debt issuance costs
1,187
1,187
Total
$
5,837
$
8,899
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.21.1
Equity and Noncontrolling Interest (Tables)
 3 Months Ended
Mar. 31, 2021
Stockholders Equity [Abstract]  
Schedule of Stockholders Equity [Table Text Block]
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
38,615
—
17
38,632
Amounts reported in other comprehensive
 
loss
—
—
—
(26,630)
(2)
(26,632)
Dividends ($
0.395
 
per share)
—
—
(7,062)
—
—
(7,062)
Share issuance and equity-based
compensation plans
24
3,577
—
—
—
3,601
Balance at March 31, 2021
$
17,875
$
908,748
$
455,493
$
(53,228)
$
565
$
1,329,453
Balance at December 31, 2019
$
17,735
$
888,218
$
412,979
$
(78,170)
$
1,604
$
1,242,366
Cumulative effect of an accounting change
—
—
(402)
—
—
(402)
Balance at January 1, 2020
17,735
888,218
412,577
(78,170)
1,604
1,241,964
Net (loss) income
—
—
(28,381)
—
37
(28,344)
Amounts reported in other comprehensive
 
 
loss
—
—
—
(43,354)
(132)
(43,486)
Dividends ($
0.385
 
per share)
—
—
(6,834)
—
—
(6,834)
Acquisition of noncontrolling interest
—
(707)
—
—
(340)
(1,047)
Distributions to noncontrolling affiliate
 
shareholders
—
—
—
—
(751)
(751)
Share issuance and equity-based
compensation plans
17
1,022
—
—
—
1,039
Balance at March 31, 2020
$
17,752
$
888,533
$
377,362
$
(121,524)
$
418
$
1,162,541
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
 
Translation
Retirement
Available-for
 
-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
reclassifications
(25,459)
781
(745)
730
(24,693)
Amounts reclassified from AOCI
—
862
(3,085)
—
(2,223)
Current period other comprehensive (loss) income
(25,459)
1,643
(3,830)
730
(26,916)
Related tax amounts
—
(351)
805
(168)
286
Net current period other comprehensive (loss) income
(25,459)
1,292
(3,025)
562
(26,630)
Balance at March 31, 2021
$
(28,334)
$
(22,175)
$
317
$
(3,036)
$
(53,228)
Balance at December 31, 2019
$
(44,568)
$
(34,533)
$
1,251
$
(320)
$
(78,170)
Other comprehensive (loss) income before
 
reclassifications
(54,619)
828
(2,135)
(5,170)
(61,096)
Amounts reclassified from AOCI
—
24,366
(32)
—
24,334
Current period other comprehensive (loss) income
(54,619)
25,194
(2,167)
(5,170)
(36,762)
Related tax amounts
—
(8,237)
456
1,189
(6,592)
Net current period other comprehensive (loss) income
(54,619)
16,957
(1,711)
(3,981)
(43,354)
Balance at March 31, 2020
$
(99,187)
$
(17,576)
$
(460)
$
(4,301)
$
(121,524)
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Fair Value
 
Measurements at March 31, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,015
$
—
$
2,015
$
—
Total
$
2,015
$
—
$
2,015
$
—
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
—
$
1,961
$
—
Total
$
1,961
$
—
$
1,961
$
—
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.21.1
Hedging Activities (Tables)
 3 Months Ended
Mar. 31, 2021
General Discussion Of Derivative Instruments And Hedging Activities [Abstract]  
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]
Fair Value
Condensed Consolidated
March 31,
 
December 31,
Balance Sheet Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
3,943
$
4,672
$
3,943
$
4,672
March 31,
 
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
3,036
$
3,598
$
3,036
$
3,598
Three Months Ended
March 31,
 
2021
2020
Amount and location of (expense) income reclassified
 
 
from AOCI into (expense) income (Effective Portion)
Interest expense, net
$
(643)
$
19
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Financial Information (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Reclassification [Line Items]      
Cost of goods sold $ 273,589 $ 244,710  
Number Of Countries In Which Entity Operates 25    
Number Of Reportable Segments 4    
Schedule of Equity Method Investments [Line Items]      
Equity Method Investment $ 96,213   $ 95,785
Argentina Subsidiary [Member]      
Financial Statement Line Items With Differences In Reported Amount And Reporting Currency Denominated Amounts [Line Items]      
Amount Recognized In Income Due To Inflationary Accounting $ 200 $ 100  
Argentina Assets Total [Member]      
Concentration Risk [Line Items]      
Concentration Risk, Percentage 1.00%    
Argentina Sales Revenue Net [Member]      
Concentration Risk [Line Items]      
Concentration Risk, Percentage 1.00%    
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Business Combination- Other (Details)
$ in Thousands, € in Millions, £ in Millions, kr in Millions, R in Millions
 3 Months Ended
Mar. 31, 2021
EUR (€)
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2020
DKK (kr)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
GBP (£)
Mar. 31, 2020
USD ($)
Mar. 31, 2020
ZAR (R)
Dec. 31, 2019
GBP (£)
Dec. 22, 2020
USD ($)
Business Acquisition [Line Items]                    
Cash Paid for Acquisitions   $ 26,655         $ 3,160      
Goodwill, Acquired During Period   5,052                
South Africa [Member]                    
Business Acquisition [Line Items]                    
Cash Paid for Acquisitions             $ 1,000 R 16.7    
Equity Method Investment, Ownership Percentage           49.00% 49.00% 49.00%    
Adjustments To Additional Paid In Capital Other             $ 700      
Tel Nordic ApS[Member]                    
Business Acquisition [Line Items]                    
Cash Paid for Acquisitions       kr 20.0 $ 2,900          
Intangible assets         $ 2,400          
Intangible Assets, Amortizable Life       17 years 17 years          
Goodwill, Acquired During Period         $ 500          
Business Combination Measurement Period           1 year 1 year 1 year    
Post Closing Adjustment       kr 0.4 $ 100          
Tin Plating Solutions [Member]                    
Business Acquisition [Line Items]                    
Cash Paid for Acquisitions   25,000                
Intangible assets   19,600                
Goodwill, Acquired During Period   $ 5,000                
Business Combination Measurement Period 1 year 1 year                
Tin Plating Solutions [Member] | Customer Lists [Member]                    
Business Acquisition [Line Items]                    
Intangible assets   $ 18,300                
Intangible Assets, Amortizable Life 19 years 19 years                
Tin Plating Solutions [Member] | Product Technology [Member]                    
Business Acquisition [Line Items]                    
Intangible assets   $ 900                
Intangible Assets, Amortizable Life 14 years 14 years                
Tin Plating Solutions [Member] | Licensed Trademark [Member]                    
Business Acquisition [Line Items]                    
Intangible assets   $ 400                
Intangible Assets, Amortizable Life 3 years 3 years                
Grindaix GmbH [Member]                    
Business Acquisition [Line Items]                    
Cash Paid for Acquisitions € 1.4 $ 1,700                
Business Acquisition, Percentage of Voting Interests Acquired   38.00%                
Coral Chemical Company [Member]                    
Business Acquisition [Line Items]                    
Cash Paid for Acquisitions     $ 54,100              
Intangible assets                   $ 29,800
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Net                   $ 53,097
Business Combination Measurement Period     1 year              
Post Closing Adjustment     $ 400              
Norman Hay [Member]                    
Business Acquisition [Line Items]                    
Cash Paid for Acquisitions | £                 £ 80.0  
Post Closing Adjustment | £           £ 2.5        
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.21.1
Business Combinations - Purchase accounting (Details) - Coral Chemical Company [Member]
$ in Thousands
Dec. 22, 2020
USD ($)
Business Acquisition [Line Items]  
Cash and cash equivalents $ 958
Accounts receivable, net 8,473
Inventories, net 4,527
Prepaid expenses and other assets 181
Property, plant and equipment 11,119
Intangible assets 29,800
Goodwill 2,867
Total assets purchased 57,925
Long-term debt included current portions 739
Accounts payable, accrued expenses and other current liabilities 3,482
Total liabilities assumed 4,221
Total consideration paid 53,704
Cash Acquired 958
Estimated Purchase Price Settlement (351)
Net cash paid 53,097
As initially Reported[Member]  
Business Acquisition [Line Items]  
Cash and cash equivalents 958
Accounts receivable, net 8,473
Inventories, net 4,527
Prepaid expenses and other assets 181
Property, plant and equipment 10,467
Intangible assets 30,300
Goodwill 2,814
Total assets purchased 57,720
Long-term debt included current portions 183
Accounts payable, accrued expenses and other current liabilities 3,482
Total liabilities assumed 3,665
Total consideration paid 54,055
Cash Acquired 958
Estimated Purchase Price Settlement 0
Net cash paid 53,097
Measurement period adjustments [Member]  
Business Acquisition [Line Items]  
Cash and cash equivalents 0
Accounts receivable, net 0
Inventories, net 0
Prepaid expenses and other assets 0
Property, plant and equipment 652
Intangible assets (500)
Goodwill 53
Total assets purchased 205
Long-term debt included current portions 556
Accounts payable, accrued expenses and other current liabilities 0
Total liabilities assumed 556
Total consideration paid (351)
Cash Acquired 0
Estimated Purchase Price Settlement (351)
Net cash paid $ 0
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Business Segments (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Segment Reporting Information [Line Items]    
Net sales $ 429,783 $ 378,561
Operating Earnings, Excluding Indirect Operating Expenses $ 109,125 87,648
Number Of Reportable Segments 4  
Reconciliation from Segment Totals to Consolidated [Abstract]    
Combination, integration and other acquisition-related expenses $ (5,815) (7,878)
Restructuring and related charges (1,175) (1,716)
Fair value step up of acquired inventory sold (801) 0
Indefinite-lived intangible asset impairment 0 (38,000)
Non-operating and administrative expenses (40,992) (38,451)
Depreciation of corporate assets and amortization (15,448) (14,047)
Operating income (loss) 44,894 (12,444)
Other income (expense), net 4,687 (21,175)
Interest expense, net (5,470) (8,461)
Income (loss) before taxes and equity in net income of associated companies 44,111 (42,080)
America's [Member]    
Segment Reporting Information [Line Items]    
Net sales 134,871 129,896
Operating Earnings, Excluding Indirect Operating Expenses 32,234 29,188
America's [Member] | Intersegment Elimination [Member]    
Segment Reporting Information [Line Items]    
Net sales 3,300 2,900
EMEA [Member]    
Segment Reporting Information [Line Items]    
Net sales 119,814 104,839
Operating Earnings, Excluding Indirect Operating Expenses 25,244 18,359
EMEA [Member] | Intersegment Elimination [Member]    
Segment Reporting Information [Line Items]    
Net sales 8,800 5,500
Asia Pacific [Member]    
Segment Reporting Information [Line Items]    
Net sales 96,706 73,552
Operating Earnings, Excluding Indirect Operating Expenses 27,478 19,541
Asia Pacific [Member] | Intersegment Elimination [Member]    
Segment Reporting Information [Line Items]    
Net sales 100 100
Global Specialty Businesses [Member]    
Segment Reporting Information [Line Items]    
Net sales 78,392 70,274
Operating Earnings, Excluding Indirect Operating Expenses 24,169 20,560
Global Specialty Businesses [Member] | Intersegment Elimination [Member]    
Segment Reporting Information [Line Items]    
Net sales $ 2,000 $ 1,300
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.21.1
Net Sales and Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Revenues [Abstract]      
Net Reporting Amount $ 17.8 $ 12.5  
Deferred Revenue $ 6.3   $ 4.0
Top Five Customers Concentration Risk [Member]      
Concentration Risk [Line Items]      
Concentration Risk, Percentage     10.00%
Top Customer Concentration Risk [Member]      
Concentration Risk [Line Items]      
Concentration Risk, Percentage     3.00%
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.21.1
Net Sales and Revenue Recognition (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Product Information [Line Items]    
Net sales $ 429,783 $ 378,561
America's [Member]    
Product Information [Line Items]    
Net sales 134,871 129,896
EMEA [Member]    
Product Information [Line Items]    
Net sales 119,814 104,839
Asia Pacific [Member]    
Product Information [Line Items]    
Net sales 96,706 73,552
Transferred At Point In Time [Member]    
Product Information [Line Items]    
Net sales 409,155 368,381
Transferred At Point In Time [Member] | America's [Member]    
Product Information [Line Items]    
Net sales 171,594 168,802
Transferred At Point In Time [Member] | EMEA [Member]    
Product Information [Line Items]    
Net sales 131,162 118,423
Transferred At Point In Time [Member] | Asia Pacific [Member]    
Product Information [Line Items]    
Net sales 106,399 81,156
Transferred Over Time [Member]    
Product Information [Line Items]    
Net sales 20,628 10,180
Transferred Over Time [Member] | America's [Member]    
Product Information [Line Items]    
Net sales 8,533 5,325
Transferred Over Time [Member] | EMEA [Member]    
Product Information [Line Items]    
Net sales 8,924 3,021
Transferred Over Time [Member] | Asia Pacific [Member]    
Product Information [Line Items]    
Net sales 3,171 1,834
Metals [Member]    
Product Information [Line Items]    
Net sales 130,810 118,150
Metals [Member] | America's [Member]    
Product Information [Line Items]    
Net sales 46,793 46,673
Metals [Member] | EMEA [Member]    
Product Information [Line Items]    
Net sales 34,274 29,888
Metals [Member] | Asia Pacific [Member]    
Product Information [Line Items]    
Net sales 49,743 41,589
Metalworking And Other[Member]    
Product Information [Line Items]    
Net sales 220,581 190,137
Metalworking And Other[Member] | America's [Member]    
Product Information [Line Items]    
Net sales 88,078 83,223
Metalworking And Other[Member] | EMEA [Member]    
Product Information [Line Items]    
Net sales 85,540 74,951
Metalworking And Other[Member] | Asia Pacific [Member]    
Product Information [Line Items]    
Net sales 46,963 31,963
Global Specialty Businesses [Member]    
Product Information [Line Items]    
Net sales 78,392 70,274
Global Specialty Businesses [Member] | America's [Member]    
Product Information [Line Items]    
Net sales 45,256 44,231
Global Specialty Businesses [Member] | EMEA [Member]    
Product Information [Line Items]    
Net sales 20,272 16,605
Global Specialty Businesses [Member] | Asia Pacific [Member]    
Product Information [Line Items]    
Net sales 12,864 9,438
Total Sales With Global Specialty Businesses [Member]    
Product Information [Line Items]    
Net sales 429,783 378,561
Total Sales With Global Specialty Businesses [Member] | America's [Member]    
Product Information [Line Items]    
Net sales 180,127 174,127
Total Sales With Global Specialty Businesses [Member] | EMEA [Member]    
Product Information [Line Items]    
Net sales 140,086 121,444
Total Sales With Global Specialty Businesses [Member] | Asia Pacific [Member]    
Product Information [Line Items]    
Net sales 109,570 82,990
Total Sales Without Global Specialty Businesses [Member]    
Product Information [Line Items]    
Net sales 351,391 308,287
Total Sales Without Global Specialty Businesses [Member] | America's [Member]    
Product Information [Line Items]    
Net sales 134,871 129,896
Total Sales Without Global Specialty Businesses [Member] | EMEA [Member]    
Product Information [Line Items]    
Net sales 119,814 104,839
Total Sales Without Global Specialty Businesses [Member] | Asia Pacific [Member]    
Product Information [Line Items]    
Net sales $ 96,706 $ 73,552
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.21.1
Leases Narrative (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Leases [Abstract]    
Operating Lease Cost $ 3,600,000 $ 3,400,000
Short Term Lease Cost 300,000 500,000
Operating Lease Payments 3,600,000 3,400,000
Right Of Use Asset Obtained In Exchange For Operating Lease Liability 3,100,000  
Lessee Lease Description [Line Items]    
Variable Lease Cost 0 0
Sublease Income $ 0 $ 0
Land Member    
Lessee Lease Description [Line Items]    
Lessee Operating Lease Term Of Contract 94 years  
Facilities, vehicles, and machinery and equipment [Member]    
Lessee Lease Description [Line Items]    
Lessee Operating Lease Term Of Contract 10 years  
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.21.1
Leases Balance Sheet (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Operating Lease Right Of Use Asset $ 38,027 $ 38,507
Operating Lease Liability Current 10,419 10,901
Operating Lease Liability Noncurrent 27,050 27,070
Operating Lease Liability $ 37,469 $ 37,971
Operating Lease Weighted Average Remaining Lease Term 1 5 years 10 months 24 days 6 years
Operating Lease Weighted Average Discount Rate Percent 426.00% 420.00%
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Leases Maturity of Lease Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months [Abstract]    
For the remainder of 2021 $ 9,269  
For the year ended December 31, 2022 9,042  
For the year ended December 31, 2023 6,932  
For the year ended December 31, 2024 5,194  
For the year ended December 31, 2025 4,211  
For the year ended December 31, 2026 and beyond 8,116  
Total lease payments 42,764  
Less: imputed interest (5,295)  
Present value of lease liabilities $ 37,469 $ 37,971
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring Activities - Narrative (Details)
 3 Months Ended
Mar. 31, 2021
People
Restructuring And Related Activities [Abstract]  
Restructuring And Related Cost Description The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain manufacturing and non-manufacturing facilities.
Restructuring And Related Cost Expected Number Of Positions Eliminated 400
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring Activities (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Restructuring Reserve [Roll Forward]    
Accrued restructuring, beginning balance $ 8,248  
Restructuring and adjustments 1,175 $ 1,716
Cash payments (3,034)  
Currency translation adjustments (419)  
Accrued restructuring, ending balance $ 5,970  
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation - Expense Table (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Allocated Share-based Compensation Expense $ 3,779 $ 4,682
Stock Options Compensation Expense [Member]    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Allocated Share-based Compensation Expense 308 432
Nonvested Stock Awards and Restricted Stock Unit Compensation Expense [Member]    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Allocated Share-based Compensation Expense 1,396 1,264
401 (k) Matching Stock Contribution Plan Compensation Expense [Member]    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Allocated Share-based Compensation Expense 1,553 0
Directors Stock Ownership Plan Compensation Expense [Member]    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Allocated Share-based Compensation Expense 203 40
Performance Incentive Stock Units [Member]    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Allocated Share-based Compensation Expense 319 0
Annual Incentive Plan [Member]    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Allocated Share-based Compensation Expense $ 0 $ 2,946
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Share Based Compensation [Line Items]    
Allocated Share-based Compensation Expense $ 3,779 $ 4,682
Stock Options [Member]    
Share Based Compensation [Line Items]    
Unrecognized Share-Based Compensation Expense, Stock Option Awards $ 2,800  
Weighted Average Remaining Life, Nonvested Stock Awards 2 years 6 months  
Restricted Stock LTIP Plan [Member]    
Share Based Compensation [Line Items]    
Unrecognized Share-based Compensation Expense, Nonvested Stock Award $ 6,300  
Weighted Average Remaining Life, Nonvested Stock Awards 2 years 1 month 6 days  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12,610  
Restricted Stock Units (RSUs) LTIP Plan [Member]    
Share Based Compensation [Line Items]    
Unrecognized Share-based Compensation Expense, Nonvested Stock Award $ 1,300  
Weighted Average Remaining Life, Nonvested Stock Awards 2 years 3 months 18 days  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 2,791  
Annual Incentive Plan [Member]    
Share Based Compensation [Line Items]    
Allocated Share-based Compensation Expense $ 0 2,946
Combination And Other Acquisition Related [Member]    
Share Based Compensation [Line Items]    
Allocated Share-based Compensation Expense 300 500
Performance Incentive Stock Units [Member]    
Share Based Compensation [Line Items]    
Unrecognized Share-based Compensation Expense, Nonvested Stock Award $ 4,800  
Weighted Average Remaining Life, Nonvested Stock Awards 2 years 6 months  
Allocated Share-based Compensation Expense $ 319 $ 0
Defined Contribution Plan [Member]    
Share Based Compensation [Line Items]    
Defined Contribution Plan Employer Matching Contribution Percent 6.00%  
Defined Contribution Plan Employer Matching Contribution Percent Maximum 3.00%  
Defined Contribution Plan Employer Matching Contribution Percent Of Match 50.00%  
Defined Contribution Plan Employer Discretionary Contribution Amount $ 1,500  
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation - Options Grant (Details)
 3 Months Ended
Mar. 31, 2021
shares
Employee Stock Option [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Options Granted 23,733
Dividend Yield 0.85%
Expected Volatility 37.33%
Risk-free Interest Rate 0.60%
Expected Term (Years) 4 years
Performance Incentive Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Options Granted 28,000
Risk-free Interest Rate 0.29%
Expected Term (Years) 3 years
Vesting shares target lower percent 0.00%
Vesting shares target upper percent 200.00%
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.21.1
Pension and Postretirement Benefits (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Mar. 31, 2019
Pension Plans, Defined Benefit [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Defined Benefit Plan, Service Cost $ 316   $ 1,174  
Defined Benefit Plan, Interest Cost 1,090   1,769  
Defined Benefit Plan, Expected Return on Plan Assets (2,082)   (1,959)  
Defined Benefit Plan, Settlement Charge 0   22,667  
Defined Benefit Plan, Amortization of Losses 855   1,047  
Defined Benefit Plan, Amortization of Prior Service Cost 2   (40)  
Defined Benefit Plan, Net Periodic Benefit Cost 181   24,658  
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year 10,000      
Defined Benefit Plan, Contributions by Employer 1,000      
Defined Benefit Plan Effect Of Settlements And Curtailments On Accumulated Benefit Obligation     22,700  
Other Postretirement Benefit Plans, Defined Benefit [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Defined Benefit Plan, Service Cost 1   2  
Defined Benefit Plan, Interest Cost 11   26  
Defined Benefit Plan, Expected Return on Plan Assets 0   0  
Defined Benefit Plan, Settlement Charge 0   0  
Defined Benefit Plan, Amortization of Losses 0   15  
Defined Benefit Plan, Amortization of Prior Service Cost 0   0  
Defined Benefit Plan, Net Periodic Benefit Cost 12   $ 43  
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year 300      
Defined Benefit Plan, Contributions by Employer $ 100      
Legacy Quaker [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Defined Benefit Plan, Settlement Charge       $ (22,700)
Defined benefit plan settlement [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Defined Benefit Plan, Contributions by Employer   $ 1,800    
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.21.1
Other Income (expense) - (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Other Income And Expenses [Abstract]    
Income from third party license fees $ 339 $ 304
Foreign exchange (losses) gains, net (1,478) 821
(Loss) gain on fixed asset disposals, net 5,410 2
Non-income tax refunds and other related credits 97 1,299
Pension and post retirement benefit income (costs), non-service components 124 (23,525)
Other operating income (expense), net 195 (76)
Total other income (expense), net $ 4,687 $ (21,175)
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes and Uncertain Tax Positions (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Effective Income Tax Rate, Continuing Operations 24.20% 31.10%  
Unrecognized Tax Benefits, Interest on Income Taxes Expense $ 0.1 $ 0.1  
Unrecognized Tax Benefits, Interest on Income Taxes Accrued     $ 3.0
Unrecognized Tax Benefits, Income Tax Penalties Accrued 3.6   3.9
Unrecognized Tax Benefits, Income Tax Penalties Expense 0.1 0.1  
Unrecognized Tax Benefits Tax Penalties Income 3.0    
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations 0.3 $ 0.8  
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible [Line Items]      
Decrease In Unrecognized Tax Benefits Is Reasonably Possible 1.5   1.3
Unrecognized Tax Benefits $ 23.5    
Income Tax Examination [Line Items]      
U.S. Tax Reform As of December 31, 2020, the Company had a deferred tax liability of $5.9 million, which primarily represents the Company’s estimate of non-U.S. taxes it will incur to repatriate certain foreign earnings to the U.S. The balance as of March 31, 2021 was $6.5 million.    
Deferred Tax Liabilities $ 6.5   $ 5.9
Valuation Allowance Amount Related To Business Combination 5.5    
Italy [Member]      
Income Tax Examination [Line Items]      
Business Combination Indemnification Assets Amount As Of Acquisition Date 5.5    
Unrecognized tax Benefits Reserve 5.5    
Germany [Member]      
Income Tax Examination [Line Items]      
Business Combination Indemnification Assets Amount As Of Acquisition Date 0.8    
Unrecognized tax Benefits Reserve $ 0.9    
Foreign Tax Authority [Member] | The Netherlands [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2015    
Foreign Tax Authority [Member] | United Kingdom [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2016    
Foreign Tax Authority [Member] | Brazil [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2011    
Foreign Tax Authority [Member] | Spain [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2016    
Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority $ 1.6    
Foreign Tax Authority [Member] | China [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2015    
Foreign Tax Authority [Member] | Italy [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2006    
Income Tax Examination Description As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except 2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP proceedings which the Company has accepted.    
Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority $ 2.4    
Foreign Tax Authority [Member] | India [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2019    
Foreign Tax Authority [Member] | Mexico [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2016    
Foreign Tax Authority [Member] | Canada [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2017    
Foreign Tax Authority [Member] | Germany [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2016    
State and Local Jurisdiction [Member]      
Income Tax Examination [Line Items]      
Income Tax Examination Year Under Examination 2011    
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share - Basic (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Earnings Per Share [Abstract]    
Net income (loss) attributable to Quaker Chemical Corporation $ 38,615 $ (28,381)
Less: (income) loss allocated to participating securities (154) 101
Net income (loss) available to common shareholders $ 38,461 $ (28,280)
Basic weighted average common shares outstanding 17,785,370 17,672,525
Basic earnings (loss) per common share $ 2.16 $ (1.60)
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share - Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Earnings Per Share [Abstract]    
Net income (loss) attributable to Quaker Chemical Corporation $ 38,615 $ (28,381)
Less: (income) loss allocated to participating securities (154) 101
Net income (loss) available to common shareholders $ 38,461 $ (28,280)
Basic weighted average common shares outstanding 17,785,370 17,672,525
Effect of dilutive securities 70,607 0
Diluted weighted average common shares outstanding 17,855,977 17,672,525
Diluted earnings (loss) per common share $ 2.15 $ (1.60)
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share - Narrative (Details)
 3 Months Ended
Mar. 31, 2021
shares
Earnings Per Share [Abstract]  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2,083
Earnings Per Share Reconciliation Disclosure Certain stock options and restricted stock units are not included in the diluted earnings (loss) per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included was 2,083 for the three months ended March 31, 2021. All of the Company’s potentially dilutive shares for the three months ended March 31, 2020 are anti-dilutive and not included in the dilutive loss per share calculations because of the Company’s net loss during the period.
XML 76 R62.htm IDEA: XBRL DOCUMENT v3.21.1
Restricted Cash (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]        
Cash and cash equivalents $ 163,455 $ 316,437 $ 181,833 $ 123,524
Restricted Cash Included in other current assets 0 34 62 353
Restricted Cash Included in other assets 0 19,480 0 19,678
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents $ 163,455 335,951 $ 181,895 $ 143,555
Loss Contingency, Settlement Agreement, Terms Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0 million. The proceeds of both settlements were restricted and could only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements were deposited into interest bearing accounts that earned less than $0.1 million offset by $0.2 million of net payments during the three months ended March 31, 2020.      
LossContingencyAccrualPayments   200    
Interest Income, Other   $ 100    
XML 77 R63.htm IDEA: XBRL DOCUMENT v3.21.1
Goodwill Assets (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
USD ($)
Goodwill [Roll Forward]  
Goodwill, Beginning Balance $ 631,212
Goodwill additions 5,052
Goodwill, Translation Adjustments (8,690)
Goodwill, Ending Balance 627,574
America's [Member]  
Goodwill [Roll Forward]  
Goodwill, Beginning Balance 213,242
Goodwill additions 1,093
Goodwill, Translation Adjustments (731)
Goodwill, Ending Balance 213,604
EMEA [Member]  
Goodwill [Roll Forward]  
Goodwill, Beginning Balance 140,162
Goodwill additions 2,626
Goodwill, Translation Adjustments (3,925)
Goodwill, Ending Balance 138,863
Asia Pacific [Member]  
Goodwill [Roll Forward]  
Goodwill, Beginning Balance 158,090
Goodwill additions 1,308
Goodwill, Translation Adjustments (956)
Goodwill, Ending Balance 158,442
Global Specialty Businesses [Member]  
Goodwill [Roll Forward]  
Goodwill, Beginning Balance 119,718
Goodwill additions 25
Goodwill, Translation Adjustments (3,078)
Goodwill, Ending Balance $ 116,665
XML 78 R64.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Finite Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Accumulated Amortization $ 149,273 $ 136,113
Total 1,019,516 1,012,371
Customer Lists And Rights To Sell [Member]    
Finite Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Accumulated Amortization 110,997 99,806
Total 846,052 839,551
Trademarks Formulations and Product Technology [Member]    
Finite Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Accumulated Amortization 32,533 30,483
Total 167,144 166,448
Other Intangible Assets [Member]    
Finite Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Accumulated Amortization 5,743 5,824
Total $ 6,320 $ 6,372
XML 79 R65.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Assets - Amortization (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]    
Amortization $ 14.8 $ 14.0
XML 80 R66.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Assets - Future Amortization (Details)
$ in Thousands
Mar. 31, 2021
USD ($)
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]  
For the year ended December 31, 2021 $ 59,372
For the year ended December 31, 2022 59,096
For the year ended December 31, 2023 58,927
For the year ended December 31, 2024 58,427
For the year ended December 31, 2025 57,710
For the year ended December 31, 2026 $ 57,484
XML 81 R67.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Assets - Finite Lived (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Finite Lived Intangible Assets [Line Items]      
Indefinite-lived intangible asset impairment $ 0 $ 38,000  
Indefinite Lived Intangible Assets Excluding Goodwill 205,100   $ 205,100
Houghton Combination [Member]      
Finite Lived Intangible Assets [Line Items]      
Indefinite Lived Intangible Assets Excluding Goodwill $ 204,000   $ 204,000
XML 82 R68.htm IDEA: XBRL DOCUMENT v3.21.1
Debt - Table (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Debt [Abstract]    
Total debt $ 913,087 $ 899,134
Debt Issuance Cost Capitalized to Term loans and Long Term Debt (10,324) (11,099)
Less: Short-term and current portion of long-term debts (43,330) (38,967)
Total long-term debt $ 859,433 $ 849,068
XML 83 R69.htm IDEA: XBRL DOCUMENT v3.21.1
Debt - Table Interest rates (Details)
Mar. 31, 2021
Dec. 31, 2020
Revolver [Member]    
Debt Instrument [Line Items]    
Long term Debt Weighted Average Interest Rate 1.61% 1.65%
Domestic Line Of Credit [Member]    
Debt Instrument [Line Items]    
Long term Debt Weighted Average Interest Rate 1.61% 1.65%
Foreign Line of Credit [Member]    
Debt Instrument [Line Items]    
Long term Debt Weighted Average Interest Rate 1.50% 1.50%
Industrial development bonds [Member]    
Debt Instrument [Line Items]    
Long term Debt Weighted Average Interest Rate 5.26% 5.26%
XML 84 R70.htm IDEA: XBRL DOCUMENT v3.21.1
Debt - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]    
Line of Credit Facility, Covenant Terms The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 4.00 to 1. The Company’s consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.  
Line of Credit Facility, Covenant Compliance As of March 31, 2021 and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants  
Debt Issuance Cost Capitalized to Term loans and Long Term Debt $ 10,324 $ 11,099
Letters Of Credit Outstanding Amount $ 6,000  
Debt, Weighted Average Interest Rate 1.60%  
Line Of Credit Facility Remaining Borrowing Capacity $ 300,000  
Revolver [Member]    
Debt Instrument [Line Items]    
Line of Credit Facility Current Borrowing Capacity 400,000  
Line of Credit Facility, Amount Outstanding 190,000 160,000
Debt Instrument, Unused Borrowing Capacity, Amount $ 204,000  
Percentage of term loan principal amortization year three 7.50%  
Percentage of term loan principal amortization year four and five 10.00%  
Percentage of term loan principal amortization year one 5.00%  
Deferred Finance Costs Noncurrent Gross $ 8,300  
Revolver [Member] | Minimum [Member]    
Debt Instrument [Line Items]    
Line Of Credit Facility Commitment Fee Percentage 0.20%  
Revolver [Member] | Maximum [Member]    
Debt Instrument [Line Items]    
Line Of Credit Facility Commitment Fee Percentage 0.30%  
Domestic Line Of Credit [Member]    
Debt Instrument [Line Items]    
Line of Credit Facility Current Borrowing Capacity $ 600,000  
Line of Credit Facility, Amount Outstanding 562,500 570,000
Debt Issuance Costs, Current, Net 10,300 11,100
Deferred Finance Costs Noncurrent Gross 15,500  
Foreign Line of Credit [Member]    
Debt Instrument [Line Items]    
Line of Credit Facility Current Borrowing Capacity 150,000  
Line of Credit Facility, Amount Outstanding $ 148,210 157,062
Corporate Bond Securities [Member]    
Debt Instrument [Line Items]    
Debt Instrument Maturity Date Description 2028  
Industrial Development Revenue Bond $ 10,000 10,000
Bank lines of credit and other debt obligations 10,000 10,000
Bank Lines of credit and other debt obligations [Member]    
Debt Instrument [Line Items]    
Bank lines of credit and other debt obligations 2,377 2,072
Letters Of Credit Outstanding Amount 9,000  
Debt Issuance Costs, Current, Net 5,500 $ 5,900
Line Of Credit Facility Remaining Borrowing Capacity $ 40,000  
Debt [Member]    
Debt Instrument [Line Items]    
Derivative Basis Spread On Variable Rate 1.64%  
Derivative Fixed Interest Rate 3.10%  
Derivative Liability, Notional Amount $ 170,000  
Repayment of long-term debt 9,600  
Deferred Finance Costs Noncurrent Gross $ 23,700  
XML 85 R71.htm IDEA: XBRL DOCUMENT v3.21.1
Debt - Interest Expense Table (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Debt [Abstract]    
Interest Expense, Debt, Excluding Amortization $ 4,650 $ 7,712
Amortization of debt issuance costs 1,187 1,187
Total Interest Expense $ 5,837 $ 8,899
XML 86 R72.htm IDEA: XBRL DOCUMENT v3.21.1
Equity and Noncontrolling Interest (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Beginning Balance $ 1,320,914,000 $ 1,242,366,000
Net income (loss) 38,632,000 (28,344,000)
Amounts reported in other comprehensive income (loss) (26,632,000) (43,486,000)
Dividends, Common Stock (7,062,000) (6,834,000)
Distributions to noncontrolling affiliate shareholders   (751,000)
Acquisition of noncontrolling interest   1,047,000
Share based compensation plans 3,601,000 1,039,000
Ending Balance 1,329,453,000 1,162,541,000
Cummulative effect of accounting change [Member]    
Beginning Balance (402,000)  
Adjusted balance [Member]    
Beginning Balance 1,241,964,000  
Common Stock [Member]    
Beginning Balance 17,851,000 17,735,000
Net income (loss) 0 0
Amounts reported in other comprehensive income (loss) 0 0
Dividends, Common Stock 0 0
Distributions to noncontrolling affiliate shareholders   0
Acquisition of noncontrolling interest   0
Share based compensation plans 24,000 17,000
Ending Balance 17,875,000 17,752,000
Common Stock [Member] | Cummulative effect of accounting change [Member]    
Beginning Balance 0  
Common Stock [Member] | Adjusted balance [Member]    
Beginning Balance 17,735,000  
Additional Paid-in Capital [Member]    
Beginning Balance 905,171,000 888,218,000
Net income (loss) 0 0
Amounts reported in other comprehensive income (loss) 0 0
Dividends, Common Stock 0 0
Distributions to noncontrolling affiliate shareholders   0
Acquisition of noncontrolling interest   707,000
Share based compensation plans 3,577,000 1,022,000
Ending Balance 908,748,000 888,533,000
Additional Paid-in Capital [Member] | Cummulative effect of accounting change [Member]    
Beginning Balance 0  
Additional Paid-in Capital [Member] | Adjusted balance [Member]    
Beginning Balance 888,218,000  
Retained Earnings [Member]    
Beginning Balance 423,940,000 412,979,000
Net income (loss) 38,615,000 (28,381,000)
Amounts reported in other comprehensive income (loss) 0 0
Dividends, Common Stock (7,062,000) (6,834,000)
Distributions to noncontrolling affiliate shareholders   0
Acquisition of noncontrolling interest   0
Share based compensation plans 0 0
Ending Balance 455,493,000 377,362,000
Retained Earnings [Member] | Cummulative effect of accounting change [Member]    
Beginning Balance (402,000)  
Retained Earnings [Member] | Adjusted balance [Member]    
Beginning Balance 412,577,000  
Accumulated Other Comprehensive Income (Loss) [Member]    
Beginning Balance (26,598,000) (78,170,000)
Net income (loss) 0 0
Amounts reported in other comprehensive income (loss) (26,630,000) (43,354,000)
Dividends, Common Stock 0 0
Distributions to noncontrolling affiliate shareholders   0
Acquisition of noncontrolling interest   0
Share based compensation plans 0 0
Ending Balance (53,228,000) (121,524,000)
Accumulated Other Comprehensive Income (Loss) [Member] | Cummulative effect of accounting change [Member]    
Beginning Balance 0  
Accumulated Other Comprehensive Income (Loss) [Member] | Adjusted balance [Member]    
Beginning Balance (78,170,000)  
Noncontrolling Interest [Member]    
Beginning Balance 550,000 1,604,000
Net income (loss) 17,000 37,000
Amounts reported in other comprehensive income (loss) (2,000) (132,000)
Dividends, Common Stock 0 0
Distributions to noncontrolling affiliate shareholders   (751,000)
Acquisition of noncontrolling interest   340,000
Share based compensation plans 0 0
Ending Balance 565,000 $ 418,000
Noncontrolling Interest [Member] | Cummulative effect of accounting change [Member]    
Beginning Balance 0  
Noncontrolling Interest [Member] | Adjusted balance [Member]    
Beginning Balance $ 1,604,000  
XML 87 R73.htm IDEA: XBRL DOCUMENT v3.21.1
Equity and Noncontrolling Interest - Parentheticals (Details) - $ / shares
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Stockholders Equity [Abstract]    
Dividends declared $ 0.395 $ 0.385
XML 88 R74.htm IDEA: XBRL DOCUMENT v3.21.1
Equity and Noncontrolling Interest - Reclassifications (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance $ (26,598) $ (78,170)
Other Comprehensive (Loss) Income, before Reclassifications, before Tax (24,693) (61,096)
Amounts Reclassified from AOCI (2,223) 24,334
Other Comprehensive Income Loss before Tax (26,916) (36,762)
Related Tax Amounts 286 (6,592)
Other Comprehensive Income (Loss), Net of Tax (26,632) (43,486)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance (53,228) (121,524)
Accumulated Translation Adjustment [Member]    
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance (2,875) (44,568)
Other Comprehensive (Loss) Income, before Reclassifications, before Tax (25,459) (54,619)
Amounts Reclassified from AOCI 0 0
Other Comprehensive Income Loss before Tax (25,459) (54,619)
Related Tax Amounts 0 0
Other Comprehensive Income (Loss), Net of Tax (25,459) (54,619)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance (28,334) (99,187)
Accumulated Defined Benefit Plans Adjustment [Member]    
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance (23,467) (34,533)
Other Comprehensive (Loss) Income, before Reclassifications, before Tax 781 828
Amounts Reclassified from AOCI 862 24,366
Other Comprehensive Income Loss before Tax 1,643 25,194
Related Tax Amounts (351) (8,237)
Other Comprehensive Income (Loss), Net of Tax 1,292 16,957
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance (22,175) (17,576)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]    
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance (3,598) (320)
Other Comprehensive (Loss) Income, before Reclassifications, before Tax (745) (5,170)
Amounts Reclassified from AOCI 0 0
Other Comprehensive Income Loss before Tax 730 (5,170)
Related Tax Amounts (168) 1,189
Other Comprehensive Income (Loss), Net of Tax 562 (3,981)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance (3,036) (4,301)
Accumulated Net Unrealized Investment Gain (Loss) [Member]    
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance 3,342 1,251
Other Comprehensive (Loss) Income, before Reclassifications, before Tax 730 (2,135)
Amounts Reclassified from AOCI (3,085) (32)
Other Comprehensive Income Loss before Tax (3,830) (2,167)
Related Tax Amounts 805 456
Other Comprehensive Income (Loss), Net of Tax (3,025) (1,711)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance $ 317 $ (460)
XML 89 R75.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements - Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance $ 2,015 $ 1,961
Assets, Fair Value Disclosure 2,015 1,961
Fair Value, Inputs, Level 1 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 0 0
Assets, Fair Value Disclosure 0 0
Fair Value, Inputs, Level 2 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 2,015 1,961
Assets, Fair Value Disclosure 2,015 1,961
Fair Value, Inputs, Level 3 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 0 0
Assets, Fair Value Disclosure $ 0 $ 0
XML 90 R76.htm IDEA: XBRL DOCUMENT v3.21.1
Hedging Activities - Narrative (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value $ 3,943  
Other Liabilities Noncurrent [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value 3,943  
Interest Rate Swap [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value   $ 4,672
Derivative Liability, Notional Amount $ 170,000  
Interest Rate Swap [Member] | Other Liabilities Noncurrent [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value   $ 4,672
XML 91 R77.htm IDEA: XBRL DOCUMENT v3.21.1
Hedging Activities - Table (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net $ 3,036   $ 3,598
Interest Rate Cash Flow Hedge Liability at Fair Value 3,943    
Interest Rate Swap [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 3,036 $ 3,598  
Interest Expense [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net $ (643) $ 19  
Interest Expense [Member] | Interest Rate Swap [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net     $ 3,598
XML 92 R78.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2021
Dec. 31, 2020
ACP [Member] | Maximum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss $ 1.0  
ACP [Member] | Minimum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss 0.1  
SB Decking [Member]    
Loss Contingencies [Line Items]    
Loss Contingency Accrual At Carrying Value 0.4  
Houghton Environmental Matters [Member]    
Loss Contingencies [Line Items]    
Loss Contingency Accrual At Carrying Value 5.7 $ 6.0
Houghton Environmental Matters [Member] | Maximum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss 6.0  
Houghton Environmental Matters [Member] | Minimum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss 5.0  
Other Environmental Matters [Member]    
Loss Contingencies [Line Items]    
Loss Contingency Accrual At Carrying Value 0.1 $ 0.1
Foreign Consumption Tax [Member]    
Loss Contingencies [Line Items]    
Loss Contingency Accrual At Carrying Value 1.7  
Business Combination Indemnification Assets Amount As Of Acquisition Date 22.0  
OtherAssetsMiscellaneousCurrent 1.1  
IncomeTaxReconciliationTaxSettlementsForeign 10.0  
Foreign Consumption Tax [Member] | Maximum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss 38.0  
Foreign Consumption Tax [Member] | Minimum [Member]    
Loss Contingencies [Line Items]    
Loss Contingency, Estimate of Possible Loss $ 0.6  
EXCEL 93 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 95 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 96 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 282 413 1 false 92 0 false 9 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://www.quakerchem.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 000200 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 2 false false R3.htm 000250 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss Condensed Consolidated Statements of Comprehensive Income (Loss) Statements 3 false false R4.htm 000300 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 4 false false R5.htm 000400 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 5 false false R6.htm 000500 - Statement - Condensed Consolidated Statement of Cash Flows Sheet http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows Condensed Consolidated Statement of Cash Flows Statements 6 false false R7.htm 010110 - Disclosure - Condensed Financial Information Sheet http://www.quakerchem.com/role/DisclosureCondensedFinancialInformation Condensed Financial Information Notes 7 false false R8.htm 010210 - Disclosure - Business Combinations Sheet http://www.quakerchem.com/role/BusinessCombinations Business Combinations Notes 8 false false R9.htm 010310 - Disclosure - Recently Issued Accounting Standards Sheet http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards Recently Issued Accounting Standards Notes 9 false false R10.htm 010410 - Disclosure - Business Segments Sheet http://www.quakerchem.com/role/BusinessSegments Business Segments Notes 10 false false R11.htm 010510 - Disclosure - Net Sales and Revenue Recognition Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognition Net Sales and Revenue Recognition Notes 11 false false R12.htm 010610 - Disclosure - Leases Sheet http://www.quakerchem.com/role/Leases Leases Notes 12 false false R13.htm 010710 - Disclosure - Restructuring and Related Activities Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivities Restructuring and Related Activities Notes 13 false false R14.htm 010810 - Disclosure - Share-Based Compensation Sheet http://www.quakerchem.com/role/ShareBasedCompensation Share-Based Compensation Notes 14 false false R15.htm 010910 - Disclosure - Pension and Postretirement Benefits Sheet http://www.quakerchem.com/role/PensionAndPostretirementBenefits Pension and Postretirement Benefits Notes 15 false false R16.htm 011010 - Disclosure - Other Income (Expense) Sheet http://www.quakerchem.com/role/OtherIncomeExpense Other Income (Expense) Notes 16 false false R17.htm 011110 - Disclosure - Income Taxes and Uncertain Tax Positions Sheet http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositions Income Taxes and Uncertain Tax Positions Notes 17 false false R18.htm 011210 - Disclosure - Earnings Per Share Sheet http://www.quakerchem.com/role/EarningsPerShare Earnings Per Share Notes 18 false false R19.htm 011310 - Disclosure - Restricted Cash Sheet http://www.quakerchem.com/role/RestrictedCash Restricted Cash Notes 19 false false R20.htm 011410 - Disclosure - Goodwill and Intangible Assets Sheet http://www.quakerchem.com/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 20 false false R21.htm 011510 - Disclosure - Debt Sheet http://www.quakerchem.com/role/Debt Debt Notes 21 false false R22.htm 011610 - Disclosure - Equity and Noncontrolling Interest Sheet http://www.quakerchem.com/role/EquityAndNoncontrollingInterest Equity and Noncontrolling Interest Notes 22 false false R23.htm 011810 - Disclosure - Fair Value Measurements Sheet http://www.quakerchem.com/role/FairValueMeasurements Fair Value Measurements Notes 23 false false R24.htm 011910 - Disclosure - Hedging Activities Sheet http://www.quakerchem.com/role/HedgingActivities Hedging Activities Notes 24 false false R25.htm 012010 - Disclosure - Commitments and Contingencies Sheet http://www.quakerchem.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 020110 - Disclosure - Accounting Policies (Policies) Sheet http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies Accounting Policies (Policies) Policies http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards 26 false false R27.htm 030310 - Disclosure - Business Combinations (Tables) Sheet http://www.quakerchem.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://www.quakerchem.com/role/BusinessCombinations 27 false false R28.htm 030410 - Disclosure - Business Segments (Tables) Sheet http://www.quakerchem.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.quakerchem.com/role/BusinessSegments 28 false false R29.htm 030510 - Disclosure - Net Sales and Revenue Recognition (Tables) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables Net Sales and Revenue Recognition (Tables) Tables http://www.quakerchem.com/role/NetSalesAndRevenueRecognition 29 false false R30.htm 030610 - Disclosure - Leases (Tables) Sheet http://www.quakerchem.com/role/LeasesTables Leases (Tables) Tables http://www.quakerchem.com/role/Leases 30 false false R31.htm 030710 - Disclosure - Restructuring Activities (Tables) Sheet http://www.quakerchem.com/role/RestructuringActivitiesTables Restructuring Activities (Tables) Tables 31 false false R32.htm 030810 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.quakerchem.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.quakerchem.com/role/ShareBasedCompensation 32 false false R33.htm 030910 - Disclosure - Pension and Postretirement Benefits (Tables) Sheet http://www.quakerchem.com/role/PensionAndPostretirementBenefitsTables Pension and Postretirement Benefits (Tables) Tables http://www.quakerchem.com/role/PensionAndPostretirementBenefits 33 false false R34.htm 031010 - Disclosure - Other Income (Expense) (Tables) Sheet http://www.quakerchem.com/role/OtherIncomeExpenseTables Other Income (Expense) (Tables) Tables http://www.quakerchem.com/role/OtherIncomeExpense 34 false false R35.htm 031110 - Disclosure - Earnings Per Share (Tables) Sheet http://www.quakerchem.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.quakerchem.com/role/EarningsPerShare 35 false false R36.htm 031210 - Disclosure - Restricted Cash (Tables) Sheet http://www.quakerchem.com/role/RestrictedCashTables Restricted Cash (Tables) Tables http://www.quakerchem.com/role/RestrictedCash 36 false false R37.htm 031310 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.quakerchem.com/role/GoodwillAndIntangibleAssets 37 false false R38.htm 031510 - Disclosure - Debt (Tables) Sheet http://www.quakerchem.com/role/DebtTables Debt (Tables) Tables http://www.quakerchem.com/role/Debt 38 false false R39.htm 031610 - Disclosure - Equity and Noncontrolling Interest (Tables) Sheet http://www.quakerchem.com/role/EquityAndNoncontrollingInterestTables Equity and Noncontrolling Interest (Tables) Tables http://www.quakerchem.com/role/EquityAndNoncontrollingInterest 39 false false R40.htm 031710 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.quakerchem.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.quakerchem.com/role/FairValueMeasurements 40 false false R41.htm 031910 - Disclosure - Hedging Activities (Tables) Sheet http://www.quakerchem.com/role/HedgingActivitiesTables Hedging Activities (Tables) Tables http://www.quakerchem.com/role/HedgingActivities 41 false false R42.htm 040110 - Disclosure - Condensed Financial Information (Details) Sheet http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails Condensed Financial Information (Details) Details http://www.quakerchem.com/role/DisclosureCondensedFinancialInformation 42 false false R43.htm 040211 - Disclosure - Business Combination- Other (Details) Sheet http://www.quakerchem.com/role/BusinessCombinationOtherDetails Business Combination- Other (Details) Details 43 false false R44.htm 040220 - Disclosure - Business Combinations - Purchase accounting (Details) Sheet http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails Business Combinations - Purchase accounting (Details) Details 44 false false R45.htm 040409 - Disclosure - Business Segments (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsDetails Business Segments (Details) Details http://www.quakerchem.com/role/BusinessSegmentsTables 45 false false R46.htm 040510 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails Net Sales and Revenue Recognition - Narrative (Details) Details 46 false false R47.htm 040520 - Disclosure - Net Sales and Revenue Recognition (Details) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails Net Sales and Revenue Recognition (Details) Details http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables 47 false false R48.htm 040625 - Disclosure - Leases Narrative (Details) Sheet http://www.quakerchem.com/role/LeasesNarrativeDetails Leases Narrative (Details) Details 48 false false R49.htm 040626 - Disclosure - Leases Balance Sheet (Details) Sheet http://www.quakerchem.com/role/LeasesBalanceSheetDetails Leases Balance Sheet (Details) Details 49 false false R50.htm 040627 - Disclosure - Leases Maturity of Lease Liabilities (Details) Sheet http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails Leases Maturity of Lease Liabilities (Details) Details 50 false false R51.htm 040710 - Disclosure - Restructuring Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails Restructuring Activities - Narrative (Details) Details 51 false false R52.htm 040720 - Disclosure - Restructuring Activities (Details) Sheet http://www.quakerchem.com/role/RestructuringActivitiesDetails Restructuring Activities (Details) Details http://www.quakerchem.com/role/RestructuringActivitiesTables 52 false false R53.htm 040810 - Disclosure - Share-Based Compensation - Expense Table (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails Share-Based Compensation - Expense Table (Details) Details 53 false false R54.htm 040820 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 54 false false R55.htm 040840 - Disclosure - Share-Based Compensation - Options Grant (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails Share-Based Compensation - Options Grant (Details) Details 55 false false R56.htm 040910 - Disclosure - Pension and Postretirement Benefits (Details) Sheet http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails Pension and Postretirement Benefits (Details) Details http://www.quakerchem.com/role/PensionAndPostretirementBenefitsTables 56 false false R57.htm 041010 - Disclosure - Other Income (expense) - (Details) Sheet http://www.quakerchem.com/role/OtherIncomeexpenseDetails Other Income (expense) - (Details) Details http://www.quakerchem.com/role/OtherIncomeExpenseTables 57 false false R58.htm 041110 - Disclosure - Income Taxes and Uncertain Tax Positions (Details) Sheet http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails Income Taxes and Uncertain Tax Positions (Details) Details http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositions 58 false false R59.htm 041210 - Disclosure - Earnings Per Share - Basic (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareBasicDetails Earnings Per Share - Basic (Details) Details 59 false false R60.htm 041220 - Disclosure - Earnings Per Share - Diluted (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareDilutedDetails Earnings Per Share - Diluted (Details) Details 60 false false R61.htm 041230 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 61 false false R62.htm 041310 - Disclosure - Restricted Cash (Details) Sheet http://www.quakerchem.com/role/RestrictedCashDetails Restricted Cash (Details) Details http://www.quakerchem.com/role/RestrictedCashTables 62 false false R63.htm 041410 - Disclosure - Goodwill Assets (Details) Sheet http://www.quakerchem.com/role/GoodwillAssetsDetails Goodwill Assets (Details) Details 63 false false R64.htm 041420 - Disclosure - Intangible Assets (Details) Sheet http://www.quakerchem.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details 64 false false R65.htm 041430 - Disclosure - Intangible Assets - Amortization (Details) Sheet http://www.quakerchem.com/role/IntangibleAssetsAmortizationDetails Intangible Assets - Amortization (Details) Details 65 false false R66.htm 041440 - Disclosure - Intangible Assets - Future Amortization (Details) Sheet http://www.quakerchem.com/role/IntangibleAssetsFutureAmortizationDetails Intangible Assets - Future Amortization (Details) Details 66 false false R67.htm 041450 - Disclosure - Intangible Assets - Finite Lived (Details) Sheet http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails Intangible Assets - Finite Lived (Details) Details 67 false false R68.htm 041508 - Disclosure - Debt - Table (Details) Sheet http://www.quakerchem.com/role/DebtTableDetails Debt - Table (Details) Details 68 false false R69.htm 041509 - Disclosure - Debt - Table Interest rates (Details) Sheet http://www.quakerchem.com/role/DebtTableInterestRatesDetails Debt - Table Interest rates (Details) Details 69 false false R70.htm 041510 - Disclosure - Debt - Narrative (Details) Sheet http://www.quakerchem.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 70 false false R71.htm 041512 - Disclosure - Debt - Interest Expense Table (Details) Sheet http://www.quakerchem.com/role/DebtInterestExpenseTableDetails Debt - Interest Expense Table (Details) Details 71 false false R72.htm 041610 - Disclosure - Equity and Noncontrolling Interest (Details) Sheet http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails Equity and Noncontrolling Interest (Details) Details http://www.quakerchem.com/role/EquityAndNoncontrollingInterestTables 72 false false R73.htm 041620 - Disclosure - Equity and Noncontrolling Interest - Parentheticals (Details) Sheet http://www.quakerchem.com/role/EquityAndNoncontrollingInterestParentheticalsDetails Equity and Noncontrolling Interest - Parentheticals (Details) Details 73 false false R74.htm 041630 - Disclosure - Equity and Noncontrolling Interest - Reclassifications (Details) Sheet http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails Equity and Noncontrolling Interest - Reclassifications (Details) Details 74 false false R75.htm 041710 - Disclosure - Fair Value Measurements - Assets (Details) Sheet http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails Fair Value Measurements - Assets (Details) Details 75 false false R76.htm 041810 - Disclosure - Hedging Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails Hedging Activities - Narrative (Details) Details 76 false false R77.htm 041820 - Disclosure - Hedging Activities - Table (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesTableDetails Hedging Activities - Table (Details) Details 77 false false R78.htm 041910 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.quakerchem.com/role/CommitmentsAndContingencies 78 false false All Reports Book All Reports kwr-2021033110q.htm exhibit101.htm exhibit103.htm exhibit104.htm exhibit311.htm exhibit312.htm exhibit321.htm exhibit322.htm kwr-20210331.xsd kwr-20210331_cal.xml kwr-20210331_def.xml kwr-20210331_lab.xml kwr-20210331_pre.xml http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2020-01-31 true true JSON 99 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kwr-2021033110q.htm": { "axisCustom": 0, "axisStandard": 23, "contextCount": 282, "dts": { "calculationLink": { "local": [ "kwr-20210331_cal.xml" ] }, "definitionLink": { "local": [ "kwr-20210331_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "kwr-2021033110q.htm" ] }, "labelLink": { "local": [ "kwr-20210331_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "kwr-20210331_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml" ] }, "schema": { "local": [ "kwr-20210331.xsd" ], "remote": [ "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 801, "entityCount": 1, "hidden": { "http://www.quakerchem.com/20210331": 3, "http://xbrl.sec.gov/dei/2019-01-31": 11, "total": 14 }, "keyCustom": 25, "keyStandard": 388, "memberCustom": 35, "memberStandard": 55, "nsprefix": "kwr", "nsuri": "http://www.quakerchem.com/20210331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://www.quakerchem.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010410 - Disclosure - Business Segments", "role": "http://www.quakerchem.com/role/BusinessSegments", "shortName": "Business Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010510 - Disclosure - Net Sales and Revenue Recognition", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognition", "shortName": "Net Sales and Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010610 - Disclosure - Leases", "role": "http://www.quakerchem.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010710 - Disclosure - Restructuring and Related Activities", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivities", "shortName": "Restructuring and Related Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010810 - Disclosure - Share-Based Compensation", "role": "http://www.quakerchem.com/role/ShareBasedCompensation", "shortName": "Share-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010910 - Disclosure - Pension and Postretirement Benefits", "role": "http://www.quakerchem.com/role/PensionAndPostretirementBenefits", "shortName": "Pension and Postretirement Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011010 - Disclosure - Other Income (Expense)", "role": "http://www.quakerchem.com/role/OtherIncomeExpense", "shortName": "Other Income (Expense)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011110 - Disclosure - Income Taxes and Uncertain Tax Positions", "role": "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositions", "shortName": "Income Taxes and Uncertain Tax Positions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011210 - Disclosure - Earnings Per Share", "role": "http://www.quakerchem.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011310 - Disclosure - Restricted Cash", "role": "http://www.quakerchem.com/role/RestrictedCash", "shortName": "Restricted Cash", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000200 - Statement - Condensed Consolidated Statements of Operations", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011410 - Disclosure - Goodwill and Intangible Assets", "role": "http://www.quakerchem.com/role/GoodwillAndIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011510 - Disclosure - Debt", "role": "http://www.quakerchem.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011610 - Disclosure - Equity and Noncontrolling Interest", "role": "http://www.quakerchem.com/role/EquityAndNoncontrollingInterest", "shortName": "Equity and Noncontrolling Interest", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011810 - Disclosure - Fair Value Measurements", "role": "http://www.quakerchem.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011910 - Disclosure - Hedging Activities", "role": "http://www.quakerchem.com/role/HedgingActivities", "shortName": "Hedging Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012010 - Disclosure - Commitments and Contingencies", "role": "http://www.quakerchem.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020110 - Disclosure - Accounting Policies (Policies)", "role": "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies", "shortName": "Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030310 - Disclosure - Business Combinations (Tables)", "role": "http://www.quakerchem.com/role/BusinessCombinationsTables", "shortName": "Business Combinations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030410 - Disclosure - Business Segments (Tables)", "role": "http://www.quakerchem.com/role/BusinessSegmentsTables", "shortName": "Business Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030510 - Disclosure - Net Sales and Revenue Recognition (Tables)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables", "shortName": "Net Sales and Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000250 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030610 - Disclosure - Leases (Tables)", "role": "http://www.quakerchem.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030710 - Disclosure - Restructuring Activities (Tables)", "role": "http://www.quakerchem.com/role/RestructuringActivitiesTables", "shortName": "Restructuring Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030810 - Disclosure - Share-Based Compensation (Tables)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationTables", "shortName": "Share-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030910 - Disclosure - Pension and Postretirement Benefits (Tables)", "role": "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsTables", "shortName": "Pension and Postretirement Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031010 - Disclosure - Other Income (Expense) (Tables)", "role": "http://www.quakerchem.com/role/OtherIncomeExpenseTables", "shortName": "Other Income (Expense) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031110 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.quakerchem.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031210 - Disclosure - Restricted Cash (Tables)", "role": "http://www.quakerchem.com/role/RestrictedCashTables", "shortName": "Restricted Cash (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031310 - Disclosure - Goodwill and Intangible Assets (Tables)", "role": "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031510 - Disclosure - Debt (Tables)", "role": "http://www.quakerchem.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031610 - Disclosure - Equity and Noncontrolling Interest (Tables)", "role": "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestTables", "shortName": "Equity and Noncontrolling Interest (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000300 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031710 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.quakerchem.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031910 - Disclosure - Hedging Activities (Tables)", "role": "http://www.quakerchem.com/role/HedgingActivitiesTables", "shortName": "Hedging Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040110 - Disclosure - Condensed Financial Information (Details)", "role": "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails", "shortName": "Condensed Financial Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "0", "lang": "en-US", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040211 - Disclosure - Business Combination- Other (Details)", "role": "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "shortName": "Business Combination- Other (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2020_TO_Mar31_2020_Entity_0000081362_us-gaap_BusinessAcquisitionAxis_kwr_SouthAfricaEquityAffiliateMember", "decimals": "-5", "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Dec22_2020_Entity_0000081362_us-gaap_BusinessAcquisitionAxis_kwr_CoralchemicalcompanyMember", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040220 - Disclosure - Business Combinations - Purchase accounting (Details)", "role": "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails", "shortName": "Business Combinations - Purchase accounting (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Dec22_2020_Entity_0000081362_us-gaap_BusinessAcquisitionAxis_kwr_CoralchemicalcompanyMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040409 - Disclosure - Business Segments (Details)", "role": "http://www.quakerchem.com/role/BusinessSegmentsDetails", "shortName": "Business Segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "kwr:OperatingIncomeLossSegmentReporting", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "kwr:NetReportingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040510 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails", "shortName": "Net Sales and Revenue Recognition - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "kwr:NetReportingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040520 - Disclosure - Net Sales and Revenue Recognition (Details)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "shortName": "Net Sales and Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362_us-gaap_TimingOfTransferOfGoodOrServiceAxis_us-gaap_TransferredAtPointInTimeMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040625 - Disclosure - Leases Narrative (Details)", "role": "http://www.quakerchem.com/role/LeasesNarrativeDetails", "shortName": "Leases Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040626 - Disclosure - Leases Balance Sheet (Details)", "role": "http://www.quakerchem.com/role/LeasesBalanceSheetDetails", "shortName": "Leases Balance Sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "myUSDPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000400 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "myUSDPerShare", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040627 - Disclosure - Leases Maturity of Lease Liabilities (Details)", "role": "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails", "shortName": "Leases Maturity of Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040710 - Disclosure - Restructuring Activities - Narrative (Details)", "role": "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails", "shortName": "Restructuring Activities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040720 - Disclosure - Restructuring Activities (Details)", "role": "http://www.quakerchem.com/role/RestructuringActivitiesDetails", "shortName": "Restructuring Activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040810 - Disclosure - Share-Based Compensation - Expense Table (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "shortName": "Share-Based Compensation - Expense Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362_us-gaap_AwardTypeAxis_kwr_StockOptionsCompensationExpenseMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040820 - Disclosure - Share-Based Compensation - Narrative (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "shortName": "Share-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember", "decimals": "-5", "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040840 - Disclosure - Share-Based Compensation - Options Grant (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails", "shortName": "Share-Based Compensation - Options Grant (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040910 - Disclosure - Pension and Postretirement Benefits (Details)", "role": "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails", "shortName": "Pension and Postretirement Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041010 - Disclosure - Other Income (expense) - (Details)", "role": "http://www.quakerchem.com/role/OtherIncomeexpenseDetails", "shortName": "Other Income (expense) - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041110 - Disclosure - Income Taxes and Uncertain Tax Positions (Details)", "role": "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails", "shortName": "Income Taxes and Uncertain Tax Positions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041210 - Disclosure - Earnings Per Share - Basic (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "shortName": "Earnings Per Share - Basic (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000500 - Statement - Condensed Consolidated Statement of Cash Flows", "role": "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows", "shortName": "Condensed Consolidated Statement of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041220 - Disclosure - Earnings Per Share - Diluted (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails", "shortName": "Earnings Per Share - Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041230 - Disclosure - Earnings Per Share - Narrative (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041310 - Disclosure - Restricted Cash (Details)", "role": "http://www.quakerchem.com/role/RestrictedCashDetails", "shortName": "Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2020_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041410 - Disclosure - Goodwill Assets (Details)", "role": "http://www.quakerchem.com/role/GoodwillAssetsDetails", "shortName": "Goodwill Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041420 - Disclosure - Intangible Assets (Details)", "role": "http://www.quakerchem.com/role/IntangibleAssetsDetails", "shortName": "Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041430 - Disclosure - Intangible Assets - Amortization (Details)", "role": "http://www.quakerchem.com/role/IntangibleAssetsAmortizationDetails", "shortName": "Intangible Assets - Amortization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "kwr:Finitelivedintangibleassetsamortizationexpensecurrentfiscalyear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041440 - Disclosure - Intangible Assets - Future Amortization (Details)", "role": "http://www.quakerchem.com/role/IntangibleAssetsFutureAmortizationDetails", "shortName": "Intangible Assets - Future Amortization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "kwr:Finitelivedintangibleassetsamortizationexpensecurrentfiscalyear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041450 - Disclosure - Intangible Assets - Finite Lived (Details)", "role": "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails", "shortName": "Intangible Assets - Finite Lived (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041508 - Disclosure - Debt - Table (Details)", "role": "http://www.quakerchem.com/role/DebtTableDetails", "shortName": "Debt - Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember", "decimals": "6", "first": true, "lang": "en-US", "name": "us-gaap:LongtermDebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041509 - Disclosure - Debt - Table Interest rates (Details)", "role": "http://www.quakerchem.com/role/DebtTableInterestRatesDetails", "shortName": "Debt - Table Interest rates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember", "decimals": "6", "first": true, "lang": "en-US", "name": "us-gaap:LongtermDebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010110 - Disclosure - Condensed Financial Information", "role": "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformation", "shortName": "Condensed Financial Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityCovenantTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041510 - Disclosure - Debt - Narrative (Details)", "role": "http://www.quakerchem.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityCovenantTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041512 - Disclosure - Debt - Interest Expense Table (Details)", "role": "http://www.quakerchem.com/role/DebtInterestExpenseTableDetails", "shortName": "Debt - Interest Expense Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041610 - Disclosure - Equity and Noncontrolling Interest (Details)", "role": "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails", "shortName": "Equity and Noncontrolling Interest (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Dec31_2019_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "myUSDPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041620 - Disclosure - Equity and Noncontrolling Interest - Parentheticals (Details)", "role": "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestParentheticalsDetails", "shortName": "Equity and Noncontrolling Interest - Parentheticals (Details)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R74": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041630 - Disclosure - Equity and Noncontrolling Interest - Reclassifications (Details)", "role": "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails", "shortName": "Equity and Noncontrolling Interest - Reclassifications (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Dec31_2019_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041710 - Disclosure - Fair Value Measurements - Assets (Details)", "role": "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails", "shortName": "Fair Value Measurements - Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041810 - Disclosure - Hedging Activities - Narrative (Details)", "role": "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "shortName": "Hedging Activities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041820 - Disclosure - Hedging Activities - Table (Details)", "role": "http://www.quakerchem.com/role/HedgingActivitiesTableDetails", "shortName": "Hedging Activities - Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362_srt_RangeAxis_srt_MaximumMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_kwr_AcpMember", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyEstimateOfPossibleLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041910 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "AS_OF_Mar31_2021_Entity_0000081362_srt_RangeAxis_srt_MaximumMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_kwr_AcpMember", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyEstimateOfPossibleLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010210 - Disclosure - Business Combinations", "role": "http://www.quakerchem.com/role/BusinessCombinations", "shortName": "Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010310 - Disclosure - Recently Issued Accounting Standards", "role": "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards", "shortName": "Recently Issued Accounting Standards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr-2021033110q.htm", "contextRef": "FROM_Jan01_2021_TO_Mar31_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 92, "tag": { "country_BR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BR", "terseLabel": "Brazil [Member]" } } }, "localname": "BR", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Canada [Member]" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CN", "terseLabel": "China [Member]" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_DE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Germany [Member]" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_ES": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ES", "terseLabel": "Spain [Member]" } } }, "localname": "ES", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_FR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FR", "terseLabel": "France [Member]" } } }, "localname": "FR", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GB", "terseLabel": "United Kingdom [Member]" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_IN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "India [Member]" } } }, "localname": "IN", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_IT": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IT", "terseLabel": "Italy [Member]" } } }, "localname": "IT", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_MX": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mexico [Member]" } } }, "localname": "MX", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "country_NL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NL", "terseLabel": "The Netherlands [Member]" } } }, "localname": "NL", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City area code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current fiscal year end date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document period focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document fiscal year focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document period end date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r773" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document quarterly report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r774" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document transition report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity address, address line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity address, address line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity address, address line 3" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity address, city or town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity address, country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity address, postal zip code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity address, state or province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity central index key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity common stock shares outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity current reporting status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity emerging growth company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity file number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity filer category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity incorporation state country code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r776" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity interactive data current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity public float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity registrant name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity shell company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity small business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r775" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity tax identification number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity voluntary filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity well known seasoned issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local phone number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r772" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Security 12g title" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security exchange name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.quakerchem.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "kwr_AcpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AC Products, Inc. Subsidiary involved in groundwater contamination litigation", "label": "Acp [Member]", "terseLabel": "ACP [Member]" } } }, "localname": "AcpMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "kwr_ArgentinaSubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Argentina Subsidiary [Member]" } } }, "localname": "ArgentinaSubsidiaryMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "kwr_AvailableForSaleSecuritiesLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.", "label": "Available For Sale Securities Liabilities Fair Value Disclosure" } } }, "localname": "AvailableForSaleSecuritiesLiabilitiesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesLiabilitiesFixedIncomeRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in fixed income common stock.", "label": "Available For Sale Securities Liabilities Fixed Income Registered Investment Companies Fair Value Disclosure", "terseLabel": "Fixed Income Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesLiabilitiesFixedIncomeRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesLiabilitiesInternationalDevelopedAndEmergingMarketsRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in international developed and emerging markets common stock.", "label": "Available For Sale Securities Liabilities International Developed And Emerging Markets Registered Investment Companies Fair Value Disclosure", "terseLabel": "International Developed And Emerging Markets Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesLiabilitiesInternationalDevelopedAndEmergingMarketsRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesLiabilitiesLargeCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in large capitalization common stock.", "label": "Available For Sale Securities Liabilities Large Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Large Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesLiabilitiesLargeCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesLiabilitiesMidCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in mid capitalization common stock.", "label": "Available For Sale Securities Liabilities Mid Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Mid Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesLiabilitiesMidCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesLiabilitiesSmallCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in small capitalization common stock.", "label": "Available For Sale Securities Liabilities Small Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Small Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesLiabilitiesSmallCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kwr_BankLinesOfCreditAndOtherDebtObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bank Lines of credit and other debt obligations [Member]" } } }, "localname": "BankLinesOfCreditAndOtherDebtObligationsMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "domainItemType" }, "kwr_BusinessAcquisitionContingentConsiderationActualCashPayment": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 37.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid to former stockholders to settle hold-back contingent consideration liability.", "label": "Business Acquisition Contingent Consideration Actual Cash Payment", "negatedLabel": "Payment of acquisition-related earnout liability", "terseLabel": "Business Acquisition Contingent Consideration Actual Cash Payment" } } }, "localname": "BusinessAcquisitionContingentConsiderationActualCashPayment", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfCompanyInSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage ownership of shares issued in connection with the Houghton Combination", "label": "Business Acquisition Equity Interest Issued Or Issuable Percentage Of Company In Shares Issued" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfCompanyInSharesIssued", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_BusinessCombinationFairValueOfEquitytransfered": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the acquisition-date fair value of the equity issued as part of the combination", "label": "Business Combination Fair Value Of Previously Held Equity Interest", "terseLabel": "Fair value of common stock issued as consideration" } } }, "localname": "BusinessCombinationFairValueOfEquitytransfered", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Businesscombinationmeasurementperiod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination Measurement Period" } } }, "localname": "Businesscombinationmeasurementperiod", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "durationItemType" }, "kwr_Businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedgross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for identifiable asset acquired in excess of (less than) the aggregate liabilities assumed including cash acquired in the business combination.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Gross", "terseLabel": "Total consideration paid", "totalLabel": "Business Acquisition, Cost of Acquired Entity, Purchase Price, Gross" } } }, "localname": "Businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedgross", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedlongtermdebtincludedcurrentportions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long-term debt included current portions", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long-term debt included current portions", "terseLabel": "Long-term debt included current portions" } } }, "localname": "Businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedlongtermdebtincludedcurrentportions", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "kwr_CadiviMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Venezuela currency rate - CADIVI", "label": "CADIVI [Member]" } } }, "localname": "CadiviMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedFinancialInformationForeignCurrencyDetails" ], "xbrltype": "domainItemType" }, "kwr_CeoTransitionCosts": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the costs related to the on going search for a new CEO in connection with the previously announced executive transition planned for the end of 2021", "label": "CEO transition costs" } } }, "localname": "CeoTransitionCosts", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kwr_CoatingsandotherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Coatings And Other [Member]" } } }, "localname": "CoatingsandotherMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationRelatedExpensesNetOfPayments": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities, net of payments.", "label": "Combination-related expenses, net of payments", "terseLabel": "Combination and other acquisition-related expenses, net of payments" } } }, "localname": "CombinationRelatedExpensesNetOfPayments", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_CombinationandotheracquisitionrelatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Combination And Other Acquisition Related [Member]" } } }, "localname": "CombinationandotheracquisitionrelatedMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CoralchemicalcompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Coral Chemical Company acquired by the Company in December 2020", "label": "Coral Chemical Company [Member]" } } }, "localname": "CoralchemicalcompanyMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "kwr_CurrencyConversionImpactsOfHyperInflationaryAccounting": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the impact to the financial statements due to the impacts of hyper-inflatonary accounting and remeasurement losses associated with currency conversions related to the Company's wholly owned Argentina subsidiary and Venezuela equity affiliate", "label": "Currency Conversion impacts of hyper-inflationary accounting and remeasurement losses" } } }, "localname": "CurrencyConversionImpactsOfHyperInflationaryAccounting", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "kwr_CustomerconcentrationrisktopfivemembermemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from the entity's top five customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk Top Five [Member]", "terseLabel": "Top Five Customers Concentration Risk [Member]" } } }, "localname": "CustomerconcentrationrisktopfivemembermemberMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_DebtinstrumentidrbMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Industrial development bonds [Member]" } } }, "localname": "DebtinstrumentidrbMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "domainItemType" }, "kwr_DefinedContributionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan [Member]" } } }, "localname": "DefinedContributionPlanMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_DefinedbenefitplansettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined benefit plan settlement [Member]" } } }, "localname": "DefinedbenefitplansettlementMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "kwr_Definedcontributionplanemployermatchingcontributionpercentmaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan Employer Matching Contribution Percent Maximum" } } }, "localname": "Definedcontributionplanemployermatchingcontributionpercentmaximum", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DicomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Venezuela currency rate - DICOM", "label": "DICOM [Member]" } } }, "localname": "DicomMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedFinancialInformationForeignCurrencyDetails" ], "xbrltype": "domainItemType" }, "kwr_DiproMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Venezuela currency rate - DIPRO", "label": "DIPRO [Member]" } } }, "localname": "DiproMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedFinancialInformationForeignCurrencyDetails" ], "xbrltype": "domainItemType" }, "kwr_DirectorRetainerAnnualFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total annual director retainer fee", "label": "Director Retainer Annual Fee" } } }, "localname": "DirectorRetainerAnnualFee", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DirectorStockOwnershipCashRetainer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the director retainer fee in company stock and cash", "label": "Director Stock Ownership Cash Retainer", "terseLabel": "Director Stock Ownership Plan Terms" } } }, "localname": "DirectorStockOwnershipCashRetainer", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_DirectorsStockOwnershipPlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the company's board of director's stock plan .", "label": "Directors Stock Ownership Plan Compensation Expense [Member]", "terseLabel": "Directors Stock Ownership Plan Compensation Expense" } } }, "localname": "DirectorsStockOwnershipPlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_Documentandentityinformationabstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Abstract]" } } }, "localname": "Documentandentityinformationabstract", "nsuri": "http://www.quakerchem.com/20210331", "xbrltype": "stringItemType" }, "kwr_EffectOfCurrencyConversionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reflects the amount charged in the current period due to currency conversion impacts of an equity affiliate.", "label": "Effect Of Currency Conversion, Amount" } } }, "localname": "EffectOfCurrencyConversionAmount", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "kwr_EffectOfCurrencyConversionPerDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the effect on diluted earnings per share of a currency conversion charge during the period due to an equity affiliate.", "label": "Effect Of Currency Conversion, Per Diluted Share" } } }, "localname": "EffectOfCurrencyConversionPerDilutedShare", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "perShareItemType" }, "kwr_EffectOfTaxRateChange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effect on EPS of tax rate change in current period", "label": "Effect Of Tax Rate Change" } } }, "localname": "EffectOfTaxRateChange", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "percentItemType" }, "kwr_EffectOfUncertainTaxPositionAdjustmentsEarningsPerShareDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the effect on diluted earnings per share of adjustments of previously recorded tax expense, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, IRS tax settlement and unusual repatriation of foreign earnings", "label": "Effect Of Uncertain Tax Position Adjustments Earnings Per Share Diluted", "terseLabel": "Effect on EPS of Uncertain Tax Position Adjustments" } } }, "localname": "EffectOfUncertainTaxPositionAdjustmentsEarningsPerShareDiluted", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "perShareItemType" }, "kwr_EmployeeStockPurchasePlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity basedcompensation cost recognized during the period in selling, general and administrative expense for the employee stock purchase plan .", "label": "Employee Stock Purchase Plan Compensation Expense [Member]", "terseLabel": "Employee Stock Purchase Plan Compensation Expense" } } }, "localname": "EmployeeStockPurchasePlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_EngineeredCustomLubricantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A material business combination of ECLI, which occurred during the periods associated with this filing.", "label": "Engineered Custom Lubricants [Member]", "terseLabel": "ECLI [Member]" } } }, "localname": "EngineeredCustomLubricantsMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "kwr_EquityMethodInvesteeNameKelkoVenezuelaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity method investee - Kelko Quaker Chemical, S.A. (Venezuela)", "label": "Equity Method Investee Name Kelko Venezuela [Member]", "terseLabel": "Kelko (Venezuela) [Member]" } } }, "localname": "EquityMethodInvesteeNameKelkoVenezuelaMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "kwr_Estimatedpurchasepricesettlement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Estimated purchase price settlement on Norman Hay Acquisition", "label": "Estimated Purchase Price Settlement" } } }, "localname": "Estimatedpurchasepricesettlement", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ExcessTaxBenefitFromShareBasedCompensationNonCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reductions in the entity's income taxes that arise when compensation cost (from non-qualified share-based compensation) recognized on the entity's tax return exceeds compensation cost from equity-based compensation recognized in financial statements. This element represents the non-cash portion.", "label": "Excess Tax Benefit From Share Based Compensation - Non Cash", "terseLabel": "Excess Tax Benefit Related to Stock Option Exercises" } } }, "localname": "ExcessTaxBenefitFromShareBasedCompensationNonCash", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_ExpectedPensionPremiumRefund": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Expected Pension Premium Refund" } } }, "localname": "ExpectedPensionPremiumRefund", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FacilitiesvehiclesandmachineryandequipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facilities, vehicles, and machinery and equipment", "label": "Facilities, vehicles, and machinery and equipment [Member]" } } }, "localname": "FacilitiesvehiclesandmachineryandequipmentMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_FairValueMeasurementWithUnobservableInputsReconciliation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gains arising from liabilities measured at fair value and categorized within Level 3 of the fair value hierarchy.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation", "terseLabel": "Realized Gains" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliation", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityUnrealizedGain": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gains arising from liabilities measured at fair value and categorized within Level 3 of the fair value hierarchy.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Unrealized Gain", "terseLabel": "Unrealized Gains" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityUnrealizedGain", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FairValueStepUpOfHoughtonInventorySold": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsDetails": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "(c)\tFair value step up of inventory sold relates to expenses associated with selling inventory from acquired businesses which was adjusted to fair value as part of purchase accounting", "label": "Fair value step up of acquired inventory sold", "negatedLabel": "Fair value step up of acquired inventory sold" } } }, "localname": "FairValueStepUpOfHoughtonInventorySold", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets Accumulated Amortization [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "kwr_FiniteLivedTrademarksFormulationsAndProductTechnology": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the trademarks formulations and product technology.", "label": "Finite Lived Trademarks Formulations And Product Technology", "terseLabel": "Trademarks, Formulations And Product Technology" } } }, "localname": "FiniteLivedTrademarksFormulationsAndProductTechnology", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Finitelivedintangibleassetsamortizationexpensecurrentfiscalyear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Estimated amortization expense for the full year", "label": "FiniteLivedIntangibleAssetsAmortizationExpenseCurrentFiscalYear", "terseLabel": "For the year ended December 31, 2021" } } }, "localname": "Finitelivedintangibleassetsamortizationexpensecurrentfiscalyear", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ForeignCurrencyExchangeMechanismAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency Exchange Mechanism [Axis]" } } }, "localname": "ForeignCurrencyExchangeMechanismAxis", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedFinancialInformationForeignCurrencyDetails" ], "xbrltype": "stringItemType" }, "kwr_ForeignCurrencyExchangeMechanismDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency Exchange Mechanism [Domain]" } } }, "localname": "ForeignCurrencyExchangeMechanismDomain", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedFinancialInformationForeignCurrencyDetails" ], "xbrltype": "domainItemType" }, "kwr_ForeignCurrencyExchangeRateChanges": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from foreign currency exchange rate changes for an obligation of a foreign operation whose functional currency is not the reporting currency.", "label": "Foreign Currency Exchange Rate Changes", "terseLabel": "Foreign Currency Exchange Rate Changes" } } }, "localname": "ForeignCurrencyExchangeRateChanges", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ForeignconsumptiontaxmemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Consumption Tax Matter", "label": "Foreign Consumption Tax [Member]" } } }, "localname": "ForeignconsumptiontaxmemberMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "kwr_GWSmithHoldbackQuantitativeDisclosuresMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quantitative disclosures of level 3 input fair value measurements.", "label": "G W Smith Holdback Quantitative Disclosures [Member]", "terseLabel": "G.W. Smith Holdback [Member]" } } }, "localname": "GWSmithHoldbackQuantitativeDisclosuresMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "domainItemType" }, "kwr_GlobalSpecialtyBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Global Specialty Businesses segment, which includes the Companys container, metal finishing, mining, offshore, specialty coatings, specialty grease and Norman Hay businesses", "label": "Global Specialty Businesses [Member]" } } }, "localname": "GlobalSpecialtyBusinessesMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAssetsDetails", "http://www.quakerchem.com/role/GoodwillNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_GrindaixgmbhMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grindaix GmbH [Member]" } } }, "localname": "GrindaixgmbhMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Houghton Combination Member", "label": "Houghton Combination [Member]" } } }, "localname": "HoughtonCombinationMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails", "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails", "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonEnvironmentalMattersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Houghton Environmental Matters [Member]" } } }, "localname": "HoughtonEnvironmentalMattersMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 16.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income Loss From Continuing Operations Before noncontrolling Interests and Income Loss From Equity Method Investments", "label": "Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments", "totalLabel": "Income (loss) before equity in net income of associated companies" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kwr_IncreaseDecreaseInDeferredCompensationAndOtherNet": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future and other certain items.", "label": "Increase Decrease In Deferred Compensation And Other Net", "terseLabel": "Deferred compensation, deferred taxes and other, net" } } }, "localname": "IncreaseDecreaseInDeferredCompensationAndOtherNet", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_IndustrialDevelopmentRevenueBond": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents an Industrial Development Revenue Bond used to fund the expansion of the company's Middletown, Ohio manufacturing facility.", "label": "Industrial Development Revenue Bond" } } }, "localname": "IndustrialDevelopmentRevenueBond", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_InflationaryPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The inflationary percentage experienced in the economy of an equity affilate based upon the blended Consumer Price Index and National Consumer Price Index.", "label": "Inflationary Percentage" } } }, "localname": "InflationaryPercentage", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "percentItemType" }, "kwr_InterestRateDerivatives": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Derivatives" } } }, "localname": "InterestRateDerivatives", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kwr_LegacyQuakerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legacy Quaker [Member]" } } }, "localname": "LegacyQuakerMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails", "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "kwr_LicensedtrademarkMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Licensed Trademark [Member]" } } }, "localname": "LicensedtrademarkMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "domainItemType" }, "kwr_Lineofcreditfacilityinitiationdatedescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line Of Credit Facility Initiation Date Description" } } }, "localname": "Lineofcreditfacilityinitiationdatedescription", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossContingencyPeriodIncreaseHighEnd": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increased period of loss contingency estimate for high end range.", "label": "Loss Contingency Period Increase, High End" } } }, "localname": "LossContingencyPeriodIncreaseHighEnd", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "kwr_LossContingencyPeriodIncreaseLowEnd": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increased period of loss contingency estimate for low end range.", "label": "Loss Contingency Period Increase, Low End" } } }, "localname": "LossContingencyPeriodIncreaseLowEnd", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "kwr_LossContingencyRangeOfOperationWellP2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated range of time that Well P-2 will operate", "label": "Loss Contingency Range Of Operation Well P2", "terseLabel": "P-2 Well Operation Range Estimate" } } }, "localname": "LossContingencyRangeOfOperationWellP2", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "kwr_LossContingencyRangeOfOperationWellP3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated range of time that Well P-3 will operate", "label": "Loss Contingency Range Of Operation Well P 3", "terseLabel": "P-3 Well Operation Range Estimate" } } }, "localname": "LossContingencyRangeOfOperationWellP3", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "kwr_MatchingStockContribution401KPlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the non-elective and elective 401 (k) match stock contribution plan .", "label": "Matching Stock Contribution 401 K Plan Compensation Expense [Member]", "terseLabel": "401 (k) Matching Stock Contribution Plan Compensation Expense [Member]" } } }, "localname": "MatchingStockContribution401KPlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_MetalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Metals [Member]" } } }, "localname": "MetalsMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_MetalworkingandOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Metalworking And Other[Member]" } } }, "localname": "MetalworkingandOtherMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_MiningNorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition of a Mining business in North America", "label": "Mining North America [Member]" } } }, "localname": "MiningNorthAmericaMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "domainItemType" }, "kwr_MiningNorthAmericaTrademarksFormulationsAndProductTechnologyMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mining North America Trademarks Formulations and Product Technology member [Member]" } } }, "localname": "MiningNorthAmericaTrademarksFormulationsAndProductTechnologyMemberMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "domainItemType" }, "kwr_NetReportingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as revenue under net reporting arrangements", "label": "Net Reporting Amount", "terseLabel": "Revenue Recognized Under Net Reporting Arrangements" } } }, "localname": "NetReportingAmount", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_NonDomesticMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operations in North America that are not attributed to the United States.", "label": "Non Domestic [Member]" } } }, "localname": "NonDomesticMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "kwr_NoncompetitionAgreementObligationQuantitativeDisclosuresMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quantitative disclosures of level 3 input fair value measurements.", "label": "Noncompetition Agreement Obligation Quantitative Disclosures [Member]", "terseLabel": "Non-competition Agreement Obligation [Member]" } } }, "localname": "NoncompetitionAgreementObligationQuantitativeDisclosuresMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "domainItemType" }, "kwr_NonoperatingCharges": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsDetails": { "order": 10.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of non-operating charges recurring against earnings in the period, which are not directly related to or being allocated to a specific segment.", "label": "Nonoperating Charges", "negatedTerseLabel": "Non-operating and administrative expenses" } } }, "localname": "NonoperatingCharges", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_NonvestedStockAwardsCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for nonvested stock and restricted stock unit awards.", "label": "Nonvested Stock Awards Compensation Expense [Member]", "terseLabel": "Nonvested Stock Awards and Restricted Stock Unit Compensation Expense [Member]" } } }, "localname": "NonvestedStockAwardsCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_NormanhaymemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Norman Hay [Member]", "label": "Norman Hay [Member]" } } }, "localname": "NormanhaymemberMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "kwr_NpcoilHoldbackQuantitativeDisclosuresMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quantitative disclosures of level 3 input fair value measurements.", "label": "Npcoil Holdback Quantitative Disclosures Member [Member]", "terseLabel": "NP Coil Dexter Holdback [Member]" } } }, "localname": "NpcoilHoldbackQuantitativeDisclosuresMemberMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "domainItemType" }, "kwr_OldlineofcreditmemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Old Line of credit [Member]", "terseLabel": "Previous Credit Facility [Member]" } } }, "localname": "OldlineofcreditmemberMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_OneJurisdictionExposurePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of exposure represented by one jurisdiction relating to possible contingency related to unasserted claims.", "label": "One Jurisdiction Exposure Percentage", "terseLabel": "Percentage of Potential Exposure Represented by One Jurisdiction" } } }, "localname": "OneJurisdictionExposurePercentage", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "percentItemType" }, "kwr_OperatingIncomeLossSegmentReporting": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues before amortization and non-operating charges.", "label": "Operating Income Loss Segment Reporting", "terseLabel": "Operating Earnings, Excluding Indirect Operating Expenses" } } }, "localname": "OperatingIncomeLossSegmentReporting", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OtherEnvironmentalMattersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Environmental Matters [Member]" } } }, "localname": "OtherEnvironmentalMattersMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "kwr_OtherLiabilitiesAcquisitionRelatedConsiderationFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of acquisition related considerations such as earnouts, holdbacks and obligations related to non-competition agreements.", "label": "Other Liabilities Acquisition Related Consideration Fair Value Disclosure", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Acquisition-related Consideration" } } }, "localname": "OtherLiabilitiesAcquisitionRelatedConsiderationFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OtherLiabilitiesFixedGeneralAccountFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of other liabilities in general accounts.", "label": "Other Liabilities Fixed General Account Fair Value Disclosure", "terseLabel": "Fixed General Account" } } }, "localname": "OtherLiabilitiesFixedGeneralAccountFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kwr_PensionAndPostRetirementBenefitCostsNonserviceComponents": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other income related to non-service pension cost components", "label": "Pension and Post Retirement Benefit Costs Non-service Components", "negatedLabel": "Pension and post retirement benefit income (costs), non-service components", "terseLabel": "Pension and Post Retirement Benefit Costs Non-service Components" } } }, "localname": "PensionAndPostRetirementBenefitCostsNonserviceComponents", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_PensionPremiumRefund": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Received refund in pension premium payment", "label": "Pension Premium Refund" } } }, "localname": "PensionPremiumRefund", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails", "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_PensionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Net Benefit Costs", "label": "Pension [Table Text Block]" } } }, "localname": "PensionTableTextBlock", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "kwr_Percentageoftermloanborrowings1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage of term loan borrowings 1" } } }, "localname": "Percentageoftermloanborrowings1", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Percentageoftermloanprincipalamortizationyearfourandfive": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage of term loan principal amortization year four and five" } } }, "localname": "Percentageoftermloanprincipalamortizationyearfourandfive", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Percentageoftermloanprincipalamortizationyearone": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage of term loan principal amortization year one" } } }, "localname": "Percentageoftermloanprincipalamortizationyearone", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Percentageoftermloanprincipalamortizationyearthree": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage of term loan principal amortization year three" } } }, "localname": "Percentageoftermloanprincipalamortizationyearthree", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Percentageoftermloanprincipalamortizationyeartwo": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage of term loan principal amortization year two" } } }, "localname": "Percentageoftermloanprincipalamortizationyeartwo", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PerformanceincentivestockunitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A component of its LTIP, which will be settled in a certain number of shares subject to market-based and time-based vesting conditions.", "label": "Performance Incentive Stock Units [Member]" } } }, "localname": "PerformanceincentivestockunitsMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "domainItemType" }, "kwr_PrimexMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Captive insurance equity affiliate of entity", "label": "Primex [Member]" } } }, "localname": "PrimexMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "kwr_ProceedsFromNonIncomeTaxRefunds": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash received during the period as refunds for the overpayment of non-income taxes and other related proceeds.", "label": "Proceeds From Non Income Tax Refunds", "terseLabel": "Non-income tax refunds and other related credits" } } }, "localname": "ProceedsFromNonIncomeTaxRefunds", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ProducttechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Product Technology [Member]" } } }, "localname": "ProducttechnologyMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "domainItemType" }, "kwr_QhprogramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Companys management approved and the Company initiated a global restructuring plan (the QH Program) as part of its plan to realize certain cost synergies associated with the Combination.", "label": "Qh Program [Member]" } } }, "localname": "QhprogramMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "kwr_RestrictedInsuranceReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount received designated as a long term asset and related non current liability and designated as non-cash", "label": "Restricted Insurance Receivable" } } }, "localname": "RestrictedInsuranceReceivable", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_RestrictedStockGaipPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares that an entity has not yet issued because the agreed-upon consideration, such as employee services, has not yet been received.", "label": "Annual Incentive Plan [Member]" } } }, "localname": "RestrictedStockGaipPlanMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_SbDeckingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inactive Subsidiary involved in asbestos litigation", "label": "Sb Decking [Member]", "terseLabel": "SB Decking [Member]" } } }, "localname": "SbDeckingMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "kwr_ScheduleOfForeignCurrencyExchangeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Foreign Currency Exchange [Table]" } } }, "localname": "ScheduleOfForeignCurrencyExchangeTable", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedFinancialInformationForeignCurrencyDetails" ], "xbrltype": "stringItemType" }, "kwr_ScheduleOfForeignCurrencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Foreign Currency [Line Items]" } } }, "localname": "ScheduleOfForeignCurrencyLineItems", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedFinancialInformationForeignCurrencyDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedAwardsVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period during which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition", "label": "Share Based Compensation Arrangement By Share Based Payment Award Nonvested Awards Vesting Period", "terseLabel": "Nonvested Stock Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedAwardsVestingPeriod", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period during which an employee has the right to exercise stock option awards.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Period", "terseLabel": "Option Award Vesting And Exercisable Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablePeriod", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRatePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The forfeiture rate applied to the amount of equity based compensation cost recognized during the period for nonvested stock.", "label": "Share Based Compensation Arrangement By Sharebased Payment Award Forfeiture Rate Percent", "terseLabel": "Forfeiture Rate, Nonvested stock awards" } } }, "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRatePercent", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_ShareBasedCompensationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation [Line Items]" } } }, "localname": "ShareBasedCompensationLineItems", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuanceExpectedTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Estimated period over which the equity-based payment award remains in effect once approved", "label": "Share Based Goods And Nonemployee Services Transaction Shares Approved For Issuance Expected Term", "terseLabel": "Director Stock Ownership Plan Life" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuanceExpectedTerm", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPercentagePerEmployee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the maximum number of shares to be held per employee as a percentage of outstanding common stock", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Maximum Number Of Shares Percentage Per Employee", "terseLabel": "ESPP: Maximum Ownership of Outstanding Shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPercentagePerEmployee", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_SimadiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Venezuela currency rate - SIMADI", "label": "SIMADI [Member]" } } }, "localname": "SimadiMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CondensedFinancialInformationForeignCurrencyDetails" ], "xbrltype": "domainItemType" }, "kwr_SouthAfricaEquityAffiliateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South Africa [Member]" } } }, "localname": "SouthAfricaEquityAffiliateMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "domainItemType" }, "kwr_StatutoryTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax rate at which income tax is calculated before applying items which increase or decrease the effective tax rate.", "label": "Statutory Tax Rate" } } }, "localname": "StatutoryTaxRate", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "percentItemType" }, "kwr_StockOptionsCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the stock options plan .", "label": "Stock Options Compensation Expense [Member]", "terseLabel": "Stock Options Compensation Expense" } } }, "localname": "StockOptionsCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "domainItemType" }, "kwr_SummitEarnoutQuantitativeDisclosuresMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quantitative disclosures of level 3 input fair value measurements.", "label": "Summit Earnout Quantitative Disclosures [Member]", "terseLabel": "Summit Earnout [Member]" } } }, "localname": "SummitEarnoutQuantitativeDisclosuresMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "domainItemType" }, "kwr_TechniquimiaHoldbackQuantitativeDisclosuresMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quantitative disclosures of level 3 input fair value measurements.", "label": "Techniquimia Holdback Quantitative Disclosures [Member]", "terseLabel": "Techniquimia Holdback [Member]" } } }, "localname": "TechniquimiaHoldbackQuantitativeDisclosuresMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "domainItemType" }, "kwr_TelnordicMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tel Nordic ApS[Member]" } } }, "localname": "TelnordicMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "domainItemType" }, "kwr_TinPlatingTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A material business combination with a business that relates to tin plating, which occurred during the periods associated with this filing.", "label": "Tin Plating Technology [Member]", "terseLabel": "Tin Plating [Member]" } } }, "localname": "TinPlatingTechnologyMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "kwr_TinplatingsolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tin Plating Solutions [Member]" } } }, "localname": "TinplatingsolutionsMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "domainItemType" }, "kwr_TotalAcquisitions2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total Acquisitions During 2016.", "label": "2016 Acquisitions [Member]" } } }, "localname": "TotalAcquisitions2Member", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "kwr_TotalAcquisitionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total Acquisitions During 2014.", "label": "2014 Acquisitions [Member]" } } }, "localname": "TotalAcquisitionsMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "kwr_TotalChangeQuantitativeDisclosuresMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total Change in Quantitative disclosures of level 3 input fair value measurements.", "label": "Total Change Quantitative Disclosures [Member]", "terseLabel": "Total [Member]" } } }, "localname": "TotalChangeQuantitativeDisclosuresMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "domainItemType" }, "kwr_TotalSalesWithGlobalSpecialtyBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Sales With Global Specialty Businesses [Member]" } } }, "localname": "TotalSalesWithGlobalSpecialtyBusinessesMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_TotalSalesWithoutGlobalSpecialtyBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Sales Without Global Specialty Businesses [Member]" } } }, "localname": "TotalSalesWithoutGlobalSpecialtyBusinessesMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_Totalacquistions3memberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total Acquisitions During 2017.", "label": "2017 Acquisitions [Member]" } } }, "localname": "Totalacquistions3memberMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "kwr_TrademarksFomrulationsAndProductTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks Formulations and Product Technology [Member]" } } }, "localname": "TrademarksFomrulationsAndProductTechnologyMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "kwr_UnrecognizedTaxBenefitsIncomeTaxPenaltiesIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Income for penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Tax Penalties Income" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesIncome", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsInterestIncomeOnIncomeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income for an overpayment of income taxes.", "label": "Unrecognized Tax Benefits Interest Income On Income Taxes" } } }, "localname": "UnrecognizedTaxBenefitsInterestIncomeOnIncomeTaxes", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Unrecognizedtaxbenefitsreserve": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unrecognized tax Benefits Reserve" } } }, "localname": "Unrecognizedtaxbenefitsreserve", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Ustaxreformact": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A decription of the Tax Cuts and Jobs Act (U.S. Tax Reform) tax legislation as enacted by the U.S. government on December 22,2017 and its effetcs on the Company's earnings.", "label": "U.S. Tax Reform" } } }, "localname": "Ustaxreformact", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "kwr_Valuationallowanceamountrelatedtobusinesscombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Valuation Allowance Amount Related To Business Combination" } } }, "localname": "Valuationallowanceamountrelatedtobusinesscombination", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_VatAssessmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assessment amount for VAT related matters", "label": "Vat Assessment [Member]", "terseLabel": "VAT Assessment [Member]" } } }, "localname": "VatAssessmentMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "kwr_VatTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total charge taken for VAT related matters", "label": "Vat Total [Member]", "terseLabel": "VAT Total [Member]" } } }, "localname": "VatTotalMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "kwr_VenezuelaSubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Venezuela Subsidiary [Member]" } } }, "localname": "VenezuelaSubsidiaryMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "kwr_VerkolSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A material business combination of Verkol S.A., which occurred during the period associated with this filing.", "label": "Verkol SA [Member]", "terseLabel": "Verkol [Member]" } } }, "localname": "VerkolSAMember", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "kwr_Vestingsharestargetlowerpercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting shares target lower percent" } } }, "localname": "Vestingsharestargetlowerpercent", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "percentItemType" }, "kwr_Vestingsharestargetupperpercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting shares target upper percent" } } }, "localname": "Vestingsharestargetupperpercent", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "percentItemType" }, "kwr_Year2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year 2018 [Member]", "terseLabel": "2018 Year [Member]" } } }, "localname": "Year2018Member", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "kwr_YearEndDecember312018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year End December 31, 2018 [Member]" } } }, "localname": "YearEndDecember312018Member", "nsuri": "http://www.quakerchem.com/20210331", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "America's [Member]", "terseLabel": "Americas [Member]" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAssetsDetails", "http://www.quakerchem.com/role/GoodwillNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAssetsDetails", "http://www.quakerchem.com/role/GoodwillNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r565", "r566", "r573", "r574", "r769" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r565", "r566", "r573", "r574" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r192", "r208", "r209", "r210", "r211", "r213", "r215", "r219" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r192", "r208", "r209", "r210", "r211", "r213", "r215", "r219" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contractual Obligation Fiscal Year Maturity Schedule [Table Text Block]" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r135", "r146", "r241", "r489", "r490", "r491", "r527", "r528" ], "lang": { "en-us": { "role": { "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance [Member]", "terseLabel": "Adjusted balance [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investee, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r459", "r465", "r666", "r667", "r668", "r669", "r670", "r671", "r690", "r742", "r745" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r459", "r465", "r666", "r667", "r668", "r669", "r670", "r671", "r690", "r742", "r745" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r221", "r363", "r366", "r691", "r741", "r743" ], "lang": { "en-us": { "role": { "label": "Product Or Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r221", "r363", "r366", "r691", "r741", "r743" ], "lang": { "en-us": { "role": { "label": "Products And Services [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r401", "r459", "r465", "r666", "r667", "r668", "r669", "r670", "r671", "r690", "r742", "r745" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r401", "r459", "r465", "r666", "r667", "r668", "r669", "r670", "r671", "r690", "r742", "r745" ], "lang": { "en-us": { "role": { "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r131", "r132", "r133", "r134", "r138", "r139", "r144", "r145", "r146", "r148", "r149", "r151", "r152", "r178" ], "lang": { "en-us": { "role": { "label": "RestatementAdjustment Member", "terseLabel": "Measurement period adjustments [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r131", "r132", "r133", "r134", "r138", "r139", "r144", "r145", "r146", "r148", "r149", "r150", "r151", "r152", "r178", "r244", "r245", "r493", "r528", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757" ], "lang": { "en-us": { "role": { "label": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r131", "r132", "r133", "r134", "r138", "r139", "r144", "r145", "r146", "r148", "r149", "r150", "r151", "r152", "r178", "r244", "r245", "r493", "r528", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757" ], "lang": { "en-us": { "role": { "label": "Restatement Domain" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r131", "r133", "r134", "r138", "r139", "r144", "r145", "r146", "r148", "r149", "r151", "r152", "r178", "r244", "r245", "r493", "r528", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757" ], "lang": { "en-us": { "role": { "label": "As initially Reported[Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "label": "Scenario Unspecified [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails", "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "label": "Equity Method Investee, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r222", "r223", "r363", "r367", "r744", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAssetsDetails", "http://www.quakerchem.com/role/GoodwillNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails", "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r222", "r223", "r363", "r367", "r744", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAssetsDetails", "http://www.quakerchem.com/role/GoodwillNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails", "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r319", "r460", "r658" ], "lang": { "en-us": { "role": { "label": "Statement Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails", "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201707Member": { "auth_ref": [ "r450" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2017-07 Compensation-Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost.", "label": "Accounting Standards" } } }, "localname": "AccountingStandardsUpdate201707Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r138", "r139", "r140", "r142", "r238", "r239", "r240", "r241", "r244", "r245", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r493", "r527", "r528", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "AccountingStandardsUpdateExtensibleList" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts and other payables" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r7", "r22", "r227", "r228" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r61", "r66", "r67", "r572" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r35", "r298" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Less accumulated depreciation", "negatedLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r66", "r74", "r571" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r58", "r59", "r60", "r66", "r67" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "Accumulated Net Unrealized Investment Gain (Loss) [Member]" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r25", "r64", "r65", "r66", "r726", "r753", "r757" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 37.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss", "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance", "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r63", "r66", "r67", "r131", "r132", "r134", "r572", "r748", "r749" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income (Loss) [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r55", "r66", "r67", "r572", "r622", "r623", "r624", "r625", "r627" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Translation Adjustment [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite Lived Intangible Assets Weighted Average Useful Life", "terseLabel": "Intangible Assets, Amortizable Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r23" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 35.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Capital in excess of par value" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r131", "r132", "r134", "r489", "r490", "r491" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r111", "r286" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization", "negatedLabel": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "auth_ref": [ "r133", "r144", "r145", "r148", "r149", "r151", "r152" ], "lang": { "en-us": { "role": { "documentation": "Type of error correction.", "label": "Adjustments For Error Correction [Domain]" } } }, "localname": "AdjustmentsForErrorCorrectionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r138", "r139", "r140", "r142", "r238", "r239", "r240", "r241", "r244", "r245", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r493", "r525", "r526", "r527", "r528", "r693", "r694", "r695", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Adjustments For New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments To Additional Paid In Capital Other" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation": { "auth_ref": [ "r336", "r341", "r497" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit.", "label": "Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation", "terseLabel": "Excess Tax Benefit From Stock Option Exercises" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails", "http://www.quakerchem.com/role/ShareBasedCompensationExcessTaxBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r468", "r482", "r495" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share-based Compensation Expense", "terseLabel": "Share-based Compensation Expense in Period, Stock Option Awards" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r229", "r249", "r252", "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance For Doubtful Accounts Receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r84", "r111", "r632" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtInterestExpenseTableDetails", "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmountRecognizedInIncomeDueToInflationaryAccounting": { "auth_ref": [ "r628" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount that will be recognized through the income statement (as well as the impact on the other financial statements) as part of highly inflationary accounting.", "label": "Amount Recognized In Income Due To Inflationary Accounting", "terseLabel": "Currency Conversion impacts of hyper-inflationary economies" } } }, "localname": "AmountRecognizedInIncomeDueToInflationaryAccounting", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r123", "r198", "r210", "r217", "r237", "r565", "r573", "r614", "r702", "r722" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r8", "r9", "r54", "r123", "r237", "r565", "r573", "r614" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total current assets", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r602" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date.", "label": "Assets Total [Member]", "terseLabel": "Argentina Assets Total [Member]" } } }, "localname": "AssetsTotalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r469", "r484" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Derivatives, Fair Value, by Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r583", "r587" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy [Policy Text Block]" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r455", "r461" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r455", "r461", "r547", "r548" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionNameOfAcquiredEntity": { "auth_ref": [ "r542" ], "lang": { "en-us": { "role": { "documentation": "Name of the acquired entity.", "label": "Business Acquisition Name Of Acquired Entity" } } }, "localname": "BusinessAcquisitionNameOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r543" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r545", "r546" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r541" ], "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsDetails": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination Acquisition Related Costs", "negatedTerseLabel": "Combination, integration and other acquisition-related expenses", "terseLabel": "Combination, integration and other acquisition-related expenses" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combination Disclosure [Text Block]" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate": { "auth_ref": [ "r550" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination.", "label": "Business Combination Indemnification Assets Amount As Of Acquisition Date", "terseLabel": "Indemnification assets" } } }, "localname": "BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh": { "auth_ref": [ "r551" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the indemnification benefit which may be realized.", "label": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh" } } }, "localname": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow": { "auth_ref": [ "r551" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the indemnification benefit which may be realized.", "label": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow" } } }, "localname": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": { "auth_ref": [ "r554" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred", "terseLabel": "Post Closing Adjustment" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": { "auth_ref": [ "r554" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.", "label": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory", "terseLabel": "Acquisition-related fair value adjustments related to inventory" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Total assets purchased", "totalLabel": "Total Assets Purchased" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents", "terseLabel": "Cash Acquired", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables", "terseLabel": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r552" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "terseLabel": "Accounts payable, accrued expenses and other current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r549", "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Acquisition, Purchase Price Allocation, Current Assets, Inventory", "terseLabel": "Inventories, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r552" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Acquisition, Purchase Price Allocation, Liabilities Assumed", "negatedTotalLabel": "Total Liabilities Assumed", "terseLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r549", "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Net", "terseLabel": "Net cash paid", "totalLabel": "Business Acquisition, Cost of Acquired Entity, Purchase Price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r549", "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment", "terseLabel": "Property, plant and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "terseLabel": "Goodwill" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination Separately Recognized Transaction [Abstract]" } } }, "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": { "auth_ref": [ "r544" ], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Equity Method Investment Realized Gain (Loss) On Revaluation", "negatedTerseLabel": "Non cash gain from purchase of equity affiliate", "terseLabel": "Gain on Revaluation of Existing Equity Interest in Step Purchase" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r115", "r116", "r117" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred But Not Yet Paid", "terseLabel": "Accrued Property, Plant and Equipment Purchases" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r6", "r32", "r113" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "Cash And Cash Equivalents Disclosure [Text Block]" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCash" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r106", "r113", "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period", "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails", "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r106", "r619" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash And Cash Equivalents Period Increase Decrease", "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashSurrenderValueFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Cash Surrender Value Fair Value Disclosure", "terseLabel": "Company Owned Life Insurance" } } }, "localname": "CashSurrenderValueFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInAccountingPrincipleIndirectEffectAxis": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Information by adjustment to financial statements for indirect effect of change in accounting principle. Includes, but is not limited to, indirect effect from adoption of amendment to accounting standards.", "label": "Change in accounting principle indirect effect [Axis]" } } }, "localname": "ChangeInAccountingPrincipleIndirectEffectAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInAccountingPrincipleIndirectEffectDomain": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Adjustment to financial statements for indirect effect of change in accounting principle. Includes, but is not limited to, indirect effect from adoption of amendment to accounting standards.", "label": "Change in accounting principle indirect effect [Domain]" } } }, "localname": "ChangeInAccountingPrincipleIndirectEffectDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ChangeInAccountingPrincipleIndirectEffectMember": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for indirect effect from change in accounting principle. Includes, but is not limited to, indirect effect from adoption of amendment to accounting standards.", "label": "Change in accounting principle indirect effect [Member]", "terseLabel": "Cummulative effect of accounting change [Member]" } } }, "localname": "ChangeInAccountingPrincipleIndirectEffectMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r315", "r316", "r317", "r329" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Dividends declared" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestParentheticalsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r131", "r132" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r21" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 34.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding 2021 - 17,875,076 shares; 2020 - 17,850,616 shares" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r70", "r72", "r73", "r81", "r713", "r738" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income (loss) attributable to Quaker Chemical Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r70", "r72", "r80", "r561", "r562", "r577", "r712", "r737" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 8.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedTerseLabel": "Less: Comprehensive (income) loss attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r70", "r72", "r79", "r560", "r577", "r711", "r736" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 7.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income Policy [Policy Text Block]" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r184", "r185", "r225", "r611", "r612" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r184", "r185", "r225", "r611", "r612", "r758" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentsOffBalanceSheetRisk": { "auth_ref": [ "r613", "r720" ], "lang": { "en-us": { "role": { "documentation": "Description of financial instruments, excluding certain derivatives, with off-balance sheet credit risk (for example, standby letters of credit or financial guarantees), including (1) information about the (shared) activity, region or economic characteristic that identifies the concentration, (2) the face or contract amount of the instrument, (3) the nature and terms of the instrument, including the market risk, cash requirements and accounting policies for it, (4) the maximum amount of loss due to credit risk that would be incurred if the counterparties failed completely to perform according to the terms of the contracts, and any security or collateral that proved to be of no value, (5) the entity's policy of requiring collateral or other security to support financial instruments subject to credit risk, information about access to collateral or other security, and a brief description of the security supporting those financial instruments, and (6) the policy of entering into and a brief description of master netting arrangements to mitigate the credit risk, and the extent to which such arrangements would reduce the maximum amount of loss due to credit risk.", "label": "Concentration Risk Credit Risk Financial Instruments Off Balance Sheet Risk", "terseLabel": "Other off balance sheet arrangements" } } }, "localname": "ConcentrationRiskCreditRiskFinancialInstrumentsOffBalanceSheetRisk", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r184", "r185", "r225", "r611", "r612" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Reclassification Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r182", "r184", "r185", "r186", "r611", "r613" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r344", "r345", "r364" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract With Customer Asset Net" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.", "label": "Contractual Obligation" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Corporate Bond Securities [Member]" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r86", "r691" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": { "auth_ref": [ "r246", "r247", "r248", "r250", "r251", "r255", "r257", "r258", "r259", "r260", "r262", "r263", "r264", "r265", "r266", "r267", "r269" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.", "label": "Credit Loss Financial Instrument [Policy Text Block]" } } }, "localname": "CreditLossFinancialInstrumentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r128", "r524" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense Benefit" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r183", "r225" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Top Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer Lists [Member]", "terseLabel": "Customer Lists And Rights To Sell [Member]" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeaseObligations": { "auth_ref": [ "r707", "r732" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term and long-term debt and lease obligation.", "label": "Debt And Capital Lease Obligations", "terseLabel": "Total debt" } } }, "localname": "DebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Short-term borrowings and current portion of long-term debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r43", "r631" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument Interest Rate During Period" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r44", "r605" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt Instrument, Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument Maturity Date Description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r46", "r125", "r337", "r338", "r339", "r340", "r630", "r631", "r633", "r719" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.", "label": "Debt Instrument, Unused Borrowing Capacity, Amount" } } }, "localname": "DebtInstrumentUnusedBorrowingCapacityAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates.", "label": "Debt [Member]" } } }, "localname": "DebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r511" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Decrease In Unrecognized Tax Benefits Is Reasonably Possible" } } }, "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsCurrentNet": { "auth_ref": [ "r53", "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Current, Net" } } }, "localname": "DeferredFinanceCostsCurrentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r36", "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Cost Capitalized to Term loans and Long Term Debt", "negatedLabel": "Debt Issuance Cost Capitalized to Term loans and Long Term Debt" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentGross": { "auth_ref": [ "r36", "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Noncurrent Gross" } } }, "localname": "DeferredFinanceCostsNoncurrentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r503", "r504" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Tax Assets Net Noncurrent", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r503", "r504" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 30.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred income taxes", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue Revenue Recognized", "terseLabel": "Deferred Revenue Revenue Recognized" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r520", "r522", "r523" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "DeferredTaxAssetsTaxCreditCarryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": { "auth_ref": [ "r520", "r522", "r523" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.", "label": "DeferredTaxAssetsTaxCreditCarryforwardsForeign" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r504", "r518" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities": { "auth_ref": [ "r377", "r400", "r703", "r723" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan. Excludes other postretirement benefit plan.", "label": "Defined Benefit Pension Plan Current And Non current Liabilities", "terseLabel": "Pension Liability" } } }, "localname": "DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForSettlementAndCurtailment": { "auth_ref": [ "r431" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease in accumulated benefit obligation of defined benefit plan from effects of settlement and curtailment.", "label": "Defined Benefit Plan Effect Of Settlements And Curtailments On Accumulated Benefit Obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForSettlementAndCurtailment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r378", "r417", "r442", "r448", "r449" ], "calculation": { "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Losses", "negatedLabel": "Defined Benefit Plan, Amortization of Losses" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r378", "r418", "r443", "r448", "r449" ], "calculation": { "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails": { "order": 7.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost", "negatedLabel": "Defined Benefit Plan, Amortization of Prior Service Cost" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r394", "r402", "r404", "r446", "r448", "r449" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Contributions by Employer" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDescriptionOfNatureOfEventResultingInSpecialOrContractualTerminationBenefitsRecognizedDuringPeriod": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Description of nature of event resulting in defined benefit plan providing special or contractual termination benefits.", "label": "Defined Benefit Plan Description Of Nature Of Event Resulting In Special Or Contractual Termination Benefits Recognized During Period" } } }, "localname": "DefinedBenefitPlanDescriptionOfNatureOfEventResultingInSpecialOrContractualTerminationBenefitsRecognizedDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear": { "auth_ref": [ "r446", "r449" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year.", "label": "Defined Benefit Plan, Expected Contributions In Current Fiscal Year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": { "auth_ref": [ "r446", "r449" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.", "label": "Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r378", "r416", "r441", "r448", "r449" ], "calculation": { "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return on Plan Assets", "negatedLabel": "Defined Benefit Plan, Expected Return on Plan Assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExplanationOfSignificantChangeInBenefitObligationOrPlanAssetsNotApparentFromOtherRequiredDisclosures": { "auth_ref": [ "r431", "r452" ], "lang": { "en-us": { "role": { "documentation": "Description of reason for changes in benefit obligation and plan assets of defined benefit plan.", "label": "Defined Benefit Plan Description Of Settlements And Curtailments" } } }, "localname": "DefinedBenefitPlanExplanationOfSignificantChangeInBenefitObligationOrPlanAssetsNotApparentFromOtherRequiredDisclosures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r378", "r383", "r415", "r440", "r448", "r449" ], "calculation": { "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r413", "r438", "r448", "r449" ], "calculation": { "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost", "totalLabel": "Defined Benefit Plan, Net Periodic Benefit Cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanOtherCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of defined benefit plan cost (credit), classified as other.", "label": "Defined Benefit Plan, Other Costs", "terseLabel": "Effect of Plan Amendment on Net Periodic Benefit Cost" } } }, "localname": "DefinedBenefitPlanOtherCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": { "auth_ref": [ "r379", "r420", "r445" ], "calculation": { "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.", "label": "Defined Benefit Plan Settlement Charge", "negatedLabel": "Defined Benefit Plan, Settlement Charge" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails", "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r381", "r414", "r439", "r448", "r449" ], "calculation": { "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan Employer Discretionary Contribution Amount" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan Employer Matching Contribution Percent" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan Employer Matching Contribution Percent Of Match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r111", "r195" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAmountOfHedgedItem": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of hedged item in hedging relationship. Excludes hedged asset or liability.", "label": "Derivative Amount Of Hedged Item" } } }, "localname": "DerivativeAmountOfHedgedItem", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.", "label": "Derivative Basis Spread On Variable Rate" } } }, "localname": "DerivativeBasisSpreadOnVariableRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract Type [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative Fixed Interest Rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r584", "r586", "r591", "r594" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument Risk [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments And Hedging Activities Disclosure [Text Block]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r582", "r584", "r591", "r594", "r595", "r597", "r599" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r589", "r593" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": { "auth_ref": [ "r590", "r598" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.", "label": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net" } } }, "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityNotionalAmount": { "auth_ref": [ "r579", "r580", "r581" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative liability.", "label": "Derivative Liability, Notional Amount" } } }, "localname": "DerivativeLiabilityNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeRemainingMaturity1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative Remaining Maturity 1" } } }, "localname": "DerivativeRemainingMaturity1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.", "label": "Derivative Variable Interest Rate" } } }, "localname": "DerivativeVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.", "label": "Description of New Accounting Pronouncements Not yet Adopted [Text Block]" } } }, "localname": "DescriptionOfNewAccountingPronouncementsNotYetAdopted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisaggregationOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation Of Revenue [Abstract]" } } }, "localname": "DisaggregationOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue [Table Text Block]" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Share based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": { "auth_ref": [ "r1", "r2", "r3", "r295", "r303" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current", "terseLabel": "Intangible Assets Reclassified as Held for Sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r341", "r718" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedLabel": "Dividends, Common Stock" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.", "label": "Domestic Line Of Credit [Member]", "terseLabel": "U.S. Term Loan [Member]" } } }, "localname": "DomesticLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "EMEA [Member]" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAssetsDetails", "http://www.quakerchem.com/role/GoodwillNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Per share data:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r82", "r144", "r145", "r146", "r147", "r148", "r158", "r161", "r169", "r172", "r173", "r178", "r179", "r714", "r739" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic earnings (loss) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r82", "r144", "r145", "r146", "r147", "r148", "r161", "r169", "r172", "r173", "r178", "r179", "r714", "r739" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted earnings (loss) per common share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareReconciliationDisclosure": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of the methodology and assumptions used in the reconciliation of earnings per share, which may include the individual income and share amount effects of all securities that affect earnings per share, the effect that has been given to preferred dividends in arriving at income available to common stockholders in computing basic earnings per share, securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic EPS in the future that were not included in the computation of diluted EPS because to do so would have been antidilutive for the period(s) presented and a description of any transaction that occurs after the end of the most recent period but before issuance of the financial statements that would have changed materially the number of common shares or potential common shares outstanding at the end of the period if the transaction had occurred before the end of the period.", "label": "Earnings Per Share Reconciliation Disclosure" } } }, "localname": "EarningsPerShareReconciliationDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r174", "r176", "r177", "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r619" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 42.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of foreign exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate, Continuing Operations" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r506", "r534" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r506", "r534" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign": { "auth_ref": [ "r506", "r534" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement.", "label": "Tax Settlement" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Weighted Average Remaining Life, Nonvested Stock Awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r483" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options", "terseLabel": "Unrecognized Share-based Compensation Expense, Nonvested Stock Award" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r483" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized Share-Based Compensation Expense, Stock Option Awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAndCostMethodInvestmentsPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the equity method of accounting for investments in common stock or other interests including unconsolidated domestic subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. Additionally, this element describes the entity's application of the cost method to equity investments or other interests that are not consolidated or accounted for under the equity method of accounting. The disclosure provided may include how equity method or cost investments are assessed for impairment.", "label": "Equity And Cost Method Investments, Policy [Policy Text Block]" } } }, "localname": "EquityAndCostMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r131", "r132", "r134", "r139", "r149", "r152", "r181", "r241", "r336", "r341", "r489", "r490", "r491", "r527", "r528", "r621", "r622", "r623", "r624", "r625", "r627", "r748", "r749", "r750" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r33", "r199", "r233" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Investments in associated companies", "terseLabel": "Equity Method Investment" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ErrorCorrectionOtherMember": { "auth_ref": [ "r133", "r144", "r145", "r148", "r149", "r151", "r152" ], "lang": { "en-us": { "role": { "documentation": "Error correction to previously issued financial statement classified as other.", "label": "Error Correction Other [Member]" } } }, "localname": "ErrorCorrectionOtherMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "auth_ref": [ "r133", "r144", "r145", "r148", "r149", "r151", "r152" ], "lang": { "en-us": { "role": { "documentation": "Information by type of error correction.", "label": "Error Corrections And Prior Period Adjustments Restatement By Restatement Period And Amount [Axis]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities": { "auth_ref": [ "r496" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.", "label": "Excess tax benefit related to stock option exercises, cash flow" } } }, "localname": "ExcessTaxBenefitFromShareBasedCompensationFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExcessTaxBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r602", "r603", "r604", "r610" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r602", "r603" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r606", "r610" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r448", "r603", "r663", "r664", "r665" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value, Hierarchy [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r609", "r610" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Fair Value by Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r402", "r404", "r409", "r448", "r603", "r663" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r402", "r404", "r409", "r448", "r603", "r664" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r448", "r603", "r665" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r602", "r603" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation, by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r606", "r610" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r607" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Interest Accretion" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r608" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "terseLabel": "Acquisitions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r608" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "terseLabel": "Payments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r606" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r448", "r663", "r664", "r665" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value, Measurements, Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLevel3RollforwardDetails", "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r583", "r588", "r597" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r231", "r232", "r251", "r254", "r255", "r256", "r261", "r268", "r269", "r270", "r271", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financial Statement Line Items With Differences In Reported Amount And Reporting Currency Denominated Amounts [Line Items]" } } }, "localname": "FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedCustomerListsGross": { "auth_ref": [ "r285" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of an asset comprised of customer information, acquired in a business combination or other transaction, having a finite beneficial life.", "label": "Finite-Lived Customer Lists, Gross", "terseLabel": "Customer Lists And Rights To Sell" } } }, "localname": "FiniteLivedCustomerListsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r285" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r287" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Next Twelve Months", "terseLabel": "For the year ended December 31, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r287" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Five", "terseLabel": "For the year ended December 31, 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r287" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Four", "terseLabel": "For the year ended December 31, 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r287" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Three", "terseLabel": "For the year ended December 31, 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r287" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Two", "terseLabel": "For the year ended December 31, 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r280", "r282", "r285", "r289", "r692", "r699" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r285", "r699" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Total", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails", "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r280", "r284" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedTrademarksGross": { "auth_ref": [ "r285" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.", "label": "Finite-Lived Trademarks, Gross" } } }, "localname": "FiniteLivedTrademarksGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency [Abstract]" } } }, "localname": "ForeignCurrencyAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyExchangeRateRemeasurement1": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.", "label": "Foreign Currency Exchange Rate Translation 1", "terseLabel": "Venezuela Currency exchange rate" } } }, "localname": "ForeignCurrencyExchangeRateRemeasurement1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedFinancialInformationForeignCurrencyDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "auth_ref": [ "r617", "r618" ], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Realized", "terseLabel": "Foreign exchange (losses) gains, net" } } }, "localname": "ForeignCurrencyTransactionGainLossRealized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of transaction giving rise to foreign currency transaction gain (loss), including but not limited to, nature of the transaction, the foreign currency involved, the accounting for the transaction.", "label": "Foreign currency transactions description" } } }, "localname": "ForeignCurrencyTransactionsDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.", "label": "Foreign Line of Credit [Member]", "terseLabel": "EURO Term Loan [Member]" } } }, "localname": "ForeignLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r111", "r294", "r301" ], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain on fixed asset disposals, net", "terseLabel": "(Loss) gain on fixed asset disposals, net" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r111" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain on disposal of property, plant and equipment and other assets", "negatedLabel": "Gain on disposal of property, plant and equipment and other assets" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r318" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related to Litigation Settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralDiscussionOfDerivativeInstrumentsAndHedgingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General Discussion Of Derivative Instruments And Hedging Activities [Abstract]" } } }, "localname": "GeneralDiscussionOfDerivativeInstrumentsAndHedgingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General Discussion Of Pension And Other Postretirement Benefits [Abstract]" } } }, "localname": "GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r272", "r273", "r701" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill, Ending Balance", "periodStartLabel": "Goodwill, Beginning Balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/GoodwillAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r274" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill additions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/GoodwillAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill And Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill And Intangible Assets Disclosure [Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r119", "r277" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill And Intangible Assets, Goodwill, Policy [Policy Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r275" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Translation Adjustments" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAssetsDetails", "http://www.quakerchem.com/role/GoodwillNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Period Increase Decrease" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r276", "r540" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "GoodwillPurchaseAccountingAdjustments", "terseLabel": "Goodwill reductions" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r85", "r123", "r198", "r209", "r213", "r216", "r219", "r237", "r614" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImmaterialErrorCorrection": { "auth_ref": [ "r150", "r153", "r154" ], "lang": { "en-us": { "role": { "documentation": "Describes nature and related effect on financial statements related to corrections of prior year errors in the current year financial statements when the effect of the prior year error was immaterial to the prior year financial statements and the current year correction is immaterial to the current year financial statements.", "label": "Immaterial Error Correction" } } }, "localname": "ImmaterialErrorCorrection", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r111", "r290" ], "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsDetails": { "order": 9.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 }, "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Indefinite-lived intangible asset impairment", "negatedLabel": "Indefinite-lived intangible asset impairment", "terseLabel": "Indefinite-lived intangible asset impairment" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails", "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r111", "r293", "r300" ], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment of Long-Lived Assets Held-for-Use", "negatedTerseLabel": "Impairment of Long-Lived Assets Held-for-Use" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r127", "r198", "r209", "r213", "r216", "r219" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income before taxes and equity in net income of associated companies", "totalLabel": "Income (loss) before taxes and equity in net income of associated companies" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r76", "r111", "r196", "r233", "r708", "r733" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 17.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Equity in net income of associated companies" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r111" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "Equity in net (income) loss of associated companies, net of dividends", "negatedLabel": "Equity in undistributed earnings of associated companies, net of dividends" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r507", "r517", "r519", "r532", "r535", "r537", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositions" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income Tax Examination Description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.", "label": "Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority" } } }, "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExaminationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Examination [Line Items]" } } }, "localname": "IncomeTaxExaminationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationTable": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.", "label": "Income Tax Examination [Table]" } } }, "localname": "IncomeTaxExaminationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationYearUnderExamination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year being audited in the income tax examination, in CCYY format.", "label": "Income Tax Examination Year Under Examination" } } }, "localname": "IncomeTaxExaminationYearUnderExamination", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "gYearListItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r124", "r151", "r152", "r197", "r505", "r533", "r536", "r740" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 15.0, "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Taxes on income (loss) before equity in net income of associated companies" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": { "auth_ref": [ "r506" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.", "label": "Income Tax Reconciliation Repatriation Of Foreign Earnings" } } }, "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxSettlementsForeign": { "auth_ref": [ "r506" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement.", "label": "IncomeTaxReconciliationTaxSettlementsForeign" } } }, "localname": "IncomeTaxReconciliationTaxSettlementsForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r107", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r110" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued liabilities", "negatedLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r110" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Accounts receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r110" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r110" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "negatedLabel": "Prepaid expenses and other current assets", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInRestructuringReserve": { "auth_ref": [ "r110" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations.", "label": "IncreaseDecreaseInRestructuringReserve", "terseLabel": "Change in restructuring liabilities" } } }, "localname": "IncreaseDecreaseInRestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r162", "r163", "r164", "r173" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": 5.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Effect of dilutive securities" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r288" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite Lived Intangible Assets Excluding Goodwill" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]", "terseLabel": "Indefinite-Lived Intangible Assets [Abstract]" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedTrademarks": { "auth_ref": [ "r288" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.", "label": "Indefinite-Lived Trademarks" } } }, "localname": "IndefiniteLivedTrademarks", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r279", "r283" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r75", "r194", "r629", "r632", "r716" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Total Interest Expense", "negatedLabel": "Interest Expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtInterestExpenseTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r92" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Interest Expense, Debt, Excluding Amortization" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtInterestExpenseTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.", "label": "Interest Income And Interest Expense Disclosure [Table Text Block]" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r715" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest expense, net", "negatedLabel": "Interest expense, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "terseLabel": "Mineral oil excise tax refund, interest" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue": { "auth_ref": [ "r586" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all interest rate derivative liabilities designated as cash flow hedging instruments.", "label": "Interest Rate Cash Flow Hedge Liability at Fair Value", "terseLabel": "Derivative Liability, Fair Value" } } }, "localname": "InterestRateCashFlowHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest rate derivatives" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InternalRevenueServiceIRSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.", "label": "Internal Revenue Service (IRS) [Member]" } } }, "localname": "InternalRevenueServiceIRSMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r192", "r208", "r209", "r210", "r211", "r213", "r215", "r219" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Elimination [Member]", "terseLabel": "Intersegment Sales Elimination [Member]" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsAndWorkInProcess": { "auth_ref": [ "r50" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.", "label": "Work-in-process and finished goods" } } }, "localname": "InventoryFinishedGoodsAndWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory Gross" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventories" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r51" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r89", "r193" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest Income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land Member" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r640" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases Of Lessee Disclosure [Text Block]" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee Lease Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r646" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee Lease Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r644" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee Leases [Policy Text Block]" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee Operating Lease Liability Maturity [Table Text Block]" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r655" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "LesseeOperatingLeaseLiabilityPaymentsDue", "terseLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r655" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year One", "terseLabel": "For the year ended December 31, 2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r655" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Five", "terseLabel": "For the year ended December 31, 2026 and beyond" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r655" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "For the year ended December 31, 2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r655" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "For the year ended December 31, 2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r655" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "For the year ended December 31, 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r655" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee Operating Lease Liability Payments Remainder Of Fiscal Year", "terseLabel": "For the remainder of 2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r655" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedTerseLabel": "Less: imputed interest", "terseLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r645" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Term Of Contract" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters Of Credit Outstanding Amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r40", "r123", "r211", "r237", "r566", "r573", "r574", "r614" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 32.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Total liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r28", "r123", "r237", "r614", "r706", "r729" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Total liabilities and equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r42", "r123", "r237", "r566", "r573", "r574", "r614" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Total current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r602" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability For Uncertain Tax Positions Noncurrent" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r19", "r704", "r721" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line of Credit Facility, Amount Outstanding", "terseLabel": "Revolver" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line Of Credit Facility Commitment Fee Percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityCovenantCompliance": { "auth_ref": [ "r15", "r18" ], "lang": { "en-us": { "role": { "documentation": "Identification of whether the entity has been in compliance with any credit facility debt covenants during the period.", "label": "Line of Credit Facility, Covenant Compliance" } } }, "localname": "LineOfCreditFacilityCovenantCompliance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCovenantTerms": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Description of the conditions for borrowing under the credit facility including the nature of any restrictions.", "label": "Line of Credit Facility, Covenant Terms" } } }, "localname": "LineOfCreditFacilityCovenantTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility Current Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line of Credit Facility, Increase (Decrease), Net" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInitiationDate1": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility first became available, in CCYY-MM-DD format.", "label": "Line Of Credit Facility Initiation Date 1" } } }, "localname": "LineOfCreditFacilityInitiationDate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate for the amounts borrowed under the credit facility, including the terms and the method for determining the interest rate (for example, fixed or variable, LIBOR plus a percentage, increasing rate, timing of interest rate resets, remarketing provisions).", "label": "Line Of Credit Facility Interest Rate Description" } } }, "localname": "LineOfCreditFacilityInterestRateDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility Maximum Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line Of Credit Facility Remaining Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt By Maturity Abstract" } } }, "localname": "LongTermDebtByMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r130", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r130", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r130", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r130", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r130", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Total long-term debt", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r46", "r334" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long term Debt Weighted Average Interest Rate" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r318", "r319", "r320", "r323", "r324", "r325", "r328", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingencies by Nature of Contingency [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r318", "r319", "r320", "r323", "r324", "r325", "r328", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r318" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual At Carrying Value" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualPayments": { "auth_ref": [ "r318" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow reducing loss contingency liability.", "label": "LossContingencyAccrualPayments" } } }, "localname": "LossContingencyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyActionsTakenByDefendant": { "auth_ref": [ "r318", "r321", "r326" ], "lang": { "en-us": { "role": { "documentation": "Describe actions taken by the defendant in the legal matter.", "label": "Loss Contingency Actions Taken By Defendant", "terseLabel": "Sao Paulo Description" } } }, "localname": "LossContingencyActionsTakenByDefendant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r322", "r327", "r330" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyLossInPeriod": { "auth_ref": [ "r318" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.", "label": "Non-income tax contingency charge" } } }, "localname": "LossContingencyLossInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r318", "r319", "r320", "r323", "r324", "r325", "r328", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyReceivableProceeds": { "auth_ref": [ "r103", "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the collection of receivables related to a loss contingency.", "label": "LossContingencyReceivableProceeds" } } }, "localname": "LossContingencyReceivableProceeds", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencySettlementAgreementTerms": { "auth_ref": [ "r318", "r321", "r326" ], "lang": { "en-us": { "role": { "documentation": "Description of the terms of a settlement agreement which resolved the legal matter, including the nature of the consideration, timing of payment, and the nature of rights obtained or lost (for example, but not limited to, patent, trademark, copyright, license and franchise rights).", "label": "Loss Contingency, Settlement Agreement, Terms" } } }, "localname": "LossContingencySettlementAgreementTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r49", "r123", "r237", "r614", "r705", "r728" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 39.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedLabel": "Distributions to noncontrolling affiliate shareholders" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "auth_ref": [ "r341", "r563", "r564" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).", "label": "Minority Interest Decrease From Redemptions", "negatedLabel": "Acquisition of Noncontrolling Interest", "terseLabel": "Acquisition of Noncontrolling Interest" } } }, "localname": "MinorityInterestDecreaseFromRedemptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MultiemployerPlansBusinessCombinationOrDivestitureDescription": { "auth_ref": [ "r455", "r461" ], "lang": { "en-us": { "role": { "documentation": "Description of the nature and effect of a business combination or divestiture on a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.", "label": "Multi employer Plans Business Combination Or Divestiture Description" } } }, "localname": "MultiemployerPlansBusinessCombinationOrDivestitureDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r106" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 41.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash (used in) provided by financing activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r106" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net cash (used in) provided by investing activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r106", "r109", "r112" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net cash provided by operating activities", "totalLabel": "Net cash (used in) provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r4", "r68", "r71", "r77", "r112", "r123", "r138", "r144", "r145", "r146", "r147", "r151", "r152", "r166", "r198", "r209", "r213", "r216", "r219", "r237", "r614", "r709", "r734" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 }, "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income (loss) attributable to Quaker Chemical Corporation", "terseLabel": "Net Income", "totalLabel": "Net income (loss) attributable to Quaker Chemical Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r68", "r71", "r151", "r152", "r568", "r576" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 19.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Less: Net income attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r144", "r145", "r146", "r147", "r158", "r159", "r168", "r173", "r198", "r209", "r213", "r216", "r219" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net income (loss) available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r160", "r168", "r173" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net (loss) income available to common stockholders, diluted", "totalLabel": "Net income (loss) available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementEarlyAdoptionEffectMember": { "auth_ref": [ "r143", "r146" ], "lang": { "en-us": { "role": { "documentation": "The effect of early adoption of guidance on financial statement line items.", "label": "New Accounting Pronouncement Early Adoption Effect [Member]" } } }, "localname": "NewAccountingPronouncementEarlyAdoptionEffectMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleDescriptionOfFinancialStatementLineItemsProspectiveTransition": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Description of the financial statement line items affected when a new accounting pronouncement or a change in accounting principle is adopted prospectively.", "label": "New Accounting Pronouncement Or Change In Accounting Principle Description Of Financial Statement Line Items Prospective Transition" } } }, "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleDescriptionOfFinancialStatementLineItemsProspectiveTransition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleDescriptionOfPriorperiodInformationRetrospectivelyAdjusted": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Description of the prior-period information that has been retrospectively adjusted when a new accounting pronouncement or a change in accounting principle is adopted.", "label": "New Accounting Pronouncement Or Change In Accounting Principle Description Of Prior period Information Retrospectively Adjusted" } } }, "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleDescriptionOfPriorperiodInformationRetrospectivelyAdjusted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements And Changes In Accounting Principles [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r136", "r137", "r140", "r141", "r155", "r156", "r157", "r242", "r243", "r369", "r370", "r371", "r372", "r492", "r529", "r530", "r531", "r696", "r697", "r698", "r752", "r753", "r754", "r755", "r757" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "New Accounting Pronouncements And Changes In Accounting Principles [Text Block]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements Or Change In Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r135", "r138", "r139", "r140", "r142", "r143", "r146", "r178", "r238", "r239", "r240", "r241", "r244", "r245", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r493", "r525", "r526", "r527", "r528", "r693", "r694", "r695", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements Or Change In Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": { "auth_ref": [ "r342", "r570" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.", "label": "NoncontrollingInterestDecreaseFromDeconsolidation", "negatedLabel": "Disposition of Noncontrolling Interest", "terseLabel": "Disposition of Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestDecreaseFromDeconsolidation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": { "auth_ref": [ "r342", "r563", "r570" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.", "label": "Noncontrolling Interest Increase From Sale Of Parent Equity Interest", "terseLabel": "Acquisition of noncontrolling interest" } } }, "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "auth_ref": [ "r342", "r563", "r570" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.", "label": "Noncontrolling Interest Increase From Subsidiary Equity Issuance", "negatedTerseLabel": "Purchase of noncontrolling affiliate shareholders", "terseLabel": "Acquisition of Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r131", "r132", "r134", "r341", "r558" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r90" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 }, "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Other income (expense), net", "totalLabel": "Total other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number Of Countries In Which Entity Operates" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number Of Reportable Segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r198", "r209", "r213", "r216", "r219" ], "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating income", "terseLabel": "Operating income (loss)", "totalLabel": "Operating income (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r647", "r656" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease Cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r642" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease Liability", "terseLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesBalanceSheetDetails", "http://www.quakerchem.com/role/LeasesMaturityOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r642" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r642" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease Liability Noncurrent", "terseLabel": "Long-term lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r643", "r651" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease Payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r641" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease Right Of Use Asset", "terseLabel": "Right of use lease assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r654", "r656" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesBalanceSheetDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r653", "r656" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term 1" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesBalanceSheetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r636", "r638" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases Future Minimum Payments Due Current", "terseLabel": "For the year ended 2019" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r636", "r638" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases Future Minimum Payments Due In Five Years", "terseLabel": "For the year ended 2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r636", "r638" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases Future Minimum Payments Due In Four Years", "terseLabel": "For the year ended 2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r636", "r638" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases Future Minimum Payments Due In Three Years", "terseLabel": "For the year ended 2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r636", "r638" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases Future Minimum Payments Due In Two Years", "terseLabel": "For the year ended 2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r636", "r638" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases Future Minimum Payments Due Thereafter", "terseLabel": "For the year ended 2024 and beyond" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r332", "r634", "r635", "r637", "r639" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.", "label": "Operating Leases Of Lessee Disclosure [Text Block]" } } }, "localname": "OperatingLeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r5", "r578" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsMiscellaneousCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.", "label": "OtherAssetsMiscellaneousCurrent" } } }, "localname": "OtherAssetsMiscellaneousCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r56", "r64", "r615", "r616", "r620" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r66", "r621", "r623", "r627" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive (Loss) Income, before Reclassifications, before Tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r78", "r234", "r621", "r626", "r627", "r710", "r735" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss before Tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r69", "r72", "r74", "r78", "r336", "r621", "r626", "r627", "r710", "r735" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 6.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Amounts reported in other comprehensive income (loss)", "totalLabel": "Other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r62", "r64" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Defined Benefit Retirement Plans", "negatedLabel": "Defined benefit retirement plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "auth_ref": [ "r560", "r561", "r571" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "negatedTerseLabel": "Related Tax Amounts", "terseLabel": "Related Tax Amounts" } } }, "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r57", "r64", "r600" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r57", "r64", "r600" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Current period change in fair value of derivatives" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r58", "r64" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Unrealized loss on available-for-sale securities" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r87", "r111", "r296" ], "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsDetails": { "order": 11.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Depreciation of Corporate Assets and Amortization", "negatedLabel": "Amortization", "negatedTerseLabel": "Depreciation of corporate assets and amortization" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherFiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r285" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.", "label": "Other Finite-Lived Intangible Assets, Gross" } } }, "localname": "OtherFiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income And Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r374", "r499" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income And Other Expense Disclosure [Text Block]" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpense" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIncomeMember": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other revenue.", "label": "Other Income [Member]" } } }, "localname": "OtherIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInformationPertainingToIncomeTaxes": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Description of events or transactions pertaining to income taxes classified as other.", "label": "Other Information Pertaining To Income Taxes" } } }, "localname": "OtherInformationPertainingToIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets Member", "terseLabel": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r10", "r11", "r41" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of other liabilities.", "label": "Other Liabilities, Fair Value Disclosure" } } }, "localname": "OtherLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 31.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r19", "r704", "r724" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Bank lines of credit and other debt obligations" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebtCurrent": { "auth_ref": [ "r16", "r17" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.", "label": "Other Long-term Debt, Current", "negatedLabel": "Less: Short-term and current portion of long-term debts" } } }, "localname": "OtherLongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Noncash Investing And Financing Items [Abstract]" } } }, "localname": "OtherNoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Liabilities Noncurrent [Member]" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingExpense": { "auth_ref": [ "r91" ], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 10.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to nonoperating activities, classified as other.", "label": "Other Nonoperating Expense", "negatedLabel": "Other non-operating expense" } } }, "localname": "OtherNonoperatingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r83" ], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 9.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other non-operating income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 8.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other operating income (expense), net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r376", "r377", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r427", "r430", "r435", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r453", "r454", "r455", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefit Plans, Defined Benefit [Member]" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherRestrictedAssetsCurrent": { "auth_ref": [ "r53" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets that are pledged or subject to withdrawal restrictions, classified as other.", "label": "Other Restricted Assets Current", "terseLabel": "Restricted Cash Included in other current assets" } } }, "localname": "OtherRestrictedAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r108" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Insurance settlement realized", "negatedLabel": "Insurance settlement realized" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": { "auth_ref": [ "r99" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 38.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.", "label": "Proceeds from payments to minority shareholders", "negatedLabel": "Purchase of noncontrolling affiliate shareholders" } } }, "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r103", "r306" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Cash payments", "negatedLabel": "Cash payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r102" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 34.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payments Of Debt Extinguishment Costs", "negatedTerseLabel": "Financing-related debt issuance costs", "terseLabel": "Financing-related debt issuance costs" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r99" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 35.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Dividends paid", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r99" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 40.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Payments of Dividends, Noncontrolling Interest", "negatedLabel": "Distributions to noncontrolling affiliate shareholders", "terseLabel": "Acquisition of Noncontrolling Interest" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r95" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments related to acquisitions, net of cash acquired", "negatedLabel": "Payments related to acquisitions, net of cash acquired", "terseLabel": "Cash Paid for Acquisitions", "totalLabel": "Business Acquisition, Cost of Acquired Entity, Purchase Price" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r96" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Investments in property, plant and equipment", "negatedLabel": "Investments in property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.", "label": "Pension and other postretirement benefit expense", "negatedLabel": "Pension And Other postretirement benefit expense" } } }, "localname": "PensionAndOtherPostretirementBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r401", "r403", "r409", "r426", "r428", "r429", "r430", "r432", "r433", "r448", "r451", "r452", "r453", "r466" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Pension And Other Postretirement Benefits Disclosure [Text Block]" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r375", "r377", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r427", "r430", "r435", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r453", "r454", "r461", "r462", "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plans, Defined Benefit [Member]" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r8", "r30", "r31" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of a reclassification adjustment made to prior period financial statement amounts.", "label": "Prior Period Reclassification Adjustment" } } }, "localname": "PriorPeriodReclassificationAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromInsuranceSettlementInvestingActivities": { "auth_ref": [ "r94", "r105" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities.", "label": "Insurance settlement interest earned" } } }, "localname": "ProceedsFromInsuranceSettlementInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r97" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 39.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from sale of common stock, net of related expenses" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r98" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 31.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from long-term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [ "r129" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 32.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Borrowings (repayments) Of Lines Of Credit", "terseLabel": "Borrowings on revolving credit facilities, net" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt": { "auth_ref": [ "r129" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 33.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from other long-term debt.", "label": "Borrowings (repayments) of other long-term debt net", "terseLabel": "Repayments on other debt, net" } } }, "localname": "ProceedsFromRepaymentsOfOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepurchaseOfEquity": { "auth_ref": [ "r129" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 36.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow resulting from the entity's share transaction.", "label": "Stock options exercised, other" } } }, "localname": "ProceedsFromRepurchaseOfEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r93" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from disposition of assets" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r4", "r68", "r71", "r104", "r123", "r138", "r151", "r152", "r198", "r209", "r213", "r216", "r219", "r237", "r560", "r567", "r569", "r576", "r577", "r614", "r717" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 18.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net income (loss)", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails", "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditionalDisclosures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional information disclosed pertaining to property, plant and equipment.", "label": "Property plant and equipment additional disclosures" } } }, "localname": "PropertyPlantAndEquipmentAdditionalDisclosures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r35", "r299" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r34", "r297" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, plant and equipment, at cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r13", "r14", "r299", "r730" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Net property, plant and equipment", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r13", "r297" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RealEstateHeldforsale": { "auth_ref": [ "r731" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of investments in land and buildings held for sale, excluding real estate considered to be inventory of the entity.", "label": "Real Estate Held for sale" } } }, "localname": "RealEstateHeldforsale", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r66", "r67", "r621", "r625", "r627" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "terseLabel": "Amounts Reclassified from AOCI" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification [Line Items]" } } }, "localname": "ReclassificationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationTable": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification [Table]" } } }, "localname": "ReclassificationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation from Segment Totals to Consolidated [Abstract]" } } }, "localname": "ReconciliationFromSegmentTotalsToConsolidatedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r101" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 30.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Payments of long-term debt", "negatedLabel": "Payments of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r100" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Repayment of long-term debt", "negatedLabel": "Payment of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r118", "r700", "r725" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted Cash Included in other assets" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock LTIP Plan [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs) LTIP Plan [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring And Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring And Related Activities Disclosure [TextBlock]" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedCostDescription": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "Information pertinent to an understanding of the specified type of restructuring cost, including the facts and circumstances leading to the expected activity, discussion of the level and quantity of personnel to be terminated, and the expected completion date.", "label": "Restructuring And Related Cost Description" } } }, "localname": "RestructuringAndRelatedCostDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The expected number of positions to be eliminated as a result of restructuring activities.", "label": "Restructuring And Related Cost Expected Number Of Positions Eliminated" } } }, "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r111", "r305", "r309", "r313" ], "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsDetails": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 }, "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring and adjustments", "negatedLabel": "Restructuring and related charges", "terseLabel": "Restructuring and related charges" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/RestructuringActivitiesDetails", "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost And Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r306", "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Accrued restructuring", "periodEndLabel": "Accrued restructuring, ending balance", "periodStartLabel": "Accrued restructuring, beginning balance", "terseLabel": "Accrued Restructuring" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring Reserve [Abstract]" } } }, "localname": "RestructuringReserveAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r305", "r312" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve Current", "periodEndLabel": "Accrued Restructuring, Ending Balance", "periodStartLabel": "Accrued Restructuring, Beginning Balance", "terseLabel": "Accrued restructuring" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveTranslationAdjustment": { "auth_ref": [ "r306", "r312" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.", "label": "Restructuring Reserve, Translation Adjustment", "negatedTerseLabel": "Currency translation adjustments", "terseLabel": "Currency Translation Adjustments" } } }, "localname": "RestructuringReserveTranslationAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r24", "r341", "r493", "r727", "r752", "r757" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 36.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r131", "r132", "r134", "r139", "r149", "r152", "r241", "r489", "r490", "r491", "r527", "r528", "r748", "r750" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r375", "r376", "r377", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r427", "r430", "r435", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r453", "r454", "r455", "r456", "r457", "r458", "r461", "r462", "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r375", "r376", "r377", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r427", "r430", "r435", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r453", "r454", "r455", "r456", "r457", "r458", "r461", "r462", "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r191", "r192", "r208", "r214", "r215", "r221", "r222", "r225", "r362", "r363", "r691" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "RevenueFromContractWithCustomerExcludingAssessedTax", "terseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r191", "r192", "r208", "r214", "r215", "r221", "r222", "r225", "r362", "r363", "r691" ], "calculation": { "http://www.quakerchem.com/role/OtherIncomeexpenseDetails": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Licenses Revenue", "terseLabel": "Income from third party license fees" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeexpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r120", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r373" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue From Contract With Customer [Policy Text Block]" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r365", "r373" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [Text Block]" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r120", "r121" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition [Policy Text Block]" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolver [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableInterestRatesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r652", "r656" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r184", "r225" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue Net [Member]", "terseLabel": "Argentina Sales Revenue Net [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r66", "r626", "r627" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r547", "r548" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationOtherDetails", "http://www.quakerchem.com/role/BusinessCombinationsPurchaseAccountingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r547", "r548" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule Of Cash And Cash Equivalents [Table Text Block]" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule Of Debt [Table Text Block]" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r434", "r435", "r436", "r437", "r448" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r585" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]" } } }, "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r468", "r481", "r495" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r4", "r123", "r236", "r237", "r614" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r280", "r284", "r692" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule Of Finite Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsDetails", "http://www.quakerchem.com/role/IntangibleAssetsFiniteLivedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r280", "r284" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule Of Finite Lived Intangible Assets [Table Text Block]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAssetsDetails", "http://www.quakerchem.com/role/GoodwillNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule Of Maturities Of Long Term Debt [Table Text Block]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule Of Net Benefit Costs [Table Text Block]" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule Of Other Nonoperating Income (Expense) [Table Text Block]" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule Of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r307", "r308", "r311" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule Of Restructuring And Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r307", "r308", "r311" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r198", "r200", "r212", "r277" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r198", "r200", "r212", "r277" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r469", "r484" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule of Stockholders Equity [Table Text Block]" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite Lived Intangible Assets Future Amortization Expense [TableText Block]" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r187", "r189", "r190", "r198", "r201", "r213", "r217", "r218", "r219", "r220", "r221", "r224", "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingMeasurementDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting Measurement Disclosures [Abstract]" } } }, "localname": "SegmentReportingMeasurementDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r119", "r202", "r203", "r204", "r205", "r206", "r207", "r222" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r88" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r110" ], "calculation": { "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1", "terseLabel": "Option Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "Discount rate from fair value on purchase date that participants pay for shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date", "terseLabel": "ESPP: Discount from Market Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Nonvested Stock Awards Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend Yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r474" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value", "terseLabel": "Exercised Options, Instrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Options Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r467", "r472" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationExpenseTableDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of shares (or other type of equity) that have been approved for issuance in the equity-based payment transaction.", "label": "Share-based Goods and Nonemployee Services Transaction, Shares Approved for Issuance", "terseLabel": "Director Stock Ownership Plan Maximum Number of Shares Authorized Under Plan" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r476", "r494" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Expected Term (Years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationOptionsGrantDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent", "terseLabel": "ESPP: Purchase Price Percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r648", "r656" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short Term Lease Cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Significant Change In Unrecognized Tax Benefits Is Reasonably Possible [Line Items]" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "A summary of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return for which the resultant tax benefit has not been recognized in the financial statements because it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.", "label": "Significant Change In Unrecognized Tax Benefits Is Reasonably Possible [Table]" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r48", "r131", "r132", "r134", "r139", "r149", "r152", "r181", "r241", "r336", "r341", "r489", "r490", "r491", "r527", "r528", "r621", "r622", "r623", "r624", "r625", "r627", "r748", "r749", "r750" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r131", "r132", "r134", "r181", "r691" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/DisclosureCondensedFinancialInformationDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Share based compensation plans" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r20", "r21", "r336", "r341" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Offering, Net of Related Expenses" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r20", "r21", "r336", "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Repurchases of common stock", "negatedLabel": "Repurchases of common stock" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r21", "r26", "r27", "r123", "r230", "r237", "r614" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 38.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Total Quaker shareholders equity", "totalLabel": "Total Quaker shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r123", "r131", "r132", "r134", "r139", "r149", "r237", "r241", "r341", "r489", "r490", "r491", "r527", "r528", "r558", "r559", "r575", "r614", "r621", "r622", "r627", "r749", "r750" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 40.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Total equity", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Beginning Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/EquityAndNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r122", "r341", "r343" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAndNoncontrollingInterest" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r650", "r656" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r657", "r659" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/StatementCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": { "auth_ref": [ "r500", "r501" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.", "label": "Tax Adjustments, Settlements, and Unusual Provisions" } } }, "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r520" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "TaxCreditCarryforwardAmount" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardDescription": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "A description of the origin, nature, and characteristics of the tax credit carryforward.", "label": "TaxCreditCarryforwardDescription" } } }, "localname": "TaxCreditCarryforwardDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardExpirationDate": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of the tax credit carryforward, in CCYY-MM-DD format.", "label": "TaxCreditCarryforwardExpirationDate" } } }, "localname": "TaxCreditCarryforwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r363", "r368" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing Of Transfer Of Good Or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r363", "r368" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing Of Transfer Of Good Or Service [Domain]" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred At Point In Time [Member]" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred Over Time [Member]" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r231", "r232", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Major Types of Debt and Equity Securities [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r138", "r139", "r140", "r142", "r238", "r239", "r240", "r241", "r244", "r245", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r493", "r525", "r526", "r527", "r528", "r693", "r694", "r695", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Type Of Adoption [Member]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "auth_ref": [ "r167", "r170", "r171" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings Allocated to Participating Securities", "negatedLabel": "Less: (income) loss allocated to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": { "auth_ref": [ "r165", "r167", "r170", "r171" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted", "negatedLabel": "Less: (income) loss allocated to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r502", "r514" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r515" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued": { "auth_ref": [ "r508" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties Accrued" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense": { "auth_ref": [ "r508" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties Expense", "negatedLabel": "Unrecognized Tax Benefits, Income Tax Penalties Expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "auth_ref": [ "r508" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense accrued for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": { "auth_ref": [ "r508" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense", "negatedLabel": "Unrecognized Tax Benefits, Interest on Income Taxes Expense" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits Period Increase" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r516" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r649", "r656" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease Cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r160", "r173" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r158", "r173" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "order": 4.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Basic weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "21B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080549-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 1.M.1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e30365-122693" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 1.N.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e30840-122693" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693" }, "r157": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "60", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2740-109256" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "65", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2793-109256" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r226": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647444&loc=SL120269210-210444" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647444&loc=SL120254536-210444" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121648281&loc=SL120267834-210445" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL120267845-210446" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919260-210447" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919272-210447" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL120267966-210447" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL120267969-210447" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121614247&loc=SL120267897-210452" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "13A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121565518&loc=SL120267917-210453" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121565518&loc=SL120269220-210453" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267853-210455" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267859-210455" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267862-210455" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120431994&loc=SL64938552-207502" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r314": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r329": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r343": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r373": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r374": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118136717&loc=SL108413206-114923" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r466": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11374-113907" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "740", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120384995&loc=d3e23524-113945" }, "r498": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r499": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r5": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1),(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28511-109314" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28446-109314" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4),(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r539": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r557": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r578": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1),(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993" }, "r601": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121549808&loc=d3e36991-112694" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 1,3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r640": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "http://asc.fasb.org/topic&trid=2208923" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r659": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13,16)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r770": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r771": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r772": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r773": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r774": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r775": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r776": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" } }, "version": "2.1" } ZIP 100 0000081362-21-000008-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000081362-21-000008-xbrl.zip M4$L#!!0 ( ,V#IE*@AP]D6T$ ,65 0 . 97AH:6)I=#$P,2YH=&WM M?5NSV\B1YOM&['_ VAZ'%''$)HB[Y'&$6E*[M=,7C5H]WHF-?< ABX>P0( & M0!V=^?5;654 2&:2R"3;.P\[=D2W^D@JU"4K*R]??OFG__'BQ;NW?WG]T?O^ MTX\_>*MZN=^JJO.6C_NA]_];[HIJVJ*N7WF(^BV>+ M%R_^_-__VY\VW;8T_U;YZL]_ZHJN5']67S?%?='Y<_]/W]B?Z#_PC?D3^A?W M]>K)NW]8UF7=_//O?J]B^/_OO+9[*M4__VY=5]V+=;XMRJ>7GXJM:KV?U*/W ML=[FU2OS>^;/O:SJ9IN7[B?%?ZB7?C!;I+NO]B>/JGC8=,=_J&M4M]ST/S-? M?_G[N?G?J]_!O%;%%Z]8Z1D47]7J19D_U?ON15&51:5>]+LS3'-5M#O]1_1P ME=)__4_?Z+_]YV&(M_72'_[H?;[\_-#4^VKUPG[UXU^^?;8(YG=>_X_GK\Q' M-D>S'N;DAMGEJU51/;STDMW7H_E^R!_4U->B6'_(_>/YJUW=%AV<9*/*O"N^ MJ%?;O'DHJA>E6G:EWGYF#^UK^P0 MJ1_K$W7;XL\C^*_'3=&I%^TN7ZJ7NT:]>&SR'=JJ?GWYO9[8OE.O/#M@$,\" M/8;7#VG_RZPZ@\&]KMZ]#*+ _AQMY2@N?_R]'\]?V5-G?CM=S!:3WPZ3:);] M]M_V%]/+CN+D'_+I<#&+)S\>1]DU'P?QS^>_.S\)\YD0](+9W706ZE\>#S4. MY$\.- ]GR3QQHV598$[T=W_VO=.A@@M#'6JH^[I#&CH-98H9^ M][^^?__M^T^>/Y_AKR13$\[BV3Q8N#&3U&SQN=6GXBDO] 9$XW:$YF1_]^&EZ1\1]\C^DY--&>=XN M;[I"MUY^G7C#Q&&IT/\J+9UDU>K_=;SZC5[H"P]'>C==E?6 M3\9P\Y[]\??I8C%_]?JA40I^9/[;?_6<.3[H&/_T WFCD'!$.9GP3H M2.RUX-\+/<#&+ CS\O^[SSWJ^WIN- MVA;+O,3?NB3D]+>&.[[P[4?>U,U.BQG\731\/+4QOI_-%N,E>;GW0555 M^U1^R:LB]Y;C-^ZT$Z$M5.]^W^IC:ULO;SVWSN_KO9ZKG@;OE+621Y+>2_?) MB$[&O;K1=U)Y[@^]J;>[O'KJ+\ ,;6\VJ4/&W0P6%\V&;'(KC]51F#@%_._U MGKD?T6R.7@.XF/ENIW<<-#BQ*W[RBJNBHAG8UL?C_Z*J0F_JOQ5+Y7UH5%MH MH[]CC^>C2PH7ZLVF4&OONZ+*JV6AA?[G]5H/W[#?Q SM@EJOU1)<&!"V>@TR MP']AL]/15MKS]]J[US']4%6R;F4BWL1]V MP@2?QO?%CR_9AR?KUI;FI??;CR>U\CA6UEO"W.U(]5T[W8^??OZK]^G[=Q_? M???SQW?,@9+9(CD=QVX=7 6G5;E#A4C41+(:SS(TP';?[?45VC7UMFC9]DPR MFZ-5@7P.XL%?$KKA&]4HNT,@<6K%WVBD[&%*H-@J"'FPQPF0G:4OU;U@D]'? M+]5#7I9/V.">\]^/8&[=KGOP:CW8I/LG\U8Y2]3\2$\TAXL/:FQ=EV7]V+[$ M7Q5X'L$BO/AJ+1:+ZPV,(,C<&^;/\,"3KD.D[R@>ZMP\Y5[BT7L[?N#MWFPW M_H+L 0^BZ-"$$YHV\2S%%Q!.'AX#]A@!>JZ5<02\)[9-$<\2I"?AVDE&B/ K M;X18L)(0>1RM:LQSSA\"K>,V:\C7]AXR-*PYQ/;44K0S5QE26J=ACVPPI) D M7W0:3JYPTDZ+^CM'OPX37W3$^' M7>?+HBRZ)ZZ;F,PR)!2WF=OM1C\$WDXUZ[K9>O#KU5X01TAF"7KDC"G1F@R+ ML<+:_7+C]><&#\&C*DO^E+&@:)NNPF]7,.='BX(T.MM1WC=<46E(?Y-WO(! VIW]=;_2$?B8^] M^!ONLG E,B*B0'R)#&?(_G.:%DYBM6_ U >;0OL26WSB$=]I">?^S,;RM(7Z M!'=8#2$F]E(#I/V,@%_W8D:$(:YE9*6^U-I;,U/\7-6/I5H]**[JTE*-QFP_ M%V5YYX%Z?:R;SV9'^7(8S9#2TONKM.T( ZJORW+?:K$IG_BKIJX*G/$07T'G MG G.V8^=_N]M;?TT=2T_&JE??[2%IUZN'IH_&G*V]&S:_;U^+XN\T5IGYKVN MN+NGUT;Z%$:'-_R'7%M:..0PAESKQC-ZD;](I /RWMUO[WI?G.^P8#-%"YK: MF??#.IA(1L)@TMH=923P3>[.943X%BXZRR&7\F:35P\*)J=-@ZZI2V_8@#OS MHO3^D=9CVB[I!$]+@E4D^%NYUM55[:WWC7G!C$?GV; 1#G.$TV&.(U\@#"_E MG\*+@8X)'RN,^[#C8N:-_X/(IJI:,J@;)I=\.AO53=+9(D[0-\XL()GTY<;Y M)LEO$*G13R+W-FD-B6[3?=XJK\W+O'G2MTE?=K;W3[RP*V6E4)NSA]8)WX9 M+X(9P7G_1P?)&S*=I:16^WZ_S2OOHVKUYBVU>::'WA9=I_AO%[(=G?;XMLX; MG >)IA.KHUADP6A/O"T:?>WJ1NNZ@O_\X[ .6,[[LLL/(YC\Q2Z0>KK1MHOQ MV_]>/WZK56'3(GR7.B+>+2?'$"@&+-5*(H+XB39!IV6QTZKUSK,&!7]N2$S4 M5^.^J+)X*.Y+!<>*I64Z"3=(2S1/!ZOD"5Z)6^UXG"S,JPKBIG!ORAIL/'W' MN/ 23D5+C/XKE9;J1G5:Q(UMT.9?M G9FM^YP>UXI@WRSV:0Y\XV%:DU M/22V$49!\G9YL;**#64(YWQC,EH$SE"HU^L[,RA[?BFZW1L D^5/[9W ?HP( MO,16K2"U>N=!P"4O);KP3.!=(P#WHB MC0E.YU_RHLSU]>,[/TB2!Y>9/P::T6#V"Q04G@GL[7I?EB^,5/XZ^P5;:7'( M3T9%@8V^6ZM=:3>"GPY *\1)>CDB8)Q9U$?H@T,#[Q-?'\7:E",>[A$3@N<[ MN7$+/YO-!P-QG"-Q"O$D\N[(5H[B'JTE,/+0S3GPON#AY\<#T4Y="TV8(X6U MS9_X&CDA--[H[7B"I"*^@=VF:+HG[UDPYV)^]&S0**![_YCK(WWE/39@1_*G M%",CNJH["'S?^_9C.(O3N_[4 +5W<*(>G(MG8-*#>\SW M':+9'.TKCO 96[4W,;P';=E $,?+E\MZKZT&=BXVI-Y/G+!(0GY",Y[/9S;Q M!D&<;5U)@N_8%5OM3>R0GU# X;B?Z@YDH.URDZ86F-()$59:UXUZ /S4G>PE M3@BC<7B)-VPKA9H2>("F H /+D R!BY&K]WXPR UR0.+F%XDXLZQ+ LZX?LR2"[T'00WYFW1+LNZ5:>S3J=S M78M J]\T03,]@Y*?RP*$<3P 2@]7SL_\4,]\OAP2'C8!)''B8Z2834*ZZ [\ M;7Y\@0"I.T_=&!"M%EL(N[,#]]3\B#" '9P?N,!;N%X79:%U4G_AGGO+?=O5 M6]6T_"02#HA0(?&B@+UP@]@] M;@I][4ZO0G81*GA\%9)YGP7:YE7^X$*AJOE20&("PE[WBN]&1$2&<]?47_1] M7CV'8#. <6P68%E72]54DK%Q^@BD?:NT6^A'",8PYSR MP8D+AB3BKZ#1EG;,3BTW55W6#^S8@N\36D'+^WZ=+SN+Q;ENH@%&>>?-9]6= MCHC/.>4[TDG0YUC:KM'2\U L19%Q'$D;)VG3('R@ +J!ZP&,>,4.4J[P.*#V MTSMK3MTPOV?Y?E4X2^>&'=M7;ARMQ>[WVH[OV+N6$+51?1&6\G:-%D'0M?PU MDBGE4P'SY[Y PJ*^:$,KZZ5:[1ME[,P^+6FL9 MZ82)(@*TFM_#[M4-X$[:SCT!@B0CB=&%,)74HXH)&"?Y6AR;9."9<,?"".5^G+0ZTQ"W\08$$1B;=T>K?H. ME2G_&+#R^R.X>:_>' Z-Q27AYXV3M"<->#].T'[DN2SYBQU\;6K>!AY("/ MW+UOZD9DN&%\LM8*)H-\>@OY#R!; &/%B6);90;#7!=;IZI_;D!Y4]A8DX>"A)0VU[4H- 4_AQ 3MC3$ MTLU:ZT?^K' H8]^J.T__8E\"D)5_!%B\E2Q];3@"\+8*C4FTE"$Q>/B&LZ>$M='!LSWS?H7,&I+GQ9P?/4J# MOBCM(,'MW5"(@@/_-Q6B$/0H$$.'@@+(0H&O68I#ZCB'HA<\YKBULA> _2BR M&M"@^VJE%_R++?J_(=J_ * #/&-$89F_B/@Q\S3L>8@LKDY4:H-Y<$Q65^IJ M(6/AU-6"'(QV"/G)%JP\S/,%5@1_6I0":O=-H^ ,;W!SBRT@(O4;6CY)('K8 M[;GVA2@':EHM+I@&LI_E,].DYZ; MZ_[:?#8!R3[)9_/]()S",-4512M4=KN M PYD7:B51+2Q&00 KF:55TLE04T22P(G\ZU:*T'TTT>*Z%.3:_'7)]2HCK" M@XO\8B"#>=XK*\ 5V%637\()[\GA^&VJX;J [G?9+^6?&< M&&Z2L<+QV[X&I>4^$,7:FQX_$%_D:M3?F+RVBW!.3EGB$)]QR?0&2RH0D#1N M5+GREDT!%AX V-G6.?6J+;6? (.4!4#@K:'#'P[?%/TBK140_ @\CX@(/)AT M@]<946^-J%^_867^: G."N*ZA'/^=_W9:ER$QS:0@'XT,+^25T6= SQM50EU; MRPDF@]BP/A7%RR0N->8 M4P/<=#O.'7^@E B 6S?EEJGD75.[9RGW^(%2D28(& MQK;H;M]HL5 2G FF\VG4KFXZ4:0P)<(71?5%.T'%0VZ&XEX5BO&DW;<[91AG M\85(^2'5+.IK2K\4=3D$";26-#R0S[X]4!1@7)M<3ZGM;''%?CA+D8 ,3/DF MGJLU\KJ 8CKK8;?*I*[U-_5LVGTQ?M$SN5 %%LE@AYM_ C>^^_?!I"[2O8\1 ME?^B>[_(/6X5YV7N\47@6V;VWYKX?,X@FX_]T-BOO_''X_GDEY.%?S7ENA]) M6"0F6->C8/KFGR%>7V ]$@63*/QC8WZ@6G]6$,9\%%X*:9TSYF-]].'!!^*+ MZY\N@CFVY8<9OU];ZJ0"=H@;??\6AWJ&UIN\<9?K* ^:5TPM'NP8F&,#8JJ..(?IA_Z-W/6+ \C MH:\=ZP<$-@3)ODDJ+>.O-EL^KH_PL38&? "6VH/D:F)N\&.B:H_="H&BY;(T MOY:-0I"FQ<@32]#8J"^FCK78[A2;7R$F<(9$G; ?9_Q<)D3TK-UCR-76JA'% M7E,BEV>TOK'1^9*%'>6^;EG"@T:-XRH4V9FDA,#7G$@YO[B;4BZN,H _'73F MAP4%@G7AH"2\76/X1W!::$H'?#W\.YN2+-]$QC8)!.HW\5T8ZB"P=1 ;J($ MQ[Z)?!L4>=>]:O?RU5:_I :B#@0[@PO/3\9B&P#0O<7Z"1STT:: -.]#W@C, MBXB(IYW!&GJ[O+V%-U-OQ'K?[8DF+'XB8/OUT_[A-!4M)DBIJ@?MCGLV^]A_ M!=#C7PI#\JIWJ#-F-O_)1SK"VBPP/@1'];R&8]7JT/08A-\[D"<]HVKY1#SJ ME^N/3YH&S!>7&Q DV0W$?/I<>#J?]&V/6XT$/;CVN&W! M@*BIU.-(.'R C.&?^%D(A;%1#2-MXRQBPUM]FS<4TEE[4U>F-ZY12U5033O2 MD!]<7 SQ"D/Z)\64G&5%DM' 85ZDD>_W!IB, XX*0NT1T5[D.@Z>B BV7PO$ MPI@4D"Y^\2.)& =V[Z+F@U&0[.MK55>2W!0:X4GE)G/0*!,?)>(9:<;'6"WB MP+W8]H4#UHN>%]:1U0R8V / W0$)C+;QB(1YYLN8GQ9)ABD0A&C5F ";U] W M9TA \6,#!$CN09D8?0T.MC:Y#$B*/R"*J^AQC#KEXWIBHMQ9#ANEXBB/&[LV M0P?/5V1G;KTR)(^K'IQK<=FJJRE9S4)^E'@QA%5@P17(?MOI"6WT \QO24#1 MX->NJX&3N%HR&+[BC3-Y8<'F/[S<^QOT3?+ [^0GST/"UK>%)2Y=M,QW^1*P MRR.?%+\Q \Y:&<,.D'^CV3<4^E*N;I;R[:U@",Q /X#6H$-!$0K4,2;'-T9I MT6Q%3+$8#G;0BR[WQAI=_F82Q3:M*DMESW\%'DIQO^\$H0M*1#T(:6NC2)_W MTK4$Y.\=&D_?2C#S6PG48W@# 5$OM7WOBP^*WS-%_/I9J$';8GZBH6V MV!8EO':UV4@[TZ4S?2F4MIC[%$E.PF5$J$3XYE"%$!K M*?XPMU=+4,L:G)EG@M8_F!]21!B2$I%S6ECY,SK#HJD4I?H7OH#Y-XB.8/R/ M10M/B[Y"RE+X#!_2[EFI \KS"A>J(?N0RS/1 695&;BO#ZP\Q?$G"AY-EWH MM&J#;)%WN/7CGN%#$-A.@>N^?&\:\M3+PC")&AT*EKQ3>O"8WAWW:^U?1P%X MB[(MK,'B2JW,9ZTV[UUS/0%;66KW8)CB*_Z1D9E+O&G31LNQ8DWC@=[V\'\R M+4:^Z(V[!C=$#D1J8S(@Z4I:I&1."5'TI*]+_T[R_1+*8__FX)6]8:., N#' M#C">P&Z)A.<'%V$,EH-;%Q).1I_!HRY,UJ(>N).@*&Q@1.,'&7$[@4T-H#5# MP]2G3/@Q#UQ: $=HKXM:#5AB,VXK@3E@8TTON#>%/8),Z@:5C/N#/?>(Y+0^ M,+X/%/H]P'Z@.S6*MS3=?;58F!H@\#WTP8=;$ZPZ^L8=[,_U\041>ER?-'Z+ MY#*'4]@@5G_,E@T/>FWI7;/=0&C9J!?Z$) ME( HKHMWY!35Q@]%$>TS-ZJR>A[?A>EV8 ?=Q@*7*!CDU[.(&KUOVWHE$8*( MX-[H[8)>,&7UWC@Z.,Q-2U?3*2#%SEL^$(G*X/6RVE M9PZ)-W(H71R:M!O0'V6PA-.]MP_ZM?5YSC[HIGTTMB 2D5;H4*7GNE0KKD;W MYP3NBE^?&!/88'&6E!K$]%W0R_DB:M2,@VM@L4.U YM&,Z$:NAA*%I4;(>2>TU15CH*M&]T.:+^!EJ#%\Z*&SW(GY0"ILJI^A22/;REX@FUNZU,:<7 MUS0F>0IUN)N\V0JZ\9+Y_&U=J0Y:.:[RK7;_;B%DA/@3:$TD))$O:',V[]D- M(=(F .-A!L*5^OL>7$0@>%^Q"[VX[L@8(N.%GUGL!'@Q'YT4R+<8VO<;Q ]?=C0,H$/EL@PY.+:GF#! M&3@ZV^E)B<=RZ-/(;N)#R@S0X_!Y3JDF /JQE;0!2HE@"E 865]RR9\(&D6[ M#P8R"%7[@H0:W=EH?.C118CG?,LA"C(711CM!=#( +"XI=G[8V[RU)W:0KZF M$;%DX(ZY>N?TMEG$]M_VE;68&E46:LWO4H:IHM\?6,J2\#F^+^/KXQ!J_) T M>LD.K<+!9QI/!Q]WR'>;HBAR11W7\ QITP0=371G<;*"/K3T'3TQB/E30HT9]5O@#/VXV.8_Y#&N2'6 M]/$@C$Y,>_+ %T%\6&$^3)4?[T7O#3$-8:LS/W8-&ODAG)# 86L?$EH%0#$( MM+O.FP8TD;ZOUQEG(0%[,E1$WK/\N<5:&Y!"51\&[Z&G0%_?*(1'G'[,U,#T M9&0M+&1$1^!-C_F5"G$P])9K^$575)-6@S&6Z$.*..?1A/E= 28?DX9#.XUA M;N'/!&GF?:6=B?6^E%$*X7C+U;V&S_'[B_T*@LD/2K_O!>U]T?Y>VTH31Z;' M/#J28T;CQ8/ND,F1(VFMCAN@&!#H&5XC@1V$,WJC2TA/\7TUC'H1$3^B)-2^<4&L_G&6Y5C(5$)? M8L0/B:-= ?(2N%^&9Y&?V2 @_<#0>#?4LP@=;HP_'J&=1YU8#BO,L8!E @%+ M^BI4: 9G'#JJ)/,M_6(E 8#)??[0CR:+/6;TNH?)U4/ M2*>?1 T:@\P5R.G'MC/P-NM*L-7P AOMRN"SBP>#6&0G6R(B%F@ZK?Q+7>AA^"E5O,.V$026Z(O<"J>- OLDTFVU7BF!7U-?=ZIJ!46("54U MV:)RM[="ZG4EJ!'% M,843W@)^6)T,<%B?R?8+Y\\*XV5J[UGQ7%IQA@TB5''6UTWQYT9=82 <)1OI M!/-4T'$[[2MJ^P:K=T-UC@" <\%6TR\R%%P(H@[Q+,169;[ M0-42>WX8D[N&ZW'#;EEP*S\;%Q/H)7L-L9BP"JPD M?59J9\D)5<2F*Y8=Q.1_D#6R+"O(1]##MX8.) Q MI!&UUB9P )Q+!JFQS:M*-8[Z0U"1@R,_N AV)FCC%A.Q.##_[TTHOFK7AO81 MH(MM\2 @4PV)V#RZMI0"9U2R'K7IZQOJ>')27W4-W:]BLW[&!#RQ M UC(\:JT>D9OO9 -QT/#>HX$SHPFH#*'POS?10 MQ4I6LWH='V.DUX=4M)F/S:SF2^&4" _6\N-XE8*@2]X(DA94# ,)6#B=;!W[ M6\S[S/)*M44C*S>A[%!')"UU1_&S>!I)[U]: 7<,50D 6'VN'LN(4)[I>RYL M%4TY%.8Q$GG]N!FA^JJ6AF9;4*".Z4NE=@..GX,.'5/(U@H49:8IFE92L@6. M>[8(#A_7H6\+5WXRPJ(Q7KE(LK-9<-[G7RG%[O&1$9FA08$(/#Y*IL>KSR=5 MSH@WQ:A)U\RP98=]*!I*28MIG/$RK9CSKLN7&[;7E!%H-] 6@GZA&:$.2S!8 MM..!1#F:\Z/^6=!7[^\KBPZ/;K& M+)?[/6JW :HS?N-&DYD%<$RTFDR2:UI-3GT[S1@--K/ _?R*-I=!)&BQ,M'F M4H\UG>@[T^8R(&ZSD$)XZ!EY=G8W=$09^B:F,SQP(FN@27\J2HVMVW\MO;B4 MB[0?]/C'N,I^.9_&M![QEG?:D(9OT,QRX\IG/Q"(D3/33 MWEL08@:B0D&.C^*#A%28MI$,ORQXM2,=HNCQ1H[:P=M]F'"2@&EP$F'MB!(M MWQ-L@>/\8X^)47IO<@"E/\MQ77D0"\A&QFZ'*[4NQJKRY_P: )QM=QUC]3+W M$N 0CB[_8KMD0,+;6 &_6%9._H@X-/RDG9^E(082'2H.$]AX#)@CUX4%*3[? M8T&Y7HI[+'Y>>49.,)U^$$=\"D-_$3D1R;N-X=%_6[3Y?5$"$S.(8"\[4"3P M^/SN^AI*M,E@Y$$U(^X/$\0)'P+J3[V;<2IK-N,/36^.VLU\$#8'Q(Z1K5AA M)_-B O\PT@]Z];[3?W.I1( EG!NS\6\@Q+CS5"% J1.TD_H&6CY@"RZ&!T< $^=G1.W%]C-P], *R$HHH MZYIK%Q' J(&5>[MO._")L60)( 3^V/O(\7'W:3\)#PI^:_0?,>QC>;$[91?B) MHQ:4[2T&J\ZRM;@9#B$IP=W%%%K&JU&J N*\;M-*"'E(KD=TTOS8/9J;DQ$3 M)SM:]O5H(E,^"O2T_-)/RK2SV^X%N*#^1*B39+H.J&+A= MYPU6$7L\G),!Q-6C%E#NJA;$\_=B#0*A!;UX8>ZDH,D2QA@5E;;TRM)DK'I" M'[XV3PGCHZX$+TQ*H&GUF1O5]99?J)$2[&14,Y<@%=!7+\;^QEU1[45L3%2' M$[IYR@UF5055W^4UDI!0_=WRIT8_YH8P2M!^ <."@-O"3(?O@I )=->M5$1U MC-%86H'*ZEF1\U&TGJ'WXCL>V'\199DHG\P<,A+GS!=TR1L:6#M9\>[S%KKP ME7QH"(7$L%SD,@(UHBK6O7.C<2?M1Q.?>4@,YI0;WM)/&QKD MHRJ!L))B+L@$((I@:'\..^U:;K-U M/\$,J@72;3=;=1"V5R.YM>C27V?G4BRTO2]DB.+T4R2Y']3VZ!,'VF!^/U"* MF@O>5V @D0R"5F;H&O('-10#"4C#J::&%@L,X2L)"Q7FUB)!M^%<0.$:!#TN MR(1@*H0G'>U)T% /30Y=:3T32&!'4(G0SZB-+=/KD&W"5G\X7URR^AE9K2"* M!S<@72SFK\YX\>9W?>0EA/-@,J !GD8\)+S&#S+W** \;Y57K7UN6NES0R5G MS$I=].8J*#0:\;":Z*2+)#_.@GLUV8?'E'SH+:""E^$\XH?9@^2@Y.$3A#!G M6NL^S#SX:/+*GX7S[/4+_]GFN2?MIHD+H_9+ *'5KB*\JREQ3BX!4B?RS4$6 M2>0JI K\W24P29BS(C^=Q_##<.:GR743BP@VA5'@^<[T%,Z)/=(YIGAANB@A M^)TW.?0<5/PA<.QQR"0+BCX2(M9H _C\Z%A"9+F!5T!T2'@(>#Z!I)*?[$R( M,JXMV(7 +(:DUQ?D-D)_Z# M)#RD.N<=H\!N\*2>&;\2D(C,07P"#P^ZTYFI M?+\"FS]5W<&;852:H' 1UR\;IKFIX2PSA!U0Z[VI M*]7R&TVD!.G NLGW*^ 65Z#TW-IA=)"01_I1[*XD'9P8!] MS (/[+CZ8\"^!OV)V04+>@W$S?),R,?SEN LN[:F^KH!5-?8+O@,,D%/IK O MW#[N^V#-P=4>^,H-*&;/?55\@L0"R$AL:6,!93A6FYI\[-_V35'O^93H6/5@ MTFJ#T=!RQ&:\" EG5Q_=EV( N>@!=]I]AE\^[(N2K0HB@F14CU75)>XL%RZF M#=ATG?A<(;=863ZG'VW"">K MHOQL<4#A.'Z%;]HCH; 6WK.O?"8X#"2!NQ7/!98=!@NL\B?//*_\,6B^+7$8 MD"))NP)$1C%VP^5Z$FPL3OJL!:GBA'!^9%3L&/V M)8A&;"Q83%4?@EJI=MD4]Y)ND%1GM'9_WSJD#Y]0GMJV@A"R8)K+=NSC,3@? M6LP48* ,H8JJ6AN=TA/]FYXHWZG&)3&UUR\5!$X"C"#*:Y3WIEXIV[5G730 M !+SP5%9 A?=-R?-3\E1+6Y,UFC$^]@PDB#-1Q5A:XFQ9A(^ZT32-BX:LP=7 MO1W8:+GB[:":K-O6A0)J*ARA>"_+\F"^T2ORZ3'Q+A?M%4J";'2]+"% QI\* M=N&?GM_)^-DPQG5;[_6>[/)"X+_CLG@)UH% Q_Y&1T/SCX7AQ49()W=H\(ML MN8(RC#@R5$%,-E \P)>8,E#3TH7_!A)!OR_*1/TDAQ<1O'B6ZM#;Y"N91%(I M4"V1AHM;$(V,B,;KKL+=L'#ORGTKY?VANA"XC-!?16E]Z&!/-5'D86%#-+=_KXLVHVU)$69;"03L$F>72K?#D*G MV*].I!TH(\B12,J*G'"4\=:Z&@Q5?F8#:Z8QDR"<06UY;^8 4-(K< 5[&/F" MOIE)W[W*< 2L!.A![%/K!X_?1R0A0!JYU(:CXMYZ#?JQXQ,F)+1U:>':-P1T M^[IL_FM)+$6+\RZ7=8C"J1;;$TS )$ MQSP@ I!O0L",Q"]'0F"8WL]LR@M+2L0W@^/! M##8ENU %[,2Z+PAV3=JMTV2I[?E+"8FK?89+Q<%R '16M2;G8X%H@BJ?D(@0 MG]XMNX+S#4K#9,YW5./!Q+/T2\MELX<.Q-KUJM2ZZ)Y[!^Q9\IID[%P[^'#K MJ(*@IZO%S9K3Z_3;:\"X%E4@XJC&!O^-17"4D0)%QLP[ MU1W*"MV^#.@R_1$#/[0FYYUW%&CF9RCI(,>],FZ_Z0[OV<2*MZJ-[VT!VOU: M"0,EN9@GYI!X'%@MQJ9X.Q3&GS,KDHQ!Z7$(]QJ_P7<:SE@6^F0Z[8::MPU. M8YM7D@8V.)2P&GD O%R/[S(X[!%QA!JR_2 ?'K0;? %JRF AW%?8 ^,P(Z@T MP#\4%;"M:BGEP[O2\UTWT/&F%Q&T)XPV@\$X:,;UV%7QIH+O!ZW[&H,PJ"5] M;ATH2^:4"#J.D'8@S#,S??YP:,:6\ M2V4(F[&03/,JC4(RF)$'LHMIU8\EQQO.G]!ZZ<6^/U,L3'%?19X=M[!DM%PV#; M;9,WVQ("9 +C'TFH22ONRU(22B9ZEW\UO,OPE$!S9D'P'1=J/!V$+&[(B)?Y MXU6=9Q-N?[;P<@O8$TG.^KY9IC\W6/5WCLJ9SU&+VURU^Z*[.VDB): PP5Z2 M:<2E5H8[W'J"0&+!'Y"JLJR; :O''PA[*K5W",P3M,K"#J\I_U[+B6.(X*=^ M5B6MFW$%Z,@?I6>%"9K"+!&TFABQ#:9EAYG<6BMC 5TPQ? M! =1]5>B6D*J M>MQIL"S%JA!U[::LYJ%VA^]54Q9M-[YOW%5E M1(H1>G?SIX%#C>9P!)Q0%,97WW!3+($-ZFCN\[6M-KY=_1%0%3>[!CJC"WJ8 M7MQC<1-3BIG+T6V\DU$ZI00>I6=RDE2ID J1;88G1)6VM8O@N0"#G#T06LU5 M+V-"Q(7A993TB,4*Y\I7-27*J9=- 0%#C,2(YH*.W.F(4!]?:0F%?T:(H@N; ML$? W5Z@"1-;LV=$]6&OV=D"F,UBG =8?7& ??Y22#:Y-1P4?PPB$M*?H[!Z M)R/ 2/N=""J0$?:%*4;:=7SU0"RJ$WM0&4$897(]^ KX@AAO&L7.ZS2AXRXW MO<4%2Z.?/8'@$87E^@:N)7*'C2-0OVPGCFK$T*A=_N2UDHM,/. 6^;:O2CXP M(2.@C5KQ"K42&F)?=@54QP 7"5_X,0QOI6RN1L9SGQ$/'!P1GR8N(R*:+G 1&;(D11^J<62_YD:]N@'%TC YN<4XNI\XUT+[ MVD/8\R_ 5E+=EC?_(7^D5CZ=)CK*1&6#D<@-F5(L)Y\,A$]?Y]8TX\#YX2'G M!J0JG4FTLLTWH@MQOH26K\: ,[$V,#C*_+%G,@+C8UM7CRHONPW5S29:2%J. M#4;$!U55[5.I+<F7O8_9^E7?KV_^H(JR04DHWM&H9^L#X_OA6_EBT2U66>:7J/4:=1(N(SPXWT>5$CS5I M-IP\GNYA^'3\VDGZF6,/$:RD-YN\>E 2LG3,LP,<;TU='LQ+8)9B&M01=L7W M:V*B55YNL(SLT'-,D-,8(Z+HH)4DO/;@*4FF1(!'.O70&)QE/FP6EHYITXKH MCV(ZS!E;S^*7;+DH'Z.!:6T-U=W0<87/.8_3@>\KRXTAR73C-G.#X=?;?7RC M%JT-6XSLP8A3_9)K$^'.*\I2/>2E*/&&$:8F5_$(F8%]93LF*UM?A00EF":C M0SU20#;,= M]-3PSWX)_2:A^"V-G9]6#4YQUW*BM;1Q]:+-+G=^0:.!C ICW MIE=POEYK,3=]U+U">W[Z@J[XHHJ%C-]@D[*@H=43 (ALJU>RS744"!B=_;!/ MG/95^<9J%00?J+#B?>FR!PZK>T,8XL3]GD5CRAAB1E@?(8/#Q%81QT>9L&!#%APQ)A[95@JN, MS1- 0/Q]+U#?5#G75C4/P*G,UP(X+&YK#)9ULZL;R_G5 9VPU5-\X [!4+S=%IVS MP[U-70FL$;S>L;&MA+P% W6!:*VP;P[P85F8J+3K/(YA&X<(RTDF,(S2/NI& M1!$?3/R4'="F:DONGR2\-R$!QSD,97HG$4D9MABKH7/!3/YTD?SIT<[$+Q_R MAB]"V#3K,"-;% E,X,6\CTL:K*.+F?)5)X4=,R%3KBVQF/E$1/N*]YHHF1:Z M,53A]GUAD3*"IS$A5+B!"XI883&"6!5->^>IKVJY[VK]2_YT*.\D7VVU&Z+O M4 Z#\?>8!$A+4L@4 TM1[0T1X UR1W%*1HQ6O.--\.T]"20""4:2S7YX'Y<(/!:@T/(J02^_R ]R+H$[JC M>_.+EL8C!9GF"1]8F-]S]Y?WW_ MZ:=WO_SB_?7[=Q_?_?P=]PVEJ'8-'XLE!O!L,P/#9N(>:.-;'86!)+7?.+QB M.%FAF FZ=EIJ07,3>M^(.,!$$"L)YA=S,XD_;5':Y)X9;!$Z'>"V&S>"UB-. MB@1D[-*Q9\@PZ+_^^OI?WGWTWGS_[L?W;U[_X+WY^>.'GS^^_O3^YY_XOAC2 MQV^_?4W,QHC?["G21_T_*;]QOM8 MWZNF\S[-O$]-OK\G!@\F\XHG$S\:_\=BN:6\OW*M1&TCH,O\ M?=UV"CA2B,EETR_JP>*S0(;08LI+.A>JOW_81*9YV8XG$LU[2,,_]IQ200E1 M%%Q\O5)?P)P5A9<1&ZF$CC/.*-#7X6 "5KRTKTH].YB YV@^=^PU9P?CFVRQ M'TTM4\"K$TPLDD_5$(?QU%GRK>LX)@%\AX/Q48UQDDR=)5_ZXVQQV6).%WSY M3^;)Q#(%P<5D<7E> 5_ZDV "294*:,63*)A:I #7I"_YY;,,^-*?I.'$64ZW M^#ZH8Y]2/X+6':D_I7ZF33%! &O9YWK.#\>4_C?V)98:""J@D MGCC-D'\#TFQ* 87\&Y#-IQ10R+\!V6("Q)]>[.%R,EB03)PFP_,8T>/!U#+Y M-R"+R<5$.YQ%?]?0[C[<^ KCRE,;1HR'&L:4QL1=F@D8+6;>E8BP8,W M 9=-IUW?47*G'A4)A& ^]:@(2!1[ -[9H?A7?42%G1V,?]5'Z-#9P?CRVH,N MS@[%?^K&O/S9P>0(\"!:S!9#(ZLQ(=S[=]XE+RV6EV<%^IJ$X_=3WWE"ES[''IF#U\)IIZHY-(U1Y\P/[!ZM.CRLEBZCV:&2/XD'/\M MP'Q_R2*B,>ET/'OA^X%BV?!"0B"#]S2.%4>WTV_Z%6G@"!%1%]$^JU]X<@ MF]_-M=O,#G?@W",Z^VP^J9-.SAY8)ONSYP-PR ZSD'Y29?$ ^1_#1&>PM)7Z MVGE.,HIJV5C&T^PH8$K4%ZGD?2HHC(HLGW\:3G5G,W9X_ MC#7Q!2Z2_F_W3G M]>SG6G!*-C;7#V9S#%1>>Q(HE9X3 >LR76FMFI-,!E/(J!VT,:TZ3P(1@WU" M(GJ&G39FD&F=')\VZ*SO<%HQ8 ASJF7!)LT)"?'7![DO.X,%<@B)VI15Z9,U MH(-[Z$/84WG@)R.>3T>=3M:3),X_XS]Z$55$!]UF!QTI(.+$,GVH6RV2Q]QB M;FX&H_M>Z+\>F&?.@X>'K0@P_^6HGXUZ?O;#I_04M)=L.]SF MG:!+.::NL?K7*Y76!'P,(ZXV,%I8 .3"=NL?_'D@L>G\.:&.WMOZF4*K;TF[ M0JK/^1J0S&HG(M]$HS@K[I$] B8%:FJJM"Z>3]=@'HM,.,^<(C*5J^; >LNS MMRT-+_(?%G-C7-O>"8[Q7/1.4P@=(V'NL_5N5S?=OG*5>&AM_G3R[&1MB]@I MI3\$,BE*B6=$Y,EA7\W:>8D4$>:_LYKHD+Y5U'6*;A!JFA'"DV$H__E# MH<*Q9*-B Z*> F_)-.+N9$MB%X;1MQ/N9F_B'[;;9$6+QF(S\QT@-:'9X%!U(MWUD"!"?6.JGCI%P#MCO66_L>LJK\88[&?L?;"]^!@=(9=O4;'/SE7NOXK0E"XE.0AGZC M 05QWPOL+E]^SODBDA%[!P1B8T?P?F2V_8CC(UJK&9YCTT@#7"5^Z)4B(K4] M2LV]Y"Z3:J&K#765$UW*XV N#.5% W[$SD[2=!AK(3"#[P3M)2)"T\.6&WTH M:>> 1_$:PWPC<*J(4D=W>]I:UC(#MS_*GZ1Z@:0"KROEFE;CDY]&TYRE5J'R-V2:PL3C*4 MQ=)#7C+[S!N^SK=%^?3R=5/D9?^1]" ?-X4,U-^85EH [UG@:?^H5L628-;6 M8S*>HZ.M\.,A/7YN*R;MF\FMT!^YE 76WYAV/(ZW8ICV6P@=4SLQ#20_V8D@ M&%+"9W8BGFR8-KD3P64+H%MN_6>???+ZY8(I@:9=//3Q7"ASFQ^=OOFI_Y%#%$< M3K.YGVS^,.V/"FC?3&';+_D7O;NM"S>'<_\SL4.7B7NN<3<3O:%6.W_X]/,W MWP.:+7^B7,YPNL3A^)$?1^;G&X@Z81FN@JJ7/LS.\XZJN<-Z8*DC\.F?U;\3L)4)1!&C1AU]V%M 4+%>5'MEDZ>_A;Z0#80)6$QSWK7I!?=0 MU/P>*S'!I;5QFIF?'L'AXU\!A;,"$3)MFOGWE@8^ 1LA.L!(&@5(HM19(DVM M!P6PM>GWS$>IH ,TU=W0B5FBWQ;H^%Q_<]/:FI^IQ9NUS;\6V_T6HM)<[/ MR6!:?CQ!015$DI+^A/GG0:V!^S?\ZKY>/9D?;;IMJ7_Q?P%02P,$% @ MS8.F4CS4H#GP"0 6BT X !E>&AI8FET,3 S+FAT;:5:;7/;N!'^WIG^ M!UR2ZR0S$LUW2G(N,[XX3=PFK9NXO?8C1$(2SA#! 4'+ZJ_O B E6Z!IL(XS MLDQ1B\7NL[O/+OC^I^GTT^7GB^_HR\VWKZC@>;,EI42Y(%B2 BWWZ",14EWZ M>/D-?;E$=T34E)<+%/I>ZH73Z8<__N']1FZ9_DUP\>&]I)*1#^1^0Y=4!G[T M_LQ<@1O.]!WP9LF+/5JN<\ZX^.75:Y*JGU>HEGM&?GFUXJ61X<;EWB_'8M>%,64[/J]\^_O@TC?X*ZEW?G>I'-(ZT/.K5B*EP4 MM%PO4%;=/]+W&J_)D?.MUBL:3EE9"47N)&\ MNR"T1OH*!_>O&-\M-K0H2'F^Y*(@HG5'S1DMNDL[6LC-0F[HX::C)L%\-D'= M"V@"ND^7@+C;*5Y)(A:8[?"^/C*9%\/;QZ*.@H)G!?FQE_E9*VT^!_1K<0$Z%14- MB'H8+$O."B,[G<5>G$2M[#3R,BWZT[^_7/UZ=8,"WXNL56;..\]FVKQ/[7SN M+&@>>]&0"=V=$?CS=H]/B'K>'0=183(D*'07%/O#"!GRZXFH)/%F0Z)B=U%9 MH 5]PR+?H#"$A.*'-N;"$;:?I8-N#-UM'_I!Z\9+?$<+]!MES%8M<9<7&&G_ M:/ M$>@+;R!.>&F+=,=L&(6#7HW<#1?&6>O52X(%TEM>V-'O[MLP'?)#-,)N M$.)&U$=>K@66C:HRO*Q_>IBDNPK:5M@EX_EME_>]2!>YAYI<(;Q%%2.X!FXB MN:,D#?S'@OAJ!>BCO "]?H M7]<31T&I-[,4^\SX$C,$QI>",T:$YZY5?"KL/[QQWY3U;44?-<. KV,A40'4 MTL)H-@):\ZX:K;@8X\#,BT++@>UB:(24T/+;124H S;CZK',\^>G,E02]:R2 M.E13^RMW"$4C33/+6,X.#"PC65H]F^S")/#\'B5^(VA)&"5WY 5I0,5MCDMG M6P=6=&PA3%%-UR5=49 DG44EEC*YBC"Z;'1R0]1=J]@2I:",(%I=;0-(3$YE MX+* 5,28NP@+B"L*,D:$5>K-[01;55S(IJ1R;X5Z,((91+[AB>0^A_O*-5+[ M$V2'A>J#7'-:9B>E:UU%0-0=A=92;@@JB,24U8BO])^F1 !8^+<$7N"P; MS*"=+U"M%7.6EUF)"^+I39CZ$^C8%'+<:YCE1JIB.V=-K>H87[U $F0OH1BS MC[9$4-?4 V79LA8H)#2*55",H#&1E34(@#W7)1HJH2YF[MS*VF PMY T&T+2 M<7XST]RC;4#3P(N#Z("O6+$E0-C$QNE@D6R%08.112=@-177M0[Y?;3(W>;6 MMU66AOQB;V<^(NRRKD&$HKJF2T:0XD0:8B6YEP9BZ 4VGI7X0_Z-D%6K/.[ M*Z3C'K)9$;%2 ZLR)VBO&A%M6;M'"MT;D6B6#+;CX6 /]TSJBZ%)-#WLA4XV MZ HT+[4=KIDSL8AZ+&&I&;EW^W&0MLYT!Q9XPTH+'; .D) <54"\:4XK1;T! M!&T*"M!+]A][F57WWUY<7;^;F&8(EVTN1TM>-C4"\K\F4M77R/]Y#.#Z"""4 M9@5H4R%ZH#8;,8:+@C:W/ &UV=#XX3FHQ0;%7Z$+1C=$;%_@V,=>ZMFS^PPB M3L/16(/.P/)W#]9>T&<\@5)GB6%P*G&LV4$K*U&?F/WMUQO N#,W#BPW8HDP M8M ",72'60,\![NS )OQO\D,O]EM:+Y!#WG*"_S:DF!K !2-@%B6M1G\39QI M#=<"6BU5G)R-%UH0$20GL+5"$14]@'26Y5N6"Q)[P#64KON)2@@U.#I,X=6N MS=Q+;FSISU+_$+[NAYEE0G>:8EGL!OSX)HRT!S3>W"UFP0*"4K=*5#5'!.+" M65;T9.IH20AQ9>=]GJ2EKC9%H6V*7=DKB+)JBP$IH&L_II6Q6;"9=5D0>)ZK M'@-H'K4L14_,("0/8R8TAKIF/2.4BQIRD"!;:/6)F&BGFHUKK^2\K&FM2_5W M4DM!1[@'"I>5A7](^!R]3?V?W^E>Y?H!7S2?_;.DLD9O8[C#=5NQEUBI^M3< M4-J=S9WXP\=Q\0@JEX112RE4]$FH/[7>.!C60%2/&32-(=N*\;TZ5W;>MX4U M7"L/[A&Y!Z\1-2#98@@)^&\:NPE\DI/*?06;V,$2=45R/2]C;(]J8'+@0T7S MEORN;4%+6-G 16_1LF#FWMDDD1G\K 3?0FG#NF[HD1WLKU)C&][4;.^>%^UA MP^F1#NA.Q!W1MD3ZT%LQYRV';.<^@_ M\&LO_\Z72#\%,4%%(RGIX+"M2%GK M@Y&)FOGO"$0?_,8]AU;)B+%9DG2#([4$+O=(-(S4$[ (> MCU"T"7429>ZKI\-'J4GDG@03Z .#;G2,A3NGL>FSGB$JMK7DC1QW\#.S,LW# M 2?$P0OF K7YJQRS(3*3K*,\UNEBIJ-CJ'A6:]&.%<)0TU<1QDJM0D;AZ[@ M_SD"U4SMSS>^K[GIDAM0-DS9=I;:;&KJ= <8^Y MS.FF3G1F^*QR$)2-%15;H[?QC*Z=9A@N&^'>LL_L4P?(<:V',*Q4[=6*WR%? MW0C<+/4:?]V[MZV99?._\$U9@]LLBZE(ZH]'"OF7M#IP0TENWM MF6(:N4_IT[B;VS@/CFQ@V@JX'XBJ4:FQS5E]AGYL<$F@J@$3D KLEN1XA*6@ M 6EM]:S4$?K.P[9'\Z;4:>OO*Z J?8HF[H4L M\[-AT"7CCV>/PD-C@T^ZZA*B- 9]+X[A;2V7NL]/LZACLU=MQM"TII^*-E+9 MNS!4SGY^)!TQ3,N2:-AD@\.T$UG (X)!6>X9.YMU3XJI&#D^&^1:COS BZUD M'9]E9R,&5/.TAUA;#T+X[IDGF\^MAYU<-Q2D7F#5@DMH-"V%@J& >>+IP3CS MYH?SEJ.:_7[,@O%A!+;TU=,<>H%9D P")0N>'UM!]W=\8&$6]3YXIU_58\R/ M?ZMWZH%F\X2S>1;Z?U!+ P04 " #-@Z92M?0D%LPS "2&@$ #@ &5X M:&EB:70Q,#0N:'1M[7U;D]M&EN;[1NQ_P+HW)J0(BB;N@-3C"%F6V^IHVQI) MO=Y7D,PJ8DP"; !4J>;7[SEY!S*!!,BJV)>Q(THJ5BDO)S//_7SGK__KU:OW M/_WM[2?OER^__L/;U[O+B52=MVM(T9&]MWWTWI&FPX_>_?2K]\M/WE?2M&5= MO?:"S3I9!Z]>_? __\=?#]WI2/\DQ?Z'OW9E=R0_D&^'".G*9^[(] MPZ_ ^?)7M\7NS_NFOE3[5VS63W_[\440;E:>^/+R M#9WDT%NU7!,?YESL]V5U_]I+S]]ZZ_U8W!/7;'$"$_$O+]^OBTM7B@X:NB'Y2P_'?'>N'UX=ROR?5FVW=[$G#CZ.M MC^5>?/10[KO#Z^Y0RE]2*_'S;.6)+[ 26/NK+=RX/U\5=QUI7A?'A^*Q?<.& MR/P$3I23Q=_$^-W#H>S(J_9<[,CK/33%V2"5V%^QA85=.O+&8P/Z:;P. M8!!/C+D.\3NZ[1!N=83?=?7Y=1ZL8_R[04UU8_[M+WZR><,.?N;T23@R=Y#P M[W!N/PC9(I]V\BA;]Z:7DT<;OMEGG#R.&6TM>T\R?YT\]][#=3I&^BA>YW+Z M,&-K>?+=QV.W#F9\[NG],!^=/XI3=>O]+'J.:Q^.;S\) G;>.#UPPF>A?LXH M;)D^E7.'.?^MIYT;MC8KT210_QYL'^;+VG9-G4?0L3R[>S+AT>?P<^P[]T7TC@U$R#DXG??KY MTT#G]%&RUB0-_X;.'O+C,6?_F?[W%+/G@77N+-R,[?SIYO:SD%T!8_H$3FB$ MS3[=]&',3]>8/DA"=@F>=?? ^1+K]&EV#>U1T2TVWXVO@LV##)7R4W;/^T.I M@7SG0!M@CIN4CY;G3"OY[@??&PX53@REVR+;^KA_PQ6>:!W%(1\[8:K)=S^\ M_[^_?/CQPQ?/!S74F"5=/ NJLV$F=I R+>.['[Y\>OO;YP]?/OS^F_?V;Y_> MO__U_6]?C-G\&?3)UIM$TB>B/&:4VH%KN P$?\0'\SWO?$$)MU!<=_NC?_I(%@3E=,+5Z.[&H_AVEQ@KDC,8;GR]M3,+EJOOO/>GIORZ 4!&&B;P/=@_E^),TWKL#.96[XNB] MJYMSW13TFHU1*+GB7J%QH>X57P";W!C>N9,@R]=),AR-D\:K&Z\[D+%'D2P_ M7FJ:&(M_5Y_.1?5H,"CGT8; ):*QU;^<>['#=1@,+[:QEF@1OXDVD[(BC1>- M!K9>1D?[XY?WG]Z__;SRY'/PM)M7-,0[%TU7DA:D(I[<3 * 7$J'!'A_.A_K M1\H9%8]D[.7OE^.CYR-;V61>0^Z+!IU(:DU(?S]]TYHR8#,EZNW.$1P&E\;$A;[KE( M&7T\?K#\]:!A'2KFR"ED.RECMM#)">(3>"C<]Y^-S#!\TB')[>]&/:P0G@W8,;#[>NZ.8_)6,BN@SJ:Q/_E >C_",;OJ-\Q)K[9Y9I,L>T!D?R!Y1RXY?D>7CA0KJ\O\ M56>&.@%@ZS.&=W"R!!YN&P]&DX@&G7'A57;TRU^8HM@I3PT(MSL2NIT(0%MI?=866\FR#.YI]'FO??C12'.%T+ M>]V?RJIL.U -X4*O9N\V-^1/0\[P#(& -. "0[,;@*."C7P/K L_A"WM2-O2 M3XM[^.T6*3"?R,-9B[8M[ZOV#7WY!J4RIYW7NR4.,R_(%MEYH53NU:5#SE2< MRZXXEO\%EZ\CS8G?P^VE@]<'6@VY@VW/IXBI2!@WFM^]0_&54'9U(D4%.A)> ML5U3;G$=-;UK;#WSIS9.@]UCTX40.*6SO+%A$*_'58GY/"0W^+FY*J?\Z1VG M0XT.PT4L*91Z](<*I14*,&Z?<:ERNG07L-S.37TJ6T+?"Z?"PC<333U5F)D* MRP)O'7"%AI35BLXOM'E8S+E<1I<%M#C MV)GX:W.#]3\$SEK*\?S94N\3HTF%K1>F MP>4>R5=RQ.$-+\^DFM4_@TAJ[CM8(*E:[AYA0AJM2%S\W06H5YSJ"TP+$U+. M6E7P,N>KEOYP-Q] L:BH VDN.\/4@/X8'X\%K-78?S"E'(Q9D.*EBE>I^(1 M?LDKSL!\ORX1QL8I;1^5[? 2_MK4E_N#:7K!>Q5VV7P5S)CL[P7N)H3?C$=V!U&,'(]9)A1[['!>A M?4S743.6#N*,4)6$&TR^X8MB&IYV;+V-:JBM*R>?M23H%U] M_95Y.)3PX&"R![B>J ]U1QDOQ#6@@U^H7.P>\P5HBNL-2JO-8Y#&\P5D'$3\ MP8VIOWU-VY[D8%H;H=O=.<3U3CXJ)09>Z3XZ-)M=3I/U542X73AWI!UMX7 MC2\9MV(^C2S>4SM_HR09X2\WZ&J#P 5EL'<$;@85?"-NO-Q?0+@L'J:8B)#I M2( D#Y:[4VB*IXS@JSD_:=3\"4[+< [EDV8R2T9(XW44F&.+=(2?J3<,>?N4 M?+*=W_QK8GCN^,D;VI6I=.?NQ!%Y6,G&YSH F"C_R>7'W:6A[[;8T4WIANQ* MUTMNT'RD'^K=H2BE+<*GX)>01T0>\=Q\/B-. M_&0M4D-L;L4\GQ_>P41+=BL#\XKGSIC^M/]39'&.!LDWFRF/M\,!JI;^3A- MQBY@$N<]]F.PMN5+50//UEE,W9#K+$,^XM4[D)\MB$@PW8EIWBT*DQM22_H) MN.K/R:)'"X7J;Y+)G0"A2!\Q^ECTC%:H4-1,_4S8VX*&5P=N#_[=")4TF;[0:G]+9H2SIRV6FKL"1.^<%\TSI)4\VT M1@9^*JKBGBD$)WK]VA[C5\;O]90\@_IW*.&^[9F>61S[6B[,][^!L:R @7EG MFD-274[>BWJ!1F5<-NH\NJ>EI:9![OONH)8B61X*7S6S^$R'=$\:OYR]ZM#0 M)VP7JR=EO46R,EYO#.W_,Q*F1WYVT;<882SW^N4UZ1;X[HQ:0;=TD_'PO;S) M5('0IX:;(1Q&^+-_D&(OTWEN4"A>E/0&@TB >>N*@.F$WSZ4+>GM3RZ,>7[K M5F7'\#, YF<2(9[O>4X#X&D[4.U0DIB!>8>%7P:0F-*!?R!)F M+(] :-IPUO3B MEV17M8#>YS635CMKD^XM(GM+D(XJ4:VP'8&=VVP$G+W:[NMG3>4VZ M+8AXI$G.$T%DS&.05"RI>$O:)Z._NCA4 )_K8[D#>JV]/PXE')?VBH!>,Z?S MUY&AR@[?3D]%XG=8N-<-ZD7^ GZ7R70A+7>5!G7/Y[KI>I)M&/I9'(,PE2;N MB5QYRM6+O.G2\=34CAS)^0 B >\+'.'*^_!%KLWF@?:C>/Z;RS8;+O+$D"P^ M6NEY?33+L 7!TQ55M[9,.%GW,9C05VX0JTT8N5.!I/6:A<+M$)IV7S2I,JC-!:-Q\56O_#1C+^X&DT!5:R];<%1=!NEG[TK&E)IM?1&+(YK=, M';((MA5J_&6K9YG/9<_ (0V=LB_KA=1\.!!0OUC:V8K^!=\^_*9!GGA!"D\6 MB8PG&F(DI*.)C89! ?,,?P'6U9 #G"RS0&[@ 7K: WOT]3U!_>^&%#TI"VR> M1)-D"U)ALL3G\L:>3#_495\N\VH8BD5/QP9EB3"'/R;_[@NJNXE3N<&3V'MP MWH=*FGXS/*5^G,\WSK)4)!+1R(AD_T*8H3%EB1+KP;E;;AHS6SI5,@H;5P;U MW!!7:,D=JLB#TM9J*DPN%>;M+V]4G M?O7*ZBL0$VX$@^T1.3^+PD]F,(B%GTX%&#Z-M JOK=O*+0KA2.YCH_$@U#=, MVB7S/5#Y1OA1E-HB;I]%IB?I? 4T#X2_8410SDBED#(]#T462F0*OF2R<'&& M3,?1)^NVDDG1ZI#I:NV_U=X7TH &16_A#=8"/,_/3 $UE^JV$0)$5U%%^G)Y MZT&5F*Y;(^<&"ZG8_5G5#T>ROR XZQ^M+L[-Y"-/- M@IL=B]J<=\(]T9??+]"\1R<2>\C2B8%)3JQ^X7I/(3"+/GX593;+-J!^79$M$W@ZMZSB D"U&RSO3>#F^ H52D5$5 M-=WRAV'-"1A_&.F,0G%83;PQUR9BLW 0\1EFHTTM(*O8W!L-32J)GP5( MJS=[FHS,'B2C(&)/B&6E[[T'(A8GSX^D!7NW(UEER2A@ M>#$=8D9:Z6PHK>>P/*"J0C MR+M.!K>OL5W,.F*EHC$=MJ^_HH]97PF6X%PZ]#&C*C+?GC8-C =;GK"?1?.= M-!(,['QIVDO!%MCR9)9@G0C[8I%2&)KU!Q4S[.OJ2*/S%-%*.NZNC78"L[.$ M.VD*L\70S]R^9&6;.U#,LM3I>%6(.+*X/3;M_"QUFAO3=CZ.GDPO=7F9H[P> M:NW#0-OOVV-YSSQ/YI1N,(%@ ]S: HEF.[=L_G564%)V6F3S.8K"@BHLQY8Y MG2?FL64^@R47HT_?L,QYP_)DO0G-Y>HA<,J-,,>GGR"%/V(9,^TMV=GQ.C9? M^F[77(#IM<41L]9$%@F(),*\?%: *F/[N1NUI+]]B1& K*8?NA4[G@JVWV"! MXH0UES>,I,!"6<%.S_J593LT9$ ),C]9*#&FIX)GA+FIK&N3&%>H=1=G-G[B3$_LY,, #T\K-QJ^WA%0G]J^,%&;B,KE@$N!FK5D'"8,+N,N/&-J.O>J M7QU%-9X@+SKT,#*,"LR.G#M;,F?@N^W /NE2$3*4 9HM 2(:];(WV&L&5U>D MPK.YD5B&-DJ^E2TF3'@GLJ?@ODBTE0",H]^)A'&3?&[]H$\^61J_.Q35O4H] M%\HX33CKRA/+J<8_43/%TG"P6$LM(K(@V]>XAO=P.QI:S#F&71Q, R#:+4+J MUU?XBG*KOW*ZOL/ 1G%OA*B"&6GI2;C1L1OEV IOL1^X'<6IA=]>)GW"#7-^ MR&O2'NJF>X4BUP.Z%]ORB/5T])K@(C"J-?SI?)9A" PVKG879?6"_0;-S^PP MJQ?TNV?2S5UST:>;K.>?O,;>G,LXZ4D90:/V4PW\6BWF)W5DX_?1_:JC(+<. M+^ZCB>H6S(!/[!,PS*?%W@P Q3Q>;Q2>&:]9+TT9'4SZ3T9DM+\)UBS.QD:/ M)A-$80ZW@N)'O1'9>C^K*EH!7\/Y) .TX=H49OE?&JH8<]G4S(?^"0P;ID1K MX?'*8C1C-)XL!TIK>>3H_;29VR8(5YAT?RI-!P?HO4Z^.*"8K*_7:AQKCQR1 M?$,VK.-I<-$W']3!A.;Z6K8"\@#S*VF1&)OH)2^X8U@U^ N8UL?NTRT^%0MS M#]VNC0'%9"'Z*!PC#+K,S1;)^N^1EQ"Z\T=8CT)6&KIRW9@G="?2VZZ_)Z;1SG7+.9NU(7T$D5M2#S:Y_\1-))U6)V V5X&2@>22BRB8#C2?C MW=(EO:$>HN=?-?0H6A&CU-!C M\3#W\63KR(FK'<3N7CD#(@732,LPHO-ZNYY/'(EPA%EL!N-/7>4KGP_../V MW'GU SI%PJ_XX8Z6- &;I;;J_M)00Y^:W*0IZWT_2H=^0'&[YXL5PR:P.P'- M!VN(;6/KB;]TZW&VED&]@>-\!.6A9 H&=;S/W[2A-%0$ZS8QIH';OS2[0]$2 M]73;$NY%T8AD'$$,<\>1TS<]V'$:"GA!/I1ZW3GS?0JH!?^L4&:,K&X5UQZS M1F_00Z4O8"%8LLVH'!0:Z("AND@SZ98OI9N?F MTF"+8LY"S"ID&.B:*)<6X,?1)]NEI&YXRO[>Y7)-O,UK<@M-IQ;YUX5"R6$@ MO.5(LR8*E@S2BB)ZL@2OPA2;3+6C4;O:C'Z;9'.W]^N3+1,JIG;A6:Q?ZQ@R MV9LJ=7M3S=:/6!B@4-?D(M[2F646E)%(!Y,YGQZV4E2=&=781O"D1TD,=5N> M8#9I>UGHF3O\1DLP:U-?J)TF"&4PG5D\(]",HT]*QVRS+ :BEONA#PK$ )E) M 9:)GEO'FF7Q/*L6]- %8M&L>M*U.B%,>HV,>$TMO6+S4U5,*(1>(QW+C7'K M:GVJ!0GWR:*B31TK$F']>M CLY2>T5^R)YK.QED*:/TM58'[;;AN2X2,S- S M,.'.IHA.I_Q:2 :FS/0C6P#/E\8I?P9WED61I3L%7Y>C3;<$F4^4L M>Y?+-8&=T/9'4 H!Y*(]+O4B;@B9:FB\Z) DV'3JB!7^:-"Q:# JN5WQC6CH MS$O#269/,DOH8VDV;)H*ZQ?KWDM>1"L)IN?ZX]Z.Q0/RBWO43JL3#?#,?WHF MSL\%A"I%)L#D3ERJV6)I2V@^"=9(H BFWE[X>!R#,LC=$8@^"5A.)QK*"^?"YF9]Q7GMOOO7I=-H9 M.BV./E5X$,S(K^V=F%JN/3>K9VA2-H ]5*AUP8_S!CN378#^J"PC8X#_S>3J M#<]#RW\?DBS<^,M$0Q8* WWBUL*H"P\BRB?3D<.-FQVI9Y!$G!4E9M\Y,"%N M1*[B5:<32W7JC1/(57+MGT":-R6SJ=&(KPJ+N@Z3N1U7V*U9F@)J EL7.K@H MCRH/V+H$BA$$W+.;C_IB)A1J\,6RWFOREDZ&N ^',/>1?R%@P+TMR2O'"5EV#;EWNQK:5\%P3>S+5]JNN MOH:_/=]C9KR"9!V,^1E"?T%SJ9PC!-B[LJ)65# /!\++42]\5RY#"#$N@P#M M;"E&9:=!O2H@C@-'X&! TOT& C>XB6BC.=3>+$1SUTAJP$K"DDW($1%2?3TC-PQ\HG,*+DVC^1[M+0J/7'IH8#[AXM,[F=S)F_3F7)J!K= M1I@K,'P0'34R1Q^EC/-&^&"!:,@[!Y;>3/%QV#['D?GGIW.:)6DJ MUY$VON6@LBMO1XY'CBB[I&>OP5_)J2B/')7V)8=(1DZ.G:"]WEGU!0C]>@4. MD7)$_C<.T10XAK\> P+2 %GRG :CGAB0)6=IH--S1[G_'!A R2@&#@L*+&!^B:<^\&C&QI,H>HZY$1XA=$X>!L%S M3-Z'H/&3; P!QX^>'_TG#>V3WP" $P;N3L]S 7#"P)TJ, : $UK$;KZ@,5G8 M!^H0LIP*82H6A3!<]6'7E^@49@-J-@DP\9/I T=PA09$)IARK JB?1(;$=2( M/PDYOUQ[7VJ[N1:&"WH*" EE7U;ZX=*QJ9FNXQ-D%UVN*@,[0G3LUZ0]?UZI5^ 8W&&O9OXSF'H=G!K MAH[,V[Z WI,C_*A9!E=LZF7\VO7T8VJ--K!S M\D"O-\N%9T4XBQRWAI$H)K#Y5B*WX]:"J0-D(!A+LFG]#.29]NN@^CEU'F&D M:[ZUGMG:Q7\/Y%'D\+1-->14=P0>Z\2RYGL9K7G%)MWBY=@^.E54,W)Z%];> MS\(1][4N][+327W9WM34=LK/ICO(YALQ9B&T)43&S@D1*$S"N866!P >.R\HR9N2@6 M1,N57GB>O6Y+54X8APMNC00&TEL#8D9P0]-R*>>E..3>0'I)K]/\2V\\.)N5 M;?$OQ>[@9K:A/LL>:,^($A(G\\,S"B4G,_TH\62[DSG@9-ETMCK,<$-X1JW] M78WLB:'XF5/,R)\.M?PL-6P//)S[:JC?_2**,JZ%0C*$BX9-!64%78LY^B"[%:9>U[0IL&"%:12"348<9D$-/\Y&+NL%6BU WI4F7%&R;0V;&9PI[<$Z!7'*10D6NEV X2UI2F8VCLAOP;TA#1_U6W!4O]*!@@\T-M M NOG:]ET%WL"'R<<,J_Y?,MX7$.BX_V[H46CH?OIG;MUD/Q>ZLE\L,# 4& - M3$B3[@L42@445.R_4B6[)ZQHN;629_6E>U7?O3K#"DEW0W=#$_^V1),2$W=D M1==.*0(6-2MS6VFZFJ4CT5BUE\P--R,5+0$UDYMJ5C:9GS-#S0HWV20\1YA- M)NPXU"RQ\H_2&GE75_O+KK-,XU:U,G\=2N^7&'KM_58S@XIF&-@2F6W!]/F, MR9YG $+[4&[+CF4KLAP#'2D5C4M-;IO[C>=[2Q2,#*I3%["SN.!BKYVG.ZSX M4LYU):H@&-XB9G'>H@%1SP$.SG)/Z-@H/D]U]>+]!C%3X/K?\HV]VQ;B\-X91 D^V. M=B=$'5WW85';KL$"!; @&M(M:K%HJ6?7<4>&]NOU:>G B>YQ'"#X"8[WH<%; M4VG&ZI!XT68!Q*2"ZNDUOZUI#[IZQ&$)2^FPHA$]2!39'QC:@IM@4R?T0RI5 M[@6:IC"X?#1U2_/6U]['(\$29S#-%Y@>!FTY$4T*+NA5J8")J+'$F1E-[>?I MAJVW:TJ$D#BR2M/R:PD7DI0'2,9D_!VI$%W[:IW,6\P/ZF??/]>?UN[6'"TC?L*_P<1B^V+Y\X;-$&O%M M\'+%3?@%DFBDYV=#*)@/\[3TW 24%X.E0)%,09']6M;''J(*RK'Y9VKV5J6. M Y.2"S(AHXACB-95Q9.RJ?59X-K:2]GQ %<'#$HE>LHMWZ BN@AC&E11X,8E MU@VJ* DFP^4=MP=L1'8CJ/I)KJ5&JL'-\ OS>S*@/BP%TUTSS6DVY(F_CDSEMQT3 ME])PQ&Z;/3 =ZW,)W#6E&O"2Z,AJ/!C4N5 *K2B0&*K[^'Q6?8XPW\ PTRD; MIGT2%A)LRI:RG O5?65G7F;$ 0FHPH>^DNO@\,W,"S,P%DU#??8I%V]$+HM, MR+RKF8+-Z-7SI]T@'>=D]9\5FKIS.YA\5&Z6];- MJFR'H"PP 1F/X3T ;$_7$.UDHMR#(&V>QM XQU"/+:E$<4S.WP HB=*5_96@(7 :@ MLY+ O5V0/F]PL,$S$E%#>1QK[PLNJNQK0M>; 2K*[-%A3=+%"^JYDLV&U_,( M]#2AYFC1[*&\T2KL;\B>0<<&!9$[,GA:1.]L0-%7?J/M(UH%%J5Q.K'"T,P3 M/YX,=40SLBBD9IZ$[*KY)GPQC'-%7WM=+\=F 5.Q#ICAAK[V8NGO,*&K9E[! M?Q0/EDGEJ[RWN"]K#Y5T*8B98X2J'?,]\V8B%L=6:SO:F\K&$Y(%$?LD M$NZB 1;I2AC+.D\6[$;^XYOMR M9\LM@VF<<@1SRT+U5.6X%@)/9JV/, *XB&EDCCY*%G> %E'U-N:(;UF>$A4\ MXP\?Y!W#N<(JL"6YW38M^OI7'ZR;I1F:O-C0; MVMV)%C.]\7'XCX?R6.S)\7Q XO5)R2'Q;H@]]&:K>\?"MV92<+)QPX""0)"Q5;%?FIUN4WMG@/A)<9?&(KUG M=K6-&Z )5C#?A9V"&L<%KHFT#2/=Z,).DTE%.;O%@:V6_E:T-K=,X%:2HT!3 MDM6@-FIH@0J4N2#8Q.RTCX5FCU5.]IPX(R5AYL[Z5: ^(CG<:L[>E.429&QA:JY<3 M95_[R_&1>UR95W +C]/[R*A@>YONL@0U2YY/Z[799&G" (+*%\X//[)<+'<) MPO0SP\+7Z8-H9%&6MMU-;:-+%=@:("VJ+!H MU>BC=)F!H:&G"ZH1]?=&'6ZT-(L]NHIFAIS*EN!SV%]V(H]P?JS'7N4J(8)9 MDP!9W$KKJ*B;D0$\T2QG<[<+,&2R4.02T61PBEZ*&0"D:43-@.@"*OR\)Z'6 M% L0_"VP4CV&Q7?6O\4%;:D>\#E==IAT-";L??<#6^M]A[%$KM2=ARE M^@8',.<9^LS/K7;= SF^P>DV( &F1[#R/E:DH= _$&GI").!D3 _-3LR5,F/ M O[65LHC\K<'5B10@L]WM2 KM['"OF;\R]YJ!UF3OF*?YGC&?J]_>YH;L M>J/J2)4 F-43!L7CC3\_YR]+DT''7.7N9Y>268_77!83)]XLD/!9+CQ7K%3 T^ *WA6T++[1D;1[ M?138@FZPWS14[F$9&HV7\2H&VIRAURF%.MT9ZS5Y?.PO@#O/-ZF>L >S/=27 MXU[.7PY0Q0M4ZA:?K9D7+:_+H/\\ZXILP=3S?$9OG2TN*$(W]%88^5B2BZVR M-_879-3G@<@FTK"?.9*O6'JTCDQ$R_GWQF E&LRJJ\$XZR)7L]:9RV22F>K8 METDFV198V""+N7QE]YTYV"V54]R^O^&D!]5,ZH%W!\RN[%'GZC,R9E5TH@^+ M11_+1C19H4+'H&"P #(DCT7.D09,^#3B*UYO1A)<%A EM/6#:;UWAY+H@?G? M6>X-96D?D;?LM?X%BVMN#2&B=:!%J8O.8I/J;NA51?5$%)T=RY, N52XM;B+ M=)V^7/&Z38$DRGK\W!#Q9_URCOU.6@LZ*!J/6?]Z!3BY&\M4\QHY)IH;D4Y['PI&3C[#,>ANX>N M"4TV0K70'2:RP'45YOF&DP40,]I2X>A3908PP[(&2VJY@_2=DA7)5;S]N8ZQ M_JYF-4[+Z#MPWH^7[9+9S51C9FB9])M86,J M@2[&=#T+X)=M U=4HMO*YW0(,09A=KXTL&BRR&PTO;FM]JR58K_GQBE5^"R$ MRQ823D<7*]!J+%FVHJ4;DW8=92B[ Y5P2=67I7 )S4RVF\$26N8R(VHM>!LQ M,T7Z"XS]1VY+L+]_"3 VW!(K=ABN8>W]42YIUV%)S9=N\5[3*U7-ISI]#F[ M_+MD<4&(NU-BU2_W2YG46]C@2T"9,=II;CD)BT"3_L5W\Y.H V,'>^ZB8:Z] M77$$7E@TWB,I6(6%O!*B [K\8(>.N1L0S.H%"<+=0H!H M6-JM]T0O'.: 9%%QQAF9L*3]=U04[P;62.-_)MWRA723,%XBE-AKMVFEAM!964PR;E6@D< -G]$@@ M4+Q:>LT/[$0'39O89R:JXO+F3<83'(N+U[O=!9-$4=T6"7$WV)E M7QJL4/W8E"?B?:)FT&5[+-N#)4L_GD[%LU!/HHOQ8#DNVF-3WQ#D%8OF+^=6 M?F0#0Q^[LR]XTL,9$>SK2]M[L#<(#%$Y0/=2LK(!@_SY9(JMA?P:U%!R\6&1865N2^&E4K:WO8A2C-Z[@>]IF8A:@[EU-PY]?^L2 M[$ML!6;$-6 MJ\/7Q:3L#1%)YJ*BQ2E]F%R]V3,%P+^!SP;F'6( !Q3WR2A MV__>)Z&$_*)%P7M1:8 6'S/Z&4?BFJ/%UK@A1X!:*<,M)-.I7]048#%0S/PK M=SP0$,1:;U"U*[LQ '.XZP."3 MZJ!$'CD%3/!1C7563C;MXSP@38)0TBT-C M&2.\RYQS!DI_G*XWN3D%[ZMJ7#(8ZK)8*3=Y.NM%P1FY M@1A,?0OH8Q 0(2Q7=@FFA,6E0.B.:#'>G?<%,^G6WB=R;^JUR29=)EL5(AH# M[O+7^/)>^2\.+P5L)D@4K/AAS+XA76V;-IN?3:E Q,;>CMLUK8*/'$?+-]M. MPSBW@D-%R63*/\QP"S@47[JRDS_3GN0L^=&0F': MYC,K0\>E+W;[R#NQB*I"M3N9L\7Z%]'T0?!]L M^\#X%;@1VT&R&7\ M^/C:0ELW@#XJ24J47[,M@P-9EN'6L\)XG8>AL8SOV^^]3_66-)WW!6SAIKAL M+=L,G2QE<'I9\ARG%SKES^#TY#)^*T[$=GZANY5H__RNV-B,\XO<[[Y_?G(9 M[K.+G"*S?W:)C+8^Z=FY2Y;[9Z>6\071VVR'%SMUT_[A7;.S&8<7N^5M[_#4 M,CXW:^__?)R?(V&X1?[&P33>@=[1$E;L* 0,P61[Q!UNS!!\$KCQ531X,*%( MN66-NQWIX++)L9_TLJ7.P-K@LLEEV-E\NI!-7+.M&3?-75LZN&ER&BL=X*MV4Z.+XH?X[C/]*-#=SK"7_X?4$L# M!!0 ( ,V#IE)2G>;_Q@L "HT . 97AH:6)I=#,Q,2YH=&V]6VMO MVS@6_;[ _@=N"PP2P%;U?CB= JGC- &F32?C+F8_TA)M$Y%%CQY)/+]^+BE* MLDPGDAIC6R"Q9>6^>._AN9?RQ_^,Q[.K+Y?WZ&;^]3<4L;#8D"1'84IP3B*T MV*$I27-^:7KU%=U
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

MH''-O\=L1IOX?(!;ZW4:!"P&>[:"S5P;H"#1RTLNGW?.4%P0D_)8HFFKGW ?@!L8 W-:S[[[I_#ORD']IV]$0L$&C[NOH MPL]++WD0#[-)/CQZWIH]5/_CSS1(D^*3#_P3R>OYQ_\\_N;%"SZ=/7[Q=3[' M<;;!.W,VY9.7QP3P#PG_E'SEG_]_MKT-P1HT9X?>GHN=6=G:DG#!;)5\6?/] M>^?\;*K$?PCHE9_HQN\X[C9X9^[6LDZE0O9+;ELWD,U!\SN@&]:73#Y./E'] MX'^(HWC#=Z9XK6H$-4/*U+8/E8&D#UJZCW@F.#PG9G@/A4! MJHC+1$,47Y?];?'X31VL:IZ_Z;M!'$,=[L=0U<=/JT3W M.4NBEAVB]N5)$OP<3D]2Y4(JU;;P((^%[OENA(>CN<-WIKE_2;U!^@N]8D5O MUWRJPT%Z3)\X'GFF_&R@%:WM-W&0>/C.D+AUK51=ILA!MK*0+$\Q;'.ESX1\ M&?K#*2GE8^;KY;WWHA$4CD /6Q'H=7'N65WG6"9JHRZYHF_2V)&8*T1+P@HX M(N=BO3 Y\0+/_O$K0PBZH=<.378XX#TT![RQ2LL UGQ+:4%D/38VA-0;^N# M1#3"\>]1*_Z=-4MWJ1>GS:V72&:Q_3JACWX8NM.$C2!2A\ZSHCYFM2]A3+W M_S==7(;/-)NF%\"I;BPVPL'VD3G8WJIR.FY6Y215UBV:YLBP; 0I/72-%7&) M=:^!F 7MA\5&.%X_,L?K]ZB22DA2<@P]TB\)76Z"*W^IV>D !?\,Y[4ML0@NX=..6B)X4C^R!C)QZNK*(-D MA1!1"@&:(T5!)"^)9$4Y(3^(^:'#.I3?8B%V>7C!C>\ M[B&7!5,(?9ESG,ZFL+'>B$"$#@W>I4B*<>1%%,MQ"HTV<,A\9 J9 MZVI17WE#^_+Q:3 M553M/N++>L21ZPNZ.'EE8S/6$E^O*;]5(WP\YML.62--D^,'?G347!/)'>& M]<@4L#9@@&KT4I9-THBOP\M*YZOPQ-4D'#X&@@2QK_F'<[Z ZL=-PD]+#7_* MCJ]?9)>G1\7O$:_\P5]LBQDR<>AF2V+6#!T$!U8K=(RCX6-3J\'WK95*=O<1 MV1E#L^E7.886V6S?;PC)-G2$6QJZ]U[.ETLZ3R]81<212B<>>V5Y<(&&24U' M.L8![W$KX-V6)KU/QW3:PX@A'11105JI8Y2Q^X,,#_P4B_X1MK4+D M#EUJ1:ML\/V9?JOV([$14\C^G(O'3O1[.,L26H,[C.(I/HYB-G<4"RVCE^;J&#G-]=.(1B4F5 MFGS-TEM7#&3BT/@=*B80A=.%NDLX?^%_ZNXCQ\'Q<2LXWG9$ME>]RFM7--T5 MR=/Q/B\[_.]H>Q FMJ5;'X%!C Y=JDBP% ) \=T*%P)$1]O;SP0V9#-F(\C9)4-VS&4?FQJ:-/:BJBXO$\3K>@#ZFX M'DH(9\Z3VE8'Q/30WIVJ8\,OWYE'CV&V%#&;M9YMZ'UT&2ZS!6)>_%K--32B MP5'X<2L*WW:\T[Z29?17;'V?O[(>*GQFA7)=^:NU-T]%'/B)52S^X$M%$,[B MHY5O'SU!A Y]=(!"F^!@^L043'^[QK*LI,K+27H.CUAVCMKE J1IOV6)32!A MA][I4&+,)@L_V/#32O.[(MEK>/XR#S8+NN!HCP\S-VG>@YQ[,5^'G["YBQB* M9F[0B ['UR>F%I2_1XU+&4J%D:HT4A27P4NI0-X %D7R&6 VHA?K/#?6CXB= M0/(.G=BA-L5ZQ O/C__.EPV=^MJ46HH7^K+DQ"1 MAE2);"L"\FUHYJX54;^T88(#V!-3 'OKT4O?W]V=W]_9=C)DSM"(73M9XUP< M5IZ8PLKBDSO?$9[9="^$P-*$CKL7!WTD[^,M=5#L9X@D.P+^0U$([ M=NU?89^Z1? 3')2=M(*R;>>]NU4HF^KXD?()A%?LD\ADX,C*]PDDK]#*[@D! M!UDGIB"K5@,N>AZB4VC6KCU?>XSC!,=*)Z98J?SDVVU]<96V&VT^I*'0HFXY M',A[U;O.Z(;PG1J<6%5853B/&@![K42N(GUTMI M"6<4^//7['_OZ4MZ$FCWQDYQ>&]J"._M5Z6J96&IR?5R:S6J2$J^YO_E>8C( M9%T\$ ]")W0HGOQVGM-H]&**8]930PN)K5C(8-O?_..VWQ (VJ$T_IIO" [F3UO!?/M] MP?ZO29Y&U0.XP9=@! 'ZTJJD[U*Z%C[);E7G)_;GEW'3)+T,JI=D[,2,:P;C<=!GARG9.D(PP\7N9NW.;V^W#NC] M;;"]F"AO/HNF=F%;@3"H![WS'2H0%[F;'4#D3K]6O9Q361A&W4*315[;@H31*NB@[UR0N+#4K%58ZIG&#U&] M)/,D-D3)6TR!6:D[+2:,/4&'':A Y3AA==*23J:XH-2LNZ#4NQL$# ND']LZ MX4/ZN6(^55YJQ'Z12#])\M_<&3I()UY95SX,<$$-_"64CXM\S4R>@M2E_,NE M8W'YW1&_A\"V3F&T"WKL,'4J?:*69N\C+O0E\K-+NZBNZ M]F(V0 M>JT9#W!SNB8L#&LXOZWW$Q:A$_HZZ]'UK6CO#KPJ1)_M2,>1K48[M MK9"2;27U.1"ZDE[N8GU;W9;\WD=<^$GD[ZCMVZY/_0"P2.O*'GW)3I)>'(@( M25:[HH]TNOEWR.^PK'L%HIQC4Y$N%"/R&]\"->NIN66C3(I7_J9)9:Z M2T>B.Y(%)7DY$-]Y'WGA C)0].OGH+U0WO;G7YIS[SJ]9"LOF>8U>_4HK[7<>%8*\DBDA[<0NB7X8*N M0G_IYZ>)9<_4>6G8^M:"H9VBRB4?V=4O MQTG9?^6:/+._-52RM*1(!PCZNRL2"<][[?9RH,,W;Y/EK@*=V#PDV4[2F ,( M7)X0Q]%%%*^\RW#)_\,_:CC7K]=#8N^>8>R]9^T:YOEQ1$16(N4E7^]%Q,6= M(_\D8TH26/HIUT[X>DHWW#F!O1FF#=]N2499H7;H*Y Y=^IU* M%TGD>X>R^P+HM_C YR?SVE\T*5E24J$#9/X]C,\ZL36-T]<;YO TWVZPYK76 MJ1()\GN&0;Y1F[RY@2U*9'_Q,L7FC;)4Z_)6! *@F_\B\D9&%'JM(@H6&]U& MC5>279>2IJ;6G[G.0^N[D0\=MM@ MZS)51$"@$[\WF?:109-^=T&3=U7H.^YT.R*?[0][^XH #?3M=Z=>9&"GWRJP M8W$$($F8_9GM)>9'VUJ7G2(.!)UB57;5E?47D!KKB4#2$#,_T#>]M^ [EHPC*0"^X%_B[90ZCU\OK33J/5C01]UE= M1=]TND(&:?K=[4UH4]N:"PW:%&-=@XJH#?2850U*4[);&O!=S'Q>IELQTT>& M8OK=A6(T%:MMRN3%"WDF,4VU'F'N*V(HT!>')"1D8*3?<6"D04U2RB/BARE] MC/,%"M7-$E4)'^)<6\4%%-;EI0B.0 \=DKR0$8[^?A$.0Z?W?^=B4X0JH+\. M8V#VF__XI),@,@K1[^X J5;5?8^A&2_'N@P5X0?H,ZLRO(FC9_861Z$72*N3 M+D/V7GM!=5/I9<@LNPYH2H\7_]ID%\J<1F'B+VC6,(BMNTL:Z[=V]9%1B7[' M9SX9L$P9,^-AB5,VH>4[OJILUN6J"$- K_U%Y#I 1B<&W44G#"I5-841RQ2* M'Y37-/(%8>(WY2N.JU\]DJ3.0W/2+Q/IIVV_!0-%. .*X5#?@J;59 -D6&/0 MW=E2[V&%FI'&>Q1O7K96109=!Q4.4]!7VLF)TM/3\F_'XK2KPR M)S]Z,OLZC=A,SQ7A*@(ST)W.QY2+.VE:QI8'R$C.H+M(SGM8 7FU<%/QUK6L MB!)!#W^W6D9&CP:MHD?=K)/85]".7)8FV5!2H,48T:FW]E,O$!N)P1(2,#@U,1H?:*HD-#F-^EF/M_H%RT:MU/#]0Q(*@/[J4 MDKA"@_]'ND;C.#WUXOB5C;@%4-;I"!D&&AC:Z+)7G5R_*42RCJ04BX$<;J@= MD][2)(W]>5K>Q++]@93RAL9^M& O;!?/(^0M[.\-'>LMF M8^?+)=6>-C- AGT&AL(^W1IG^^HEQ;U@)"N2%&62HE#KHE:$A:!/_VJB1H:' M!B8WK=A1-E]N_>,B3_\3\0L=^Z%HIX] :RV:\+A\#O&]=;$K@DK0UPJ\U=Z"MK;*3LH&>?Z,@#$:A.F,BHSM!0 M5 =5UW<5I'45*B(UT&L'KD)D/&;8*AZS%MWN>;BHZ^;+1.\OR?VZ9^*E)'VB MA/)U=4OQ9_9,U@6IB,! !QZX()%QEF&K.$OFU[O4B]-F28IDMD7Y0!_],.2K M.-R2IB*@ EUI&Q_MOW%KB R1# UML-F[7LU3<4D#+=Z@8@9TNPVIE MT4WLAW-_'; /%WY,YVG&HVIO%1HBXQ]#4_&/=K4K!22R<<3F56M8UT5.]GF6 ME5"1UYD[AX:*. GTC(/:JCDZ?8@,*@JCY1 M?H^A3E?(2,/0T!4?+6OW5F5EN>UK2Q$7@)XY-&V-D!& 4:L(0-N1U!L%MEFM M-H&7^L^T$%&TE,66Q:^<4=9( ?2A7SI45K1:^=E::SZ;CH31*+,[;<$(1DB" M/S)%\%M53AJF%[DR7B#G5,\'' MD8*R0Y]TJZDHO$O9^U;?SR')^BH%R(:6M>+],__9 M7]!PP5>OB+O S^@\\/3;94=(ACTRQ;#WJ%*AD3(!6>3?6!>(@D]#2UL1R(T7 M7\=W*=\Y)EA<852=/I!T>F2*3C?72-F$L,09DK8N$06'AL:V(A%AO>0R23;Z M9@-)GD>MR/.;9"'70B6%(Y*E.")9&NN"4&!F:&:+@CC>I$]1S'=8Z42!1,HC M4TA97Y,Z89 JF75M*# QM+85;=3ML1@A2?#(% G>>?P=%22BI_A_>F3MY?NN M_P?Q2BV0P<>CCQ_%_Y-$".5_$%^T(-DA6YLT2=D?'+ PZ_7(!]*;'$TGHZ./ MDW&9@=LU_V;T\6C<*[ZQ+C0%.89>[%1HZY@^T3#QGZG80$\_T_1Z>>^]Z#2' MI,0C4Y187Q,Y"%HFR0Y@H>3'JRA)?A('QG-\QY(?D>,TC?V'32J.G$\C/JAQ MX!BBD8(,0V^XK)TQD@*/VU'@EGL9V@K(SP44< $1;T0TBM=1=JJ/;2&-%2 8NL8)(1/%XDQ91+.'I.#C=H?=O-O [RTFV&.P:%V$ M"GP.7?3=B1")VL?F4+MY_=4,$,L?(?FO',R048'XH9.[E#%[9&:F[+PL/_GC M-*8+/^5_7?BA%\Y]?H!ADL8;$8N_7BY/O("OP+Y[HE0DTRD7&0T8&XL&8"M< MB54JB?!O2%96]G=9&I&*(ZP\DA=(1(DBL755*N(,T('?@RJ1X8AQJW!$VS5] M[R;-:W&K0\2T]I!K+1%:\^*8+^];N;!+>JR(7T#W6-3L)#>=/*R_^HV9E M^Q@9SQ@;BV?45Z>F%3MY)6521U:OCQ4Q"&AYFV(I#%:[P6:,#$2,C04BZJM3 M)Y9**8[LGQDK8@[0\!:U:4\G M"229GQA;\:VOBEX81Z1*9ET<"G .K>VV.)"P?-(*EF.G.@J%W/*%NTE2W@_F MDCP41!S:NU-YB#T0O_OIT^DF2:,5C<4QY_JSW"=(O#TQMLA;7Q6I[1!I"$]$ MBE1$)",.W!(P4;!J:._NY;'Q@NN'P'\4KY-.%TCB/#%&G!5UV!4$^Y)4WUJ7 M@8+U0O-V*8-L.0\]B<+%'9UO8G'70>WFH D2XTZ,8=R:NE2RR!,1GHI4R9S9 M-311@%=H\BXEDJ372W[7!=^K=T?C9W].D[LHT*WOGB"!ZL38^FY=12IQ)"*> M],C3D(1]8UT,"B(*[=NA& 1^YM$W!7[>;\7&!$E')Z;H:(NJE8+)@CL\DS*X MX^+2C8F"FT*?="@IA'%U'\,[[V7\^R6Z1,:TJ6O':LBL>G$%#:MKTUU MZ()(1O)T/()-\I0D3VI=)PIF"JW>I4ZR,?V5GZ3U Y0I$I9.3<%26(-*#_F$ M17SGS%ADJJ"CT+I.:@")1J>MT&A;U+&W$,2QUO[C$_OS/F*CU2!P1QL*6 JM MWKTV $>JUPF2ETY-\=+ZV@"YJ*"Z*T)1@%-H=N>%@F2G4Z/L=#^UW$=K+4J2&=]A"-R.#21'BJ8+'0"1V*ASZD M>Y_L-45"V*DA"*NN1"D/]JU+S8<"M4+#=JL <2*_N![TBM\&5H4N=$N#IDC< M.C6$6^LKLZ6([$Z![+97H=3^EW//= M3F3!TEI7A(*@0@-WJXC?*:<$=''\3&./GP*;[6WAMP[J)($DJ%-#!+6A-G+# M<42*A"1/66[J(3RM=:$H$"HT>[="J9WDSI#D=&:(G%8/OCV2<&2^.E-@4FC* M;OULF>'[E9+M75J0@+0F2D NG?%=*W0UJ2$9+D<6KH^ M4X!0Z(QNE90OD-%)!4D_9P;I9_[DA1;NGJ(X_<#\OR(/15N2W8*? HM+P++Y M<>(:WYF"FT(GV%+/)R_E"[]?S_2 ;(9DIC-#"U7U%=$.9HI$Y,P!*C93X%-H M:Y>%@22GLU;D] TP_:#5H6"FT. NJ..,)O/87^LW3K&JHX0B\G?;@DAUTG4Y M6VHA4@;+RI&L52I'X8$NE3./>2SK,OP2QG0>/8;\7/A[[R5?X)U<)K?L^RCT M'H+7FRA)?"VG[7_$<5J1WXR2WE#'2EE99J8N(F<7J^&+ LAE0JHB2%&&=;%! MW*MP4I=B6U(VG5CDRVW*_Q0VU6P)9Z4AA64,_#;4IQ)1EK!<:%3]MTAK72N0 M!"OL?@!:P3%AD=_@N.<[$@PDQ0KC=R^8[/1-UCI?^=Z#'XA]L]KC!/H?<718 MY#?9M&AJ W22GWF;>B_6+UZ1;"(IPRKT?9,R<*17Y#?>D.PK#Z8+$E1)K"L$ MPER%O2TJ1!S)42<.'-L5^;L31UD;I2X\\:UU24".J["RRY+ L5N1OY.>1*\& M/J7)OA6'5O.CJ#/\;UT<$-,J[-V].++M])0?R9#D(94:@>!0K&L9I",MKH3^<$Y1.24@$VS.,8!MJU5)"UK6C M@+/0 U:T(S%,G5203+9G;/6MJA)*OG+E#H7M*2@LM'"G4O!#NLB#ZC?,YL?S M^6:U"?@ ,?^TVG-[&6:!^2) S]KF.YJF6=WX3MU-G'I^L-(NT.WWD!"W9VR! MKB$[2(+D/T#RL@C_"7*^7-)YRD_#J+)G9WM))23D.B32TY1%.'-ZL>052=5V M0?*.-_D9BG-FO(M-NHGI^6H=1*_B6*3L)D"^G_R6\BMI%C2^7E[XR=P+_D$] MS7[8?@\)GGOFP/,[5;Q.MT?D/$G]E1!C5BXI"B9;)1,_).6)EJ)HPLNV+E<% MVH8>M2G7:LD!FX?_RKS#3Y(]V]#[2&HH=,LQ>DCHW3,'O=]4S=HFM"I"Q$]X M(=FQNZR8[&C$LB#KLE/0F&\6)>XL[P\-+)X6%? M$3" SG.^G]Z>AVJ[[3XRT- W%VAXCUK7=MY5/G+ZY,76=UQ+QI2D9S=L85)Z MR'A&?[]X1N>/P72=!9&2E;RZR\L:*OM<$Q;KT%%$: MZ"V;W?!U^L1'Y$FJ"]OUD8&6?F>!EJHJ]?VD2)=Z57](:7^ C ,S$8 ZNM42ZSD,VVOG#G" M5#)8)1[H!'>:HQLV-HCSFW[YN"!;-*A3$Q+<#SH#]_M4LEW;),H@>2%.#*$& M"CH//72H4D/"^,%^,-Y<)_B=:DZ!Y:&K7(A3WM)T$X?7 MAD2Z)U2D.R]T'W M[%U?QSV#CUE&4K"H8RF->K6):\@]M#35F>OE3&OEY_Y69GT>GG^S![^ MEB:;(/7#Q\OPCC4KOA=<9XMMO'FZ\0*^D=;/9%"1 M /,F:B/W[ 'X7^(12/D,?-E2_A3D.E_QGCT'D1ZD*#N1EXBZ=!"WY%CIG7$J MBK&U6NSDM0@>ZH2.#&D,.MN4H:E7_9AC>^GU=3JZRLA&R65VPXX02#E5+>MN70(1%#1;@!^NIP98<,/0P-'Q>/ MTEZAM>*K5^MB4L07H >Z%-,ZYNR$3V/9WX%8@LZL*D*(G C=ZE5F+_F5GFF69G5/CA8W'+D&Y/T1")]X?&\+Z^ M*I4VBC2D3%1=J]2SK@X%8X?FMJ&.ZA:J6S_YX_C%UW8]2!8^-,;"]551J$.Z M=8NG(E]Y.NN+P(8*G@P-;D,?96?\.1(;GH+:K6%#)$<>&N/(#?51**5,>42* MM(YL[QHJJ#&TO-W6A._D_(TN'ED[?#QG7XF17A4]O:_5H?X@DS4-CI+FQ1@I%B;0D2\Q/ORN2B]N,K8M&09>A^6V()FO8 MKY?\!:0+OC)-@[^#YRSS8+.B"+S4[+Q*%-$GNF>W96$!_.<((R:!'QAAT MA[:I'U0=9:?*__(H_'5^8]JJ;Y-][ M^ON=1TA6/C)VY']7AFGS;CR\EI,/^:>/^!?9KY/RYTGQ^^+;.K@B'L/Z7&6D MX/A0'8Z\&E<-&S1'2)(_,D;R]ZE4&TFZM$MSI,#[T!..2(CU_1(;;*11 M.=PXWQULN#%Z4 0HH--MZ+L &/O,OI ABI'Q$(6J,@JME=#&K3F8(D@!36Y# M(\4^@GOVDV<1#__I%(*,3XR,QR=@513Z*!(1GHI\S=+9[R,580EH,.(^-Q!T5=H$)8%\63$9'.K8&4(FX C=ZE2.2-4_0;Z[OY MM)]O>XJCD/TYS[;M?8[2?]#T>!&M6:^N$P\RDC R%DEX0QTK455;NZ(E&ZM\ M(U5^LET #Y225YJ2O RG(E8C1? !>JQ#Y96!O>OE:;1:TS 1DVHQ_>9G2"9I M1K49QU*8X5@0[H.0>E>")[IRF&/T8&0\:F@B&XVKY1C"<[8G2H M91PK@BO0>9W*<1TE7O!K'&W6;-X<;!:LK^'VCGBOLV'S]S6-\^OD4N9LG\V5 MLKW[^5)CG2*1$9.QJ8@)NL*2*$5)1!3%@QMY840NC93%B5TC>8'Y$1Q'Q3I_ MZ[)41#2@![\'62(C%6.CJ_K?39M :=OHS$O(;S18D"4_P_04-%PGK:E91>)?6]+S(&,'85(Q 486JY!Q:VV5I(.'XV.BY]HWZ^/*WN[^) M4X3(5>2%[LA"0<6AI;N3Q?FG\^-Z&2 1^-@0 J\>O+S'@'WBCI\58!N:TB4_ M(VGUN!6M;OFZN^YL!4N&]NS0V5[,=SPF-S06M*D)S4V0F'AB"!-KZU&J($_ M3\_)P9I+)&VB +O0UO9TP7>'S'6:0.+:B2%39K2'@6Z[)0 %9H;GNRX NCP[D?Y/OP2["M4PH2HTX,8=1]JU73F&QGD3;? M69>0 H9"/]B34$-<U)X

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end

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�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ǎ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

KG/'1WY1Z-_")N$,!/+P@4".* MK^7F. (/='-<';X5=%@3NRM@OO*QKH#WALYQ!)]W^%BA<[*#'+PK8+ZA;9UA M'J9MQQ:YAH-W#=Q'[N$#57TH!)!<3]4[ @]4]:X.#U+U5\!\I>JO@/>&JG<$ M'Z;JQ\=\3=5? ?,-5>\,\S!5/[;(-53]-7 ?N8>?E1B7X(.:O@GJ=H:H.8Y7 M Y=19]BV/5I$*."6!\X!5'3AC M_O6 4U83,4? T8ERJXA.(NQ

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